Citrus Sinensis ID: 017083

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------
Protein Sequence
MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccEEEEEEcccEEEEccccccccccccccccccEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEEccccHHHHHHHccccccHHHHHHHHHHHHHHHccHHcccccccccccccccccccccEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccEEEEEEEccEEEEEcccccccEEEEEccccEEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccEEEEEccccEEHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEcccccccccccccccccccccHHHcccHHHHcEcccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHHHHcccHHHHHHHHHccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHcHHHcccccc
Coil and Loop (DISEMBL)
maaaakdsssggatssvkgvlthggkyvqyNVYGNLFevsskyvppirpigrgAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIkdiirppkkdtfndVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYvhsasvlhrdlkpsnlllnascdlkigdfglarttsetdfMTEYVVTrwyrapelllncteyTAAIDIWSVGCIlgeimtreplfpgkdyvHQLRLITELigspddaslgflrsdnARRYVRqlprcrkqqfatrfpnkssgAVDLLEKMlvfdpnkritveealrhpylqslhdlndepvcprpfhfdfehsscteDHIRELIWResvkfnpdptc
Flexible Loop (DISEMBL)
maaaakdsssggatssvkgvlthggKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKignafdniiDARRTLREIKLLRHMEHEnviaikdiirppkkdTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFglarttsetdfMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELigspddaslgflRSDNARRYVRQLprcrkqqfatrfpnkssgavDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIwresvkfnpdptc
Low Complexity Region (SEG)
MaaaakdsssggatssVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered region (IsUnstruct)
*****************KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESV********
Disordered Region (DISOPRED)
****************************QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP*****QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Disordered Region (DISEMBL)
******************GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered Region (DISPRO)
**********************HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	377	2.2.26 [Sep-21-2011]
Q39024	376	Mitogen-activated protein	yes	no	0.986	0.989	0.831	0.0
Q5J4W4	394	Mitogen-activated protein	yes	no	0.957	0.916	0.822	0.0
Q40353	371	Mitogen-activated protein	N/A	no	0.973	0.989	0.811	0.0
Q336X9	376	Mitogen-activated protein	no	no	0.954	0.957	0.819	0.0
Q9LMM5	369	Mitogen-activated protein	no	no	0.949	0.970	0.832	1e-178
Q39025	376	Mitogen-activated protein	no	no	0.992	0.994	0.764	1e-174
Q8GYQ5	372	Mitogen-activated protein	no	no	0.949	0.962	0.798	1e-173
Q40531	371	Mitogen-activated protein	N/A	no	0.949	0.964	0.756	1e-167
Q9LQQ9	363	Mitogen-activated protein	no	no	0.936	0.972	0.745	1e-161
Q40532	393	Mitogen-activated protein	N/A	no	0.978	0.938	0.686	1e-160

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/373 (83%), Positives = 345/373 (92%), Gaps = 1/373 (0%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
           M+A +   SSG  +SS KGV THGG YVQYNVYGNLFEVS KYVPP+RPIGRGAYGIVCA
Sbjct: 1   MSAESCFGSSGDQSSS-KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCA 59

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 120
           A NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL+HM+HENVIA+KDII+PP+++ FND
Sbjct: 60  ATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFND 119

Query: 121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           VYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA
Sbjct: 120 VYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 179

Query: 181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE MT
Sbjct: 180 NCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMT 239

Query: 241 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 300
           REPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RFPN S
Sbjct: 240 REPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMS 299

Query: 301 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHI 360
           +GAVDLLEKMLVFDP++RITV+EAL HPYL  LHD+N+EPVC RPF+FDFE  + TE++I
Sbjct: 300 AGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENI 359

Query: 361 RELIWRESVKFNP 373
           +ELI+RE+VKFNP
Sbjct: 360 KELIYRETVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  640 bits (1651), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/361 (82%), Positives = 335/361 (92%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           + +KG LTHGG+YVQYNVYGNLFEVSSKYVPPIRP+GRGA GI+CA VN++TR+EVAIKK
Sbjct: 32  AQIKGTLTHGGRYVQYNVYGNLFEVSSKYVPPIRPVGRGACGIICAVVNAQTRQEVAIKK 91

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN IDA+RTLREIKLLRHM+H+NVI+IKDIIRPP+++ FNDVYIVYELMDTDLH 
Sbjct: 92  IGNAFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRENFNDVYIVYELMDTDLHH 151

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           ++RS+Q LTDDHCQYFLYQ+LRGLKYVHSA+VLHRDL+PSNLLLNA CDLKIGDFGLART
Sbjct: 152 LLRSNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNLLLNAKCDLKIGDFGLART 211

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           T+ETDFM EYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQL
Sbjct: 212 TNETDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQL 271

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 314
           RLITELIGSPDD+SLGFLRSDNARRYVR LP+  KQQF  RFP  SSGA+DLLE+MLVFD
Sbjct: 272 RLITELIGSPDDSSLGFLRSDNARRYVRSLPQYPKQQFRARFPTMSSGAMDLLERMLVFD 331

Query: 315 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           P+KRITV+EAL HPYL SLH++ DEPVCP PF FDFE  S TE+ I+E+IWRE++KFNP+
Sbjct: 332 PSKRITVDEALCHPYLASLHEIYDEPVCPAPFSFDFEQPSLTEEDIKEIIWREALKFNPE 391

Query: 375 P 375
           P
Sbjct: 392 P 392

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/367 (81%), Positives = 338/367 (92%)

Query: 9   SSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE 68
           S   A ++++GV THGG+Y+QYN+YGNLFEVS KYVPPIR +GRGAYGIVCAAVN+ETRE
Sbjct: 2   SVESAENNIRGVPTHGGRYLQYNIYGNLFEVSRKYVPPIRSVGRGAYGIVCAAVNAETRE 61

Query: 69  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 128
           EVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENV++IKDIIRPP+K+ FN VYIV ELM
Sbjct: 62  EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSIKDIIRPPQKENFNHVYIVSELM 121

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 188
           DTDLHQIIRS+Q +TDDHC+YF+YQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGD
Sbjct: 122 DTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 181

Query: 189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           FGLARTTSETDFMTEYVVTRWYRAPELLLNC++YTAAIDIWSVGCILGEI+TR+PLFPG+
Sbjct: 182 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPGR 241

Query: 249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 308
           DYVHQLRL+TELIGSPDDASLGFLRS+NARRYVRQLP+  KQ F+ RFPN S GAVDLLE
Sbjct: 242 DYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPGAVDLLE 301

Query: 309 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRES 368
           KML+FDP+KRI V+EAL HPY+  LHD+N+EPVC RPF FDFE    TE+ I+ELIW+ES
Sbjct: 302 KMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPFSFDFEEPMFTEEDIKELIWKES 361

Query: 369 VKFNPDP 375
           V+FNPDP
Sbjct: 362 VRFNPDP 368

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  634 bits (1635), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 295/360 (81%), Positives = 329/360 (91%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
            +KG+ THGG+YV YNVYGN FEVSSKY PPIRPIGRGAYGIVCAAVNSE  EEVAIKKI
Sbjct: 15  QIKGMGTHGGRYVLYNVYGNFFEVSSKYAPPIRPIGRGAYGIVCAAVNSENGEEVAIKKI 74

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
           GNAFDN IDA+RTLREIKLLRHM+HEN+IAIKDIIRPP++D FNDVYIV ELMDTDLHQI
Sbjct: 75  GNAFDNHIDAKRTLREIKLLRHMDHENIIAIKDIIRPPRRDNFNDVYIVSELMDTDLHQI 134

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS+Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNL LNA+CDLKI DFGLARTT
Sbjct: 135 IRSNQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANCDLKIADFGLARTT 194

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           +ETD MTEYVVTRWYRAPELLLNC++YTAAID+WSVGCILGEI+TR+PLFPG+DY+ QL+
Sbjct: 195 TETDLMTEYVVTRWYRAPELLLNCSQYTAAIDVWSVGCILGEIVTRQPLFPGRDYIQQLK 254

Query: 256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 315
           LITELIGSPDD+SLGFLRSDNARRY++QLP+  +Q F  RF N S+GAVDLLEKMLVFDP
Sbjct: 255 LITELIGSPDDSSLGFLRSDNARRYMKQLPQYPRQDFRLRFRNMSAGAVDLLEKMLVFDP 314

Query: 316 NKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           ++RITV+EAL HPYL SLHD+N+EP CP PF FDFE  S TE+HI+ELIWRES+ FNPDP
Sbjct: 315 SRRITVDEALHHPYLASLHDINEEPTCPAPFSFDFEQPSFTEEHIKELIWRESLAFNPDP 374

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  623 bits (1606), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 298/358 (83%), Positives = 327/358 (91%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
           S +GV  +GG+YVQYNVYGNLFEVS KYVPP+RPIGRGA GIVCAA NSET EEVAIKKI
Sbjct: 12  SNRGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKI 71

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
           GNAF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH I
Sbjct: 72  GNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHI 131

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART 
Sbjct: 132 IRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTK 191

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLR
Sbjct: 192 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLR 251

Query: 256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 315
           LITELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RFPN S  AVDLL+KMLVFDP
Sbjct: 252 LITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDP 311

Query: 316 NKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           N+RITV+EAL HPYL  LH+ N+EPVC RPFHFDFE  S TE++I+ELI+RESVKFNP
Sbjct: 312 NRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  612 bits (1579), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 286/374 (76%), Positives = 329/374 (87%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
           A   +S++    +++KGVL HGG+Y QYNVYGNLFEVS+KYVPPIRPIGRGAYG VCAAV
Sbjct: 2   AKEIESATDLGDTNIKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAV 61

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
           +SET EE+AIKKIG AFDN +DA+RTLREIKLLRH+EHENV+ IKDIIRPPKK+ F DVY
Sbjct: 62  DSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVY 121

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
           IV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN++C
Sbjct: 122 IVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNC 181

Query: 183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           DLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN +EYT+AID+WSVGCI  EIMTRE
Sbjct: 182 DLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTRE 241

Query: 243 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 302
           PLFPGKDYVHQL+LITELIGSPD ASL FLRS NAR+YV++LP+  +Q F+ RFP+ +S 
Sbjct: 242 PLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNST 301

Query: 303 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRE 362
           A+DLLEKMLVFDP KRITVEEAL +PYL +LHDLNDEPVC   F F FE  S TE+ I+E
Sbjct: 302 AIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKE 361

Query: 363 LIWRESVKFNPDPT 376
           L+W ESVKFNP P+
Sbjct: 362 LVWLESVKFNPLPS 375

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1

 Score =  608 bits (1569), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 286/358 (79%), Positives = 323/358 (90%)

Query: 17  VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
           +K V THGG+YVQYNVYG LFEVS KYVPPIRPIGRGA GIVCAAVNS T E+VAIKKIG
Sbjct: 14  IKVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIG 73

Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
           NAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+
Sbjct: 74  NAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRIL 133

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
           RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS
Sbjct: 134 RSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTS 193

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
           +TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRL
Sbjct: 194 DTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRL 253

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           ITEL+GSPD++SLGFLRSDNARRYVRQLPR  KQQFA RFP   + A+DLLE+MLVFDPN
Sbjct: 254 ITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPN 313

Query: 317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           +RI+V+EAL H YL   HD+  EPVC  PF FDFEH SCTE+HI+ELI++ESVKFNPD
Sbjct: 314 RRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPD 371

Negative regulator of the auxin transduction signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  588 bits (1515), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 271/358 (75%), Positives = 316/358 (88%)

Query: 17  VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
           +KG+ TH GKYV+YNV GN FEV+SKY+PPI+P+GRGAYG+VC A NSET+EEVAIKKIG
Sbjct: 11  IKGIPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSETKEEVAIKKIG 70

Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
           NAF+N IDA+RTLREIKLL HM+HEN+I IKDI+RPP ++ FNDVYIVYELMDTDLHQII
Sbjct: 71  NAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQII 130

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
           RS Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTTS
Sbjct: 131 RSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 190

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
           E DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL E++ REPLFPG+DY  QL L
Sbjct: 191 EADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLGL 250

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           I  L+GSP+D+ LGFLRSDNAR+YV+ LPR  +  F+ +FP+ S  A+DL E+MLVFDP 
Sbjct: 251 IIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDLAERMLVFDPA 310

Query: 317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           KRITVE+AL HP+L SLH++N+EPVC  PF+FDFE +S +ED I+ELIW E++KF+P+
Sbjct: 311 KRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWNEALKFDPN 368

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1

 Score =  568 bits (1463), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 263/353 (74%), Positives = 304/353 (86%)

Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G+LT+ G+YV YNV GN+FE+SSKY+PPI PIGRGAYGIVC A NSET EEVAIKKI NA
Sbjct: 8   GILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANA 67

Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
           FDN +DA+RTLREIKLL HM+H+NVI IKDII  P+K+ F DVYIVYELMDTDLHQIIRS
Sbjct: 68  FDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRS 127

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
            Q LTDDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNL+LN +CDLKI DFGLART++ET
Sbjct: 128 TQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNET 187

Query: 199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           + MTEYVVTRWYRAPELLLN +EYT AIDIWSVGCI  EI+ RE LFPGKDYV QL+LIT
Sbjct: 188 EIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLIT 247

Query: 259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 318
           EL+GSPDD+ L FLRSDNAR+YV+QLP  +KQ F  +FPN S  A+DL EKMLVFDP+KR
Sbjct: 248 ELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKR 307

Query: 319 ITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 371
           ITV+EAL+ PYL SLH++N+EP CP PF FDFE ++  E  I+EL+WRES+ F
Sbjct: 308 ITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 254/370 (68%), Positives = 317/370 (85%), Gaps = 1/370 (0%)

Query: 5   AKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS 64
           A  S       ++   L+HGG+++QYN++GN+FEV++KY PPI PIG+GAYGIVC+A+NS
Sbjct: 21  APPSQPVAGIDNIPATLSHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSALNS 80

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 124
           ET E VAIKKI NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP+++ FNDVYI 
Sbjct: 81  ETNEHVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQREAFNDVYIA 140

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
           YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLNA+CDL
Sbjct: 141 YELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 200

Query: 185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           KI DFGLAR TSETDFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PL
Sbjct: 201 KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 260

Query: 245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 304
           FPG+D+VHQLRL+ ELIG+P +A + FL ++NA+RY+RQLP  R+Q F  +FP+ +  A+
Sbjct: 261 FPGRDHVHQLRLLMELIGTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVEKFPHVNPAAI 319

Query: 305 DLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
           DL+EKML FDP +RITVE+AL HPYL SLHD++DEPVC  PF+FDFE  + TE+ ++ELI
Sbjct: 320 DLVEKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVCMTPFNFDFEQHALTEEQMKELI 379

Query: 365 WRESVKFNPD 374
           +RE + FNP+
Sbjct: 380 YREGLAFNPE 389

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	377
297748121	377	mitogen-activated protein kinase 4 [Goss	0.984	0.984	0.895	0.0
449452284	383	PREDICTED: mitogen-activated protein kin	0.984	0.968	0.879	0.0
255537569	387	big map kinase/bmk, putative [Ricinus co	0.957	0.932	0.900	0.0
224075008	362	predicted protein [Populus trichocarpa]	0.954	0.994	0.897	0.0
225426166	375	PREDICTED: mitogen-activated protein kin	0.986	0.992	0.868	0.0
25052804	374	mitogen-activated protein kinase 4 [Petr	0.973	0.981	0.859	0.0
224053859	377	predicted protein [Populus trichocarpa]	0.976	0.976	0.852	0.0
359489658	375	PREDICTED: mitogen-activated protein kin	0.984	0.989	0.843	0.0
356528691	380	PREDICTED: mitogen-activated protein kin	0.962	0.955	0.851	0.0
357507521	372	Mitogen-activated protein kinase [Medica	0.957	0.970	0.861	0.0

>gi|297748121|gb|ADI52627.1| mitogen-activated protein kinase 4 [Gossypium hirsutum]

 Score =  696 bits (1797), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/374 (89%), Positives = 351/374 (93%), Gaps = 3/374 (0%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
            + K SSS G  SS+KGV THGGKYV YNVYGNLFEVSSKYVPPIRPIGRGA GIVCAAV
Sbjct: 6   GSTKHSSSEG--SSIKGVPTHGGKYVHYNVYGNLFEVSSKYVPPIRPIGRGANGIVCAAV 63

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
           NSETR+EVAIKKIGNAFDNIIDARRTLREIKLLRHM+HENVIAIKDIIRPPKK+TFNDVY
Sbjct: 64  NSETRQEVAIKKIGNAFDNIIDARRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDVY 123

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
           IVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPS+LLLNA C
Sbjct: 124 IVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSSLLLNAKC 183

Query: 183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAID+WSVGCI GEIMTRE
Sbjct: 184 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDMWSVGCIFGEIMTRE 243

Query: 243 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 302
           PLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NARRY RQLP+CRKQQF+ RFPN S G
Sbjct: 244 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNARRYFRQLPQCRKQQFSARFPNMSPG 303

Query: 303 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRE 362
           AVDLLEKMLVFDPNKRIT EEAL HPYL SLHD+NDEPVCPRPF FDFE SSCTEDHI+E
Sbjct: 304 AVDLLEKMLVFDPNKRIT-EEALCHPYLASLHDINDEPVCPRPFSFDFEQSSCTEDHIKE 362

Query: 363 LIWRESVKFNPDPT 376
           LIWRES++FNPDP 
Sbjct: 363 LIWRESLQFNPDPV 376

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452284|ref|XP_004143889.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus] gi|449518403|ref|XP_004166231.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/372 (87%), Positives = 352/372 (94%), Gaps = 1/372 (0%)

Query: 4   AAKDSSSGGAT-SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
           A K+SSS  AT   +KGVLTHGG+YVQYNVYGNLFEVS+KYVPP+RPIGRGAYG+VCAAV
Sbjct: 2   ATKESSSTTATEGKIKGVLTHGGRYVQYNVYGNLFEVSAKYVPPLRPIGRGAYGLVCAAV 61

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
           NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL HMEHEN+IAI+DIIRPPK++ FNDVY
Sbjct: 62  NSETHEEVAIKKIGNAFDNIIDAKRTLREIKLLCHMEHENIIAIRDIIRPPKREVFNDVY 121

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
           IVYELMDTDLHQIIRSDQ LTDDHCQYFLYQLLRGLKYVHSA VLHRDLKPSNLLLNA+C
Sbjct: 122 IVYELMDTDLHQIIRSDQPLTDDHCQYFLYQLLRGLKYVHSAKVLHRDLKPSNLLLNANC 181

Query: 183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAID+WSVGCILGEIMTRE
Sbjct: 182 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDVWSVGCILGEIMTRE 241

Query: 243 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 302
           PLFPGKDYVHQLRLITEL+GSPDDASLGFLRSDNARRYV+QLP+ RKQQF+ RFPN S  
Sbjct: 242 PLFPGKDYVHQLRLITELLGSPDDASLGFLRSDNARRYVKQLPQYRKQQFSARFPNMSPS 301

Query: 303 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRE 362
           A+DLLEKMLVFDPNKRITVEEAL HPYLQSLHD+NDEPVC RPF+FDFE  SCTE+HI+E
Sbjct: 302 ALDLLEKMLVFDPNKRITVEEALCHPYLQSLHDINDEPVCARPFNFDFEQPSCTEEHIKE 361

Query: 363 LIWRESVKFNPD 374
           LIW+ESV+FNPD
Sbjct: 362 LIWKESVRFNPD 373

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537569|ref|XP_002509851.1| big map kinase/bmk, putative [Ricinus communis] gi|223549750|gb|EEF51238.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  689 bits (1779), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/361 (90%), Positives = 344/361 (95%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           + +KGV THGG+YVQYN YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK
Sbjct: 24  NKIKGVPTHGGRYVQYNAYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 83

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN +DA+RTLREIKLLRHM+HEN+IAI+DIIRPPKK+ FNDVYIVYELMDTDLH 
Sbjct: 84  IGNAFDNRVDAKRTLREIKLLRHMDHENIIAIRDIIRPPKKEAFNDVYIVYELMDTDLHH 143

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA VLHRDLKPSNLLLNA+CDLKIGDFGLART
Sbjct: 144 IIRSDQPLTDDHCQYFLYQLLRGLKYVHSAHVLHRDLKPSNLLLNANCDLKIGDFGLART 203

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQL
Sbjct: 204 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQL 263

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 314
           RLITELIGSPDDASLGFLRSDNARRYVRQLP+ RKQ F  RFPN S+GA DLLEKMLVFD
Sbjct: 264 RLITELIGSPDDASLGFLRSDNARRYVRQLPQYRKQNFTLRFPNVSAGAADLLEKMLVFD 323

Query: 315 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           PNKRITVEEAL HPYL SLHD+NDEPVCPRPFHFDFEH SCTE+HI++LIWRES+KFNPD
Sbjct: 324 PNKRITVEEALCHPYLSSLHDINDEPVCPRPFHFDFEHPSCTEEHIKDLIWRESMKFNPD 383

Query: 375 P 375
           P
Sbjct: 384 P 384

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075008|ref|XP_002304516.1| predicted protein [Populus trichocarpa] gi|222841948|gb|EEE79495.1| predicted protein [Populus trichocarpa]

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/360 (89%), Positives = 342/360 (95%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           S +KGVLTHGG+YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS+T EEVAIKK
Sbjct: 1   SKIKGVLTHGGRYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSDTHEEVAIKK 60

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN IDA+RTLREI LLRHM+HENVIAI+DI RPPKK+ FNDVYIVYELMDTDLHQ
Sbjct: 61  IGNAFDNRIDAKRTLREIMLLRHMDHENVIAIRDITRPPKKEAFNDVYIVYELMDTDLHQ 120

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           IIRSDQ L DDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLART
Sbjct: 121 IIRSDQALNDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLART 180

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL
Sbjct: 181 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 240

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 314
           RLITELIGSPDDASLGFLRS+NARRYVRQLP+ +KQ F+ RFPN S GAVDLLEKMLVFD
Sbjct: 241 RLITELIGSPDDASLGFLRSNNARRYVRQLPQYKKQNFSARFPNMSPGAVDLLEKMLVFD 300

Query: 315 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           PN RITV+EAL H YL SLHD+NDEPVCPRPFHFDFEH SCTE+HI+ELIWRESVKFNPD
Sbjct: 301 PNNRITVDEALCHSYLSSLHDINDEPVCPRPFHFDFEHPSCTEEHIKELIWRESVKFNPD 360

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/373 (86%), Positives = 348/373 (93%), Gaps = 1/373 (0%)

Query: 5   AKDSSSG-GATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVN 63
           + D+SSG G   ++KGV THGG+YV+YNVYGN FEVS+KYVPPIRP+GRGAYGIVCAAVN
Sbjct: 2   SMDASSGSGDGGNIKGVPTHGGRYVRYNVYGNFFEVSAKYVPPIRPVGRGAYGIVCAAVN 61

Query: 64  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 123
           SET EEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVIAIKDIIRPPKK+TFNDVYI
Sbjct: 62  SETHEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDVYI 121

Query: 124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 183
           VYELMDTDLHQII S+Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CD
Sbjct: 122 VYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181

Query: 184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREP
Sbjct: 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREP 241

Query: 244 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA 303
           LFPGKDYVHQLRLITEL+GSPDDASLGFLRS+NARRYVRQLP+  KQQ + RFPN S  A
Sbjct: 242 LFPGKDYVHQLRLITELLGSPDDASLGFLRSNNARRYVRQLPQYPKQQISARFPNMSPSA 301

Query: 304 VDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIREL 363
           VDLLEKMLVFDP KRITV+EAL HPYL SLHD+NDEPVCP PF FDFE SS TE++I+EL
Sbjct: 302 VDLLEKMLVFDPTKRITVDEALCHPYLSSLHDINDEPVCPSPFSFDFEQSSITEENIKEL 361

Query: 364 IWRESVKFNPDPT 376
           IWRESVKFNPDPT
Sbjct: 362 IWRESVKFNPDPT 374

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/370 (85%), Positives = 349/370 (94%), Gaps = 3/370 (0%)

Query: 9   SSGGATSS---VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE 65
           SS  AT+    +KGV THGG+YVQYNVYGNLFEVS KYVPPIRP+GRGAYGIVCAA+NS+
Sbjct: 3   SSSAATADHTHIKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSD 62

Query: 66  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 125
           TREEVAIKKIGNAFDN IDA+RTLREIKLLRHM HENVIAIKDIIRPP+ ++FNDVYIVY
Sbjct: 63  TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMNHENVIAIKDIIRPPQIESFNDVYIVY 122

Query: 126 ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 185
           ELMDTDLHQIIRS+QQLTDDHC+YFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLK
Sbjct: 123 ELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 182

Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE+MTR+PLF
Sbjct: 183 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEVMTRQPLF 242

Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
           PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP+  KQQF+ RF NKS GA+D
Sbjct: 243 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQYPKQQFSARFLNKSPGALD 302

Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIW 365
           LLEKML+FDPN+RITV+EAL HPYL +LHD+N+EPVCPRPF FDFE  +CTE++I+ELIW
Sbjct: 303 LLEKMLIFDPNRRITVDEALCHPYLAALHDINEEPVCPRPFSFDFEQPTCTEENIKELIW 362

Query: 366 RESVKFNPDP 375
           +ESVKFNPDP
Sbjct: 363 KESVKFNPDP 372

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053859|ref|XP_002298015.1| predicted protein [Populus trichocarpa] gi|222845273|gb|EEE82820.1| predicted protein [Populus trichocarpa]

 Score =  672 bits (1735), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/372 (85%), Positives = 345/372 (92%), Gaps = 4/372 (1%)

Query: 10  SGGAT----SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE 65
            GGA     S +KG+LTHGG+YVQYNVYGNLFEVSSKYVPP+RPIGRGAYGIVCAAVNSE
Sbjct: 6   GGGAVRRNGSEIKGLLTHGGRYVQYNVYGNLFEVSSKYVPPVRPIGRGAYGIVCAAVNSE 65

Query: 66  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 125
           T EEVAIKKIGNAFDN IDA+RTLREIKLL HM+HENVIA++DIIRPPK + FNDVYIVY
Sbjct: 66  THEEVAIKKIGNAFDNRIDAKRTLREIKLLCHMDHENVIAMRDIIRPPKMEAFNDVYIVY 125

Query: 126 ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 185
           ELMDTDLHQIIRS+Q L DDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLN++CDLK
Sbjct: 126 ELMDTDLHQIIRSEQSLNDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNSNCDLK 185

Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           IGDFGLARTT+ETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLF
Sbjct: 186 IGDFGLARTTAETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLF 245

Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
           PGKDYVHQLRLITELIGSPDDASLGFLRS+NARRYVRQLP+ +K+ F+  FPN S GA+D
Sbjct: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSNNARRYVRQLPQYKKKIFSATFPNMSPGAID 305

Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIW 365
           LLEKMLVFDP+ RITV+EAL H YL SLH +NDEPVCPRPFHFDFE  SCTE+HI+ELIW
Sbjct: 306 LLEKMLVFDPSNRITVDEALCHQYLSSLHAINDEPVCPRPFHFDFEQPSCTEEHIKELIW 365

Query: 366 RESVKFNPDPTC 377
           RES+KFNPDP+C
Sbjct: 366 RESMKFNPDPSC 377

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359489658|ref|XP_003633959.1| PREDICTED: mitogen-activated protein kinase homolog MMK2-like [Vitis vinifera] gi|147786894|emb|CAN75543.1| hypothetical protein VITISV_000466 [Vitis vinifera] gi|297745345|emb|CBI40425.3| unnamed protein product [Vitis vinifera]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/371 (84%), Positives = 345/371 (92%)

Query: 5   AKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS 64
           + +SS+G    +++GV THGG+YVQYNVYGNLFEVS KYVPPIRP+GRGAYGIVCAA+NS
Sbjct: 2   SMESSAGSVEGNIRGVSTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS 61

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 124
           ETREEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVI +KDIIRPPK++ FNDVYIV
Sbjct: 62  ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIVLKDIIRPPKRENFNDVYIV 121

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
           YELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKYVHSA+VLHRDLKPSNLLLNA+CDL
Sbjct: 122 YELMDTDLHQIIRSNQPLNDDHCRYFLYQVLRGLKYVHSANVLHRDLKPSNLLLNANCDL 181

Query: 185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTR+PL
Sbjct: 182 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 241

Query: 245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 304
           FPG+DYVHQLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+  +QQF  RFPN S GA+
Sbjct: 242 FPGRDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQQFQARFPNMSPGAI 301

Query: 305 DLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
           DLLEKMLVFDPN+RITVE AL HPYL  LHD+N+EPVCPRPF FDFE  S TE++I+ELI
Sbjct: 302 DLLEKMLVFDPNRRITVEGALSHPYLAPLHDINEEPVCPRPFVFDFEQPSFTEENIKELI 361

Query: 365 WRESVKFNPDP 375
           WRESVKFNPDP
Sbjct: 362 WRESVKFNPDP 372

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528691|ref|XP_003532933.1| PREDICTED: mitogen-activated protein kinase 2-like [Glycine max]

 Score =  666 bits (1718), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/363 (85%), Positives = 342/363 (94%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           + +K VLTHGGKY QYNVYGNLFEVSSKYVPPIRPIGRG  GIVCAAVNSET E+VAIKK
Sbjct: 18  AKIKRVLTHGGKYAQYNVYGNLFEVSSKYVPPIRPIGRGVNGIVCAAVNSETHEQVAIKK 77

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDNIIDA+RTLREIKLLRHM+H+N+IAIKDIIRPPKK+TFNDVYIVYELMDTDLH 
Sbjct: 78  IGNAFDNIIDAKRTLREIKLLRHMDHDNIIAIKDIIRPPKKETFNDVYIVYELMDTDLHH 137

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           II SDQ L+++HCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLL+NA+CDLKIGDFGLART
Sbjct: 138 IIHSDQPLSEEHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLMNANCDLKIGDFGLART 197

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYT+AID+WSVGCILGEIMTREPLFPGKDYVHQL
Sbjct: 198 TSETDFMTEYVVTRWYRAPELLLNCSEYTSAIDVWSVGCILGEIMTREPLFPGKDYVHQL 257

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 314
           RLITEL+GSPDDASL FLRSDNARRY+RQLP+ RKQ+F+TRFPN    A+DLLEKML+FD
Sbjct: 258 RLITELLGSPDDASLEFLRSDNARRYIRQLPQYRKQKFSTRFPNMLPKALDLLEKMLIFD 317

Query: 315 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           PNKRITV+EAL HPYL SLH++NDEPVCPRPF FDF+  +CTE+H++ELIW+ESVKFNPD
Sbjct: 318 PNKRITVDEALCHPYLSSLHNINDEPVCPRPFSFDFDQPTCTEEHMKELIWKESVKFNPD 377

Query: 375 PTC 377
           P C
Sbjct: 378 PPC 380

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507521|ref|XP_003624049.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355499064|gb|AES80267.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  665 bits (1715), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/361 (86%), Positives = 343/361 (95%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           +++KGVLTHGG+YVQYN+YGNLFEVS+KYVPPIRPIGRGAYGIVCAAVN+ETREEVAIKK
Sbjct: 9   NNIKGVLTHGGRYVQYNIYGNLFEVSNKYVPPIRPIGRGAYGIVCAAVNAETREEVAIKK 68

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           +GNAFDN IDA+RTLREIKL RHM+HENVIA+KDIIRPP+K+ FNDVYIVYELMDTDLHQ
Sbjct: 69  VGNAFDNRIDAKRTLREIKLQRHMDHENVIALKDIIRPPQKENFNDVYIVYELMDTDLHQ 128

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           IIRS+Q LTDDHC+YFLYQLLRGLKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLART
Sbjct: 129 IIRSNQTLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLART 188

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTR+PLFPGKDYVHQL
Sbjct: 189 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRKPLFPGKDYVHQL 248

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 314
           +LITELIGSPDDASLGF+RSDNARRYV+QLP+  +QQFA RFPN S GAVDLLE+MLVFD
Sbjct: 249 KLITELIGSPDDASLGFIRSDNARRYVKQLPQYPRQQFAARFPNMSPGAVDLLERMLVFD 308

Query: 315 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           PN+RITV+EALRH YL  LHD+N+EPVC RPF+FDFE  S TE  I+ELIWRESVKFNPD
Sbjct: 309 PNRRITVDEALRHQYLAPLHDINEEPVCSRPFNFDFEKPSFTEADIKELIWRESVKFNPD 368

Query: 375 P 375
           P
Sbjct: 369 P 369

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	377
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.944	0.946	0.851	3.2e-168
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.944	0.964	0.834	1.9e-161
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.949	0.962	0.798	9.9e-158
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.954	0.957	0.788	2.6e-157
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.936	0.972	0.745	2.8e-146
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.946	0.903	0.687	2.4e-140
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.938	0.956	0.652	1.1e-133
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.946	0.908	0.639	1.7e-128
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.933	0.956	0.554	7e-109
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.920	0.655	0.578	3e-108

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1636 (581.0 bits), Expect = 3.2e-168, P = 3.2e-168
 Identities = 303/356 (85%), Positives = 335/356 (94%)

Query:    18 KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN 77
             KGV THGG YVQYNVYGNLFEVS KYVPP+RPIGRGAYGIVCAA NSET EEVAIKKIGN
Sbjct:    17 KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGN 76

Query:    78 AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
             AFDNIIDA+RTLREIKLL+HM+HENVIA+KDII+PP+++ FNDVYIVYELMDTDLHQIIR
Sbjct:    77 AFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIR 136

Query:   138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             S+Q LTDDHC++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLK+GDFGLART SE
Sbjct:   137 SNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSE 196

Query:   198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE MTREPLFPGKDYVHQLRLI
Sbjct:   197 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256

Query:   258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
             TELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RFPN S+GAVDLLEKMLVFDP++
Sbjct:   257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316

Query:   318 RITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
             RITV+EAL HPYL  LHD+N+EPVC RPF+FDFE  + TE++I+ELI+RE+VKFNP
Sbjct:   317 RITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNP 372

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1572 (558.4 bits), Expect = 1.9e-161, P = 1.9e-161
 Identities = 297/356 (83%), Positives = 326/356 (91%)

Query:    18 KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN 77
             +GV  +GG+YVQYNVYGNLFEVS KYVPP+RPIGRGA GIVCAA NSET EEVAIKKIGN
Sbjct:    14 RGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGN 73

Query:    78 AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
             AF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH IIR
Sbjct:    74 AFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIR 133

Query:   138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             S+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART SE
Sbjct:   134 SNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSE 193

Query:   198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLRLI
Sbjct:   194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253

Query:   258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
             TELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RFPN S  AVDLL+KMLVFDPN+
Sbjct:   254 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNR 313

Query:   318 RITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
             RITV+EAL HPYL  LH+ N+EPVC RPFHFDFE  S TE++I+ELI+RESVKFNP
Sbjct:   314 RITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1537 (546.1 bits), Expect = 9.9e-158, P = 9.9e-158
 Identities = 286/358 (79%), Positives = 323/358 (90%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +K V THGG+YVQYNVYG LFEVS KYVPPIRPIGRGA GIVCAAVNS T E+VAIKKIG
Sbjct:    14 IKVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIG 73

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
             NAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+
Sbjct:    74 NAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRIL 133

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS
Sbjct:   134 RSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTS 193

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             +TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRL
Sbjct:   194 DTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRL 253

Query:   257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             ITEL+GSPD++SLGFLRSDNARRYVRQLPR  KQQFA RFP   + A+DLLE+MLVFDPN
Sbjct:   254 ITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPN 313

Query:   317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
             +RI+V+EAL H YL   HD+  EPVC  PF FDFEH SCTE+HI+ELI++ESVKFNPD
Sbjct:   314 RRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPD 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1533 (544.7 bits), Expect = 2.6e-157, P = 2.6e-157
 Identities = 284/360 (78%), Positives = 322/360 (89%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +KGVL HGG+Y QYNVYGNLFEVS+KYVPPIRPIGRGAYG VCAAV+SET EE+AIKKIG
Sbjct:    16 IKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIG 75

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
              AFDN +DA+RTLREIKLLRH+EHENV+ IKDIIRPPKK+ F DVYIV+ELMDTDLHQII
Sbjct:    76 KAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQII 135

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q L DDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN++CDLKI DFGLARTTS
Sbjct:   136 RSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTS 195

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             ET++MTEYVVTRWYRAPELLLN +EYT+AID+WSVGCI  EIMTREPLFPGKDYVHQL+L
Sbjct:   196 ETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKL 255

Query:   257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             ITELIGSPD ASL FLRS NAR+YV++LP+  +Q F+ RFP+ +S A+DLLEKMLVFDP 
Sbjct:   256 ITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPV 315

Query:   317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 376
             KRITVEEAL +PYL +LHDLNDEPVC   F F FE  S TE+ I+EL+W ESVKFNP P+
Sbjct:   316 KRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNPLPS 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
 Identities = 263/353 (74%), Positives = 304/353 (86%)

Query:    19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
             G+LT+ G+YV YNV GN+FE+SSKY+PPI PIGRGAYGIVC A NSET EEVAIKKI NA
Sbjct:     8 GILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANA 67

Query:    79 FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
             FDN +DA+RTLREIKLL HM+H+NVI IKDII  P+K+ F DVYIVYELMDTDLHQIIRS
Sbjct:    68 FDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRS 127

Query:   139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
              Q LTDDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNL+LN +CDLKI DFGLART++ET
Sbjct:   128 TQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNET 187

Query:   199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
             + MTEYVVTRWYRAPELLLN +EYT AIDIWSVGCI  EI+ RE LFPGKDYV QL+LIT
Sbjct:   188 EIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLIT 247

Query:   259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 318
             EL+GSPDD+ L FLRSDNAR+YV+QLP  +KQ F  +FPN S  A+DL EKMLVFDP+KR
Sbjct:   248 ELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKR 307

Query:   319 ITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 371
             ITV+EAL+ PYL SLH++N+EP CP PF FDFE ++  E  I+EL+WRES+ F
Sbjct:   308 ITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
 Identities = 246/358 (68%), Positives = 308/358 (86%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +   L+HGG+++QYN++GN+FEV++KY PPI PIG+GAYGIVC+A+NSET E VAIKKI 
Sbjct:    36 IPATLSHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIA 95

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
             NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP ++ FNDVYI YELMDTDLHQII
Sbjct:    96 NAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQII 155

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLAR TS
Sbjct:   156 RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 215

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             E+DFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PLFPG+D+VHQLRL
Sbjct:   216 ESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 275

Query:   257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             + ELIG+P +  L FL ++NA+RY+RQLP   +Q    +FP     A+DL+EKML FDP 
Sbjct:   276 LMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPR 334

Query:   317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
             +RITV +AL HPYL SLHD++DEP C  PF+FDFE+ + +E+ ++ELI+RE++ FNP+
Sbjct:   335 RRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
 Identities = 231/354 (65%), Positives = 300/354 (84%)

Query:    20 VLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF 79
             V THGG+++ Y+++G+LFE++SKY PPI PIGRGAYGIVC+ +++ET E VA+KKI NAF
Sbjct:    14 VETHGGQFISYDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETNELVAMKKIANAF 73

Query:    80 DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD 139
             DN +DA+RTLREIKLLRH++HEN+IAI+D++ PP +  F+DVYI  ELMDTDLHQIIRS+
Sbjct:    74 DNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSN 133

Query:   140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
             Q L+++HCQYFLYQLLRGLKY+HSA+++HRDLKPSNLLLNA+CDLKI DFGLAR TSE D
Sbjct:   134 QSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSEND 193

Query:   200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             FMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PLFPGKD+VHQ+RL+TE
Sbjct:   194 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTE 253

Query:   260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 319
             L+G+P ++ LGF  +++A+RY+RQLP   +Q  A  F + +  A+DL+++ML FDPN+RI
Sbjct:   254 LLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRI 313

Query:   320 TVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
             TVE+AL H YL  LHD NDEP+C +PF F+FE     E+ I+E+I++E++  NP
Sbjct:   314 TVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 229/358 (63%), Positives = 291/358 (81%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             + G L+H G+Y+QYN++G++FE+ +KY PPIRPIGRGA GIVC+AV+SET E+VAIKKI 
Sbjct:    33 IPGTLSHDGRYIQYNLFGHIFELPAKYKPPIRPIGRGACGIVCSAVDSETNEKVAIKKIT 92

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
               FDN I+A+RTLREIKLLRH +HEN++AI+D+I PP++D+F DVYIV ELM+ DL++ +
Sbjct:    93 QVFDNTIEAKRTLREIKLLRHFDHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTL 152

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             +SDQ+LT DH  YF+YQ+LRGLKY+HSA+VLHRDLKPSNLLL+  CDLKI DFGLAR T 
Sbjct:   153 KSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATP 212

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             E++ MTEYVVTRWYRAPELLL  ++YTAAID+WSVGCI  EIM REPLFPGKD V+QLRL
Sbjct:   213 ESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRL 272

Query:   257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             + ELIG+P +  LG L S+ A+RY+RQLP   +Q F  +FPN    A+DL+EKML FDP 
Sbjct:   273 LLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPK 331

Query:   317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
             +RI+V+EAL HPYL S HD+ DEP C  PF+FD +    +E+  RELI+ E++ FNP+
Sbjct:   332 QRISVKEALAHPYLSSFHDITDEPECSEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1076 (383.8 bits), Expect = 7.0e-109, P = 7.0e-109
 Identities = 198/357 (55%), Positives = 266/357 (74%)

Query:    19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
             G+   G  Y  Y+++  LFE+ +KYVP I+PIGRGAYG+VC+++N ET E VAIKKI N 
Sbjct:    10 GIKQQGKHY--YSMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNERVAIKKIHNV 66

Query:    79 FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
             F+N +DA RTLRE+KLLRH+ HENVIA+KD++ P  + +F DVY+VYELMDTDLHQII+S
Sbjct:    67 FENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKS 126

Query:   139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
              Q L+DDHC+YFL+QLLRGLKY+HSA++LHRDLKP NLL+NA+CDLKI DFGLART+   
Sbjct:   127 SQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGN 186

Query:   199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             + FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  EI+ R+P+FPG + ++QL+LI
Sbjct:   187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246

Query:   258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
               ++GS  ++ + F+ +  ARR+++ LP  R    +  +P  +  A+DLL++MLVFDP K
Sbjct:   247 INVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTK 306

Query:   318 RITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
             RI+V +AL HPY+  L D    P    P   D + +   E  IRE++W E + ++P+
Sbjct:   307 RISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENM-EEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 203/351 (57%), Positives = 260/351 (74%)

Query:    28 VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR 87
             + Y VYG+ F V  +Y   ++ IG GAYG+VC+A ++ T E+VAIKKI  AFDN+ D +R
Sbjct:   134 ISYFVYGSQFTVPRRY-SIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKR 192

Query:    88 TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC 147
             TLREI LLRH +HEN+I+IKDI++P  K+ F DVYIV ELMDTDLHQII S Q L+DDHC
Sbjct:   193 TLREIHLLRHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHC 252

Query:   148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYV 205
             QYF+YQ+LRGLK++HSA+VLHRDLKPSNLL+N  C LKI D GLAR    T   FMTEYV
Sbjct:   253 QYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLARVEDATHQGFMTEYV 312

Query:   206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
              TRWYRAPE++L+  +YT AIDIWSVGCI  E++ R+PLF GKDY+HQ+ LI E IGSP 
Sbjct:   313 ATRWYRAPEVILSWNKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPS 372

Query:   266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
             +  +  + ++ AR+++R +    K  FA  FP  +  A+DLLE+ML FDP+KR+TVEEAL
Sbjct:   373 EEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEAL 432

Query:   326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP-DP 375
              HPY QSLHD +DEP+C   F  +FE      D ++ELI+ E + ++P DP
Sbjct:   433 AHPYFQSLHDPSDEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPEDP 483

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q336X9	MPK6_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8194	0.9549	0.9574	no	no
Q8GYQ5	MPK12_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7988	0.9496	0.9623	no	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.5770	0.9336	0.9166	N/A	no
Q9LMM5	MPK11_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8324	0.9496	0.9701	no	no
Q9LQQ9	MPK13_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7450	0.9363	0.9724	no	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.7047	0.9496	0.8994	no	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.6961	0.9575	0.9162	N/A	no
Q5J4W4	MPK2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8227	0.9575	0.9162	yes	no
P0CP67	CPK1_CRYNB	2, ., 7, ., 1, 1, ., 2, 4	0.5235	0.8567	0.8825	N/A	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.6401	0.9655	0.9864	N/A	no
P42525	ERK1_DICDI	2, ., 7, ., 1, 1, ., 2, 4	0.5759	0.9177	0.6540	yes	no
O42781	MAPK2_PNECA	2, ., 7, ., 1, 1, ., 2, 4	0.5138	0.9071	0.9743	N/A	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7569	0.9496	0.9649	N/A	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.6864	0.9787	0.9389	N/A	no
P0CP66	CPK1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.5235	0.8567	0.8825	yes	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5770	0.9336	0.9462	N/A	no
Q00859	MAPK_FUSSO	2, ., 7, ., 1, 1, ., 2, 4	0.5440	0.8461	0.8985	N/A	no
Q39025	MPK5_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7647	0.9920	0.9946	no	no
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8310	0.9867	0.9893	yes	no
P39745	SUR1_CAEEL	2, ., 7, ., 1, 1, ., 2, 4	0.5307	0.8859	0.7522	yes	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5573	0.8116	0.8225	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.6898	0.9867	0.9612	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8119	0.9734	0.9892	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.994
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	377
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.0
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-175
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-168
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-155
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-152
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-142
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-130
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-126
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-121
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-119
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-118
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-116
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-115
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-114
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-107
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-107
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-98
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-94
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-93
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-91
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-87
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-86
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-85
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-84
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-83
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-83
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-77
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-77
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-76
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-76
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-75
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-74
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-73
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-72
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-71
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-70
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-69
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-69
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-68
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-67
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-65
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-65
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-64
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-64
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-62
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-60
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-60
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-58
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-55
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-52
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-52
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-47
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-45
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-45
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-45
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-43
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-41
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-38
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-35
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-33
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-26
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-25
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-24
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-14
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-04
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.004

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  680 bits (1757), Expect = 0.0
 Identities = 253/338 (74%), Positives = 291/338 (86%), Gaps = 2/338 (0%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           FEV +KYVP   PIGRGAYGIVC+A NSET E+VAIKKI NAFDN IDA+RTLREIKLLR
Sbjct: 1   FEVDTKYVPIK-PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR 59

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H++HENVIAIKDI+ PP ++ FNDVYIVYELMDTDLHQIIRS Q L+DDHCQYFLYQLLR
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL 215
           GLKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTTSE  DFMTEYVVTRWYRAPEL
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           LLNC+EYT AID+WSVGCI  E++ R+PLFPGKDYVHQL+LITEL+GSP +  LGF+R++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
            ARRY+R LP   +Q FA  FP+ +  A+DLLEKMLVFDP+KRITVEEAL HPYL SLHD
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299

Query: 336 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            +DEPVC  PF FDFE  + TE+ I+ELI+ E + ++P
Sbjct: 300 PSDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  564 bits (1455), Expect = 0.0
 Identities = 201/327 (61%), Positives = 253/327 (77%), Gaps = 5/327 (1%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            ++PIG GAYG+VC+AV+  T  +VAIKKI N FD++IDA+R LREIKLLRH+ HEN+I 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + DI+RPP  + FNDVYIV ELM+TDLH++I+S Q LTDDH QYFLYQ+LRGLKY+HSA+
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCTE 221
           V+HRDLKPSN+L+N++CDLKI DFGLAR       E  F+TEYVVTRWYRAPELLL+ + 
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           YT AIDIWSVGCI  E++TR+PLFPG+DY+ QL LI E++G+P +  L F+ S+ AR Y+
Sbjct: 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
           + LP+  K+  +  FP  S  A+DLLEKMLVFDP KRIT +EAL HPYL  LHD  DEPV
Sbjct: 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303

Query: 342 CPRPFHF-DFEHSSCTEDHIRELIWRE 367
              PF F  F+    TE+ ++ELI+ E
Sbjct: 304 AKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  491 bits (1267), Expect = e-175
 Identities = 192/339 (56%), Positives = 247/339 (72%), Gaps = 8/339 (2%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V  +Y   +  IG GAYG+VC+A +  T  +VAIKKI + F++    +RTLREIK+LR
Sbjct: 1   FDVGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILR 58

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             +HEN+I I DIIRPP  ++FNDVYIV ELM+TDL+++I++ Q L++DH QYFLYQ+LR
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILR 117

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRA 212
           GLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRA
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE++LN   YT AIDIWSVGCIL E+++  PLFPGKDY+HQL LI  ++G+P    L  +
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            S  AR Y++ LP   K  +   FPN    A+DLL+KML F+P+KRITVEEAL HPYL+ 
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Query: 333 LHDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESVK 370
            HD +DEPV   PF FDFE      ++ ++ELI+ E ++
Sbjct: 298 YHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  473 bits (1220), Expect = e-168
 Identities = 192/333 (57%), Positives = 255/333 (76%), Gaps = 7/333 (2%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V S+Y  PI  IG GAYG+VC+A+++ + ++VAIKKI +AFD    A+RTLRE+K+LR
Sbjct: 1   FDVGSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR 59

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H +H+N+IAI+DI+RPP  D F DVY+V +LM++DLH II SDQ LT++H +YFLYQLLR
Sbjct: 60  HFKHDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYR 211
           GLKY+HSA+V+HRDLKPSNLL+N  C+L+IGDFG+AR  ++S T+   FMTEYV TRWYR
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APELLL+  EYT AID+WSVGCI  E++ R  LFPGK+YVHQL+LI  ++GSP +  L  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + SD  R+Y++ LPR +   ++  FP  S  A+DLL +ML FDP +RITVE+AL+HP+L 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Query: 332 SLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
             HD +DEP CP PF FDFE    + + ++E I
Sbjct: 299 QYHDPDDEPTCPPPFDFDFEAIELSREQLKEAI 331

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  440 bits (1134), Expect = e-155
 Identities = 169/348 (48%), Positives = 237/348 (68%), Gaps = 6/348 (1%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + +  +   ++EV  +Y   + P+G GAYG VC+A +++T  +VAIKK+   F + I A+
Sbjct: 1   FYRQELNKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK 59

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           RT RE++LL+HM+HENVI + D+  P    + F DVY+V  LM  DL+ I++  Q+L+DD
Sbjct: 60  RTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDD 118

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           H Q+ +YQ+LRGLKY+HSA ++HRDLKPSN+ +N  C+LKI DFGLAR T +   MT YV
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYV 176

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
            TRWYRAPE++LN   Y   +DIWSVGCI+ E++T + LFPG D++ QL+ I  L+G+PD
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
           +  L  + S++AR Y++ LP+  K+ F   F   +  A+DLLEKMLV DP+KRIT  EAL
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HPYL   HD  DEPV P P+   FE    T D  +EL+++E + F P
Sbjct: 297 AHPYLAEYHDPEDEPVAP-PYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  431 bits (1109), Expect = e-152
 Identities = 187/331 (56%), Positives = 237/331 (71%), Gaps = 14/331 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENV 103
           I+ +G+GAYGIVC+A N+ET EE  VAIKKI N F   I A+R LRE+KLLRH   H+N+
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 104 IAI--KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             +   DI+ P     FN++Y+  ELM+ DLHQIIRS Q LTD H Q F+YQ+L GLKY+
Sbjct: 65  TCLYDMDIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELL 216
           HSA+VLHRDLKP NLL+NA C+LKI DFGLAR  SE       FMTEYV TRWYRAPE++
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L+   YT AID+WSVGCIL E++ R+P+F GKDYV QL  I +++G+PD+ +L  + S  
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 336
           A+ Y+R LP   K+ F + FPN +  A+DLLEK+L FDP KRI+VEEAL HPYL   HD 
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301

Query: 337 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +DEPVC +PF F FE     E+ +R++I  E
Sbjct: 302 DDEPVCQKPFDFSFESEDSMEE-LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  406 bits (1044), Expect = e-142
 Identities = 167/334 (50%), Positives = 236/334 (70%), Gaps = 13/334 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G+YG+VC+A+++ T E+VAIKKI + F+++ DA R LREIKLLR + H +++ IK I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           + PP +  F D+Y+V+ELM++DLHQ+I+++  LT +H Q+FLYQLLR LKY+H+A+V HR
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127

Query: 170 DLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTRWYRAPELLLNC----TE 221
           DLKP N+L NA C LKI DFGLAR     T    F T+YV TRWYRAPEL   C    ++
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSK 184

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           YT AIDIWS+GCI  E++T +PLFPGK+ VHQL LIT+L+G+P   ++  +R++ ARRY+
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
             + + +   F+ +FPN    A+ LLE++L FDP  R T EEAL  PY + L  +  EP 
Sbjct: 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304

Query: 342 C-PRP-FHFDFEHSSCTEDHIRELIWRESVKFNP 373
             P     F+FE    T++ +RELI+RE ++++P
Sbjct: 305 AQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  377 bits (970), Expect = e-130
 Identities = 148/315 (46%), Positives = 213/315 (67%), Gaps = 12/315 (3%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            +  KY   ++ +G+GAYGIV  A++  T+E VA+KKI +AF N  DA+RT REI  L+ 
Sbjct: 4   HILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62

Query: 98  M-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           + +H N++ + ++I+    +   D+Y+V+E M+TDLH +IR++  L D H +Y +YQLL+
Sbjct: 63  LGDHPNIVKLLNVIK---AENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLK 118

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------FMTEYVVTRWY 210
            LKY+HS +V+HRDLKPSN+LLN+ C +K+ DFGLAR+ SE +       +T+YV TRWY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           RAPE+LL  T YT  +D+WSVGCILGE++  +PLFPG   ++QL  I E+IG P    + 
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            ++S  A   +  LP   ++      P  S  A+DLL+K+LVF+PNKR+T EEAL HPY+
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Query: 331 QSLHDLNDEPVCPRP 345
              H+ +DEPV P P
Sbjct: 299 AQFHNPSDEPVLPYP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  367 bits (943), Expect = e-126
 Identities = 163/336 (48%), Positives = 227/336 (67%), Gaps = 8/336 (2%)

Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           ++G +FE++++YV  ++P+G GA+G+VC+A +  T + VAIKKI   F   + A+RT RE
Sbjct: 1   IFGTVFEITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           +KLL+H+ HEN+I++ DI   P      D+Y V EL+ TDLH+++ S + L     QYFL
Sbjct: 60  LKLLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFL 114

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
           YQ+LRGLKYVHSA V+HRDLKPSN+L+N +CDLKI DFGLAR       MT YV TR+YR
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYR 172

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APE++L   +Y   +DIWS GCI  E++  +PLFPGKD+V+Q  +IT+L+G+P D  +  
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + S+N  R+V+ LP+     F+ +F N    A+DLLEKMLVFDP KRI+  EAL HPYL 
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Query: 332 SLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
             HD  DEPV    F + F  +    D  + +++ E
Sbjct: 293 PYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  352 bits (904), Expect = e-121
 Identities = 134/286 (46%), Positives = 176/286 (61%), Gaps = 8/286 (2%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A +  T E VAIKKI   F++    +  LREIKLL+ + H N+I +
Sbjct: 4   LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSAS 165
            D+ R        D+Y+V+E MDTDL+++I+  Q+ L +   + +LYQLL+GL + HS  
Sbjct: 64  LDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +LHRDLKP NLL+N    LK+ DFGLAR+  S     T YVVTRWYRAPELLL    Y+ 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIWSVGCI  E+++R PLFPGK  + QL  I   +G+PD        S  AR Y    
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSF 237

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P+         FPN S  A+DLL +ML +DP+KRIT E+AL HPY 
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  348 bits (893), Expect = e-119
 Identities = 167/339 (49%), Positives = 226/339 (66%), Gaps = 6/339 (1%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 12  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 129

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT YV TRWYRAPE
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPE 187

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
           ++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    H
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307

Query: 335 DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           D +DEPV   P+   FE      D  + L + E + F P
Sbjct: 308 DPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  345 bits (885), Expect = e-118
 Identities = 159/339 (46%), Positives = 225/339 (66%), Gaps = 6/339 (1%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL
Sbjct: 10  VWEVPERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P    + FN+VY+V  LM  DL+ I++  Q+L+D+H Q+ +YQL
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQL 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSN+ +N  C+L+I DFGLAR     D MT YV TRWYRAPE
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPE 185

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
           ++AR+Y++ LP   +Q     F   +  A+DLLEKMLV D +KRI+  EAL HPY    H
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305

Query: 335 DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           D  DEP    P+    E+   T +  +EL + E   F P
Sbjct: 306 DPEDEPEAE-PYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  340 bits (873), Expect = e-116
 Identities = 152/339 (44%), Positives = 213/339 (62%), Gaps = 7/339 (2%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++E+  +Y    + +G GAYG VC+A++  T E+VAIKK+   F + I A+R  RE+ LL
Sbjct: 10  VWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68

Query: 96  RHMEHENVIAIKDIIRP-PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+       D F D Y+V   M TDL +I+     L++D  QY +YQ+
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQM 126

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           L GLKY+HSA ++HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++LN   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P    +  L  
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
             A+ Y++ LP+  ++ F+T FP  S  AVDLLEKML  D +KR+T  EAL HPY  S  
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 335 DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           D ++E    +P+    E+   + D  ++ I++E   F+P
Sbjct: 305 DADEETE-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  338 bits (869), Expect = e-115
 Identities = 145/349 (41%), Positives = 212/349 (60%), Gaps = 29/349 (8%)

Query: 44  VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           V P RPIG GA+G+V +  +    + VA+KK+ N F N++  +R  RE+K+L   +H+NV
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           ++  DI++PP  D F ++Y+V ELM +DLH+II S Q L+ DH + FLYQ+LRGLKY+HS
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCTE 221
           A +LHRD+KP NLL+N++C LKI DFGLAR     E+  MT+ VVT++YRAPE+L+    
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           YT+A+DIWSVGCI  E++ R  LF  +  + QL LIT+L+G+P   ++       AR ++
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHI 240

Query: 282 RQLPRCRKQQFATRFPNKSSG----AVDLLEKMLVFDPNKRITVEEALRHPYLQS----- 332
            + P   K          SS     AV LL +MLVFDP+KRI+  +AL HPYL       
Sbjct: 241 LRGP--HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRY 298

Query: 333 ---------------LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR 366
                          ++  + EP    PF  ++E +  +   ++E + +
Sbjct: 299 HTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  334 bits (859), Expect = e-114
 Identities = 155/348 (44%), Positives = 228/348 (65%), Gaps = 6/348 (1%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           Y +  V   ++EV  +Y   ++ +G GAYG VC+A++  T  +VAIKK+   F + + A+
Sbjct: 1   YYRQEVNKTIWEVPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK 59

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE++LL+HM+HENVI + D+  P    D F+D Y+V   M TDL ++++  ++L++D
Sbjct: 60  RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED 118

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             Q+ +YQ+L+GLKY+H+A ++HRDLKP NL +N  C+LKI DFGLAR T     MT YV
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYV 176

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VTRWYRAPE++LN   YT  +DIWSVGCI+ E++T +PLF G D++ QL  I ++ G+P 
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  L+S++A+ YV++LPR RK+ F +  PN +  AV++LEKMLV D   RIT  EAL
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296

Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HPY +  HD  DE   P P+   F+    + +  + L + E + F P
Sbjct: 297 AHPYFEEFHDPEDETEAP-PYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  316 bits (813), Expect = e-107
 Identities = 116/286 (40%), Positives = 165/286 (57%), Gaps = 15/286 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA--RRTLREIKLLRHMEHENVIAIK 107
           +G G YG+V  A + +T E VA+KKI    DN  +      LREI LL+ ++H N++ + 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D+I   +K     +Y+V+E  D DL + +      L+ +  +  +YQLLRGL Y HS  +
Sbjct: 65  DVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLKP N+L+N    LK+ DFGLAR         T  VVT WYRAPE+LL    Y+ A
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTA 179

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS-LGFLRSDNARRYVRQL 284
           +DIWSVGCI  E++T +PLFPG   + QL  I +++G+P + S  G  +  +   Y    
Sbjct: 180 VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD---YKPTF 236

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P+   +      P      +DLL KML ++P KRI+ +EAL+HPY 
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  318 bits (818), Expect = e-107
 Identities = 151/349 (43%), Positives = 212/349 (60%), Gaps = 26/349 (7%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F V  +Y   ++PIG GA GIVCAA ++ T + VAIKK+   F N+  A+R  RE+ L++
Sbjct: 12  FTVLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70

Query: 97  HMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            + H+N+I + ++  P K  + F DVY+V ELMD +L Q+I+ D  L  +   Y LYQ+L
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQML 128

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
            G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +L    Y   +DIWSVGCI+GE++    LFPG D++ Q   I E +G+P D  +  L+  
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP- 246

Query: 276 NARRYVRQLPRCRKQQFATRFP-------------NKSSGAVDLLEKMLVFDPNKRITVE 322
             R YV   P+     F   FP              K+S A DLL KMLV DP KRI+V+
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306

Query: 323 EALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHI----RELIWRE 367
           +AL+HPY+   +D   E   P P  +D  HS    +H     +ELI++E
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYD--HSIDEREHTVEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  292 bits (750), Expect = 6e-98
 Identities = 114/290 (39%), Positives = 167/290 (57%), Gaps = 14/290 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVI 104
           I  IG G YG V  A N +T E VA+KKI    +N  +      +REIKLL+ + H N++
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
            +K+I+    K     +Y+V+E MD DL  ++ S + + T+   + ++ QLL GL+Y+HS
Sbjct: 62  RLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCTE 221
             +LHRD+K SN+L+N    LK+ DFGLAR  +   +   T  V+T WYR PELLL  T 
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRY 280
           Y   +D+WSVGCIL E+   +P+F G   + QL  I EL GSP D +  G  +       
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238

Query: 281 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             +  +  K++    F +     A+DLL+K+L  DP KRI+ ++AL+H Y
Sbjct: 239 --KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  282 bits (723), Expect = 2e-94
 Identities = 102/285 (35%), Positives = 157/285 (55%), Gaps = 35/285 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G G++G V  A + +T + VAIK I        D  R LREIK+L+ ++H N++ +
Sbjct: 4   LEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+      +  + +Y+V E  +  DL  +++   +L++D  +++L Q+L  L+Y+HS  
Sbjct: 63  YDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP N+LL+    +K+ DFGLAR     + +T +V T  Y APE+LL    Y  A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKA 176

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWS+G IL E++T +P FPG D   QL  + + IG P                     
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP--------------------- 212

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
              K  F     + S  A DL+ K+LV DP KR+T EEAL+HP+ 
Sbjct: 213 ---KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  283 bits (726), Expect = 1e-93
 Identities = 136/356 (38%), Positives = 205/356 (57%), Gaps = 40/356 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F++ S+Y+  +RP+G G+ G+V +AV+S+  + VA+KKI     +    +  LREIK++R
Sbjct: 1   FDLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIR 57

Query: 97  HMEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQLTDDHC 147
            ++H+N++ + +++ P   D           N VYIV E M+TDL  ++     L+++H 
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHA 116

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT----SETDFMT 202
           + F+YQLLRGLKY+HSA+VLHRDLKP+N+ +N     LKIGDFGLAR      S   +++
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 262
           E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T +PLF G   + Q++LI E + 
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 263 SPDDASLG--------FLRSDNA--RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV 312
              +            F+R+D    RR +R L            P  +  A+D LE++L 
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDL-----------LPGVNPEALDFLEQILT 285

Query: 313 FDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE-DHIRELIWRE 367
           F+P  R+T EEAL HPY+       DEPV   PFH + E         I  +I+  
Sbjct: 286 FNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNW 341

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  275 bits (705), Expect = 5e-91
 Identities = 121/295 (41%), Positives = 165/295 (55%), Gaps = 18/295 (6%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLR 96
           +Y    + +G G Y +V  A + ET   VAIKKI       A D I      LREIKLL+
Sbjct: 1   RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQ 57

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLL 155
            ++H N+I + D+     K   N   +V+E M+TDL ++I+     LT    + ++   L
Sbjct: 58  ELKHPNIIGLLDVF--GHKSNIN---LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL 112

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPE 214
           RGL+Y+HS  +LHRDLKP+NLL+ +   LK+ DFGLAR+  S    MT  VVTRWYRAPE
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           LL     Y   +D+WSVGCI  E++ R P  PG   + QL  I E +G+P + +   + S
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                YV   P          FP  S  A+DLL+++L  +PNKRIT  +AL HPY
Sbjct: 233 LP--DYVEFKPF-PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  264 bits (677), Expect = 5e-87
 Identities = 111/297 (37%), Positives = 168/297 (56%), Gaps = 30/297 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           I+ +G G +G V  A N ET E VAIKK+   F +  +    LRE+K LR + EH N++ 
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVK 62

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 163
           +K++ R       +++Y V+E M+ +L+Q+++  +    ++   +  +YQ+L+GL ++H 
Sbjct: 63  LKEVFR-----ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
               HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+LL  T Y+
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD----------ASLGFLR 273
           + +DIW++GCI+ E+ T  PLFPG   + QL  I  ++G+P            + LGF  
Sbjct: 178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-- 235

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    + P+          PN S  A+DL++ ML +DP KR T  +AL+HPY 
Sbjct: 236 ---------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  264 bits (676), Expect = 8e-87
 Identities = 109/288 (37%), Positives = 170/288 (59%), Gaps = 17/288 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG GA+GIV  A + ET E VA+KK+        I    + LREIK L+  +H  V+ + 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLL 65

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D+         +   +V E M +DL +++R  ++ L +   + ++  LL+G+ Y+H+  +
Sbjct: 66  DVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTA 224
           +HRDLKP+NLL++A   LKI DFGLAR  SE +    +  V TRWYRAPELL    +Y  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--DNARRYVR 282
            +D+W+VGCI  E++   PLFPG++ + QL ++   +G+P++ +   L S  D  +    
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +      ++    FP+ S  A+DLL+ +LV+DP+KR++  EALRHPY 
Sbjct: 241 ESKPIPLEEI---FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  264 bits (676), Expect = 6e-86
 Identities = 147/360 (40%), Positives = 210/360 (58%), Gaps = 25/360 (6%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 5   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I  +  L 
Sbjct: 64  AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LD 121

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT 
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E +G+
Sbjct: 182 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240

Query: 264 PDDASLGFLRS--DNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEK 309
           P   S  F+       R YV   P+     F   FP+            K+S A DLL K
Sbjct: 241 P---SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSK 297

Query: 310 MLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD--FEHSSCTEDHIRELIWRE 367
           MLV DP+KRI+V+EALRHPY+   +D   E   P P  +D   E      +  +ELI++E
Sbjct: 298 MLVIDPDKRISVDEALRHPYITVWYD-PAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 356

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  261 bits (668), Expect = 6e-85
 Identities = 146/356 (41%), Positives = 215/356 (60%), Gaps = 19/356 (5%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 2   QFYSVEVGDSTFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDH 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLV 312
               +  L+    R YV   P+     F   FP+            K+S A DLL KMLV
Sbjct: 238 CPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 313 FDPNKRITVEEALRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
            DP KRI+V+EAL+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 297 IDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  259 bits (664), Expect = 4e-84
 Identities = 144/345 (41%), Positives = 206/345 (59%), Gaps = 19/345 (5%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++
Sbjct: 20  FTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78

Query: 97  HMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQML 136

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
            G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+  
Sbjct: 197 ILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP- 254

Query: 276 NARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEE 323
             R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+E
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314

Query: 324 ALRHPYLQSLHD-LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           AL+HPY+   +D    E   P+      +    T +  +ELI++E
Sbjct: 315 ALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  254 bits (650), Expect = 2e-83
 Identities = 94/286 (32%), Positives = 151/286 (52%), Gaps = 31/286 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G G++G V  A +  T + VA+K +    +     +   REI++LR + H N++ +
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D          + +Y+V E  +  DL   +     L++D  +    Q+LRGL+Y+HS  
Sbjct: 64  IDAFE-----DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRDLKP N+LL+ +  +KI DFGLA+   ++   +T +V T WY APE+LL    Y  
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+G IL E++T +P F G++ + QL+LI  ++G P +       S          
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS---------- 228

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                          S  A DL++K L  DP+KR T EE L+HP+ 
Sbjct: 229 --------------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  254 bits (650), Expect = 8e-83
 Identities = 113/288 (39%), Positives = 164/288 (56%), Gaps = 16/288 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVIAIK 107
           I  G YG+V  A + +T E VA+KK+    +   +     +LREI +L  ++H N++ +K
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +++        + +Y+V E ++ DL  ++    Q       +  + QLL G+ ++H   +
Sbjct: 71  EVV---VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLK SNLLLN    LKI DFGLAR         T+ VVT WYRAPELLL   EY+ A
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQ- 283
           ID+WSVGCI  E++T++PLFPGK  + QL  I +L+G+P +    GF     A++     
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTK 247

Query: 284 LPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            P     Q   +FP    S    DLL ++L +DP KRI+ E+AL+HPY
Sbjct: 248 YPYN---QLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  239 bits (612), Expect = 3e-77
 Identities = 117/291 (40%), Positives = 163/291 (56%), Gaps = 24/291 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG+V  A +  T E VA+KKI    ++       +REI LL+ + H N++ + D+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +    K     +Y+V+E +D DL + + S     L     + +LYQLL+G+ Y HS  VL
Sbjct: 67  VHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------MTEYVVTRWYRAPELLLNCTE 221
           HRDLKP NLL++    LK+ DFGLAR      F       T  VVT WYRAPE+LL   +
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--DNARR 279
           Y+  +DIWS+GCI  E++ R PLFPG   + QL  I   +G+PD+     + S  D    
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---- 232

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           Y    P+  +Q  +   PN     +DLL KMLV+DP KRI+ + AL+HPY 
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  239 bits (612), Expect = 3e-77
 Identities = 105/285 (36%), Positives = 164/285 (57%), Gaps = 9/285 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+V    N  T E VAIKK   + D+    +  LRE+K+LR + HEN++ +K+ 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R   +     +Y+V+E ++  L +++  S   L  D  + +++QLL+ + Y HS +++H
Sbjct: 69  FRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           RD+KP N+L++ S  LK+ DFG AR         +T+YV TRWYRAPELL+  T Y   +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           D+W++GCI+ E++  EPLFPG   + QL LI + +G    +      S+     V     
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243

Query: 287 CRKQQFATRFPNKSSG-AVDLLEKMLVFDPNKRITVEEALRHPYL 330
            + +    R+P K S  A+D L+  L  DP +R+T +E L+HPY 
Sbjct: 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  238 bits (609), Expect = 1e-76
 Identities = 117/287 (40%), Positives = 168/287 (58%), Gaps = 12/287 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR--RTLREIKLLRHMEHENVIAIK 107
           IG G YGIV  A ++ + E VA+KK+    DN  D     +LREI LL ++ H N++ +K
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKV--RMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASV 166
           +++        + +++V E  + DL  ++ +     ++   +  + QLLRGL+Y+H   +
Sbjct: 73  EVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRDLK SNLLL     LKI DFGLART       MT  VVT WYRAPELLL CT YT A
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQL 284
           ID+W+VGCIL E++  +PL PGK  + QL LI +L+G+P+++   GF       ++   L
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT--L 247

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           P+        +FP  S   + LL  +L++DP KR T EEAL   Y +
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  236 bits (604), Expect = 4e-76
 Identities = 112/297 (37%), Positives = 158/297 (53%), Gaps = 32/297 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHME---HE 101
           IG GAYG V  A +  T   VA+KK+      +  +       TLREI LL+ +E   H 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV-----RVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLK 159
           N++ + D+   P+ D    + +V+E +D DL   +       L  +  +  + QLLRG+ 
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++HS  ++HRDLKP N+L+ +   +KI DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS 181

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------PDDASLGFLR 273
           + Y   +D+WSVGCI  E+  R PLF G     QL  I ++IG       P + SL   R
Sbjct: 182 S-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL--PR 238

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           S          P    + F +  P      +DLL+KML F+P+KRI+  EAL+HPY 
Sbjct: 239 S--------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  235 bits (601), Expect = 5e-75
 Identities = 118/347 (34%), Positives = 185/347 (53%), Gaps = 53/347 (15%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARR-------- 87
           F +S +Y+     +G G YG V  A ++ T + VAIKK+      N +   R        
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 88  ---TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
              TLRE+K++  ++HEN++ + D+    + D  N   +V ++M +DL +++    +LT+
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTE 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----------- 193
              +  L Q+L GL  +H    +HRDL P+N+ +N+    KI DFGLAR           
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 194 ----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
               T    + MT  VVT WYRAPELL+   +Y  A+D+WSVGCI  E++T +PLFPG++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238

Query: 250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP------RCRKQQFATRFPNKSSGA 303
            + QL  I EL+G+P         +++     ++LP        + +   T FPN S  A
Sbjct: 239 EIDQLGRIFELLGTP---------NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDA 289

Query: 304 VDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR--PFHF 348
           +DLL+ +L  +P +RI+ +EAL+H Y +S    +  P  P   PF+F
Sbjct: 290 IDLLQSLLKLNPLERISAKEALKHEYFKS----DPLPCDPSQLPFNF 332

Length = 335

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  231 bits (591), Expect = 7e-74
 Identities = 116/308 (37%), Positives = 160/308 (51%), Gaps = 41/308 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAI 106
           +G G +G V  A   +T   VA+KKI   N  D   I A   LREIK+L+ ++H NV+ +
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKKLKHPNVVPL 72

Query: 107 KDII--RPPK-KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            D+   RP K K     VY+V   MD DL  ++ +   +LT+   + ++ QLL G+ Y+H
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------------TTSETDFMTEYVVTRW 209
              +LHRD+K +N+L++    LKI DFGLAR                   + T  VVTRW
Sbjct: 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVVTRW 191

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           YR PELLL    YT A+DIW +GC+  E+ TR P+  GK  + QL LI +L G+P + + 
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNK--------SSGAVDLLEKMLVFDPNKRITV 321
              RS         LP C      T +P              +DLL K+L  DP KR+T 
Sbjct: 252 PGWRS---------LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 322 EEALRHPY 329
            +AL HPY
Sbjct: 303 SDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  229 bits (586), Expect = 2e-73
 Identities = 101/284 (35%), Positives = 161/284 (56%), Gaps = 13/284 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           IG G +  V  A + +T +  AIK +   F ++ +    LREI+ LR +  H N++ + +
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIE 65

Query: 109 II--RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSAS 165
           ++  R   +        V+ELMD +L+++I+  ++ L +   + ++YQLL+ L ++H   
Sbjct: 66  VLFDRKTGRLAL-----VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           + HRD+KP N+L+     LK+ DFG  R        TEY+ TRWYRAPE LL    Y   
Sbjct: 121 IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIW+VGC+  EI++  PLFPG + + Q+  I +++G+PD   L   R      Y    P
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY--NFP 237

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             +        PN S+  +DLL+K+L +DP++RIT ++ALRHPY
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  226 bits (578), Expect = 3e-72
 Identities = 113/286 (39%), Positives = 159/286 (55%), Gaps = 10/286 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I    K     +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 65  LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPDYKPS 237

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            P+  +Q F+   P       DLL +ML +DPNKRI+ + AL HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  224 bits (572), Expect = 2e-71
 Identities = 109/290 (37%), Positives = 159/290 (54%), Gaps = 24/290 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVI 104
           +G G Y  V    N  T E VA+K+I       +DA        +REI L++ ++HEN++
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKELKHENIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYV 161
            + D+I      T N + +V+E MD DL + + +      L  +  + F YQLL+G+ + 
Sbjct: 62  RLHDVIH-----TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNC 219
           H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++LL  
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGS 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y+ +IDIWSVGCI+ E++T  PLFPG +   QL  I  ++G+P +++           
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP--GISQLPE 233

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
           Y    PR   Q     FP+     +DLL ++L  +P  RI+  +AL+HP+
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  222 bits (568), Expect = 1e-70
 Identities = 114/290 (39%), Positives = 165/290 (56%), Gaps = 11/290 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG+V  A +  T E +A+KKI    ++       +REI LL+ M+H N++ ++D+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH--CQYFLYQLLRGLKYVHSASVL 167
           +   K+     +Y+V+E +D DL + + S      +    + +LYQ+LRG+ Y HS  VL
Sbjct: 70  VHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 168 HRDLKPSNLLLNASCD-LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           HRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAPE+LL    Y+  
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI  E++ ++PLFPG   + +L  I  ++G+P++ +   + S     Y    P
Sbjct: 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFP 242

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           +   +  AT  P      VDLL KML  DP+KRIT   AL H Y + L D
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  218 bits (557), Expect = 6e-69
 Identities = 125/301 (41%), Positives = 172/301 (57%), Gaps = 27/301 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-----IIDARRTLREIKLLRHMEHE 101
           I  IG G YG V  A + +T E VA+KK+    DN      I A   +REIK+LR + H 
Sbjct: 12  IGQIGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITA---IREIKILRQLNHR 66

Query: 102 NVIAIKDIIRPP------KKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQL 154
           N++ +K+I+         KKD     Y+V+E MD DL  ++ S     ++DH + F+ QL
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRA 212
           L GL Y H  + LHRD+K SN+LLN    +K+ DFGLAR   + E+   T  V+T WYR 
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA---SL 269
           PELLL    Y  AID+WS GCILGE+ T++P+F     + QL LI+ L GSP  A    +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             L   N  +  +Q  R  +++F+   P   + A+DLL+ ML  DP+KR T EEAL  P+
Sbjct: 246 IKLPYFNTMKPKKQYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Query: 330 L 330
           L
Sbjct: 302 L 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  218 bits (556), Expect = 7e-69
 Identities = 104/288 (36%), Positives = 161/288 (55%), Gaps = 11/288 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G YG+V    N +T + VA+KKI    +        +REI LL+ ++H N++ +
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +D++    +     +Y+++E +  DL +    +   Q +  +  + +LYQ+L+G+ + HS
Sbjct: 65  QDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAPE+LL    Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
           +  +DIWS+G I  E+ T++PLF G   + QL  I  ++G+P +     + S     Y  
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDYKN 237

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             P+ +K    +   N     +DLLEKML++DP KRI+ ++AL HPY 
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  216 bits (553), Expect = 2e-68
 Identities = 112/288 (38%), Positives = 160/288 (55%), Gaps = 14/288 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 5   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSAS 165
            D++   KK T     +V+E  D DL +   S     D    + F++QLL+GL + HS +
Sbjct: 65  YDVLHSDKKLT-----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           VLHRDLKP NLL+N + +LK+ DFGLAR        +  E VVT WYR P++L     Y+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYS 178

Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYV 281
            +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P + S  G  +  + + Y 
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                          P  +S   DLL+ +LV +P +RI+ EEAL+HPY
Sbjct: 239 MYPATTSLVNVV---PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  213 bits (544), Expect = 5e-67
 Identities = 108/294 (36%), Positives = 154/294 (52%), Gaps = 26/294 (8%)

Query: 49  PIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHEN 102
            +G G+Y  V    +  T + VA+K+I      G  F  I       RE  LL+ ++H N
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHAN 64

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYV 161
           ++ + DII   K  T      V+E +DTDL Q +         H  + FL+QLLRGL Y 
Sbjct: 65  IVTLHDIIHTKKTLTL-----VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCT 220
           H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL  T
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSP-DDASLGFLRSDNAR 278
           EY+ ++D+W VGCI  E+ T  PLFPG  D   QL  I  ++G+P ++   G   +   +
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239

Query: 279 RYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            Y    P    +      P  ++     +L  K L ++P KRI+  EA++HPY 
Sbjct: 240 PY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  209 bits (535), Expect = 2e-65
 Identities = 112/314 (35%), Positives = 163/314 (51%), Gaps = 40/314 (12%)

Query: 50  IGRGAYGIVCAAVNSETR--EEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG YG V  A     +  +E AIKK  G+       ++   REI LLR ++HENV+++
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYV 161
            ++     +     VY++++  + DL QII+         +     +  L+Q+L G+ Y+
Sbjct: 68  VEVFL---EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 162 HSASVLHRDLKPSNLLLNASCD----LKIGDFGLAR-------TTSETDFMTEYVVTRWY 210
           HS  VLHRDLKP+N+L+         +KIGD GLAR         ++ D     VVT WY
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITELI 261
           RAPELLL    YT AIDIW++GCI  E++T EP+F G++            QL  I E++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241

Query: 262 GSPDDASLGFLRS----DNARRYVRQL--PRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 315
           G+P +     ++     D   +  +    P     ++  +     S   DLL K+L +DP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301

Query: 316 NKRITVEEALRHPY 329
            KRIT EEAL HPY
Sbjct: 302 TKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  209 bits (534), Expect = 3e-65
 Identities = 110/309 (35%), Positives = 164/309 (53%), Gaps = 31/309 (10%)

Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRH 97
           SKY   +  IG+G +G V  A + +T++ VA+KK+   N  +   I A   LREIK+L+ 
Sbjct: 12  SKYEK-LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKILQL 67

Query: 98  MEHENVIAIKDIIRPPKKDTFN---DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQ 153
           ++HENV+ + +I R             Y+V+E  + DL  ++ +   + T    +  +  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTR 208
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR  S +     +  T  VVT 
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS----- 263
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247

Query: 264 -PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRIT 320
            P    L   +         +LP+ +K++   R     K   A+DL++K+LV DP KRI 
Sbjct: 248 WPGVDKLELFK-------KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300

Query: 321 VEEALRHPY 329
            + AL H +
Sbjct: 301 ADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  206 bits (526), Expect = 2e-64
 Identities = 98/284 (34%), Positives = 167/284 (58%), Gaps = 11/284 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G+YG+V    N ET + VAIKK   + D+ +  +  LREI++L+ ++H N++ + ++
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R  +K     +++V+E  D T L+++ ++ + + +   +  ++Q L+ + + H  + +H
Sbjct: 69  FRRKRK-----LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+KP N+L+     +K+ DFG AR  +      T+YV TRWYRAPELL+  T+Y   +D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS--PDDASLGFLRSDNARRYVRQLP 285
           +W++GC+  E++T +PL+PGK  V QL LI + +G   P    + F  +   +      P
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI-FSTNQFFKGLSIPEP 242

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             R+    ++FPN SS A+  L+  L  DP +R++ EE L HPY
Sbjct: 243 ETRE-PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  205 bits (524), Expect = 4e-64
 Identities = 107/292 (36%), Positives = 161/292 (55%), Gaps = 13/292 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIA 105
           +  IG G YG V  A +  T + VA+KK     D        LREI LL+ +     ++ 
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-----LTDDHCQYFLYQLLRGLKY 160
           + D+    +K+    +Y+V+E +D+DL + + S+ +     L     + F+YQLL+G+ +
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 161 VHSASVLHRDLKPSNLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
            H   V+HRDLKP NLL++     LKI D GL R  +      T  +VT WYRAPE+LL 
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNA 277
            T Y+  +DIWSVGCI  E+  ++PLFPG   + QL  I +L+G+P +    G  +  + 
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW 245

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             +    P+ + Q  +   P+ S   +DLL+KML +DP KRI+ + AL HPY
Sbjct: 246 HEF----PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  200 bits (509), Expect = 8e-62
 Identities = 111/287 (38%), Positives = 156/287 (54%), Gaps = 11/287 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 72

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   K  T     +V+E +D DL Q +       + H  + FL+QLLRGL Y H   VLH
Sbjct: 73  IHTEKSLT-----LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  T+Y+  ID
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPR 286
           +W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L ++  + Y    P+
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--NYPK 245

Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            R        P   S   +LL K+L F+  KRI+ EEA++HPY   L
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  196 bits (499), Expect = 2e-60
 Identities = 108/284 (38%), Positives = 159/284 (55%), Gaps = 11/284 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL++++H N++ + DI
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIREVSLLKNLKHANIVTLHDI 71

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   +  T     +V+E +D+DL Q + +   L   H  + F++QLLRGL Y H   +LH
Sbjct: 72  IHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  TEY+  ID
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNARRYVRQLPR 286
           +W VGCIL E+ T  P+FPG     +L LI  L+G+P ++   G   ++  R Y+   P+
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL--FPQ 244

Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            R Q      P   +  +DLL  +L+++   RI+ E ALRH Y 
Sbjct: 245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  195 bits (498), Expect = 3e-60
 Identities = 102/285 (35%), Positives = 172/285 (60%), Gaps = 13/285 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG+V    + ET + VAIKK   + D+ +  +  +REI++L+ + HEN++ + ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R  K+     +Y+V+E +D T L  + +    L +   + +L+Q+LRG+++ HS +++H
Sbjct: 69  FRRKKR-----LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+KP N+L++ S  +K+ DFG ART  +  +  T+YV TRWYRAPELL+  T+Y  A+D
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--SPDDASLGFLRSDNARRYVRQLP 285
           IW+VGC++ E++T EPLFPG   + QL  I + +G   P    + F +  N      +LP
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQK--NPLFAGMRLP 240

Query: 286 RCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             ++ +    RFP  S   +DL ++ L  DP+ R +  + L H +
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  191 bits (486), Expect = 3e-58
 Identities = 108/287 (37%), Positives = 158/287 (55%), Gaps = 11/287 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 72

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           +   K  T     +V+E +D DL Q +     +   H  + FLYQ+LRGL Y H   VLH
Sbjct: 73  VHTDKSLT-----LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  +EY+  ID
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNARRYVRQLPR 286
           +W VGCI  E+ +  PLFPG     +L LI  L+G+P ++   G   +D  + Y    P+
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFPK 245

Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            + Q      P   +  ++LL K L ++  KRI+ EEA++H Y +SL
Sbjct: 246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  184 bits (467), Expect = 1e-55
 Identities = 105/284 (36%), Positives = 165/284 (58%), Gaps = 12/284 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+V    + ET+E VAIKK  ++ +N      TLRE+K+LR ++ EN++ +K+ 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R   K     +Y+V+E ++ ++ +++      +  +  + ++YQL++ + + H   ++H
Sbjct: 69  FRRRGK-----LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAI 226
           RD+KP NLL++ +  LK+ DFG AR  SE      TEYV TRWYR+PELLL    Y  A+
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAV 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           D+WSVGCILGE+   +PLFPG+  + QL  I +++G P  A    L   N R +  + P 
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG-PLPAEQMKLFYSNPRFHGLRFPA 241

Query: 287 C-RKQQFATRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHP 328
               Q    R+    SG  +DL++ +L  +P  R   E+ L HP
Sbjct: 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  179 bits (455), Expect = 7e-54
 Identities = 103/299 (34%), Positives = 164/299 (54%), Gaps = 13/299 (4%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLL 95
           F  ++ Y+  +  +G G+Y  V   ++    + VA+K I     + +      +RE  LL
Sbjct: 1   FGAATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLL 57

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQL 154
           + ++H N++ + DII   +  TF     V+E M TDL Q +I+    L   + + F++QL
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAP 213
           LRGL Y+H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSP-DDASLGF 271
           ++LL  T+Y++A+DIW  GCI  E++  +P FPG  D   QL  I  ++G P +D   G 
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            +  N +       + ++ +   +  ++   A DL  +ML+  P  RI+ ++AL HPY 
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  176 bits (448), Expect = 1e-53
 Identities = 67/193 (34%), Positives = 111/193 (57%), Gaps = 10/193 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V  A + +T ++VAIK I    D+       LREI++L+ + H N++ +  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVL 167
                 +  N +Y+V E  +   L  +++ ++  L++D     L Q+L GL+Y+HS  ++
Sbjct: 60  F-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 168 HRDLKPSNLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           HRDLKP N+LL++    +K+ DFGL++  TS+   +   V T  Y APE+LL    Y+  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 226 IDIWSVGCILGEI 238
            DIWS+G IL E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  176 bits (447), Expect = 1e-52
 Identities = 105/295 (35%), Positives = 153/295 (51%), Gaps = 20/295 (6%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR---HMEHEN 102
           P+  IG GAYG V  A +  +   VA+K +    +       T+RE+ LL+     +H N
Sbjct: 4   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKY 160
           ++ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LRGL +
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL  T
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+  R 
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DDWPRD 234

Query: 281 VRQLPRC----RKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           V  LPR     R  +      P        LL +ML F+P+KRI+   AL+HP+ 
Sbjct: 235 V-TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  173 bits (442), Expect = 3e-52
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 36/287 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRG++G V  A++ +T E +A+K +  + D+  +     REI++L  ++H N++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
              R  +K+T N   I  E +    L  +++   +L +   + +  Q+L GL Y+HS  +
Sbjct: 66  GSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPELLLNCTEYT 223
           +HRD+K +N+L+++   +K+ DFG A+     ET   T  V  T ++ APE ++   EY 
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYG 181

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A DIWS+GC + E+ T +P +               IGS  +                +
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALY---KIGSSGE--------------PPE 224

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +P            + S  A D L K L  DP KR T +E L+HP+L
Sbjct: 225 IP-----------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  164 bits (415), Expect = 6e-48
 Identities = 104/294 (35%), Positives = 152/294 (51%), Gaps = 19/294 (6%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HE 101
            +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H 
Sbjct: 5   CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLK 159
           NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ- 183

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA----SLGFLRSD 275
           + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +      +   R  
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
              +          Q       +      DLL K L F+P KRI+   AL HPY
Sbjct: 244 FHSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (414), Expect = 6e-47
 Identities = 80/324 (24%), Positives = 137/324 (42%), Gaps = 42/324 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHM-EHENVI 104
           +R +G G++G V  A +   R+ VA+K +    ++      R LREI++L  +    N++
Sbjct: 5   LRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
            + D  +         +Y+V E +D   L  +++   +   L++    + L Q+L  L+Y
Sbjct: 62  KLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 161 VHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-------FMTEYVVTRWYRA 212
           +HS  ++HRD+KP N+LL+     +K+ DFGLA+   +           +  V T  Y A
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 213 PELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           PE+LL  +    +++ DIWS+G  L E++T  P F G+          ++I         
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII--------- 227

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                         P        +     S  A DLL+K+L  DP  R++    L H  L
Sbjct: 228 ---------LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Query: 331 QSLHDLNDEPVCPRPFHFDFEHSS 354
             L     +               
Sbjct: 279 AHLKLKESDLSDLLKPDDSAPLRL 302

Length = 384

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  164 bits (416), Expect = 1e-46
 Identities = 97/297 (32%), Positives = 163/297 (54%), Gaps = 22/297 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A+  +T E+VAIKK+      + D +   RE+ +++++ H N+I +KD 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 110 -----IRPPKKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKY 160
                 +  +K+ F +V  V E +   +H+ +    R++  L     + + YQL R L Y
Sbjct: 128 YYTECFKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 161 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           +HS  + HRDLKP NLL++ +   LK+ DFG A+          Y+ +R+YRAPEL+L  
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
           T YT  ID+WS+GCI+ E++   P+F G+  V QL  I +++G+P +  L  +  + A  
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD- 304

Query: 280 YVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
              + P  + +     FP  +   A++ + + L ++P KR+   EAL  P+   L D
Sbjct: 305 --IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  156 bits (396), Expect = 2e-45
 Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 46/293 (15%)

Query: 43  YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
               +  IG+G +G V  A +  T +EVAIK I    ++     + + EI++L+  +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           ++      ++       ++++IV E      L  +++S +Q LT+    Y   +LL+GL+
Sbjct: 59  IVKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  ++HRD+K +N+LL +  ++K+ DFGL+   S+T      V T ++ APE ++N 
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VING 171

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y    DIWS+G    E+   +P  P  +                      L    A  
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKP--PYSE----------------------LPPMKALF 207

Query: 280 YVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            +                N    S    D L+K L  +P KR T E+ L+HP+
Sbjct: 208 KIATNG-------PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  156 bits (395), Expect = 6e-45
 Identities = 105/307 (34%), Positives = 160/307 (52%), Gaps = 42/307 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEH 100
           +  +G G+Y  V    +    + VA+K I      G  F  I       RE  LL+ ++H
Sbjct: 10  LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKH 62

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLK 159
            N++ + DII    K+T     +V+E + TDL Q + +    L  ++ + FL+QLLRGL 
Sbjct: 63  ANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN 218
           Y+H   +LHRDLKP NLL++ + +LK+ DFGLAR  S  +   +  VVT WYR P++LL 
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRSDNA 277
            TEY+  +D+W VGCI  E++     FPG KD   QL  I  ++G+P++ +   + S   
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS--- 234

Query: 278 RRYVRQLPRCRKQQFATRFPNKS-----------SGAVDLLEKMLVFDPNKRITVEEALR 326
                 LP  + ++F T +  K+           + A DL  K+L   P  R++ + AL 
Sbjct: 235 ------LPHFKPERF-TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287

Query: 327 HPYLQSL 333
           H Y   L
Sbjct: 288 HEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  154 bits (393), Expect = 6e-45
 Identities = 79/298 (26%), Positives = 143/298 (47%), Gaps = 49/298 (16%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KY   I+ IG+G++G V         +   +K+I  +  +  +    L E+K+L+ + H 
Sbjct: 1   KYEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59

Query: 102 NVIAIKDIIRPPKKDTFND---VYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQ 153
           N+I   +        +F +   + IV E  D  DL Q I+  ++      ++    +  Q
Sbjct: 60  NIIKYYE--------SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRA 212
           L   LKY+HS  +LHRD+KP N+ L ++  +K+GDFG+++  S T  + + VV T +Y +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PEL  N   Y    DIWS+GC+L E+ T +  F G+   + L L  +++           
Sbjct: 172 PELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKIL----------- 216

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        + +     +++   SS   +L+  +L  DP +R ++ + L+ P++
Sbjct: 217 -------------KGQYPPIPSQY---SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  151 bits (385), Expect = 2e-43
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 50/290 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG GA G V  A +  T +EVAIKK+     N       + EI +++  +H N++   D 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIV---DY 80

Query: 110 IRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                 D++   +++++V E MD    TD+  I ++  ++ +    Y   ++L+GL+Y+H
Sbjct: 81  Y-----DSYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           S +V+HRD+K  N+LL+    +K+ DFG  A+ T E       V T ++ APE++    +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KD 192

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y   +DIWS+G +  E+   EP +  +  +  L LIT   G P           N  ++ 
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP--------PLKNPEKW- 242

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                             S    D L K LV DP KR + EE L+HP+L+
Sbjct: 243 ------------------SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  146 bits (369), Expect = 6e-41
 Identities = 107/322 (33%), Positives = 157/322 (48%), Gaps = 54/322 (16%)

Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A   + ++E   A+K+I    +    +    REI LLR ++H NVIA++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIR---------SDQQLTDDHCQYFLYQLLRGL 158
            +       +   V+++++  + DL  II+            QL     +  LYQ+L G+
Sbjct: 65  KVFL---SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITELI 261
           RAPELLL    YT AIDIW++GCI  E++T EP+F  +          +  QL  I  ++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-------------SGAVDLLE 308
           G P D     +R       + + P  +K    T + N S             S    LL+
Sbjct: 242 GFPADKDWEDIRK------MPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295

Query: 309 KMLVFDPNKRITVEEALRHPYL 330
           K+L  DP KRIT E+AL+ PY 
Sbjct: 296 KLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  140 bits (355), Expect = 7e-39
 Identities = 105/316 (33%), Positives = 159/316 (50%), Gaps = 42/316 (13%)

Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A   + +++   A+K+I    +    +    REI LLR ++H NVI+++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+  +         QL     +  LYQ+L G+
Sbjct: 65  KVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--------YVH-QLRLITELI 261
           RAPELLL    YT AIDIW++GCI  E++T EP+F  +         Y H QL  I  ++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 262 GSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFPNK-SSGAVDLLEKMLVFD 314
           G P D     ++     S   + + R     C   ++  +   K  S A  LL+K+L  D
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 315 PNKRITVEEALRHPYL 330
           P KRIT E+A++ PY 
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  137 bits (348), Expect = 3e-38
 Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 56/298 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVI- 104
           ++ +G+G+ G+V    +  T +  A+KKI    D   + R+ L RE+K LR  E   V+ 
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 105 ---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              A     +        ++ IV E MD   L  +++   ++ +    Y   Q+L+GL Y
Sbjct: 64  CYGAF---YKE------GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 161 VHSAS-VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLN 218
           +H+   ++HRD+KPSNLL+N+  ++KI DFG+++    T      +V T  Y +PE  + 
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQ 173

Query: 219 CTEYTAAIDIWSVGCILGE-IMTREPLFPGK--DYVHQLRLI--TELIGSPDDASLGFLR 273
              Y+ A DIWS+G  L E  + + P  P     +   ++ I        P +       
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF----- 228

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           S   R ++     C                   L+K    DP KR +  E L+HP+++
Sbjct: 229 SPEFRDFIS---AC-------------------LQK----DPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 7e-38
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 38/283 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRGA+G+V   +N ET + VAIK+I          +  ++EI LL++++H N++     
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I      T + +YI+ E  +   L QII+      +     ++YQ+L+GL Y+H   V+H
Sbjct: 68  IE-----TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAID 227
           RD+K +N+L      +K+ DFG+A   ++       VV T ++ APE++   +  + A D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASD 181

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 287
           IWS+GC + E++T  P +   + +  L  I +    P                   LP  
Sbjct: 182 IWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-------------------LP-- 220

Query: 288 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                       S    D L +    DPN R T ++ L+HP++
Sbjct: 221 ---------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 79/289 (27%), Positives = 135/289 (46%), Gaps = 49/289 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAI 106
           +G+G++G V      +T +  A+K +      II  +    TL E  +L  + H  ++ +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               +  +K     +Y+V E     +L   +  + + +++  +++  +++  L+Y+HS  
Sbjct: 59  HYAFQTEEK-----LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +++RDLKP N+LL+A   +K+ DFGLA+  +SE      +  T  Y APE+LL    Y  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGK 172

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D WS+G +L E++T +P F  +D       I E I          L+           
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKI----------LKDP--------- 209

Query: 285 PRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPY 329
                     RFP   S  A DL+  +L  DP KR+     EE   HP+
Sbjct: 210 ---------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  130 bits (330), Expect = 1e-35
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHE 101
            + +G GA+G V              EVA+K +    D         LRE +++R ++H 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLDHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGL 158
           N++ +  +    +      + IV E M   DL   +R    ++L+      F  Q+ RG+
Sbjct: 62  NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRA 212
           +Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y V       RW  A
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-A 172

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           PE L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 173 PESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  130 bits (330), Expect = 1e-35
 Identities = 83/295 (28%), Positives = 143/295 (48%), Gaps = 51/295 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIK 107
           IG+G++G V         + +  K+I   + N+ +  +   + E+ +LR ++H N++   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 108 D-IIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
           D II    +     +YIV E  +  DL Q+I    +  + + ++     L QLL  L   
Sbjct: 66  DRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 162 H-----SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H       +VLHRDLKP+N+ L+A+ ++K+GDFGLA+    ++ F   YV T +Y +PE 
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L +   Y    DIWS+GC++ E+    P F  ++   QL+L +++               
Sbjct: 182 LNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGK----------- 226

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                 R++P              SS   ++++ ML  DP+KR + EE L+ P +
Sbjct: 227 -----FRRIP-----------YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  129 bits (328), Expect = 2e-35
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHE 101
            + +G GA+G V          + + EVA+K +  +A +  I+    LRE +++R ++H 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLK 159
           NV+ +  +    +      +YIV E M+  DL   +R +  +L+      F  Q+ RG++
Sbjct: 62  NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAP 213
           Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y         RW  AP
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-AP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           E L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 173 ESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (313), Expect = 2e-33
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 58/295 (19%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIA 105
           +G G++G V   +N +  +  A+K++ +  D+    +  +    +EI LL  ++H N++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                R         +YI  EL+    L ++++      +   + +  Q+L GL+Y+H  
Sbjct: 67  YLGTEREEDN-----LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           + +HRD+K +N+L++ +  +K+ DFG+A+   E  F   +  + ++ APE++     Y  
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL--IGS-------PDDASLGFLRSD 275
           A DIWS+GC + E+ T +P +       QL  +  +  IG        PD        SD
Sbjct: 182 AADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDHL------SD 229

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            A+ ++ +                           L  DP+ R T  E L HP++
Sbjct: 230 EAKDFILKC--------------------------LQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  124 bits (313), Expect = 3e-33
 Identities = 85/307 (27%), Positives = 133/307 (43%), Gaps = 76/307 (24%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENV 103
           IG G +G V  AVN +T E +A+K+I            I D      E+K+L  ++H N+
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNL 61

Query: 104 -----IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHC-QYFLYQLLR 156
                + +              VYI  E      L +++   + L D+H  + +  QLL 
Sbjct: 62  VKYYGVEVHR----------EKVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLE 110

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYR 211
           GL Y+HS  ++HRD+KP+N+ L+ +  +K+GDFG A      TT+  + +     T  Y 
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 212 APELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------ 263
           APE++       +  A DIWS+GC++ E+ T +  +   D   Q   I   +G+      
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGAGHKPPI 227

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 323
           PD   L                              S    D L++ L  DP KR T  E
Sbjct: 228 PDSLQL------------------------------SPEGKDFLDRCLESDPKKRPTASE 257

Query: 324 ALRHPYL 330
            L+HP++
Sbjct: 258 LLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  120 bits (304), Expect = 8e-32
 Identities = 86/325 (26%), Positives = 132/325 (40%), Gaps = 91/325 (28%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK----------LL 95
             + IG G++  V  A   ET +E AIK        I+D R+ ++E K          L 
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 96  RHMEHENVIAIKDIIRPPKK--DTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQY 149
           R   H  +I          K   TF D   +Y V E   + +L Q IR    L +   ++
Sbjct: 57  RLNGHPGII----------KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------ 203
           +  ++L  L+Y+HS  ++HRDLKP N+LL+    +KI DFG A+                
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 204 ---------------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
                          +V T  Y +PELL        + D+W++GCI+ +++T +P F G 
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Query: 249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 308
           +     + I +                             +  F   FP     A DL+E
Sbjct: 226 NEYLTFQKILK----------------------------LEYSFPPNFPPD---AKDLIE 254

Query: 309 KMLVFDPNKRITV----EEALRHPY 329
           K+LV DP  R+ V    +E   HP+
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  114 bits (288), Expect = 1e-29
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 51/289 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKK--IGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G+YG V  A++ ET + VAIK   +      II      +EI +L+  +   ++   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYY 64

Query: 108 DIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                  K+   D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS
Sbjct: 65  GSYF---KN--TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS 117

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEY 222
              +HRD+K  N+LLN     K+ DFG++   ++T      V+ T ++ APE++     Y
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGY 176

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
               DIWS+G    E+   +P  P  D +H +R I  +   P                  
Sbjct: 177 NNKADIWSLGITAIEMAEGKP--PYSD-IHPMRAIFMIPNKP------------------ 215

Query: 283 QLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                     +   P K S    D ++K LV DP +R +  + L+HP++
Sbjct: 216 ------PPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (288), Expect = 1e-29
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
            + +G GA+G V           T  +VA+K +     +  +    L E  +++ + H N
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPN 62

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           ++ +  +    +      +YIV E M   DL   +R   ++LT         Q+ +G++Y
Sbjct: 63  IVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 213
           + S + +HRDL   N L+  +  +KI DFGL+R   E D    Y          +W  AP
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-AP 173

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           E L +  ++T+  D+WS G +L EI T   +P +PG  
Sbjct: 174 ESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQP-YPGMS 209

Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  114 bits (287), Expect = 1e-29
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 25/204 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           + IG+G + +V  A+       VA+KK+   F+ ++DA+     L+EI LL+ ++H NVI
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLL 155
                       +F   N++ IV EL D  DL ++I   +  ++L  +    +YF  QL 
Sbjct: 66  KYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
             L+++HS  ++HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 215 LLLNCTEYTAAIDIWSVGCILGEI 238
            +     Y    DIWS+GC+L E+
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  113 bits (284), Expect = 3e-29
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 54/296 (18%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PIR +G+GA+G       +E    V  K++     +  + R  L EI +L  ++H N+IA
Sbjct: 4   PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 106 -----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDH-CQYFLYQLLRG 157
                + D          N + I  E  +   L+  I R   QL ++    ++L+Q++  
Sbjct: 64  YYNHFMDD----------NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELL 216
           + Y+H A +LHRD+K  N+ L  +  +K+GDFG+++       M E VV T +Y +PEL 
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL- 172

Query: 217 LNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
             C   +Y    DIW++GC+L E++T +  F   +    L L+ +++            +
Sbjct: 173 --CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGN--------YT 219

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                Y                   SS  + L+  +L  DP KR T +E L  P L
Sbjct: 220 PVVSVY-------------------SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (281), Expect = 1e-28
 Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 34/234 (14%)

Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G GA+G V             EVA+K +     +  + +  L+E ++++ + H NV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFLYQL 154
            +  +           +Y+V E M+  DL   +R             L+      F  Q+
Sbjct: 60  RLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 207
            +G++Y+ S   +HRDL   N L+     +KI DFGL+R   + D+   Y          
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPI 171

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPLFPGKDYVHQLRLITE 259
           RW  APE L +   +T+  D+WS G +L EI T    P +PG      L  + +
Sbjct: 172 RWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  109 bits (275), Expect = 8e-28
 Identities = 81/301 (26%), Positives = 135/301 (44%), Gaps = 53/301 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAI 106
           I +GAYG V  A    T +  AIK I  A     N +D   T R+I  L   +   V+ +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               +        ++Y+V E +   DL  ++ +   L +D  + ++ +++  L+Y+HS  
Sbjct: 59  YYSFQ-----GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFM-------TEYVVTRWYRAPELL 216
           ++HRDLKP N+L++++  LK+ DFGL++         +          V T  Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L    ++  +D WS+GCIL E +   P F G+          E+               N
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIF-------------QN 212

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL 333
                 + P              S  A+DL+ K+LV DP KR+   ++EE   HP+ + +
Sbjct: 213 ILNGKIEWPED---------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263

Query: 334 H 334
            
Sbjct: 264 D 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  105 bits (265), Expect = 2e-26
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHMEHENVIAIK 107
           +G+G+YG V         +  A+K++     ++    R   + EI++L  + H N+I+ K
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 108 DIIRPPKKDTF---NDVYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLK 159
           +         F   N + IV E     DL + I   ++    + +        QLLRGL+
Sbjct: 66  E--------AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
            +H   +LHRDLK +N+LL A+  +KIGD G+++   +    T+ + T  Y APE+    
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG- 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y+   DIWS+GC+L E+ T  P F  +  +  LR                        
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRY----------------------- 211

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                 + ++ ++    P  S    + +  ML   P  R   ++ L  P +
Sbjct: 212 ------KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 72/289 (24%), Positives = 140/289 (48%), Gaps = 45/289 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR----EIKLLRHMEHENVIA 105
           +G+GA+G V    + +T  E+A+K++    D+  + ++ +     EI+LL++++HE ++ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP-ETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               +R  +      + I  E M    +   +++   LT+   + +  Q+L G++Y+HS 
Sbjct: 69  YYGCLRDDET-----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++HRD+K +N+L +++ ++K+GDFG    L    S    M     T ++ +PE++    
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WSVGC + E++T +P  P  ++   +  I ++   P +              
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNP------------- 226

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             QLP            + S  A + L +  V +  KR + EE LRH +
Sbjct: 227 --QLP-----------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 4e-26
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 59/293 (20%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI--- 104
           IG+G++G V  A++  T + VAIK I    A D I D     +EI+ L       +    
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYY 65

Query: 105 --AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
              +K           + ++I+ E        DL +  +    L + +  + L ++L GL
Sbjct: 66  GSFLKG----------SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGL 111

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLL 217
           +Y+H    +HRD+K +N+LL+   D+K+ DFG++ + TS       +V T ++ APE++ 
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
             + Y    DIWS+G    E+   EP  P  D  H +R++  +  +   +  G   S   
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEP--PLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           + +V     C                       L  DP +R + +E L+H ++
Sbjct: 228 KDFVSL---C-----------------------LNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 43/293 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-------GNAFDNIIDARRTLR-EIKLLRHMEHE 101
           IG+G YG V  A+N  T E +A+K++       G       D  + LR EI+ L+ ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++                + I  E +    +   +R+  +  +   ++F  Q+L GL Y
Sbjct: 69  NIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 217
           +HS  +LHRDLK  NLL++A    KI DFG+++ + +    D       + ++ APE++ 
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 218 NCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           + ++ Y+A +DIWS+GC++ E      +F G+        I  +        LG  RS  
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLE------MFAGRRPWSDEEAIAAMF------KLGNKRS-- 229

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                  +P            N S  A+D L      +P+ R T  E L+HP+
Sbjct: 230 ----APPIP-------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (261), Expect = 8e-26
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 53/298 (17%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            +  +G G  G+V   ++  T + +A+K I    +  I  ++ LRE+ +L       ++ 
Sbjct: 5   YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIV- 62

Query: 106 IKDIIRPPKKDTF-------NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFL-YQLLR 156
                       F        D+ I  E MD   L +I++  Q    +     +   +L+
Sbjct: 63  -----------GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111

Query: 157 GLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
           GL Y+H    ++HRD+KPSN+L+N+   +K+ DFG++     +   T +V T  Y APE 
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE- 169

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
            +   +Y+   DIWS+G  L E+ T    FP                  +D   G     
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR--FP--------------YPPENDPPDGIF--- 210

Query: 276 NARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  +L +    +   R P+   S    D +   L+ DP +R + +E L HP+++
Sbjct: 211 -------ELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 1e-25
 Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 48/296 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR---HMEHENV 103
           ++PI +GA+G V  A    T +  AIK +  +    + A+  +  +K  R    ++ E+ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS---DMIAKNQVTNVKAERAIMMIQGESP 57

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              K       KD    +Y+V E ++  D   +I++   L +D  + ++ +++ G++ +H
Sbjct: 58  YVAKLYYSFQSKDY---LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
              ++HRD+KP NLL++ +  LK+ DFGL+R   E     ++V T  Y APE +L   + 
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVGD- 170

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
               D WS+GC++ E +   P F  +  D V    +++  I  P++              
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD-NILSRRINWPEEV------------- 216

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL 333
                              S  AVDL+ ++L  DP KR+     +E   HP+ +S+
Sbjct: 217 ---------------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (260), Expect = 1e-25
 Identities = 73/296 (24%), Positives = 135/296 (45%), Gaps = 54/296 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENV 103
           +R IG+GA+G VC     +T++  A+K +       ++       L E ++L+ + H  +
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--KCVEKGSVRNVLNERRILQELNHPFL 62

Query: 104 IAIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F D   +Y+V +L+   DL   +    + +++  ++++ +++  L+
Sbjct: 63  VNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  ++HRD+KP N+LL+    + I DF +A   +     T    T  Y APE +L  
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCR 173

Query: 220 TEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
             Y+ A+D WS+G    E +  + P + G       R I + I                 
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHS-----RTIRDQI----------------- 210

Query: 279 RYVRQLPRCRKQQFATR-FPNK-SSGAVDLLEKMLVFDPNKRI--TVEEALRHPYL 330
                     KQ+ A   +P   S+ A+D + K+L  DP KR+   +++   HPY 
Sbjct: 211 --------RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 7e-25
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 44/287 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G+V   V    +   A+K+I  +  N  +    + E ++L  ++   +I   + 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASV 166
                K     + IV E  +  DLH++++    + L +D    F  Q+L GL ++HS  +
Sbjct: 68  FLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTE--YT 223
           LHRD+K  NL L+A  ++KIGD G+A+  S  T+F    V T +Y +PEL   C +  Y 
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYN 179

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+W++G +L E  T +                     P DA       +N    + +
Sbjct: 180 EKSDVWALGVVLYECCTGK--------------------HPFDA-------NNQGALILK 212

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           + R      +  +   S     L+++ L  D  +R    + LR+P L
Sbjct: 213 IIRGVFPPVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (254), Expect = 8e-25
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 51/296 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRT------LREIKLLRHMEHEN 102
           IG G++G V   +N+ + E +A+K++   +       R+        REI LL+ ++HEN
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++                 Y+    +   L+     ++ L  +    F+ Q+L+GL Y+H
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYLH 123

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRAPEL 215
           +  ++HRD+K +N+L++    +KI DFG+++        T+    R       ++ APE+
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +   T YT   DIWS+GC++ E++T +  FP    +  +  I E   SP+          
Sbjct: 184 VKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPE---------- 231

Query: 276 NARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                                P N SS A+D LEK    D NKR T  E L+HP+L
Sbjct: 232 --------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (253), Expect = 1e-24
 Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 57/292 (19%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A +  T  +VA+KK+    D     RR L   E+ ++R  +H N++ + 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 108 DIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
                    ++   +++++V E ++    TD    I +  ++ ++        +L+ L +
Sbjct: 83  S--------SYLVGDELWVVMEFLEGGALTD----IVTHTRMNEEQIATVCLAVLKALSF 130

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC 219
           +H+  V+HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ APE++   
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR- 189

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y   +DIWS+G ++ E++  EP +  +  +  ++ I               R +   +
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---------------RDNLPPK 234

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 330
                          +  +K S  +   L++MLV DP +R T  E L HP+L
Sbjct: 235 L--------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 99.3 bits (247), Expect = 5e-24
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +R +G G++G      +  + ++ A+K+I    +   + D+R+   E  LL  M+H N++
Sbjct: 5   LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
           A K+       +    +YIV E  D  DL Q I+  Q+     +D    +  Q+  G+++
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           +H   VLHRD+K  N+ L  +  +K+GDFG AR  TS   +   YV T +Y  PE+  N 
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN- 174

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
             Y    DIWS+GCIL E+ T +  F    + +
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 99.3 bits (247), Expect = 5e-24
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 41/289 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG G++G +  A      E   IK+I      + +   + +E+ LL  M+H N++  
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHS 163
               +   +     ++IV E  D  DL + I   + +  ++D    +  Q+  GLK++H 
Sbjct: 65  FASFQENGR-----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 164 ASVLHRDLKPSNLLLNASCDL-KIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE 221
             +LHRD+K  N+ L+ +  + K+GDFG+AR  +++ +     V T +Y +PE+  N   
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RP 178

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y    DIWS+GC+L E+ T +  F G +  HQL L                         
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVLKI----------------------- 214

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                C+   FA   PN S     L+ ++    P  R ++   L+ P+L
Sbjct: 215 -----CQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 84/314 (26%), Positives = 144/314 (45%), Gaps = 57/314 (18%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHME 99
           +Y+     IG G+ GIVC A    T ++VA+KK+    D     RR L   E+ ++R   
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYH 77

Query: 100 HENVIAIKDIIRPPKKDTFN------DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           HENV+           D +N      ++++V E ++      I +  ++ ++        
Sbjct: 78  HENVV-----------DMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS 126

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRA 212
           +LR L Y+H+  V+HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ A
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE +++   Y   +DIWS+G ++ E++  EP +  +  +  +R I               
Sbjct: 187 PE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------------- 230

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             DN    V+   +             SS     L+ MLV +P++R T +E L+HP+L+ 
Sbjct: 231 -RDNLPPRVKDSHKV------------SSVLRGFLDLMLVREPSQRATAQELLQHPFLK- 276

Query: 333 LHDLNDEPVCPRPF 346
              L   P C  P 
Sbjct: 277 ---LAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 52/298 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G GA+G V  A + ET    A K I   + + + D    + EI +L   +H N++ + +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 109 IIRPPKKDTF---NDVYIVYELMDTD-LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                    +   N ++I+ E  D   L  I+   ++ LT+   +Y   Q+L  L ++HS
Sbjct: 70  --------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC--- 219
             V+HRDLK  N+LL    D+K+ DFG+ A+  S       ++ T ++ APE ++ C   
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE-VVACETF 180

Query: 220 --TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               Y    DIWS+G  L E+   EP  P  + ++ +R++ + I   +  +L     D  
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLK-ILKSEPPTL-----DQP 231

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
            ++                   SS   D L+  LV DP+ R T  E L+HP++    D
Sbjct: 232 SKW-------------------SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 75/301 (24%), Positives = 126/301 (41%), Gaps = 58/301 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHE 101
           I  IG GA  +V AA+     E+VAIK+I       + D +       +E++ +    H 
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL------RKEVQAMSQCNHP 59

Query: 102 NVIAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQIIRS--DQQLTDDHC-QYFLYQL 154
           NV+            +F   +++++V   +    L  I++S   +   D+      L ++
Sbjct: 60  NVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-----YVVTRW 209
           L+GL+Y+HS   +HRD+K  N+LL     +KI DFG++ + ++    T      +V T  
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           + APE++     Y    DIWS G    E+ T     P   Y     L+  L   P     
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPP---- 225

Query: 270 GFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                         L      ++++  F         ++   L  DP+KR T EE L+H 
Sbjct: 226 -------------SLETGADYKKYSKSFR-------KMISLCLQKDPSKRPTAEELLKHK 265

Query: 329 Y 329
           +
Sbjct: 266 F 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 74/213 (34%), Positives = 110/213 (51%), Gaps = 25/213 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  IG GA G V   ++  T    A+K I GN  D +   R+  REI++LR + H NV+ 
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVVK 136

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             D+      D   ++ ++ E MD       H  I  +Q L D        Q+L G+ Y+
Sbjct: 137 CHDMF-----DHNGEIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQILSGIAYL 184

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL---L 217
           H   ++HRD+KPSNLL+N++ ++KI DFG++R  ++T D     V T  Y +PE +   L
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 218 NCTEYTA-AIDIWSVG-CILGEIMTREPLFPGK 248
           N   Y   A DIWS+G  IL   + R P   G+
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.6 bits (240), Expect = 6e-23
 Identities = 78/253 (30%), Positives = 127/253 (50%), Gaps = 47/253 (18%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVI 104
           + IGRG +  V  A     R+ VA+KK+   F+ ++DA+     ++EI LL+ + H NVI
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVI 65

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLL 155
              D        +F   N++ IV EL D  DL Q+I   +  ++L  +    +YF+ QL 
Sbjct: 66  KYLD--------SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLC 116

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPE 214
             ++++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTRE----------------------PLFPGKDYVH 252
             ++   Y    DIWS+GC+L E+   +                      P  P + Y  
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235

Query: 253 QLRLITELIGSPD 265
           +LR +  +   PD
Sbjct: 236 KLRELVSMCIYPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 96.2 bits (239), Expect = 6e-23
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 43/290 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G+G+YG V    +    ++  IKK+     +  + +   +E +LL  ++H N++A 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
           ++      +D    +YIV    +  DL+  ++    + L ++    +  Q+   L+Y+H 
Sbjct: 65  RESWE--GEDGL--LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLK  N+ L  +  +K+GD G+AR   ++ D  +  + T +Y +PEL  N   Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPY 179

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE--LIGSPDDASLGFLRSDNARRY 280
               D+W++GC + E+ T +  F  KD    +  I E  L   P D             Y
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD-------------Y 226

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             +L                    +L+  ML   P KR +V+  LR PY+
Sbjct: 227 SPEL-------------------GELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 45/294 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD 108
           IG G YG V  A + +T + VAIK +    D   + +    E  +LR    H N+     
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYG 70

Query: 109 IIRPPKKDTFND-VYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                     +D +++V EL      TDL + + +  ++L ++   Y L + LRGL Y+H
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
              V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA-CDE 189

Query: 222 -----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y A  D+WS+G    E+   +P  P  D +H +R + ++  +P       L+S  
Sbjct: 190 QPDASYDARSDVWSLGITAIELADGKP--PLCD-MHPMRALFKIPRNPPPT----LKS-- 240

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                   P    ++F            D + + L+ +  +R  +EE L HP++
Sbjct: 241 --------PENWSKKF-----------NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 16/204 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YGIV AA +  T+  +AIK+I          +    EI L  +++H N      I
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRN------I 67

Query: 110 IRPPKKDTFNDVYIVY--ELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHSA 164
           ++    D+ N  + ++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H  
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 165 SVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE- 221
            ++HRD+K  N+L+N  S  +KI DFG ++  +  +  TE +  T  Y APE++      
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           Y A  DIWS+GC + E+ T +P F
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD- 108
           +G G +G V            A+K +       I        I   +      ++   + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK---RHIVETGQQEHIFSEK-----EILEECNH 52

Query: 109 --IIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             I++  +  TF D   +Y LM+     +L  I+R      +   ++++  ++   +Y+H
Sbjct: 53  PFIVKLYR--TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           +  +++RDLKP NLLL+++  +K+ DFG A+          +  T  Y APE++LN   Y
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGY 169

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKD 249
             ++D WS+G +L E++T  P F   D
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 7e-22
 Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 54/296 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ IG G YG V  A +  T E VAIK I    G+ F+ I       +EI +L+   H N
Sbjct: 8   IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ------QEISMLKECRHPN 61

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           ++A     +R  K      ++IV E        D++Q+ R    L++    Y   + L+G
Sbjct: 62  IVAYFGSYLRRDK------LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKG 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL 216
           L Y+H    +HRD+K +N+LL    D+K+ DFG+ A+ T+       ++ T ++ APE+ 
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 217 LNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
               +  Y    DIW++G    E+   +P  P  D +H +R +             FL S
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-LHPMRAL-------------FLIS 217

Query: 275 DNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            +        P+ + K++++  F        D ++K L  DP KR T  + L+HP+
Sbjct: 218 KSN----FPPPKLKDKEKWSPVF-------HDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.9 bits (233), Expect = 9e-22
 Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 51/289 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR------EIKLLRHMEHENV 103
           IG G+ GIVC A    +  +VA+K        ++D R+  R      E+ ++R  +H+NV
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 104 IAI-KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + K  +         +++++ E +       I S  +L ++        +L+ L Y+H
Sbjct: 81  VEMYKSYL------VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH 134

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           S  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE++   T 
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TP 193

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y   +DIWS+G ++ E++  EP +     V  ++    L  SP             +   
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSP---------PPKLKNAH 241

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +  P  R                D LE+ML  +P +R T +E L HP+L
Sbjct: 242 KISPVLR----------------DFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 17/211 (8%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KYV  ++ IG G++G      + E  ++  IK+I  +  +  +   + +E+ +L +M+H 
Sbjct: 1   KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP 59

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQL--TDDHCQYFLYQLL 155
           N++  ++        +F +   +Y +MD     DL++ I + + +   +D    +  Q+ 
Sbjct: 60  NIVQYQE--------SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE 214
             LK+VH   +LHRD+K  N+ L     +K+GDFG+AR  + T +     + T +Y +PE
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +  N   Y    DIW++GC+L E+ T +  F
Sbjct: 172 ICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 14/214 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IGRGAYG V    +  T   VA+K I      D++ D +R   E+ LL  +         
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS---QPP 62

Query: 108 DIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +I +      K     ++I+ E  +    + +     + + +    + ++L  LKY+H  
Sbjct: 63  NITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            V+HRD+K +N+L+  + ++K+ DFG+ A     +   + +V T ++ APE++     Y 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              DIWS+G  + E+ T  P +   D    + LI
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 84  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138

Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEV 197

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPKLKNLHK 241

Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 242 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 66/247 (26%), Positives = 132/247 (53%), Gaps = 23/247 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +G+GA+G V    +++T  E+A+K++   FD   ++  T +E       I+LL+++ HE 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQV--QFDP--ESPETSKEVNALECEIQLLKNLLHER 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++     +R P + T +   I  E M    +   ++S   LT++  + +  Q+L G+ Y+
Sbjct: 66  IVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL 217
           HS  ++HRD+K +N+L ++  ++K+GDFG ++           M     T ++ +PE ++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VI 181

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
           +   Y    DIWSVGC + E++T +P  P  ++   +  I ++   P +  L    SD+ 
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNPVLPPHVSDHC 238

Query: 278 RRYVRQL 284
           R +++++
Sbjct: 239 RDFLKRI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 66/248 (26%), Positives = 136/248 (54%), Gaps = 25/248 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +GRGA+G V    +++T  E+A+K++   FD   D++ T +E       I+LL+++ H+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQV--PFDP--DSQETSKEVNALECEIQLLKNLRHDR 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++     +R P++   +   I  E M    +   +++   LT++  + +  Q+L+G+ Y+
Sbjct: 66  IVQYYGCLRDPEEKKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL 216
           HS  ++HRD+K +N+L +++ ++K+GDFG ++   +T  M+   +     T ++ +PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE-V 180

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           ++   Y    D+WSV C + E++T +P  P  +Y   +  I ++   P    L    SD 
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTKPMLPDGVSDA 237

Query: 277 ARRYVRQL 284
            R +++Q+
Sbjct: 238 CRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 80/287 (27%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA 105
           IR +GRGA+GIV        ++ V IK+I        D R     E ++L+ + H N+I 
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVH 162
             +     K      + IV E      L + I  R +  L +D   +F  Q+L  L +VH
Sbjct: 64  YYENFLEDKA-----LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 163 SASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +  +LHRDLK  N+LL+     +KIGDFG+++  S        V T  Y +PE L     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKP 177

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y    DIW++GC+L E+ + +  F   +    L  +   I S   A +    S + R+  
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN----LPALVLKIMSGTFAPISDRYSPDLRQ-- 231

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                                   L+  ML  DP+KR  + + +  P
Sbjct: 232 ------------------------LILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 69/288 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENV 103
           I+ +G G++G V    +  + +  A+K +  +   I+  ++    L E ++L+ + H  +
Sbjct: 6   IKTLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F D   +Y +M+     +L   +R   +  +   +++  Q++  L+
Sbjct: 64  VNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-W-------YR 211
           Y+HS  +++RDLKP NLLL++   +KI DFG A+           V  R +       Y 
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYL 165

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APE++L+   Y  A+D W++G ++ E++   P F    +      I E I        G 
Sbjct: 166 APEIILS-KGYGKAVDWWALGILIYEMLAGYPPF----FDDNPIQIYEKILE------GK 214

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKR 318
           +                      RFP+  S    DL+  +L  D  KR
Sbjct: 215 V----------------------RFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.9 bits (225), Expect = 6e-21
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 51/255 (20%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVI 104
           + IGRG +  V  A        VA+KK+   FD ++DA+     ++EI LL+ + H NVI
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 105 A-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQ 153
                 I+D          N++ IV EL D  DL ++I+     ++L  +    +YF+ Q
Sbjct: 66  KYYASFIED----------NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 212
           L   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTRE----------------------PLFPGKDY 250
           PE  ++   Y    DIWS+GC+L E+   +                      P  P   Y
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 233

Query: 251 VHQLRLITELIGSPD 265
             +LR +  +  +PD
Sbjct: 234 SEELRQLVNMCINPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G G +G V   +       VAIK + +  D+++  +   +E++ L+ + H+++I++ 
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVR-VAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 108 DII---RPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYV 161
            +     P        VYI+ ELM+   L   +RS   Q L          Q+  G+ Y+
Sbjct: 69  AVCSVGEP--------VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNC 219
              + +HRDL   N+L+      K+ DFGLAR   E  +++    +  +W  APE   + 
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASH 178

Query: 220 TEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITE 259
             ++   D+WS G +L E+ T   + +PG +       IT 
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 16/200 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIAIKD 108
           IG G++G V  A NS T E VA+KK+  +     +  +  ++E+K L+ ++H N I  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 109 IIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                K+ T    ++V E      +DL ++ +  + L +       +  L+GL Y+HS +
Sbjct: 89  CYL--KEHT---AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YT 223
           ++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE++L   E  Y 
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYD 198

Query: 224 AAIDIWSVGCILGEIMTREP 243
             +D+WS+G    E+  R+P
Sbjct: 199 GKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.0 bits (218), Expect = 8e-20
 Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 43/286 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           IG+GA G V  A++  T +EVAIK++     N+    +    + EI ++R  +H N++  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-----NLQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D          +++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 82  LD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWS+G +  E++  EP +  ++ +  L LI    G+P+                  L 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------------------LQ 236

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
              K     R         D L + L  D  KR + +E L+HP+L+
Sbjct: 237 NPEKLSAIFR---------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 47  IRPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G G +G V       +   T E+VA+K + N            REI++LR ++HEN
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  K +   P       + ++ E + +   +      +   +  +  L+  Q+ +G+ Y
Sbjct: 68  IVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+   E     +Y   +        WY A
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFWY-A 180

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           PE L      +A+ D+WS G  L E+ T 
Sbjct: 181 PECLRTSKFSSAS-DVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 68/293 (23%), Positives = 141/293 (48%), Gaps = 48/293 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +G+GA+G V    + +T  E+A K++   FD   ++  T +E       I+LL++++HE 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQV--QFDP--ESPETSKEVSALECEIQLLKNLQHER 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++     +R   + T   +++ Y +    +   +++   LT+   + +  Q+L G+ Y+H
Sbjct: 66  IVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN 218
           S  ++HRD+K +N+L +++ ++K+GDFG ++           +     T ++ +PE++ +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI-S 182

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              Y    D+WS+GC + E++T +P  P  +Y   +  I ++   P +  L    S++AR
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTNPQLPSHISEHAR 239

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            ++  +                             +   R + EE LRHP+ Q
Sbjct: 240 DFLGCI---------------------------FVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 73/287 (25%), Positives = 133/287 (46%), Gaps = 40/287 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR---EIKLLRHMEHENVIAI 106
           +G+G++G V    + +   E  +K +       ++   T++   E +LL  ++H  ++  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                  ++D F  +    E  D D  L ++  + + L+++    +  QLL G+ Y+H  
Sbjct: 68  HASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +LHRDLK  N+ L  +  LKIGDFG++R      D  T +  T +Y +PE L +   Y 
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYD 183

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
           +  DIWS+GCIL E+      F G+++   L ++  ++  P  +                
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS---------------- 224

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           LP    +Q  +           +++ ML  DP+ R +  E LR+P++
Sbjct: 225 LPETYSRQLNS-----------IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 57/302 (18%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I  +GRGAYG+V    +  T   +A+K+I  A  N  + +R L ++ +           
Sbjct: 5   VIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD----- 58

Query: 106 IKDIIRPPKKDTF-------NDVYIVYELMDTDLH----QIIRSDQQLTDDHCQYFLYQL 154
                  P   TF        DV+I  E+MDT L     ++      + +D        +
Sbjct: 59  ------CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112

Query: 155 LRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           ++ L+Y+HS  SV+HRD+KPSN+L+N +  +K+ DFG++    ++   T     + Y AP
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172

Query: 214 ELL---LNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL 269
           E +   LN   Y    D+WS+G  + E+ T R P    K    QL+ + E          
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPS----- 225

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                          P+   ++F+  F        D + K L  +  +R    E L+HP+
Sbjct: 226 ---------------PQLPAEKFSPEF-------QDFVNKCLKKNYKERPNYPELLQHPF 263

Query: 330 LQ 331
            +
Sbjct: 264 FE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 51/296 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YG V  A   +T E VA+K++          +  L ++  +RH+  E     +DI
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRM---------KKSLLFKLNEVRHVLTE-----RDI 54

Query: 110 IRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           +   K +        F D   +Y  M+     D   ++ +   L++DH ++++ ++   +
Sbjct: 55  LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
             +H    +HRDLKP N L++AS  +K+ DFGL++      +    V +  Y APE +L 
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLR 171

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              Y   +D WS+GC+L E +   P F G               +P++        +N +
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNET------WENLK 211

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
            +   L R           N S  A DL+ K++     +  ++E+   HP+ + + 
Sbjct: 212 YWKETLQRPVYDD---PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 42/295 (14%)

Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K  K  +  ++I D ++   EI++L
Sbjct: 4   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 60

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + + R+  ++       +  Q
Sbjct: 61  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR----- 208
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD   EY   +     
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLDS 174

Query: 209 ---WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
              WY APE L+    Y A+ D+WS G  L E++T    +   +    + L  ++IG P 
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLT----YCDSES-SPMTLFLKMIG-PT 226

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT 320
              +   R        ++LPR          PN       L+ K   F P+KR T
Sbjct: 227 HGQMTVTRLVRVLEEGKRLPRP---------PNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.9 bits (210), Expect = 9e-19
 Identities = 59/234 (25%), Positives = 115/234 (49%), Gaps = 28/234 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIA 105
           +G GA+     A + +T   +A+K++    +   +    +    +EI+L+  + H ++I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 106 IKDIIRPPKKDTFNDVYIVYELM-----DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +       +   FN   +  E M        L +     + +  ++ +    QLLRGL Y
Sbjct: 68  MLGATC--EDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSY 118

Query: 161 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPE 214
           +H   ++HRD+K +NLL++++   L+I DFG A     + T   +F  + + T  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL---IGSPD 265
           +L    +Y  + D+WSVGC++ E+ T +P +  + + + L LI ++     +P 
Sbjct: 179 VLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 46/305 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +  G+ G V  A     + +  + KIG           TL E  LL+++ H +VI +
Sbjct: 71  IKTLTPGSEGRVFVA-TKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRM 122

Query: 107 KD-IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           KD ++            +V     +DL+  + +  + L  D       Q+L GL+Y+H+ 
Sbjct: 123 KDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            ++HRD+K  N+ +N    + IGD G A+       F+     T    APE+L    +Y 
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETNAPEVLAR-DKYN 234

Query: 224 AAIDIWSVGCILGEIMT------REPLFPGKDYV-----HQLRLITELIGSPDDASLGFL 272
           +  DIWS G +L E++        +P    ++YV     H L++I+ L   P++    F 
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE----FP 290

Query: 273 RSDNAR---RYVRQLPRCRKQQFATRFPNKS------SGAVDLLEKMLVFDPNKRITVEE 323
           R   +R    ++       +Q + TR+P          G   L+ KML FD   R + EE
Sbjct: 291 RDPGSRLVRGFIE-YASLERQPY-TRYPCFQRVNLPIDGEF-LVHKMLTFDAAMRPSAEE 347

Query: 324 ALRHP 328
            L +P
Sbjct: 348 ILNYP 352

Length = 357

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +  T E VAIKK+  +   +    +  ++E++ L+ + H N I 
Sbjct: 20  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 106 IKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            K      ++ T    ++V E      +D+ ++ +  + L +       +  L+GL Y+H
Sbjct: 80  YKGCYL--REHT---AWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH 132

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE- 221
           S   +HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ APE++L   E 
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEG 189

Query: 222 -YTAAIDIWSVG--CILGEIMTRE-PLF 245
            Y   +D+WS+G  CI  E+  R+ PLF
Sbjct: 190 QYDGKVDVWSLGITCI--ELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 49/294 (16%)

Query: 50  IGRGAYGIV-CAAVNSETREEVAIKKIGNAFDNIIDARRTLR----EIKLLRHMEHENVI 104
           +G+GAYG V C   N    + +A+K++     N++ A +       E+ LL+ ++H N++
Sbjct: 8   LGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 105 AIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                +     D  N + I  E +    +  I+     L +     +  Q+L G+ Y+H+
Sbjct: 66  QY---LGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELL 216
             V+HRD+K +N++L  +  +K+ DFG AR         + ++ +     T ++ APE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-V 179

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           +N + Y    DIWS+GC + E+ T +P     D +  +  I                   
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-----------------GA 222

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            R  + +LP          F   S+ A+D +   L  D ++R +  + LRH +L
Sbjct: 223 HRGLMPRLPD--------SF---SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 27/274 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V   +++ T+E VAIK I    A D I D ++   EI +L   +   +    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                  K     ++I+ E +       +     L + +    L ++L+GL Y+HS   +
Sbjct: 69  GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE++   + Y    
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKA 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-- 284
           DIWS+G    E+   EP  P  D +H +R++  LI      +L    S   + +V     
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-LHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLN 238

Query: 285 --PRCR-------KQQFATRFPNKSSGAVDLLEK 309
             PR R       K +F TR+  K+S   +L+++
Sbjct: 239 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 272

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 84.0 bits (207), Expect = 4e-18
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEH 100
           K    +R IG G++G V  A +  T E VAIKK+  +     +  +  ++E+K L+ ++H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 101 ENVIAIKDI-IRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            N I  K   +R       +  ++V E      +DL ++ +  + L +       +  L+
Sbjct: 85  PNSIEYKGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQ 136

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL Y+HS +++HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ APE++
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVI 193

Query: 217 LNCTE--YTAAIDIWSVGCILGEIMTREP 243
           L   E  Y   +D+WS+G    E+  R+P
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 21/176 (11%)

Query: 78  AFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFND-VYIVYELMD-TDLHQ 134
           +  +I+       E+ +++  + H N      I+R  K    ND +YIV +L++   L +
Sbjct: 51  SIGDIVS------EVTIIKEQLRHPN------IVRYYKTFLENDRLYIVMDLIEGAPLGE 98

Query: 135 IIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASCDLKIGDF 189
              S     Q+ T++       Q++  L+Y+H    ++HRDL P+N++L     + I DF
Sbjct: 99  HFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158

Query: 190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           GLA+       +T  V T  Y  PE++ N   Y    D+W+ GCIL ++ T +P F
Sbjct: 159 GLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 8e-18
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 47  IRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEH 100
            R +G GA+G V             +E VA+K +     N  DAR+   RE +LL + +H
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQH 67

Query: 101 ENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--------------QQL 142
           EN++    +     PP         +V+E M+  DL++ +RS                +L
Sbjct: 68  ENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM- 201
           T         Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD+  
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 202 ---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
                 +  RW   PE ++    +T   D+WS G +L EI T  ++P +
Sbjct: 180 VGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.1 bits (202), Expect = 1e-17
 Identities = 70/284 (24%), Positives = 130/284 (45%), Gaps = 39/284 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAIK++             + EI ++R  ++ N++   D 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 83

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L ++HS  V+HR
Sbjct: 84  ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE----------------------- 234

Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P + S    D L + L  D ++R + +E L+HP+L+
Sbjct: 235 -----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.1 bits (202), Expect = 1e-17
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 39/284 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 84

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 85  ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE----------------------- 235

Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E L+H +L+
Sbjct: 236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 76/293 (25%), Positives = 129/293 (44%), Gaps = 49/293 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           IG+G++G V      +T+   A+K I  A   I+   +   TL E  +L  +    ++ +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           K   + P+K     +Y+V   ++  +L   ++ + +      +++  +LL  L+ +H  +
Sbjct: 59  KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V++RDLKP N+LL+    + + DFGL +    + D    +  T  Y APELLL    YT 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTK 172

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D W++G +L E++T  P F  ++     R I                           
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-------------------------- 206

Query: 285 PRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYLQSL 333
                 Q   RFP      A DLL  +L  DP +R+     +E   HP+   L
Sbjct: 207 ------QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 55/310 (17%)

Query: 53  GAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHMEHENVIAIKDII 110
           GA G   A ++++T E V IK            +R  T  E  +LR + H ++I +K   
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA----------GQRGGTATEAHILRAINHPSIIQLKGTF 152

Query: 111 RPPKKDTFNDVY-IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                 T+N    ++     TDL+  + + + +           +LR ++Y+H   ++HR
Sbjct: 153 ------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206

Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY--------RAPELLLNCTE 221
           D+K  N+ +N   D+ +GDFG A       F  +    ++Y         APELL     
Sbjct: 207 DIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWAGTIATNAPELLAR-DP 259

Query: 222 YTAAIDIWSVGCILGEIMT-------REPLFPGKDYVHQLRLITELIGS-----PDDASL 269
           Y  A+DIWS G +L E+ T       ++ L    D   Q++LI    G+     P DA  
Sbjct: 260 YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ- 318

Query: 270 GFLRSDNARRYVRQLPR-CRKQQFATRFPNKSSGAVD---LLEKMLVFDPNKRITVEEAL 325
               ++    Y+    +  RK      + N     +D   L+ KML FD + R + E  L
Sbjct: 319 ----ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374

Query: 326 RHPYLQSLHD 335
                Q + D
Sbjct: 375 DFAAFQDIPD 384

Length = 391

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 71/284 (25%), Positives = 131/284 (46%), Gaps = 39/284 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAIK+I             + EI +++ +++ N++   D 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD- 83

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++H+  V+HR
Sbjct: 84  ----SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHR 139

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE----------------------- 234

Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E L+HP+L+
Sbjct: 235 -----LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 16/208 (7%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEH 100
           K    +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            N I  +      ++ T    ++V E      +DL ++ +  + L +       +  L+G
Sbjct: 75  PNTIQYRGCYL--REHT---AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++L
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVIL 184

Query: 218 NCTE--YTAAIDIWSVGCILGEIMTREP 243
              E  Y   +D+WS+G    E+  R+P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 50/295 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +   +    + EI +L   +H N++ +
Sbjct: 10  IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKL 67

Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   +    Q L  L Y+
Sbjct: 68  LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 221 E----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y    D+WS+G  L E+   EP        H+L                     N
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPH------HEL---------------------N 212

Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             R + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 213 PMRVLLKIAKSEPPTLAQ--PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 73/313 (23%), Positives = 133/313 (42%), Gaps = 48/313 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A K++       I  R+     L E ++L  +  + V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           + +        KD    V  +    D   H     +    ++   ++  ++L GL+ +H 
Sbjct: 63  VNLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + ++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE+L N   YT
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYT 179

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            + D W +GC++ E++  +  F G+                        +    R  V +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGR------------------------KEKVKREEVDR 215

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-----EALRHPYLQSLH---- 334
                ++ ++ +F   S  A  + + +L  DP +R+  +     E  RHP+ ++++    
Sbjct: 216 RVLETEEVYSAKF---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272

Query: 335 --DLNDEPVCPRP 345
              + D P  P P
Sbjct: 273 EAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 85/331 (25%), Positives = 150/331 (45%), Gaps = 57/331 (17%)

Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V      +  +  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 104 IAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +   K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 61  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG---FLRSDNAR 278
           +T + D WS G ++ E++T    F GKD    + +I +       A LG   FL S  A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-------AKLGMPQFL-SPEAQ 226

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
             +R L +        R P    GA                 VEE  RHP+  ++ D N 
Sbjct: 227 SLLRALFK--------RNPANRLGAGPD-------------GVEEIKRHPFFSTI-DWNK 264

Query: 339 ----------EPVCPRP---FHFDFEHSSCT 356
                     +P   RP   F+FD E +S T
Sbjct: 265 LYRREIKPPFKPAVGRPDDTFYFDPEFTSRT 295

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 68/271 (25%), Positives = 129/271 (47%), Gaps = 41/271 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLL-RHMEHEN-- 102
           IG+G +G V      +TR   A+K +       I A++    T+ E  +L R +  E+  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK---KEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++ +K   +       +D+Y+V + M   +L   ++ + + ++D  ++++ +L+  L+++
Sbjct: 58  IVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCT 220
           H   +++RDLKP N+LL+A+  + + DFGL++   ++      +  T  Y APE+LL+  
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR------S 274
            YT  +D WS+G ++ E+      F  +D     R I          + G +R      S
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI----------AFGKVRFPKNVLS 222

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
           D  R++V+ L          R P    GA  
Sbjct: 223 DEGRQFVKGL--------LNRNPQHRLGAHR 245

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 42/284 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V    
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                  K     ++I+ E +       +       +      L ++L+GL Y+HS   +
Sbjct: 69  GSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE++   + Y +  
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKA 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G    E+   EP  P  D +H +R++  +  +      G                
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLTG---------------- 223

Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               +F+  F        + ++  L  DP+ R T +E L+H ++
Sbjct: 224 ----EFSKPFK-------EFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 75/310 (24%), Positives = 140/310 (45%), Gaps = 54/310 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       + +  A+K +      +I A+     TL E ++L++  H  + +
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKK---EVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +K   +   +  F   Y+       +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 60  LKYSFQTKDRLCFVMEYV----NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +++RDLK  NL+L+    +KI DFGL +   ++   M  +  T  Y APE+L +  +Y  
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGR 174

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D W +G ++ E+M     F  +D+     LI              L  D         
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------LMED--------- 211

Query: 285 PRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH--DL 336
                     +FP   S+ A  LL  +L+ DPNKR+       +E +RH +   ++  D+
Sbjct: 212 ---------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262

Query: 337 NDEPVCPRPF 346
            D+ + P PF
Sbjct: 263 YDKKLVP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)

Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG+G +G V       +   +   A+K + N   ++ +  + L+E  +++   H NV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
           ++  I  P +      V + Y +   DL   IRS+    T      F  Q+ +G++Y+ S
Sbjct: 60  SLLGICLPSEGSPL--VVLPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL-------- 215
              +HRDL   N +L+ S  +K+ DFGLAR   +     EY     +   +L        
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALE 172

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTR 241
            L   ++T   D+WS G +L E+MTR
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 72/316 (22%), Positives = 135/316 (42%), Gaps = 54/316 (17%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +++         +T + + +V  LM   D   H     +    ++   ++  ++  GL+ 
Sbjct: 63  VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE++ N  
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-E 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            YT + D W +GC++ E++  +  F  +                        +    R  
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQR------------------------KEKVKREE 212

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH- 334
           V +  +  +++++ +F   S  A  +  ++L  DP  R+       EE   HP+ ++ + 
Sbjct: 213 VERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269

Query: 335 -----DLNDEPVCPRP 345
                 + + P CP P
Sbjct: 270 KRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 31/218 (14%)

Query: 39  VSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIK--KIGNAFDNIIDARRTLREIK 93
           +   YV   + IG G +G VC     +  +   +VAIK  K G++    +D    L E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEAS 57

Query: 94  LLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQ 148
           ++   +H N+I ++ ++   RP        V I+ E M+   L + +R +D + T     
Sbjct: 58  IMGQFDHPNIIRLEGVVTKSRP--------VMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
             L  +  G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +++    Y    
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKG 167

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 168 GKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 33/214 (15%)

Query: 48  RPIGRGAYGIV-CAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGL 158
             ++      T   +YI+ E M    L   ++SD+       +L D     F  Q+  G+
Sbjct: 67  HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGM 115

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPEL 215
            ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE 
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE- 173

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)

Query: 47  IRPIGRGAYGIV---CAA--VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           IR +G+G++G+V    A   V  E    VAIK + N   ++ +    L E  +++     
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCH 69

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHC--------QYFLY 152
           +V+ +  ++      T     +V ELM   DL   +RS ++   ++         Q F+ 
Sbjct: 70  HVVRLLGVV-----STGQPTLVVMELMAKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQ 123

Query: 153 ---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
              ++  G+ Y+ +   +HRDL   N ++     +KIGDFG+ R   ETD+   Y     
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGK 180

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  APE L +   +T   D+WS G +L E+ T
Sbjct: 181 GLLPVRWM-APESLKDGV-FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 56/311 (18%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       T +  A+K +      +I A+     TL E ++L++  H  + A
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKE---VIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +   +  F     V E  +  +L   +  ++  ++D  +++  +++  L Y+HS 
Sbjct: 60  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            V++RDLK  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  +Y 
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 173

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+D W +G ++ E+M     F  +D+      + ELI   +                  
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEE------------------ 211

Query: 284 LPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HD 335
                      RFP   S  A  LL  +L  DP +R+       +E + H +  S+   D
Sbjct: 212 ----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQD 261

Query: 336 LNDEPVCPRPF 346
           +  + + P PF
Sbjct: 262 VVQKKLEP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 87/373 (23%), Positives = 144/373 (38%), Gaps = 106/373 (28%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I+ IGRGA+G V    + +T +  A+K               LR+  +++  +  +V A
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMKV--------------LRKSDMIKRNQIAHVRA 50

Query: 106 IKDIIRPPKKD-------TFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQ 153
            +DI+             +F D   +Y +M+     DL + +IR D    ++  ++++ +
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAE 109

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA------------RTTSETDFM 201
           L+  L  VH    +HRD+KP N+L++A   +K+ DFGL                S     
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 202 TEYVVTRW------------------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
            + V+ R                   Y APE+L   T Y    D WS+G IL E++   P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFP 228

Query: 244 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK---S 300
            F                   D     + +  N +  +             RFP     S
Sbjct: 229 PF-----------------YSDTLQETYNKIINWKESL-------------RFPPDPPVS 258

Query: 301 SGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQSLHDLNDEPVCPRPF-----------HF 348
             A+DL+ + L+ DP  R+   EE   HP+ + + D  +      PF           +F
Sbjct: 259 PEAIDLICR-LLCDPEDRLGSFEEIKSHPFFKGI-DWENLRETKPPFVPELSSPLDTSNF 316

Query: 349 D-FEHSSCTEDHI 360
           D FE      D++
Sbjct: 317 DDFEDDKDLSDYL 329

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 49/293 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ IG G YG V  A N  T E  AIK I    G  F  +       +EI +++  +H N
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV------QQEIIMMKDCKHSN 67

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           ++A     +R  K      ++I  E      L  I      L++    Y   + L+GL Y
Sbjct: 68  IVAYFGSYLRRDK------LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LL 217
           +HS   +HRD+K +N+LL  +  +K+ DFG+ A+ T+       ++ T ++ APE+  + 
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               Y    DIW+VG    E+   +P  P  D +H +R +             FL + + 
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL-------------FLMTKSN 225

Query: 278 RRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                Q P+ + K +++  F +        ++  L  +P KR T E+ L+HP+
Sbjct: 226 ----FQPPKLKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 62/303 (20%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLREIKLLRHMEH 100
           +G+G +G VCA     T +  A KK+        D +R          L E K+L  +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLY--QLLRG 157
             ++++         +T +D+ +V  LM+  DL   I +  +      +   Y  Q++ G
Sbjct: 53  RFIVSLAYAF-----ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L+++H   +++RDLKP N+LL+   +++I D GLA        +     T  Y APE+L 
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 218 NCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               Y  ++D +++GC L E I  R P    K+ V +                       
Sbjct: 168 G-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----------------------- 203

Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL 330
                 +L R R  + A  +P+K S  A DL E +L  DP KR+     + +E   HP  
Sbjct: 204 -----EELKR-RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257

Query: 331 QSL 333
           + L
Sbjct: 258 KDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 47/292 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G G YG V  A N  T E  A+K I    G+ F  I       +EI +++  +H N
Sbjct: 14  IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI------QQEIFMVKECKHCN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++A        +K     ++I  E      L  I      L++    Y   + L+GL Y+
Sbjct: 68  IVAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLN 218
           HS   +HRD+K +N+LL  + D+K+ DFG+ A+ T+       ++ T ++ APE+  +  
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              Y    DIW+VG    E+   +P  P  D +H +R +             FL S +  
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL-------------FLMSKSN- 225

Query: 279 RYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
               Q P+ + K ++++ F N        ++  L  +P KR T E  L H +
Sbjct: 226 ---FQPPKLKDKTKWSSTFHN-------FVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHM-EHENVI 104
           I  IG+G YG V    N +     A+K      D I D    +  E  +L+ +  H NV+
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVK----ILDPISDVDEEIEAEYNILQSLPNHPNVV 82

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLK 159
               +     K     +++V EL +    T+L + ++   Q+L +    Y LY  L GL+
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           ++H+  ++HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ APE++  
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA- 201

Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREP 243
           C +     Y A  D+WS+G    E+   +P
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 52/296 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +   +    + EI++L    H  ++ +   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 110 IRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                K     ++I+ E      +D  + ++   D+ LT+   Q    Q+L  L+Y+HS 
Sbjct: 78  FYWDGK-----LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC---- 219
            ++HRDLK  N+LL    D+K+ DFG+ A+          ++ T ++ APE+++ C    
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM-CETMK 188

Query: 220 -TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
            T Y    DIWS+G  L E+   EP        H+L                     N  
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPH------HEL---------------------NPM 221

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           R + ++ +      +   P+K S    D L+  L   P  R +  + L HP++ S+
Sbjct: 222 RVLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENV 103
           + IG G +G VC+    +  +    VAIK +   +      RR  L E  ++   +H N+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNI 67

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+
Sbjct: 68  IHLEGVVTKSKP-----VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPEL 215
                +HRDL   N+L+N++   K+ DFGL+R   E D    Y         RW  APE 
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TAPE- 179

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT 240
            +   ++T+A D+WS G ++ E+M+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 12/200 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVT 65

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                     KDT   ++I+ E +       +     L +      L ++L+GL Y+HS 
Sbjct: 66  KYYGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYT 223
             +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++   + Y 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYD 179

Query: 224 AAIDIWSVGCILGEIMTREP 243
           +  DIWS+G    E+   EP
Sbjct: 180 SKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 75/297 (25%), Positives = 136/297 (45%), Gaps = 54/297 (18%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G YG V    + +T +  AIK +    D   +     +EI +L+   H   IA    
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 106 --IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             IK    PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL 
Sbjct: 71  AFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLS 125

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN 218
           ++H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA- 184

Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           C E     Y    D+WS+G    E+    P  P  D +H +R +  +  +P         
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNP--------- 232

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                      PR + ++++ +F +        +E  LV + ++R T E+ ++HP++
Sbjct: 233 ----------APRLKSKKWSKKFQS-------FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 67/242 (27%), Positives = 100/242 (41%), Gaps = 37/242 (15%)

Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +Y+  IR +G G +G V        N  T E VA+K  K      N        +EI +L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN---TSGWKKEINIL 60

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           + + HEN++  K             + ++ E +     +      +L       F  Q+ 
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKG---LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC 117

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR------- 208
            G+ Y+HS   +HRDL   N+LL+    +KIGDFGLA+   E     EY   R       
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 174

Query: 209 -WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR------------EPLFPGKDYVHQLR 255
            WY A E L       A+ D+WS G  L E++T             E + P +  +  +R
Sbjct: 175 FWY-AVECLKENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232

Query: 256 LI 257
           LI
Sbjct: 233 LI 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 75/297 (25%), Positives = 135/297 (45%), Gaps = 46/297 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHM-EHENVI 104
           I  IG+G YG V   +N +   + A+K      D I D    +  E  +L+ + +H NV+
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVK----ILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLK 159
               +         + +++V EL +    TDL +  ++  +++ +    Y L++ L GL+
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           ++H    +HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ APE++  
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA- 197

Query: 219 C-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           C     + Y A  D+WS+G    E+   +P  P  D +H +R + ++  +P         
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPP-------- 246

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                      P   + +        S+   D + K L  D  KR TV + L+H ++
Sbjct: 247 -----------PTLHQPELW------SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)

Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHM-EH 100
           + +G GA+G V  A       S+   +VA+K +     +    R  L  E+K++ H+  H
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNH 98

Query: 101 ENVIAIKD--IIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQ--LTDDHCQYFLYQLL 155
           EN++ +     I  P       + ++ E     DL   +R  ++  LT +    F YQ+ 
Sbjct: 99  ENIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV------- 206
           +G+ ++ S + +HRDL   N+LL     +KI DFGLAR     D M +  YVV       
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +W  APE + NC  YT   D+WS G +L EI +
Sbjct: 207 VKWM-APESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 36/224 (16%)

Query: 48  RPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A        + +  VA+K + +A DN   AR+   RE +LL +++HE
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHE 67

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHC 147
           +++    +         + + +V+E M   DL++ +R+               +LT    
Sbjct: 68  HIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----E 203
            +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+       
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 183 MLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 49  PIGRGAYGIVCAA-----VNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHM-EHE 101
           P+G GA+G V  A      N      VA+K +  +A +   D    + E+++++ + +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHK 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYEL-----------------MDTDLHQIIRSDQQLTD 144
           N+I +  +           +Y+V E                             ++ LT 
Sbjct: 77  NIINLLGVCTQEGP-----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                F YQ+ RG++++ S   +HRDL   N+L+     +KI DFGLAR     D+  + 
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 205 VVTR----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    W  APE L +   YT   D+WS G +L EI T
Sbjct: 192 TNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 69/308 (22%), Positives = 128/308 (41%), Gaps = 72/308 (23%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVI 104
           + +G+G++G V  A    T E  A+K +    D I+   D   T+ E ++L         
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAG----- 53

Query: 105 AIKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
                 + P          T + ++ V E ++  DL   I+   +  +   +++  +++ 
Sbjct: 54  ------KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL 107

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------Y 210
           GL+++H   +++RDLK  N+LL++   +KI DFG+ +     + +   V T        Y
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDY 162

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
            APE+L     Y  A+D W++G +L E++  +  F G D               +D    
Sbjct: 163 IAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDD---------------EDELFQ 206

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEAL 325
            +  D   RY R L               S  A  +L+  L  +P KR+       ++  
Sbjct: 207 SILEDEV-RYPRWL---------------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250

Query: 326 RHPYLQSL 333
            HP+ + +
Sbjct: 251 GHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR---EIKLLRHMEHENV 103
           I+ +G G +G V    +  +    A+K +  A   +I  ++      E ++L+ + H  +
Sbjct: 6   IKTVGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           I +          T +D   +Y LM+     +L   +R+  + ++    ++  +++  L+
Sbjct: 64  IRLFW--------TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  +++RDLKP N+LL+    +K+ DFG A+     D       T  Y APE++ + 
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS- 172

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGK 248
             +  A+D W++G ++ E++   P F   
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD- 108
           IGRGA+G V   ++  +   +A+K+I +  D         +E K L  M+ + V+   D 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLL-MDLDVVMRSSDC 62

Query: 109 --IIRPPKKDTFN--DVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLK 159
             I++      F   D +I  ELMD  L +  +         + ++         ++ L 
Sbjct: 63  PYIVKF-YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 160 YVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+     ++HRD+KPSN+LL+ + ++K+ DFG++    ++   T     R Y APE +  
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 219 CTE--YTAAIDIWSVGCILGEIMTREPLFP 246
                Y    D+WS+G  L E+ T +  FP
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGK--FP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 34/221 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRT--LREI 92
           E+   ++   + IG G +G V      +       VAIK +   +    + +R   L E 
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEA 57

Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY 152
            ++    H N+I ++ ++       F    I+ E M+         D+ L D   ++  Y
Sbjct: 58  SIMGQFSHHNIIRLEGVV-----TKFKPAMIITEYMENG-----ALDKYLRDHDGEFSSY 107

Query: 153 QL---LRG----LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           QL   LRG    +KY+   + +HRDL   N+L+N++ + K+ DFGL+R   E D    Y 
Sbjct: 108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYT 166

Query: 206 VT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +      RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 167 TSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 73/316 (23%), Positives = 134/316 (42%), Gaps = 54/316 (17%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +++         +T + + +V  LM   D   H     +    +    ++  ++  GL+ 
Sbjct: 63  VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N  
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-E 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            YT + D W++GC+L E++  +                    SP       ++ +   R 
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVERL 216

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH- 334
           V+++     ++++ +F   S  A  L + +L  DP +R+        E   HP  + ++ 
Sbjct: 217 VKEVQ----EEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269

Query: 335 -----DLNDEPVCPRP 345
                 + + P  P P
Sbjct: 270 KRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 27/230 (11%)

Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131

Query: 177 LLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 235
           L+N+  ++K+ DFG++      D M   +V TR Y +PE L   T YT   DIWS+G  L
Sbjct: 132 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSL 188

Query: 236 GEIMT-REPLFP--GKDYVHQLRLITELIGSPDDASLGFLRSDNARR---------YV-- 281
            E+   R P+ P   K+             + +          ++ R         Y+  
Sbjct: 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
              P+     F+  F        D ++K L  +P +R  ++E  +HP+++
Sbjct: 249 EPPPKLPSGAFSDEF-------QDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)

Query: 117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
           T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N
Sbjct: 67  TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126

Query: 176 LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           +LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVL 185

Query: 235 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 294
           L E++  +  F G D         EL  S        +R DN   Y R L R        
Sbjct: 186 LYEMLIGQSPFHGHDE-------EELFQS--------IRMDNP-CYPRWLTR-------- 221

Query: 295 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSL 333
                   A D+L K+ V +P +R+ V+  +R HP+ + +
Sbjct: 222 -------EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 81/333 (24%), Positives = 142/333 (42%), Gaps = 40/333 (12%)

Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           Y V G   +VS++    +  +G G +G V  A + + +E  A+K + N      DA+  +
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEI 176

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY 149
           + ++ +R  +  +   +  I R  + +T   + IV       L   I      +  H   
Sbjct: 177 QFMEKVRQADPADRFPLMKIQRYFQNET-GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235

Query: 150 FLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS----------------CDLKIGDFGLA 192
            ++Q    L Y H+   ++H DLKP N+L+  S                C ++I D G  
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293

Query: 193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
               E    T  V TR YR+PE++L    +  + D+WS+GCI+ E+ T + L+   D + 
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352

Query: 253 QLRLITELIGS-PDD--------------ASLGFLRSDNARRYVRQLPRCRKQQFATRFP 297
            L L+ + +G  P +               S G LR     +++ ++ R R  +   R  
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDD 412

Query: 298 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                  DL+  +L +D  KR+   +   HPY+
Sbjct: 413 L----LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 74/300 (24%), Positives = 124/300 (41%), Gaps = 67/300 (22%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAF-------DNIIDARRTLREIKLLRHMEHEN 102
           +GRG +G V  A   +T E  AIK +           ++++  +R        RH    N
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A           T + V  V E     DL   I +D   ++    ++   ++ GL+Y+
Sbjct: 67  LFACFQ--------TEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYL 117

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPE 214
           H   +++RDLK  NLLL+    +KI DFGL +        TS       +  T  + APE
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           +L   T YT A+D W +G ++ E++  E  FPG D               ++     + +
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVN 215

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 329
           D   RY R L R                A+ ++ ++L  +P +R+       E+  + P+
Sbjct: 216 DEV-RYPRFLSR---------------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G +G V       T ++VA+K I       + A+  L E  ++  + H+N++ +  +
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL--LRGLKYVHSASV 166
           I        N +YIV ELM   +L   +R+  +      Q   + L    G++Y+ S  +
Sbjct: 68  I------LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDL   N+L++     K+ DFGLAR  S     ++  V +W  APE L +  ++++  
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKH-KKFSSKS 178

Query: 227 DIWSVGCILGEIMT--REP 243
           D+WS G +L E+ +  R P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 61/247 (24%), Positives = 109/247 (44%), Gaps = 38/247 (15%)

Query: 131 DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 190
           DL   I+S  +  +   +++  +++ GL+++H   +++RDLK  N+LL+    +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 191 LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +     +     +  T  Y APE+L    +Y  ++D WS G +L E++  +  F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 309
                          +D     + +D    + R +               S  A D L K
Sbjct: 201 ---------------EDELFDSILNDRP-HFPRWI---------------SKEAKDCLSK 229

Query: 310 MLVFDPNKRITVEEALR-HPYLQSLH--DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR 366
           +   DP KR+ V+  +R HP+ + +    L    + P PF    +  S   +  RE    
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP-PFKPKVKSPSDASNFDREFT-N 287

Query: 367 ESVKFNP 373
           E V+ +P
Sbjct: 288 EKVRLSP 294

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 66/286 (23%), Positives = 117/286 (40%), Gaps = 50/286 (17%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQ-YNVYGNLFEVSSKYVPPIRPIGRGAYG-IVCA 60
            A  D++     +  K  L H  +++  + V  +L                GA+G I   
Sbjct: 124 EAPPDAAGPVPLAQAK--LKHDDEFLAHFRVIDDLPA--------------GAFGKIFIC 167

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTL---------------REIKLLRHMEHENVIA 105
           A+ + T E  A + + +         R +                EI  L  + HEN++ 
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDD----HCQYFLYQLLRGLKY 160
           I++I+R        + Y++ +  D DL+  +        D       +  + QLL  ++Y
Sbjct: 228 IEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEY 282

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--VVTRWYRAPELLLN 218
           +H   ++HRD+K  N+ LN    + +GDFG A    +     +Y  V T    +PE+L  
Sbjct: 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342

Query: 219 CTEYTAAIDIWSVGCILGEIMTRE--PLFPGKDYVHQ--LRLITEL 260
              Y    DIWS G IL ++++ +  P+  G     +  L++I  L
Sbjct: 343 -DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 30/224 (13%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  L+
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLM 55

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHC 147
           + ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D   
Sbjct: 56  KTLQHDKLVRLYAVVTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--- 107

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---Y 204
             F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++       
Sbjct: 108 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
              +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 166 FPIKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 81/340 (23%), Positives = 134/340 (39%), Gaps = 102/340 (30%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I+ IGRGA+G V      +T    A+KK              LR+ ++L   +  +V A
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKK--------------LRKSEMLEKEQVAHVRA 50

Query: 106 IKDIIRPPKKD-------TFNDVYIVYELMD----TDLH-QIIRSDQQLTDDHCQYFLYQ 153
            +DI+             +F D   +Y +M+     D+   +++ D   T++  ++++ +
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAE 109

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--------- 204
            +  +  +H    +HRD+KP NLLL+A   +K+ DFGL  T  +    TE+         
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALP 168

Query: 205 -------------------------------VVTRWYRAPELLLNCTEYTAAIDIWSVGC 233
                                          V T  Y APE+ L  T Y    D WS+G 
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGV 227

Query: 234 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ-QF 292
           I+ E+                     L+G P      F  SDN +   R++   ++  QF
Sbjct: 228 IMYEM---------------------LVGYPP-----FC-SDNPQETYRKIINWKETLQF 260

Query: 293 ATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPY 329
               P  S  A DL+++ L  +  +R+    V E   HP+
Sbjct: 261 PDEVP-LSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 40/219 (18%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R +G G +G V     N  T  +VA+K  K G      +     L+E ++++ + H+ +
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKL 63

Query: 104 IAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQ 153
           + +  +     P       +YIV E M    L   ++S         QL D        Q
Sbjct: 64  VQLYAVCSEEEP-------IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD-----MAAQ 111

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---Y 210
           +  G+ Y+ S + +HRDL   N+L+  +   KI DFGLAR   E D  T     ++   +
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKW 170

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            APE   N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 171 TAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   V      E   VA+K   N         + L+E  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAY 59

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFL 151
           ++R  +H +++ +  +I      T N V+IV EL    +L   +  +   L       + 
Sbjct: 60  IMRQFDHPHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TR 208
           YQL   L Y+ S   +HRD+   N+L+++   +K+GDFGL+R   +  +          +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           W  APE  +N   +T+A D+W  G  + EI+  
Sbjct: 174 WM-APE-SINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 58/278 (20%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ I  GAYG V    + ETR+  A+KKI     N+I           LR+ + + V   
Sbjct: 6   IKLISNGAYGAVYLVRHKETRQRFAMKKINK--QNLI-----------LRN-QIQQVFVE 51

Query: 107 KDIIRPPKKDTFND------VYIVYE-------LMD----TDLHQIIRSDQQLTDDHCQY 149
           +DI+      TF +      ++  +E       +M+     D   ++++   L  D  + 
Sbjct: 52  RDIL------TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARM 105

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR------TTS------E 197
           +  + +  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++      TT+      E
Sbjct: 106 YFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 198 TD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            D   F+ + V  T  Y APE++L    Y   +D W++G IL E +     F G D   +
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEE 223

Query: 254 L--RLITELIGSPD-DASLGFLRSDNARRYVRQLPRCR 288
           L  ++I++ I  P+ D +L     D   R +RQ P  R
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 73/249 (29%), Positives = 113/249 (45%), Gaps = 35/249 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG G +G V    +  T+E    K I        +  + + E+ ++R ++H+N++  
Sbjct: 18  IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQY-FLYQLLRGLKYV 161
            D  R   K     +YI+ E  D  DL + I+   ++    ++H       QLL  L Y 
Sbjct: 78  ID--RFLNKAN-QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 162 HS-------ASVLHRDLKPSNLLL-----------------NASCDLKIGDFGLARTTSE 197
           H+         VLHRDLKP N+ L                 N     KIGDFGL++    
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 198 TDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
                  V T +Y +PELLL+ T+ Y    D+W++GCI+ E+ + +  F   +   Q  L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ--L 252

Query: 257 ITELIGSPD 265
           I+EL   PD
Sbjct: 253 ISELKRGPD 261

Length = 1021

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 47  IRPIGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHEN 102
           IR +G G++G ++ A   +E    VAIK+   +   II  ++      E K+L ++ H  
Sbjct: 35  IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKILNYINHPF 92

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            + +       K +++  +Y+V E ++  +    +R +++  +D   ++  Q++   +Y+
Sbjct: 93  CVNLYGSF---KDESY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            S ++++RDLKP NLLL+    +K+ DFG A+      +      T  Y APE+LLN   
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGH 205

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
             AA D W++G  + EI+   P F
Sbjct: 206 GKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 56/301 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIA 105
           +  +G G YG V    + +T +  AIK      D   D    ++ EI +L+   H   IA
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 106 ------IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
                 IK    PP  D  + +++V E       TDL +  + +  L +D   Y   ++L
Sbjct: 77  TYYGAFIKK--SPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREIL 131

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE 214
           RGL ++H+  V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191

Query: 215 LLLNCTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           ++  C E     Y    DIWS+G    E+    P  P  D +H +R +  +  +P     
Sbjct: 192 VIA-CDENPDATYDYRSDIWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPP---- 243

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                          P+ + ++++ +F       +D +E  LV +   R + E+ L+HP+
Sbjct: 244 ---------------PKLKSKKWSKKF-------IDFIEGCLVKNYLSRPSTEQLLKHPF 281

Query: 330 L 330
           +
Sbjct: 282 I 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 58/293 (19%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G++G V  A +  T E  AIK         +  R  L+ +K ++H+  E  I     
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIK--------CLKKREILK-MKQVQHVAQEKSILMELS 76

Query: 106 ---IKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              I +++   + +  N VY + E ++  +L   +R   +  +D  +++  +L+   +Y+
Sbjct: 77  HPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS  +++RDLKP NLLL+    +K+ DFG A+   +  F      T  Y APE ++    
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKG 191

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           +  A+D W++G +L E +   P F                   DD           R Y 
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF------------------FDDTPF--------RIYE 225

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 329
           + L    + +F   F  +   A DL++ +L  D  KR+      V +   HPY
Sbjct: 226 KILA--GRLKFPNWFDGR---ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 28/207 (13%)

Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA 105
           IG G +G VC   +    + E  VAIK + + +      RR  L E  ++   +H N+I 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIH 69

Query: 106 IKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKY 160
           ++ ++   RP        V I+ E M+   L   +R +D Q T       L  +  G+KY
Sbjct: 70  LEGVVTKSRP--------VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-------TDFMTEYVVTRWYRAP 213
           +   + +HRDL   N+L+N++   K+ DFGL+R   +       T  +   +  RW  AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAP 180

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E  +   ++T+A D+WS G ++ E+M+
Sbjct: 181 E-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 67/298 (22%), Positives = 125/298 (41%), Gaps = 44/298 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G GA G V       T    A+K I     N    ++ LRE+++ +  +   ++  
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL----LRGLKYV 161
                     +   + I  E  +   L  I +  ++      +  L ++    L+GL Y+
Sbjct: 65  YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS  ++HRD+KPSN+LL     +K+ DFG++     +   T +  T +Y APE +     
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQG-KP 179

Query: 222 YTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQLRLITELIGSP-----DDASLGFLRS 274
           Y+   D+WS+G  L E+      FP  G+  +  + L++ ++  P     D+   G   S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           +  +                          D +++ L  DP +R T  + L HP++++
Sbjct: 240 EEFK--------------------------DFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 71/314 (22%), Positives = 132/314 (42%), Gaps = 50/314 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +++        KD    V  +    D   H     +    +    ++  +L  GL+ +  
Sbjct: 63  VSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             +++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE++ N  +YT
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYT 179

Query: 224 AAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
            + D W +GC++ E I  + P    K+ V                     + +   R V+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERV---------------------KREEVDRRVK 218

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH--- 334
           +     +++++ +F   S  A  +   +L  +P +R+           +HP  ++++   
Sbjct: 219 E----DQEEYSEKF---SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271

Query: 335 ---DLNDEPVCPRP 345
              ++ + P CP P
Sbjct: 272 LEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREE-----VAIKKIGNAFDNII--DARRTLREIKLLRHM 98
            I  +GRG +G V  A      EE     V +K +    D  +  + RR   E+ + R +
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRKL 65

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR---------SDQQLTDDHCQ 148
            H+NV+ +  + R  + +     Y++ E  D  DL Q +R             L+     
Sbjct: 66  SHKNVVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 205
               Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++        +
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
             RW  APE +    +++   D+WS G ++ E+ T+  L
Sbjct: 181 PLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 48/215 (22%)

Query: 47  IRPIGRGAYGIVCAAVNSETR--EEVAIKKIGN---AFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G G +G+V      + R   +VAIK I     + D+ I+      E K++  + H 
Sbjct: 9   LKELGSGQFGVV---HLGKWRGKIDVAIKMIREGAMSEDDFIE------EAKVMMKLSHP 59

Query: 102 NVIAIKDII---RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-----QLTDDHCQYFLY 152
           N++ +  +    RP        ++IV E M    L   +R  +     +   D C     
Sbjct: 60  NLVQLYGVCTKQRP--------IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS---- 107

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYV 205
            +   ++Y+ S   +HRDL   N L+     +K+ DFGLAR       T+S+    T++ 
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFP 164

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           V +W  AP  + + + +++  D+WS G ++ E+ +
Sbjct: 165 V-KW--APPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 42/230 (18%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIK--KIGNAFDNIIDARRTLREIK 93
           +E+    +  +R +G G +G V   + N+ T   VA+K  K G       D +  L E +
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM-----DPKDFLAEAQ 53

Query: 94  LLRHMEHENVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------QQL 142
           +++ + H  +I   A+  +  P        +YIV ELM    L + ++          QL
Sbjct: 54  IMKKLRHPKLIQLYAVCTLEEP--------IYIVTELMKYGSLLEYLQGGAGRALKLPQL 105

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
            D        Q+  G+ Y+ + + +HRDL   N+L+  +   K+ DFGLAR   E  +  
Sbjct: 106 ID-----MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159

Query: 203 EYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                ++   + APE       ++   D+WS G +L EI+T  R P +PG
Sbjct: 160 AREGAKFPIKWTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G++G V  A    T E  AIK +    D II   D   T+ E         + V+A+
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKK--DVIIQDDDVECTMVE---------KRVLAL 56

Query: 107 KDIIRPP-------KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
               +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL
Sbjct: 57  PG--KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLL 217
            ++HS  +++RDLK  N++L+A   +KI DFG+ +        T  +  T  Y APE++ 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
               Y  ++D W+ G +L E++  +P F G+D     + I E
Sbjct: 175 Y-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 66/308 (21%), Positives = 132/308 (42%), Gaps = 61/308 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL-RHMEHENVIA 105
           +R +G GAYG V             ++K+G      + A + L++  ++ +    E+   
Sbjct: 5   LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53

Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIR------------SDQQLTDDHCQYFLY 152
            + ++   ++  F  V + Y    DT LH I+               +  T+   + ++ 
Sbjct: 54  ERQVLEAVRRCPFL-VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWY 210
           +++  L ++H   +++RD+K  N+LL++   + + DFGL++     E +    +  T  Y
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 211 RAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
            APE++   +  +  A+D WS+G +  E++T    F      +                 
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---------------- 216

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI---TVEEAL 325
              +S+ +RR ++  P          FP   S+ A D ++K+L  DP KR+     +E  
Sbjct: 217 ---QSEISRRILKSKP---------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264

Query: 326 RHPYLQSL 333
            HP+ Q +
Sbjct: 265 NHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 58/263 (22%), Positives = 114/263 (43%), Gaps = 57/263 (21%)

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-------NDVYIVYELMDTD-LHQIIR 137
           ++ LRE++++       ++            +F       N++ +  E MD   L +I +
Sbjct: 48  KQILRELQIMHECRSPYIV------------SFYGAFLNENNICMCMEFMDCGSLDRIYK 95

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG----LA 192
               +  +        ++ GL Y+++   ++HRD+KPSN+L+N+   +K+ DFG    L 
Sbjct: 96  KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155

Query: 193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
            + ++T     +V T  Y +PE  +   +YT   D+WS+G  + E+   +  FP      
Sbjct: 156 NSIADT-----FVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK--FPFAF--- 204

Query: 253 QLRLITELIGSPDDASLGFLRSDNARRYVRQ----LPRCRKQQFATRFPNKSSGAVDLLE 308
                + +     D  +G L  D  ++ V++    LP       ++ FP       D ++
Sbjct: 205 -----SNIDDDGQDDPMGIL--DLLQQIVQEPPPRLP-------SSDFPED---LRDFVD 247

Query: 309 KMLVFDPNKRITVEEALRHPYLQ 331
             L+ DP +R T ++    P   
Sbjct: 248 ACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 82/338 (24%), Positives = 125/338 (36%), Gaps = 49/338 (14%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
              + +SS    S V+         +QYN+  +L         P    G      VC   
Sbjct: 76  EPCETTSSSDPASVVR---------MQYNILSSL--------TP----GSEGEVFVCTKH 114

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
             E R++V +K +          +   REI +L+ + H  +I +    R   K T   V 
Sbjct: 115 GDEQRKKVIVKAV-------TGGKTPGREIDILKTISHRAIINLIHAYR--WKSTVCMVM 165

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
             Y+    DL   +     L  +       +LL  L Y+H   ++HRD+K  N+ L+   
Sbjct: 166 PKYK---CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222

Query: 183 DLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           +  +GDFG A          +   +  T    +PELL     Y A  DIWS G +L E+ 
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMS 281

Query: 240 T-REPLF--PGKDYVHQLRLITELIGSPDDASLGFLRSDNAR---RYVRQLPRCRKQQFA 293
                LF    K    QLR I   I       L F ++ +      + +     R     
Sbjct: 282 VKNVTLFGKQVKSSSSQLRSI---IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTI 338

Query: 294 TRFPNKSSGAVD---LLEKMLVFDPNKRITVEEALRHP 328
                K    +D   L+ KML FD   R + ++ L  P
Sbjct: 339 PPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 21/219 (9%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +EV  + +  ++ +G G +G V     +   + VAIK +       +     L E  L++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK---QGSMSPEAFLAEANLMK 56

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQ 153
            ++H  ++ +  ++      T   +YI+ E M+   L   +++ +  +LT +       Q
Sbjct: 57  QLQHPRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWY 210
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W 
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW- 169

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 170 TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)

Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G+G +G V  C    +   T E VA+KK+ ++    +  R   REI++L+ ++H+N
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQHDN 66

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLK 159
           ++  K +     +    ++ +V E L    L   ++  ++  D H +  LY  Q+ +G++
Sbjct: 67  IVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQICKGME 122

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYR 211
           Y+ S   +HRDL   N+L+ +   +KIGDFGL +   +     EY   R        WY 
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWY- 178

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT 240
           APE  L  ++++ A D+WS G +L E+ T
Sbjct: 179 APE-SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR----------------SDQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R                 D+Q+T
Sbjct: 81  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 196 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVV 206
             YQ++  L  VHS  ++HRDLK +N+ L  +  +K+GDFG ++  S++   D  + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 266
           T +Y APEL      Y+   D+WS+G IL E++T    F G      ++ +  L G  D 
Sbjct: 234 TPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290

Query: 267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
                                            SSG   LL+ +L  +P  R T ++ L 
Sbjct: 291 FPCPV----------------------------SSGMKALLDPLLSKNPALRPTTQQLLH 322

Query: 327 HPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
             +L+ + +L  + V          HS     H RE I R+
Sbjct: 323 TEFLKYVANLFQDIV---------RHSETISPHDREEILRQ 354

Length = 478

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 31/253 (12%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK + N   ++ +    L E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---DQQLTDDHC 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS   + +      
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 175 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 233 FVMEGGLLDKPDN 245

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 79/297 (26%), Positives = 140/297 (47%), Gaps = 35/297 (11%)

Query: 50  IGRGAYGIVCAAVNSET---------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           +G+G +G V       T         R+EV I K     D +     T+ E ++L++  H
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVA---HTVTESRVLQNTRH 54

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+
Sbjct: 55  PFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 109

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +
Sbjct: 110 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI-TELIG-----SPDDASL--G 270
             +Y  A+D W +G ++ E+M     F  +D+     LI  E I      SP+  SL  G
Sbjct: 170 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 228

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L+ D  +R +   P   K+    RF   S    D+++K L+     ++T E   R+
Sbjct: 229 LLKKDPKQR-LGGGPSDAKEVMEHRFFL-SINWQDVVQKKLLPPFKPQVTSEVDTRY 283

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 39/227 (17%)

Query: 48  RPIGRGAYGIVCAAVN---SETREE--VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A     S T+++  VA+K +    D  + AR+   RE +LL +++HE
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHE 67

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFL 151
           +++    +         + + +V+E M   DL++ +R+         D Q      +  L
Sbjct: 68  HIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 152 YQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-- 202
            Q+L        G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R    TD+    
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
               +  RW   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 183 GHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 68/263 (25%), Positives = 104/263 (39%), Gaps = 50/263 (19%)

Query: 65  ETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 121
            T  EVAIK +    D   +     R  RE  L   + H N++A+ D    P       +
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP--PGL--L 54

Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           + V+E +    L +++ +D  L        + Q+L  L   H+  ++HRDLKP N++++ 
Sbjct: 55  FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 181 SCD---LKIGDFGL------------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +      K+ DFG+            A  T      TE + T  Y APE L      T  
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRG-EPVTPN 169

Query: 226 IDIWSVGCILGEIMTREPLFPGKD----YVHQLRLITELIGSPDDASL-----GFLRSDN 276
            D+++ G I  E +T + +  G         QL        SP D SL     G      
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQGASVAEILYQQL--------SPVDVSLPPWIAGHPLGQV 221

Query: 277 ARRYVRQLPRCRK---QQFATRF 296
            R+ + + PR R       A RF
Sbjct: 222 LRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 51/212 (24%), Positives = 109/212 (51%), Gaps = 17/212 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-----LLRHMEHENVI 104
           IG+G++G V  A      +  A+K +      I+  R+  + I      LL++++H  ++
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQK---KIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +  +K     +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS
Sbjct: 60  GLHYSFQTTEK-----LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
            ++++RDLKP N+LL++   + + DFGL +   +++D  T +  T  Y APE++     Y
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPY 173

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
              +D W +G +L E++   P F  +D V ++
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 50  IGRGAYGIV----CAAVNSET-REEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V    C  +  E  +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHI 69

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ---------------QLTDDHC 147
           +    +    +      + +V+E M   DL++ +RS                 QLT    
Sbjct: 70  VRFYGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +  RW   PE +L   ++T   DIWS G +L EI T
Sbjct: 185 MLPIRWM-PPESILY-RKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 8e-13
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IG+G +G V   V  +   EVA+K    +       R+ L+E ++L+  +H N++ + 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 108 DII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +   + P       +YIV EL+     L  + +   +LT             G++Y+ S
Sbjct: 59  GVCVQKQP-------IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLL 217
            + +HRDL   N L+  +  LKI DFG++R   E   +       + +  +W  APE  L
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW-TAPE-AL 167

Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           N   YT+  D+WS G +L E  +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 33/107 (30%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 204 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            +  T  Y APE+L+    +  A+D WS+G ++ +++T  P F  ++
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 56/251 (22%)

Query: 48  RPIGRGAYGIVCAA----VNSETREE---VAIKKI-GNAFDNIIDARRTLREIKLLRHM- 98
           +P+G G +G V  A    ++    ++   VA+K +  NA D   D    + E++L++ + 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--DLADLISEMELMKLIG 75

Query: 99  EHENVIAIKDII-------------------------RPPKKDTFNDVYIVYELMDTDLH 133
           +H+N+I +  +                          RPP  D   D+  V E       
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE------- 128

Query: 134 QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
                 +QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR
Sbjct: 129 ------EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 194 TTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPLFPGK 248
              + D+  +    R    + APE L +   YT   D+WS G ++ EI T    P +PG 
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP-YPGI 240

Query: 249 DYVHQLRLITE 259
                 +L+ E
Sbjct: 241 PVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 32/192 (16%)

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+ DFG++     +     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEI-MTREP---LFPGKDYVHQLRLITELIGSPDDASL 269
           E +    +Y    D+WS+G    E+ + R P   +   +  +  L+L+  ++   D+   
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDP- 217

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                          P     QF+ +F       V  + + +   P +R   E  + HP+
Sbjct: 218 ---------------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255

Query: 330 LQSLHDLNDEPV 341
           +   +D N E V
Sbjct: 256 IVQYNDGNAEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 43/130 (33%), Positives = 75/130 (57%), Gaps = 5/130 (3%)

Query: 120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 177
           ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 178 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 238 I-MTREPLFP 246
           + + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V         ++VA+K +    D+   A+  L E  ++  + H N++ +  +
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +        N +YIV E M    L   +RS     +T      F   +  G++Y+   + 
Sbjct: 69  VL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDL   N+L++     K+ DFGLA+  S+     +  V +W  APE L    +++   
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPEALRE-KKFSTKS 180

Query: 227 DIWSVGCILGEIMT-------REPL 244
           D+WS G +L EI +       R PL
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)

Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTR--VAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 69  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 118 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 176

Query: 218 NCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
               +T   D+WS G +L E+ T  R P +PG
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELTTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 128 MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           M T L+Q        ++D  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 188 DFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           DFGL++   + E +    +  T  Y APE++     +  A+D WS+G ++ E++T    F
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAV 304
                         L G  +       +S+ +RR ++  P          FP+     A 
Sbjct: 208 -------------TLEGERNT------QSEVSRRILKCDP---------PFPSFIGPEAQ 239

Query: 305 DLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 346
           DLL K+L  DP KR+        E   HP+ + L    L    V   PF
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV-NPPF 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 34/188 (18%)

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVT 207
           ++  +++ GL+++HS  +++RDLK  N++L+    +KI DFG+ +     D   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
             Y APE+L    +YT ++D WS G +L E++  +  F G D               +D 
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---------------EDE 203

Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR- 326
               +R D    Y R + +  K               D+LEK+   DP +R+ V   +R 
Sbjct: 204 LFESIRVDTP-HYPRWITKESK---------------DILEKLFERDPTRRLGVVGNIRG 247

Query: 327 HPYLQSLH 334
           HP+ ++++
Sbjct: 248 HPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 5/136 (3%)

Query: 128 MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           MD         ++QLT        YQ+ RG++Y+ S   +HRDL   N+L+     +KI 
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176

Query: 188 DFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           DFGLAR     D+  +    R    + APE L +   YT   D+WS G +L EI T    
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS 235

Query: 245 -FPGKDYVHQLRLITE 259
            +PG       +L+ E
Sbjct: 236 PYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 60/315 (19%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG +G V       T +  A+K +  +          L +  +    E  ++++I + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKS--------VLLAQETVSFFEEERDILSISNS 60

Query: 110 IRPPK-KDTFND---VYIVYELM-DTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+ +  F D   +Y+V E     DL  ++ R + Q  +D  Q++L +L+  +  VH 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLL---- 217
              +HRD+KP N+L++ +  +K+ DFG A   T ++       V T  Y APE+L     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 218 --NCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
               T Y    D WS+G I  E I  R P                       ++  +   
Sbjct: 181 DGKGT-YGVECDWWSLGVIAYEMIYGRSPF------------------HEGTSAKTYNNI 221

Query: 275 DNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            N +R++             +FP     SS  +DL++ +L     +R+  E    HP+  
Sbjct: 222 MNFQRFL-------------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS 267

Query: 332 SLHDLNDEPVCPRPF 346
            + D N+      PF
Sbjct: 268 KI-DWNNIRNSLPPF 281

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 46/199 (23%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++  + H  ++ +
Sbjct: 9   MKELGSGQFGVVHLG-KWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             +    K      +YIV E M+    L+ + +   +L+ D        +  G++Y+   
Sbjct: 65  YGVCTQQKP-----LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTE 221
           S +HRDL   N L++++  +K+ DFG+ R   + ++ +        +W   PE + N ++
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSK 177

Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 67/255 (26%), Positives = 121/255 (47%), Gaps = 40/255 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLRE---IKLLRH 97
           IGRG +G V     ++T +  A+K         +D +R          L E   + L+  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNERIMLSLVST 53

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
            +   ++ +      P K  F     + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL+++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 167

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF---PGKDYVHQLRLITELIG-------SPDD 266
              T Y ++ D +S+GC+L +++     F     KD  H++  +T  +        SP+ 
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPEL 226

Query: 267 ASL--GFLRSDNARR 279
            SL  G L+ D ++R
Sbjct: 227 KSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 50  IGRGAYGIVCAAVNSE---TREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +G G++G+V     S        VA+K  K     D + D    L+E  ++  ++HEN+I
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--------QLLR 156
            +  ++                +M T+L  +     +L  D   +FL         Q+  
Sbjct: 60  RLYGVVLTHPL-----------MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR----- 211
           G++Y+ S   +HRDL   N+LL +   +KIGDFGL R   + +   ++ V   +      
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYVMEEHLKVPFA 165

Query: 212 --APELLLNCTEYTAAIDIWSVGCILGEIMT--REP 243
             APE  L    ++ A D+W  G  L E+ T   EP
Sbjct: 166 WCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 44/229 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           IR IG+G  G V  A +      VA+KKI  +  +N +  +R LRE K+   + H  ++ 
Sbjct: 7   IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELM----DTDLHQIIRSDQQ---LTDDHCQ-----YFL-- 151
           +  I         +D   VY  M       L  +++S  Q   L+ +  +      FL  
Sbjct: 67  VYSI--------CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 152 -YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT--------------- 195
            +++   ++YVHS  VLHRDLKP N+LL    ++ I D+G A                  
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 196 ----SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               S      + V T  Y APE LL     + + DI+++G IL +++T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 15/213 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--IDARRTLREIKLLRHMEHENVI 104
           I+ IGRGA+G V    +  +++  A+K + + F+ I   D+     E  ++ H   E ++
Sbjct: 48  IKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSEWIV 106

Query: 105 AIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +  K      +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS
Sbjct: 107 QLHYAFQDDKY-----LYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHS 160

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN--- 218
              +HRD+KP N+LL+ S  LK+ DFG          +     V T  Y +PE+L +   
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
              Y    D WSVG  L E++  +  F     V
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A+   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIK--------ILKKDVVIQDDDVECTMVEKRVLALSG- 58

Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 59  -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
           HS  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE ++   
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQ 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y  ++D W+ G +L E++  +  F G+D
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 74/258 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +G GA+G VC A   +T                + A +TLR+  +L   +  +V A 
Sbjct: 6   IKTLGIGAFGEVCLARKVDT--------------KALYAMKTLRKKDVLLRNQVAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++       +D  ++++ +L 
Sbjct: 52  RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSET-------------- 198
             ++ VH    +HRD+KP N+L++    +K+ DFGL    R T ++              
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 199 DFMTEY-------------------------------VVTRWYRAPELLLNCTEYTAAID 227
           DF  E+                               V T  Y APE+LL  T YT   D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCD 230

Query: 228 IWSVGCILGEIMTREPLF 245
            WSVG IL E++  +P F
Sbjct: 231 WWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 19/140 (13%)

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           D  R  +  ++ D  +  E+++ D       +  L  +    F YQ+ +G+ ++ S + +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCT 220
           HRDL   N+LL      KI DFGLAR     D  + YVV        +W  APE + NC 
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292

Query: 221 EYTAAIDIWSVGCILGEIMT 240
            YT   D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 74/327 (22%), Positives = 140/327 (42%), Gaps = 67/327 (20%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +    +  A+K +          ++ + + K  +H+  E  + +K++
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVL---------QKKAILKKKEEKHIMSERNVLLKNV 53

Query: 110 IRP------PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L Y+H
Sbjct: 54  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
           S ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE +L+   
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQP 172

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y   +D W +G +L E++   P F  ++                         DN     
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY--------------------DNILNKP 212

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE----EALRHPYLQSLH--D 335
            QL            PN ++ A  LLE +L  D  KR+  +    E   H +   ++  D
Sbjct: 213 LQLK-----------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261

Query: 336 LNDEPVCPRPF-----------HFDFE 351
           L ++ + P PF           HFD E
Sbjct: 262 LINKKITP-PFNPNVSGPNDLRHFDPE 287

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            +  +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIK--------ILKKDVVIQDDDVECTMVEKRVLA 55

Query: 106 IKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           ++D  +PP          T + +Y V E ++  DL   I+   +  +    ++  ++  G
Sbjct: 56  LQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------YR 211
           L ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR       Y 
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYI 168

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           APE++     Y  ++D W+ G +L E++  +P F G+D
Sbjct: 169 APEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 70/254 (27%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG GA+G VC     +T    A+K              TLR+  +L   +  +V A 
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++       +D  ++++ +L 
Sbjct: 52  RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSET-------------- 198
             ++ VH    +HRD+KP N+L++    +K+ DFGL    R T ++              
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171

Query: 199 DFMTEY---------------------------VVTRWYRAPELLLNCTEYTAAIDIWSV 231
           +   E+                           V T  Y APE+LL  T YT   D WSV
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV 230

Query: 232 GCILGEIMTREPLF 245
           G IL E++  +P F
Sbjct: 231 GVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 19/109 (17%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV- 206
           F  Q+ +G+ ++ S + +HRD+   N+LL      KI DFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 207 ------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                  +W  APE + +C  YT   D+WS G +L EI +  + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 60/251 (23%), Positives = 118/251 (47%), Gaps = 36/251 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V           +A +K   +F     A + L++  +L+  E  +++A +++
Sbjct: 3   IGKGSFGKVL----------LAKRKSDGSFY----AVKVLQKKTILKKKEQNHIMAERNV 48

Query: 110 IRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           +    K  F             +Y V + ++  +L   ++ ++   +   +++  ++   
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELL 216
           + Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE+L
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD----YVHQLRLITELIGSPDDAS---- 268
                Y   +D W +G +L E++   P F  +D    Y + L    +L G    A+    
Sbjct: 169 RK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLL 227

Query: 269 LGFLRSDNARR 279
           +G L  D  RR
Sbjct: 228 VGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G +G V  A       + ++VA+K +     +  D    LRE   ++  +H NVI
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLR 156
            +  + +R   K       ++   M   DLH  +   +       L       F+  +  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRA 212
           G++Y+ S + +HRDL   N +LN +  + + DFGL++     D+  +   +    +W   
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
             L  N   YT   D+W+ G  + EIMTR
Sbjct: 185 ESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 66/245 (26%), Positives = 122/245 (49%), Gaps = 24/245 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  + A
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+HS 
Sbjct: 60  LKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 165 -SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
            +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L +  +Y
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDY 173

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFLRS 274
             A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L+ 
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233

Query: 275 DNARR 279
           D  +R
Sbjct: 234 DPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 49/220 (22%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSE 197
           ++  +   Q +  +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Query: 198 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQL 254
            +    +  T  Y AP+++      +  A+D WS+G ++ E++T    F   G+      
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-- 217

Query: 255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVF 313
                              ++ +RR ++  P          +P + S  A D+++++L+ 
Sbjct: 218 -------------------AEISRRILKSEP---------PYPQEMSALAKDIIQRLLMK 249

Query: 314 DPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 346
           DP KR+       +E  +HP+ Q ++  DL  + V P PF
Sbjct: 250 DPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV-PAPF 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 27/203 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLRE---IKLLRH 97
           IGRG +G V     ++T +  A+K         +D +R          L E   + L+  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNERIMLSLVST 53

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
            +   ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL+++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 167

Query: 217 LNCTEYTAAIDIWSVGCILGEIM 239
                Y ++ D +S+GC+L +++
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/246 (23%), Positives = 117/246 (47%), Gaps = 26/246 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +    +  A+K         +  ++ + + K  +H+  E  + +K++
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVK---------VLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 110 IRP------PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L Y+H
Sbjct: 54  KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTE 221
           S ++++RDLKP N+LL++   + + DFGL +   E +   + +  T  Y APE+L     
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QP 172

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDY-------VHQ-LRLITELIGSPDDASLGFLR 273
           Y   +D W +G +L E++   P F  +D        +++ LRL   +  S      G L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232

Query: 274 SDNARR 279
            D  +R
Sbjct: 233 KDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 77/308 (25%), Positives = 131/308 (42%), Gaps = 72/308 (23%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YG V   ++  T   +A+K+I    D      + + E+ +L    H+ V      
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-KFNQIIMELDIL----HKAV------ 57

Query: 110 IRPPKKDTF------NDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             P   D +        VY+  E MD      L+    + + + +D  +   Y +++GLK
Sbjct: 58  -SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 160 YVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPE 214
           ++    +++HRD+KP+N+L+N +  +K+ DFG    L  + ++T+     +  + Y APE
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPE 171

Query: 215 LLLNCT-----EYTAAIDIWSVG-CILGEIMTREPLFPGKDYVH---QLRLITELIGSPD 265
            + +        YT   D+WS+G  IL   + R P +P + Y +   QL  I +  G P 
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP 228

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
                             LP              S  A D + K L   PN+R T  + L
Sbjct: 229 -----------------TLP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Query: 326 RHPYLQSL 333
            HP+L   
Sbjct: 261 EHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 110 I--RPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R    Q++      Y   Q+   ++Y+   
Sbjct: 71  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---------RWYRAPEL 215
           + +HRDL   N L+  +  +K+ DFGL+R       MT    T         +W  APE 
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKW-TAPES 176

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVH 252
           L     ++   D+W+ G +L EI T    P +PG D   
Sbjct: 177 LAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 38/279 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  ++
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H 
Sbjct: 60  GLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE+L    +Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 223 TAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
             ++D W++G ++ E+M  R P               +++GS D+         N   Y+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF--------------DIVGSSDNP------DQNTEDYL 213

Query: 282 RQLPRCRKQQFATRFPNKSS-GAVDLLEKMLVFDPNKRI 319
            Q+    KQ    R P   S  A  +L+  L  DP +R+
Sbjct: 214 FQVI-LEKQ---IRIPRSLSVKAASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G +G VCA     T +  A KK+    D     +++  ++ LL     E V +   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL----DKKRLKKKSGEKMALLEKEILEKVNSPFIV 56

Query: 110 IRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                 ++   + +V  LM   D   H     ++ L  +   ++  Q+  G+ ++HS  +
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RD+KP N+LL+   + ++ D GLA    +   +T+   T  Y APE+L     Y+  +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPV 175

Query: 227 DIWSVGCILGEIMT-REPLFPGKDY 250
           D +++GC + E++  R P    KD+
Sbjct: 176 DWFAMGCSIYEMVAGRTPF---KDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 70/337 (20%), Positives = 133/337 (39%), Gaps = 97/337 (28%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVI 104
            I+ +G+G  G V       T +  A+K +           +R L E ++L  ++H  + 
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL- 63

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQII--RSDQQLTDDHCQYFLYQLLRGL 158
                  P    +F     +  +MD     +L +++  +  + L+++  +++  ++L  L
Sbjct: 64  -------PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---------------------- 196
           +Y+H   +++RDLKP N+LL+ S  + + DF L++ +                       
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 197 -------ETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
                  E  F +  +V T  Y APE++     + +A+D W++G +L E++     F G 
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGS 235

Query: 249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT------RFPNK--- 299
           +                                      R + F+        FP     
Sbjct: 236 N--------------------------------------RDETFSNILKKEVTFPGSPPV 257

Query: 300 SSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQS 332
           SS A DL+ K+LV DP+KR+       E  +HP+ + 
Sbjct: 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 40/126 (31%), Positives = 72/126 (57%), Gaps = 8/126 (6%)

Query: 131 DLHQIIRSDQQLTD---DHCQYFLY-QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 186
           DL Q I+S  +      +H    L+ Q+L  + +VHS  ++HRD+K +N+LL ++  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 187 GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           GDFG ++  + T   D    +  T +Y APE+      Y+   D++S+G +L E++T + 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKR 243

Query: 244 LFPGKD 249
            F G++
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 53/301 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENVIA 105
           +G+G +G V A     T +  A KK+       +  R+     + E ++L  +    +++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNK---KRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DL-HQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
           +    +     T  D+ +V  +M+  DL + I   D++     +    ++  Q++ GL++
Sbjct: 58  LAYAFQ-----TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N+LL+   +++I D GLA    +    T+ Y  T  + APELL   
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            EY  ++D +++G  L E++                           A+ G  R+   + 
Sbjct: 172 EEYDFSVDYFALGVTLYEMI---------------------------AARGPFRARGEKV 204

Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 333
             ++L + R    +  +P+K S  +    E +L  DP KR+       +    HP  + L
Sbjct: 205 ENKELKQ-RILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263

Query: 334 H 334
           +
Sbjct: 264 N 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 39/207 (18%)

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIG 187
           D DL  +++ + +L++   +  + QL+  L  +H  +++H D+K  N+L + + D + + 
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 188 DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           D+GL +   T S  D   +Y       +PE  +    Y  + D W+VG +  E++T +  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 304
            P K+                D  L        +R  ++LP            N S  A 
Sbjct: 204 HPFKEDE--------------DEELDL--ESLLKRQQKKLP---------FIKNVSKNAN 238

Query: 305 DLLEKMLVFDPNKR-ITVEEALRHPYL 330
           D ++ ML ++ N R     E ++HP+L
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHENVIA 105
           +G+G++G V  A    T E  AIK +    D I+   D   T+ E ++L    +H  + A
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKK--DVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +   +     ++ V E ++  DL   I+  ++  +   +++  ++   L ++H  
Sbjct: 61  LHCCFQTKDR-----LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYT 223
            V++RDLK  N+LL+A    K+ DFG+ +        T  +  T  Y APE+L    EY 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYG 174

Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            ++D W++G ++ E+M  +P F
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 69/290 (23%)

Query: 70  VAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIR--PPKKDTFNDVYIVYE 126
           VA+K +    D   +AR   L+E+K+L  +   N+  +  +    PP       + ++ E
Sbjct: 49  VAVKVLRP--DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIME 99

Query: 127 LMDT-DLHQIIRSDQQLTDDHCQY--------FLY---QLLRGLKYVHSASVLHRDLKPS 174
            M+  DL+Q ++     T               LY   Q+  G++Y+ S + +HRDL   
Sbjct: 100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159

Query: 175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCTEYTAAID 227
           N L+  +  +KI DFG++R    +D+   Y V        RW     +LL   ++T   D
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLL--GKFTTKSD 214

Query: 228 IWSVGCILGEIMT--REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +W+ G  L EI+T  RE  +   +++   ++I       ++A   F R D  + Y+ + P
Sbjct: 215 VWAFGVTLWEILTLCREQPY---EHLTDQQVI-------ENAGHFF-RDDGRQIYLPRPP 263

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKML---VFDPNKRITVEEALRHPYLQS 332
            C K               D+ E ML     D   R T  E   H +LQ 
Sbjct: 264 NCPK---------------DIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 41/130 (31%), Positives = 73/130 (56%), Gaps = 5/130 (3%)

Query: 120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 177
           ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136

Query: 178 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 238 I-MTREPLFP 246
           + + R P+ P
Sbjct: 195 MAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 29/264 (10%)

Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDH 146
           ++ E +LLR + H  V+A+ D +R     T     +V     +DL+  +    + L    
Sbjct: 207 SVHEARLLRRLSHPAVLALLD-VRVVGGLTC----LVLPKYRSDLYTYLGARLRPLGLAQ 261

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG---LARTTSETDFMTE 203
                 QLL  + Y+H   ++HRD+K  N+L+N   D+ +GDFG    AR +  T F   
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLF--PGKDYVHQ-----LR 255
              T    APE+L     YT ++DIWS G ++ E       LF     D         LR
Sbjct: 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380

Query: 256 LITELIGSPDDASLGFLRSDNAR---RYVRQLPRCRKQQFA----TRFPNKSSGAVDLLE 308
           +I +     D+    F +   +R   +Y  +  R R+  +     TR+         L+ 
Sbjct: 381 IIRQAQVHVDE----FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVC 436

Query: 309 KMLVFDPNKRITVEEALRHPYLQS 332
           + L FD  +R +  E LR P  QS
Sbjct: 437 RALTFDGARRPSAAELLRLPLFQS 460

Length = 461

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YV 205
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  I+ +G G +G V     N  T+  V   K G      +     L E +++
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIM 55

Query: 96  RHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDTDLHQIIRSD--------QQLTDDH 146
           + + H+ ++ +  ++   P       +YIV E M          D          L D  
Sbjct: 56  KKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD-- 106

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
                 Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + ++      
Sbjct: 107 ---MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163

Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
               +W  APE  L    +T   D+WS G +L E++T  R P +PG
Sbjct: 164 KFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V   +      +VA+K I N       A+  L E  ++  + H N++ +
Sbjct: 11  LQTIGKGEFGDV--MLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 163
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+ +
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  APE L    +++
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPEALRE-KKFS 177

Query: 224 AAIDIWSVGCILGEIMT----REPLFPGKDYV 251
              D+WS G +L EI +      P  P KD V
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 61.2 bits (148), Expect = 9e-11
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 87  RTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQL 142
           + L E ++L+  +H N++ +  +   R P       +YIV EL+     L  + +   +L
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQRQP-------IYIVMELVPGGDFLSFLRKKKDEL 90

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
                  F      G+ Y+ S + +HRDL   N L+  +  LKI DFG++R   +  + +
Sbjct: 91  KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150

Query: 203 ---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              + +  +W  APE  LN   Y++  D+WS G +L E  +
Sbjct: 151 SGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 16/196 (8%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   +    ++ + VA+K + N  ++       LRE  +++ +++  ++ + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            I             +V EL +   L++ ++ ++ +T+ +    ++Q+  G+KY+   + 
Sbjct: 63  GICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-----RWYRAPELLLNCTE 221
           +HRDL   N+LL      KI DFGL++     +   +         +WY APE  +N  +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYK 174

Query: 222 YTAAIDIWSVGCILGE 237
           +++  D+WS G ++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
           T + +++V E ++  DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126

Query: 176 LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           +LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    EY  ++D W++G +
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVL 185

Query: 235 LGEIM---------TREPLFPGKDYVHQLRLITELIGSPDDASL-------GFLRSDNAR 278
           + E+M         T  P    +DY+ Q+ ++ + I  P   S+       GFL  D   
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFLNKDPKE 244

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAV------DLLEKMLVFDPNK 317
           R       C+ Q   T F +  S         DLLEK  V  P K
Sbjct: 245 RL-----GCQPQ---TGFSDIKSHTFFRSIDWDLLEKKQVTPPFK 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 30/206 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGN---AFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G G +G+V        + +VAIK I     + D  I+      E K++  + HE +
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSEDEFIE------EAKVMMKLSHEKL 61

Query: 104 IAIKDII---RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQ-LTDDHCQYFLYQLLRGL 158
           + +  +    RP        +YIV E M    L   +R   +             +  G+
Sbjct: 62  VQLYGVCTKQRP--------IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPE 214
            Y+ S   +HRDL   N L++    +K+ DFGL+R   + ++     +++ V RW   PE
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT 240
           +LL   ++++  D+W+ G ++ E+ +
Sbjct: 172 VLLYS-KFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 21/226 (9%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        ++  +VA+K +  A     +    L E   ++  +H NV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 106 IKDI-IRPPKKDTFNDVYIVYELMD-TDLHQII------RSDQQLTDDHCQYFLYQLLRG 157
           +  + ++  + + +    ++   M   DLH  +         Q L       F+  +  G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPE 214
           ++Y+ S S +HRDL   N +LN + ++ + DFGL++     D+  +  + +    + A E
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPG------KDYVHQ 253
            L +   YT   D+WS G  + EI TR +  +PG       DY+ Q
Sbjct: 185 SLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 22/203 (10%)

Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G V   V    S    EVA+K +          +  LRE  ++  ++H  ++ +
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             + +         + +V EL     L + ++  +++     +   +Q+  G+ Y+ S  
Sbjct: 62  IGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLN 218
            +HRDL   N+LL      KI DFG++R          Y  T       +WY APE  +N
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWY-APE-CIN 171

Query: 219 CTEYTAAIDIWSVGCILGEIMTR 241
             ++++  D+WS G  L E  + 
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 36/236 (15%)

Query: 50  IGRGAYGIVCAAV------NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           +G GA+G V                 VA+K +        + +  L+E  L+ +  H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 104 IAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL------ 155
           + +  +         N+  YI+ ELM+  DL   +R  +          L +LL      
Sbjct: 62  VKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 156 -RGLKYVHSASVLHRDLKPSNLLLNAS---CD--LKIGDFGLARTTSETDFMTE----YV 205
            +G  Y+     +HRDL   N L++      D  +KIGDFGLAR   ++D+  +     +
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITE 259
             RW  APE LL+  ++T   D+WS G ++ EI+T  ++P +P  +    L+ +T 
Sbjct: 176 PVRWM-APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 14/194 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
               +      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 62  CTQKQP-----IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R   +  + +    + +  +W  APE  LN   Y+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-ALNYGRYS 174

Query: 224 AAIDIWSVGCILGE 237
           +  D+WS G +L E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R IGRG+Y  V      +TR   A+K I       D  ID  +T + +       H  ++
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +   +     ++ V E +   DL   ++  ++L ++H +++  ++   L ++H 
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    +Y
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 223 TAAIDIWSVGCILGEIMT-REP 243
             ++D W++G ++ E+M  R P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 47/199 (23%), Positives = 98/199 (49%), Gaps = 22/199 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G +G+V      E R+ VAIK I       +     + E +++  + H  ++ +  +
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 110 I--RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSAS 165
              R P       + +V+E M+   L   +R+ + + + +        +  G+ Y+ S++
Sbjct: 68  CTERSP-------ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTE 221
           V+HRDL   N L+  +  +K+ DFG+ R   +  +     T++ V +W  +PE + + ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSK 177

Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 6/135 (4%)

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I     ++  D Y+      T    +I     L+      F YQ+  G++++ S + +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 170 DLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAA 225
           DL   N+L+     +KI DFGLAR    +++++++   ++  +W  APE + N   YT  
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321

Query: 226 IDIWSVGCILGEIMT 240
            D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 38/118 (32%), Positives = 68/118 (57%), Gaps = 8/118 (6%)

Query: 129 DTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 186
           D+++  ++  D  + LT      F YQ+ RG++++ S + +HRDL   N+LL     +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278

Query: 187 GDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            DFGLAR    +++++++   ++  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI---GNAFDNIIDARRTLR--EIKLLRHMEHENVI 104
           IG G  G V      +T   +A+K++   GN  +N    +R L   ++ L  H     V 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVK 78

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD----HCQYFLYQLLRGLKY 160
                I         DV+I  ELM T L ++++  Q    +         + + L  LK 
Sbjct: 79  CYGYFITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---L 217
            H   V+HRD+KPSN+LL+AS ++K+ DFG++    ++   T       Y APE +    
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
              +Y    D+WS+G  L E+ T +  +  
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 69/320 (21%), Positives = 136/320 (42%), Gaps = 61/320 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G            EVA+ K+ NA D +  A + L + ++L+  E       
Sbjct: 6   LKVIGRGAFG------------EVAVVKLKNA-DKVF-AMKILNKWEMLKRAETACFREE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQL 154
           +D++              F D   +Y +MD     DL  ++ + + +L +D  +++L ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRA 212
           +  +  VH    +HRD+KP N+L++ +  +++ DFG      E   +   V   T  Y +
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 213 PELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
           PE+L    +    Y    D WS+G  + E++  E  F  +  V                 
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------------- 216

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALR 326
                      Y + +    + QF  +  + S  A DL+ +++    ++  +  +E+  +
Sbjct: 217 -----------YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265

Query: 327 HPYLQSLHDLNDEPVCPRPF 346
           HP+   + D ++   C  P+
Sbjct: 266 HPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 64/247 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V           V  K  G+ +     A + LR+  +L   +  ++ A 
Sbjct: 6   LKVIGRGAFGEV---------RLVQKKDTGHVY-----AMKILRKADMLEKEQVGHIRAE 51

Query: 107 KDIIRPPK-----------KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +DI+               +D  N +Y++ E +   D+  ++     LT++  Q+++ + 
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLN-LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAET 110

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-------RT--------TSETD 199
           +  +  +H    +HRD+KP NLLL++   +K+ DFGL        RT        +  +D
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 200 FMTEYVVTR-----WYR----------------APELLLNCTEYTAAIDIWSVGCILGEI 238
           F  + + ++     W R                APE+ +  T Y    D WS+G I+ E+
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEM 229

Query: 239 MTREPLF 245
           +   P F
Sbjct: 230 LIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 28/224 (12%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDDHC 147
             +++     +V+ +  ++   +        +V ELM   DL   +RS   + +      
Sbjct: 60  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174

Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 175 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 38/229 (16%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGN-----AFDNIIDARRTLREIKLLRH 97
           I+ +G GA+G V   V      + +  VAIK +       A   I      L E  ++  
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEI------LDEAYVMAS 65

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLL 155
           ++H +V+ +  I    +      V ++ +LM    L   +R+ +  +   +   +  Q+ 
Sbjct: 66  VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RW 209
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKW 177

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQL 254
             A E +L+   YT   D+WS G  + E+MT   +P    P  + +  L
Sbjct: 178 M-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 31/211 (14%)

Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  T+  VAIK +       +     L+E ++++ + H+ ++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTK--VAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++          QL D        Q+  G+ Y
Sbjct: 69  VV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-----MAAQIADGMAY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLL 217
           +   + +HRDL+ +N+L+  +   KI DFGLAR   + ++          +W  APE  L
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 176

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E++T+  + +PG
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 62/246 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V           V  K  G+ +     A + LR+  +L   +  ++ A 
Sbjct: 6   LKVIGRGAFGEV---------RLVQKKDTGHIY-----AMKILRKADMLEKEQVAHIRAE 51

Query: 107 KDIIRPPKKD-------TFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+             +F D   +Y++ E +   D+  ++     L+++  Q+++ + +
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-------RT--------TSETDF 200
             +  +H    +HRD+KP NLLL+A   +K+ DFGL        RT           +DF
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 201 MTEYVVTR-----W----------------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
             + + ++     W                Y APE+ +  T Y    D WS+G I+ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEML 230

Query: 240 TREPLF 245
              P F
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI-----IRSDQQL 142
           L+EIK++  +++ N+I +  +         + + ++ E M+  DL+Q      I S    
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 143 TDD-------HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
            ++       +  Y   Q+  G+KY+ S + +HRDL   N L+     +KI DFG++R  
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              D+        +  RW     +LL   ++T A D+W+ G  L E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 43/211 (20%), Positives = 83/211 (39%), Gaps = 21/211 (9%)

Query: 48  RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G G +G V     S+   ++ +VA+K +        +    L E   ++  +H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL------- 155
            +  +              ++   M   DLH  +   +       +    Q L       
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDI 122

Query: 156 -RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWY 210
             G++Y+ + + +HRDL   N +L     + + DFGL++     D+  +  +     +W 
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
               L      YT+  D+W+ G  + EI TR
Sbjct: 183 AIESLADRV--YTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 25/169 (14%)

Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHC 147
           L+EIK++  ++  N+I +  +       T + + ++ E M+  DL+Q + S  +  +   
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFL-SRHEPQEAAE 120

Query: 148 Q------------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           +            +   Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R  
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              D+        +  RW     +LL   ++T A D+W+ G  L EI+T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 74/258 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +G GA+G VC A   +T    A+K              TLR+  +L   +  +V A 
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMK--------------TLRKKDVLNRNQVAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++   +   +   ++++ +L 
Sbjct: 52  RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL------------------------ 191
             ++ VH    +HRD+KP N+L++    +K+ DFGL                        
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 192 ------------------------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
                                   A    +       V T  Y APE+LL    YT   D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCD 230

Query: 228 IWSVGCILGEIMTREPLF 245
            WSVG IL E++  +P F
Sbjct: 231 WWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 35/184 (19%)

Query: 70  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYE 126
           VA+KKI     +  D +   +EI   R ++H N++        P   +F   +++Y+V  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELYVVSP 79

Query: 127 LMDTDLHQIIRSDQQLTDDHC---------QYFLYQLLRGLKYVHSASVLHRDLKPSNLL 177
           LM         S + L   H           + L  +L  L Y+HS   +HR +K S++L
Sbjct: 80  LMAYG------SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 178 LNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELL-LNCTEYTAAIDI 228
           L+    + +     +        R     DF    V    + +PE+L  N   Y    DI
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 229 WSVG 232
           +SVG
Sbjct: 194 YSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 71/314 (22%), Positives = 132/314 (42%), Gaps = 56/314 (17%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G++G V  A   E+    A+K +       D+ ++   T + I  L    H  + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    + P +     ++ V E ++  DL   I+  ++  +   +++  ++   L ++H 
Sbjct: 60  QLYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+     K+ DFG+ +        T  +  T  Y APE+L     Y
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLY 173

Query: 223 TAAIDIWSVGCILGEIMTREPLFPG--KDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
             ++D W++G +L E++     F    +D + +  L  E++         +L  D     
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------TWLSQD----- 222

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEA-LRHPYLQSLH 334
                                 AVD+L+  +  +P  R+       EEA LRHP+ + L 
Sbjct: 223 ----------------------AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260

Query: 335 --DLNDEPVCPRPF 346
              LN   + P PF
Sbjct: 261 WEKLNRRQIEP-PF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A     E    R  E  NV+  
Sbjct: 6   IKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRA-----ETACFR--EERNVLVN 57

Query: 107 KDIIRPPKKD-TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKY 160
            D          F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLN 218
           +H    +HRD+KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L  
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 219 CTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             +    Y    D WS+G  + E++  E  F  +  V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 40/129 (31%), Positives = 74/129 (57%), Gaps = 14/129 (10%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM---TEYV 205
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG----KDYVHQLRLITE 259
             +W  APE + +   YT   D+WS G +L EI +    P +PG    +++  +L+  T 
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEEFCQRLKDGTR 295

Query: 260 LIGSPDDAS 268
           +  +P++A+
Sbjct: 296 M-RAPENAT 303

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 20/144 (13%)

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + LT +    + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 198 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG- 247
                +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG 
Sbjct: 226 D---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGV 279

Query: 248 ---KDYVHQLRLITELIGSPDDAS 268
              +++  +L+  T +  +P+ A+
Sbjct: 280 QIDEEFCRRLKEGTRM-RAPEYAT 302

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVC-AAVNSETREE--VAIKKIGNAFDNIIDARRT--LREI 92
           E+ +K +   R +G G +G +C   +   ++ E  VAI  +        D +R   L E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEA 57

Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYF 150
             L   +H N++ ++ +I        N + IV E M    L   +R  + QL        
Sbjct: 58  LTLGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG-LARTTSETDF--MTEYVVT 207
           L  L  G+KY+     +H+ L    +L+N+    KI  F  L    SE  +  M+     
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            W  APE  +    +++A D+WS G ++ E+M+
Sbjct: 173 LW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 39/205 (19%)

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQ-IIR----SDQQLT 143
           +E +L+  ++H N++ +  +    +        +++E +   DLH+ ++R    SD    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 144 DDH--------CQYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
                      C  FL    Q+  G++Y+ S   +HRDL   N L+     +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 193 RTTSETDFMTEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EP 243
           R     D+   Y V        RW   PE +L   ++T   DIWS G +L EI +   +P
Sbjct: 172 RDIYSADY---YRVQSKSLLPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 244 L--FPGKDYVHQLRLITELIGSPDD 266
              F  ++ +  +R   +L+  P+D
Sbjct: 227 YYGFSNQEVIEMIR-SRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 22/236 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V   V  ++ ++V   K+ + F+ I  +        R+I     M   N
Sbjct: 48  VKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAFAN 101

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              +  +    + D +  +Y+V E M   DL  ++ S+  + +   +++  +++  L  +
Sbjct: 102 SPWVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAI 158

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
           HS  ++HRD+KP N+LL+    LK+ DFG      ET  +     V T  Y +PE+L + 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 220 ---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 269
                Y    D WSVG  L E++  +  F     V     I +   S   P+D  +
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +    + +Q+ +G++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 25/160 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PI RGA+G V         +  A+K +  A  ++I+           ++M H+ V A 
Sbjct: 9   VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMIN-----------KNMVHQ-VQAE 54

Query: 107 KDIIRPPKK----------DTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +D +   K            + N+VY+V E L+  D+  ++       ++    ++ ++ 
Sbjct: 55  RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
             L Y+H   ++HRDLKP N+L++    +K+ DFGL++ T
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 127 LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 186
           L + +  Q + S QQL          Q+  G+ Y+H   V+H+D+   N +++    +KI
Sbjct: 105 LGEANNPQAL-STQQLVH-----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158

Query: 187 GDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            D  L+R     D+      E    +W  A E L+N  EY++A D+WS G +L E+MT
Sbjct: 159 TDNALSRDLFPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 49/253 (19%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRT---- 88
           EV    +  +R +G GA+G V   +           +VA+K +                 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE------SCSEQDESD 55

Query: 89  -LREIKLLRHMEHENVIAI--KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD 144
            L E  ++    H+N++ +      R P+       +I+ ELM   DL   +R ++   +
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPR-------FILLELMAGGDLKSFLRENRPRPE 108

Query: 145 DHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLA 192
                 +  LL        G KY+     +HRD+   N LL  +C       KI DFG+A
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL--TCKGPGRVAKIADFGMA 166

Query: 193 RTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP 246
           R      +  +     +  +W   PE  L+   +T+  D+WS G +L EI +    P +P
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YP 223

Query: 247 GKDYVHQLRLITE 259
           G+     +  +T 
Sbjct: 224 GRTNQEVMEFVTG 236

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G GA+G V   +      + +  VAIK++  A     + +  L E  ++  +++ +
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 70

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKY 160
           V  +  I         + V ++ +LM    L   +R  +  +   +   +  Q+ +G+ Y
Sbjct: 71  VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELL 216
           +    ++HRDL   N+L+     +KI DFGLA+     E ++  E   V  +W  A E +
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESI 183

Query: 217 LNCTEYTAAIDIWSVGCILGEIMT 240
           L+   YT   D+WS G  + E+MT
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 48  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 101

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              +  +    + D +  +Y+V E M   DL  ++ S+  + +   +++  +++  L  +
Sbjct: 102 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 158

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
           HS   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L + 
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 220 ---TEYTAAIDIWSVGCILGEIMTREPLF 245
                Y    D WSVG  L E++  +  F
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 50  IGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-- 106
           IG G +G ++    +    +   + K   A     +    L+E++  R + H NV+    
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ-----LLRGLKY 160
           + I   P         +V E     DL   +RS++ +     Q  + Q     +  GL +
Sbjct: 63  QCIESIP-------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL 216
           +H A  +H DL   N  L A   +KIGD+GLA      D+        V  RW  APEL+
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELV 174

Query: 217 ------LNCTEYTAAIDIWSVGCILGEIMT 240
                 L   + T   +IWS+G  + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 48  RPIGRGAYG-IVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + IG G +G ++   VNS  T  +V +K++     ++ +  + L E +  R ++H N++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC-----QYFLYQLLRGLKY 160
                     +    + ++      DL   +RS ++           Q    ++  GL +
Sbjct: 60  CLGQC----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELL 216
           +H  + +H DL   N LL A   +KIGD+GL+    + D+       +V  RW  APEL+
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELV 174

Query: 217 ------LNCTEYTAAIDIWSVGCILGEI 238
                 L   + T   ++WS+G  + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 208
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 198 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 208
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W  A E +L+   +T   D+WS G  + E+MT
Sbjct: 177 WM-ALESILH-RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 72  VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 180

Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 29/173 (16%)

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
           +E  L+  + H N++ +  ++   +      V +++E ++  DLH+ +      +D  C 
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQP-----VCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 149 Y--------------FLY---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
                          FL+   Q+  G++Y+ S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +R     D+        +  RW   PE ++   ++++  DIWS G +L EI +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 77/295 (26%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+GA+G        E R    ++K        I A +TL + ++ +  +  +V A 
Sbjct: 6   VKVIGKGAFG--------EVR---LVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +D++             +F D   +Y +M+     DL  ++      ++D  ++++ + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---------------------- 193
             ++ VH    +HRD+KP N+L++    +K+ DFGL+                       
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 194 ---------------TTSETDFMTEY-----------VVTRWYRAPELLLNCTEYTAAID 227
                          T S  D +  +           V T  Y APE+ L    Y    D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECD 230

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLIT---ELIGSPDDASLGFLRSDNARR 279
            WS+G I+ E +   P F  ++     R I    E +  PDD  L     D  RR
Sbjct: 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 51/227 (22%), Positives = 103/227 (45%), Gaps = 34/227 (14%)

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDVYI 123
           E  + VAIK + +  +     R   +   ++R  ++H N++ +  ++   +  +    Y 
Sbjct: 33  EQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90

Query: 124 VYELMDTDLHQII-----RSDQQLTDDHCQ-----------YFLYQLLRGLKYVHSASVL 167
            +    +DLH+ +      SD   TDD              + + Q+  G++++ S  V+
Sbjct: 91  SH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYT 223
           H+DL   N+L+    ++KI D GL R     D+        +  RW  +PE ++   +++
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY-GKFS 204

Query: 224 AAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSPDD 266
              DIWS G +L E+ +   +P   +  +D +  +R   +++  PDD
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQVLPCPDD 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
            +   L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 197 ETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 208
           Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W     +L+   ++T A D+W+ G  L EI+
Sbjct: 206 WMAWECILMG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 17/119 (14%)

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
            ++T  +    ++Q+  G+KY+   + +HRDL   N+LL      KI DFGL++     D
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 200 FMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
               Y   R        WY APE  +N  ++++  D+WS G  + E  +    +  K Y
Sbjct: 150 ---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEAFS----YGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 153 QLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY- 204
           QLL        G+ Y+     +HRDL   N+L+  +   KI DFGL+R   +  ++ +  
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 205 --VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +  RW       LN + YT   D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 16/131 (12%)

Query: 123 IVYELMDT-DLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 177
           +V+E  +  DL   +  +Q    +      Q    ++  G+ ++H  + LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 178 LNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAID 227
           L +   +K+GD+G+  +  + D++     + V  RW  APEL+      L   E T   +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190

Query: 228 IWSVGCILGEI 238
           +W++G  L E+
Sbjct: 191 VWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D      V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE +   +E T A D WS+G IL E++T
Sbjct: 151 PE-VGGISEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           LT      F   +  G++Y+     +HRDL   N+L+  +   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 202 TEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    +  RW       LN + YT   D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V   V  +   +V   KI N ++ +  A     E    R  E  +V+  
Sbjct: 6   LKVIGRGAFGEVAV-VKMKNTGQVYAMKILNKWEMLKRA-----ETACFR--EERDVLVN 57

Query: 107 KDIIRPPKKDT-----FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLR 156
            D     +  T     F D   +Y +MD     DL  ++ + + +L +D  +++L +++ 
Sbjct: 58  GD----RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL 113

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPE 214
            +  VH    +HRD+KP N+LL+ +  +++ DFG  L      T      V T  Y +PE
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 215 LLLNCTE----YTAAIDIWSVGCILGEIMTREPLF 245
           +L    +    Y    D WS+G  + E++  E  F
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 19/42 (45%), Positives = 28/42 (66%)

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
           + Q+L GL+ +H   ++HRD+KP NLL+     +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVT-R 208
           Q+ +G+ Y+    ++HR+L   N+LL +   ++I DFG+A      D   F +E+    +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W     +L     YT   D+WS G  + E+M+
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 81/231 (35%)

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMT---- 202
           Q  + Q+L  L  +HS  ++HRD+KP N++ +  S   KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 203 ---EYVVTRWYRAPELLLNCTEYTAA---------------------IDIWSVGCILGEI 238
              E+++   Y APE  +  T+  +A                      DI+S G I  ++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 239 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR-RYVRQLPRCRKQQFATR-- 295
                 FP                         LRSD+   ++ RQL R      A R  
Sbjct: 373 A-----FPN------------------------LRSDSNLIQFNRQLKRNDYDLVAWRKL 403

Query: 296 FPNKSSGAV---------------DLLEKMLVFDPNKRITVEEALRHPYLQ 331
              ++S  +               +LL+ M+ F   +RI+ + AL HPY  
Sbjct: 404 VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 34/169 (20%), Positives = 60/169 (35%), Gaps = 27/169 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-------NAFDNIIDARRTLR 90
           E   +   P   IG+GA   +      E     A+ K            D  +   RT  
Sbjct: 329 EEVKRRKIPDHLIGKGAEADI---KKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRA 385

Query: 91  EIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 148
           E +LL       V    I D+      D      ++  +   DL  ++  + +L      
Sbjct: 386 EARLLSEARRAGVPTPVIYDV------DPEEKTIVMEYIGGKDLKDVLEGNPEL------ 433

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + ++   +  +H A ++H DL  SN ++     L + DFGL + +  
Sbjct: 434 --VRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 12/26 (46%), Positives = 15/26 (57%)

Query: 303 AVDLLEKMLVFDPNKRITVEEALRHP 328
             DL+ KML  DP KR + +E L H 
Sbjct: 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 44/185 (23%), Positives = 80/185 (43%), Gaps = 16/185 (8%)

Query: 73  KKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK----DIIRPPKKDTFNDVYIVYELM 128
           KK       +ID   T  EIK LR ++  N++ I     DI+     D    + ++ E  
Sbjct: 52  KKFHKGHKVLIDI--TENEIKNLRRIDSNNILKIYGFIIDIV-----DDLPRLSLILEYC 104

Query: 129 DTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKI 186
               L +++  ++ L+            +GL  ++   +  +++L   + L+  +  LKI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164

Query: 187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF 245
              GL +  S   F  + V    Y + ++L +  +EYT   DI+S+G +L EI T +  F
Sbjct: 165 ICHGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 246 PGKDY 250
                
Sbjct: 223 ENLTT 227

Length = 283

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 37.6 bits (88), Expect = 0.004
 Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 16/121 (13%)

Query: 79  FDNIIDARRTLREIKLLR--HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
            D  I   RT  E +LL        N   + D+      D  N   ++  +    L  +I
Sbjct: 35  LDERIRRERTRNEARLLSRARKAGVNTPVVYDV------DPDNKTIVMEYIEGKPLKDVI 88

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
                  D+  +     + +    +H A ++H DL  SN+++     L + DFGL + + 
Sbjct: 89  EEGN---DELLREIGRLVGK----LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSD 140

Query: 197 E 197
           E
Sbjct: 141 E 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	377
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.6
KOG1243	690	consensus Protein kinase [General function predict	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.42
COG4248	637	Uncharacterized protein with protein kinase and he	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.13
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.12
PRK09902	216	hypothetical protein; Provisional	99.01
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.88
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
PLN02876	822	acyl-CoA dehydrogenase	98.03
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.01
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.87
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.85
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.69
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
KOG2270	520	consensus Serine/threonine protein kinase involved	97.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.58
PRK05231	319	homoserine kinase; Provisional	97.55
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.43
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.4
PRK12396	409	5-methylribose kinase; Reviewed	97.34
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.32
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.31
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
PLN02756	418	S-methyl-5-thioribose kinase	97.08
PLN02236	344	choline kinase	96.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.76
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.53
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.46
PRK10593	297	hypothetical protein; Provisional	96.1
PTZ00384	383	choline kinase; Provisional	96.08
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.58
PRK11768	325	serine/threonine protein kinase; Provisional	95.49
PTZ00296	442	choline kinase; Provisional	95.43
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.22
PRK06148	1013	hypothetical protein; Provisional	95.11
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.54
PHA03111	444	Ser/Thr kinase; Provisional	94.5
PRK10271	188	thiK thiamine kinase; Provisional	94.41
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.07

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-63  Score=432.43  Aligned_cols=346  Identities=66%  Similarity=1.129  Sum_probs=325.4

Q ss_pred             eEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeE
Q 017083           27 YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        27 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      +..+.+.+..|+++.+|. .++.||.|+||.|+.+.++.+|+.||||++...+.+....++..+|+.+|+.++|+||+.+
T Consensus         8 ~~~~~~~~~~~~i~~~y~-~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen    8 YYDYEVFGELFEIPRYYV-LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             ceEEEeeeeEEeccceec-ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence            566788889999999999 5999999999999999999999999999999888888899999999999999999999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                      .+++..+..+.++.+|+|+|+|+.+|.+.++.++.++++.+..+++||++||.|+|+.|++|||+||.|++++.+..+||
T Consensus        87 ~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   87 LDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             EeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence            99999977778889999999999999999999988999999999999999999999999999999999999999999999


Q ss_pred             eeeecccccCC---CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          187 GDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       187 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      +|||+++....   ....+.+..|.+|+|||++.....++.+.||||+||++.||++|+..|++.+..+++..|.+.++.
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            99999998763   455677888999999999988899999999999999999999999999999999999999999999


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCC
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP  343 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~  343 (377)
                      |.+.....+.......++.+.....++.+...+++.++.+.+|+++||..||.+|+|++|+|.|||+...++.++++.|.
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCCcCCCCCChHHHHHHHHHHHhhcCCCC
Q 017083          344 RPFHFDFEHSSCTEDHIRELIWRESVKFNPDP  375 (377)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (377)
                      ..+.. ++.. .+.+.+++.+.+|.++|.|..
T Consensus       327 ~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~  356 (359)
T KOG0660|consen  327 PIFDS-FEHE-LTEEELRELIYKEILDFHPDV  356 (359)
T ss_pred             CCCcc-cccc-ccHHHHHHHHHHHHHhhCccc
Confidence            76665 3444 888999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-58  Score=404.41  Aligned_cols=261  Identities=34%  Similarity=0.571  Sum_probs=226.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHH-----HHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-----DARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +||.+.+.||+|+||.|-+|..+.+|+.||||+++++.....     ......+|+++|++|+||+||+++++|..... 
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds-  250 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS-  250 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc-
Confidence            455599999999999999999999999999999987643221     22345699999999999999999999998866 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC---CCeEEeeeecc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLA  192 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~---~~vkl~Dfg~~  192 (377)
                          .|+|+||++ |+|.+.+-.++.+.++..+.+++|++.|+.|||++||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ----~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 ----SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             ----eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence                799999998 5999999999999999999999999999999999999999999999999876   56899999999


Q ss_pred             cccCCCccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccc
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASL  269 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  269 (377)
                      +..+......+.|||+.|.|||++.+.  ..+..++|||||||++|-+|+|.+||....... ...              
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e--------------  392 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE--------------  392 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH--------------
Confidence            999988999999999999999999762  224458899999999999999999998754333 222              


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                   ++...+-...+..|..++.++.+||.+||.+||+.|||++|+|+||||+...
T Consensus       393 -------------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  393 -------------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             -------------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                         2223333444566778999999999999999999999999999999998655

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-57  Score=383.53  Aligned_cols=287  Identities=33%  Similarity=0.644  Sum_probs=244.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |+.+.++|+|+||+||+|+++.||+.||||++....++....+-.++|+++|++|+|+|+|.++++|.....     +++
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk-----lhL   78 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK-----LHL   78 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce-----eEE
Confidence            458899999999999999999999999999998877777777778899999999999999999999999877     999


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCccc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~  201 (377)
                      |+|||+.++.+.+.. -...+...++.+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+... ..+..
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999999887777765 4578999999999999999999999999999999999999999999999999999877 45566


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc-hhHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS-DNARRY  280 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~  280 (377)
                      ..+..|.||+|||++.+..+|+.++||||+||++.||++|...|++.++.+++..|+..++...+....-... ..+...
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            7788899999999999999999999999999999999999999999999999999999998765543211110 000000


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ... .-.........++.++.-+.+|+++||..||++|++-+++|.||||.+..+.
T Consensus       239 ~lP-~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  239 RLP-EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             ecC-CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            000 0111222344577889999999999999999999999999999999766543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-56  Score=389.25  Aligned_cols=265  Identities=25%  Similarity=0.415  Sum_probs=230.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      ..+....++.++.||+|..|+||+++|+.+++.+|+|.+... .+....+++.+|+++++..+|||||++|++|..+.. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-  151 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-  151 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-
Confidence            456666888899999999999999999999999999999433 455677889999999999999999999999998752 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                         .++|+||||+ |+|..+++..+++++..+..++.+|++||.|||+ .+|+||||||+||||+..|.|||||||.+..
T Consensus       152 ---~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  152 ---EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             ---eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence               2899999998 5999999988999999999999999999999995 9999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .... ...++.||..|||||.+.+ ..|+.++||||||++++|++.|+.||...  .....+..+..++..+++..    
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l----  302 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL----  302 (364)
T ss_pred             hhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC----
Confidence            7666 5688899999999999998 89999999999999999999999999874  22334444444444333321    


Q ss_pred             cchhHHHHHHhccccccccccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                             .. ..|+++.+||..||++||.+|||+.|+++|||++....
T Consensus       303 -----------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  303 -----------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             -----------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                                   11 36999999999999999999999999999999986654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-55  Score=405.00  Aligned_cols=256  Identities=32%  Similarity=0.523  Sum_probs=232.7

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|...+.||+|||+.||.+++..+|+.||+|++.+. ..+....+...+|++|.+.|+|||||+++++|++...     
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n-----   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN-----   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc-----
Confidence            4555899999999999999999999999999999764 3455667888999999999999999999999999966     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +|||.|+|. ++|..+++.+++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|...... 
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999998 799999999999999999999999999999999999999999999999999999999999999987755 


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ....+.||||.|.|||++.. ...+..+||||+||++|.||.|++||......+.+..|...-...|             
T Consensus       173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-------------  238 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-------------  238 (592)
T ss_pred             cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-------------
Confidence            67788999999999999987 8889999999999999999999999999998888888876333222             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                        ..++.++.+||.+||+.||.+|||++++|.|+||.+-.
T Consensus       239 ------------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  239 ------------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             ------------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                              25699999999999999999999999999999995433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-56  Score=397.17  Aligned_cols=292  Identities=38%  Similarity=0.692  Sum_probs=253.4

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  116 (377)
                      .+.++|- ++++||.|.||.||+|+.+.+|..||||.+++.+... ..-.-++|+..|++|+ ||||+++.+++.+... 
T Consensus         7 ~~m~RY~-~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~-   83 (538)
T KOG0661|consen    7 IFMDRYT-VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-   83 (538)
T ss_pred             hHHHHHH-HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-
Confidence            3455666 9999999999999999999999999999998765442 2234468999999999 9999999999998762 


Q ss_pred             CCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         .+|+|||||+.+|.++++. ++.|++..++.|+.||++||+|+|.+|+.|||+||+||||+.+..+||+|||+++..
T Consensus        84 ---~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   84 ---ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             ---eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence               3999999999999999986 457999999999999999999999999999999999999998889999999999999


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ........++.|.||+|||++...+.|+.+.|+|++||+++|+.+.+..|++.+..+++.+|-++++.|....+... ..
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~  239 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YN  239 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HH
Confidence            88888999999999999999998899999999999999999999999999999999999999999999988765432 11


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      .....-..+............+..+.++.+||.+||.+||++||||.++|+||||+.....
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            2222222344444444455566789999999999999999999999999999999876654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=389.88  Aligned_cols=290  Identities=38%  Similarity=0.631  Sum_probs=248.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ......|+.+++||+|.||.||++++..+|+.||+|+++..........-..+|+.||++|+||||+++.+++.+...  
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~--  190 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS--  190 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC--
Confidence            334456678999999999999999999999999999998876666666677799999999999999999999988732  


Q ss_pred             CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                       ..+|+|+|||+.+|.-++.. .-.|++.+++.++.||+.||+|||++||.|||||.+|||||.+|.+||+|||+++...
T Consensus       191 -~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  191 -GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             -ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence             23999999999999998876 4589999999999999999999999999999999999999999999999999999655


Q ss_pred             CCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          197 ETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       197 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...  .....+-|+||+|||++.+...|+.++|+||.|||+.||+.|+..|.+....++++.|.++++.|.+..+.....
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            443  456677799999999999989999999999999999999999999999999999999999999999887653222


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .....+  .-...-+..+.+.+..++....+|+..||..||.+|.||.++|+++||..
T Consensus       350 P~~~~~--kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  350 PHATIF--KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             Cccccc--CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            211111  01111122233446788999999999999999999999999999999943

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.6e-54  Score=355.64  Aligned_cols=291  Identities=40%  Similarity=0.687  Sum_probs=249.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      .+++||+|.||+||++++..+|+.||||+++.......-.....+|+..|+.++|+||+.+.++|...+.     +.+|+
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-----l~lVf   80 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-----LSLVF   80 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-----eEEEE
Confidence            7899999999999999999999999999998764444445677899999999999999999999998876     89999


Q ss_pred             ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc-cc
Q 017083          126 ELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TE  203 (377)
Q Consensus       126 e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~-~~  203 (377)
                      ||++.+|...++. ...++...++.++.++++|++|||++.|.||||||.|+||+.+|.+||+|||+++..+..... ..
T Consensus        81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            9999999999986 456899999999999999999999999999999999999999999999999999987766433 33


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc-hhHHHHHH
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS-DNARRYVR  282 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~  282 (377)
                      ...|.+|+|||++.|...|+..+|+||.||++.||+.|...|++.++.+++..|.+.++.|.+..+..+.. ..+.++. 
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-  239 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-  239 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence            47799999999999999999999999999999999999999999999999999999999998876654322 2222221 


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCC
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP  345 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~  345 (377)
                         ..........++..+.++.+|+.+||..||.+|+|+.|+|+|+||++..-......-|.+
T Consensus       240 ---~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p  299 (318)
T KOG0659|consen  240 ---QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP  299 (318)
T ss_pred             ---cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence               112222233567789999999999999999999999999999999987665544444444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-54  Score=372.83  Aligned_cols=260  Identities=28%  Similarity=0.501  Sum_probs=232.0

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+..+++++++.||+|+||+||.++.+.+++.||+|++++... .....+....|..+|.+++||+||+++..|+..+. 
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k-   99 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK-   99 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe-
Confidence            3455677799999999999999999999999999999987643 33356778899999999999999999999999876 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc-
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~-  194 (377)
                          +|+|+||+.| .|...+.+.+.|++..++.++..|+.||.|||++||+||||||+|||++.+|+++|+|||+++. 
T Consensus       100 ----LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  100 ----LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             ----EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence                9999999985 9999999999999999999999999999999999999999999999999999999999999984 


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ........+.+||+.|||||++.+ ..++.++|.||||+++|+|++|..||...+.......|...-.            
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------  242 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------  242 (357)
T ss_pred             ccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence            445566777899999999999998 7999999999999999999999999999988877777765221            


Q ss_pred             hhHHHHHHhccccccccccccCCC-CChhHHHHHHHhcCCCCCCCC----CHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rp----s~~ell~~p~f~~~~  334 (377)
                                         ...+. ++.+++++|+++|..||++|.    ++.++-+||||..+.
T Consensus       243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence                               11223 689999999999999999995    789999999998776

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=380.04  Aligned_cols=258  Identities=27%  Similarity=0.461  Sum_probs=230.0

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ..++..++.||.|+|++|++|+++.+++.||||++.++.. ++...+-...|-.+|.+| .||.|++++..|.+...   
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s---  148 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES---  148 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc---
Confidence            3466689999999999999999999999999999987643 333344556788899999 69999999999999976   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        +|+|+||++ |+|+++|..-+.|++.-++.++.+|+.||+|||++||+||||||+|||++++|+++|+|||.++....
T Consensus       149 --LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  149 --LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             --eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence              999999998 79999999999999999999999999999999999999999999999999999999999999986543


Q ss_pred             Ccc------------c--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          198 TDF------------M--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       198 ~~~------------~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      ...            .  ..++||..|.+||++.. +..++.+|||+|||++|+|+.|..||.+.+....+.+|+.+...
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            211            1  45899999999999988 88999999999999999999999999999999999999887554


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      .+                               +++++.+.+||+++|..||++|+|+.++..||||..+.-
T Consensus       306 fp-------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw  346 (604)
T KOG0592|consen  306 FP-------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW  346 (604)
T ss_pred             CC-------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence            43                               366899999999999999999999999999999987763

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-52  Score=356.07  Aligned_cols=289  Identities=38%  Similarity=0.630  Sum_probs=244.1

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|+.+..|++|.||.||+++++.+++.||+|+++.........-..++|+.+|.+.+|||||.+-.++.....   ..+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---cee
Confidence            34568999999999999999999999999999998876555444556799999999999999999999987755   449


Q ss_pred             EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      |+|||||+.+|.+++..- .+|...+++.+..|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+..+.+ .
T Consensus       153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence            999999999999999874 48999999999999999999999999999999999999999999999999999988876 3


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......-|+||+|||++.+...|+.+.|+||+||++.||+.+...|++....+++..|..+++.|.+..+.....-...+
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            45566779999999999999999999999999999999999999999999999999999999999888765433222211


Q ss_pred             HHHhccccccccccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .+. ............++.  ++....+|+..+|..||.+|.||.|.|+|+||....
T Consensus       313 ~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  313 KMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            000 000000011111222  568899999999999999999999999999998744

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-51  Score=379.12  Aligned_cols=328  Identities=50%  Similarity=0.937  Sum_probs=263.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.+.||+|+||.||+++++.++..||+|++............+.+|+.++++++||||+++++++.......+..+|++
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            47889999999999999999999999999987544444455678899999999999999999999876654444568999


Q ss_pred             EecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc----c
Q 017083          125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----F  200 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~----~  200 (377)
                      |||++++|.+.+.....+++..++.++.||++||+|||++||+||||||+||+++.++.+||+|||++.......    .
T Consensus        83 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  162 (338)
T cd07859          83 FELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF  162 (338)
T ss_pred             EecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987543221    1


Q ss_pred             ccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+....+.++......+.......
T Consensus       163 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  242 (338)
T cd07859         163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR  242 (338)
T ss_pred             ccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence            2345789999999998642 567889999999999999999999999988888888888887777666555444444455


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCC--CCCCCcCCCCCCh
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR--PFHFDFEHSSCTE  357 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~  357 (377)
                      ................++..++.+.++|.+||+.||++|||+.|+++||||+.............  ...+.+.....+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (338)
T cd07859         243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTK  322 (338)
T ss_pred             HHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCH
Confidence            55555444444445556778899999999999999999999999999999998877654443332  2233444555666


Q ss_pred             HHHHHHHHHHHhhcC
Q 017083          358 DHIRELIWRESVKFN  372 (377)
Q Consensus       358 ~~~~~~~~~~~~~~~  372 (377)
                      +..+..+-.+-+..+
T Consensus       323 ~~~~~~~~~~~~~~~  337 (338)
T cd07859         323 EDVRELIYREILEYH  337 (338)
T ss_pred             HHHHHHHHHHHHhcC
Confidence            777776656554443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-52  Score=364.63  Aligned_cols=324  Identities=34%  Similarity=0.600  Sum_probs=257.8

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .++-.+.+|.|+||.||.+....+++.||||+.-.+.      +--.+|+++|++++|||||++..+|........-...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            3447889999999999999999999999999884331      1122699999999999999999998876654223456


Q ss_pred             EEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeecccccCC
Q 017083          123 IVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~~~~~~~  197 (377)
                      +||||++.+|.+.++.    +.+++...++-+.+||++||+|||+.||+||||||.|+|||.+ |.+||||||.|+....
T Consensus        99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen   99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            8999999999999874    6789999999999999999999999999999999999999976 7899999999999888


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ......+..|..|+|||++.+...|+.+.||||.||++.||+.|+..|++.+..+++..|.+.++.|.......++....
T Consensus       179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence            88888999999999999999999999999999999999999999999999999999999999999998877655444322


Q ss_pred             HHHHHhccccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC--CCCCCCCCcCC--
Q 017083          278 RRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV--CPRPFHFDFEH--  352 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~--~~~~~~~~~~~--  352 (377)
                      +.-   ........-.. .....++++.+|+.++|+.+|++|.++.|++.||||..+.+.+..-.  .+-+-.+++..  
T Consensus       259 ~~~---~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e  335 (364)
T KOG0658|consen  259 EFK---FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAE  335 (364)
T ss_pred             ccc---CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHH
Confidence            111   11111111111 23467999999999999999999999999999999998887642222  22233333333  


Q ss_pred             CCCChHHHHHHHHHHHhhcCCCC
Q 017083          353 SSCTEDHIRELIWRESVKFNPDP  375 (377)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~  375 (377)
                      .....+-....+.+....++.++
T Consensus       336 ~~~~~~~~~~l~p~~~~~~~~~~  358 (364)
T KOG0658|consen  336 LGISPELVNVLIPEHLREQEKDK  358 (364)
T ss_pred             hccchHHHHhhccHhhhhhcccc
Confidence            33344455555555555555443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-51  Score=344.70  Aligned_cols=257  Identities=26%  Similarity=0.446  Sum_probs=228.8

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ..-+++++++.||.|+||.|-+++++.+|..||+|++.+.. .+-.+.+...+|..+|+.+.||+++++++.+.+...  
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~--  118 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN--  118 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe--
Confidence            34456779999999999999999999999999999997652 344455667789999999999999999999999866  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +|+||||++ |.|.++++..++|++..++.++.||+.||+|||+++|++||+||+|||+|.+|.+||+|||+++...
T Consensus       119 ---lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  119 ---LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             ---EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence               999999998 5999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ..  ....|||+.|+|||.+.. +.++.++|.|||||++|||+.|..||...+.......|.+-.-..            
T Consensus       196 ~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f------------  260 (355)
T KOG0616|consen  196 GR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF------------  260 (355)
T ss_pred             Cc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC------------
Confidence            66  778899999999999988 899999999999999999999999999998877777775521111            


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                         .+.+++++++||+++|++|-++|.     ...++.+||||..+.
T Consensus       261 -------------------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  261 -------------------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             -------------------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence                               124699999999999999999993     677999999998654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-51  Score=357.47  Aligned_cols=258  Identities=31%  Similarity=0.487  Sum_probs=228.4

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +|. +.++||.|+||+||+++++.++..||||.+.+........+.+..|+.+|+.++|||||.++++++.+..     +
T Consensus        11 ~y~-~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~-----i   84 (429)
T KOG0595|consen   11 DYE-LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF-----I   84 (429)
T ss_pred             cce-ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe-----E
Confidence            444 7788999999999999999999999999998876666677888899999999999999999999998865     9


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC------CCeEEeeeecccc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS------CDLKIGDFGLART  194 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~------~~vkl~Dfg~~~~  194 (377)
                      |+|||||. |+|..+++..+.+++..++.++.||+.||++||+++|+||||||.|||++..      -.+||+|||+++.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999998 6999999999999999999999999999999999999999999999999875      3479999999999


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ........+.+|++.|||||++.. .+|+.++|+||+|+++|+|++|+.||......+.+..+..-....+..       
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-------  236 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-------  236 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-------
Confidence            998888899999999999999987 899999999999999999999999999988888777665432222111       


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                           ...+++...+|+...|+.+|.+|.+..+-+.|+++..-.
T Consensus       237 ---------------------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  237 ---------------------PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ---------------------hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                                 123466778999999999999999999999999986544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-50  Score=370.27  Aligned_cols=335  Identities=76%  Similarity=1.263  Sum_probs=286.4

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+|. +.+.||+|+||+||++++..+++.||+|.+............+..|+.+++.++|+||+++++++......
T Consensus         1 ~~~~~~y~-~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           1 FEVDTKYV-PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             Ccccccee-EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            45666766 88899999999999999999999999999876544444456677899999999999999999988766544


Q ss_pred             CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          117 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      .+..+++++||++++|.+.+...+++++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          80 AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             ccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            44568999999999999999888899999999999999999999999999999999999999999999999999987654


Q ss_pred             CC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          197 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       197 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .. .......++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+....+.+.+.........
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            43 22334567888999999876456889999999999999999999999998888888888888888877777666666


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC  355 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~~  355 (377)
                      ....+................+.+++.+.++|++||+.+|++|||+.++++||||..+......+.++.++.+|++..+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDAL  319 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhc
Confidence            66666666555544444555667899999999999999999999999999999999999988888889999999999998


Q ss_pred             ChHHHHHHHHHHHhhcC
Q 017083          356 TEDHIRELIWRESVKFN  372 (377)
Q Consensus       356 ~~~~~~~~~~~~~~~~~  372 (377)
                      ....+.+++-.|-+-.-
T Consensus       320 ~~~~~~~~~~~~~~~~~  336 (337)
T cd07858         320 TEEDIKELIYNEMLAYH  336 (337)
T ss_pred             CHHHHHHHHHHHHhhcC
Confidence            88899999888876543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-50  Score=366.39  Aligned_cols=263  Identities=26%  Similarity=0.449  Sum_probs=228.0

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .++-++++++..||+|+||.||+|+.+.||..||+|++++.. ....+.+..+.|=.+|...++|.||++|..|.+... 
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~-  215 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY-  215 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe-
Confidence            456678889999999999999999999999999999998753 334456677789999999999999999999999977 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          +|+||||.+ |++..+|...+.++++.++.++.+++.||+.||+.|++||||||+|+|||..|++||+|||++...
T Consensus       216 ----LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  216 ----LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             ----eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence                999999998 599999999999999999999999999999999999999999999999999999999999998411


Q ss_pred             CC----------------------Cc--------------------------cccccccccccCCCccccccCCCCCcch
Q 017083          196 SE----------------------TD--------------------------FMTEYVVTRWYRAPELLLNCTEYTAAID  227 (377)
Q Consensus       196 ~~----------------------~~--------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~D  227 (377)
                      ..                      ..                          .....+|||.|+|||++.+ ..++..+|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cD  370 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECD  370 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCcccc
Confidence            00                      00                          0133688999999999999 77999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHH
Q 017083          228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL  307 (377)
Q Consensus       228 iwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  307 (377)
                      .||||||+||||.|.+||.+....+...+|........                           .+....++++++|||
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------------------------fP~~~~~s~eA~DLI  423 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------------------------FPEEVDLSDEAKDLI  423 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------------------------CCCcCcccHHHHHHH
Confidence            99999999999999999999999999988877432211                           111235679999999


Q ss_pred             HHhcCCCCCCCC---CHHHHhcCccccCCc
Q 017083          308 EKMLVFDPNKRI---TVEEALRHPYLQSLH  334 (377)
Q Consensus       308 ~~~L~~dp~~Rp---s~~ell~~p~f~~~~  334 (377)
                      .+||. ||++|.   .+.||..||||..+.
T Consensus       424 ~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  424 TRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            99999 999998   699999999999776

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-50  Score=351.64  Aligned_cols=291  Identities=38%  Similarity=0.690  Sum_probs=244.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCC-CCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKK-DTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~~~  121 (377)
                      +..+++||+|.||+||+|+++.+|+.||+|+++-....+.......+|+.+++.|+|+| |+.+++++..... .....+
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            44788999999999999999999999999999876544334456679999999999999 9999999877652 222358


Q ss_pred             EEEEecCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          122 YIVYELMDTDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ++|+||+.-+|..++....    .++...++.++.||+.||+|||+++|+||||||.||+|+..|.+||+|||+++....
T Consensus        93 ~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   93 YLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI  172 (323)
T ss_pred             EEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence            9999999999999998654    577889999999999999999999999999999999999999999999999997663


Q ss_pred             C-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 T-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      + .......+|.+|+|||++.+...|+...||||+||++.||++++..|++....+++..|.++++.|.+..+..+....
T Consensus       173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~  252 (323)
T KOG0594|consen  173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP  252 (323)
T ss_pred             CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence            3 446777889999999999998889999999999999999999999999999999999999999999887765433211


Q ss_pred             HHHHHHhccccc-cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          277 ARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       277 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ..+.  ...... ........+..++...+++.+||+.+|.+|.|++.+|.||||+.....
T Consensus       253 ~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  253 DYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             cccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            1111  222222 233334455566899999999999999999999999999999987643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=370.28  Aligned_cols=254  Identities=34%  Similarity=0.494  Sum_probs=221.7

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC---HHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  118 (377)
                      .|++.+.||+|+||+|+.+++..+++.||+|++.+....   ......+.+|+.+++.++ ||||+++++++.....   
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~---   94 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK---   94 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe---
Confidence            344999999999999999999999999999988764211   123455668999999999 9999999999998865   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeeccccc-
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT-  195 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~~~~~-  195 (377)
                        +++||||+.| +|.+.+...+++.+..++.++.|++.|++|||++||+||||||+||+++.+ +++||+|||++... 
T Consensus        95 --~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   95 --IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             --EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence              9999999985 999999999999999999999999999999999999999999999999999 99999999999988 


Q ss_pred             CCCccccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .........+|++.|+|||++.+.. ..+.++||||+|+++|.|++|..||...+.......|..-...           
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~-----------  241 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK-----------  241 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc-----------
Confidence            5667889999999999999999855 4468999999999999999999999997766666554331111           


Q ss_pred             hhHHHHHHhccccccccccccCCCC-ChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                          ....+ ++++.+||++||..||.+|+|+.+++.||||+.
T Consensus       242 --------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 --------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                11233 899999999999999999999999999999996

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-49  Score=366.78  Aligned_cols=334  Identities=47%  Similarity=0.904  Sum_probs=259.4

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..|++.++|. +++.||.|+||+||++.+..++..||+|++............+.+|+.++++++||||+++++++....
T Consensus         9 ~~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878           9 TVWEVPERYQ-NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             HHhhhhhhhh-hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            3467777776 899999999999999999999999999999765433344566778999999999999999999886543


Q ss_pred             C-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      . .....+++++++++++|.+.+. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence            2 2234579999999989988775 4579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....  .....+++.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.+.........
T Consensus       167 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            65443  3445789999999999775678899999999999999999999999988888888888777766555444333


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS  353 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~  353 (377)
                      ......+...............+...++.+.+||.+||+.||.+|||+.|+|+||||............ .+........
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~  323 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEA-EPYDESPENK  323 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcccccc-Cccccchhhh
Confidence            333444444333333333333445678889999999999999999999999999999987665433322 2333333334


Q ss_pred             CCChHHHHHHHHHHHhhcCC
Q 017083          354 SCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~  373 (377)
                      ....++..+....+..+|.|
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         324 ERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             hccHHHHHHHHHHHHHhcCC
Confidence            44556666666666555544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-52  Score=347.99  Aligned_cols=255  Identities=30%  Similarity=0.477  Sum_probs=217.1

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEee-eecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD-IIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~~  118 (377)
                      +...|+++++||.|.||+||++++..+|..+|+|.++....+.........|+.+|++|+|||||++++ .|.++..   
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e---   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE---   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch---
Confidence            345566999999999999999999999999999999977777777788889999999999999999998 3433321   


Q ss_pred             CcEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhc--CC--ceecCCCCCceEEccCCCeEEeee
Q 017083          119 NDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHS--AS--VLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~--~~--i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                       -++|+||+|+ |+|.+.++.    .+.+++..++.++.|++.||.++|+  .+  +.||||||.||+++.+|.+||+||
T Consensus        94 -vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   94 -VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             -hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence             1789999998 799998863    5679999999999999999999998  45  999999999999999999999999


Q ss_pred             ecccccCCC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          190 GLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       190 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      |+++..... .......|||+||+||.+.+ ..++.++|||||||++|||+..+.||.+.+......+|..--.++    
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~----  247 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP----  247 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC----
Confidence            999987765 45567899999999999998 899999999999999999999999999998777776665421111    


Q ss_pred             cccccchhHHHHHHhccccccccccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                                .+ ..+|.++..||..|+.+||.+||+.     +|+++.+.
T Consensus       248 --------------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  248 --------------------------LPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             --------------------------CcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                                      11 1458889999999999999999985     45554443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=353.16  Aligned_cols=273  Identities=25%  Similarity=0.357  Sum_probs=228.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |-+..+.|++.+.||.|..++||+++...+++.||||++..+..+.. .+.+++|++.++.++||||++++..|..+.. 
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-   98 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-   98 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence            55556777799999999999999999999999999999987765554 7889999999999999999999999999866 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          +|+||.||. |++.++++.  ...+++..+..|+.++++||.|||.+|.+|||||+.||||+.+|.|||+|||.+.
T Consensus        99 ----LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   99 ----LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ----eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence                999999998 699999976  4469999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC----ccc-cccccccccCCCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          194 TTSET----DFM-TEYVVTRWYRAPELLL-NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       194 ~~~~~----~~~-~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      .....    ... ....|++.|||||++. +...|+.++||||||++.+||.+|..||........+  ++.+.+.++..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~  252 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTL  252 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCc
Confidence            43222    112 6678999999999954 3467899999999999999999999999876654433  44555555433


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      .......                   +....++.++..+|..||+.||++||||+++|+|+||++.+..
T Consensus       253 ~t~~~~~-------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  253 LTSGLDK-------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             ccccCCh-------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            2222111                   1223457789999999999999999999999999999987753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-48  Score=365.38  Aligned_cols=327  Identities=43%  Similarity=0.755  Sum_probs=253.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +++++.||+|+||+||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.......+..+|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            45889999999999999999999999999999765445555677889999999999999999999998776444446899


Q ss_pred             EEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--ccc
Q 017083          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--DFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--~~~  201 (377)
                      ++||+.++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......  ...
T Consensus        82 v~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~  161 (372)
T cd07853          82 VTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM  161 (372)
T ss_pred             EeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccC
Confidence            999999999999988889999999999999999999999999999999999999999999999999998754332  122


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|+.||........+..+.+..+.++......... .....+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~  240 (372)
T cd07853         162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHI  240 (372)
T ss_pred             CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HHHHHH
Confidence            3446788999999998756678999999999999999999999999998888888888877766543322211 111111


Q ss_pred             Hhccccccc--cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC--------------------CCCC
Q 017083          282 RQLPRCRKQ--QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD--------------------LNDE  339 (377)
Q Consensus       282 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~--------------------~~~~  339 (377)
                      .......+.  .........++++.+||.+||+.||++|||+.|+|+||||+....                    ...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (372)
T cd07853         241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFE  320 (372)
T ss_pred             HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccC
Confidence            111111110  001122356889999999999999999999999999999987431                    1122


Q ss_pred             CCCCCCCCCCcCCCCCChHHHHHHHHHHHhhc
Q 017083          340 PVCPRPFHFDFEHSSCTEDHIRELIWRESVKF  371 (377)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (377)
                      +..+.++..+..+.......+++.+..+..+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         321 PSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             CCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            22334555555555556667777777655544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-49  Score=367.19  Aligned_cols=264  Identities=31%  Similarity=0.452  Sum_probs=236.9

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.+.||.|+-|.|-+|+|..||+..|||++.+. .........+.+|+-||+.+.|||++.+|++++.+..     +|++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~-----lylv   90 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH-----LYLV   90 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce-----EEEE
Confidence            677899999999999999999999999999876 3344456778899999999999999999999999866     9999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      .||++ |.|.+++...+++++.++.+++.||+.|+.|+|..+|+|||+||+|+|++..++|||+|||+|..........+
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99998 69999999999999999999999999999999999999999999999999999999999999999888888999


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      .||++-|.+||++.+....+.++||||.||+||.||+|+.||.+.+....+.++.+-..                     
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f---------------------  229 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF---------------------  229 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------------------
Confidence            99999999999999966778999999999999999999999998776666655544221                     


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP  345 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~  345 (377)
                                .....+++++++||++||.+||++|.|..|+++|||++.......+...+.+
T Consensus       230 ----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~  281 (786)
T KOG0588|consen  230 ----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPP  281 (786)
T ss_pred             ----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCC
Confidence                      2224779999999999999999999999999999999998888776554444

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-51  Score=335.66  Aligned_cols=262  Identities=29%  Similarity=0.481  Sum_probs=228.6

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .+.|- +-+.||+|.|+.||+|.++.+|+.+|+|+++.........+++.+|+.|-+.|+||||+++.+.+.+.+.    
T Consensus        10 ~d~y~-l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~----   84 (355)
T KOG0033|consen   10 SDNYD-VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF----   84 (355)
T ss_pred             chhhh-HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce----
Confidence            33444 8899999999999999999999999999997665555577888999999999999999999999988866    


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC--C-CeEEeeeeccccc
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--C-DLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~--~-~vkl~Dfg~~~~~  195 (377)
                       .|+|+|++.| +|...|-.+.-+++..+-..+.||++||.|+|.+||+|||+||+|+++-..  + -+||+|||++...
T Consensus        85 -~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   85 -HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             -eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence             8999999986 888777766778999999999999999999999999999999999999432  2 4899999999988


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      +.........|||.|+|||++.. .+++..+|||+.|+++|-||.|+.||.+.+....+..|..-...            
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd------------  230 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD------------  230 (355)
T ss_pred             CCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC------------
Confidence            87777788999999999999988 89999999999999999999999999987766666666542221            


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                     ...+.|+.+++++++|+++||..||.+|.|+.|.|+|||+.+-..
T Consensus       231 ---------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  231 ---------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             ---------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence                           123357889999999999999999999999999999999976543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-50  Score=336.06  Aligned_cols=269  Identities=30%  Similarity=0.527  Sum_probs=233.5

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc------CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  114 (377)
                      +|. +.+.||.|..++|-+|.++.+|..+|+|++.-...      .....+...+|+.||+++. ||+|+++.+.|+.+.
T Consensus        18 ~y~-pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   18 KYE-PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hcC-hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            455 88899999999999999999999999999853321      1122344568999999996 999999999999986


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .     +++|+|.|+ |.|.+++.+.-.+++...+.|+.|+++|++|||.++||||||||+|||++++.+++|+|||++.
T Consensus        97 F-----~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   97 F-----VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             h-----hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            6     899999998 8999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccccccCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ...........+||++|.|||.+..     ...|+..+|+|++|+++|.||.|..||-......++..|++-        
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG--------  243 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG--------  243 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc--------
Confidence            9999988999999999999999853     356889999999999999999999999877766677666652        


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP  343 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~  343 (377)
                                         .-+...+.|.+++...++||.+||++||++|.|++|+|.||||+++-........|
T Consensus       244 -------------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  244 -------------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             -------------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence                               22334566778899999999999999999999999999999998766544444444

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-48  Score=353.68  Aligned_cols=280  Identities=37%  Similarity=0.706  Sum_probs=226.4

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||.|+||+||++.++.++..||+|.+...... .....+.+|+.++++++||||+++++++.....     .+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~   79 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERC-----LT   79 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe-----EE
Confidence            345889999999999999999999999999998654221 223456789999999999999999999987654     89


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc
Q 017083          123 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~  200 (377)
                      ++|||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus        80 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            99999999999988654 45789999999999999999999999999999999999999999999999998754432 22


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch-hHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD-NARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~  279 (377)
                      .....+++.|+|||.+.+...++.++|||||||++|+|++|..||........+..+....+.++...+...... ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            344567899999999877567899999999999999999999999998888888888888777766544332211 1111


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ..  .............+.++.++.+||++||+.||.+|||++|+|+||||
T Consensus       240 ~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            10  11111122222345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.8e-50  Score=362.21  Aligned_cols=255  Identities=31%  Similarity=0.530  Sum_probs=230.2

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|+||.||+++.+.+.+.||+|.+.+..........+.+|++|++.++||||+.++++|+....     +|+|
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~-----~~vV   79 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH-----LWVV   79 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-----EEEE
Confidence            38899999999999999999999999999999887788888899999999999999999999999998854     9999


Q ss_pred             EecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cccc
Q 017083          125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTE  203 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~~  203 (377)
                      .||+.|+|..++...+.++++.++.++.+++.||.|||+++|.|+|+||.||++..+|.+|+||||+++.++... ....
T Consensus        80 te~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   80 TEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             ehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            999999999999999999999999999999999999999999999999999999999999999999999888764 4566


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      .-||+.|||||++.+ ..++..+|+|||||++|||+.|++||......+....|...-..+                   
T Consensus       160 ikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-------------------  219 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-------------------  219 (808)
T ss_pred             ccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-------------------
Confidence            788999999999998 899999999999999999999999998877666655554421111                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                  ....+..+..|++.+|.+||.+|.|..+++.|||.+.....
T Consensus       220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence                        12568899999999999999999999999999999865544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=361.96  Aligned_cols=255  Identities=29%  Similarity=0.485  Sum_probs=220.6

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ..+|....+||+|+-|.||.+....++..||+|.+...  .....+.+.+|+.+|+..+|+|||++++.|.....     
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----  344 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----  344 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----
Confidence            34667888999999999999999999999999999765  23345667899999999999999999999998854     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|+||||++| +|.+.+.. -.+++.++..|+.++++||+|||.+||+|||||.+|||++.+|.+||+|||++.......
T Consensus       345 LWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999985 77777654 459999999999999999999999999999999999999999999999999987766543


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......||++|||||++.. +.|+++.||||||+++.||+.|..||-..+....+..|..--. +              
T Consensus       424 ~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P--------------  487 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-P--------------  487 (550)
T ss_pred             CccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-C--------------
Confidence             6778899999999999987 8999999999999999999999999988776666666644111 1              


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                   .......+|+.+.+|+.+||+.|+.+|++|.|||+||||+.
T Consensus       488 -------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  488 -------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             -------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                         11122367999999999999999999999999999999953

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.2e-48  Score=358.90  Aligned_cols=322  Identities=58%  Similarity=1.052  Sum_probs=268.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||.|++|.||++.++.+|..||+|.+............+.+|+.++++++||||+++++++..... ....+++
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~l   85 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA-DFKDVYV   85 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC-CCceEEE
Confidence            337889999999999999999999999999997654444455677789999999999999999998875442 2245899


Q ss_pred             EEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc----
Q 017083          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~----  199 (377)
                      ++||++++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......    
T Consensus        86 v~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  165 (334)
T cd07855          86 VMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK  165 (334)
T ss_pred             EEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCC
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987543321    


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......++..|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.++.............
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~  245 (334)
T cd07855         166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVR  245 (334)
T ss_pred             cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHH
Confidence             1234467889999999876556889999999999999999999999998888888888888887776665555555455


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCCCChH
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED  358 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (377)
                      ..................+..+.++.++|++||+.+|++|||+.+++.||||........+..+..+++.++.....+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (334)
T cd07855         246 KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSRE  325 (334)
T ss_pred             HHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChh
Confidence            44444433333333334567799999999999999999999999999999999999999988898999999998888888


Q ss_pred             HHHHHHHH
Q 017083          359 HIRELIWR  366 (377)
Q Consensus       359 ~~~~~~~~  366 (377)
                      .+-+++-+
T Consensus       326 ~~~~~~~~  333 (334)
T cd07855         326 QLKEAIVK  333 (334)
T ss_pred             hHHHHhhc
Confidence            87776643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-47  Score=356.76  Aligned_cols=296  Identities=45%  Similarity=0.798  Sum_probs=229.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  115 (377)
                      +.+.++|. +++.||+|+||+||++.+..+|..||+|++............+.+|+.+++.++||||+++++++..... 
T Consensus        17 ~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          17 FTVLKRYQ-QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhhceE-EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            44555655 8999999999999999999999999999997654455556677899999999999999999999875532 


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ..+..+|++|||++++|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          96 EEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             cccceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            2223479999999999888774  35888999999999999999999999999999999999999999999999999765


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.+..+.+......... .
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  251 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-P  251 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH-H
Confidence            54444455678999999999987 778999999999999999999999999888777766666665554432211110 0


Q ss_pred             hHHHHHHhcccccc------------ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          276 NARRYVRQLPRCRK------------QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       276 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      ....+.........            ..........++.+.+||.+||+.||++|||+.|+|+||||+...+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence            01111111110000            000111123467899999999999999999999999999998655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-49  Score=346.74  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=211.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ..+.||+|+||+||++.+..+|...|+|.+...  +....+.+.+|+.+|.+++|||||++++.......   ..++|.|
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~m   95 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIFM   95 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEeee
Confidence            788899999999999999999999999998765  22236778899999999999999999997444332   2389999


Q ss_pred             ecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCC----C
Q 017083          126 ELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSE----T  198 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~----~  198 (377)
                      ||++ |+|.+++...+ ++++..++.++.||++||+|||++||+|+||||+|||++. ++.+||+|||++.....    .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9998 69999998766 7999999999999999999999999999999999999999 79999999999987663    2


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-DYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      .......||+.|||||++.+.....+++|||||||++.||++|..||... .....+..+-..                 
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----------------  238 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----------------  238 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-----------------
Confidence            33456788999999999986233446999999999999999999999873 222222222110                 


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                  ...+.....++.++.+||.+|+..||++||||.++|+|||.++...
T Consensus       239 ------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 ------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                        0111223458999999999999999999999999999999987554

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-48  Score=340.94  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=226.6

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ...++-+.+++++.||+|.-|+||++..+.++..+|+|++.+... ......+...|-.||..++||.++.+|+.|+.+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            357778888999999999999999999999999999999987643 3445567788999999999999999999999886


Q ss_pred             CCCCCcEEEEEecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .     .|++||||+| +|+.+.+.  ++.|++..++.++..|+.||+|||..||++|||||+||||.++|+|.|+||.+
T Consensus       151 ~-----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  151 Y-----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             e-----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence            6     8999999985 88888764  56799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-----------------------------------C----------------------ccccccccccccCCCc
Q 017083          192 ARTTSE-----------------------------------T----------------------DFMTEYVVTRWYRAPE  214 (377)
Q Consensus       192 ~~~~~~-----------------------------------~----------------------~~~~~~~~~~~y~aPE  214 (377)
                      +.....                                   .                      .....++||-.|.|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            842110                                   0                      0123356788899999


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc
Q 017083          215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT  294 (377)
Q Consensus       215 ~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (377)
                      ++.+ ...+.++|.|+|||++|||+.|..||.+.+..+.+..|...--.                             .+
T Consensus       306 vI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-----------------------------Fp  355 (459)
T KOG0610|consen  306 VIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-----------------------------FP  355 (459)
T ss_pred             eeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-----------------------------CC
Confidence            9999 88899999999999999999999999999988888777542111                             12


Q ss_pred             cCCCCChhHHHHHHHhcCCCCCCCCC----HHHHhcCccccCCc
Q 017083          295 RFPNKSSGAVDLLEKMLVFDPNKRIT----VEEALRHPYLQSLH  334 (377)
Q Consensus       295 ~~~~~~~~~~~li~~~L~~dp~~Rps----~~ell~~p~f~~~~  334 (377)
                      ..+.++..++|||+++|.+||++|..    |.|+-+||||+.++
T Consensus       356 ~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  356 EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence            22356789999999999999999997    99999999999877

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=347.08  Aligned_cols=283  Identities=26%  Similarity=0.402  Sum_probs=226.6

Q ss_pred             cccccCceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH------------HHHH
Q 017083           19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------------IDAR   86 (377)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~------------~~~~   86 (377)
                      ..+....+...++.+.++..|  ..|++++.||+|.||.|-++++..+++.||||++.+.....            ...+
T Consensus        76 ~~vket~k~~~~~~~~~~k~l--Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~e  153 (576)
T KOG0585|consen   76 RRVKETNKIVRYDDDQDRKQL--NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIE  153 (576)
T ss_pred             cccceeeeeeeecCcccceeh--hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHH
Confidence            333344444555555555544  33458999999999999999999999999999996542111            1125


Q ss_pred             HHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhcCC
Q 017083           87 RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSAS  165 (377)
Q Consensus        87 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~LH~~~  165 (377)
                      +..+|+.+|++|.|||||+++++.-+...   ..+|+|+|||...-.......++ +++.+++.++.+++.||+|||.+|
T Consensus       154 kv~~EIailKkl~H~nVV~LiEvLDDP~s---~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg  230 (576)
T KOG0585|consen  154 KVRREIAILKKLHHPNVVKLIEVLDDPES---DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG  230 (576)
T ss_pred             HHHHHHHHHHhcCCcCeeEEEEeecCccc---CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            67899999999999999999999877654   55999999998433333344455 999999999999999999999999


Q ss_pred             ceecCCCCCceEEccCCCeEEeeeeccccc------CCCccccccccccccCCCcccccc---CCCCCcchHHHHHHHHH
Q 017083          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTT------SETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILG  236 (377)
Q Consensus       166 i~H~dik~~NIli~~~~~vkl~Dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~  236 (377)
                      |+||||||+|+|++.+|.+||+|||.+...      +.........||+.|+|||.+.+.   ...+.+.|||||||+||
T Consensus       231 iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY  310 (576)
T KOG0585|consen  231 IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY  310 (576)
T ss_pred             eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence            999999999999999999999999998755      223345568999999999998762   33577999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCC
Q 017083          237 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  316 (377)
Q Consensus       237 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  316 (377)
                      .|+.|+.||.+......+.+|.+.--.                             .+..+.+...+.+||++||++||+
T Consensus       311 CllfG~~PF~~~~~~~l~~KIvn~pL~-----------------------------fP~~pe~~e~~kDli~~lL~KdP~  361 (576)
T KOG0585|consen  311 CLLFGQLPFFDDFELELFDKIVNDPLE-----------------------------FPENPEINEDLKDLIKRLLEKDPE  361 (576)
T ss_pred             HhhhccCCcccchHHHHHHHHhcCccc-----------------------------CCCcccccHHHHHHHHHHhhcChh
Confidence            999999999998877777777652111                             122346788999999999999999


Q ss_pred             CCCCHHHHhcCccccCCcC
Q 017083          317 KRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       317 ~Rps~~ell~~p~f~~~~~  335 (377)
                      +|.+..++..|||...--+
T Consensus       362 ~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  362 QRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             heeehhhheecceeccCCC
Confidence            9999999999999976533

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.2e-47  Score=354.50  Aligned_cols=298  Identities=45%  Similarity=0.784  Sum_probs=232.5

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+.++|. +++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus        19 ~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          19 TFTVLKRYQ-NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hhchhccee-EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            355556665 8999999999999999999999999999997655455556677899999999999999999998865432


Q ss_pred             -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 -DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 -~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                       .....+|+||||++++|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875          98 LEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             ccccCeEEEEEeCCCCCHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence             2224489999999999988875  3578899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+.+.+........
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            665544556678999999999987 7789999999999999999999999999888877777766666554322111110


Q ss_pred             hhHHHHHHhcccc------------ccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 017083          275 DNARRYVRQLPRC------------RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND  338 (377)
Q Consensus       275 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~  338 (377)
                      . ...+.......            ............+..+.+||.+||+.||.+|||+.++|+||||+...+...
T Consensus       255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         255 T-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             H-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            0 01111100000            000001111224567899999999999999999999999999987665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-47  Score=346.26  Aligned_cols=282  Identities=37%  Similarity=0.597  Sum_probs=220.6

Q ss_pred             cCCcccccCCccceEEEEEeCC-CCcEEEEEeccccccCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      |++++.||+|+||+||++++.. ++..||+|.+............+.+|+.+++.+   +||||+++++++.........
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            4488999999999999999854 468899999875433333334455677666665   699999999998654333334


Q ss_pred             cEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          120 DVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      .+++++||++++|.+.+..  ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T cd07862          83 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF  162 (290)
T ss_pred             cEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence            5899999999999998865  34589999999999999999999999999999999999999999999999999986655


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........+..+....+.+.+..+...... .
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  240 (290)
T cd07862         163 QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL-P  240 (290)
T ss_pred             CcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc-c
Confidence            544556678999999999977 67889999999999999999999999998888888888776665543322110000 0


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                         ................+.++..+.+||.+||+.||++|||+.|+|+||||
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         241 ---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ---chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence               00011111122223345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.6e-48  Score=358.02  Aligned_cols=280  Identities=34%  Similarity=0.576  Sum_probs=230.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-C-----CCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-H-----ENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~  117 (377)
                      |++++.||+|+||+|-+|.+..+++.||||++++.   .....+...|+.+|..|+ |     -|+|+++++|...    
T Consensus       188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr----  260 (586)
T KOG0667|consen  188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR----  260 (586)
T ss_pred             EEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc----
Confidence            34899999999999999999999999999999874   445677788999999997 4     2899999999988    


Q ss_pred             CCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC--CeEEeeeeccc
Q 017083          118 FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~--~vkl~Dfg~~~  193 (377)
                       +++|||+|..+.+|.++++.++  +++...++.++.||+.||.+||+.||+|+||||+|||+.+-+  .|||+|||.+.
T Consensus       261 -~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 -NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             -cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence             4499999999999999998754  689999999999999999999999999999999999997654  59999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....-  ..++.+..|+|||++.+ .+++.+.||||||||+.||.+|.+.|++.+..+++..|.++++.|++..+....
T Consensus       340 ~~~q~v--ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  340 FESQRV--YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             ccCCcc--eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            776553  37788999999999999 999999999999999999999999999999999999999999988876543211


Q ss_pred             chhHHHHHHh----------------------------c-cccccc-c---ccccCC-CCChhHHHHHHHhcCCCCCCCC
Q 017083          274 SDNARRYVRQ----------------------------L-PRCRKQ-Q---FATRFP-NKSSGAVDLLEKMLVFDPNKRI  319 (377)
Q Consensus       274 ~~~~~~~~~~----------------------------~-~~~~~~-~---~~~~~~-~~~~~~~~li~~~L~~dp~~Rp  319 (377)
                      ..  ..+.+.                            . ...+.. .   ...... .-...+.+||++||..||.+|+
T Consensus       417 ~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  417 KA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             cc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence            11  111111                            0 000000 0   000011 2245689999999999999999


Q ss_pred             CHHHHhcCccccCCcCC
Q 017083          320 TVEEALRHPYLQSLHDL  336 (377)
Q Consensus       320 s~~ell~~p~f~~~~~~  336 (377)
                      |+.++|+||||+.....
T Consensus       495 tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTSLE  511 (586)
T ss_pred             CHHHHhcCccccccccc
Confidence            99999999999865543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-47  Score=347.55  Aligned_cols=284  Identities=33%  Similarity=0.584  Sum_probs=217.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||+++++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.....     .+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~   79 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKET-----LT   79 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe-----EE
Confidence            344899999999999999999999999999998754322 223456789999999999999999999987754     89


Q ss_pred             EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc
Q 017083          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~  200 (377)
                      ++|||++++|.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...... ..
T Consensus        80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            9999999999988865 356899999999999999999999999999999999999999999999999998754322 22


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccccccccc-hhHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRS-DNAR  278 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  278 (377)
                      .....+++.|+|||++.+...++.++|||||||++|+|++|..||.... ....+..+....+.+....+..... ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            3445678999999998765668889999999999999999999998754 3345555555555443322111000 0000


Q ss_pred             HHHHhccccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .  ..............+  ...++.+.+|+.+||+.||++|||+.|+++||||+++.
T Consensus       240 ~--~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         240 P--ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             c--ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0  000000000000011  12467899999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-47  Score=346.56  Aligned_cols=281  Identities=35%  Similarity=0.634  Sum_probs=220.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+++++.+++.||+|++............+.+|+.+++.++||||+++++++.....     +++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   77 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-----LYL   77 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE-----EEE
Confidence            448899999999999999999999999999997654444455677889999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--c
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  200 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--~  200 (377)
                      ||||+++++.+.+.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            999999876666543 4578999999999999999999999999999999999999999999999999998654322  2


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh-HHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN-ARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~  279 (377)
                      .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....+..+........... ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 YTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            234567899999999987 678999999999999999999999999888777777777666555433221110000 000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...................++.++.+||++||+.||++|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000000000000001122468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-47  Score=350.88  Aligned_cols=323  Identities=62%  Similarity=1.097  Sum_probs=272.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+.+.||.|++|.||++++..++..||+|.+............+.+|+.+++.++|+||+++++++.......+..+|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            34788999999999999999999999999999765444455677889999999999999999999988876444456899


Q ss_pred             EEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc----
Q 017083          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~----  199 (377)
                      +|||++++|.+.+..+.++++..++.++.||+.||++||++|++|+||||.||+++.++.++|+|||++.......    
T Consensus        82 v~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~  161 (330)
T cd07834          82 VTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG  161 (330)
T ss_pred             EecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999998655442    


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+...++.++|+||||+++++|++|..||...........+....+.+......+........
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  241 (330)
T cd07834         162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN  241 (330)
T ss_pred             cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhh
Confidence            23445678899999999884478999999999999999999999999999888888888888777766655555555555


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCC-CcCCCCCChH
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF-DFEHSSCTED  358 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  358 (377)
                      +................+.++..+.++|.+||+.+|++|||+.++++||||+++.....+.....++.+ .+.+-..+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (330)
T cd07834         242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEE  321 (330)
T ss_pred             HHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCHH
Confidence            555555554444555566789999999999999999999999999999999999988777777777766 4556667888


Q ss_pred             HHHHHHHH
Q 017083          359 HIRELIWR  366 (377)
Q Consensus       359 ~~~~~~~~  366 (377)
                      ..++++.+
T Consensus       322 ~~~~~~~~  329 (330)
T cd07834         322 ELKELIYE  329 (330)
T ss_pred             HHhHHhhc
Confidence            88877654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-47  Score=350.78  Aligned_cols=334  Identities=50%  Similarity=0.941  Sum_probs=275.9

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..+++.++|- +++.||+|++|+||++++..++..||+|.+............+.+|+.++++++|||++++++++....
T Consensus         9 ~~~~~~~~y~-~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851           9 TVWEVPDRYQ-NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             ceecccCceE-EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            3467777765 899999999999999999999999999998764434444566778999999999999999999887654


Q ss_pred             C-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      . .....+++++||++++|.+++.. .++++..++.++.||++||++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          88 SLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence            3 33345899999999999988865 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....  .....++..|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.+++.......
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65433  3345668889999998764567899999999999999999999999888888888888877766665555555


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS  353 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~  353 (377)
                      ......+...............+...+..+.++|.+||+.||++|||+.++++||||+.......... ...+..++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~  323 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSFESR  323 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcchhhh
Confidence            55555555555554444444455667999999999999999999999999999999998877665444 56677888889


Q ss_pred             CCChHHHHHHHHHHHhhcCC
Q 017083          354 SCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~  373 (377)
                      +...+.+..++..+..-|.|
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         324 DLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             hcCHHHHHHHhHHHHHhccC
Confidence            99999999999988877765

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=358.85  Aligned_cols=261  Identities=24%  Similarity=0.387  Sum_probs=230.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  114 (377)
                      ..+..+.+.+++.||+|+||+|+++..+.+++.||||++++.. ......+....|.+|+.... ||+++.++.+|..+.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4566678889999999999999999999999999999998864 44456777888999998776 999999999999885


Q ss_pred             CCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          115 KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      .     +|+||||+.|+-.-.+...+.|++..++.++..|+.||+|||++||+|||||.+|||+|.+|.+||+|||+++.
T Consensus       443 ~-----l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  443 H-----LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             e-----EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence            5     99999999874444455678999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          195 TS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       195 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .- ......+++||+.|+|||++.+ ..|+.++|.|||||++||||.|+.||++.+.++....|...-..          
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~----------  586 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR----------  586 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----------
Confidence            44 5567889999999999999998 89999999999999999999999999999999888888662111          


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                           ....+|.++..+++++|..||++|..     +.+|..||||+++.
T Consensus       587 ---------------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  587 ---------------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             ---------------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence                                 11357999999999999999999983     68999999999876

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-46  Score=347.94  Aligned_cols=327  Identities=58%  Similarity=0.989  Sum_probs=255.6

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.++|. +.+.||+|++|+||++.+..+|..||+|.+... ........+.+|+.++++++||||+++++++........
T Consensus         3 ~~~~y~-i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQ-NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceE-EEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            445554 899999999999999999999999999998642 223345667789999999999999999998876655444


Q ss_pred             CcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          119 NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       119 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ..+++++||++++|.+.+. ..++++..++.++.||++||++||++|++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          81 NDVYIVQELMETDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ceEEEEehhcccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            5689999999999988775 467999999999999999999999999999999999999999999999999998764432


Q ss_pred             c----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .    ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...........+....+.+..........
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1    123356788999999876646788999999999999999999999998887777777777776655544333333


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS  354 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~  354 (377)
                      .....+................+..++.+.+++.+||+.||++|||+.++++||||.........+....++.+|++.-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFD  319 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcccc
Confidence            33333333222222222222345678899999999999999999999999999999999887777777667777766543


Q ss_pred             -CChHHHHHHHHHHH
Q 017083          355 -CTEDHIRELIWRES  368 (377)
Q Consensus       355 -~~~~~~~~~~~~~~  368 (377)
                       .......+.+-+|.
T Consensus       320 ~~~~~~~~~~~~~~~  334 (336)
T cd07849         320 DLPKEKLKELIFEEI  334 (336)
T ss_pred             ccCHHHHHHHHHHHh
Confidence             23456666665553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-48  Score=338.42  Aligned_cols=253  Identities=28%  Similarity=0.473  Sum_probs=229.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++.+.||+|.||.|-++.....|+.||||.+++.. .+.+..-.+++|++||..|+||||+.+|++|+....     +
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-----I  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-----I  128 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce-----E
Confidence            4558999999999999999999999999999998764 445566778899999999999999999999999876     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      .|||||.. |.|.+++...+.+++.+++.++.||+.|+.|+|.++++|||||.+|||+|.++++||+|||++.......+
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            99999997 69999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ..++||++.|.+||.+.+...-++.+|.||||+++|.|..|..||.+.+.......|.+-....                
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE----------------  272 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE----------------  272 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----------------
Confidence            9999999999999999986666899999999999999999999999998777776665422222                


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                      +.-+.++.-||++||.+||++|.|..++.+|=|...
T Consensus       273 ----------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  273 ----------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             ----------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence                            244677899999999999999999999999988753

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.1e-47  Score=342.18  Aligned_cols=282  Identities=34%  Similarity=0.595  Sum_probs=220.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |++++.||+|+||+||++.++.+++.||+|.+..............+|+.+++.+   +||||+++++++..........
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            3478999999999999999999999999999875432222223445566666655   7999999999987654433455


Q ss_pred             EEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      +++++||++++|.+.+...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        82 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd07863          82 VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ  161 (288)
T ss_pred             EEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc
Confidence            8999999999999988653  35899999999999999999999999999999999999999999999999999876554


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....+.+....+.......  
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (288)
T cd07863         162 MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP--  238 (288)
T ss_pred             ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc--
Confidence            44455677899999999977 778999999999999999999999998888777777777766554432221100000  


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                        ................+.++..+.++|.+||+.||++|||+.|+++||||
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 --RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             --ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              00000111112223345678889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-47  Score=354.17  Aligned_cols=282  Identities=25%  Similarity=0.327  Sum_probs=218.6

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ....|.+++.||+|+||.||++.+..+++.||+|....        ..+.+|++++++++||||++++++|..+..    
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----  157 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKF----  157 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe----
Confidence            33456699999999999999999999999999997532        345689999999999999999999987654    


Q ss_pred             cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       120 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                       .++++|++.++|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus       158 -~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        158 -TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             -eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence             899999999999999988888999999999999999999999999999999999999999999999999998653322 


Q ss_pred             -ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCccccc
Q 017083          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-------YVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~  270 (377)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....       ....+..+....+..+.... 
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~-  314 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP-  314 (391)
T ss_pred             ccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC-
Confidence             22334578999999999977 778999999999999999999998875432       33455555555554432211 


Q ss_pred             cccchhHHHHH-Hhcccccc-cccc---ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          271 FLRSDNARRYV-RQLPRCRK-QQFA---TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       271 ~~~~~~~~~~~-~~~~~~~~-~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ..........+ ........ ....   .....++.++.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            11111111111 11100000 0000   1112457789999999999999999999999999999986643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-47  Score=350.12  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +.||+|+||+||+++++.+|+.||+|++..... .......+.+|+.++++++||||+++++++.....     ++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-----~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR-----LCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE-----EEEEEe
Confidence            358999999999999999999999999975422 23344567789999999999999999999988754     899999


Q ss_pred             cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCcccccc
Q 017083          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEY  204 (377)
Q Consensus       127 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~~~~  204 (377)
                      |++ ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            998 5898988888899999999999999999999999999999999999999999999999999987532 22334456


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhc
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  284 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (377)
                      .|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...   .                    
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---~--------------------  211 (323)
T cd05571         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---E--------------------  211 (323)
T ss_pred             ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C--------------------
Confidence            78999999999987 77899999999999999999999999877655444333210   0                    


Q ss_pred             cccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                              ......+++++.+||++||+.||++||     ++.++++||||+++.
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                    011135688999999999999999999     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-47  Score=344.75  Aligned_cols=253  Identities=22%  Similarity=0.372  Sum_probs=213.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++.++.+++.||+|++..... .......+.+|+.++++++||||+++++++.....     ++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~~   77 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF-----LY   77 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe-----EE
Confidence            4478999999999999999999999999999865321 22344567789999999999999999999887654     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++|||++ ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  .
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence            9999998 589999988889999999999999999999999999999999999999999999999999998765433  2


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   .                 
T Consensus       156 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~---~-----------------  214 (291)
T cd05612         156 WTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG---K-----------------  214 (291)
T ss_pred             ccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---C-----------------
Confidence            34568999999999877 67889999999999999999999999887655444333221   0                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~~  335 (377)
                                 ......+++.+.+||++||+.||.+||+     ++++++||||+.+..
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         215 -----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             -----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                       0011245788999999999999999995     999999999986553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-46  Score=348.28  Aligned_cols=295  Identities=46%  Similarity=0.813  Sum_probs=230.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  115 (377)
                      +.+.++|. +++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++..... 
T Consensus        13 ~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          13 FTVLKRYQ-NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhhcee-EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            34455554 8899999999999999999999999999997665555556777889999999999999999999875432 


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      .....++++|||+++++.+.+..  .+++..++.++.|+++||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        92 ~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          92 EEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             cccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            22344799999999998887753  5888999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.+..+.+.+....... .
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  247 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-P  247 (355)
T ss_pred             CCccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc-H
Confidence            65544556678999999999977 678999999999999999999999999988777777666666554433211111 1


Q ss_pred             hHHHHHHhccccc------------cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          276 NARRYVRQLPRCR------------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       276 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ....+........            ...........+..+.+||.+||+.||++|||+.|+|+||||+...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            1111111110000            000001112346678999999999999999999999999999866544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-47  Score=362.87  Aligned_cols=288  Identities=32%  Similarity=0.577  Sum_probs=223.4

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC---C
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---D  116 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~  116 (377)
                      ..+.|.+++.||+|+||+||++.+..+++.||||++....      ....+|+.+++.++||||++++++|.....   .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3445668999999999999999999999999999885431      223469999999999999999988754321   1


Q ss_pred             CCCcEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeec
Q 017083          117 TFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGL  191 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~  191 (377)
                      ....++++|||++++|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            112367999999999887764    356799999999999999999999999999999999999999765 699999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ++............+++.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+....+.+.......
T Consensus       218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            98765554455567899999999987756789999999999999999999999999888888888887777665433211


Q ss_pred             ccchhHHHHHHhccccccccccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      .... ....  .............+ ...+.++.+||.+||+.||.+|||+.|+|+||||..+.+.
T Consensus       298 ~~~~-~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        298 MNPN-YADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             hchh-hhcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            1000 0000  00000000000111 2467899999999999999999999999999999887653

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-46  Score=344.59  Aligned_cols=333  Identities=46%  Similarity=0.860  Sum_probs=265.1

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|.+.++|- +++.||+|++|+||++.+..++..||+|.+............+.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEVPDRYR-DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhccccceE-EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            356666766 8999999999999999999999999999986554444445667899999999999999999999876542


Q ss_pred             -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 -DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 -~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                       .....+++++||++++|.+++.. ..+++..++.++.||++||+|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          89 LDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence             12234689999998888887764 6799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ....  .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...........+.......+.........
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            5433  23446688899999987645678899999999999999999999998877666666666554444332222223


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS  354 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~  354 (377)
                      .....+................+.+++.+.++|.+||..||++|||+.+++.||||+.......... ..++.-++.+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  324 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETE-APPYDDSFDEVD  324 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccC-CCCccccHHhhc
Confidence            3333344444333333333445678889999999999999999999999999999998877654443 335777778888


Q ss_pred             CChHHHHHHHHHHHhhcCC
Q 017083          355 CTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~  373 (377)
                      ..-++++.+...|.++|.|
T Consensus       325 ~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         325 QSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             cchHHHHHHHHHHHHhcCC
Confidence            8889999999999999876

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.9e-47  Score=340.28  Aligned_cols=259  Identities=23%  Similarity=0.374  Sum_probs=212.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++.+..+|+.||+|.+.+.... ......+.+|+.++++++|++|+++++++.....     ++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~-----~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA-----LC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-----EE
Confidence            34788999999999999999999999999998654222 2233456789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          123 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++||++ |+|.+.+..  ..++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998 588777653  3468999999999999999999999999999999999999999999999999998765444


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......               
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  220 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------------  220 (285)
T ss_pred             eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc---------------
Confidence            4455678999999999987 788999999999999999999999998765433222222211110               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~~  335 (377)
                                  .......++..+.+||++||+.||++||+     ++++++||||.++..
T Consensus       221 ------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         221 ------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             ------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                        01112356889999999999999999997     999999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-47  Score=349.32  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=213.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++.+.||+|+||+||+++++.+++.||+|++.... ........+.+|+.++++++||||+++++++..+..     +
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~   93 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR-----V   93 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE-----E
Confidence            3458899999999999999999999999999996542 122344567899999999999999999999988755     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +++|||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......  
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            99999997 589999988889999999999999999999999999999999999999999999999999999865443  


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   ..               
T Consensus       172 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---~~---------------  232 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---RL---------------  232 (329)
T ss_pred             cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---Cc---------------
Confidence            234578999999999987 67889999999999999999999999876654444333220   00               


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  333 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~  333 (377)
                                   .....++..+.+||++||+.||.+||+     +.++++||||...
T Consensus       233 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        233 -------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                         001235788999999999999999996     7999999999874

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-46  Score=342.77  Aligned_cols=285  Identities=36%  Similarity=0.680  Sum_probs=228.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.++++||+|+||+||+++++.++..||+|.+...... .....+.+|+.++++++||||+++++++..+..     .++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   81 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS-----LTL   81 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe-----EEE
Confidence            34899999999999999999999999999998754322 223456689999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      +|||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus        82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            9999999999887654 458899999999999999999999999999999999999999999999999987544332 23


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+.+....+........... 
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN-  240 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh-
Confidence            3456788999999987656788999999999999999999999999888888888888877766544322211110000 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ...............+.++.++.+||.+||+.||.+|||+.|+++||||+.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            011111111112234567899999999999999999999999999999997653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=343.78  Aligned_cols=259  Identities=33%  Similarity=0.521  Sum_probs=227.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCc
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +|++.+.||.|.||.||.|+++.+|+.+|+|.+.+..... .......+|+.+|+++. |||||.+++.|+....     
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~-----  110 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS-----  110 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe-----
Confidence            4447899999999999999999999999999998764432 24567889999999999 9999999999999865     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC----CCeEEeeeeccccc
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTT  195 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~----~~vkl~Dfg~~~~~  195 (377)
                      +++|||++. |.|.+.+... .+++..+..++.||+.|+.|||+.|++||||||+|+|+...    +.++++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999998 5999988776 49999999999999999999999999999999999999643    47999999999988


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .........+||+.|+|||++.. ..++..+||||+|+++|.|++|..||...........+..                
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~----------------  252 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR----------------  252 (382)
T ss_pred             cCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc----------------
Confidence            88777889999999999999987 7899999999999999999999999998776655553333                


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                 .......+.|..++..+.++|++||..||.+|+|+.++|+|||+++...
T Consensus       253 -----------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  253 -----------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             -----------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                       1223445667889999999999999999999999999999999987643

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-46  Score=359.63  Aligned_cols=290  Identities=24%  Similarity=0.381  Sum_probs=222.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC------CCceeEeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH------ENVIAIKDI  109 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~  109 (377)
                      .+.+....|++++.||+|+||+||++.+..+++.||||+++..   .........|+.+++.++|      .++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3444445566999999999999999999999999999999643   1223344567777776654      458888888


Q ss_pred             ecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCC------
Q 017083          110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASC------  182 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~------  182 (377)
                      |....    .+++++|++++++|.+.+...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++      
T Consensus       200 ~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        200 FQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            87543    348999999999999999888899999999999999999999997 5999999999999998765      


Q ss_pred             ----------CeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 017083          183 ----------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (377)
Q Consensus       183 ----------~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~  252 (377)
                                .+||+|||.+.....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                      499999998754332  2345678999999999987 778999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc---------cC--CCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT---------RF--PNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       253 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                      .+..+.+..+.++..............++.............         ..  ...++.+.+||.+||+.||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            888888888777654332222222222222221111000000         00  0124668899999999999999999


Q ss_pred             HHHhcCccccCCcC
Q 017083          322 EEALRHPYLQSLHD  335 (377)
Q Consensus       322 ~ell~~p~f~~~~~  335 (377)
                      .|+|+||||+....
T Consensus       433 ~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        433 RQMTTHPYVLKYYP  446 (467)
T ss_pred             HHHhcCccccccCC
Confidence            99999999987543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-46  Score=338.92  Aligned_cols=258  Identities=27%  Similarity=0.358  Sum_probs=216.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcE-EEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      ...+.+....+.+.+.||.|+||+||.+..+.+  . ||+|++..........+.+.+|+.+|.+++|||||+++|++..
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            345677777777888899999999999988654  5 9999998765555557789999999999999999999999998


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCceEEccCC-CeEEe
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASC-DLKIG  187 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dik~~NIli~~~~-~vkl~  187 (377)
                      ...    .++|||||++ |+|..++..  ...++...+..++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus       111 ~~~----~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  111 PPG----SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             CCC----ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence            752    2899999998 699999877  678999999999999999999999999 99999999999999998 99999


Q ss_pred             eeecccccCCC-ccccccccccccCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          188 DFGLARTTSET-DFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       188 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      |||+++..... .......||+.|||||++.+ ...++.++||||||+++|||++|..||......+....+......+ 
T Consensus       187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-  265 (362)
T KOG0192|consen  187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-  265 (362)
T ss_pred             CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-
Confidence            99999876654 33445788999999999985 2689999999999999999999999999987644333332211111 


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                  ......++.+..|+.+||..||++||++.+++.
T Consensus       266 ----------------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 ----------------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ----------------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                        111237889999999999999999999999875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-47  Score=313.40  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=227.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +++++.+.||+|-||.||+++.+.++..||+|++.+.. .......++.+|++|...|+||||+++|++|-+...     
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r-----   96 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR-----   96 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce-----
Confidence            45668999999999999999999999999999997653 233344667799999999999999999999999866     


Q ss_pred             EEEEEecCC-CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          121 VYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +|+++||.+ |++...+.  ...++++.....++.|++.|+.|+|.++++||||||+|+|++.+|.+|++|||-+-... 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999998 79999998  56789999999999999999999999999999999999999999999999999887665 


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      .......+||..|.|||...+ ...+..+|+|++|++.||++.|..||......+.+.+|.+.-...|            
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------  242 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------  242 (281)
T ss_pred             CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence            445778899999999999988 8889999999999999999999999999888888888877544333            


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                         ..++..+.|||.+||..+|.+|.+..|++.|||+...
T Consensus       243 -------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 -------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                               3568999999999999999999999999999998653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-46  Score=338.61  Aligned_cols=285  Identities=37%  Similarity=0.681  Sum_probs=225.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||.|+||.||++.++.++..||+|.+...... .....+.+|+.++++++||||+++++++.....     +++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~-----~~l   81 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-----LTL   81 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCe-----EEE
Confidence            44889999999999999999999999999998654322 123456689999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||++++|.+.+.. ...+++..++.++.||++||+|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus        82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            999999999988865 4568999999999999999999999999999999999999999999999999987544322 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+...++.++||||||+++|+|++|..||...........+......+.+..+......... ..
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-KS  240 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc-cc
Confidence            34456889999999876566788999999999999999999999998888888888777766655432211100000 00


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ...............+.+++.+.+||.+||+.||.+|||++|+++||||+.+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            000111111112223467889999999999999999999999999999987764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-46  Score=342.48  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=210.3

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +.||+|+||+||++.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.....     +|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-----~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-----LCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE-----EEEEEe
Confidence            358999999999999999999999999975422 22344566789999999999999999999987754     899999


Q ss_pred             cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Ccccccc
Q 017083          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  204 (377)
Q Consensus       127 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~~  204 (377)
                      |++ ++|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            998 58888888888899999999999999999999999999999999999999999999999999875322 2223446


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhc
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  284 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (377)
                      .|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+....                       
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----------------------  211 (323)
T cd05595         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------------------  211 (323)
T ss_pred             cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------------
Confidence            78999999999977 778999999999999999999999998776554443332100                       


Q ss_pred             cccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                              ......+++.+.+||.+||+.||++|+     ++.++++||||.+..
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                    001135688999999999999999998     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.1e-45  Score=341.64  Aligned_cols=296  Identities=47%  Similarity=0.838  Sum_probs=231.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  115 (377)
                      |.+.++|- +++.||+|+||+||++.+..+++.||+|.+.+..........+.+|+.++++++||||++++++|..... 
T Consensus        12 ~~~~~~y~-~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          12 FTVLKRYQ-NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhhcceE-EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            45555655 8899999999999999999999999999987654444555677789999999999999999999875532 


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ......|+++||++++|.+.+...  +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          91 EEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            233458999999999999988644  899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....+.+++........ 
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  246 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-  246 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh-
Confidence            55444445567889999999987 7789999999999999999999999998887777777777666654432211110 


Q ss_pred             hHHHHHHhcccccccccc-------------ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          276 NARRYVRQLPRCRKQQFA-------------TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      ....+.............             ......+..+.++|.+||+.||++|||+.|+|+||||.......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence            111111111100000000             00123466789999999999999999999999999998665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-45  Score=341.01  Aligned_cols=331  Identities=46%  Similarity=0.847  Sum_probs=249.0

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..|++.++|. +.+.||+|++|.||++++..+|+.||+|++............+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~~~~y~-~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           9 TVWELPERYT-SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhccccceE-EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            3467777766 889999999999999999999999999998764433334456778999999999999999999987653


Q ss_pred             C-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      . .....+++++||+..+|...+  +..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            2 122447999999998887765  3468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....  .....++..|+|||.+.+...++.++|+|||||++++|++|+.||...........+....+.+.+.......
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            65332  2344668889999998764568899999999999999999999999888777777777766655444333322


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS  353 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~  353 (377)
                      ......+...............++..+..+.+||++||+.||++||++.+++.||||+...+...+. ++.++.-...++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~-~~~~~~~~~~~~  322 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET-EQQPYDDSLENE  322 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC-CCCcccchhhhh
Confidence            2222333222222222222233456788899999999999999999999999999999988644333 344444443344


Q ss_pred             CCChHHHHHHHHHHHhhc
Q 017083          354 SCTEDHIRELIWRESVKF  371 (377)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~  371 (377)
                      ....+..-.-+-+|..+|
T Consensus       323 ~~~~~~~~~~~~~~~~~~  340 (342)
T cd07879         323 KLSVDEWKKHIYKEVKSF  340 (342)
T ss_pred             hCCHHHHHHHhhhhhhcc
Confidence            444444444443444333

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-46  Score=346.19  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=215.7

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCC-cEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.-+.|.+++.||+|+||.||++.++.++ ..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            344455668999999999999999876655 689999986532 122345567789999999999999999999987754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           ++++|||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus       106 -----~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        106 -----LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             -----EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence                 899999997 58999998888999999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ....  .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....            
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~------------  245 (340)
T PTZ00426        181 VDTR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII------------  245 (340)
T ss_pred             cCCC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC------------
Confidence            5433  345678999999999987 6788999999999999999999999988765554444432110            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                         .....+++.+.++|++||+.||++|+     +++++++||||.++.
T Consensus       246 -------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        246 -------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                               01134588899999999999999995     999999999998764

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-46  Score=344.17  Aligned_cols=250  Identities=26%  Similarity=0.447  Sum_probs=209.8

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +.||+|+||+||++.++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++.+.....     +++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR-----LCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE-----EEEEEe
Confidence            358999999999999999999999999975422 23345677789999999999999999999987754     899999


Q ss_pred             cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Ccccccc
Q 017083          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  204 (377)
Q Consensus       127 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~~  204 (377)
                      |++ ++|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            998 58888888888899999999999999999999999999999999999999999999999999875332 2233456


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhc
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  284 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (377)
                      .|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...   .                    
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---~--------------------  211 (328)
T cd05593         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---D--------------------  211 (328)
T ss_pred             cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC---C--------------------
Confidence            78999999999977 67899999999999999999999999876654433322110   0                    


Q ss_pred             cccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                              ......+++.+.+||++||+.||++|+     ++.++++||||....
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         212 --------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             --------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                    011135688999999999999999997     899999999998653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-45  Score=338.88  Aligned_cols=318  Identities=57%  Similarity=0.978  Sum_probs=253.9

Q ss_pred             cCCcccccCCccceEEEEEeCCC--CcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |.+.+.||+|+||.||++++..+  +..||+|.+............+.+|+.++++++ ||||+++++...... .....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~   80 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNE   80 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCc
Confidence            34788899999999999999888  899999998765444444566778999999995 999999998754321 12244


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +++++++++++|.+.+....++++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence            8899999999999999888899999999999999999999999999999999999999999999999999987544321 


Q ss_pred             ----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          200 ----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       200 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                          ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+....+.+++.........
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP  240 (332)
T ss_pred             cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence                1233567889999998866456889999999999999999999999998888888888887777665443333333


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC  355 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~~  355 (377)
                      ....+................+..+..+.+++.+||+.||++|||+.+++.||||+..++....+.|..+++++|+... 
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  319 (332)
T cd07857         241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED-  319 (332)
T ss_pred             hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc-
Confidence            3333333333333333334455678899999999999999999999999999999999988888889999888887543 


Q ss_pred             ChHHHHHH
Q 017083          356 TEDHIREL  363 (377)
Q Consensus       356 ~~~~~~~~  363 (377)
                      +-+..++.
T Consensus       320 ~~~~~~~~  327 (332)
T cd07857         320 SMEELRDM  327 (332)
T ss_pred             cHHHHHHH
Confidence            33344443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-45  Score=337.01  Aligned_cols=323  Identities=50%  Similarity=0.924  Sum_probs=262.3

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      +++.+.+.++|- +++.||.|+||.||++.+..+++.||+|.+............+..|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~y~-~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           2 FGTVFEITNRYV-DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             CcceeccccceE-EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            456677777765 8999999999999999999999999999886543333445667789999999999999999999865


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ...    .+++++||++++|.+.+.. .++++..+..++.||++||+|||++|++|+||+|.||+++.++.++|+|||.+
T Consensus        81 ~~~----~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          81 PLE----DIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             CCC----cEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence            332    2789999999898887754 56888899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ......  .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.+..+.+++......
T Consensus       156 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         156 RIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            754332  234456788999998866466889999999999999999999999998888888888888777766554433


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH  352 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~  352 (377)
                      .......+................+.++..+.++|++||+.+|++|||+.+++.||||...+....++....-|.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFND  313 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhc
Confidence            33333333333333333333344556789999999999999999999999999999999999888778877888898888


Q ss_pred             CCCChHHHHHH
Q 017083          353 SSCTEDHIREL  363 (377)
Q Consensus       353 ~~~~~~~~~~~  363 (377)
                      ....-+.++..
T Consensus       314 ~~~~~~~~~~~  324 (328)
T cd07856         314 ADLPVDTWKVM  324 (328)
T ss_pred             ccCCHHHHHHH
Confidence            87777777654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.1e-46  Score=345.92  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=210.8

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||++.++.+++.||+|++.+... .......+..|..++..++|++|+++++.+.....     +
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~-----~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN-----L   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe-----E
Confidence            34588999999999999999999999999999975421 22234567789999999999999999999988754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      |+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999998 5999999888899999999999999999999999999999999999999999999999999986532210 


Q ss_pred             -----------------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 017083          200 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (377)
Q Consensus       200 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p  244 (377)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123578999999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCC---CCCCH
Q 017083          245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN---KRITV  321 (377)
Q Consensus       245 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rps~  321 (377)
                      |...........+.......                           ..+....+++++.+||.+|+. +|.   .||++
T Consensus       236 f~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~  287 (363)
T cd05628         236 FCSETPQETYKKVMNWKETL---------------------------IFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV  287 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcc---------------------------cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence            98877665555443311100                           001112468899999999775 444   46899


Q ss_pred             HHHhcCccccCCc
Q 017083          322 EEALRHPYLQSLH  334 (377)
Q Consensus       322 ~ell~~p~f~~~~  334 (377)
                      +|+++||||+.+.
T Consensus       288 ~ei~~hp~f~~~~  300 (363)
T cd05628         288 EEIKTNPFFEGVD  300 (363)
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-46  Score=340.26  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=208.9

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||+|+||+||+++++.+++.||+|++.... ........+..|+.++++++||||+++++++.....     ++++|||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK-----LYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe-----EEEEEcCC
Confidence            799999999999999999999999986532 223345667789999999999999999999987654     89999999


Q ss_pred             C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Ccccccccc
Q 017083          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVV  206 (377)
Q Consensus       129 ~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~~~~  206 (377)
                      + ++|.+.+...+++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ........|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            8 59999998888899999999999999999999999999999999999999999999999999875332 223345678


Q ss_pred             ccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccc
Q 017083          207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR  286 (377)
Q Consensus       207 ~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (377)
                      ++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..   .+                      
T Consensus       156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~---~~----------------------  209 (312)
T cd05585         156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ---EP----------------------  209 (312)
T ss_pred             CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc---CC----------------------
Confidence            999999999987 7789999999999999999999999987665544433321   10                      


Q ss_pred             cccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCc
Q 017083          287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  334 (377)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~ell~~p~f~~~~  334 (377)
                            ......+++.+.+||.+||+.||++||   ++.++++||||....
T Consensus       210 ------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         210 ------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                  011135688999999999999999997   689999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-46  Score=343.34  Aligned_cols=260  Identities=25%  Similarity=0.451  Sum_probs=217.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||.||++++..+++.||+|++.+... .......+..|+.+++.++||||+++++++.....     +|
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-----~~   77 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-----LY   77 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE-----EE
Confidence            4488999999999999999999999999999975432 22234567789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++|||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....  ..
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence            9999997 59999998888899999999999999999999999999999999999999999999999999876543  24


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........+              
T Consensus       156 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------  220 (333)
T cd05600         156 NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP--------------  220 (333)
T ss_pred             CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC--------------
Confidence            45678999999999987 688999999999999999999999998877666555444321111000              


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                               ........++.++.+||.+||..+|.+||++.++++||||....
T Consensus       221 ---------~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         221 ---------VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             ---------CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence                     00001135688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-47  Score=321.84  Aligned_cols=276  Identities=26%  Similarity=0.449  Sum_probs=230.2

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPP  113 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  113 (377)
                      ..+.|.++|..-.++||-|-.|.|-.|.++.+++++|+|++.-       ....++|++..-... |||||.++++|+..
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            5677888999888999999999999999999999999999853       245667888777665 99999999999764


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEe
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIG  187 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~  187 (377)
                      -. +-..+.+|||.++ |.|.+.+..++.  |++.++..|+.||..|+.|||+.+|.||||||+|+|++.++   .+||+
T Consensus       128 ~~-~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  128 YQ-GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             cc-CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence            32 2244789999998 599999987654  99999999999999999999999999999999999997654   48999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||+++....+....+.+.|++|.|||++.. ..++...|+||||+++|-||+|+.||........-..+..-       
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r-------  278 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR-------  278 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH-------
Confidence            9999999888888899999999999999866 78999999999999999999999999876533222222111       


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC  342 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~  342 (377)
                                      +....-.+..+.|..+|..++++|+++|..+|++|.|+.++++|||+.+.....+.+.+
T Consensus       279 ----------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  279 ----------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             ----------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence                            11122233455677889999999999999999999999999999999988776655543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-45  Score=339.27  Aligned_cols=285  Identities=20%  Similarity=0.326  Sum_probs=218.8

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +..+.|++++.||+|+||.||+++++.++..+|+|.+.... .......+.+|++++++++||||+++++++.....   
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE---   77 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE---
Confidence            45566779999999999999999999999999999997542 23345678899999999999999999999987754   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                        ++++|||+++ +|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++....
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          78 --ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             --EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence              8999999985 9999998888899999999999999999999986 69999999999999999999999999987654


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc------
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG------  270 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------  270 (377)
                      .. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.............      
T Consensus       156 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cc-ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            33 2344578999999999987 678999999999999999999999998776544333222111000000000      


Q ss_pred             ---------c----ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          271 ---------F----LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       271 ---------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                               .    ...................  ......+++++.+||.+||+.||++|||+.++++||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                     0    0000000111111000000  00112468899999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-45  Score=331.26  Aligned_cols=280  Identities=37%  Similarity=0.688  Sum_probs=222.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||.|++|+||+++++.++..||+|.+............+.+|+.++++++||||+++++++..+..     +++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~~   76 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR-----LYL   76 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-----EEE
Confidence            347889999999999999999999999999987544333344667789999999999999999999987654     899


Q ss_pred             EEecCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||++++|.+.+...   ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          77 IFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            9999999998887642   568999999999999999999999999999999999999999999999999987554332 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+...++.++|+||||+++++|++|..||...........+....+.+.+..+...  .....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  234 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLPD  234 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc--hhhHH
Confidence            2233456888999999876456788999999999999999999999987776666666555554433322111  11111


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      +..................+++++.++|++||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            222222222222333345689999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-45  Score=345.91  Aligned_cols=258  Identities=25%  Similarity=0.383  Sum_probs=210.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||+++++.+++.||+|++.... ........+..|+.+++.++||||+++++++.....     ++
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-----~~   77 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN-----LY   77 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE-----EE
Confidence            458899999999999999999999999999997542 233345677889999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---  198 (377)
                      +||||++ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......   
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999997 599999988888999999999999999999999999999999999999999999999999987532100   


Q ss_pred             ---------------------------------------------ccccccccccccCCCccccccCCCCCcchHHHHHH
Q 017083          199 ---------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC  233 (377)
Q Consensus       199 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  233 (377)
                                                                   .......||+.|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence                                                         00123468999999999977 67899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcC-
Q 017083          234 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV-  312 (377)
Q Consensus       234 ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-  312 (377)
                      ++|+|++|..||...........+......                           ...+....+++++.+||.+|+. 
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~dli~~ll~~  289 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------------LHIPPQVKLSPEAVDLITKLCCS  289 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------------cCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999999877654443333211000                           0011123568999999999664 


Q ss_pred             -CCCCCCCCHHHHhcCccccCCc
Q 017083          313 -FDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       313 -~dp~~Rps~~ell~~p~f~~~~  334 (377)
                       .+|..|+++.++++||||+.+.
T Consensus       290 ~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         290 AEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             cccccCCCCHHHHhcCcccCCCC
Confidence             4555699999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-46  Score=346.48  Aligned_cols=257  Identities=25%  Similarity=0.419  Sum_probs=212.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++++..+++.||||++.... ........+.+|+.+++.++||||+++++++..+..     ++
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-----~~   77 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY-----LY   77 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe-----EE
Confidence            458899999999999999999999999999997532 122344567789999999999999999999998755     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......  
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999997 5899999888889999999999999999999999999999999999999999999999999986432211  


Q ss_pred             -------------------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 017083          200 -------------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  242 (377)
Q Consensus       200 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~  242 (377)
                                                           ......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence                                                 0112468999999999877 77899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC--
Q 017083          243 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT--  320 (377)
Q Consensus       243 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps--  320 (377)
                      .||...........+......                           ...+....+++.+.+||++||. +|.+|++  
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~  288 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKET---------------------------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNN  288 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCc---------------------------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence            999887765544443321000                           0011112468899999999997 9999997  


Q ss_pred             -HHHHhcCccccCCc
Q 017083          321 -VEEALRHPYLQSLH  334 (377)
Q Consensus       321 -~~ell~~p~f~~~~  334 (377)
                       +.++++||||....
T Consensus       289 ~~~~ll~h~~~~~~~  303 (364)
T cd05599         289 GVNEIKSHPFFKGVD  303 (364)
T ss_pred             CHHHHhcCCCcCCCC
Confidence             99999999998653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-48  Score=340.80  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=218.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |..++.||+|+||.||++.+..+++.||+|++..+... ...+.+.+|+.++.+++++||.++|+.|..+..     +++
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi   88 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI   88 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence            33679999999999999999999999999999765433 356788899999999999999999999999866     999


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      +||||. |++.+.++.++.+++..+..++.+++.|+.|||..+.+|+|||+.||++..+|.+||+|||.+....... ..
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            999998 5999999988888999999999999999999999999999999999999999999999999987765543 34


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      .++.||+.|||||++.+ ..|+.++||||||++.+||++|.+|+........+..|-                       
T Consensus       169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-----------------------  224 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-----------------------  224 (467)
T ss_pred             ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-----------------------
Confidence            78999999999999986 889999999999999999999999998765422211111                       


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                             +...+......++.+++|+..||+.||+.||+|.++|+|+|++...
T Consensus       225 -------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  225 -------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             -------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                   0111111125688999999999999999999999999999998744

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-46  Score=346.35  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=215.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||+||++.+..+++.||+|++.+.... ......+..|+.++..++||||+++++++..+..     ++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~   77 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH-----LY   77 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe-----EE
Confidence            44889999999999999999999999999999754222 2344567789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +||||++ ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......  
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999997 5999999888889999999999999999999999999999999999999999999999999987654332  


Q ss_pred             ----------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 017083          200 ----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (377)
Q Consensus       200 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~  251 (377)
                                                  ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                        2334568999999999988 68899999999999999999999999887755


Q ss_pred             HHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCccc
Q 017083          252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYL  330 (377)
Q Consensus       252 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~ell~~p~f  330 (377)
                      .....+.......                           ..+....+++.+.+||.+||. ||.+||+ +.++++||||
T Consensus       237 ~~~~~i~~~~~~~---------------------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         237 ETYNKIINWKESL---------------------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             HHHHHHhccCCcc---------------------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            5544443311100                           111122368999999999998 9999999 9999999999


Q ss_pred             cCCc
Q 017083          331 QSLH  334 (377)
Q Consensus       331 ~~~~  334 (377)
                      +.+.
T Consensus       289 ~~~~  292 (350)
T cd05573         289 KGID  292 (350)
T ss_pred             CCCC
Confidence            8754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-45  Score=338.89  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=209.3

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.+++.||+|++.+.. ........+..|..++..+ +||||+++++++.....     +|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-----~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-----LFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE-----EEEEE
Confidence            46999999999999999999999999987542 1223445667788888876 59999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9998 58988888888999999999999999999999999999999999999999999999999999875322 223445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   ..                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~~------------------  213 (320)
T cd05590         156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND---EV------------------  213 (320)
T ss_pred             cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---CC------------------
Confidence            678999999999977 77899999999999999999999999887765555444321   00                  


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~ell~~p~f~~~~  334 (377)
                                .....++.++.+||++||+.||++||++      +++++||||+.+.
T Consensus       214 ----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         214 ----------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence                      0112468889999999999999999998      9999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-44  Score=334.45  Aligned_cols=332  Identities=50%  Similarity=0.903  Sum_probs=255.1

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+.++|- +++.||+|+||.||++.+..++..||+|++............+.+|+.++++++||||+++++++.....
T Consensus        12 ~~~~~~~y~-~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          12 IWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HhhccCceE-EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            466666666 8899999999999999999999999999997654344445667789999999999999999998865432


Q ss_pred             -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 -DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 -~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                       ......++++++++++|.+.+.. ..+++..++.++.||++||+|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          91 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             ccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence             12234789999998899887754 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ....  .....++..|+|||.+.+...++.++|||||||++|+|++|..||...........+......+++........
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            4332  33456788899999987655678899999999999999999999988887777777777766666555444444


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCCCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS  354 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~~~  354 (377)
                      .....+...................++.+.++|.+||+.||.+||++.++++||||++.......+... .+........
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~-~~~~~~~~~~  326 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRD  326 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC-CccCcchhcc
Confidence            333334333333222222233335688899999999999999999999999999999888766555433 3333333334


Q ss_pred             CChHHHHHHHHHHHhhcC
Q 017083          355 CTEDHIRELIWRESVKFN  372 (377)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~  372 (377)
                      ...++.....-+|..+|-
T Consensus       327 ~~~~~~~~~~~~~~~~~~  344 (345)
T cd07877         327 LLIDEWKSLTYDEVISFV  344 (345)
T ss_pred             cCHHHHHHHHHHHHHhcC
Confidence            455666665555555553

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-46  Score=338.24  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=230.7

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|+.++++|+|+||.+++++++.+++.|++|++..........+...+|+.++.+++|||||.+.+.|..++.-    ++
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~----l~   80 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL----LC   80 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCce----EE
Confidence            34589999999999999999999999999999988776777777888999999999999999999999988542    89


Q ss_pred             EEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          123 IVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      |+|+||+| ++.+.+...  .-++++.+..|+.|++.|+.|||+++|.|||||+.|||++.++.|+|+|||+++......
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999985 888888753  468999999999999999999999999999999999999999999999999999998886


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......||+.|++||.+.+ .+|+.++|||||||++|||++-+.+|...+.......|......|.+            
T Consensus       161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------  227 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------  227 (426)
T ss_pred             hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence             7888999999999999988 99999999999999999999999999999988887777765533322            


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                        ...+.++..+|+.||+.+|..||++.++|.+|..+..
T Consensus       228 ------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  228 ------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                              3568899999999999999999999999999988743

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-45  Score=339.80  Aligned_cols=258  Identities=23%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.+++.||+|++++... .......+..|..+++++ +||||+++++++.....     +|++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~-----~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-----LFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-----EEEEE
Confidence            468999999999999999999999999976432 223445677899999988 69999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~~~  203 (377)
                      ||++ ++|...+...+++++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9998 5898888888899999999999999999999999999999999999999999999999999987432 2233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH-H
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV-R  282 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~  282 (377)
                      ..|++.|+|||++.+ ..++.++|+|||||++|+|++|..||........             .      ........ .
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-------------~------~~~~~~~~~~  215 (329)
T cd05588         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN-------------P------DQNTEDYLFQ  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccc-------------c------cccchHHHHH
Confidence            678999999999987 7789999999999999999999999964221000             0      00000000 0


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSLH  334 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~ell~~p~f~~~~  334 (377)
                      .... .   .......++..+.++|++||+.||.+|++      +.++++||||.++.
T Consensus       216 ~~~~-~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         216 VILE-K---QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             HHHc-C---CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            0000 0   00112356888999999999999999987      78999999998653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-45  Score=339.64  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=209.3

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +.||+|+||+||++.++.+|+.||+|++.+... .......+..|+.+++.++||||+++++++.....     +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~-----~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-----LCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE-----EEEEEe
Confidence            358999999999999999999999999976432 22344566789999999999999999999987754     899999


Q ss_pred             cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccC-CCccccc
Q 017083          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  203 (377)
Q Consensus       127 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~~~  203 (377)
                      |++ ++|...+...+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++.... .......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            998 5888888888889999999999999999999997 799999999999999999999999999987532 2223345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------------------  212 (325)
T cd05594         156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------------------  212 (325)
T ss_pred             ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC----------------------
Confidence            678999999999977 778999999999999999999999998776554443332100                      


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                               ......+++++.+||++||+.||++|+     ++.++++||||.+..
T Consensus       213 ---------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         213 ---------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence                     001124688999999999999999997     999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-45  Score=344.63  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=210.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||+++++.+++.||+|++.+.. ........+.+|+.++++++||||+++++.+..+..     ++
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~-----~~   77 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-----LY   77 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-----EE
Confidence            458999999999999999999999999999997532 123345567789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---  198 (377)
                      +||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999998 589999988888999999999999999999999999999999999999999999999999987422100   


Q ss_pred             ---------------------------------------------ccccccccccccCCCccccccCCCCCcchHHHHHH
Q 017083          199 ---------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC  233 (377)
Q Consensus       199 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  233 (377)
                                                                   .......||+.|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence                                                         00123468999999999987 77899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCC
Q 017083          234 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF  313 (377)
Q Consensus       234 ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  313 (377)
                      ++|+|++|..||...........+......                           ...+....+++++.++|.+|+ .
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~s~~~~~li~~l~-~  288 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------------------LHIPPQAKLSPEASDLIIKLC-R  288 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------------------cCCCCcccCCHHHHHHHHHHc-c
Confidence            999999999999887655444333221100                           011122357899999999987 5


Q ss_pred             CCCCCCC---HHHHhcCccccCCc
Q 017083          314 DPNKRIT---VEEALRHPYLQSLH  334 (377)
Q Consensus       314 dp~~Rps---~~ell~~p~f~~~~  334 (377)
                      +|.+|++   +.++++||||+.+.
T Consensus       289 ~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         289 GPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             CHhHcCCCCCHHHHhcCCCcCCcC
Confidence            9999997   99999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-45  Score=344.31  Aligned_cols=257  Identities=22%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||+||++.++.+++.||+|++.+.. ........+.+|+.++++++||||+++++++.....     +|
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-----~~   77 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY-----LY   77 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe-----eE
Confidence            448899999999999999999999999999986532 123344567789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +||||++ |+|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999997 5999999888889999999999999999999999999999999999999999999999999985321100  


Q ss_pred             ----------------------------------------------cccccccccccCCCccccccCCCCCcchHHHHHH
Q 017083          200 ----------------------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC  233 (377)
Q Consensus       200 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  233 (377)
                                                                    ......||+.|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence                                                          0012468999999999977 77899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCC
Q 017083          234 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF  313 (377)
Q Consensus       234 ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  313 (377)
                      ++|+|++|..||...........+......                           ...+....++.++.+||.+||. 
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~s~~~~dli~~lL~-  288 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRET---------------------------LYFPDDIHLSVEAEDLIRRLIT-  288 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------------------cCCCCCCCCCHHHHHHHHHHhc-
Confidence            999999999999887655544443321000                           0001122468899999999998 


Q ss_pred             CCCCC---CCHHHHhcCccccCCc
Q 017083          314 DPNKR---ITVEEALRHPYLQSLH  334 (377)
Q Consensus       314 dp~~R---ps~~ell~~p~f~~~~  334 (377)
                      +|.+|   +++.++++||||+...
T Consensus       289 ~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         289 NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            77665   5999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-45  Score=331.02  Aligned_cols=278  Identities=38%  Similarity=0.672  Sum_probs=216.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++++.||+|++|.||+++++.+|+.||+|.+............+.+|+.++++++||||+++++++.....     ++++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-----~~lv   77 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK-----LTLV   77 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc-----eEEE
Confidence            47889999999999999999999999999987543333334566789999999999999999999987754     8999


Q ss_pred             EecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cccc
Q 017083          125 YELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMT  202 (377)
Q Consensus       125 ~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~~  202 (377)
                      +||++++|.+.+.. .+.+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            99999999988765 567999999999999999999999999999999999999999999999999998765433 2223


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ...++..|+|||.+.+...++.++|||||||++|+|++|..|+ ...+....+..+.+..+.+.............  . 
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-  234 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD--Y-  234 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc--c-
Confidence            3456888999999877556789999999999999999988874 55555666666666555443322110000000  0 


Q ss_pred             Hhcccc-ccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRC-RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...... .........+.+++++.+||.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000000 0000112234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=330.53  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=232.8

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +-+.||+|-|++|-+++|..+|.+||||++.++..+......+.+|++.|+.++|||||++|++.-....     +|+|.
T Consensus        22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK-----lyLiL   96 (864)
T KOG4717|consen   22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK-----LYLIL   96 (864)
T ss_pred             hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce-----EEEEE
Confidence            7788999999999999999999999999999887777777888999999999999999999999877655     99999


Q ss_pred             ecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE-ccCCCeEEeeeecccccCCCcccc
Q 017083          126 ELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-NASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       126 e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli-~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      |.-+ |+|.++|.. ...+.++.++.++.||+.||.|+|+..+|||||||+||++ ..-|-|||.|||++..........
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            9998 599998764 6689999999999999999999999999999999999866 557889999999999998888899


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ..+|++.|.|||.+.+.....+++||||||+++|-|.+|+.||...++-+.+..|+......|                 
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-----------------  239 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-----------------  239 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-----------------
Confidence            999999999999999977778999999999999999999999999888888887776433222                 


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE  339 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~  339 (377)
                                    ..++.++.+||..||..||++|.+.+|+.+++|+|.+.+...-
T Consensus       240 --------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  240 --------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             --------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence                          3568999999999999999999999999999999988765543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-45  Score=335.52  Aligned_cols=250  Identities=26%  Similarity=0.464  Sum_probs=207.9

Q ss_pred             cccccCCccceEEEEEeC---CCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           47 IRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ++.||+|+||.||++++.   .+++.||+|++.+...  .......+..|+.+++.++||||+++++++..+..     +
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-----~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK-----L   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe-----E
Confidence            467999999999999863   5788999999875321  22233456789999999999999999999988754     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      |++|||+++ +|.+.+...+.+.+..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999985 89999988888999999999999999999999999999999999999999999999999998743322 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...   .               
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~---~---------------  216 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---K---------------  216 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C---------------
Confidence            2344578999999999977 67889999999999999999999999887655444333221   0               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~  333 (377)
                                   ....+.+++.+.+||++||+.||++||     ++.++++||||...
T Consensus       217 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         217 -------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                         011235688899999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-45  Score=344.89  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||+++++.+++.||+|++.+... .......+.+|+.+++.++||||+++++.+..+..     ++
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-----~~   77 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-----LY   77 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE-----EE
Confidence            4589999999999999999999999999999865321 12234556789999999999999999999988754     99


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---  198 (377)
                      ++|||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......   
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999997 599999988888999999999999999999999999999999999999999999999999987422100   


Q ss_pred             -----------------------------------------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHH
Q 017083          199 -----------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  237 (377)
Q Consensus       199 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~e  237 (377)
                                                               .......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye  236 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence                                                     00113468999999999977 778999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC
Q 017083          238 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  317 (377)
Q Consensus       238 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  317 (377)
                      |++|..||...........+.....                           ....+....+++.+.++|.+|+ .+|.+
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~l~-~~p~~  288 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWET---------------------------TLHIPSQAKLSREASDLILRLC-CGAED  288 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCc---------------------------cccCCCCCCCCHHHHHHHHHHh-cCHhh
Confidence            9999999988765544333321100                           0001112357889999999977 59999


Q ss_pred             CC---CHHHHhcCccccCCc
Q 017083          318 RI---TVEEALRHPYLQSLH  334 (377)
Q Consensus       318 Rp---s~~ell~~p~f~~~~  334 (377)
                      |+   ++.++++||||+.+.
T Consensus       289 R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         289 RLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cCCCCCHHHHhCCCCcCCCC
Confidence            99   999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-45  Score=335.11  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=208.9

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||+++++.+++.||+|++.+... .......+..|..++..+ +||||+++++++.....     +|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~-----~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-----LFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe-----EEEEE
Confidence            469999999999999999999999999975421 223445566788888866 69999999999988754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9998 58988888888899999999999999999999999999999999999999999999999999875332 222345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....                     
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------------------  213 (321)
T cd05591         156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------------------  213 (321)
T ss_pred             cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            568999999999877 7789999999999999999999999988776665544432100                     


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-------CHHHHhcCccccCC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-------TVEEALRHPYLQSL  333 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-------s~~ell~~p~f~~~  333 (377)
                                .....++.++.++|.+||+.||++||       ++.++++||||..+
T Consensus       214 ----------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         214 ----------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                      00123588899999999999999999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=326.46  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=210.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+..+..     ++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-----LC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-----EE
Confidence            34788999999999999999999999999998654222 2223456789999999999999999999987644     89


Q ss_pred             EEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          123 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++|||++ ++|.+.+..  ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999998 588877754  3468999999999999999999999999999999999999999999999999988655443


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||...........+...+....              
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  221 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------------  221 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence            3445578899999999977 6788999999999999999999999987654433333322111110              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~  333 (377)
                                   ......++..+.+||.+||+.||++||     ++.++++||||...
T Consensus       222 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         222 -------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             -------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence                         011234688899999999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-44  Score=331.19  Aligned_cols=277  Identities=36%  Similarity=0.617  Sum_probs=205.8

Q ss_pred             cccccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ..+||+|+||+||+|+++  .+++.||+|.+.....    ...+.+|+.++++++||||+++++++.....   ..++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEE
Confidence            568999999999999975  3678899999865422    2346689999999999999999999865433   348999


Q ss_pred             EecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE----ccCCCeEEeeeec
Q 017083          125 YELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  191 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli----~~~~~vkl~Dfg~  191 (377)
                      +||++++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999998887532         258899999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 017083          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------VHQLRLIT  258 (377)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~---------~~~~~~i~  258 (377)
                      +.......    ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.....         ...+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654321    233457789999999998756689999999999999999999999975442         24455555


Q ss_pred             HHhCCCCccccccccc-hhHHHHHHhcccccc------ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          259 ELIGSPDDASLGFLRS-DNARRYVRQLPRCRK------QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...+.+....+..... ...............      ..........+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            5555544432221110 000000000000000      00001112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=335.86  Aligned_cols=252  Identities=26%  Similarity=0.431  Sum_probs=218.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      -+.|++..+.+..++.||+|.||.||.+..+.+ ..||+|.++..   ....+.+.+|+++|++|+|++||++++++..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            567999999999999999999999999988554 57999999753   23346778999999999999999999999987


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ..     +||||||+. |+|.++++.  +..+...+...++.||++|++||+++++|||||...||||++++.+||+|||
T Consensus       274 ~p-----iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  274 EP-----IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             Cc-----eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence            65     899999998 899999986  5678999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +++........  ...-....|+|||++.. +.++.++|||||||+|+||++ |+.||......+.+..+.+-...+   
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp---  424 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP---  424 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---
Confidence            99965544322  22333677999999987 889999999999999999998 899999998888777776533222   


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                                                 ....+|+.+.+++..||..+|++|||+..+.
T Consensus       425 ---------------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  425 ---------------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                                       2346799999999999999999999999765

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-44  Score=325.83  Aligned_cols=280  Identities=40%  Similarity=0.705  Sum_probs=222.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|++|+||+++++.++..||||.+............+.+|++++++++||||+++++++.....     .++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~~   76 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-----LYL   76 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc-----EEE
Confidence            457889999999999999999999999999987544333344577889999999999999999999987654     899


Q ss_pred             EEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-c
Q 017083          124 VYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (377)
Q Consensus       124 v~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~  200 (377)
                      +|||+.++|.+.+..  ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          77 VFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             EeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            999999899888865  4568999999999999999999999999999999999999999999999999987554332 2


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.+.......  .......
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  234 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--VTSLPDY  234 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh--hhHHHHH
Confidence            23345678899999987745568899999999999999999999998887777666666555544322110  1111111


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .........+......+.+++.+.++|.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            22222222333333345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-45  Score=338.33  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=210.1

Q ss_pred             cccccCCccceEEEEEe---CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           47 IRPIGRGAYGIVCAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~---~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++.||+|+||+||++.+   +.+|+.||+|++............+..|+.++++++||||+++++++..+..     +|+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-----LYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE-----EEE
Confidence            36799999999999976   4578999999997653333344556789999999999999999999987754     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      ||||++ ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999997 599999988888999999999999999999999999999999999999999999999999998765433 233


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....                   
T Consensus       156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-------------------  215 (318)
T cd05582         156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-------------------  215 (318)
T ss_pred             ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            45678999999999977 6778999999999999999999999988765554443322100                   


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                  .....+++.+.+||++||+.||++||+     ..++++||||+.+.
T Consensus       216 ------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         216 ------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence                        111246888999999999999999999     77899999998753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-44  Score=333.15  Aligned_cols=301  Identities=49%  Similarity=0.897  Sum_probs=238.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|.+.+.||+|+||.||++.+..++..+|+|.+............+.+|+.+++++ +||||+++++++.....   ..+
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~   84 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDI   84 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceE
Confidence            34488999999999999999999999999998865444444556677899999999 99999999999875432   337


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      ++++||++++|.+.+..+ .+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          85 YLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999999999999988765 78899999999999999999999999999999999999999999999999987543321  


Q ss_pred             ----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          200 ----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       200 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                          ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...........+....+.+...........
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                2234567889999999876567889999999999999999999999988877777777776655544333322222


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  347 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~  347 (377)
                      .....+...............+.++.++.++|.+||+.||++|||+.++++||||+.......+...+.++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~  315 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPIT  315 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCcc
Confidence            222333333333333344445568999999999999999999999999999999998866554444444433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.6e-45  Score=334.30  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=211.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCC-CCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      |++++.||+|+||.||++.++.+++.||+|++.+... .......+..|..++..++| ++|+++++++.....     +
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----~   76 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-----L   76 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE-----E
Confidence            4588999999999999999999999999999975422 22345567789999999976 468889999887654     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~  199 (377)
                      |+||||++ ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ..
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999997 59999998888899999999999999999999999999999999999999999999999999864322 22


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....                  
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------------  217 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------------  217 (324)
T ss_pred             ceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            3345678999999999987 778999999999999999999999998877655554443211                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~ell~~p~f~~~~  334 (377)
                                   ......++..+.+++++||..||.+|++.     .++++||||..+.
T Consensus       218 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         218 -------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                         01112468889999999999999999976     8999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.7e-45  Score=335.12  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=206.1

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHH-HHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||+++++.+|+.||+|++..... .......+..|.. +++.++||||+++++.+.....     ++++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~-----~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK-----LYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-----EEEEE
Confidence            369999999999999999999999999965421 1222334444444 5678999999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9998 48999988888999999999999999999999999999999999999999999999999999875322 233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...   .                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------------  212 (323)
T cd05575         156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-------------------  212 (323)
T ss_pred             ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------------
Confidence            678999999999987 77899999999999999999999999887655544433220   0                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f~~~~  334 (377)
                               ....+.++..+.++|++||+.||.+||++    .++++||||....
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         213 ---------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                     11224568899999999999999999987    6999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.4e-45  Score=336.72  Aligned_cols=258  Identities=22%  Similarity=0.412  Sum_probs=204.4

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.+++.||+|++.+... .......+..|..++.++ +||||+++++++.....     +++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-----~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-----LFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE-----EEEEE
Confidence            469999999999999999999999999976532 233445667888888877 79999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998 58888888888999999999999999999999999999999999999999999999999999875322 223345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH-HH
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY-VR  282 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~  282 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.........                   ....... ..
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------------------~~~~~~~~~~  215 (329)
T cd05618         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------------------DQNTEDYLFQ  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-------------------ccccHHHHHH
Confidence            678999999999987 77899999999999999999999999532100000                   0000000 00


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSLH  334 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~ell~~p~f~~~~  334 (377)
                      ....    ........++..+.+||++||+.||++||+      +.++++||||+++.
T Consensus       216 ~i~~----~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         216 VILE----KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             HHhc----CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            0000    001112356888999999999999999998      58999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.2e-45  Score=334.50  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHH---HhcCCCCceeEeeeecCCCCCCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLL---RHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ++++.||+|+||+||++.++.+++.||+|++.+.. ........+..|..++   +.++||||+++++++.....     
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~-----   76 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH-----   76 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE-----
Confidence            47889999999999999999999999999997542 1222334555565554   56679999999999987754     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-C
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~  198 (377)
                      +|+||||+++ +|...+. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus        77 ~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            8999999985 7776664 46799999999999999999999999999999999999999999999999999865322 2


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....                
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------  218 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------  218 (324)
T ss_pred             CcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            23345678999999999987 7789999999999999999999999988776555444332100                


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                     .....+++.+.++|++||+.||++||     ++.++++||||..+.
T Consensus       219 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         219 ---------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                           01124688899999999999999999     799999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-44  Score=333.02  Aligned_cols=286  Identities=20%  Similarity=0.320  Sum_probs=217.0

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +..+.|++.++||.|+||+||++.+..++..+|+|.+.... .......+.+|++++++++||||+++++++..+..   
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE---   77 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE---
Confidence            45566779999999999999999999999999999887542 33345678899999999999999999999988754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                        ++++|||+. ++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          78 --ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             --EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence              899999997 59999998888899999999999999999999975 79999999999999999999999999987543


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-ccccc--ccc
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD-DASLG--FLR  273 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~--~~~  273 (377)
                      .. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+........ .....  ...
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         156 DS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             hh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            32 2234567889999999977 6788999999999999999999999987654433222211111000 00000  000


Q ss_pred             --------------chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 --------------SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    ...................  ....++.++.+||.+||+.||++|||+.|++.||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                          0000001111100000000  0113578899999999999999999999999999998543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.9e-45  Score=332.85  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||.||+++++.+|+.||+|.++.... ..........|..++..+ +||+|+++++++.....     +|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH-----LFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE-----EEEEE
Confidence            469999999999999999999999999975421 112344556677777754 79999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||+. ++|...+.....+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9998 58999988888899999999999999999999999999999999999999999999999999864322 223345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....   +                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---~------------------  213 (316)
T cd05620         156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---P------------------  213 (316)
T ss_pred             cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---C------------------
Confidence            678999999999987 778999999999999999999999998876555444332210   0                  


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-~ell~~p~f~~~~  334 (377)
                                .....++.++.+||++||+.||++||++ +++++||||..+.
T Consensus       214 ----------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         214 ----------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                      0012358889999999999999999997 5888999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-44  Score=335.11  Aligned_cols=276  Identities=25%  Similarity=0.333  Sum_probs=208.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||.||++.+..++..||+|+....        ....|+.++++++||||+++++++.....     .+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~  133 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-----TC  133 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCe-----eE
Confidence            456899999999999999999999999999986432        23468999999999999999999987754     89


Q ss_pred             EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +++|++.++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus       134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999999999998865 567899999999999999999999999999999999999999999999999999765444344


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCh---------HHHHHHHHHHhCCCCcccccc
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDY---------VHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf-~~~~~---------~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ....|+..|+|||++.+ ..++.++|||||||++|+|+++..++ .....         ...+..+....+..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            45678999999999987 67899999999999999999865544 33211         112222222222222211111


Q ss_pred             ccchhHHHHHHhccccccccc----cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          272 LRSDNARRYVRQLPRCRKQQF----ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      ........+..... ......    ......++..+.+||.+||+.||++|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYAS-LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcc-cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            11111111111111 111100    01122567888999999999999999999999999999864

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.1e-45  Score=333.60  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=208.7

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.++..||+|++.+... .......+..|..+++.+ +||||+++++++.....     ++++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~-----~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR-----LFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-----EEEEE
Confidence            469999999999999999999999999975421 223345667788888888 69999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9998 58988888888999999999999999999999999999999999999999999999999999865322 222344


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...   .                   
T Consensus       156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~---~-------------------  212 (318)
T cd05570         156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED---E-------------------  212 (318)
T ss_pred             eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---C-------------------
Confidence            568999999999987 77899999999999999999999999877655544333220   0                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~ell~~p~f~~~~  334 (377)
                               ......++..+.+||++||+.||++|||+     .++++||||....
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         213 ---------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                     00112468889999999999999999999     9999999998753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.6e-45  Score=335.56  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             cCCcccccCCccceEEEEEeC---CCCcEEEEEeccccc--cCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      |++++.||+|+||+||++++.   .+++.||+|++.+..  ........+..|+.+++.++ ||+|+++++++.....  
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~--   79 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK--   79 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE--
Confidence            447899999999999999874   478899999986532  12233456778999999995 9999999999987754  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         ++++|||++ ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus        80 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          80 ---LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             ---EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence               899999998 5999999888889999999999999999999999999999999999999999999999999987543


Q ss_pred             CC--ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          197 ET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       197 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ..  .......|++.|+|||++.+...++.++|||||||++|+|++|..||...........+.....            
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------  224 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL------------  224 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh------------
Confidence            32  2233457899999999998745578899999999999999999999965332111111111000            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                 ..    .......+++.+.++|.+||+.||++||     +++++++||||+...
T Consensus       225 -----------~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         225 -----------KC----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             -----------cC----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                       00    0111235688999999999999999999     889999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-45  Score=326.82  Aligned_cols=257  Identities=33%  Similarity=0.560  Sum_probs=214.5

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++++.||+|+||+||++.+..++..||+|.+...............|+.+++.++||||+++++++.....     ++++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----~~~v   76 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY-----LYIV   76 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE-----EEEE
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc-----cccc
Confidence            47889999999999999999999999999998765444444455669999999999999999999988644     8999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc-CCCcccc
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT  202 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~-~~~~~~~  202 (377)
                      ||++++ +|.+++.....+++..+..++.||++||++||++|++|+||||+||+++.++.++|+|||.+... .......
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999997 99999987888999999999999999999999999999999999999999999999999998763 3334455


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...++..|+|||++......+.++||||||+++++|++|..||...........+............             
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------  223 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------------  223 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------------
Confidence            6777999999999883378899999999999999999999999987545555444443221111100             


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                 ......+..+.++|++||+.||++|||+.++++||||
T Consensus       224 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 -----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                       0001123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-44  Score=329.06  Aligned_cols=289  Identities=39%  Similarity=0.658  Sum_probs=224.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++++.||.|+||.||++.++.+|+.||+|.+..............+|+.++++++|+|++++++++.....   ..+
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~   83 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---DSI   83 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---CeE
Confidence            34558999999999999999999999999999986543332223345679999999999999999999876533   337


Q ss_pred             EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++++||++++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99999999999888875 4678999999999999999999999999999999999999999999999999998655432 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+...++.++||||||+++|+|++|..||........+..+....+.+....+..........
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            22233457789999998765668899999999999999999999999988888888888776655443321110000000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .. .................++.+.++|.+||+.||++|||+.+++.||||+...
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         244 KF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            00 0000000011112234688899999999999999999999999999998554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-45  Score=339.25  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=214.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+..+.|++++.||+|+||+||+++++.++..||+|.+.+.. ........+.+|+.+++.++||||+++++++..+..
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3445556668999999999999999999999999999996532 122234456789999999999999999999987754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       118 -----~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         118 -----LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             -----EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence                 899999997 588887754 5689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc--cccccccccccCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          195 TSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       195 ~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .....  ......|++.|+|||++.+.   ..++.++|||||||++|+|++|..||...........+......      
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------  265 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS------  265 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc------
Confidence            54332  22345789999999998652   24788999999999999999999999887755444444321000      


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  333 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~  333 (377)
                                           ...+....++..+.+||++||+.+|.+  |+|++++++||||++.
T Consensus       266 ---------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         266 ---------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             ---------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                                 001112356899999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.4e-45  Score=337.20  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=212.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||+|+||+||++.++.+++.||+|+++.... .......+.+|+.+++.++|+||+++++++.....     ++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~-----~~   77 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN-----LY   77 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe-----EE
Confidence            4488999999999999999999999999999976432 22244567789999999999999999999987654     89


Q ss_pred             EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +||||++ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999997 5999988765 689999999999999999999999999999999999999999999999999997654332 


Q ss_pred             -cccccccccccCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          200 -FMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                       ......+++.|+|||++..     ...++.++|||||||++|+|++|..||...........+......          
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------  227 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF----------  227 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc----------
Confidence             2233467999999999863     255788999999999999999999999887665554444321100          


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                       ...+..+.++..+.+||++||+ +|.+|||+.++++||||+.+.
T Consensus       228 -----------------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         228 -----------------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             -----------------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence                             0011123568899999999998 999999999999999998754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-44  Score=333.65  Aligned_cols=258  Identities=28%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ..++.+++||+|+||+||++++..+++.||||++.... .......+.+|+.+++.++|+||+++++++.....     +
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-----I  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe-----E
Confidence            45568899999999999999999999999999986542 23345678899999999999999999999987754     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      +++|||+.+ +|.+    .....+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus       148 ~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        148 QVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999999985 6543    234567888899999999999999999999999999999999999999999998765432 2


Q ss_pred             cccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          200 FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ......|+..|+|||.+...    ...+.++|||||||++|+|++|..||...........+......            
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------------  291 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS------------  291 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc------------
Confidence            23445789999999987431    23456899999999999999999999743322221111111100            


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                     ........++.++.+||.+||+.||++|||+.|+++||||......
T Consensus       292 ---------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        292 ---------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             ---------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence                           0111223568899999999999999999999999999999876543

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.4e-45  Score=332.67  Aligned_cols=250  Identities=26%  Similarity=0.431  Sum_probs=205.2

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.+..+++.||+|.++.... ..........|..++..+ +||||+++++++..+..     +++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-----~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH-----LFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-----EEEEE
Confidence            369999999999999999999999999975421 122334445566666654 79999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9997 58999988888899999999999999999999999999999999999999999999999999875432 233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+...   .+                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---~~------------------  213 (316)
T cd05592         156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND---RP------------------  213 (316)
T ss_pred             ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---CC------------------
Confidence            678999999999987 67899999999999999999999999887765544443221   00                  


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-~ell~~p~f~~~~  334 (377)
                                .....++.++.+||.+||+.||++||++ .++++||||..+.
T Consensus       214 ----------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         214 ----------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                      0112468889999999999999999986 5888999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-44  Score=338.19  Aligned_cols=264  Identities=25%  Similarity=0.338  Sum_probs=213.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      +.+..+.|++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|..+++.++||||+++++++..+..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3444556678999999999999999999999999999986532 222334556789999999999999999999987754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus       118 -----~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 -----LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             -----EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence                 899999997 589888764 4689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCc--cccccccccccCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          195 TSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       195 ~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .....  ......||+.|+|||++.+.   ..++.++|||||||++|+|++|..||...........+.......     
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----  266 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-----  266 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc-----
Confidence            54332  22356789999999998653   237889999999999999999999998877655554443211100     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  333 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~  333 (377)
                                            ..+....++..+.++|.+||..++.+  |+++.|+++||||+..
T Consensus       267 ----------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         267 ----------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ----------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                                  01112356889999999999865544  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-44  Score=323.94  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||+|+||+||++.++.+++.||+|.+..... .......+..|+.++++++|+||+++.+++.....     ++++|||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-----~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD-----LCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe-----EEEEEeCC
Confidence            7999999999999999999999999865422 22234566789999999999999999999987754     89999999


Q ss_pred             C-CCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-ccc
Q 017083          129 D-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  202 (377)
Q Consensus       129 ~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~  202 (377)
                      + ++|...+.    ....+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            8 58877663    24568999999999999999999999999999999999999999999999999987654332 233


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......                  
T Consensus       156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------  216 (280)
T cd05608         156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND------------------  216 (280)
T ss_pred             ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc------------------
Confidence            4577899999999987 778899999999999999999999997654322211111111000                  


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                               .......++..+.+++.+||+.||++||     +++++++||||+...
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence                     0011235788999999999999999999     889999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-44  Score=325.10  Aligned_cols=279  Identities=33%  Similarity=0.667  Sum_probs=215.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|++|.||++.++.+++.||+|.+............+.+|+.++++++|||++++++++.....     +++
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~~   77 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-----LHL   77 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE-----EEE
Confidence            447889999999999999999999999999986543333334567789999999999999999999987654     899


Q ss_pred             EEecCCCCHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~~L~-~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||+++++. ..+.....+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            9999997544 455556679999999999999999999999999999999999999999999999999998655433 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++|+||||+++++|++|..||......+....+........+..........   +.
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  234 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ---FF  234 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc---cc
Confidence            334567889999998765667889999999999999999999999887766666665544433221110000000   00


Q ss_pred             Hhccccc---cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRCR---KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .......   ........+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0000000   000111234678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.4e-45  Score=339.18  Aligned_cols=258  Identities=25%  Similarity=0.401  Sum_probs=211.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||+++++.+++.||+|++.... ........+..|..++..++||+|+++++.+.....     +
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-----~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN-----L   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-----E
Confidence            3457899999999999999999999999999996532 122344567789999999999999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||||++ |+|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.+|.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999998 5899999888899999999999999999999999999999999999999999999999999986432110 


Q ss_pred             -----------------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 017083          200 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (377)
Q Consensus       200 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p  244 (377)
                                                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0123468999999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CH
Q 017083          245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TV  321 (377)
Q Consensus       245 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~  321 (377)
                      |...........+......                           ...+....++..+.+||.+|+. ||.+|+   ++
T Consensus       236 f~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~  287 (360)
T cd05627         236 FCSETPQETYRKVMNWKET---------------------------LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGV  287 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCc---------------------------eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence            9887765554444321000                           0001112468899999999874 999998   58


Q ss_pred             HHHhcCccccCCc
Q 017083          322 EEALRHPYLQSLH  334 (377)
Q Consensus       322 ~ell~~p~f~~~~  334 (377)
                      .++++||||+.+.
T Consensus       288 ~ei~~hp~f~~~~  300 (360)
T cd05627         288 EEIKSHPFFEGVD  300 (360)
T ss_pred             HHHhcCCCCCCCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-44  Score=337.20  Aligned_cols=280  Identities=25%  Similarity=0.314  Sum_probs=214.2

Q ss_pred             cccccCCcccccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ....|++++.||+|+||.||++...  .++..||+|.+...       ....+|+.++++++||||+++++++.....  
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~--  160 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST--  160 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE--
Confidence            3445669999999999999999764  35678999988543       234579999999999999999999987644  


Q ss_pred             CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          118 FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                         ++++||++.++|.+++....++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus       161 ---~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        161 ---VCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ---EEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence               89999999999999997778899999999999999999999999999999999999999999999999999876543


Q ss_pred             Ccc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCcccccc
Q 017083          198 TDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---VHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       198 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ...   .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...   ...+..+.+.++..+......
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            321   234568999999999977 7789999999999999999999999976543   344444554444332221111


Q ss_pred             ccchhHHHHHHhcccc-ccccccc---cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          272 LRSDNARRYVRQLPRC-RKQQFAT---RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                       ........+.+.... ++....+   ....++.++.++|++||..||++|||+.|+|.||||...
T Consensus       317 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        317 -GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             -cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence             011111111111111 1111000   012457789999999999999999999999999999753

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.1e-44  Score=322.61  Aligned_cols=280  Identities=39%  Similarity=0.703  Sum_probs=223.5

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.+.||.|++|.||++.+..+|..||+|.+............+.+|+.++++++||||+++++++.....     +++|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~~v   77 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG-----FVLV   77 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe-----eEEE
Confidence            47889999999999999999999999999997654434455678899999999999999999999987644     8999


Q ss_pred             EecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--cc
Q 017083          125 YELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FM  201 (377)
Q Consensus       125 ~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--~~  201 (377)
                      +||++++|.+.+.. ..++++..++.++.||++||+|||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            99997799998864 5678999999999999999999999999999999999999999999999999987655432  23


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++||||||+++++|++|..+|...........+....+.+....+......  ..+.
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL--PDYN  235 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc--chhh
Confidence            34567889999999877556789999999999999999999889888777777777766655543222111100  0000


Q ss_pred             H-hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          282 R-QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       282 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      . ..............+..+..+.++|++||+.||.+|||++++++||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            0 0011111112223456788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.1e-44  Score=325.33  Aligned_cols=283  Identities=39%  Similarity=0.687  Sum_probs=222.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++.+.||.|++|.||++.++.+++.+++|.++...........+.+|+.++++++||||+++++++.....   ..++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~~   82 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKIY   82 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcEE
Confidence            3458899999999999999999999999999997543333333456789999999999999999999876532   3489


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc
Q 017083          123 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~  200 (377)
                      +++||++++|.+++... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            99999999999988764 35899999999999999999999999999999999999999999999999998866554 22


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc-hhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS-DNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~  279 (377)
                      .....++..|+|||.+.+....+.++|+||||+++++|++|..||...........+....+.+.+..+..... .....
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            33455688899999987645578899999999999999999999999888888877777666554433221100 00000


Q ss_pred             HHHhccccccccccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                        ..............++.  +++.+.++|++||+.||++|||+.|+++||||
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 --KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             --cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              00000011111222333  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-44  Score=331.48  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=211.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      |.+++.||+|+||+||+++++.+++.||+|++.+... .......+..|..++..+. |++|+++++++.....     +
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----~   76 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR-----L   76 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE-----E
Confidence            4478899999999999999999999999999976432 2223345567788887774 8999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~  199 (377)
                      ++||||++ |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999997 59999998888899999999999999999999999999999999999999999999999999875432 22


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....                 
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----------------  218 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----------------  218 (323)
T ss_pred             ccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence            3345678999999999987 7789999999999999999999999988776655544433110                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                    .....++.++.+++.+||+.||++|++     ..++++||||+.+.
T Consensus       219 --------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         219 --------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             --------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                          011246889999999999999999997     48999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-44  Score=329.26  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=206.2

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHh-cCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++++..+++.||+|.++.... ..........|..++.. ++||||+++++++.....     ++++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~-----~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-----LFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-----EEEEE
Confidence            469999999999999999999999999975421 12233445567777775 489999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ |+|.+.+.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9997 59999998888899999999999999999999999999999999999999999999999999875322 222345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....   +                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---~------------------  213 (316)
T cd05619         156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN---P------------------  213 (316)
T ss_pred             ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---C------------------
Confidence            678999999999987 678999999999999999999999998876555444432210   0                  


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-ell~~p~f~~~~  334 (377)
                                .....++..+.++|.+||+.||++||++. ++++||||..+.
T Consensus       214 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         214 ----------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             ----------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                      00123578899999999999999999996 899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.4e-44  Score=319.85  Aligned_cols=253  Identities=21%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||+|+||+||++.++.+|+.||+|.+....... .....+..|++++++++||||+++++++..+..     ++++|||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-----~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH-----LCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe-----EEEEEecC
Confidence            799999999999999999999999986532221 223345579999999999999999999987644     89999999


Q ss_pred             C-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccccc
Q 017083          129 D-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  205 (377)
Q Consensus       129 ~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~  205 (377)
                      + ++|.+.+...  ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            7 5888877543  358888999999999999999999999999999999999999999999999987765544444567


Q ss_pred             cccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcc
Q 017083          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  285 (377)
Q Consensus       206 ~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (377)
                      ++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.....                       
T Consensus       156 ~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  211 (277)
T cd05607         156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-----------------------  211 (277)
T ss_pred             CCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-----------------------
Confidence            8899999999987 6689999999999999999999999976432211111111000                       


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 017083          286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  334 (377)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f~~~~  334 (377)
                         ..........++.++.+|+.+||+.||++||++    .++++||||+.+.
T Consensus       212 ---~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         212 ---EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             ---ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence               000011123568899999999999999999999    6788999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.9e-44  Score=321.12  Aligned_cols=279  Identities=36%  Similarity=0.678  Sum_probs=217.9

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++++.||+|+||.||++.++.++..||+|.+........ .....+|+.+++++. |+|++++++++..+..   ..+++
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~l   77 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLAL   77 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEEE
Confidence            478899999999999999999999999999876533322 223457888888886 9999999999987622   23899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      ++||++++|.+.+.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++. +.++|+|||++..........
T Consensus        78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          78 VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999999999988876 457899999999999999999999999999999999999999 999999999998765544444


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...++..|+|||.+.....++.++|||||||++|+|++|..||...+.......+....+.+.+.............+  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY--  234 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc--
Confidence            556788999999876546678899999999999999999999998887777777777666554432111000000000  


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ..............+.++..+.++|.+||+.+|++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000000001111123568999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=284.92  Aligned_cols=274  Identities=40%  Similarity=0.710  Sum_probs=235.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ..++||+|.||+||+++++.+++.||+|.++...+++......++|+.+++.++|.|||++++....+..     +.+|+
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk-----ltlvf   80 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-----LTLVF   80 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce-----eEEeH
Confidence            6789999999999999999999999999998877777777888999999999999999999999887755     89999


Q ss_pred             ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cccc
Q 017083          126 ELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTE  203 (377)
Q Consensus       126 e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~~  203 (377)
                      |||..+|..++.+ ++.++.+.++.++.|+++|+.++|++++.|||+||.|.+|+.+|.+||+|||+++..+-+- -...
T Consensus        81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            9999999998875 7789999999999999999999999999999999999999999999999999999777653 3445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ..-|.+|++|.++.+.+.++.+.|+||-||++.|+.. |...|++.+..+++.+|..+++.+.+..+..+.         
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t---------  231 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT---------  231 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc---------
Confidence            5669999999999998889999999999999999986 788899999999999999999999877654321         


Q ss_pred             hcccccccc-------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          283 QLPRCRKQQ-------FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       283 ~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      .+.....-.       -....+.++..-.+|++++|.-+|.+|.++++.++||||...
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            010000000       001123456667899999999999999999999999999753

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.8e-44  Score=323.12  Aligned_cols=284  Identities=39%  Similarity=0.669  Sum_probs=221.9

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccC---HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+++.||.|++|.||++.+..+++.||+|.+......   ......+..|+.++++++|+||+++++++.....     .
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~   77 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN-----I   77 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE-----E
Confidence            3678899999999999999999999999999765333   2234456689999999999999999999988644     8


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||||+.++|.+++.... .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          78 NLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             EEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            9999999889999998765 79999999999999999999999999999999999999999999999999998655432 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+...++.++|+|||||++++|++|..+|........+..+....+.+..........  ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  235 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS--LPD  235 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc--ccc
Confidence            223345577899999987656678999999999999999999888887776666666655544433322110000  000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      . ..............+...+..+.++|.+||+.||++|||+.|+++||||++....
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         236 Y-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             c-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            0 0001111111222344568899999999999999999999999999999976643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-45  Score=303.03  Aligned_cols=267  Identities=21%  Similarity=0.336  Sum_probs=224.3

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  112 (377)
                      ++.+...-+.++.+..||.|..|+|++++.+.+|...|||.+.+.. +....++++..+.++.+.. .|+||+.+++|..
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            6677777788889999999999999999999999999999998763 4456778888888888776 8999999999988


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      +..     ++|.||.|..-+..+++. .+++++..+-.+...++.||.||.+ ++|+|||+||+|||+|+.|++||||||
T Consensus       163 n~d-----V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  163 NTD-----VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             Cch-----HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence            765     889999998766666554 5679999999999999999999995 589999999999999999999999999


Q ss_pred             cccccCCCccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  267 (377)
                      .+...-.+.......|.+.|||||.+.-.  ..|+.++||||||++++||.+|+.||.+.+.+ +.+..+   +...|+.
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---ln~ePP~  314 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---LNEEPPL  314 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---HhcCCCC
Confidence            99988888778888899999999998642  46788999999999999999999999885432 333333   2222211


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .                         +...++|+.+.+|+..||++|+.+||...++|+|||+....
T Consensus       315 L-------------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 L-------------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             C-------------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            1                         11124799999999999999999999999999999987544

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-44  Score=331.15  Aligned_cols=250  Identities=26%  Similarity=0.472  Sum_probs=205.5

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHH-HHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.+|+.||+|++.+... .......+..|.. +++.++||||+++++.+.....     ++++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~-----~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK-----LYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE-----EEEEE
Confidence            469999999999999999999999999965422 2223344445544 5677899999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~~~  203 (377)
                      ||++ ++|...+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9998 4888888888899999999999999999999999999999999999999999999999999987532 2233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   .                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-------------------  212 (325)
T cd05604         156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-------------------  212 (325)
T ss_pred             ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-------------------
Confidence            678999999999987 77889999999999999999999999887655544333220   0                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f~~~~  334 (377)
                               ....+..+..+.++|++||..||.+||++    .++++||||....
T Consensus       213 ---------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         213 ---------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             ---------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence                     01123568889999999999999999976    5999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.9e-45  Score=310.20  Aligned_cols=289  Identities=39%  Similarity=0.650  Sum_probs=231.5

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      .+|+.+++||+|.||.||++..+.+..    .+|||+++.+.+.........+|+.+++.++|||++.+..+|...+   
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d---  100 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD---  100 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence            356689999999999999996655533    6899999876444334456779999999999999999999998742   


Q ss_pred             CCcEEEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC----CCeEEee
Q 017083          118 FNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGD  188 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~----~~vkl~D  188 (377)
                       ..+++++||.+.+|..+|+-     .+.++...++.|++||+.|+.|||++=|.||||||.||+|..+    |+|||+|
T Consensus       101 -~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 -KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             -ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence             23999999999999999862     3568999999999999999999999999999999999999988    8999999


Q ss_pred             eecccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------hHHHHH
Q 017083          189 FGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLR  255 (377)
Q Consensus       189 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~---------~~~~~~  255 (377)
                      ||+++....+-    ......-|.+|+|||++.+...|+.+.|+|++||++.||++..+.|.+..         ..+++.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999776552    23445669999999999998899999999999999999999888885533         347788


Q ss_pred             HHHHHhCCCCccccccccc-hhHHHHHHhcc-----ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          256 LITELIGSPDDASLGFLRS-DNARRYVRQLP-----RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                      +|.++++.|.+..+..... ......+..+.     +..-......+...++...+|+.+||+.||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            9999999998877654332 11212222221     11111222233445777999999999999999999999999999


Q ss_pred             ccCCc
Q 017083          330 LQSLH  334 (377)
Q Consensus       330 f~~~~  334 (377)
                      |+.-.
T Consensus       340 F~~d~  344 (438)
T KOG0666|consen  340 FTEDP  344 (438)
T ss_pred             cccCC
Confidence            98654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=333.37  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ||+|+||+||+++++.+++.||+|++.+.. ...........|..++..+   +||+|+++++.+.....     +|++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~-----~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD-----LYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----EEEEE
Confidence            799999999999999999999999986532 1222334445666777655   69999999999988754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||++ ++|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9997 58999988888999999999999999999999999999999999999999999999999999875332 233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+...++.++|||||||++|+|++|..||...........+......                    
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------  215 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--------------------  215 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            678999999999876456889999999999999999999999887655544333210000                    


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----s~~ell~~p~f~~~~  334 (377)
                                .....+++++.+||++||+.||.+||    ++.++++||||....
T Consensus       216 ----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         216 ----------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                      00113588899999999999999998    799999999998653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-43  Score=321.01  Aligned_cols=285  Identities=40%  Similarity=0.720  Sum_probs=222.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||.|++|+||++.++.+|+.||+|.+............+.+|+.++++++||||+++++++.....     +++
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   78 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-----LYL   78 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe-----EEE
Confidence            447889999999999999999999999999986543333344567789999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCCC-c
Q 017083          124 VYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      |+||++++|.+.+.....  +++..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++...... .
T Consensus        79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999999999988865443  578888999999999999999999999999999999985 457999999999765432 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.+....+....  ....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT--SLPD  236 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc--cchh
Confidence            22344568889999998765567899999999999999999999999887777776666666655443322110  0011


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      +................+.+++.+.+++.+||+.+|++||++.++++||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            11111111112222234567889999999999999999999999999999987653

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=319.42  Aligned_cols=279  Identities=41%  Similarity=0.735  Sum_probs=221.3

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++++.||.|++|+||++.++.+|..||+|++............+.+|+.+++.++|||++++++++.....     .+++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-----~~iv   76 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK-----LYLV   76 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCe-----EEEE
Confidence            47889999999999999999999999999987653333334567789999999999999999999987644     8999


Q ss_pred             EecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          125 YELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      +||++++|.+++....  .+++..+..++.|+++||+|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             EeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9999999999987655  78999999999999999999999999999999999999999999999999987544321 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+......+....+...  .....+.
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  234 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV--TSLPDYK  234 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh--hhchhhh
Confidence            33355788999998876456788999999999999999999999988877666666555444433221110  0001111


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...............+.++..+.++|.+||+.||.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            1122222222333355678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-44  Score=329.18  Aligned_cols=250  Identities=24%  Similarity=0.431  Sum_probs=204.0

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHH-HHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREI-KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||+++++.+++.||+|++.+... .......+..|. .+++.++||||+++++.+.....     ++++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~-----~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK-----LYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-----EEEEE
Confidence            369999999999999999999999999865421 122233444444 46788999999999999987754     89999


Q ss_pred             ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||+++ +|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99984 8888888888899999999999999999999999999999999999999999999999999875322 223345


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..   .+                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~-------------------  212 (321)
T cd05603         156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP-------------------  212 (321)
T ss_pred             ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC-------------------
Confidence            678999999999977 7789999999999999999999999988765544433321   10                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f~~~~  334 (377)
                               ....+..+..+.++|.+||+.||.+||++    .++++|+||..+.
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         213 ---------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence                     01123567889999999999999999865    5999999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-43  Score=336.76  Aligned_cols=275  Identities=26%  Similarity=0.333  Sum_probs=205.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+.+.||+|+||.||++.+..+++.||+|....        ..+.+|++++++++|+||+++++++..+..     .++
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~-----~~l  237 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGL-----TCL  237 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE-----EEE
Confidence            4488999999999999999999999999996422        235689999999999999999999887654     899


Q ss_pred             EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc---
Q 017083          124 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---  199 (377)
                      ++|++.++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......   
T Consensus       238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            9999999999988653 569999999999999999999999999999999999999999999999999987643321   


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCccccccc
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-------YVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ......||..|+|||++.+ ..++.++|||||||++|||++|..++....       ....+..+...............
T Consensus       318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            1234568999999999987 778999999999999999999876543221       12223333322221111111110


Q ss_pred             cchhHHHHHHhcccc-cccccc---ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          273 RSDNARRYVRQLPRC-RKQQFA---TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .......+....... ......   ..+..++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            111111111111100 100011   112246778999999999999999999999999999975

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-43  Score=326.71  Aligned_cols=290  Identities=37%  Similarity=0.630  Sum_probs=229.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHH------------HHHHHHHHHHHHhcCCCCce
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID------------ARRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv  104 (377)
                      +++.++|..+.+.||.|+||+||++.++.+++.||+|++.........            ...+.+|+.+++.++|+||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            567888987788899999999999999999999999998654221100            12466899999999999999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCe
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~v  184 (377)
                      ++++++.....     .+++|||++++|.+.+.....+++..+..++.||+.||++||++|++|+||+|+||+++.++.+
T Consensus        84 ~~~~~~~~~~~-----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         84 GLVDVYVEGDF-----INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeeEEEecCCc-----EEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            99999987754     8999999999999999888889999999999999999999999999999999999999999999


Q ss_pred             EEeeeecccccCCC---------------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 017083          185 KIGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (377)
Q Consensus       185 kl~Dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~  249 (377)
                      +|+|||++......               .......++..|+|||.+.+...++.++|+||||+++|+|++|..||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998755411               112223457789999998775567899999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       250 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                      ....+..+....+.+....+.......   .................+..+..+.++|.+||+.+|++|||++++|.|||
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLP---LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcc---cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            888887777777665543221100000   00000000111112223456888999999999999999999999999999


Q ss_pred             ccCCc
Q 017083          330 LQSLH  334 (377)
Q Consensus       330 f~~~~  334 (377)
                      |+...
T Consensus       316 ~~~~~  320 (335)
T PTZ00024        316 FKSDP  320 (335)
T ss_pred             cCCCC
Confidence            98654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=326.96  Aligned_cols=260  Identities=22%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||+++++.+++.||+|++.+.. ........+.+|..+++.++|+||+++++++..+..     +|
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~   77 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN-----LY   77 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe-----EE
Confidence            458999999999999999999999999999986531 222334557789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +||||++ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999997 599998875 56799999999999999999999999999999999999999999999999999875443321


Q ss_pred             --ccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          201 --MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       201 --~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                        .....|++.|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.....            
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------------  225 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------------  225 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence              223468999999999863    24568899999999999999999999987765554443322100            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                    ........+.++..+.++|++||..++++  |+++.++++||||....
T Consensus       226 --------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         226 --------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             --------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                          00111223357899999999999754443  88999999999997653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-44  Score=328.67  Aligned_cols=249  Identities=24%  Similarity=0.449  Sum_probs=204.9

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHH-HHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREI-KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||+++++.+++.||+|++.+... .......+..|. .+++.++||||+++++++.....     ++++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~-----~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-----LYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-----EEEEE
Confidence            369999999999999999999999999965321 112223344444 45678899999999999987754     89999


Q ss_pred             ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-Cccccc
Q 017083          126 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (377)
Q Consensus       126 e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~~~~~~  203 (377)
                      ||+++ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            99985 8999988888899999999999999999999999999999999999999999999999999875332 223445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   +                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------------  212 (325)
T cd05602         156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-------------------  212 (325)
T ss_pred             ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------------
Confidence            678999999999987 77899999999999999999999999887765554444321   0                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH----HHhcCccccCC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE----EALRHPYLQSL  333 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~----ell~~p~f~~~  333 (377)
                               ....+.++..+.++|++||+.||.+|+++.    ++++|+||...
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         213 ---------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ---------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                     111246788999999999999999999765    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.7e-44  Score=320.87  Aligned_cols=282  Identities=34%  Similarity=0.651  Sum_probs=216.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|++|.||++.++.+++.||+|.+..........+.+.+|+.+++.++||||+++++++..+..     .++
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   77 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-----LYL   77 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe-----EEE
Confidence            347899999999999999999999999999987654443345567789999999999999999999987654     899


Q ss_pred             EEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||++++ |.........+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            99999974 55555555679999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++||||||+++++|++|..||...........+........+...............
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34567888999999876556788999999999999999999999887766666666655443322111100000000000


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...............+.++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0000000011112345778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=310.68  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=230.0

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      -.+..+.+..++.||+|.||+|-+|+-+.+++.||+|++++.. ......+..+.|-++|+..+||.+..+...|.....
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            4556667778999999999999999999999999999998864 334456677889999999999999999999987755


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +|+||||+. |.|.-.+.....++++..+.+...|+.||.|||+++|++||+|.+|.++|.+|++||+|||+++.
T Consensus       243 -----lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 -----LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             -----EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence                 999999998 58888888888999999999999999999999999999999999999999999999999999974


Q ss_pred             -cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          195 -TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       195 -~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                       .........++||+.|+|||++.. ..|+.++|.|.+|+++|||++|+.||...+....+..|..---..         
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF---------  387 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF---------  387 (516)
T ss_pred             cccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC---------
Confidence             445567889999999999999987 899999999999999999999999999988777776664421111         


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                            ...++++++.|+..+|..||.+|.     .+.|+..|+||.++.
T Consensus       388 ----------------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  388 ----------------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             ----------------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence                                  136799999999999999999997     789999999998776

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-47  Score=319.28  Aligned_cols=256  Identities=24%  Similarity=0.403  Sum_probs=217.1

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +-+.++++||+|+||.||++.|+.+|..+|||.+..    .....++.+|+.++++++.|++|++|+.|.....     +
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----L  103 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----L  103 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----e
Confidence            344589999999999999999999999999999864    3567889999999999999999999999987765     9


Q ss_pred             EEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      |||||||+ |+..++++. +++++++++..++...++||+|||...-+|||||..|||++.+|..||+|||.+...... 
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            99999998 799999875 678999999999999999999999999999999999999999999999999999765543 


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ...+...||+.|||||++.. -.|+..+||||||++..||..|+.||..-.....+.   .+-..||++..         
T Consensus       184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~PPPTF~---------  250 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKPPPTFK---------  250 (502)
T ss_pred             HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCCCCCCC---------
Confidence            44567899999999999988 788999999999999999999999997654332221   11111111110         


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                      ....-+.++.+++++||.++|++|-|+-++++|||+++...
T Consensus       251 ----------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  251 ----------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             ----------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence                            00112778999999999999999999999999999988764

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-43  Score=327.72  Aligned_cols=304  Identities=41%  Similarity=0.759  Sum_probs=222.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +++.+|. +.+.||.|+||.||++.+..+|..||+|++.....  ...+.+.+|+.++++++||||+++++++.......
T Consensus         2 ~~~~~y~-~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           2 DLGSRYM-DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcCcceE-EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            3445555 89999999999999999999999999999865422  34566778999999999999999998877654211


Q ss_pred             ---------CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEe
Q 017083          118 ---------FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIG  187 (377)
Q Consensus       118 ---------~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~  187 (377)
                               ...+++++||++++|.+.+.. .++++..++.++.||+.||+|||+.|++|+||||+||+++. ++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                     134789999999998887754 57899999999999999999999999999999999999985 4568999


Q ss_pred             eeecccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          188 DFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       188 Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      |||.+.......    ......++..|+|||.+.+...++.++|||||||++|+|++|..||...........+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999987543221    1223356788999998765466788999999999999999999999887766555444433222


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCC
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP  343 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~  343 (377)
                      ..+........ .....................+.++.++.+||.+||+.||.+|||+.++++||||+......+.+...
T Consensus       238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~  316 (342)
T cd07854         238 VREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSL  316 (342)
T ss_pred             CChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCC
Confidence            21111100000 00000110011111112223446788999999999999999999999999999998765443444443


Q ss_pred             CCC
Q 017083          344 RPF  346 (377)
Q Consensus       344 ~~~  346 (377)
                      .++
T Consensus       317 ~~~  319 (342)
T cd07854         317 HPF  319 (342)
T ss_pred             CCc
Confidence            333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.6e-44  Score=332.21  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=213.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+..+.|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|..+++.++||||+++++.+.....
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445566679999999999999999999999999999986532 222234456789999999999999999999987754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           ++++|||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus       118 -----~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         118 -----LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             -----EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence                 899999997 588888764 4689999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCc--cccccccccccCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          195 TSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       195 ~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .....  ......||+.|+|||++.+.   ..++.++|||||||++|+|++|..||...+.......+.......     
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----  266 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-----  266 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-----
Confidence            54332  22356789999999998652   237889999999999999999999998877655554443211100     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                            ..+....++..+.++|.+||..++.+  |+++.++++||||++..
T Consensus       267 ----------------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         267 ----------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             ----------------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                                  01122467899999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-43  Score=320.20  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++.+.||+|+||+||++.+..+++.||+|.+...... ......+..|+.++++++|++++++++.+.....     +++
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-----~~l   77 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA-----LCL   77 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-----EEE
Confidence            4678899999999999999999999999998654322 2233556789999999999999999999987644     899


Q ss_pred             EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +|||++ ++|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999997 5888877543  3589999999999999999999999999999999999999999999999999876554433


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|..||....................               
T Consensus       158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------  221 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------------  221 (285)
T ss_pred             ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------------
Confidence            344578999999999977 7789999999999999999999999976542211111111110000               


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                  ......+++++.+|+++||+.||++|||     +.|+++||||....
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         222 ------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             ------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence                        0112346888999999999999999999     99999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.8e-44  Score=326.80  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++.++.+++.||+|++.+... .......+..|..++.++ +||+|+++++++.....     +++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-----LFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-----EEEEE
Confidence            469999999999999999999999999976432 223445677899999888 59999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  203 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~~~~  203 (377)
                      ||++ ++|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9997 5898888888889999999999999999999999999999999999999999999999999987532 2233445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCccccccccchhHHHH
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---QLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......   ....+.....                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  216 (327)
T cd05617         156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------------  216 (327)
T ss_pred             ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------------
Confidence            678999999999987 778999999999999999999999996422110   0000000000                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~ell~~p~f~~~~  334 (377)
                           .    ........++..+.++|++||+.||++|++      +.++++||||+.+.
T Consensus       217 -----~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         217 -----E----KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             -----h----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                 0    001112346888999999999999999997      57999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=331.36  Aligned_cols=255  Identities=28%  Similarity=0.483  Sum_probs=226.0

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      -+.||+|.||+||-+.++.+|+.||||++.+.........+++.|+.||+++.||.||.+-..|+..+.     +++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-----vFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-----VFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-----EEEEeh
Confidence            357999999999999999999999999998876555566888999999999999999999999998866     999999


Q ss_pred             cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeecccccCCCccc
Q 017083          127 LMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       127 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~~~~~~~~~  201 (377)
                      .+.|++++.|.+  .+++++...+.++.||+.||.|||.+||+|.||||+|||+....   .+||||||+++..++..+.
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            999999998865  57899999999999999999999999999999999999997643   5999999999999999999


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....||+.|+|||++.+ +.++..-|+||+|+++|.-|.|..||....  +....|++.....                 
T Consensus       724 rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMy-----------------  783 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMY-----------------  783 (888)
T ss_pred             hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcccccc-----------------
Confidence            99999999999999998 889999999999999999999999996543  3444444433222                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                ....|..+++.+.+||..+|++.-.+|.|.+..|.|||+|+.+.+
T Consensus       784 ----------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w  828 (888)
T KOG4236|consen  784 ----------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTW  828 (888)
T ss_pred             ----------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHH
Confidence                      234467889999999999999999999999999999999987753

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.7e-43  Score=319.39  Aligned_cols=285  Identities=38%  Similarity=0.669  Sum_probs=220.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||.|+||+||++.+..+++.||+|.+............+.+|+.+++++. ||||+++++++..........+|
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            34788999999999999999999999999998654333333456778999999996 69999999998765443333479


Q ss_pred             EEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccC
Q 017083          123 IVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTS  196 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~  196 (377)
                      ++|||++++|.+.+...     ..+++..++.++.||++||.|||++|++|+||+|+||+++. ++.++|+|||++....
T Consensus        83 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~  162 (295)
T cd07837          83 LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS  162 (295)
T ss_pred             EEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence            99999999998887642     35799999999999999999999999999999999999998 8899999999987543


Q ss_pred             CC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          197 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       197 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .. .......+++.|+|||.+.+...++.++||||||+++|+|++|..||...........+......+.......... 
T Consensus       163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (295)
T cd07837         163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK-  241 (295)
T ss_pred             CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh-
Confidence            32 1222335678899999987646678999999999999999999999998877777666666555443332211000 


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                       .... .......+.......+.++..+.+||.+||+.||.+||++.|++.||||+
T Consensus       242 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         242 -LRDW-HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             -ccch-hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence             0000 00111111222223456789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-43  Score=325.70  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=210.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +..+.||+|+||+||++.++.+|+.||+|++.+... .......+..|..+++.+. |++|+++++++.....     +|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----~~   77 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR-----LY   77 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE-----EE
Confidence            467889999999999999999999999999975422 2223455677888888886 5778889999887654     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~  200 (377)
                      +||||++ |+|.+.+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus        78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            9999997 599999988888999999999999999999999999999999999999999999999999998754322 22


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....                  
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------  218 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------  218 (323)
T ss_pred             ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            344568999999999977 7789999999999999999999999988776555444432110                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                   .....++..+.+++.+||+.||.+|++     ..++++||||+.+.
T Consensus       219 -------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         219 -------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             -------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                         011246888999999999999999997     57999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=312.97  Aligned_cols=252  Identities=26%  Similarity=0.449  Sum_probs=208.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH---HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.+.+.||+|++|.||.+.+..+++.||+|.+.......   .....+.+|+.++++++||||+++++++..+..     
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   78 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET-----   78 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe-----
Confidence            347889999999999999999999999999987543222   233567789999999999999999999988754     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++++||++ ++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            899999998 4899999888889999999999999999999999999999999999999999999999999987543321


Q ss_pred             cc----cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          200 FM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       200 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..    ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..   ...          
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~----------  224 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT----------  224 (263)
T ss_pred             cccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc---cCC----------
Confidence            11    23456788999999987 6688999999999999999999999977654433322211   000          


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                      .......++..+.++|++||..+|.+|||+.++++||||
T Consensus       225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ----------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                            011123568889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=336.37  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=214.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      .+|+..||.|+||.||++.++.++..-|-|.+...  .....+.++-|+.||..++||+||++++.|.....     +||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            34788899999999999999999888889988543  45567888899999999999999999998877744     999


Q ss_pred             EEecCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-CCcc
Q 017083          124 VYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDF  200 (377)
Q Consensus       124 v~e~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~~~~  200 (377)
                      +.|||+|+-.+.+.  .+..+.+.++..+++|++.||.|||+++|+|||||..|||++-+|.|+|+|||.+.... ....
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999976555443  47789999999999999999999999999999999999999999999999999875433 3345


Q ss_pred             ccccccccccCCCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          201 MTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ...+.||++|||||+..    ...+|++++||||||+++.+|..+.+|-...+....+-.|.+   +.|++..       
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLl-------  256 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLL-------  256 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCccc-------
Confidence            67789999999999974    236799999999999999999999999888776655544443   3222211       


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                        ....-+..+.||+++||..||..||++.++|+||||+++.
T Consensus       257 ------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  257 ------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                              0112367799999999999999999999999999999765

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-43  Score=323.08  Aligned_cols=277  Identities=37%  Similarity=0.616  Sum_probs=202.5

Q ss_pred             cccccCCccceEEEEEeCC--CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ..+||+|+||+||+++++.  ++..||+|.+....    ....+.+|+.++++++||||+++++++.....   ..++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEE
Confidence            4579999999999999754  56789999886532    12346689999999999999999999865433   348999


Q ss_pred             EecCCCCHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE----ccCCCeEEeeeec
Q 017083          125 YELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  191 (377)
Q Consensus       125 ~e~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli----~~~~~vkl~Dfg~  191 (377)
                      +||++++|.+.+..         ...+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99999999888752         1247889999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 017083          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------VHQLRLIT  258 (377)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~---------~~~~~~i~  258 (377)
                      +.......    ......+++.|+|||.+.+...++.++|||||||++|+|++|..||.....         ......+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654332    223456788999999987756688999999999999999999999975432         23344444


Q ss_pred             HHhCCCCcccccccc-chhHHHHHHhccccc------cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          259 ELIGSPDDASLGFLR-SDNARRYVRQLPRCR------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...+.+....+.... ...............      ...........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            444443332221100 000000000000000      000011112346678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-43  Score=319.12  Aligned_cols=279  Identities=37%  Similarity=0.707  Sum_probs=219.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|++|+||+++++.+|..||+|.+...... .....+.+|+.++++++|+||+++++++.....     .++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   75 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENK-----LML   75 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-----EEE
Confidence            34789999999999999999999999999998754322 234566789999999999999999999988754     899


Q ss_pred             EEecCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||++++|.+++...   .++++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            9999999999888653   468999999999999999999999999999999999999999999999999987544321 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|++||.+.+...++.++|+||||+++|+|++|..||...........+.+....+.........  ....
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  233 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLPE  233 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCch
Confidence            22334567889999998765567889999999999999999999999888777777776665554433221111  0000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      +................+..+..+.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000111111111111234568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-46  Score=305.44  Aligned_cols=301  Identities=34%  Similarity=0.555  Sum_probs=243.4

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      .+...|......++-+.+||+|.||.||+++.+.+|++||+|++-.+-.+.......++|+.+|+.|+|+|++.+++++.
T Consensus         7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen    7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            33444555555555889999999999999999999999999988665445555567789999999999999999999876


Q ss_pred             CCCCCC---CCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          112 PPKKDT---FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       112 ~~~~~~---~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      ......   -..+|+|+.+|+.+|.-++... .+++...++.++.++..||.|+|.+.|.|||+|+.|+||+.+|.++|+
T Consensus        87 tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             hccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence            544322   1238999999999999998765 689999999999999999999999999999999999999999999999


Q ss_pred             eeecccccCCCcc-----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017083          188 DFGLARTTSETDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       188 Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      |||+++..+....     .....-|++|++||.+.+...++++.|||+-||++.+|+++.+.+.++...+++..|..+++
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9999975543321     23344599999999999989999999999999999999999999999999999999999999


Q ss_pred             CCCccccccccchhHHHHHH--hccccccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          263 SPDDASLGFLRSDNARRYVR--QLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      +.....+..+..-....-+.  .+.............  ...+++.+|+.+||..||.+|++++++|+|.||..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            98877665543332222221  122222222222222  23678999999999999999999999999999964

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.7e-43  Score=316.99  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=211.2

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +..+.||+|+||+||++.+..+++.+|+|.+...... ......+.+|+.+++.++|++++.+++.+..+..     .++
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-----~~l   77 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA-----LCL   77 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-----EEE
Confidence            3678899999999999999999999999998654222 2233456789999999999999999999987754     899


Q ss_pred             EEecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          124 VYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++||+++ +|.+.+..  ..++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999985 78777754  34699999999999999999999999999999999999999999999999999876544433


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.........              
T Consensus       158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--------------  222 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--------------  222 (285)
T ss_pred             ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--------------
Confidence            445578999999999977 67899999999999999999999999876654444333322111110              


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                   .....++..+.+|+.+||+.||++||+     +.+++.|+||.+..
T Consensus       223 -------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         223 -------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             -------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence                         112356888999999999999999999     89999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=318.78  Aligned_cols=281  Identities=36%  Similarity=0.648  Sum_probs=212.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||.|++|+||++.++.+++.||+|.+....... ....+.+|+.++++++|+||+++++++..+..     .+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~   79 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKT-----LT   79 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCe-----EE
Confidence            3458899999999999999999999999999986542221 22345689999999999999999999987654     89


Q ss_pred             EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-c
Q 017083          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~  200 (377)
                      +||||++++|.+.+.. ...+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9999999999998865 3468999999999999999999999999999999999999999999999999986543221 1


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|..||.... ..+....+.+..+.+.+.......... ..
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP-EF  238 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc-cc
Confidence            2223457889999998764567889999999999999999999997665 445555555555544332211110000 00


Q ss_pred             HHHhccccccccccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKS--SGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...................++  ..+.+++.+||+.+|++|||+.|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000001111112223344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-43  Score=320.55  Aligned_cols=285  Identities=36%  Similarity=0.587  Sum_probs=217.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC---CCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~  121 (377)
                      .+++.||+|+||.||++.+..+++.||+|.+............+.+|+.++++++||||+++++++.....   ......
T Consensus        15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   94 (310)
T cd07865          15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF   94 (310)
T ss_pred             EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence            38899999999999999999999999999986543333233455679999999999999999998765432   112347


Q ss_pred             EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++++||++++|.+.+... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        95 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  174 (310)
T cd07865          95 YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN  174 (310)
T ss_pred             EEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence            999999999998887654 378999999999999999999999999999999999999999999999999987543321 


Q ss_pred             ----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          200 ----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       200 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                          ......++..|+|||.+.+...++.++||||||+++|+|++|..||...........+....+..++.........
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (310)
T cd07865         175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL  254 (310)
T ss_pred             cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence                1123456788999999876455788999999999999999999999998888777777777766554432221110


Q ss_pred             hHHHHHHhcccccccccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          276 NARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...... .............  ....+..+.+||.+||..||.+|||++++|+||||
T Consensus       255 ~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         255 ELFKKM-ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhhhc-cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000000 0000000000000  01136678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=339.50  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=214.2

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC---CCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~~~  119 (377)
                      .|.+.+.||+|+||+||++.+..+|+.||+|++............+.+|+.++..++|+|+++++..+......   ...
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            34489999999999999999999999999999976655555667788999999999999999998877543321   112


Q ss_pred             cEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          120 DVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      .++++|||++ |+|.+.+..    ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~  192 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM  192 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence            3689999998 599988864    34689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          195 TSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       195 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ....   .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...           
T Consensus       193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~-----------  260 (496)
T PTZ00283        193 YAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG-----------  260 (496)
T ss_pred             ccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------
Confidence            4432   22345678999999999987 77899999999999999999999999876654433322210           


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                         ...+..+.+++.+.+++.+||+.||.+||++.++++|||++...
T Consensus       261 -------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        261 -------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                               00112245688999999999999999999999999999987644

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3e-43  Score=323.76  Aligned_cols=283  Identities=18%  Similarity=0.232  Sum_probs=207.5

Q ss_pred             CcccccCC--ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           46 PIRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        46 ~~~~lg~G--~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++++||+|  +|++||++.++.+|+.||+|.+............+..|+.+++.++||||+++++++..+..     .++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-----~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE-----EEE
Confidence            57889999  77899999999999999999997665455555667789999999999999999999987754     899


Q ss_pred             EEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      |+||++ ++|.+++..  ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.++++||+........  
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999998 588888864  346899999999999999999999999999999999999999999999999865432111  


Q ss_pred             ------ccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc-c
Q 017083          199 ------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-G  270 (377)
Q Consensus       199 ------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~  270 (377)
                            .......++..|+|||++.+. ..++.++|||||||++|+|++|..||.............  .+..+.... .
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcccccccc
Confidence                  111223456779999998753 357899999999999999999999998655433222211  111110000 0


Q ss_pred             cccchh-------------HHHHHH---hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          271 FLRSDN-------------ARRYVR---QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       271 ~~~~~~-------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ......             ......   ...........+....+++.+.+||++||+.||++|||+.++++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            000000             000000   0000000000111224578899999999999999999999999999998765


Q ss_pred             C
Q 017083          335 D  335 (377)
Q Consensus       335 ~  335 (377)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=318.30  Aligned_cols=281  Identities=37%  Similarity=0.698  Sum_probs=219.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||+|++|.||++.++.+++.||+|.++...........+.+|++++++++|+||+++++++..+..     .++
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~i   77 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-----LYL   77 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE-----EEE
Confidence            448899999999999999999999999999987654444455778899999999999999999999987644     899


Q ss_pred             EEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--c
Q 017083          124 VYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  200 (377)
Q Consensus       124 v~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--~  200 (377)
                      ++||+++++.+.+ .....+++..+..++.||+.|+.|||+++++|+||+|+||++++++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9999998666554 445679999999999999999999999999999999999999999999999999987655443  3


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|..||........+..+....+..++..............
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            34456788899999998744788999999999999999999999988777766666666555444322111100000000


Q ss_pred             HHhcccc-ccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          281 VRQLPRC-RKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       281 ~~~~~~~-~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                       ...... ........++. ++..+.+||++||..+|++|||+.++++||||
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 -VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             -cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             000000 00001111222 48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=316.74  Aligned_cols=282  Identities=40%  Similarity=0.669  Sum_probs=222.8

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+++.||.|++|.||++.+..+++.+|+|.+............+..|+.++++++|+|++++++++.....   ...+++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv   78 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK---GSIYMV   78 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC---CcEEEE
Confidence            47889999999999999999999999999998764334445667789999999999999999999987621   238999


Q ss_pred             EecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--cc
Q 017083          125 YELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FM  201 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--~~  201 (377)
                      +||++++|.+++... ..+++..++.++.||+.||++||+.|++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          79 FEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             eccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            999999999888765 579999999999999999999999999999999999999999999999999988655442  22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++||||||+++++|++|..||...........+......+....+............
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            33456788999998876556789999999999999999999999988887777777776665544332211111000000


Q ss_pred             HhccccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .. .............. ++..+.+++++||+.+|.+||++.++++||||
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            00 00001111122233 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.7e-43  Score=324.61  Aligned_cols=260  Identities=22%  Similarity=0.381  Sum_probs=209.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||+||+++++.+++.||+|++.+.. ........+..|..++..++|++|+++++++.....     ++
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~   77 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN-----LY   77 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE-----EE
Confidence            458899999999999999999999999999986532 122233456788999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +||||++ |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999997 699999876 5678999999999999999999999999999999999999999999999999987543322 


Q ss_pred             -cccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          200 -FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                       ......|++.|+|||++..    ...++.++|||||||++|+|++|..||...+.......+.....            
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------------  225 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------------  225 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------------
Confidence             1233578999999999863    24678899999999999999999999988776555544432100            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                    ..........++..+.+||++||..++.+  |+++.++++||||+++.
T Consensus       226 --------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         226 --------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             --------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                          00111223457899999999999765544  78999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=330.72  Aligned_cols=270  Identities=21%  Similarity=0.291  Sum_probs=222.5

Q ss_pred             ccCceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC
Q 017083           22 THGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE  101 (377)
Q Consensus        22 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~  101 (377)
                      .+.++..+..+....|+|....+.+...||+|.||+||++.+-.+   ||||+++.........+.|.+|+..+++-+|.
T Consensus       372 ~~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~  448 (678)
T KOG0193|consen  372 KISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE  448 (678)
T ss_pred             ccccccccCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchh
Confidence            345556666677788999999999999999999999999998765   99999999888888899999999999999999


Q ss_pred             CceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       102 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                      ||+-+.|++....      +.||+-||+| +|..++.. .-+|.....+.|+.||++|+.|||.++|+|+|||..|||+.
T Consensus       449 NIlLFMG~~~~p~------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~  522 (678)
T KOG0193|consen  449 NILLFMGACMNPP------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH  522 (678)
T ss_pred             hheeeehhhcCCc------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence            9999999998764      5899999998 88888864 45799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeeecccc---cCCCccccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017083          180 ASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~---~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~  254 (377)
                      ++++|||+|||++..   .....-.....+...|||||+++.  ..+++..+||||||+++|||++|..||.....++.+
T Consensus       523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi  602 (678)
T KOG0193|consen  523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII  602 (678)
T ss_pred             cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence            999999999999864   222333455667888999999964  367899999999999999999999999844333222


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      -.+-+-...+                          .........+.++++|+..||..++++||.+.+||.
T Consensus       603 fmVGrG~l~p--------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  603 FMVGRGYLMP--------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             EEecccccCc--------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1110000000                          001112355779999999999999999999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-43  Score=324.32  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             eeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeee
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDII  110 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  110 (377)
                      |.++.+.+++.+.||+|+||.||++.+     +.+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            667777788999999999999999975     3445789999997542 233456788999999999 799999999988


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhC--------------------------------------------------
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------  139 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--------------------------------------------------  139 (377)
                      ....    ..++++|||++ |+|.+++...                                                  
T Consensus        81 ~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (338)
T cd05102          81 TKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS  156 (338)
T ss_pred             cCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence            6543    23799999998 5898888642                                                  


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc---ccccc
Q 017083          140 ------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY  204 (377)
Q Consensus       140 ------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~  204 (377)
                                  .++++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++.......   .....
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence                        236778889999999999999999999999999999999999999999999997643221   11223


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      .++..|+|||++.+ ..++.++|||||||++|+|++ |..||..............  ...                   
T Consensus       237 ~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~--~~~-------------------  294 (338)
T cd05102         237 RLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK--DGT-------------------  294 (338)
T ss_pred             CCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--cCC-------------------
Confidence            44678999999977 778999999999999999997 9999987543322211111  000                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                              ........++.+.+++.+||+.||++|||+.|+++
T Consensus       295 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 --------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    00011245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7e-43  Score=314.62  Aligned_cols=280  Identities=47%  Similarity=0.786  Sum_probs=225.0

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+++.||.|++|.||++.+..+++.+++|.+............+..|+.++++++|+||+++++++..+..     ++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~~v   76 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD-----LYLV   76 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC-----EEEE
Confidence            47788999999999999999999999999987654444455677889999999999999999999887744     8999


Q ss_pred             EecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-ccc
Q 017083          125 YELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  202 (377)
Q Consensus       125 ~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~  202 (377)
                      +||++++|.+.+.. ...+++..+..++.||+.||.+||+++++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        77 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          77 FEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             EeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99999999988876 4688999999999999999999999999999999999999999999999999987665443 223


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+.+..+.+.+......... ......
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-ARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-hhhhhh
Confidence            3456788999999987447899999999999999999999999998888777777766555443322221110 000001


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ..............+.++.++.++|.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111111122222345678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=341.30  Aligned_cols=262  Identities=24%  Similarity=0.365  Sum_probs=214.1

Q ss_pred             EEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEee-
Q 017083           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD-  108 (377)
Q Consensus        31 ~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-  108 (377)
                      +-.|..|+|+...+++.+.|++|||+.||+|++...|..||||++-..  +....+...+|+.+|++|+ |+|||.|++ 
T Consensus        26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            346789999999999999999999999999999888899999988654  5667788889999999998 999999999 


Q ss_pred             eecCC-CCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCC
Q 017083          109 IIRPP-KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASC  182 (377)
Q Consensus       109 ~~~~~-~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~  182 (377)
                      ..... +..+-..+.|+||||+ |+|.++|..  ...|++.++..|+.++++|+++||...  |+|||||-+|||++.+|
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            33333 2222355889999999 699999974  456999999999999999999999987  99999999999999999


Q ss_pred             CeEEeeeecccccCCCc-c---------ccccccccccCCCcccc--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 017083          183 DLKIGDFGLARTTSETD-F---------MTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~~~~-~---------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~  250 (377)
                      ..||||||.+.-..... .         ......|+.|+|||.+.  .....+.++|||+|||+||.|+....||.....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            99999999986322111 1         12234589999999974  336789999999999999999999999987532


Q ss_pred             HHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       251 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...+    +..                             ...+.++.++..+.+||+.||+.||++||++-+++.+
T Consensus       264 laIl----ng~-----------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  264 LAIL----NGN-----------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             eeEE----ecc-----------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            2111    100                             1122335678899999999999999999999999874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=318.88  Aligned_cols=279  Identities=25%  Similarity=0.380  Sum_probs=232.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .-+..++++.-+.||+||||.||-|+.+.||+.||+|++.+...+. ......+.|-+||.+++.++||.+-.+|+.+..
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            4566778889999999999999999999999999999996543332 334556789999999999999999999998866


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                           +++|+..|+ |+|.-.|-+-  +.|++..++.++.+|+.||++||..+||+||+||+|||+|+.|++.|+|+|++
T Consensus       260 -----LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  260 -----LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             -----eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence                 999999998 5888777553  48999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .............||.+|||||++.+ ..|+...|.|||||++|+|+.|+.||...........+.+.....+       
T Consensus       335 vei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------  406 (591)
T KOG0986|consen  335 VEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------  406 (591)
T ss_pred             EecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-------
Confidence            99888887888899999999999998 7799999999999999999999999976554433322222111111       


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcC------CCCCCC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLHD------LNDEPV  341 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~~------~~~~~~  341 (377)
                                          ..-...+|+++.+|.+.+|..||++|.     .+.++-+||||+.++-      .-..+.
T Consensus       407 --------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPf  466 (591)
T KOG0986|consen  407 --------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPF  466 (591)
T ss_pred             --------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCC
Confidence                                011135799999999999999999998     7889999999998773      334556


Q ss_pred             CCCCCCC
Q 017083          342 CPRPFHF  348 (377)
Q Consensus       342 ~~~~~~~  348 (377)
                      +|.+..+
T Consensus       467 iPdp~aV  473 (591)
T KOG0986|consen  467 IPDPGAV  473 (591)
T ss_pred             CCCcccc
Confidence            6666555

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.4e-43  Score=318.03  Aligned_cols=289  Identities=39%  Similarity=0.637  Sum_probs=223.6

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-----
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-----  115 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----  115 (377)
                      .+.|++.+.||+|++|+||++.++.+|+.||+|.++...........+..|+.++++++|||++++++++.....     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            345568899999999999999999999999999997543333334566789999999999999999999876541     


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      .....+++++||+++++...+... ..+++..++.++.||+.||+|||+.||+|+||+|+||++++++.+||+|||++..
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            011248999999999888887653 4689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          195 TSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       195 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .....  ......++..|+|||.+.+....+.++|||||||++++|++|+.||...+....+..+....+.+........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T cd07864         166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV  245 (302)
T ss_pred             ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence            54332  1223345778999999876456788999999999999999999999988888888888887766654432211


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ............ ..........+..++..+.+++.+||+.||++|||+.+++.||||
T Consensus       246 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         246 IKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            100000000000 000011112234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-42  Score=313.64  Aligned_cols=260  Identities=28%  Similarity=0.404  Sum_probs=209.5

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.|+++++||.|+||.||++.+..++..+++|.+...  .......+.+|+.+++.++||||+++++.+..+..     
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   83 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK-----   83 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe-----
Confidence            34555999999999999999999999999999998654  34456678889999999999999999999887654     


Q ss_pred             EEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ++++|||+++ +|...+.. ...+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            8999999986 66666643 567899999999999999999999999999999999999999999999999988654322


Q ss_pred             -ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          199 -DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                       .......++..|+|||.+.+    ...++.++|+|||||++|+|++|..||...........+   .....+       
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~-------  233 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPP-------  233 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcCCCc-------
Confidence             22234567888999999853    245678999999999999999999999775543322222   111110       


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                        .......++.++.++|++||+.||++||++.++++||||..+..
T Consensus       234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         234 ------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             ------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                              00112346788999999999999999999999999999987653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=315.19  Aligned_cols=279  Identities=41%  Similarity=0.717  Sum_probs=225.0

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.+.||.|++|.||++++..+++.||+|.+............+..|+.++++++|+|++++++++.....     ++++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~~v   76 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK-----LYLV   76 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc-----eEEE
Confidence            36788999999999999999999999999998754334445667789999999999999999999987744     8999


Q ss_pred             EecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-ccc
Q 017083          125 YELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  202 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~  202 (377)
                      +||++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        77 ~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          77 FEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             ecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            999999999999875 579999999999999999999999999999999999999999999999999987654432 223


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ....+..|+|||.+.+...++.++|+||||+++++|++|..||........+..+....+.+.+..+.......  .+..
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  234 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKP  234 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--cccc
Confidence            34557789999998774578999999999999999999999999988887777777766655543322111110  0001


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ..............+.++..+.++|++||+.||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            111111222223345668899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-43  Score=348.35  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=211.8

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||++.++.++..||+|.+............+..|+.++++++||||++++++|.....   ..+|
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~~ly   90 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---QKLY   90 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---CEEE
Confidence            3448999999999999999999999999999997665555566788899999999999999999999865433   3489


Q ss_pred             EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcC-------CceecCCCCCceEEcc----------
Q 017083          123 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-------SVLHRDLKPSNLLLNA----------  180 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~-------~i~H~dik~~NIli~~----------  180 (377)
                      |||||++ ++|.++|..    ...+++..++.|+.||+.||+|||+.       +|+|+||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999998 599888864    35799999999999999999999984       4999999999999964          


Q ss_pred             -------CCCeEEeeeecccccCCCccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 017083          181 -------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (377)
Q Consensus       181 -------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~  252 (377)
                             .+.+||+|||++.............+++.|+|||++.+. ..++.++|||||||++|+|++|..||.......
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~  250 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS  250 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence                   234899999999876555444556789999999998642 457889999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       253 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .+.....  ..+.                            ......+.++.+||.+||+.+|.+||++.++|.||||+.
T Consensus       251 qli~~lk--~~p~----------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        251 QLISELK--RGPD----------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             HHHHHHh--cCCC----------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            2221111  1110                            111345888999999999999999999999999999986


Q ss_pred             CcC
Q 017083          333 LHD  335 (377)
Q Consensus       333 ~~~  335 (377)
                      +..
T Consensus       301 i~~  303 (1021)
T PTZ00266        301 VGP  303 (1021)
T ss_pred             cCC
Confidence            654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7e-43  Score=336.21  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=209.3

Q ss_pred             cCCcccccCCccceEEEEEeCCC-CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||.|++|.||++.+..+ +..||+|.+...  .......+..|+.+++.++||||+++++++..+..     +|
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-----~~  141 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK-----LL  141 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE-----EE
Confidence            44889999999999999998887 788999977543  34445667789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +||||++ |+|.+.+..    ..++++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999997 588877643    45789999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          198 TD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       198 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ..   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....  .          
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~----------  288 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--Y----------  288 (478)
T ss_pred             ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C----------
Confidence            32   2344568999999999977 778999999999999999999999998776544443332210  0          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                        ......++..+.++|.+||..||++||++.+++.|+|++..
T Consensus       289 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 ------------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                              01112468889999999999999999999999999998654

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-42  Score=306.99  Aligned_cols=252  Identities=28%  Similarity=0.474  Sum_probs=208.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|++|.||++.++.+++.||+|.+............+.+|+.++++++|+|++++++.+....    ..+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~l   77 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYI   77 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEE
Confidence            34889999999999999999999999999999765444555667888999999999999999998876432    23789


Q ss_pred             EEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++||++ ++|.+.+..  ...+++..++.++.+++.|+++||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999998 588888865  346899999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...  ..               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------------  219 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KL---------------  219 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CC---------------
Confidence            2334567889999999887 77889999999999999999999999876644433222210  00               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                   .......++.+.+++.+||+.||++|||+.++++||||
T Consensus       220 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         01113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-42  Score=315.09  Aligned_cols=280  Identities=23%  Similarity=0.347  Sum_probs=212.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||+|+||.||++.+..++..+|+|.+.... ......++.+|++++++++||||+++++++..+..     +++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   76 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE-----ISI   76 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE-----EEE
Confidence            558899999999999999999999999999987542 33345668899999999999999999999987754     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++||++ ++|.+++...+.+++..+..++.||++||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  155 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-A  155 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-c
Confidence            999998 5999999888889999999999999999999997 599999999999999999999999999886543322 2


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc------ccc---
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL------GFL---  272 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------~~~---  272 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+............      ...   
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            34567889999999876 66889999999999999999999999766533322222111110000000      000   


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      ..................  ......++.++.+|+.+||..||++|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            000001111111100000  00111367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.9e-42  Score=307.22  Aligned_cols=250  Identities=28%  Similarity=0.453  Sum_probs=209.7

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|++|.||++.++.+++.|++|.+............+.+|+.+++.++|||++++++++.....     .+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv   77 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-----LNIV   77 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE-----EEEE
Confidence            46788999999999999999999999999987654455566778899999999999999999999987754     8999


Q ss_pred             EecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-c
Q 017083          125 YELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~  200 (377)
                      +||++ ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99997 5999988763  578999999999999999999999999999999999999999999999999987654432 2


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....+++.|+|||++.+ ..++.++|+||||+++++|++|..||...........+..   ..                
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~----------------  217 (256)
T cd08529         158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---GV----------------  217 (256)
T ss_pred             hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CC----------------
Confidence            234467888999999987 6788999999999999999999999987764443332221   00                


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                 .......++..+.+++.+||+.+|++||++.++++|||+
T Consensus       218 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 -----------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -----------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                       001111457889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6e-43  Score=322.12  Aligned_cols=260  Identities=21%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||+||+++++.+++.||+|.+.+.. ........+..|..++..++|++|+++++++.....     .|
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~-----~~   77 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY-----LY   77 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-----EE
Confidence            448899999999999999999999999999986532 122234456788999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +||||+. |+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999997 599999876 56789999999999999999999999999999999999999999999999999876543322


Q ss_pred             --ccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          201 --MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       201 --~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                        .....|++.|+|||++.+.    ..++.++||||||+++|+|++|..||...+.......+.....            
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------------  225 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE------------  225 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC------------
Confidence              2235689999999998642    3567899999999999999999999987765554443322100            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                    ..........++..+.++|.+||..++.+  |++++++++||||+.+.
T Consensus       226 --------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         226 --------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             --------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence                          00112223457889999999999976654  57999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=311.57  Aligned_cols=281  Identities=39%  Similarity=0.649  Sum_probs=218.9

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ++++.||.|++|.||+++++.++..||+|.+............+.+|+.+++++   +|+|++++++++..........+
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            478899999999999999998999999999975543333344555677777665   59999999999987654344458


Q ss_pred             EEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++++||++++|.+.+....  .+++..++.++.||++||.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~  161 (287)
T cd07838          82 TLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM  161 (287)
T ss_pred             EEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc
Confidence            9999999999998887643  58999999999999999999999999999999999999999999999999987765544


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+......+.............  
T Consensus       162 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (287)
T cd07838         162 ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR--  238 (287)
T ss_pred             ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch--
Confidence            4444567888999999987 6788999999999999999999999998887777777766554432221111000000  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                        ...............+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 --SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             --hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence              0001111111122234567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-42  Score=313.90  Aligned_cols=252  Identities=25%  Similarity=0.443  Sum_probs=213.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|++++++++||||+++++++.....     ++
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~   77 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN-----LY   77 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe-----EE
Confidence            4478999999999999999999999999999865322 23345667889999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++|||++ ++|.+.+...+.+++..+..++.||++||.+||++|++|+||+|.||+++.++.++|+|||++......  .
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence            9999995 699999988889999999999999999999999999999999999999999999999999998876544  3


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+ ...+.++||||||+++|+|++|..||...........+..   ...                
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~----------------  215 (290)
T cd05580         156 YTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE---GKV----------------  215 (290)
T ss_pred             CCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCc----------------
Confidence            34567889999999876 6788999999999999999999999987664433333221   000                


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                  .....++..+.++|++||..||.+|+     +++|+++||||+...
T Consensus       216 ------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         216 ------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                        01124578899999999999999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-42  Score=311.47  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=209.3

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+++++++.||.|+||.||++.+..++..+++|.+...  .......+.+|+.+++.++|||++++++++.....     
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-----   76 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-----   76 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE-----
Confidence            34567899999999999999999999999999998654  34456677889999999999999999999987644     


Q ss_pred             EEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      .++++||+++ +|...+.. ..++++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            8999999985 67666654 567899999999999999999999999999999999999999999999999998754332


Q ss_pred             -ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          199 -DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                       .......++..|+|||++..    ...++.++|+|||||++|+|++|..||...........+....  .+.       
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------  227 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT-------  227 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--CCC-------
Confidence             22344567889999999842    2456789999999999999999999998765444333322210  000       


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                         ......++..+.++|.+||+.||.+||++.++++||||...
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 -------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                               01112457889999999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-42  Score=312.23  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .+++++.||+|+||+||++.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+.....     .+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-----IS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE-----EE
Confidence            4568899999999999999999999999999986542 23344668899999999999999999999987754     89


Q ss_pred             EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccc
Q 017083          123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      +++||+++...+..   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        76 lv~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~  151 (279)
T cd06619          76 ICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AK  151 (279)
T ss_pred             EEEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-cc
Confidence            99999996433332   357888999999999999999999999999999999999999999999999987654332 33


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCccccccccchhHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL---RLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........   ..........               
T Consensus       152 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  215 (279)
T cd06619         152 TYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---------------  215 (279)
T ss_pred             CCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc---------------
Confidence            4578889999999987 67899999999999999999999999653211100   0000000000               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                              .  .........++++.++|.+||+.||++||++.|+++||||+....
T Consensus       216 --------~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         216 --------D--PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             --------C--CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence                    0  000012246788999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=326.87  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=216.2

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +-|.-++.||.|+||.||.+++..+.+.||||++.... .......++++|+..|++++|||++.+-++|.....     
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----
Confidence            34557899999999999999999999999999997653 344456789999999999999999999999998866     


Q ss_pred             EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .|+|||||-|+-.+++.- .+++-+..+..|+.+.+.||+|||+.+.+|||||..|||+++.|.|||+|||.+....   
T Consensus       101 aWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            899999999987777753 6789999999999999999999999999999999999999999999999999987654   


Q ss_pred             cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      +.+.++|||+|||||++.-  -+.|+-++||||||++..||...++|+...+....+..|..- .+|.-.+.        
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs~--------  248 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSN--------  248 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCCc--------
Confidence            3567899999999999853  378999999999999999999999998777766655555331 11111111        


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                          .-+..+..|+..||++-|.+|||..++|+|+|.+
T Consensus       249 --------------------eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  249 --------------------EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             --------------------hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence                                2377899999999999999999999999999985

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=316.77  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=211.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||+|++|+||++.+..+++.||+|.+...... ......+..|+.+++.++|+||+++++.+.....     .+
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~   77 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY-----LC   77 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE-----EE
Confidence            44788999999999999999999999999999765333 2355678899999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          123 IVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++||+.+ +|.+++...  ..+++..++.++.||++||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999975 898888653  578999999999999999999999999999999999999999999999999986432211


Q ss_pred             ------------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 017083          200 ------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (377)
Q Consensus       200 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~  249 (377)
                                                    ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                                          1123456888999999987 678899999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC----HHHHh
Q 017083          250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT----VEEAL  325 (377)
Q Consensus       250 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps----~~ell  325 (377)
                      .......+..   ...                          .......++..+.++|++||..||++|||    +.+++
T Consensus       237 ~~~~~~~~~~---~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         237 RDETFSNILK---KEV--------------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             hHHHHHHHhc---CCc--------------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            5544433321   000                          00111236889999999999999999999    99999


Q ss_pred             cCccccCCc
Q 017083          326 RHPYLQSLH  334 (377)
Q Consensus       326 ~~p~f~~~~  334 (377)
                      +||||++..
T Consensus       288 ~~~~~~~~~  296 (316)
T cd05574         288 QHPFFRGVN  296 (316)
T ss_pred             cCchhhcCC
Confidence            999999865

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=311.36  Aligned_cols=257  Identities=30%  Similarity=0.436  Sum_probs=210.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++++.||.|++|+||++.+..++..+|+|.+...  .......+..|+.++++++||||+++++.+..+..     +
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   77 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK-----L   77 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe-----E
Confidence            3456899999999999999999989999999998643  44456678899999999999999999999987654     8


Q ss_pred             EEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          122 YIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++|||+++ +|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999985 88888765 457999999999999999999999999999999999999999999999999988654332 


Q ss_pred             ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .......+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...........+..   ...+        
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~--------  226 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPP--------  226 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCC--------
Confidence            22334567888999999752    24567899999999999999999999987654443322211   1100        


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                       .......++..+.++|.+||+.+|.+||++.++++||||.+.
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 -----------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                             001112467889999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-42  Score=307.09  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=204.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC---HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.+.+.||+|+||.||++.+..++..|++|.+......   ......+.+|+.++++++||||+++++++.....   ..
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~   80 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---KT   80 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---CE
Confidence            34788999999999999999999999999998654322   2334567789999999999999999999876432   33


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++++||++ ++|.+.+.....+++...+.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            789999998 489999988788999999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                         .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+   .......        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~---~~~~~~~--------  228 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTNP--------  228 (266)
T ss_pred             ccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH---hcCCCCC--------
Confidence               11223457888999999877 77889999999999999999999999765433332221   1111100        


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                        .....+++.+.++| +||..+|++||+++|+++||||+
T Consensus       229 ------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         229 ------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                              01123577788888 67888999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-42  Score=309.28  Aligned_cols=255  Identities=28%  Similarity=0.386  Sum_probs=206.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.+.+.+.||+|+||.||++++..+++.||+|.++..  .......+.+|+.+++.++||||+++++.+.....     +
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~-----~   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK-----L   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-----E
Confidence            3455889999999999999999999999999998654  22334567789999999999999999999887654     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++++||++ ++|.+++...+.+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999998 599999988889999999999999999999999999999999999999999999999999998754432 2


Q ss_pred             cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ......++..|+|||.+..  ...++.++|+|||||++|+|++|..||..................++            
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------  229 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP------------  229 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC------------
Confidence            2334567889999999742  24578899999999999999999999866543322221111000000            


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                                    .......++..+.++|.+||..+|++|||++++++|||
T Consensus       230 --------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 --------------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --------------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                          00011245778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=309.10  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=210.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|++|.||++.+..++..||+|.+.... .......+.+|+.+++.++|+|++++++++.....     +++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~~   76 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK-----LWI   76 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe-----EEE
Confidence            347899999999999999999999999999987543 23344567889999999999999999999887644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      ++||+++ +|.+.+... ++++..++.++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||++...... ...
T Consensus        77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             EEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            9999985 888888764 8899999999999999999999999999999999999999999999999999776544 223


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...   ..+.              
T Consensus       156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~--------------  217 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---NPPS--------------  217 (274)
T ss_pred             ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---CCCC--------------
Confidence            44567888999999987 66899999999999999999999999776533332222211   0000              


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                ..  ...++..+.+++.+||..+|++|||+.++++||||+....
T Consensus       218 ----------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         218 ----------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ----------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                      00  0126788999999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-42  Score=310.12  Aligned_cols=257  Identities=27%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      +.+.|++++.||+|+||.||++++..+++.||+|++....  ......+.+|+.++++++||||+++++.+.....    
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~----   80 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK----   80 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE----
Confidence            4456779999999999999999999999999999986542  2234567789999999999999999999987654    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                       +++++||++ ++|.+.+....++++..+..++.|++.|+.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        81 -~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          81 -LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             -EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence             899999998 589888887888999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 D-FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      . ......++..|+|||.+..  ...++.++|+||||+++|+|++|..||...........+.....             
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------  226 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-------------  226 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-------------
Confidence            2 2234567888999998742  24567899999999999999999999865442222111111000             


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                                   ..........++..+.+||++||+.+|++|||++++++|+|
T Consensus       227 -------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 -------------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -------------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                         00000011245788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-42  Score=310.72  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=202.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHH-HHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +++++.||+|+||.||+++++.+|+.||+|.+........ ...+..|+.+ ++.++||||+++++++..+..     ++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-----~~   76 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGD-----VW   76 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-----EE
Confidence            4478899999999999999999999999999876543332 3344455554 566789999999999987654     89


Q ss_pred             EEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||++++|.+++..    ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999988877753    34689999999999999999999997 999999999999999999999999999876554


Q ss_pred             CccccccccccccCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccc
Q 017083          198 TDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ........++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||.... ....+..+   .......      
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~------  227 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQ------  227 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCC------
Confidence            4333345678889999988642   346789999999999999999999996532 11221111   1110000      


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                          .....++.++.++|.+||..+|++||+++++++||||+...
T Consensus       228 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         228 --------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             --------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                                00113588899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-42  Score=308.86  Aligned_cols=253  Identities=25%  Similarity=0.461  Sum_probs=211.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||.|+||.||++.+..++..||+|.+.+... .....+.+.+|++++++++||||+++++.+..+..     ++
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~   76 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN-----MY   76 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe-----EE
Confidence            3478899999999999999999999999999976432 22456778899999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +++||+++ +|.+.+....++++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            99999985 89999887778999999999999999999999999999999999999999999999999998876655444


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..................                  
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  217 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA------------------  217 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc------------------
Confidence            55667888999999877 66899999999999999999999999876642111111111000                  


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV--EEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~--~ell~~p~f  330 (377)
                                ........+..+.++|.+||+.||.+||++  +|+++||||
T Consensus       218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                      011123457899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-42  Score=316.80  Aligned_cols=285  Identities=36%  Similarity=0.618  Sum_probs=219.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC---CCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~  120 (377)
                      |.+++.||.|++|.||+++++.++..+|+|.+..............+|+.++++++||||+++++++.....   .....
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            348999999999999999999999999999986543333233456689999999999999999998765432   12234


Q ss_pred             EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++++||+++++...+.. ...+++..++.++.||++||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        90 ~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  169 (311)
T cd07866          90 VYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP  169 (311)
T ss_pred             EEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCC
Confidence            799999999988887764 4579999999999999999999999999999999999999999999999999987543321


Q ss_pred             c------------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          200 F------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       200 ~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      .            .....+++.|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.+.+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T cd07866         170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE  249 (311)
T ss_pred             cccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            1            1223457789999998764567899999999999999999999999888887777777766655443


Q ss_pred             cccccc-chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          268 SLGFLR-SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       268 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...... ......  .......+......+...++.+.++|.+||+.||++|||+.|+++||||
T Consensus       250 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         250 TWPGWRSLPGCEG--VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hchhhhhcccccc--cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            221100 000000  0000011111222344567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-42  Score=314.14  Aligned_cols=265  Identities=27%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  112 (377)
                      .+.+.|.++-|+++++||+||.+.||++.... ...||+|++.....+......+.+|+..|.+|+ |.+|+.++++-..
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            46789999999999999999999999997643 466888888777778888999999999999997 9999999999887


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhCCCCC-HHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLT-DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~-~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ++.     +|+|||+-+.+|..+++...... .-.++.++.|+++|+.++|..||||.||||.|+|+-. |++||+|||.
T Consensus       432 d~~-----lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGI  505 (677)
T KOG0596|consen  432 DGY-----LYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGI  505 (677)
T ss_pred             Cce-----EEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeech
Confidence            755     99999999999999998765443 3588999999999999999999999999999998765 4799999999


Q ss_pred             ccccCCCc---cccccccccccCCCcccccc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017083          192 ARTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       192 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~  258 (377)
                      +.......   .....+||+.||+||++...          -..++++|||||||++|+|+.|+.||..-.  ....++.
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~  583 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH  583 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH
Confidence            98876654   34568999999999999541          125789999999999999999999995422  2222332


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCC--ChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .+....  .                         .-.++.+  ..++.++++.||..||++|||..|||+|||++-+.
T Consensus       584 aI~~P~--~-------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  584 AITDPN--H-------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             hhcCCC--c-------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            221110  0                         1112332  22389999999999999999999999999998633

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-42  Score=309.72  Aligned_cols=259  Identities=24%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .+++++.||+|+||+||++.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+.....     ++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA-----VY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe-----EE
Confidence            3568999999999999999999999999999886542 33345678899999999999999999999887654     89


Q ss_pred             EEEecCCC-CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||+++ +|..++...   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            99999985 787777653   378999999999999999999996 5999999999999999999999999999876543


Q ss_pred             CccccccccccccCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          198 TDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .. .....++..|+|||.+.+.     ..++.++|+|||||++|+|++|..||...........+.......+       
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  227 (286)
T cd06622         156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-------  227 (286)
T ss_pred             Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence            32 2334577889999998542     2347899999999999999999999976554333333332222111       


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                          ....+.++.++.++|.+||+.+|++||++.++++||||.....
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence                                1122346889999999999999999999999999999976553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.5e-42  Score=310.89  Aligned_cols=279  Identities=35%  Similarity=0.627  Sum_probs=207.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||+|+||.||++.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++++..+..     .++
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-----~~l   80 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKET-----LTF   80 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe-----EEE
Confidence            33889999999999999999999999999998654322 223356689999999999999999999987644     899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      ++||+++++.+.+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus        81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            999999988887754 456788889999999999999999999999999999999999999999999998754332 122


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccc-chhHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLR-SDNARR  279 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~-~~~~~~  279 (377)
                      ....+++.|+|||.+.+...++.++||||||+++++|++|..||...... +.+..+....+.+.+....... ......
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            33456888999999876456788999999999999999999999765432 3333343333333222110000 000000


Q ss_pred             HHHhccccccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .+  ............+.  ..+..+.+++.+||..||++|||+.+++.||||
T Consensus       241 ~~--~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EW--FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hh--ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00  00000011111111  236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-42  Score=306.12  Aligned_cols=249  Identities=29%  Similarity=0.486  Sum_probs=205.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-------HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +...||+|++|.||++.+..+++.+|+|.+.......       ...+.+.+|+.++++++||||+++++++.....   
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   80 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH---   80 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc---
Confidence            6788999999999999999999999999886543221       123567789999999999999999999887754   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        .++++||+++ +|.+++...+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 --~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 --LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             --cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence              8999999975 8999998888899999999999999999999999999999999999999999999999999876542


Q ss_pred             Cc-------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          198 TD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       198 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ..       ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...   .      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~------  228 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---A------  228 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---C------
Confidence            21       1122356788999999877 67888999999999999999999999876543333222210   0      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                           .......++..+.++|++||+.||.+||++.++++||||
T Consensus       229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ---------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ---------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                 001113468889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-43  Score=322.18  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=229.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +|.+.+.||+|.|++|.++++..++..||||.+.++..+......+.+|+++|+.++|||||+++.+......     +|
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~-----ly  131 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT-----LY  131 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce-----eE
Confidence            4558999999999999999999999999999999988887777778899999999999999999999987765     99


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +||||+. |.+.+++...+...+..++.++.|++.|++|||+++|+|||||++||+++.+.++||+|||++.........
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence            9999997 699999999999999999999999999999999999999999999999999999999999999999988889


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ...+|++.|.|||++.+....++.+|+||||+++|.|+.|..||.+........+...                      
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------------------  269 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------------------  269 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------------
Confidence            9999999999999999977778999999999999999999999988653322211110                      


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                               ........++.++.+||+++|..+|.+|++.+++++|.|.......
T Consensus       270 ---------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 ---------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ---------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                     0111122468899999999999999999999999999999876655

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.8e-42  Score=304.56  Aligned_cols=253  Identities=31%  Similarity=0.504  Sum_probs=210.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|++|.||++.+..++..||+|.+............+..|++++++++||||+++++.+.....   ..+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~   78 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYI   78 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEE
Confidence            347889999999999999999999999999987655555566778899999999999999999998765433   34799


Q ss_pred             EEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh-----cCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          124 VYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVH-----SASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH-----~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ++||++ ++|.+.+..    ..++++..++.++.||+.||++||     +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            999998 588888865    467899999999999999999999     8999999999999999999999999999998


Q ss_pred             ccCCCcc-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ....... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+....           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  226 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-----------  226 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-----------
Confidence            7654432 344567889999999877 668899999999999999999999998876444333322100           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                         ........+..+.+++.+||+.+|++||++.++++|||+
T Consensus       227 -------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 -------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                               001112567889999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.4e-42  Score=304.89  Aligned_cols=251  Identities=27%  Similarity=0.480  Sum_probs=207.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++.+.||+|++|.||++.++.++..+++|.+...    .....+.+|+.++++++||||+++++.+.....     +
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----~   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTD-----L   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCc-----E
Confidence            3455899999999999999999998999999998653    226778899999999999999999999988754     8


Q ss_pred             EEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      |+++||+++ +|.+.+.. ...+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            999999985 88888865 5678999999999999999999999999999999999999999999999999988665443


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......++..|+|||.+.+ ..++.++||||||+++++|++|..||...........+..   ...             
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------------  216 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPP-------------  216 (256)
T ss_pred             cccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCC-------------
Confidence             2334456888999999877 6788999999999999999999999976543322211100   000             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                  ........++..+.++|.+||+.||++|||+.++|.||||
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 ------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                        0001112457889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.9e-42  Score=305.89  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=209.1

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++.+.||.|++|+||++.+..++..+++|++....... ....+.+|+.+++.++|+|++++++.+.....     .+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~   75 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE-----LW   75 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE-----EE
Confidence            3458899999999999999999999999999987543333 56778899999999999999999999887644     89


Q ss_pred             EEEecCCC-CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          123 IVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      +++|++++ +|.+.+...   ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999985 888888753   45899999999999999999999999999999999999999999999999998755433


Q ss_pred             c-----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          199 D-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       199 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .     ......++..|+|||.+......+.++|+||||+++++|++|..||.............   ...+...     
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-----  227 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL---QNDPPSL-----  227 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh---cCCCCCc-----
Confidence            2     12344678889999998774478999999999999999999999997665433222221   1111000     


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                       .....+..+++.+.+++.+||..||++|||+.++++||||
T Consensus       228 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         228 -----------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                             0001134678899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=309.45  Aligned_cols=278  Identities=38%  Similarity=0.709  Sum_probs=219.5

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      .+.+.||.|++|+||++++..+++.|++|.+...... .......+|+..+++++ |+|++++++++..+..     .++
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~-----~~l   75 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE-----LYF   75 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc-----EEE
Confidence            4788899999999999999999999999998765332 22234457899999999 9999999999988644     899


Q ss_pred             EEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          124 VYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +|||++++|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            99999989999887754  7899999999999999999999999999999999999999999999999999876654444


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+...++.++|+||||+++++|++|..||...........+....+.+....+..  ........
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  233 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE--GYKLASKL  233 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh--Hhhhhccc
Confidence            4566788899999986656689999999999999999999999998888777777777666554332110  00000000


Q ss_pred             -HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 -RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                       ..+............+..+..+.++|++||+.||++|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence             0000000111111223347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-42  Score=310.18  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=207.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+...+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+..     .
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-----~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-----C   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc-----E
Confidence            445788999999999999999999999999998754332 34556788999999996 9999999999877644     7


Q ss_pred             EEEEecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          122 YIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ++++||++.++.++..     ....+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus        79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9999999987666542     24679999999999999999999997 49999999999999999999999999998765


Q ss_pred             CCCccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ..........++..|+|||.+.+.  ..++.++||||||+++|+|++|..||....  .....+.......++..     
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~-----  231 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL-----  231 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-----
Confidence            544334445678889999998763  368899999999999999999999997644  12222222211111000     


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                        .......++..+.+||.+||+.||++|||++++++||||+...
T Consensus       232 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         232 ------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                              0011134688999999999999999999999999999998644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-42  Score=305.14  Aligned_cols=255  Identities=29%  Similarity=0.394  Sum_probs=207.9

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++.+.||.|++|.||++.+..+++.+++|.+....  ......+.+|+.++++++||||+++++.+.....     +
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~   75 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK-----L   75 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCE-----E
Confidence            34458899999999999999999999999999997542  2245678899999999999999999999887654     8


Q ss_pred             EEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++|||+++ +|.+++... .++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999985 888888765 789999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 -FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                       ......++..|+|||.+.+.  ..++.++|+||||+++++|++|..||...........+......++ .         
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-~---------  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-K---------  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-c---------
Confidence             23345678889999998762  2678899999999999999999999987664444333222100000 0         


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                                      .......+.++.+++++||..+|..|||+.+++.|+|
T Consensus       226 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 ----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                            0001234677999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-42  Score=306.17  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=207.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccC----HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ++.+.||+|++|.||++.+..++..||+|.+......    ......+..|+.++++++|+||+++++++.....     
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----   77 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH-----   77 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-----
Confidence            4678899999999999999999999999998754321    1234677889999999999999999999987754     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCCC
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~~  198 (377)
                      +++++||+++ +|.+++...+++++..+..++.||+.||++||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            8999999985 8999988888899999999999999999999999999999999999998876 5899999998765432


Q ss_pred             c-----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          199 D-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       199 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .     ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  228 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------  228 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC--------
Confidence            1     1223456888999999876 6788999999999999999999999975543322222222111000        


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                        .......+++.+.+++.+||+.+|++|||+.++++||||+
T Consensus       229 ------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         229 ------------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                              0111224688899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.8e-42  Score=310.79  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=209.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||.|++|+||++.+..+++.|++|.+....  ......+.+|+.+++.++|||++++++.+.....     +++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   93 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE-----LFV   93 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce-----EEE
Confidence            337889999999999999999999999999986532  2234667889999999999999999999987644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||+++ +|...+. ...+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        94 v~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          94 VMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            9999985 7777665 4568999999999999999999999999999999999999999999999999887544332 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.... .+                 
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~-----------------  233 (296)
T cd06655         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP-----------------  233 (296)
T ss_pred             CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cc-----------------
Confidence            34467889999999877 678899999999999999999999998776544333222100 00                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                .......+++.+.++|++||..||++|||+.++++||||+....
T Consensus       234 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         234 ----------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             ----------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                      00112356888999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=322.25  Aligned_cols=247  Identities=25%  Similarity=0.387  Sum_probs=212.4

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.|+|+=+-+.-++.||+|+.|.||+++.+  ++.||||+++.         .-..+++.|++|+||||+.+.++|....
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence            457887777778999999999999999764  57899998843         1235788999999999999999999887


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .     +|||||||. |-|.+.++.+.++.......|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||.++
T Consensus       186 c-----yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  186 C-----YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             e-----eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            6     899999998 7999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ........-.+.||..|||||++.+ .+++.++|||||||+|||||+|..||...+....+-                  
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw------------------  321 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW------------------  321 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE------------------
Confidence            8877767778999999999999998 889999999999999999999999997654222110                  


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                               .+.  ......+.....+..++-|+++||+..|..||++.++|.|
T Consensus       322 ---------GVG--sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  322 ---------GVG--SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ---------ecc--CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                     000  0011122234678899999999999999999999999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.8e-42  Score=304.51  Aligned_cols=249  Identities=23%  Similarity=0.407  Sum_probs=206.9

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||.|++|.||++++..++..+|+|.+...... ......+.+|+.++++++||||+++++.+..+..     +++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-----IYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc-----cEEEEecC
Confidence            79999999999999999999999999754322 2345678899999999999999999999887754     89999999


Q ss_pred             C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccccccc
Q 017083          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT  207 (377)
Q Consensus       129 ~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  207 (377)
                      + ++|.+.+.....+++..+..++.||++||+|||+++++|+||+|+||+++.++.++|+|||++.............++
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            7 599999988788999999999999999999999999999999999999999999999999999876654333445678


Q ss_pred             cccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCccccccccchhHHHHHHhcc
Q 017083          208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  285 (377)
Q Consensus       208 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (377)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++|..||....  .......+..   ...                    
T Consensus       156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~--------------------  211 (262)
T cd05572         156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK---GNG--------------------  211 (262)
T ss_pred             cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---cCC--------------------
Confidence            89999999876 678899999999999999999999997765  2222222111   000                    


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCC
Q 017083          286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  333 (377)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~  333 (377)
                            ........++.+.++|.+||+.||++||+     +.|+++||||++.
T Consensus       212 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         212 ------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence                  00111234788999999999999999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.6e-42  Score=303.48  Aligned_cols=251  Identities=25%  Similarity=0.451  Sum_probs=208.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||++|++.+..+|+.||+|.+............+.+|+.++++++||||+++++++.....     .++
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~l   76 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN-----LYI   76 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe-----EEE
Confidence            347899999999999999999999999999987543344456678899999999999999999999987744     899


Q ss_pred             EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||+. ++|.+.+...  ..+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999997 5898888653  357899999999999999999999999999999999999999999999999987654432 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ...+.++|+||||+++++|++|..||...........+..  +..               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY---------------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC---------------
Confidence            1223457888999999877 6788899999999999999999999987655444332211  110               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                   ......++.++.++|.+||+.+|++||++.++++||||
T Consensus       219 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 -------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                         11123568889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.6e-42  Score=308.06  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=205.2

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||+|+||+||++.++.+|+.||+|.+...... ......+..|+.++++++||||+++++.+.....     +|+++||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD-----LCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe-----EEEEEecC
Confidence            69999999999999999999999998654222 2234456789999999999999999999987654     89999999


Q ss_pred             C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccccc
Q 017083          129 D-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  205 (377)
Q Consensus       129 ~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~  205 (377)
                      + ++|.+.+....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            8 58998887655  78999999999999999999999999999999999999999999999999987655443344456


Q ss_pred             cccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcc
Q 017083          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  285 (377)
Q Consensus       206 ~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (377)
                      ++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....                       
T Consensus       156 ~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  211 (277)
T cd05577         156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----------------------  211 (277)
T ss_pred             CCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----------------------
Confidence            6788999999877 6688999999999999999999999977553222222211100                       


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                          .........+++.+.++|++||+.||++||     ++.++++||||..+.
T Consensus       212 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         212 ----EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ----cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence                001112235688999999999999999999     999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4e-42  Score=311.23  Aligned_cols=257  Identities=28%  Similarity=0.501  Sum_probs=209.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +++.....||+|+||.||++.+..++..||||.+...  .......+.+|+.+++.++|+||+++++.+.....     .
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-----~   94 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-----L   94 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe-----E
Confidence            3444577899999999999999999999999998653  23345667899999999999999999999887654     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++++||+++ +|.+++. .+.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus        95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999986 6766654 457899999999999999999999999999999999999999999999999998754322 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+........              
T Consensus       174 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  238 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--------------  238 (292)
T ss_pred             cCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc--------------
Confidence            2234567889999999876 6788999999999999999999999987665544433322111100              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                    ......+..+.+++.+||..||++|||+.++++||||.....
T Consensus       239 --------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         239 --------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             --------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence                          011245788999999999999999999999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=314.86  Aligned_cols=283  Identities=38%  Similarity=0.635  Sum_probs=209.8

Q ss_pred             CCcccccCCccceEEEEEeCC--CCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~--~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+++.||+|++|.||++.++.  ++..||+|.+.... ........+.+|+.+++.++||||+++++++.....   ..+
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~   79 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---KSV   79 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---ceE
Confidence            378889999999999999988  89999999997632 112233556789999999999999999999987632   338


Q ss_pred             EEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc----CCCeEEeeeecc
Q 017083          122 YIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA----SCDLKIGDFGLA  192 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~----~~~vkl~Dfg~~  192 (377)
                      ++|+||++++|.+.+..     ...+++..++.++.||+.||+|||+.+++|+||+|+||+++.    ++.+||+|||++
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999999988887753     136889999999999999999999999999999999999999    889999999998


Q ss_pred             cccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHH
Q 017083          193 RTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---------QLRLITE  259 (377)
Q Consensus       193 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~---------~~~~i~~  259 (377)
                      ........    .....++..|+|||.+.+...++.++||||||+++++|++|..||.......         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543321    2334668889999998775668899999999999999999999997654322         3333333


Q ss_pred             HhCCCCcccccc-ccchhHHHHHHhcccccc-----ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          260 LIGSPDDASLGF-LRSDNARRYVRQLPRCRK-----QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       260 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .+..+.+..... ..................     ....+.+...+..+.++|.+||+.||++|||+.|+++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            333332221110 000000000000000000     00011112567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.3e-42  Score=306.57  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=209.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++..+.||.|++|.||++.++.+++.+++|.+..... ......+.+|+.++++++||||+++++.+.....     +++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~l   76 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD-----ISI   76 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE-----EEE
Confidence            4578899999999999999999999999999876533 2445677899999999999999999999887744     899


Q ss_pred             EEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          124 VYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++||++ ++|.+++... ..+++..+..++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999 5999998765 788999999999999999999999 9999999999999999999999999999875543321


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCccccccccchhHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      . ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||.....  ......+.........            
T Consensus       157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------  222 (265)
T cd06605         157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP------------  222 (265)
T ss_pred             h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC------------
Confidence            2 2667888999999877 6789999999999999999999999965421  1111112111111110            


Q ss_pred             HHHHhccccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          279 RYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                     ..... ++..+.++|.+||..||++|||+.+++.||||+..
T Consensus       223 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         223 ---------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ---------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                           00111 68889999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=297.67  Aligned_cols=333  Identities=43%  Similarity=0.747  Sum_probs=265.4

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..|.+..+|. -+..+|.|.- .|..+.|.-.++.||+|+....+.+....++..+|+..+..++|+||++++.+|....
T Consensus        11 s~ftv~~Ry~-nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   11 STFTVPKRYV-NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             cceeeeeeee-eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            4577888888 8899999999 8999999999999999999887777667788889999999999999999999998764


Q ss_pred             C-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      . ..+..+|+|||+|..+|.+.+.  ..++-..+..++.|++.|++|||+.||+||||||+||+++.+..+||.|||++.
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence            3 2334589999999999999987  567888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....-..+.+..+..|.|||++.+ ..+...+||||+||++.||+.|...|++.+..++..++.+..+.+.+.-.....
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             ccCcccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            7766656777888999999999999 559999999999999999999999999999999999999999988776433221


Q ss_pred             chhHHHHHHh------------ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC-CCC
Q 017083          274 SDNARRYVRQ------------LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN-DEP  340 (377)
Q Consensus       274 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~-~~~  340 (377)
                      . ..+.+...            ++........+..+.-+..+.+|+.+||..||++|.|++++|+||||+.....+ .+.
T Consensus       246 ~-~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~a  324 (369)
T KOG0665|consen  246 P-TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEA  324 (369)
T ss_pred             H-HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccC
Confidence            1 11111111            111111111111112345688999999999999999999999999998333222 122


Q ss_pred             CCCCCCCCCcCCCCCChHHHHHHHHHHHhhcCC
Q 017083          341 VCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      ..|.+.+-.+.-...+.+++++++.+|--.|++
T Consensus       325 p~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  325 PPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             CCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            222223233334455699999999999998887

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-41  Score=303.31  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEecccccc----CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.+.||+|+||+||++.+ .++..+|+|.+.....    .......+.+|+.+++.++|+||+++++++.....     
T Consensus         3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   76 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-----   76 (265)
T ss_pred             cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe-----
Confidence            4788899999999999987 5788999998864321    22334567789999999999999999999987744     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++++||+++ +|.+++....++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            8999999975 89999888788999999999999999999999999999999999999999999999999998754221 


Q ss_pred             ------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          199 ------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       199 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                            .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------  226 (265)
T ss_pred             ccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC---------
Confidence                  11233457888999999877 67889999999999999999999999775544333222211110         


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                         .......++..+.++|++||+.+|++||++.++++||||
T Consensus       227 -------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                               011123568889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=297.98  Aligned_cols=274  Identities=25%  Similarity=0.398  Sum_probs=226.1

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      |-.-.+.||+|+|+.|--|....+|..||||++.+..  .....+..+|++++...+ |+||+.++++|+++..     +
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-----F  151 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-----F  151 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-----E
Confidence            4434668999999999999999999999999998863  334677889999999997 9999999999999876     9


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeecccccCC
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSE  197 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~~~~~~  197 (377)
                      |+|||.+. |.|++.|...+-|++.++.+++.+|+.||.+||.+||.|||+||+|||....+.   ||||||.+......
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999997 599999999999999999999999999999999999999999999999987665   79999999764322


Q ss_pred             C--------ccccccccccccCCCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          198 T--------DFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       198 ~--------~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      .        .-..+.+|+..|||||+..    ....|+.+.|.||||+++|-||+|+.||.+.-..+        ++   
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------CG---  300 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--------CG---  300 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------CC---
Confidence            1        1234577888999999963    22568999999999999999999999997753110        00   


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                       =..+..+..=.......+....-......|..+|.++.+||.++|..|+.+|.++.++++|||++....
T Consensus       301 -WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  301 -WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             -ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence             011223334455556666666666677778899999999999999999999999999999999986553

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-41  Score=302.29  Aligned_cols=251  Identities=29%  Similarity=0.407  Sum_probs=209.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|++|.||++.+..++..+|+|.+............+.+|+.++++++|||++++++.+.....     +++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~l   76 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA-----LMI   76 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE-----EEE
Confidence            347889999999999999999999999999997654444556778899999999999999999999876644     899


Q ss_pred             EEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCCCc
Q 017083          124 VYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~~~  199 (377)
                      ++||+++ +|.+++...  ..+++..+..++.+++.|+++||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999985 899988753  4589999999999999999999999999999999999998655 57999999998766554


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+....  .               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~--~---------------  218 (256)
T cd08220         157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT--F---------------  218 (256)
T ss_pred             cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC--C---------------
Confidence            4445677889999999877 668899999999999999999999997765444333222100  0               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                   ......++..+.+++.+||+.||++|||+.|++.||||
T Consensus       219 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 -------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                         01112468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.2e-42  Score=306.01  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=202.9

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCC-CCcEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT-FNDVY  122 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~-~~~~~  122 (377)
                      ++.+.||+|+||+||++.+..+++.||+|.+....   .....+..|+.+++++ +|+||+++++++....... ...++
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            47889999999999999999999999999986542   2235677899999998 6999999999987643221 23488


Q ss_pred             EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          123 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++||++ ++|.+++...  ..+++..+..++.|++.|++|||+++++|+||+|+||++++++.++|+|||++...... 
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            9999998 4898888753  46899999999999999999999999999999999999999999999999998765432 


Q ss_pred             ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .......++..|+|||++.+    ...++.++|+|||||++|+|++|..||...........+..   ..          
T Consensus       166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~----------  232 (272)
T cd06637         166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP----------  232 (272)
T ss_pred             ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC----------
Confidence            22334567889999999863    13577899999999999999999999976543322211110   00          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                      ........++..+.+|+.+||..||.+|||+.++++||||
T Consensus       233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ----------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                            0001122467889999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.4e-42  Score=309.76  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||+|++|.||++.+..++..|++|.+.....  .....+.+|+.+++.++|+|++++++.+..+..     .++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~-----~~l   94 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWV   94 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE-----EEE
Confidence            3378899999999999999999999999999875432  234667889999999999999999999887644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      |+||+++ +|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            9999984 88887754 568999999999999999999999999999999999999999999999999887543322 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..  ...+                
T Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--~~~~----------------  234 (296)
T cd06654         174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTP----------------  234 (296)
T ss_pred             CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--CCCC----------------
Confidence            33467889999999877 6778999999999999999999999977654332221111  0000                


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                .......++..+.++|.+||..||++|||+.++++||||....
T Consensus       235 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         235 ----------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ----------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                      0011234678899999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-41  Score=306.23  Aligned_cols=254  Identities=20%  Similarity=0.187  Sum_probs=204.0

Q ss_pred             eeecccccCCc--ccccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhcCCCCceeEeeeecC-
Q 017083           37 FEVSSKYVPPI--RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRP-  112 (377)
Q Consensus        37 ~~i~~~~~~~~--~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-  112 (377)
                      ..+..+.+...  ..||+|++|.||++..  +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.+ 
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            34444444444  6789999999999977  68899999997653322 224677799999999999999999999876 


Q ss_pred             -CCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeee
Q 017083          113 -PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       113 -~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                       ...   ..++++|||++ |+|.+.+...+.+++.....++.+++.||.+||+ .+++||||||+||+++.++.+||+||
T Consensus        91 ~~~~---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988         91 VDDL---PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             ccCC---CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence             221   33899999998 5899999888889999999999999999999998 49999999999999999999999999


Q ss_pred             ecccccCCCccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          190 GLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       190 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      |++......  .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+......+    
T Consensus       168 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----  241 (283)
T PHA02988        168 GLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----  241 (283)
T ss_pred             chHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----
Confidence            998765433  2344678899999998652 568999999999999999999999998876554443332211000    


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               ......++.+.+|+.+||+.||++|||+.|+++
T Consensus       242 -------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                     011246888999999999999999999999985

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-41  Score=300.85  Aligned_cols=251  Identities=29%  Similarity=0.485  Sum_probs=211.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||.|+||.||.+++..++..+++|.+............+.+|+.++++++|+||+++++++.....     +++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~~   76 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT-----LLI   76 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe-----EEE
Confidence            347899999999999999999999999999987654455566778899999999999999999999988754     899


Q ss_pred             EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||++ ++|.+.+...  ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.+||+|||++....... 
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999998 5999988764  568999999999999999999999999999999999999999999999999987654433 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|.|||.+.+ ..++.++|+||||+++++|++|..||...........+..  +..               
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------------  218 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNY---------------  218 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCC---------------
Confidence            2344567899999999877 5678899999999999999999999987665444433321  000               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                   ......++..+.++|.+||..+|.+||++.++++|||+
T Consensus       219 -------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 -------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                         01113568889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-41  Score=302.52  Aligned_cols=257  Identities=29%  Similarity=0.448  Sum_probs=213.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +++.+.||.|++|.||++++..+++.|++|++...... .....+.+|+.++.+++|+|++++++++.....     +++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~l   76 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE-----ISI   76 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe-----EEE
Confidence            44789999999999999999999999999998765322 456778899999999999999999999987744     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++||++ ++|.+++....++++..+..++.|+++|+++||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            999999 6999999888889999999999999999999999 99999999999999999999999999998866544322


Q ss_pred             -cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          202 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       202 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+........               
T Consensus       157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------------  220 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---------------  220 (264)
T ss_pred             ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---------------
Confidence             24567888999999877 6788999999999999999999999977642111111222111111               


Q ss_pred             HHhccccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  ...... ++..+.++|.+||..+|++|||+.++++||||+...
T Consensus       221 ------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 ------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                        011123 688899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-41  Score=308.35  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||.||++.++.+++.|++|.+..... .......+.+|+.+++.++||||+++++.+..+..     ++
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~   77 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH-----LC   77 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE-----EE
Confidence            4478999999999999999999999999999865422 12234567789999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      ++|||++| +|.+.+...+.+++..+..++.|++.||.|||+++++|+||+|.||+++.++.++|+|||++.......  
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999985 899999888889999999999999999999999999999999999999999999999999876321100  


Q ss_pred             --------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          200 --------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       200 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                                    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+.......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                          0112356778999999877 6789999999999999999999999987665443333322110000


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  334 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~ell~~p~f~~~~  334 (377)
                                                  .....++..+.++|++||+.||++||+   +.++++||||....
T Consensus       237 ----------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         237 ----------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ----------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                                        011246888999999999999999997   89999999997644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.5e-42  Score=311.16  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=207.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||+|++|.||++.+..++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++.....     +++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~l   93 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWV   93 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE-----EEE
Confidence            338899999999999999999999999999986542  2234567889999999999999999999987654     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            9999985 88887754 568899999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. .+.+                 
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------------  233 (297)
T cd06656         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------------  233 (297)
T ss_pred             CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------------
Confidence            34567888999999877 7788999999999999999999999976543222111100 0000                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                .......++..+.+|+.+||..||++||++.++++||||+.....
T Consensus       234 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         234 ----------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             ----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence                      001122467889999999999999999999999999999876643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-42  Score=330.96  Aligned_cols=284  Identities=24%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcE-EEEEe--------------cccc-ccCHHHHHHHHHHHHHHHhcCCCCceeE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREE-VAIKK--------------IGNA-FDNIIDARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~-valK~--------------~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      .|++++.||+|+||+||+|..+..... .+.|.              +.+. .........+.+|+.++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            355999999999999999976543221 22221              1111 1122234567789999999999999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~  181 (377)
                      ++++.....     .|++++++.++|.+++...     .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       229 ~~~~~~~~~-----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSEAN-----TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEECCe-----eEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            999987755     8999999999988877542     233466788899999999999999999999999999999999


Q ss_pred             CCeEEeeeecccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHH
Q 017083          182 CDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK--DYVHQLRL  256 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p-f~~~--~~~~~~~~  256 (377)
                      +.+||+|||++.......  ......|+..|+|||++.+ ..++.++|||||||++|+|++|..+ +...  .....+..
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            999999999997654332  2334578999999999987 7789999999999999999998754 4322  22233333


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccc-cccccccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPR-CRKQQFAT--RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      +...+......... . ......++..... ........  ....++..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus       383 ~~~~~~~~~~~~p~-~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        383 IIDSLSVCDEEFPD-P-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHhcccChhhcCC-c-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            33322221111100 0 0001111111000 00000000  112457788999999999999999999999999999764


Q ss_pred             c
Q 017083          334 H  334 (377)
Q Consensus       334 ~  334 (377)
                      .
T Consensus       461 ~  461 (501)
T PHA03210        461 E  461 (501)
T ss_pred             C
Confidence            4

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-41  Score=318.47  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..+.|.++.+.+++.+.||+|+||.||++++...     +..||+|++..... ......+.+|+.+++.+ +|+||+++
T Consensus        29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeE
Confidence            4456778888888999999999999999986443     35799999975432 23456678999999999 79999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------------------------------------
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------------------------------------  139 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------------------------------------  139 (377)
                      ++++.....     ++++|||++ |+|.+++...                                              
T Consensus       108 ~~~~~~~~~-----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (374)
T cd05106         108 LGACTHGGP-----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV  182 (374)
T ss_pred             eeEecCCCC-----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence            999987755     899999998 5888887532                                              


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          140 ------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       140 ------------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                                              .++++..++.++.||+.||+|||++|++||||||+||++++++.++|+|||++...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~  262 (374)
T cd05106         183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI  262 (374)
T ss_pred             ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence                                    24678889999999999999999999999999999999999999999999998754


Q ss_pred             CCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          196 SETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       196 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      .....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......        
T Consensus       263 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~--------  333 (374)
T cd05106         263 MNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ--------  333 (374)
T ss_pred             cCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC--------
Confidence            43221   112234567999999877 778999999999999999997 99999765433322222110000        


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           .......++++.+++.+||+.||++|||+.++++
T Consensus       334 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 ---------------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---------------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 0011235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-41  Score=304.80  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=197.8

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccccCHH-HHHHHHHHHHHHH---hcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLR---HMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .||+|+||.||++.+..+++.+|+|.+.+...... .......+..+++   ..+||+++.+++.+.....     .+++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK-----LCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe-----EEEE
Confidence            48999999999999999999999999865432222 1222334443333   3469999999999987654     8999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      |||++ ++|.+.+...+.+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++....... ...
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence            99998 5888888888889999999999999999999999999999999999999999999999999987544332 233


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..++..|+|||.+.+...++.++||||+||++|+|++|..||......... .+.......                   
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~-------------------  214 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTV-------------------  214 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcC-------------------
Confidence            467899999999865356789999999999999999999999754321111 111110000                   


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                              .......++..+.++|++||+.||++||     |+.|+++||||+.+.
T Consensus       215 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         215 --------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             --------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence                    0111235688999999999999999999     699999999998755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-41  Score=299.83  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=207.9

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc---CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      ..+.||+|++|+||++.+..++..|++|.+.....   .......+..|+.+++.++|+||+++++++.....     ++
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~   78 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN-----LY   78 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe-----EE
Confidence            66889999999999999998999999999865321   12345677899999999999999999999887654     89


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +++||+++ +|.+.+.....+++..++.++.||+.|+++||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence            99999985 89999988778999999999999999999999999999999999999999999999999998765544434


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.....++.++|+||||+++|+|++|..||...........+....                    
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------  218 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--------------------  218 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--------------------
Confidence            456678889999998763338899999999999999999999997765333222221100                    


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                               ........+++.+.+++++||+.+|++||++.+++.|||+
T Consensus       219 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ---------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ---------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                     0011123568889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.4e-41  Score=305.09  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||+|+||.||++.++.+++.+|+|.+...   ......+..|+.+++++ +|||++++++++..........++
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            34888999999999999999999999999998643   12335567899999999 799999999998765432234589


Q ss_pred             EEEecCCC-CHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||+++ +|.+++.    ....+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            99999975 8888775    346789999999999999999999999999999999999999999999999999876543


Q ss_pred             Cc-cccccccccccCCCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          198 TD-FMTEYVVTRWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       198 ~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .. ......++..|+|||.+....    .++.++|||||||++|+|++|..||...........+..   ......    
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~----  253 (291)
T cd06639         181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTL----  253 (291)
T ss_pred             ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCC----
Confidence            22 223446788899999975422    357899999999999999999999987654443332221   111000    


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                           ......+..+.++|.+||+.+|++||++.|+++||||+
T Consensus       254 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 ---------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                 00123467799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=284.14  Aligned_cols=265  Identities=28%  Similarity=0.332  Sum_probs=211.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .....|.++-|++.+.||+|||+.||++++..+++.||+|++...  .....+..++|+...++++|||+++++++...+
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            445677888888999999999999999999999999999999775  345677889999999999999999999988776


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCCCeEE
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~~vkl  186 (377)
                      ..++-...||+++|.. |+|.+.+..    +..+++.++..|+.+|++||++||+..  +.||||||.||++++.+.++|
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence            6655566999999997 789998864    336899999999999999999999998  999999999999999999999


Q ss_pred             eeeecccccCCC-----c-----cccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017083          187 GDFGLARTTSET-----D-----FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (377)
Q Consensus       187 ~Dfg~~~~~~~~-----~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~  254 (377)
                      .|||.+....-.     +     .......|..|+|||++.-.  ...+.++|||||||++|.|+.|..||..-      
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------  244 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------  244 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH------
Confidence            999998753311     1     01224558889999998532  44688999999999999999999999531      


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                         ...-++..                  +.-...+...+....+|..+.++|+.||++||.+||++.+++.+
T Consensus       245 ---~~~GgSla------------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  245 ---YQQGGSLA------------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ---hhcCCeEE------------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               11000000                  00001111112223479999999999999999999999999864

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-41  Score=304.58  Aligned_cols=261  Identities=21%  Similarity=0.346  Sum_probs=210.6

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ....+++++.||+|++|+||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++.+.....    
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----   77 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN----   77 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE----
Confidence            3455668999999999999999999999999999886542 23345678899999999999999999999988744    


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                       +++++||+++ +|.+.+...+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          78 -ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             -EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence             8999999985 888888877889999999999999999999997 6899999999999999999999999998865432


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHHHHhCCCCcccc
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ--------LRLITELIGSPDDASL  269 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~--------~~~i~~~~~~~~~~~~  269 (377)
                      .. .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........        ...+.......     
T Consensus       157 ~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (284)
T cd06620         157 SI-ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----  229 (284)
T ss_pred             hc-cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence            21 234567889999999877 6788999999999999999999999976543210        01111111000     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                         ...  .....++..+.+|+.+||+.||++|||+.|+++|+||....
T Consensus       230 -------------------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         230 -------------------PPR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             -------------------CCC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                               000  00113577899999999999999999999999999997644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-41  Score=301.68  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=204.4

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccC--------HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.+.||.|++|.||++.+..+|+.+|+|.+......        ....+.+..|+.++++++|||++++++++.....  
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   82 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY--   82 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc--
Confidence            778899999999999999999999999988542111        1123456789999999999999999999887644  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         .++++||++ ++|.+.+...+++++..++.++.||+.||.+||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ---~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          83 ---LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             ---eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence               899999997 5899998887889999999999999999999999999999999999999999999999999987543


Q ss_pred             CCc---cccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          197 ETD---FMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       197 ~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...   ......++..|+|||.+.... .++.++|+||||++++++++|..||...........+..   ..        
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~--------  228 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KR--------  228 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cc--------
Confidence            221   123345688899999987633 478899999999999999999999976543332221111   00        


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                    ..........+.++..+.++|.+||..+|++|||++++++||||
T Consensus       229 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 --------------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             --------------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                          00001112234578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-41  Score=299.95  Aligned_cols=254  Identities=26%  Similarity=0.481  Sum_probs=205.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc---cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.+.+.||+|+||.||.+.+..+++.||+|.+....   ........+.+|+.++++++||||+++++++.....   ..
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~   80 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---RT   80 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---ce
Confidence            347889999999999999999999999999885432   122345677889999999999999999998876432   33


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++++||++ ++|.+.+...+.+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            789999998 589999887778899999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                         .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........   .....+..         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~---------  227 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIATQPTN---------  227 (265)
T ss_pred             ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH---HHhcCCCC---------
Confidence               11233457888999999977 678899999999999999999999997654333322   21111110         


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                       ......++..+.++|.+||. +|++||+++++++|||+.
T Consensus       228 -----------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 -----------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             -----------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                             11123457789999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-41  Score=303.42  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=202.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCC-CCCCc
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK-DTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  120 (377)
                      .+++.+.||.|+||+||++.+..+++.+|+|.+...   ......+..|+.+++++ +|+||+++++++..... .....
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            344788999999999999999999999999998653   23445677899999998 69999999999864321 12245


Q ss_pred             EEEEEecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          121 VYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ++++|||+++ +|.+++..  ...+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            8999999985 88888865  34578888999999999999999999999999999999999999999999999875442


Q ss_pred             C-ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          198 T-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       198 ~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      . .......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...........+..   ...       
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~-------  243 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP-------  243 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCC-------
Confidence            2 22334567889999999753    24577899999999999999999999976543322221111   000       


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                         .......++..+.+||++||+.||.+|||+.|+++||||
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                               001112468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-41  Score=307.73  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=207.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      ++.....||.|+||.||++.+..++..||+|.+....  ......+.+|+.+++.++|||++++++.+..+..     .+
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-----~~   94 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-----LW   94 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe-----EE
Confidence            3445668999999999999999999999999986532  2234567789999999999999999999887654     89


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-c
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~  200 (377)
                      +++||+++ +|.+++. ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        95 iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659          95 VLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             EEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence            99999985 7776654 4678999999999999999999999999999999999999999999999999987543321 2


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..   ....              
T Consensus       174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~--------------  235 (297)
T cd06659         174 RKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP--------------  235 (297)
T ss_pred             ccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCC--------------
Confidence            234567889999999977 6789999999999999999999999987665444433321   1100              


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                 .......++..+.++|.+||+.+|++||++.++++||||....
T Consensus       236 -----------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         236 -----------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             -----------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                       0111235678899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-41  Score=315.23  Aligned_cols=268  Identities=25%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             CceeEEEEEecc----eeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHH
Q 017083           24 GGKYVQYNVYGN----LFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKL   94 (377)
Q Consensus        24 ~~~~~~~~~~~~----~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~   94 (377)
                      ++++..+++.--    .+.++.+.+++.+.||+|+||+||++++     ..++..||+|+++.... ......+.+|+.+
T Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~i   91 (375)
T cd05104          13 GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKV   91 (375)
T ss_pred             CceEEEecCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHH
Confidence            445555554432    4566677788999999999999999974     34567899999865432 2344667889999


Q ss_pred             HHhc-CCCCceeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC--------------------------------
Q 017083           95 LRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--------------------------------  140 (377)
Q Consensus        95 l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~--------------------------------  140 (377)
                      ++.+ +||||+++++++.....     .+++|||++ |+|.+++....                                
T Consensus        92 l~~l~~HpnIv~l~~~~~~~~~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  166 (375)
T cd05104          92 LSYLGNHINIVNLLGACTVGGP-----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLN  166 (375)
T ss_pred             HHHhcCCcceeeeeeeeccCCc-----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhh
Confidence            9999 79999999999988755     899999998 58888875421                                


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceE
Q 017083          141 -------------------------------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (377)
Q Consensus       141 -------------------------------------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIl  177 (377)
                                                                 .+++..+..++.||+.||+|||++|++||||||+||+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  246 (375)
T cd05104         167 EYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNIL  246 (375)
T ss_pred             hhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEE
Confidence                                                       4677888999999999999999999999999999999


Q ss_pred             EccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017083          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (377)
Q Consensus       178 i~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~  253 (377)
                      ++.++.++|+|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus       247 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~  325 (375)
T cd05104         247 LTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK  325 (375)
T ss_pred             EECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH
Confidence            99999999999999876543321   112233567999999987 778999999999999999997 8889976543332


Q ss_pred             HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       254 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .........                             ........+.++.+||.+||+.||++|||+.++++.
T Consensus       326 ~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         326 FYKMIKEGY-----------------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHhCc-----------------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            221111000                             000112347789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=298.15  Aligned_cols=294  Identities=46%  Similarity=0.809  Sum_probs=249.7

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ..++++-+.||.|+||+||.++|..+|+.||+|++.....+-...+.+.+|+.+|.-++|.|++..+++......+-+..
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            45677889999999999999999999999999999887777777788899999999999999999999988877766677


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +|+++|.+..+|+.+|-+-..++.+.++-+++||++||.|||+.||.||||||.|.|++.+..+||||||+++.....+ 
T Consensus       132 iYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            8999999999999999999999999999999999999999999999999999999999999999999999998765443 


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......-|.+|+|||.+.+...|+.+.||||+||++.|++..+..|...+..+++..|.++++.+..+.++..+...-.
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             3445566899999999999888999999999999999999999999999999999999999999988777665544333


Q ss_pred             HHHHhcccccccccccc---CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATR---FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ..+..-.+.........   ......+...++.+||..||.+|.+..+.+.|++....+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            33332211111111111   112345688999999999999999999999999986554

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.1e-41  Score=303.79  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ..+.+++++.||+|+||+||++.+..+++.+|+|++....   .....+..|+.+++++ +||||+++++++........
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            3344458999999999999999999999999999886431   1234567899999999 69999999998864432223


Q ss_pred             CcEEEEEecCCC-CHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          119 NDVYIVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ..++++|||+++ +|.+++.    .+..+++..++.++.|+++||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            458999999984 8887764    34568899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc-cccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          194 TTSETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       194 ~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ...... ......+++.|+|||.+..    ...++.++|||||||++|+|++|..||...........+..   ..... 
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-  248 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPT-  248 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCc-
Confidence            654322 2234467889999999853    14478899999999999999999999976543332221111   00000 


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                              .......+..+.++|.+||+.||++|||+.|+++|+||
T Consensus       249 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 ------------------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                    00011246789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=299.07  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=201.3

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHH-HhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLL-RHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||.|++|.||++.+..+++.||+|.+.+.... ......+..|..++ ...+|+|++++++++.....     +++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY-----LYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-----EEEEE
Confidence            5699999999999999999999999998654221 12223334454443 45579999999999987644     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY  204 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~  204 (377)
                      ||++ ++|.+++...+.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9997 59999998888899999999999999999999999999999999999999999999999998875433   2234


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhc
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  284 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (377)
                      .++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+......                     
T Consensus       154 ~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  211 (260)
T cd05611         154 VGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------------  211 (260)
T ss_pred             CCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---------------------
Confidence            56788999999887 55889999999999999999999999877655544333221000                     


Q ss_pred             cccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCc
Q 017083          285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  334 (377)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~ell~~p~f~~~~  334 (377)
                            ........++..+.+++.+||+.||++||   ++.|+++||||..++
T Consensus       212 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         212 ------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                  00111225688999999999999999999   457999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.8e-41  Score=297.89  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=208.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|++|.||++.+..++..|++|.+............+..|+.+++.++|+||+++++.+.....     ++++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----~~lv   77 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-----VYIF   77 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE-----EEEE
Confidence            37889999999999999999999999999997765444567788899999999999999999999876644     8999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc---
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---  200 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---  200 (377)
                      +||++ ++|.+.+.....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99998 58999988877799999999999999999999999999999999999999999999999999876544322   


Q ss_pred             --ccccccccccCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          201 --MTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       201 --~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        .....++..|+|||.+.+..  ..+.++||||||+++++|++|..||............  ......           
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~-----------  224 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHK-----------  224 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCC-----------
Confidence              12345678899999987622  2788999999999999999999999765422222111  111100           


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                    ...+....++..+.++|++||+.+|.+|||+.+++.|||+
T Consensus       225 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 --------------PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             --------------CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                          0011123458889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=300.45  Aligned_cols=280  Identities=31%  Similarity=0.553  Sum_probs=219.2

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC--CC----CceeEeeeecCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HE----NVIAIKDIIRPP  113 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~~~~  113 (377)
                      ..+|. +++.+|+|.||.|-.|.+..++..||||+++.-   ..-.+..+-|+++++++.  .|    .+|.+.++|...
T Consensus        88 ~~Ry~-i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYE-IVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccee-hhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            44455 999999999999999999999999999999653   222344556899999994  22    366777778776


Q ss_pred             CCCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-----------
Q 017083          114 KKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----------  180 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-----------  180 (377)
                      +.     .|||+|.++-++.+++..++  +++...++.+.+|+++++++||+.+++|-||||+||++-.           
T Consensus       164 gh-----iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GH-----ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             Cc-----eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            44     89999999999999998754  7899999999999999999999999999999999999821           


Q ss_pred             ---------CCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 017083          181 ---------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (377)
Q Consensus       181 ---------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~  251 (377)
                               +..|+|+|||.++......  .....|..|+|||++.+ -.+++++||||+||+|+|+.+|...|...++.
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     2348999999998766653  55677899999999999 88999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccchhHHHHHHhc-----------------cccccccccccC-CCCChhHHHHHHHhcCC
Q 017083          252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQL-----------------PRCRKQQFATRF-PNKSSGAVDLLEKMLVF  313 (377)
Q Consensus       252 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~-~~~~~~~~~li~~~L~~  313 (377)
                      +.+..++.++++.|........   ..++...-                 ..+.+....... ......+.|||++||..
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            9999999999966654432221   11111100                 000000000000 01233588999999999


Q ss_pred             CCCCCCCHHHHhcCccccCCc
Q 017083          314 DPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       314 dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ||.+|+|+.|+|.||||....
T Consensus       393 DP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  393 DPARRITLREALSHPFFARLT  413 (415)
T ss_pred             CccccccHHHHhcCHHhhcCC
Confidence            999999999999999998654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7e-41  Score=305.39  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|.+.+.||+|++|+||++.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++..+..     
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-----   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT-----   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe-----
Confidence            34558899999999999999999999999999986432 233344678899999999999999999999987654     


Q ss_pred             EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .++++||+.|++.+.+.. ..++++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            899999999998888764 567899999999999999999999999999999999999999999999999998765433 


Q ss_pred             cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                        ....++..|+|||.+.+  ...++.++||||||+++|+|++|..||...+.......+..   .....          
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~----------  233 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPT----------  233 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCC----------
Confidence              23456788999998752  25678899999999999999999999977654443322211   00000          


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                      ......+..+.++|.+||+.||++||++.+++.||||+..
T Consensus       234 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         234 ----------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ----------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                            0011246789999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=293.59  Aligned_cols=283  Identities=21%  Similarity=0.312  Sum_probs=229.8

Q ss_pred             cCceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCC
Q 017083           23 HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHE  101 (377)
Q Consensus        23 ~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~  101 (377)
                      .......+-...+.+.+.....+-+..||.|+||+|++..|+.+|+..|||.++.... +....+++.|+....+- +.|
T Consensus        45 ~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   45 YSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             hccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCc
Confidence            3333455556677888999999999999999999999999999999999999987643 34556777888776665 589


Q ss_pred             CceeEeeeecCCCCCCCCcEEEEEecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCc
Q 017083          102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN  175 (377)
Q Consensus       102 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~N  175 (377)
                      |||++||+...++.     .||.||.|+-+|..+.+     ....+++..+-.|....+.||.||.. .+|+|||+||+|
T Consensus       124 ~IVkfyGa~F~EGd-----cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSN  198 (361)
T KOG1006|consen  124 NIVKFYGALFSEGD-----CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSN  198 (361)
T ss_pred             HHHHHhhhhhcCCc-----eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhh
Confidence            99999999877765     89999999998887765     35679999999999999999999995 589999999999


Q ss_pred             eEEccCCCeEEeeeecccccCCCccccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017083          176 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (377)
Q Consensus       176 Ili~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~  254 (377)
                      ||++..|.+||||||.+.....+-......|...|+|||.+.... .++.++|+||||+++||+.+|..||..-  ...+
T Consensus       199 ILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w--~svf  276 (361)
T KOG1006|consen  199 ILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW--DSVF  276 (361)
T ss_pred             eEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH--HHHH
Confidence            999999999999999998777666666677888899999997644 4899999999999999999999888553  3344


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ..+..+....++...                      .......++..+.++|..||.+|-+.||..++++++||+.-..
T Consensus       277 eql~~Vv~gdpp~l~----------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  277 EQLCQVVIGDPPILL----------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHHHcCCCCeec----------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            444443333222211                      0111235788999999999999999999999999999997655


Q ss_pred             C
Q 017083          335 D  335 (377)
Q Consensus       335 ~  335 (377)
                      .
T Consensus       335 ~  335 (361)
T KOG1006|consen  335 V  335 (361)
T ss_pred             h
Confidence            3

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-41  Score=301.80  Aligned_cols=255  Identities=25%  Similarity=0.480  Sum_probs=209.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +.-...||.|++|.||++.+..+++.+++|.+...  .......+.+|+.+++.++|||++++++++.....     .++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~-----~~~   93 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-----LWV   93 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe-----EEE
Confidence            33567899999999999999999999999988543  23344567889999999999999999999887644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||+++ +|.+.+.. .++++..+..++.|++.|+++||++|++||||+|+||+++.++.++|+|||.+....... ..
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            9999974 88888776 678999999999999999999999999999999999999999999999999876543322 12


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...   .+..              
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~--------------  234 (285)
T cd06648         173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPK--------------  234 (285)
T ss_pred             ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCC--------------
Confidence            33457889999999877 67889999999999999999999999776654444333221   1000              


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                 ......++..+.+++.+||+.+|++|||+.++++||||+...+
T Consensus       235 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         235 -----------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             -----------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                       0111236788999999999999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.6e-41  Score=305.17  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             cccccCCcccccCCccceEEEEEeCC----------------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV  103 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  103 (377)
                      +...+++.++||+|+||.||+|.+..                ++..||+|.+.... .......+.+|+.++.+++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            44556689999999999999998643                34479999987543 23345678899999999999999


Q ss_pred             eeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHhc
Q 017083          104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------QQLTDDHCQYFLYQLLRGLKYVHS  163 (377)
Q Consensus       104 v~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------------------~~~~~~~~~~i~~qi~~al~~LH~  163 (377)
                      +++++++.....     .+++|||++ ++|.+++...                   ..+++..+..++.||+.||+|||+
T Consensus        82 v~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          82 IRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             eEEEEEEecCCc-----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999987654     899999997 5898887542                   235677889999999999999999


Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  240 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~  240 (377)
                      .||+|+||||+||+++.++.+||+|||++........   .....++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999876543321   222344678999999877 778999999999999999986


Q ss_pred             --CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCC
Q 017083          241 --REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  318 (377)
Q Consensus       241 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  318 (377)
                        +..||...........+........                       ........+.++..+.+|+.+||+.||++|
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~R  292 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCRER  292 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence              5677877655544443332211110                       000111223568889999999999999999


Q ss_pred             CCHHHHh
Q 017083          319 ITVEEAL  325 (377)
Q Consensus       319 ps~~ell  325 (377)
                      ||+.++.
T Consensus       293 Ps~~~i~  299 (304)
T cd05096         293 PSFSDIH  299 (304)
T ss_pred             cCHHHHH
Confidence            9999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-41  Score=300.94  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=204.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCC-CCCCc
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK-DTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  120 (377)
                      .|++.+.||.|++|+||++.++.+++.+++|.+....   .....+.+|+.+++++ +|+||+++++++..... .....
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3448899999999999999999999999999987542   2346788999999999 69999999999876542 22345


Q ss_pred             EEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          121 VYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ++++|||+++ +|.+++..    +..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            8999999985 88887754    457899999999999999999999999999999999999999999999999998754


Q ss_pred             CCC-ccccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          196 SET-DFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       196 ~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ... .......++..|+|||.+...    ..++.++||||||+++|+|++|..||...........+..   ......  
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~--  238 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTL--  238 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCC--
Confidence            332 223345678889999987531    3467789999999999999999999976544333322211   111000  


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                             ......+..+.+||.+||..||++|||+.++++|||+
T Consensus       239 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 -----------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                   0011357789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-40  Score=298.32  Aligned_cols=250  Identities=28%  Similarity=0.433  Sum_probs=199.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ....||+|+||.||++.+..++..|++|.+...  .......+.+|+.+++.++|+||+++++++..+..     .++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~   84 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF-----FKIFM   84 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE-----EEEEE
Confidence            445799999999999999999999999988654  33455678899999999999999999999987754     89999


Q ss_pred             ecCC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCCCc-
Q 017083          126 ELMD-TDLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       126 e~~~-~~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ||++ ++|.+.+... ..+  ++..+..++.||+.||+|||++||+|+||+|+||+++. ++.++|+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9998 5899888753 445  78888999999999999999999999999999999986 6789999999987654322 


Q ss_pred             cccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.................                
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------------  228 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------------
Confidence            22334568889999998652 2378899999999999999999999975432211110000000                


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                  ........+++.+.+++++||+.+|++|||+.+++.||||
T Consensus       229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        0011123467889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.3e-41  Score=299.38  Aligned_cols=251  Identities=22%  Similarity=0.395  Sum_probs=205.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++....+.+.+.||.|++|.||++.++.+++.||+|.+...   ......+.+|+.++++++|+||+++++++..... 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   76 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   76 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC-
Confidence            455566666889999999999999999999999999998653   2345678899999999999999999999887654 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          ++++|||++ ++|.+.+...  ..+++..+..++.|+++||+|||++|++|+||||+||++++++.++|+|||++.
T Consensus        77 ----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          77 ----FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             ----cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence                899999997 5899888653  358899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ........  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....         
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------  222 (263)
T cd05052         153 LMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------  222 (263)
T ss_pred             ccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---------
Confidence            65543221  12233567999999876 778899999999999999998 999998766544433332110         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           ........+.++.++|.+||+.||++|||+.++++
T Consensus       223 ---------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ---------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                 00112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.6e-41  Score=300.29  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=201.5

Q ss_pred             ecccccCCcccccCCccceEEEEEeC---CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      +..+.+++.+.||+|+||.||++.++   ..+..||+|.++... .......+.+|+.++++++||||+++++++..+..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            34455668899999999999999875   345689999997643 23345678899999999999999999999987644


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           .++||||+++ +|.+++.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++++|||.+.
T Consensus        81 -----~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          81 -----MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             -----cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence                 8999999985 78877765 4578999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccc--ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .........  ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||...........+.+...        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------  226 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------  226 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------
Confidence            543222111  2233567999999877 788999999999999999775 9999987765554444322100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .+....++..+.+++.+||+.+|.+||++.++++
T Consensus       227 ----------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 ----------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                  1112356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6e-41  Score=302.22  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=203.7

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCC-----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      -..+++++.||+|+||.||++.+...+     ..|++|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            345678999999999999999886655     679999987542 33345668899999999999999999999987654


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                           .++++||++ ++|.+++...                ..+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus        83 -----~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~  157 (283)
T cd05048          83 -----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV  157 (283)
T ss_pred             -----eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence                 899999998 5999988654                457888999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017083          179 NASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~  254 (377)
                      ++++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999987543322   1233455788999999877 678999999999999999998 99999877655443


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ..+...   .                           .......++.++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~---~---------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSR---Q---------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcC---C---------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            333221   0                           011123568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-40  Score=299.85  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=198.5

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccccCHHH-HHHHHHH---HHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID-ARRTLRE---IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~-~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .||+|+||.||++.+..+++.||+|.+.+....... ......|   +..++...||+|+++++.+.....     ++++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-----~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK-----LSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE-----EEEE
Confidence            389999999999999999999999998754322111 1223333   344445679999999999987754     8999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      +||+. ++|...+...+.+++..++.++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcC
Confidence            99998 4888888877889999999999999999999999999999999999999999999999999987544332 234


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..++..|+|||.+.+...++.++||||+|+++|+|++|..||..................                    
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  214 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------------  214 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------------
Confidence            568899999999876456889999999999999999999999765322111111100000                    


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                              ........+..+.+++.+||..+|.+||     ++.++++||||....
T Consensus       215 --------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         215 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence                    0011124588999999999999999999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.5e-41  Score=300.73  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |..++.||.|+||.||.+.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+..+..     .++
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   79 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK-----LWI   79 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-----EEE
Confidence            447889999999999999999999999999987542 23345678899999999999999999999987754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      +|||+++ +|.+.+.. +++++..+..++.|++.|+++||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            9999985 88887764 578999999999999999999999999999999999999999999999999987654332 12


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..   .                  
T Consensus       159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~------------------  216 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK---N------------------  216 (277)
T ss_pred             ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---C------------------
Confidence            23456788999999876 6789999999999999999999999976553332221110   0                  


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                               ........++..+.+++.+||+.+|++||++.++++||||....
T Consensus       217 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         217 ---------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ---------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                     00111224577899999999999999999999999999997644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.6e-41  Score=299.05  Aligned_cols=249  Identities=31%  Similarity=0.485  Sum_probs=206.2

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||.|++|.||++.+..+|+.+++|.+..... .......+.+|+.++++++||||+++++.+..+..     .|+++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN-----LYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE-----EEEEEecC
Confidence            6899999999999999999999999875432 22345677889999999999999999999887644     89999999


Q ss_pred             CC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--------
Q 017083          129 DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--------  199 (377)
Q Consensus       129 ~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--------  199 (377)
                      ++ +|.+++...+.+++..+..++.||++||++||+.+++|+||+|+||+++.++.++|+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            74 999999887789999999999999999999999999999999999999999999999999987543321        


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......++..|+|||.+.+ ...+.++|+||||+++++|++|..||...........+...  ...             
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------------  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE-------------  219 (265)
T ss_pred             ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC-------------
Confidence             2233456788999999877 56889999999999999999999999877655444333220  000             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCccccCC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYLQSL  333 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~ell~~p~f~~~  333 (377)
                                    ......++..+.+++++||+.+|++|||+   .++|+||||..+
T Consensus       220 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 --------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             --------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                          00011248889999999999999999999   999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.9e-41  Score=308.88  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI  109 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~  109 (377)
                      +|+++.+-|++.+.||.|+||.||++.+.     .+++.||+|++..... ......+.+|+.+++++ +|+||++++++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            36778788889999999999999999753     3457899999875432 23345677899999999 79999999998


Q ss_pred             ecCCCCCCCCcEEEEEecCCC-CHHHHHHhC-------------------------------------------------
Q 017083          110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------------------------------------------------  139 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~-------------------------------------------------  139 (377)
                      +....    ..+++++||+++ +|.+.+...                                                 
T Consensus        80 ~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          80 CTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             EecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            76543    238899999984 888877532                                                 


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc---ccccc
Q 017083          140 ------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY  204 (377)
Q Consensus       140 ------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~  204 (377)
                                  .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......   .....
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~  235 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  235 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence                        257888999999999999999999999999999999999999999999999997653221   11223


Q ss_pred             ccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       205 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      .++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.........                      
T Consensus       236 ~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------------------  292 (337)
T cd05054         236 RLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG----------------------  292 (337)
T ss_pred             CCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc----------------------
Confidence            44667999999987 788999999999999999997 999997644322221111100                      


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                          .   ........++++.+++.+||+.+|++||++.|++++
T Consensus       293 ----~---~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 ----T---RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ----C---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                0   000112457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-40  Score=295.58  Aligned_cols=250  Identities=30%  Similarity=0.511  Sum_probs=210.7

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||.|++|.||++.+..++..|++|.+............+.+|+++++.++|||++++++.+.....     .+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-----~~lv   77 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK-----LCIV   77 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE-----EEEE
Confidence            47889999999999999999999999999997765555566778899999999999999999999987744     8999


Q ss_pred             EecCCC-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          125 YELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +||+++ +|.+.+...    ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999985 899888763    779999999999999999999999999999999999999999999999999987655443


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......+++.|+|||.+.+ ...+.++|+||||+++++|++|..||...........+..   ..              
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~--------------  219 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK---GQ--------------  219 (258)
T ss_pred             ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc---CC--------------
Confidence             2334567888999999877 6688999999999999999999999977664433322211   00              


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                   .......++..+.+++++||..+|++|||+.++|+||||
T Consensus       220 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 -------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                         011112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-41  Score=303.52  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=206.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |..++.||+|+||.||++.+..++..||+|.+..... ......+.+|+.++++++||||+++++.+..+..     +++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   79 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK-----LWI   79 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc-----eEE
Confidence            3377889999999999999999999999999875432 2345678899999999999999999999987644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      |+||+++ +|.+.+. .+++++..++.++.|+++|+.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          80 IMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            9999985 7777765 4678999999999999999999999999999999999999999999999999987654432 12


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..   .                  
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~------------------  216 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK---N------------------  216 (277)
T ss_pred             hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc---C------------------
Confidence            23456888999999877 6788999999999999999999999875443222211100   0                  


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                               .........+..+.++|.+||+.+|++||++.++++||||....
T Consensus       217 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ---------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                     00011124577899999999999999999999999999997644

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-40  Score=292.57  Aligned_cols=250  Identities=31%  Similarity=0.501  Sum_probs=208.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+.+.||+|++|.||++.+..++..+++|++.....  .....+.+|+.++++++|++++++++.+.....     .++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~l   74 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE-----LWI   74 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-----EEE
Confidence            4478899999999999999998999999999976532  355678899999999999999999999987744     899


Q ss_pred             EEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          124 VYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ++||++ ++|.+.+... ..+++..+..++.|++.|+.+||++|++||||+|+||+++.++.++|+|||.+.........
T Consensus        75 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  154 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR  154 (253)
T ss_pred             EEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence            999999 5898888765 68999999999999999999999999999999999999999999999999998776654334


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ...+.++|+||||+++++|++|..||...........+..  ...+.               
T Consensus       155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~---------------  216 (253)
T cd05122         155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPG---------------  216 (253)
T ss_pred             cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCC---------------
Confidence            45667888999999877 6688999999999999999999999987654433332221  00000               


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                                 ......++..+.++|.+||+.||++|||+.++++|||
T Consensus       217 -----------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 -----------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -----------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                       0001123788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-41  Score=300.32  Aligned_cols=255  Identities=25%  Similarity=0.421  Sum_probs=206.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC---CCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |.+++.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.++++++   |||++++++++..+..     
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~-----   76 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR-----   76 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE-----
Confidence            4578899999999999999999999999999875432 234456778999999997   9999999999887654     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .+++|||+++ +|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            8999999975 88887755 578999999999999999999999999999999999999999999999999987655432


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+..   ..++            
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~------------  220 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKPP------------  220 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CCCC------------
Confidence             233446788899999987645678899999999999999999999976543322211100   0000            


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  ..  .....+.++.+++.+||+.||++||++.++++||||++..
T Consensus       221 ------------~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         221 ------------RL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------------CC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                        00  0112578899999999999999999999999999997644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-40  Score=293.99  Aligned_cols=254  Identities=29%  Similarity=0.463  Sum_probs=211.7

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|++|.||++.+..++..|++|.+............+.+|+.++++++||||+++++.+.....   ..++++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv   79 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK---NTLNIF   79 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC---CeEEEE
Confidence            36788999999999999999999999999997765444567788899999999999999999999987621   238999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc---
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---  200 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---  200 (377)
                      +||++ ++|.+.+.....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99996 69999988877999999999999999999999999999999999999999999999999999987665543   


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||.......  ..+.....                  
T Consensus       160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~------------------  218 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS------------------  218 (260)
T ss_pred             ccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc------------------
Confidence            445667888999999877 568999999999999999999999998765111  11111110                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                              ...........+..+.++|.+||..||++||++.++++||||
T Consensus       219 --------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                    000111122458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-40  Score=301.56  Aligned_cols=271  Identities=22%  Similarity=0.364  Sum_probs=213.6

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeee
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDII  110 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~  110 (377)
                      +.+..+.+.-+.+++.+.||+|++|+||++.++.++..||+|.+...... .....+..|+.++.++. ||||+++++++
T Consensus         5 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618           5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             ecceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            45566677777888999999999999999999999999999999754322 23445566777666665 99999999999


Q ss_pred             cCCCCCCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEee
Q 017083          111 RPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGD  188 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~D  188 (377)
                      .....     .+++|||+++.+.+++.. ...+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++.++|+|
T Consensus        84 ~~~~~-----~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          84 ITDSD-----VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             ecCCe-----EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence            87754     899999999888887765 4578999999999999999999997 5999999999999999999999999


Q ss_pred             eecccccCCCccccccccccccCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       189 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      ||++.............++..|+|||.+.+.   ..++.++||||||+++|+|++|..||......  ...+........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~  236 (296)
T cd06618         159 FGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEP  236 (296)
T ss_pred             cccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCC
Confidence            9998765544333444567889999998652   24788999999999999999999999764322  111222111110


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ..                         .+....++.++.+|+.+||..||.+||++.++++||||+....
T Consensus       237 ~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         237 PS-------------------------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CC-------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            00                         0001135788999999999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.9e-41  Score=307.20  Aligned_cols=282  Identities=19%  Similarity=0.242  Sum_probs=205.5

Q ss_pred             cccccCC--ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G--~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ...||.|  +||+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..+..     .+++
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-----~~~v   77 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-----LWVI   77 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc-----eEEE
Confidence            3457777  88999999999999999999987654444456778899999999999999999999988755     8999


Q ss_pred             EecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          125 YELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +||+. +++.+++...  ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++++||+.........  
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99998 4888887753  458899999999999999999999999999999999999999999999998653221110  


Q ss_pred             ------cccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc-c
Q 017083          200 ------FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG-F  271 (377)
Q Consensus       200 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~  271 (377)
                            ......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............   .++..... .
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDIT  234 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc---CCCCCCcccc
Confidence                  01112235669999998763 3468899999999999999999999987654433322221   11110000 0


Q ss_pred             ccchhHHHHHHhc-------c----------c-cccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          272 LRSDNARRYVRQL-------P----------R-CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       272 ~~~~~~~~~~~~~-------~----------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      .............       .          . .............++.+.+||++||+.||++|||++|+|+||||.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence            0000000000000       0          0 00000111123457889999999999999999999999999999887


Q ss_pred             cCC
Q 017083          334 HDL  336 (377)
Q Consensus       334 ~~~  336 (377)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-40  Score=293.89  Aligned_cols=241  Identities=20%  Similarity=0.325  Sum_probs=197.1

Q ss_pred             cccCCccceEEEEEe--CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           49 PIGRGAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +||+|+||.||++.+  ..++..+|+|++..........+.+..|+.+++.++||||+++++++....      .+++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES------WMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC------cEEEEe
Confidence            699999999999964  456788999998766555556678889999999999999999999875432      689999


Q ss_pred             cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc----
Q 017083          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----  201 (377)
Q Consensus       127 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~----  201 (377)
                      |++ ++|.+++.....+++..+..++.|++.||++||++|++|+||||.||+++.++.++|+|||++.........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            998 589999988788999999999999999999999999999999999999999999999999998765443211    


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....                   
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------------  215 (257)
T cd05116         156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------------  215 (257)
T ss_pred             CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------------
Confidence            12233568999999866 678889999999999999997 999998765544333332100                   


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                 ..+....+++++.++|.+||+.||++||++.+|..
T Consensus       216 -----------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 -----------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                       01112356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-40  Score=296.30  Aligned_cols=243  Identities=23%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             Ccccc--cCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPI--GRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~l--g~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +.+.+  |+|+||.||++.++.++..+|+|.+.......       .|+.....+ +|||++++++.+.....     ++
T Consensus        18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~-----~~   85 (267)
T PHA03390         18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKG-----HV   85 (267)
T ss_pred             cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCe-----eE
Confidence            55555  99999999999999999999999986532111       122222222 69999999999988754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCCCcc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++|||++ ++|.+++..+.++++..++.++.||++||.+||+.|++|+||+|+||+++.++ .++|+|||++......  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999997 59999998878999999999999999999999999999999999999999998 9999999998765433  


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ-LRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                       ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||........ ...+....                  
T Consensus       164 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  223 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------------------  223 (267)
T ss_pred             -ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------------------
Confidence             23456888999999977 6788999999999999999999999975432221 11111100                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~ell~~p~f~~  332 (377)
                                .......+..++.+.+||.+||+.+|.+||+ ++++|+||||.+
T Consensus       224 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 ----------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ----------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                      0111222357899999999999999999996 699999999974

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-40  Score=298.62  Aligned_cols=263  Identities=23%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.++.||.|++|.||++.+..+++.+|+|.+..... ......+.+|++++++++||||++++++|.....   ..++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv   79 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIA   79 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEEEE
Confidence            378899999999999999999999999999875432 2345678899999999999999999999865543   348999


Q ss_pred             EecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          125 YELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      |||+++ +|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999984 88776642    4568899999999999999999999999999999999999999999999999986544332


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....  ..................         
T Consensus       160 -~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------  228 (287)
T cd06621         160 -AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL---------  228 (287)
T ss_pred             -cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh---------
Confidence             223456788999999877 6788999999999999999999999976521  011111111111000000         


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  ..........++.+.++|.+||+.+|++|||+.|+++||||++..
T Consensus       229 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         229 ------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                        000000112367799999999999999999999999999996544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-40  Score=295.85  Aligned_cols=250  Identities=29%  Similarity=0.510  Sum_probs=205.5

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|+||.||++.++.+|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+.....     ++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~-----~~lv   77 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR-----LFIV   77 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe-----EEEE
Confidence            37888999999999999999999999999986543333345667789999999999999999999887754     8999


Q ss_pred             EecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC-eEEeeeecccccCCCc-
Q 017083          125 YELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETD-  199 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~-vkl~Dfg~~~~~~~~~-  199 (377)
                      +||+++ +|.+.+....  .+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||.+....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999974 8988886533  4789999999999999999999999999999999999998865 6999999987654432 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..   ..               
T Consensus       158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---------------  218 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---GY---------------  218 (257)
T ss_pred             cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cc---------------
Confidence            2233457888999999876 6788999999999999999999999987654433322211   00               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                  .....+..+.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                        111123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-40  Score=302.28  Aligned_cols=253  Identities=27%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+...+.||+|+||+||++++..++..+|+|.+.... ........+.+|+.++++++|||++++++++..+..     .
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT-----A  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-----E
Confidence            3557889999999999999999999999999986542 233345678889999999999999999999987754     8


Q ss_pred             EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++++||++|+|.+.+.. ..++++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++.....   
T Consensus       101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            99999999998887754 56789999999999999999999999999999999999999999999999998865433   


Q ss_pred             ccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          201 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .....++..|+|||.+..  ....+.++|+||||+++|+|++|..||...........+......               
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  242 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------  242 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC---------------
Confidence            233467888999999742  256788999999999999999999999776544444333221100               


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                    .......++.+.+++.+||+.+|.+||++.++++|+|+..
T Consensus       243 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         243 --------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             --------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                          0011245778999999999999999999999999999954

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.5e-40  Score=300.75  Aligned_cols=252  Identities=26%  Similarity=0.421  Sum_probs=206.9

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ..+.||+|++|+||++++..++..|++|.+..... .......+.+|+.+++.++|||++++++++.....     .+++
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv   99 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT-----AWLV   99 (313)
T ss_pred             cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-----EEEE
Confidence            67789999999999999999999999999865422 23344567889999999999999999999988754     8999


Q ss_pred             EecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      +||+.+++.+.+.. ..++++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++.....   ...
T Consensus       100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~  176 (313)
T cd06633         100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANS  176 (313)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCC
Confidence            99999998888765 45789999999999999999999999999999999999999999999999998864332   234


Q ss_pred             cccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          204 YVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ..++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+...  ..+                
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~----------------  238 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP----------------  238 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCC----------------
Confidence            567888999999852  256788999999999999999999999776654444333211  000                


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                 .......+..+.+|+.+||+.+|.+||++.+++.||||+...
T Consensus       239 -----------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         239 -----------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             -----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                       001124567899999999999999999999999999998533

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.5e-41  Score=300.52  Aligned_cols=250  Identities=31%  Similarity=0.509  Sum_probs=209.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      |.+.+.||+|++|.||++.++.++..||+|++..... .......+..|+.++++++ ||||+++++++..+..     .
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-----~   77 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN-----L   77 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce-----E
Confidence            3488899999999999999999999999999876422 2334466778999999998 9999999999887654     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +++||+++ ++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999995 69999998888999999999999999999999999999999999999999999999999999875543221


Q ss_pred             ---------------------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          201 ---------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       201 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                                           .....++..|+|||.+.+ ..++.++|+||||++++++++|..||...........+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                 123355788999999877 6688999999999999999999999988764444433322


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYL  330 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f  330 (377)
                      ...                               .....+++.+.++|.+||+.+|++|||+    .++++||||
T Consensus       237 ~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 LEY-------------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             cCC-------------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            110                               0112458889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-40  Score=299.98  Aligned_cols=257  Identities=26%  Similarity=0.488  Sum_probs=209.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .++....+||+|+||.||++.++.++..||+|++...  .......+.+|+.+++.++|+|++++++.+.....     .
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~   92 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-----L   92 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE-----E
Confidence            3444567899999999999999999999999988543  23345668889999999999999999999987654     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +++|||+++ +|.+.+ ...++++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        93 ~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657          93 WVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             EEEEecCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence            999999986 676655 44578999999999999999999999999999999999999999999999999886544322 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+......                
T Consensus       172 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----------------  234 (292)
T cd06657         172 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------------  234 (292)
T ss_pred             cccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc----------------
Confidence            1233457888999998876 67789999999999999999999999876655444333221100                


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                  .......+++.+.+++.+||+.||.+||++.++++||||.....
T Consensus       235 ------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 ------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                        00112346888999999999999999999999999999987663

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=291.78  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=211.0

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||+|++|.||++.+..+++.|++|.+............+.+|++++++++|+|++++++++.....     ++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~~v   77 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS-----LYII   77 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE-----EEEE
Confidence            47889999999999999999999999999998765544566788899999999999999999999887644     8999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc-cc
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MT  202 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~-~~  202 (377)
                      +||+++ +|.+.+....++++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999985 8999988888899999999999999999999999999999999999999999999999999986654432 23


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..                       
T Consensus       158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------------  213 (254)
T cd06627         158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-----------------------  213 (254)
T ss_pred             ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------------
Confidence            4566888999999877 5588999999999999999999999976553322222110                       


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                             .........++..+.+++.+||..+|++|||+.++++||||
T Consensus       214 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 -------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                   00111123568889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.3e-40  Score=292.34  Aligned_cols=242  Identities=23%  Similarity=0.378  Sum_probs=194.7

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEec
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  127 (377)
                      +.||+|+||+||+++++.+++.+|+|.+.... .......+.+|++++++++||||+++++++.....     +++++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-----IYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC-----eEEEEee
Confidence            46999999999999999999999999886543 23345678899999999999999999999987754     8999999


Q ss_pred             CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccc---
Q 017083          128 MD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---  202 (377)
Q Consensus       128 ~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~---  202 (377)
                      ++ ++|.+.+... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..........   
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            97 5898888654 468999999999999999999999999999999999999999999999999987544321111   


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....                   
T Consensus       155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-------------------  214 (252)
T cd05084         155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------------------  214 (252)
T ss_pred             CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------------
Confidence            1122456999999877 678899999999999999997 8888876554433322221000                   


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                 .......+..+.+|+.+||+.+|++|||+.++++
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -----------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0111245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.5e-40  Score=297.32  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      |++..+.+++.+.||+|++|+||++.++.     ++..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45566777799999999999999998643     35679999986432 2334556789999999999999999999998


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                      ....     .+++|||++ ++|.+++....          .++...+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus        80 ~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~  154 (277)
T cd05062          80 QGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  154 (277)
T ss_pred             CCCC-----eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence            7654     899999998 58988886522          3567788999999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999875433221   112234677999999877 778999999999999999998 7889987665544433


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      +...  ..                            .......+..+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~--~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         234 VMEG--GL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHcC--Cc----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2221  00                            01112457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-40  Score=295.25  Aligned_cols=250  Identities=22%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+.++++++||+|++|.||++.+. ++..||+|.+...   ....+.+.+|+.++++++|+||+++++.+..... 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   75 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP-   75 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence            5677788889999999999999999874 5577999988643   2235678899999999999999999999887654 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .++++||++ ++|.+++..  ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          76 ----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             ----cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence                899999997 599998865  3568888999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....         
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------  221 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------  221 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---------
Confidence            6543321  122334667999999876 678889999999999999998 999998765544443332210         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           ..+....++.++.+++.+||..+|++|||++++++
T Consensus       222 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 ---------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 01112356888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=317.33  Aligned_cols=252  Identities=28%  Similarity=0.441  Sum_probs=206.9

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      .||+|.||+||.++|+.+...+|||.+...  +.....-+.+|+.+.+.|+|.|||+++|.+..++.     +-|.||-+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf-----~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF-----FKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-----EEEEeecC
Confidence            589999999999999999999999999765  33345567789999999999999999999888765     77899999


Q ss_pred             CC-CHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCCC-cccc
Q 017083          129 DT-DLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET-DFMT  202 (377)
Q Consensus       129 ~~-~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~~-~~~~  202 (377)
                      +| +|.+++++. +++  .+..+-.+.+||++||.|||++.|||||||-+||||+. .|-+||+|||.++....- ....
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            85 888888753 455  78889999999999999999999999999999999975 778999999999876544 4466


Q ss_pred             ccccccccCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          203 EYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ++.||+-|||||++.. ...|+.++|||||||++.||.+|++||......+...--.-...                   
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-------------------  795 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-------------------  795 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-------------------
Confidence            7889999999999965 35689999999999999999999999976554332211000000                   


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                               .-++....++.+++.||.+|+.+||.+||+|+++|.+||++.-+.
T Consensus       796 ---------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  796 ---------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             ---------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence                     001122356888999999999999999999999999999987643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-40  Score=297.04  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +.+++.||.|+||.||++.+..++..||+|.+..... ......+.+|+.++++++||||+++++.+..+..     .++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   79 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----LWI   79 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe-----EEE
Confidence            4478889999999999999999999999998864322 2345677889999999999999999999987754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      ++||+++ +|.+.+. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          80 IMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            9999985 7777765 4578999999999999999999999999999999999999999999999999987554332 12


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....++..|+|||.+.+ ...+.++|+||||+++++|++|..||...........+..   ..                 
T Consensus       159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-----------------  217 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---NN-----------------  217 (277)
T ss_pred             ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc---CC-----------------
Confidence            23456888999999876 6778899999999999999999999976554333322211   00                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                .......++.++.++|.+||+.+|.+||++.++++||||...
T Consensus       218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 ----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                      001112468889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-40  Score=301.49  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=207.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |.+++.||+|+||+||++.+..++..|++|.+...  .....+.+.+|+.++++++|||++++++.+.....     .++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-----~~l   93 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE-----LWV   93 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc-----EEE
Confidence            34889999999999999999889999999998643  22334667889999999999999999999887644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      |+||+++ +|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            9999985 88887754 468899999999999999999999999999999999999999999999999876544332 22


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...........+..   ..                 
T Consensus       173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---~~-----------------  231 (293)
T cd06647         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NG-----------------  231 (293)
T ss_pred             ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---CC-----------------
Confidence            33467888999999877 6788999999999999999999999976543322211110   00                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                              .........++..+.++|++||..+|++||++.+++.|+||+..+..
T Consensus       232 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~  278 (293)
T cd06647         232 --------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL  278 (293)
T ss_pred             --------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence                    00001122457789999999999999999999999999999887754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-42  Score=314.60  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=216.2

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccc--ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA--FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .+|.+.-..||+|+|-+||++.|..+|..||.-.++..  ........++..|+.+|+.|+||||+++|.++.+...   
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence            45666778899999999999999999999996655322  2345556888999999999999999999999988766   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEcc-CCCeEEeeeecccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~-~~~vkl~Dfg~~~~  194 (377)
                      ..+-+|+|.+. |+|..+.+..+..+...++.|+.||++||.|||++.  |+|||||-+||||+. .|.|||+|+|+|..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            33678999997 899999999999999999999999999999999885  999999999999986 57899999999998


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...... ....|||.|||||++.  ..|+..+||||||+.++||+++.+||..-....++.+  ++.....+.+...   
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK--KV~SGiKP~sl~k---  267 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK--KVTSGIKPAALSK---  267 (632)
T ss_pred             hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH--HHHcCCCHHHhhc---
Confidence            776653 3489999999999997  4899999999999999999999999987555544432  2233333322211   


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                             --.+++++||.+||.. .+.|||+.|||+||||+.-
T Consensus       268 -----------------------V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 -----------------------VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------------------cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                   1267899999999999 9999999999999999874

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-40  Score=304.16  Aligned_cols=276  Identities=22%  Similarity=0.290  Sum_probs=202.6

Q ss_pred             cccCC--ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           49 PIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        49 ~lg~G--~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +||+|  ++|.||++++..+++.||+|++............+.+|+.+++.++|+||+++++++.....     .+++||
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~-----~~~~~e   79 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE-----LYVVSP   79 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe-----EEEEEe
Confidence            34444  55667888888899999999997654445567788999999999999999999999987755     899999


Q ss_pred             cCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-----
Q 017083          127 LMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-----  198 (377)
Q Consensus       127 ~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-----  198 (377)
                      |++ ++|.+++..  ...+++..++.++.|+++||+|||+++|+|+||+|+||+++.++.++|+|||.+......     
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            998 588888865  346889999999999999999999999999999999999999999999999988643221     


Q ss_pred             ---ccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                         .......++..|+|||.+.+. ..++.++|+|||||++++|++|..||.........  +....+..+.....    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~----  233 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDK----  233 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCcccccc----
Confidence               112334557789999998653 35788999999999999999999999876544332  12222211110000    


Q ss_pred             hhHHHHHHhc---------cccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          275 DNARRYVRQL---------PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       275 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ..........         ..............++.++.+|+.+||+.||++|||++++|+||||+...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence            0000000000         000000011111234678899999999999999999999999999987663

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-40  Score=294.20  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=204.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||.|+||.||++.+..++..+|+|.++... .....+.+.+|+.+++.++|+||+++++.+..+..     +++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   75 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH-----LYI   75 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-----EEE
Confidence            347899999999999999999999999999986542 23355677889999999999999999999987754     899


Q ss_pred             EEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      ++||++ ++|.+.+..  ...+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999998 588888764  3458899999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+....                  
T Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  216 (255)
T cd08219         156 YACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------------  216 (255)
T ss_pred             ccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC------------------
Confidence            2334567888999999877 678999999999999999999999998766544433332110                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                  .......++..+.++|.+||+.||++|||+.++++.
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                        001112457789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-40  Score=295.08  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.+...|.+++.||.|+||+||++.++. +..+++|.+...  .......+..|+.+++.++|+||+++++++.....  
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   76 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP--   76 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC--
Confidence            4455667799999999999999999987 889999998754  23345678889999999999999999999987755  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                         ++++|||+++ +|.+++..  ...+++..+..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        77 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          77 ---VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             ---eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence               8999999985 99999875  34689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          195 TSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       195 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  222 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR----------  222 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------
Confidence            543321 122334667999999877 678899999999999999998 8999987665544444332100          


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                          .......+..+.+++.+||+.||++|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 --------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                0112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=292.50  Aligned_cols=243  Identities=26%  Similarity=0.425  Sum_probs=204.0

Q ss_pred             ccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.||+|+||.||++.+...   +..|++|.+....... ....+.+|+.+++.++|+|++++++++.....     ++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-----~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-----LYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCc-----eEEE
Confidence            4699999999999999866   8899999998764333 46778899999999999999999999988544     8999


Q ss_pred             EecCC-CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          125 YELMD-TDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      |||++ ++|.+.+...         ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99995 6999998875         7899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .....   ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------  224 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---------  224 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence            65432   2334456788999999877 578999999999999999998 699998876555444433200         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                           .......++.++.+++.+||+.+|++|||+.+++++
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 ---------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ---------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                 011123458899999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-40  Score=296.98  Aligned_cols=260  Identities=25%  Similarity=0.443  Sum_probs=204.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      |++..+.|.+.+.||+|+||.||++.++.     .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45666777799999999999999997652     34579999986543 2233446778999999999999999999988


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                      ....     .+++|||++ |+|.+++...          ..++...+..++.||+.||.|||+++++|+||||+||+++.
T Consensus        80 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~  154 (288)
T cd05061          80 KGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH  154 (288)
T ss_pred             CCCC-----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence            7654     899999997 6999998642          23456778899999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999875433221   112234567999999877 678999999999999999998 7889987665543332


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc------Cccc
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR------HPYL  330 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~------~p~f  330 (377)
                      +...   .                           ........++.+.+++.+||+.||++|||+.++++      ||||
T Consensus       234 ~~~~---~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  283 (288)
T cd05061         234 VMDG---G---------------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF  283 (288)
T ss_pred             HHcC---C---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence            2210   0                           00111244788999999999999999999999987      8998


Q ss_pred             cCC
Q 017083          331 QSL  333 (377)
Q Consensus       331 ~~~  333 (377)
                      ..+
T Consensus       284 ~~~  286 (288)
T cd05061         284 PEV  286 (288)
T ss_pred             CCC
Confidence            764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-40  Score=297.11  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=201.5

Q ss_pred             ccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+.+.+.||+|+||.||++.+..     ++..||+|.+..... ......+.+|++++++++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            3445588999999999999998753     357899999875432 2345678899999999999999999999988754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                           .+++|||++ ++|.+++...              ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.
T Consensus        83 -----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~  157 (280)
T cd05049          83 -----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             -----eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence                 899999998 5999988653              34788899999999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                      ++.++|+|||++.......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999999999987543221   1223344678999999987 778999999999999999998 9999987665554443


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +....                              ........+..+.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGR------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            32100                              00111246888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.5e-40  Score=309.65  Aligned_cols=257  Identities=24%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~  107 (377)
                      +..|+++.+.+++++.||+|+||+||++++...     +..||+|++.... .......+.+|+.+++++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            456888889898999999999999999987443     3479999997542 3334567889999999996 99999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-----------------------------------------------
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-----------------------------------------------  139 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----------------------------------------------  139 (377)
                      +++.....     ++++|||++ |+|.+++...                                               
T Consensus       108 ~~~~~~~~-----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (400)
T cd05105         108 GACTKSGP-----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ  182 (400)
T ss_pred             EEEccCCc-----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence            99987754     899999998 5888877532                                               


Q ss_pred             -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          140 -------------------------------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       140 -------------------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                                                                       ..+++..+..++.||+.||+|||+++++|+|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d  262 (400)
T cd05105         183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD  262 (400)
T ss_pred             ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence                                                             2367778889999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~  246 (377)
                      |||+||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus       263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            99999999999999999999987543321   1223345678999999877 778999999999999999997 899987


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .............  ...                           .......++..+.+++.+||+.||++|||+.++.+
T Consensus       342 ~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         342 GMIVDSTFYNKIK--SGY---------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ccchhHHHHHHHh--cCC---------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            6433222211111  000                           00112356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.3e-40  Score=292.72  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=208.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||.|++|.||++.++.++..+++|.+............+.+|+.++++++|+||+++++++.....     .++
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~~   76 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK-----LCI   76 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE-----EEE
Confidence            347889999999999999999999999999997654445556677889999999999999999999987744     899


Q ss_pred             EEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          124 VYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ++||+++ +|.+.+..    ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999975 88888765    457899999999999999999999999999999999999999999999999998766544


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...                  
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG------------------  216 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Confidence             3334567888999999877 77888999999999999999999999877654333222110                  


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                  .........+.++.+++.+||+.+|++|||+.++++||++
T Consensus       217 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ------------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                        0011112457889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=293.23  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=202.9

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+.+++.+.||+|++|.||++.+.. ++.||+|.+....   .....+.+|+.++++++||||+++++++..... 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   75 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-   75 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC-
Confidence            45677777799999999999999998754 5779999986542   234567889999999999999999999887654 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .++++||++ ++|.+.+....  .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          76 ----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             ----eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence                899999995 69999987644  68999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ........  .....+..|+|||.+.+ ..++.++||||||+++++|++ |..||...........+.....        
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------  222 (261)
T cd05068         152 VIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------  222 (261)
T ss_pred             EccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            66533211  11222457999999877 778999999999999999999 9999987665544443322100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .......+..+.+++.+||+.+|++||++.++++
T Consensus       223 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ----------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                  0111245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.3e-40  Score=297.14  Aligned_cols=253  Identities=32%  Similarity=0.503  Sum_probs=210.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .+++...||+|++|.||++.+..++..|++|.+.....   ....+.+|+.+++.++|+|++++++.+.....     .+
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~   91 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE-----LW   91 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE-----EE
Confidence            34578899999999999999998999999999975422   45677889999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          123 IVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +++||++ ++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999 69999998766 89999999999999999999999999999999999999999999999999886544321 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...  ..+.             
T Consensus       172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-------------  235 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIPP-------------  235 (286)
T ss_pred             hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCC-------------
Confidence            2233456788999999877 67889999999999999999999999876554433322210  0000             


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                   ......++..+.++|.+||+.+|.+|||+.++++|+||..
T Consensus       236 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         236 -------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             -------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                         0111236788999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4e-40  Score=292.53  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=198.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +++++.+.||+|+||.||++.++. +..+|+|.+....   .....+.+|+.++++++||||+++++++.....     +
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-----L   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC-----E
Confidence            455678899999999999998754 5679999886432   224567889999999999999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +++|||++ ++|.+.+.. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999998 589988865 3468999999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ..  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......             
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-------------  220 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-------------  220 (256)
T ss_pred             eeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------------
Confidence            22  12234567999999876 678899999999999999999 89999877655544444321000             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                       ......+..+.+++.+||+.+|++|||+.++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             001134678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.6e-41  Score=329.73  Aligned_cols=259  Identities=30%  Similarity=0.437  Sum_probs=199.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC--------
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK--------  114 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------  114 (377)
                      +++.++.||+||||.||+++++-+|+.||||++.... .......+.+|+..+.+|+|||||+|+..+.+..        
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4558999999999999999999999999999998876 6667788999999999999999999987322100        


Q ss_pred             --------------------------------------------------------------------------------
Q 017083          115 --------------------------------------------------------------------------------  114 (377)
Q Consensus       115 --------------------------------------------------------------------------------  114 (377)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------CCCC--------CcEEEEEecCCCCHHHH-HHhCCCC-CHHHHHHHHHHHHHHHHHHhcCCc
Q 017083          115 ------------------KDTF--------NDVYIVYELMDTDLHQI-IRSDQQL-TDDHCQYFLYQLLRGLKYVHSASV  166 (377)
Q Consensus       115 ------------------~~~~--------~~~~iv~e~~~~~L~~~-l~~~~~~-~~~~~~~i~~qi~~al~~LH~~~i  166 (377)
                                        ....        ..+||-||||+.++... +..+... ..+.+++++.+|++||.|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                              0000        12789999999755554 4444433 478899999999999999999999


Q ss_pred             eecCCCCCceEEccCCCeEEeeeecccccC-------------------CCccccccccccccCCCccccccC--CCCCc
Q 017083          167 LHRDLKPSNLLLNASCDLKIGDFGLARTTS-------------------ETDFMTEYVVTRWYRAPELLLNCT--EYTAA  225 (377)
Q Consensus       167 ~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~  225 (377)
                      +||||||.|||++.++.|||+|||+++...                   .........||..|+|||++.+..  .++.+
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999997511                   112346678999999999998755  69999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHH
Q 017083          226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD  305 (377)
Q Consensus       226 ~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (377)
                      +|+|||||++|||+.   ||..  ..+....+..+.....+...                        .-+...-+.-.+
T Consensus       799 iDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~~------------------------~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEPA------------------------DFFDPEHPEEAS  849 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCCc------------------------ccccccchHHHH
Confidence            999999999999975   4533  22333333332211111000                        001223445679


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          306 LLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       306 li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      +|++||+.||++||||.|||++.||.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999997

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.3e-40  Score=302.13  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=200.3

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcE----EEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +....|++++.||+|+||+||++++..++..    ||+|.+... ........+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            3445677999999999999999998766654    899998643 23334567888999999999999999999987642


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            .+++++|+. |+|.+.+... ..++...+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        83 ------~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          83 ------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             ------ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence                  578999997 6899988764 46888999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc---cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          193 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       193 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      .........   .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------  228 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  228 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-------
Confidence            865543221   12233567999999977 778999999999999999997 999997765443222221100       


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                             ..+..+..+.++.+++.+||..||++||++.+++.+
T Consensus       229 -----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 -----------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                   001123457789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.8e-40  Score=295.46  Aligned_cols=250  Identities=22%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             ccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+.+.+.||+|++|.||++.+..     ++..|++|.+.... .......+..|+.++++++|+||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3455688999999999999999987     77889999886542 23344668889999999999999999999887654


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---Ce
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DL  184 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~v  184 (377)
                           .++++||++ ++|.+++....       .+++..+..++.||+.||+|||+++++|+||+|+||+++.++   .+
T Consensus        84 -----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          84 -----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence                 799999997 59999887543       478899999999999999999999999999999999998765   48


Q ss_pred             EEeeeecccccCCCccc---cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017083          185 KIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITEL  260 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  260 (377)
                      +|+|||++.........   .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999865332211   12223467999999977 678999999999999999996 99999876654433322110


Q ss_pred             hCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                         ..                           ......++..+.+++.+||+.+|++|||+.++++|
T Consensus       238 ---~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 ---GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ---Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               00                           01123568889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=291.12  Aligned_cols=253  Identities=25%  Similarity=0.483  Sum_probs=205.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc---cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |++.+.||+|++|.||++.+..++..||+|.+....   ........+.+|+.++++++|+||+++++++.....   ..
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~   80 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---KK   80 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---CE
Confidence            347889999999999999999999999999875432   123345677889999999999999999999876433   33


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +++++||++ ++|.+.+...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            789999997 489999888778999999999999999999999999999999999999999999999999998764321 


Q ss_pred             ---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                         .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.........   ......+..         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~---------  227 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIATQPTK---------  227 (264)
T ss_pred             ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHcCCCC---------
Confidence               11233567888999999987 66889999999999999999999999765433322   222211111         


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                       ......+++.+.++|.+||+ +|..||++.++++|||.
T Consensus       228 -----------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 -----------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -----------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                             11123568889999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.8e-40  Score=293.21  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             CcccccCCccceEEEEEeCCCCc--EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC-CCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK-KDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~  122 (377)
                      +.+.||+|+||.||++++..++.  .+|+|.++.........+.+..|+.+++.++|+||+++++++.... .......+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            67889999999999999877765  6899998766555566778889999999999999999999765432 12224478


Q ss_pred             EEEecCC-CCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          123 IVYELMD-TDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      +++||++ ++|.+.+..      ...+++..+..++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  162 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI  162 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccccc
Confidence            9999998 588887642      234789999999999999999999999999999999999999999999999999865


Q ss_pred             CCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          196 SETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       196 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      .....   .....+++.|++||.+.+ ..++.++||||||+++|+|++ |..||...........+...   .       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~-------  231 (272)
T cd05075         163 YNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG---N-------  231 (272)
T ss_pred             CcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---C-------
Confidence            43321   112234667999999877 778999999999999999999 88999776544433322210   0       


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                          .....+.++..+.++|.+||+.||++|||+.+++++
T Consensus       232 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 --------------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                001123567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.7e-40  Score=292.11  Aligned_cols=247  Identities=20%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.+.+++.||+|++|+||.+.+.. +..+|+|.+....   .....+.+|+.++++++||||+++++++.....     
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   73 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP-----   73 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC-----
Confidence            3455688999999999999997754 4569999886532   234567899999999999999999999987654     


Q ss_pred             EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ++++|||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|.||+++.++.+||+|||.+......
T Consensus        74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            799999997 5899988763 46899999999999999999999999999999999999999999999999998755433


Q ss_pred             ccc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 DFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ...  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+......            
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------  220 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------------
Confidence            221  12234567999999976 678899999999999999998 99999776654433333221000            


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                        ......+..+.+++.+||+.||++||++.+++.+
T Consensus       221 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                              0112347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.4e-40  Score=295.95  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=200.1

Q ss_pred             cccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..+.+.+.+.||.|+||+||++.+     ..++..+|+|.+...  .......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            345566899999999999999985     334567899988654  3344567889999999999999999999998765


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ-------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                      .     +++++||++ ++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus        81 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          81 P-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             c-----cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            4     899999998 58988886433             4899999999999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999875543221   122334677999999877 778999999999999999998 8999987665544433


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +...   ..                           .......+.++.+|+.+||+.||.+|||+.+++.
T Consensus       235 i~~~---~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         235 ITQG---RV---------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHcC---Cc---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3221   00                           0111245788999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=290.81  Aligned_cols=244  Identities=29%  Similarity=0.501  Sum_probs=205.4

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  128 (377)
                      ||.|++|.||++.+..+++.+++|.+..... .......+..|+.++++++||||+++++.+..+..     ++++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK-----LYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe-----eEEEEecC
Confidence            7999999999999998999999999876532 22345677889999999999999999999887654     89999999


Q ss_pred             C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cccccccc
Q 017083          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVV  206 (377)
Q Consensus       129 ~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~~~~~~  206 (377)
                      + ++|.+.+.....+++..+..++.|+++|+.+||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            5 699999988888999999999999999999999999999999999999999999999999998765443 23344567


Q ss_pred             ccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccc
Q 017083          207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR  286 (377)
Q Consensus       207 ~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (377)
                      +..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..   ..                      
T Consensus       156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~----------------------  209 (250)
T cd05123         156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---DP----------------------  209 (250)
T ss_pred             CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---CC----------------------
Confidence            888999999877 6678899999999999999999999977665333333221   00                      


Q ss_pred             cccccccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCccc
Q 017083          287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYL  330 (377)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~ell~~p~f  330 (377)
                            ......++..+.++|++||..||++||++   .++++||||
T Consensus       210 ------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                  01112348889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-40  Score=290.06  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |.+..+.+++.+.||.|++|.||++...  |+.||+|.+.....   ...++.+|+.++++++|+||+++++++..... 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-   74 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP-   74 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC-
Confidence            3456677789999999999999999774  78899999975422   45678899999999999999999999887544 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .+++|||++ ++|.+++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          75 ----LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             ----eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccc
Confidence                899999998 59999987655  68999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .......  ....+..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+....           
T Consensus       151 ~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  216 (256)
T cd05039         151 EASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----------  216 (256)
T ss_pred             ccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            6643322  2334567999999876 678889999999999999997 999997765444332222100           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                         ........++.+.++|.+||..+|++|||+.+++.
T Consensus       217 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                               00112346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=329.21  Aligned_cols=264  Identities=24%  Similarity=0.380  Sum_probs=224.7

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+...+|++++.||+|+||.|.+++++.+++.||.|++++- ..+....+-|..|-.+|-.-+.+=|+.++.+|.++.. 
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~-  149 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY-  149 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc-
Confidence            45667888999999999999999999999999999999762 1233345667788888888889999999999999866 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          +|+||||++ |+|..++..-.+++++.++.++..|+.||..||+.|+|||||||+|||+|..|++||+|||.+-.+
T Consensus       150 ----LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  150 ----LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             ----eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence                999999998 599999988789999999999999999999999999999999999999999999999999988776


Q ss_pred             CCCc--cccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          196 SETD--FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       196 ~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ....  .....+|||.|.|||++...    +.|++..|.|||||++|||+.|..||...+....+.+|++--...     
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l-----  300 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL-----  300 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc-----
Confidence            6443  34567899999999998532    568999999999999999999999999988888887777631110     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~ell~~p~f~~~~  334 (377)
                                            ..+....+|..+.+||++++. +|+.|..   +.++-+||||.++.
T Consensus       301 ----------------------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  301 ----------------------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ----------------------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence                                  001123579999999999886 5677876   99999999998766

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-40  Score=294.24  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCC-----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      |++..+.+.+.+.||+|+||.||++.++..+     ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            5677777889999999999999999886544     789999986542 2334456788999999999999999999998


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                      ....     .+++|||++ ++|.+++...          ..+++..+..++.||+.||.|||+++++|+||+|+||+++.
T Consensus        80 ~~~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          80 TGQP-----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             CCCC-----cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            7754     899999997 6999988642          23677889999999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            99999999999875543321   223345678999999876 678999999999999999998 9999987665544433


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +..  ...                            .......+..+.++|.+||+.+|++|||+.++++
T Consensus       234 ~~~--~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         234 VID--GGH----------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             Hhc--CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            321  000                            0111235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=292.16  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             CCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-CCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  120 (377)
                      .+.+.||+|+||.||.+.+..+   +..||+|.++...........+..|+..++.++||||+++++++..... .....
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            4788999999999999987653   4789999998655555566788899999999999999999998765443 23344


Q ss_pred             EEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          121 VYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .++++||++ ++|...+...      ..+++..+..++.|++.||+|||+++++|+||||+||++++++.+||+|||++.
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcccee
Confidence            789999998 5888877432      358899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .......   ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+..   ..     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~-----  232 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH---GN-----  232 (273)
T ss_pred             eccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC-----
Confidence            6543321   111233567999999876 778999999999999999999 8899977664443332221   00     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            ........+..+.+++.+||+.||++|||+.|++++
T Consensus       233 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 ----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  011123568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.6e-41  Score=319.10  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=222.9

Q ss_pred             EEEEEecceeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC
Q 017083           28 VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN  102 (377)
Q Consensus        28 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~  102 (377)
                      ...+......+++...++..++||+|+||+||+++..     .....||||.++... ......+|++|+.++..|+|||
T Consensus       472 ~~~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~n  550 (774)
T KOG1026|consen  472 PQLNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPN  550 (774)
T ss_pred             CCCCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCC
Confidence            3455677789999999999999999999999999752     223569999997653 3446788999999999999999


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHhcCCce
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--------------QLTDDHCQYFLYQLLRGLKYVHSASVL  167 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~al~~LH~~~i~  167 (377)
                      ||+++|++..+..     +++|+|||. |+|.+++....              +++..+...|+.||+.|+.||-++.+|
T Consensus       551 IVrLlGVC~~~~P-----~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FV  625 (774)
T KOG1026|consen  551 IVRLLGVCREGDP-----LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFV  625 (774)
T ss_pred             eEEEEEEEccCCe-----eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccc
Confidence            9999999999877     999999998 89999997422              278889999999999999999999999


Q ss_pred             ecCCCCCceEEccCCCeEEeeeecccccCCCccc---cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 017083          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP  243 (377)
Q Consensus       168 H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~  243 (377)
                      ||||-+.|+||.++..|||+|||+++..-..+..   ....-...|||||.+.- ++++.++||||+||+++|+++ |..
T Consensus       626 HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~Q  704 (774)
T KOG1026|consen  626 HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQ  704 (774)
T ss_pred             ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccC
Confidence            9999999999999999999999999865544322   23344678999999988 899999999999999999997 899


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 017083          244 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       244 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      ||.+..+.+-+..++.                              ....+...+.|.++.+|+..||+.+|++||+++|
T Consensus       705 Py~glSn~EVIe~i~~------------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  705 PYYGLSNQEVIECIRA------------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             cccccchHHHHHHHHc------------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            9999998888877754                              1123334578999999999999999999999999


Q ss_pred             Hh
Q 017083          324 AL  325 (377)
Q Consensus       324 ll  325 (377)
                      +=
T Consensus       755 I~  756 (774)
T KOG1026|consen  755 IH  756 (774)
T ss_pred             HH
Confidence            83

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=296.25  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=195.3

Q ss_pred             CcccccCCccceEEEEEeC----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           46 PIRPIGRGAYGIVCAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.+.||.|.||.||++...    ..+..|+||.++.. ........+.+|++.+++++||||+++++++.....     +
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccc-----c
Confidence            5678999999999999987    45678999999553 344457888999999999999999999999996544     8


Q ss_pred             EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          122 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ++|+||++ |+|.+++...  ..+++..+..|+.||+.||.|||+++++|++|++.||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999998 6999999886  68999999999999999999999999999999999999999999999999999876322


Q ss_pred             c---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 D---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .   ..........|+|||.+.+ ..++.++||||||++++||++ |..||...........+.+..             
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-------------  222 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-------------  222 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-------------
T ss_pred             ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-------------
Confidence            1   2233445778999999977 668999999999999999999 789998876555444442211             


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                       .......++..+.++|.+||..||++|||+.++++
T Consensus       223 -----------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 -----------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                             11112356888999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.6e-40  Score=298.63  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+...+.||+|++|+||+++++.++..+|+|.+.... ........+.+|+.+++.++|+|++++++++.....     .
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----A   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe-----e
Confidence            3457889999999999999999999999999986432 233345667789999999999999999999987644     8


Q ss_pred             EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++++||+.+++.+.+.. ..++++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            99999999988887754 556899999999999999999999999999999999999999999999999998765432  


Q ss_pred             ccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          201 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ....++..|+|||.+.+  ....+.++||||||+++++|++|..||...........+...  ..+             
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~-------------  232 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESP-------------  232 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc--CCC-------------
Confidence             23456788999999752  245788999999999999999999998765433322222110  000             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                    .......+..+.+||++||+.+|++||++.++++|||+...
T Consensus       233 --------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 --------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             --------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                          00112457889999999999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.9e-41  Score=274.54  Aligned_cols=289  Identities=29%  Similarity=0.575  Sum_probs=231.6

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  115 (377)
                      |. ..+.|++++++|.|.++.||.+.+..+.++++||+++     .-..+.+.+|+.||+.|. ||||+++++++.+...
T Consensus        34 wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   34 WG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            44 3345569999999999999999999999999999995     446778899999999998 9999999999988765


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~  193 (377)
                         ....+++||++. +...+.   ..++.-.++.++.+++.||.|+|++||.|||+||.|++|+... .++|+|+|++.
T Consensus       108 ---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  108 ---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence               336799999986 666665   5688889999999999999999999999999999999999765 69999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccc-c--
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDAS-L--  269 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~-~--  269 (377)
                      ..-...--+-...+..|-.||++.....++.+-|+|||||++..|+..+.|| .+.++.+++.+|.++++...-.. .  
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            7665543444455778999999998788999999999999999999988885 66778889999988887432211 0  


Q ss_pred             -ccccchhHHHHHHhcccccccccccc-CCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          270 -GFLRSDNARRYVRQLPRCRKQQFATR-FPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       270 -~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                       .-.-...+..++.+..+.....+... ... .++++.+|+.++|..|..+|+||+|++.||||..+.+..
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence             01122334444445544444433322 222 479999999999999999999999999999998776543

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-39  Score=293.98  Aligned_cols=251  Identities=20%  Similarity=0.345  Sum_probs=200.2

Q ss_pred             cccccCCcccccCCccceEEEEEe----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .-..+++.+.||+|+||+||++.+    ..++..+++|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            335566889999999999999985    3456789999997542 33345677889999999999999999999887754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD-----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIl  177 (377)
                           .+++|||++ ++|.+++...                 ..+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus        82 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil  156 (283)
T cd05090          82 -----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL  156 (283)
T ss_pred             -----eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence                 899999998 5898887532                 24678889999999999999999999999999999999


Q ss_pred             EccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017083          178 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (377)
Q Consensus       178 i~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~  253 (377)
                      ++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||........
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999997653322   1223344667999999876 678999999999999999998 9999977654433


Q ss_pred             HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       254 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...+....                              .......+++.+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         236 IEMVRKRQ------------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33332100                              011123568889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.2e-40  Score=297.13  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=205.2

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCC-----cEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI  109 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~  109 (377)
                      .+++....+++.+.||+|+||.||++.++..+     ..+|+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            46677777778999999999999999886443     679999987643 233456688999999999 79999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~----------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik  172 (377)
                      +..+..     ++++|||++ ++|..++..                ...+++..+..++.|++.||+|||+++|+|+|||
T Consensus        85 ~~~~~~-----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  159 (293)
T cd05053          85 CTQEGP-----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA  159 (293)
T ss_pred             EcCCCC-----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            987755     899999997 589888853                3468889999999999999999999999999999


Q ss_pred             CCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 017083          173 PSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  248 (377)
Q Consensus       173 ~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~  248 (377)
                      |+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            9999999999999999999976543321   112233567999999876 778999999999999999997 99999877


Q ss_pred             ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       249 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ........+....                              ........+..+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         239 PVEELFKLLKEGY------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6554443332110                              001122457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-39  Score=290.86  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++....|++.++||+|+||+||++.+..+ ..||+|++.....   ..+.+..|+.+++.++||||+++++.+...   
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---   73 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---   73 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECCC---
Confidence            456666677999999999999999988665 4699999975322   235678899999999999999999987543   


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         ..+++|||++ ++|.+++...  ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          74 ---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             ---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence               2689999998 5999998753  457899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||...+ ..++.++||||||+++|+|++ |..||...........+....  .      
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--~------  221 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--R------  221 (262)
T ss_pred             eccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC--C------
Confidence            6543321  123345677999998876 678999999999999999999 888997765544433322100  0      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            ......++..+.+++.+||+.||++||++.+++.
T Consensus       222 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 ----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                  0111356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=293.79  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             cccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .++|+.+++.||+|+||+||++.    ...++..||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46788899999999999998864    34577889999987542 22345667789999999999999999998765432


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                         ..++++|||+++ +|.+.+.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        81 ---~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          81 ---KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ---ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence               337899999984 88888765 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......     .+......    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~----~  226 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-----EEMIGPKQ----G  226 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-----hhhhcccc----c
Confidence            543221    122334567999999876 678899999999999999999999986543211     01000000    0


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ............   ..   ...+.....+..+.+++.+||+.+|++|||++++++
T Consensus       227 ~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 QMTVVRLIELLE---RG---MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ccchhhhhhhhh---cC---CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000000   00   011122356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-39  Score=296.38  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCc--EEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |.+.+.||+|+||.||++.++.++.  .+++|.++.. ........+.+|+.++.++ +||||+++++++.....     
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-----   77 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY-----   77 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-----
Confidence            4478899999999999999887765  4688877632 2333456788899999999 69999999999887654     


Q ss_pred             EEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC
Q 017083          121 VYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~  183 (377)
                      +++++||++ ++|.+++....                .+++..++.++.|++.||+|||++|++|+||||+||+++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            899999998 59999886532                4788899999999999999999999999999999999999999


Q ss_pred             eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017083          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      +||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.... 
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence            99999999864332211111222456999999876 678999999999999999997 999998766544333221100 


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                   .......++..+.+|+.+||+.+|.+|||+.++++.
T Consensus       236 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 -----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                         001112468889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-39  Score=293.11  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+++++++.||+|+||+||++.+..+++    .||+|.+.... .......+.+|..+++.++||||+++++++.... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC-
Confidence            45667789999999999999999877776    48999987543 3334567788999999999999999999886532 


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           .+++++|++ |+|.+.+.. ...+++..+..++.||+.||+|||+++++|+||||+||++++++.+||+|||++.
T Consensus        83 -----~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 -----VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             -----cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence                 578999998 699998876 4568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc---cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------  228 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE--------  228 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------
Confidence            65433221   12233567999999877 678999999999999999998 899997655443332222100        


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            ..+.....+..+.+++.+||..||++||++.++++
T Consensus       229 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         229 ----------------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  01112356788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-39  Score=289.99  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=199.9

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+.++++++||+|++|+||++.+. ++..+|+|.+......   ...+.+|+.++++++|++++++++++...   
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---   73 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSEE---   73 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECCC---
Confidence            5667778889999999999999999875 5567999998754322   34678999999999999999999987543   


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         ..+++|||++ ++|.+.+..  ...+++..++.++.|++.||+|||+++++|+||+|+||++++++.++|+|||++.
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          74 ---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             ---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence               2689999998 599998875  3458999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....         
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------  220 (260)
T cd05070         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---------  220 (260)
T ss_pred             eccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence            6543321  122234567999999876 778899999999999999999 899997765444443332100         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                                           ..+.....+..+.+|+.+||..+|++|||+.+++
T Consensus       221 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         221 ---------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                                 0011235678899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=290.32  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=200.8

Q ss_pred             cccCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.+.+.+.||+|+||+||++.++.+   ...||+|.+.... .......+..|+.++++++||||+++++.+.....   
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP---   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc---
Confidence            4456899999999999999998654   4579999987543 33345667889999999999999999999987655   


Q ss_pred             CcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                        .+++|||+++ +|.+++.. .+.+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        80 --~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          80 --VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             --eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence              8999999985 89988865 4478999999999999999999999999999999999999999999999999998764


Q ss_pred             CCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          197 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       197 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ....   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....          
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  226 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR----------  226 (266)
T ss_pred             ccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            2211   112233567999999877 778999999999999999997 9999976654444333322100          


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                          .+.....+..+.+++.+||+.+|++||++.+++++
T Consensus       227 --------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         227 --------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                01112458889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=288.88  Aligned_cols=241  Identities=20%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             ccccCCccceEEEEEeCCCC---cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++||+|+||.||++....++   ..+|+|.+...... .....+..|++++++++||||+++++++...      .++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE------PLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC------ceEEE
Confidence            46999999999999875554   78999999765333 3456788999999999999999999987643      27999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc--
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--  201 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~--  201 (377)
                      |||++ ++|.+++.....+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99997 599999988788999999999999999999999999999999999999999999999999998765433211  


Q ss_pred             --cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          202 --TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       202 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                        ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...   .              
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---~--------------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---E--------------  215 (257)
T ss_pred             cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---C--------------
Confidence              11122457999999876 678999999999999999997 99999776654433332211   0              


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                   ..+.....+..+.++|.+||+.+|++||++.++++
T Consensus       216 -------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 -------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         01122356788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.6e-40  Score=291.81  Aligned_cols=249  Identities=29%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||.|+||.||+++++.+++.||+|.+... .........+.+|+.+++.++||||+++++++.....     .+
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~   78 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE-----LN   78 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe-----EE
Confidence            44888999999999999999999999999988643 2334445677889999999999999999999887644     89


Q ss_pred             EEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||+++ +|.+++..    ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999984 88877742    34588999999999999999999999999999999999999999999999999876543


Q ss_pred             Ccc-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccccccccc
Q 017083          198 TDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--HQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       198 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||......  .....+.. ...++         
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~---------  227 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPP---------  227 (267)
T ss_pred             hhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCC---------
Confidence            321 223467888999999877 66889999999999999999999998654321  11111110 01010         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                         ......+..+.+++.+||+.+|++||++.++++.
T Consensus       228 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 -------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                               0012357789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-40  Score=294.59  Aligned_cols=251  Identities=19%  Similarity=0.308  Sum_probs=200.7

Q ss_pred             cccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ....++++++||+|+||+||++.+..+     +..||+|++.... .......+..|+.++.+++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            344566899999999999999987543     5789999997543 2334466788999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceE
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIl  177 (377)
                      .     .++++||++ ++|.+++...                ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        82 ~-----~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          82 P-----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             c-----eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence            5     899999998 5888887421                34788889999999999999999999999999999999


Q ss_pred             EccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017083          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (377)
Q Consensus       178 i~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~  253 (377)
                      +++++.+||+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||........
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  235 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  235 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999876543321   223344678999999876 678999999999999999998 8889887665544


Q ss_pred             HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       254 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...+....                              ........+..+.+|+.+||+.+|.+||++.+++..
T Consensus       236 ~~~i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         236 IEMIRNRQ------------------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            43332210                              001123568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.7e-40  Score=298.31  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcE--EEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .++.+.+.||+|+||+||++.++.++..  +++|.+... ........+.+|+.++.++ +||||+++++++.....   
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~---   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY---   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC---
Confidence            3455789999999999999999887764  577776532 2333456778899999999 79999999999987754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~  181 (377)
                        +++++||++ ++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+||+++.+
T Consensus        83 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          83 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             --ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence              899999997 58999886432                47888999999999999999999999999999999999999


Q ss_pred             CCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017083          182 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITEL  260 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  260 (377)
                      +.++|+|||++..............+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.. 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-  238 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-
Confidence            9999999999864322211112223567999998866 668899999999999999998 9999976654433322211 


Q ss_pred             hCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                        ..                           ........++.+.+|+.+||+.+|++||++.+++.+
T Consensus       239 --~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 --GY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --CC---------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              00                           001112457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-39  Score=294.43  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=202.3

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCC----------------cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCce
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETR----------------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv  104 (377)
                      .+.+++++.||+|+||.||++.+...+                ..||+|.+..... ......+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            445669999999999999999876544                4589999876532 24456788999999999999999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik  172 (377)
                      ++++++..+..     .++++|++. ++|.+++....           .+++..++.++.|++.||+|||++|++|+|||
T Consensus        83 ~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          83 RLLGVCTVDPP-----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             EEEEEEecCCC-----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            99999987754     899999998 58998887655           68999999999999999999999999999999


Q ss_pred             CCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 017083          173 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG  247 (377)
Q Consensus       173 ~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~--g~~pf~~  247 (377)
                      |+||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++||||||+++|+|++  +..||..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999987543322   1223345678999999877 678999999999999999987  6788877


Q ss_pred             CChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       248 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ......+..+.......                       .........+..+.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDD-----------------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccc-----------------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65554443333211100                       000111112345788999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-39  Score=290.28  Aligned_cols=249  Identities=23%  Similarity=0.393  Sum_probs=202.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |+|..+.++++++||+|+||.||++..+ +++.||+|.+.....   ....+.+|+.++++++|+||+++++++...   
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   73 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQE---   73 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEccC---
Confidence            5677888889999999999999999865 567899999875432   345788899999999999999999987543   


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         .+++++||+. ++|.+.+..  +..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          74 ---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             ---CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence               2799999997 599998865  3468899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------  221 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--------  221 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--------
Confidence            6542221  122344677999999876 678899999999999999998 9999987665544433322110        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .+.....+.++.+++.+||..+|++|||++++++
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 ----------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  0112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=289.91  Aligned_cols=246  Identities=19%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ..+++.+.||+|+||.||++.++ ++..+|+|++.....   ....+.+|+.++++++||||+++++++.....     .
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~   74 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP-----I   74 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-----e
Confidence            45668999999999999999886 466899999864322   23467789999999999999999999887754     8


Q ss_pred             EEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++++||++ ++|.+++.. ...+++..+..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            99999997 589998875 3468999999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ..  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....              
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  219 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--------------  219 (256)
T ss_pred             ccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence            11  11223457999999887 778899999999999999998 8999987665544433322100              


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                      .......+.++.+++.+||..+|++|||+.++++.
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                            01112468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=290.20  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+.+++.+.||+|++|+||++.+. ++..+|+|.+.....   ....+..|+.++++++|+||+++++++..... 
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   75 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-   75 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-
Confidence            5677788889999999999999999975 457799999875422   34568889999999999999999999887644 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .++++||++ ++|.+.+...  ..++...+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ----~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          76 ----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             ----eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence                899999998 5899988764  368999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  ......+..|+|||.+.+ ...+.++|+||||+++++|++ |..||...........+......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------  223 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------  223 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            6543211  112223567999999987 678999999999999999998 99999877655544443221100       


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                             ......+.++.+++.+||+.+|++||+++++++
T Consensus       224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                   111244788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-39  Score=293.46  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             cCCcccccCCccceEEEEEeC---CCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      |++.+.||.|+||.||.+.+.   .+|..||+|.+.....  .....+.+.+|+.+++++. |++|+++++++..+..  
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~--   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK--   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe--
Confidence            347889999999999999875   4789999999865321  2223456778999999994 9999999999987644  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +++++||++ ++|.+.+....++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ---~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          80 ---LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             ---EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence               899999998 4999999888889999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc--cccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          197 ETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       197 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ...  ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------  227 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------  227 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc---------
Confidence            322  22345678889999998652 346789999999999999999999996533222222221111000         


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                    .    .+....+++.+.+++++||+.||++||     ++.++++||||+...
T Consensus       228 --------------~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         228 --------------E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             --------------C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                          0    011124678899999999999999997     899999999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=293.08  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCC--------------cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCce
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETR--------------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~--------------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv  104 (377)
                      ++.+.|++.+.||+|+||.||++++..++              ..||+|.++... .......+.+|++++++++|+|++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            44556778999999999999999875432              358999987543 233456788999999999999999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      ++++++.....     .+++|||++ ++|.+++....            .+++..+..++.|++.||+|||++|++|+||
T Consensus        81 ~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl  155 (295)
T cd05097          81 RLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL  155 (295)
T ss_pred             eEEEEEcCCCc-----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence            99999987654     899999998 48888875421            3678889999999999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP  246 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~--g~~pf~  246 (377)
                      ||+||+++.++.+||+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++  +..||.
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            99999999999999999999875433221   122234678999999877 678999999999999999988  667887


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..........+.......                       .........+.+++.+.+|+.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQ-----------------------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ccChHHHHHHHHHhhhhc-----------------------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            766555444333221110                       001111122346889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-39  Score=293.91  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             eeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI  109 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~  109 (377)
                      .+.+....+.+.+.||+|+||.||++.+     ..++..+|+|++.... .......+.+|+.+++++ +||||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            4677777888999999999999999975     3455689999987543 233456788999999999 79999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                      +.....     +++++||+. ++|.+++....  .+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|
T Consensus       108 ~~~~~~-----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         108 CTIGGP-----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             EecCCc-----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence            987754     899999998 68999887533  3899999999999999999999999999999999999999999999


Q ss_pred             eeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017083          187 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      +|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...............  
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~--  259 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--  259 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc--
Confidence            99999875543321   122344678999999877 678899999999999999998 99999775543332222110  


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..                           ........++.+.+++.+||+.+|++|||+.++++
T Consensus       260 ~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         260 GY---------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CC---------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            00                           00111245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-39  Score=296.34  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=202.7

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      .|++..+.+.+.+.||+|+||.||++.+..       +...+|+|.+.... .......+..|+.+++++ +||||++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            466666666799999999999999998643       23569999997542 334456788899999999 799999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                      +++.....     .++++||++ ++|.+++....                .++...+..++.|++.||+|||++|++|+|
T Consensus        91 ~~~~~~~~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d  165 (307)
T cd05098          91 GACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD  165 (307)
T ss_pred             EEEecCCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            99987754     899999998 59999987532                478889999999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~  246 (377)
                      |||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.
T Consensus       166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999875543221   111223467999999877 678999999999999999998 888987


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..........+....                              ..+.....+.++.+||.+||..+|++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         245 GVPVEELFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             cCCHHHHHHHHHcCC------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            765444333322100                              01112356889999999999999999999999986


Q ss_pred             C
Q 017083          327 H  327 (377)
Q Consensus       327 ~  327 (377)
                      +
T Consensus       295 ~  295 (307)
T cd05098         295 D  295 (307)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=337.87  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=215.2

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      -.-+||.|.||.||.|.+..+|...|+|.+.-..........+.+|+.++..++|||+|++|++-...+.     ++|.|
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v~IFM 1313 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----VYIFM 1313 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----HHHHH
Confidence            3557999999999999999999999999987665555566777899999999999999999999877755     89999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-----c
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-----D  199 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-----~  199 (377)
                      |||+ |+|.+.+..++-.++...+.+..|++.|++|||++|||||||||.||+++.+|.+|++|||.+.....+     .
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            9998 689999888888889999999999999999999999999999999999999999999999999876544     2


Q ss_pred             cccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ..+...||+.|||||++.+.  .....++|||||||++.||++|+.||...+....+.  .++                 
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM--y~V----------------- 1454 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM--YHV----------------- 1454 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH--hHH-----------------
Confidence            34678899999999999874  346779999999999999999999998766554432  111                 


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                             .-....+.+   ..++.+-.+||.+||..||++|+++.|+++|.|-..-.
T Consensus      1455 -------~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1455 -------AAGHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             -------hccCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence                   111111222   23799999999999999999999999999999876544

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-39  Score=289.91  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=199.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||.|++|.||+++++.++..+++|.+.... ........+.+|+.+++.++||||+++++++..+..     .+
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~   78 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-----LN   78 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe-----EE
Confidence            347889999999999999999999999999886532 233345677899999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||+++ +|.+++..    ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999985 88887753    45689999999999999999999999999999999999999999999999999876544


Q ss_pred             Ccc-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccccccccc
Q 017083          198 TDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--HQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       198 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||......  .....+... ..+          
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------  226 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP----------  226 (267)
T ss_pred             CCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCC----------
Confidence            322 234567889999999977 67888999999999999999999999654322  111111100 000          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                        .......+..+.+++.+||..||++|||+.++++
T Consensus       227 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         227 ------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                              0011246788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-39  Score=286.87  Aligned_cols=247  Identities=23%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |.+..+.+.+.+.||+|+||.||++...  |..+|+|.+...    .....+..|+.++++++|++++++++++....  
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   72 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK--   72 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC--
Confidence            3455667778999999999999999664  678999998643    23456788999999999999999999765432  


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                        ..+++++||++ ++|.+.+....  .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          73 --GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             --CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence              22799999998 59999887643  47889999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ......  .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+....           
T Consensus       151 ~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  216 (256)
T cd05082         151 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------  216 (256)
T ss_pred             eccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            544332  22334567999999876 678899999999999999997 999997765444333332100           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                         ........++.+.+++.+||+.+|++|||+.++++
T Consensus       217 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                               00112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-39  Score=292.17  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=197.6

Q ss_pred             cccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +.+.+.+.||+|+||.||++.+..     ++..+++|.+...  .......+.+|+.++++++|+||+++++++..... 
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc-
Confidence            344478899999999999998543     4556899988643  23334567899999999999999999999987654 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                          .+++|||++ ++|.+++...                +.+++..++.++.||+.|++|||++|++|+||||+||+++
T Consensus        82 ----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          82 ----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG  157 (291)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence                899999997 5999988653                2378899999999999999999999999999999999999


Q ss_pred             cCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017083          180 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~  255 (377)
                      .++.++|+|||++.......   ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..........
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999987654332   1223445778999999877 778899999999999999998 999997766544333


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .+...   .                           ........+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~---~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQG---R---------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCC---C---------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            22110   0                           00111235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-39  Score=289.93  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=199.1

Q ss_pred             cccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..+.+...++||+|+||.||++..     ..++..+++|.+...  .......+.+|+++++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            345566899999999999999964     335678999988653  3445567889999999999999999999988775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ---------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                      .     .++++||++ ++|.+++....               .+++..+..++.||+.|++|||++|++|+||||+||++
T Consensus        81 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          81 P-----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             c-----eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence            4     899999998 58988886542               47889999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017083          179 NASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~  254 (377)
                      ++++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.........
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            9999999999999875433221   122233577999999877 678999999999999999998 89999776554433


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..+...   .                           .......+++.+.++|.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~---~---------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         235 ECITQG---R---------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHcC---c---------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            322210   0                           00112356888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=306.29  Aligned_cols=244  Identities=31%  Similarity=0.480  Sum_probs=202.8

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  117 (377)
                      ..+.|. +...+|.|+|+.|-.+.+..++..+++|++.+..      .+..+|..++... +||||+++.+.+.++..  
T Consensus       320 ~~~~y~-~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~--  390 (612)
T KOG0603|consen  320 FTESYE-FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE--  390 (612)
T ss_pred             cchhhc-cccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCce--
Confidence            344555 7777999999999999999999999999997652      2233566566655 59999999999998866  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE-ccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-NASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli-~~~~~vkl~Dfg~~~~~  195 (377)
                         .|+|||.+.| .+.+.+...+.+. ..+..|+.+|+.|+.|||++|++||||||+|||+ +..|.++|+|||.+...
T Consensus       391 ---~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  391 ---IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ---eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence               8999999986 6677776655555 7888899999999999999999999999999999 68899999999999876


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ...  ....+.|..|.|||++.. ..++.++||||||++||+||+|+.||......   ..+...+..+...        
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------  532 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------  532 (612)
T ss_pred             chh--hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc--------
Confidence            655  455677899999999986 88999999999999999999999999886655   2222222222111        


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                           ..+|.++++||++||+.||.+||++.+++.||||
T Consensus       533 ---------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ---------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                                 3569999999999999999999999999999999

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.1e-39  Score=287.48  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++....+++.++||+|++|+||++.+..+ ..+|+|.+....   .....+.+|++++++++|++++++++++...   
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   73 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE---   73 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence            345555566889999999999999988655 469999886532   2235677899999999999999999987543   


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         ..+++|||+++ +|.+.+...  ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++.
T Consensus        74 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 ---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             ---CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence               26899999984 899988753  347889999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||...+ ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------  221 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------  221 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            6543321  122344677999998876 778999999999999999999 8999987665444333322100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .......+..+.+++++||..||++||+++++++
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 ----------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                  0112356888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.7e-39  Score=294.29  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=202.9

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..|.+....+.+.+.||+|+||.||++++..       ....+|+|.+.... .......+..|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            3466677777799999999999999998632       34568999987543 234456788899999999 59999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      ++++.....     +++++||++ ++|.+++...                ..+++..+..++.||+.||.|||++|++|+
T Consensus        84 ~~~~~~~~~-----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~  158 (314)
T cd05099          84 LGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR  158 (314)
T ss_pred             EEEEccCCc-----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999987654     899999998 5899988653                347888899999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf  245 (377)
                      ||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus       159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999976543221   111223457999999877 778999999999999999998 88999


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ...........+....                              ........+.++.+++.+||+.||++|||+.+++
T Consensus       238 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll  287 (314)
T cd05099         238 PGIPVEELFKLLREGH------------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV  287 (314)
T ss_pred             CCCCHHHHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            7766554444332200                              0011234577899999999999999999999998


Q ss_pred             c
Q 017083          326 R  326 (377)
Q Consensus       326 ~  326 (377)
                      +
T Consensus       288 ~  288 (314)
T cd05099         288 E  288 (314)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-39  Score=298.82  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=198.5

Q ss_pred             eeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI  109 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~  109 (377)
                      +|+++.+.|++.+.||+|+||+||+|++     ..+++.||+|+++.... ......+.+|+.++.++ +||||++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            3677777888999999999999999985     34678899999975432 23456678899999999 58999999998


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-------------------------------------------------
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------------------------------------  139 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------------------------------------------------  139 (377)
                      +.....    .++++|||++ |+|.+++...                                                 
T Consensus        80 ~~~~~~----~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (343)
T cd05103          80 CTKPGG----PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE  155 (343)
T ss_pred             eecCCC----ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence            765432    2789999998 5898887642                                                 


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          140 ------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       140 ------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                                        ..++...+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  235 (343)
T cd05103         156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  235 (343)
T ss_pred             CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence                              135677888899999999999999999999999999999999999999999987643221  


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                       ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..............  ...             
T Consensus       236 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~-------------  299 (343)
T cd05103         236 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--EGT-------------  299 (343)
T ss_pred             hhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh--ccC-------------
Confidence             1112234567999999877 778999999999999999997 8999876543222111110  000             


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                 .   .......++.+.+++.+||+.||++|||+.|+++|
T Consensus       300 -----------~---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         300 -----------R---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -----------C---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       0   00011346789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=304.05  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=217.6

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCc---E-EEEEeccc-cccCHHHHHHHHHHHHHHHhcCCCCceeE
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---E-VAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~-valK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      +.-+.|++.-..+.+.++||+|+||.||++..+..+.   . ||+|..+. .........++.+|++++++++|||||++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3445699999999999999999999999998866432   3 89998875 22456677889999999999999999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCe
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~v  184 (377)
                      ||+.....+     ++|+||+|. |+|.++++..+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+
T Consensus       227 yGVa~~~~P-----l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  227 YGVAVLEEP-----LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEcCCCc-----cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence            999998877     999999998 59999999877 49999999999999999999999999999999999999999999


Q ss_pred             EEeeeecccccCCCcccc-ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH-Hh
Q 017083          185 KIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE-LI  261 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~-~~  261 (377)
                      ||+|||++.......... ..--...|+|||.+.. ..++.++||||+||++||+.+ |..||.+....+....+.. ..
T Consensus       302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~  380 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY  380 (474)
T ss_pred             EeCccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc
Confidence            999999987665322222 1223677999999988 799999999999999999998 8889999888877666633 21


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..+.                              ....+..+..++.+||..||++|||+.++.+
T Consensus       381 r~~~------------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  381 RMPI------------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             cCCC------------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            1111                              1245788999999999999999999999865

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-39  Score=321.03  Aligned_cols=250  Identities=27%  Similarity=0.358  Sum_probs=197.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |+++++||+|+||+||++++..+|+.||+|++..... ......++.+|+.++++++||||+++++++..+..     .+
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~-----ly   78 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP-----VY   78 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE-----EE
Confidence            3488999999999999999999999999999976432 23345678899999999999999999999987754     89


Q ss_pred             EEEecCCC-CHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          123 IVYELMDT-DLHQIIRSD-----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ++|||++| +|.+.+...           .+.+...+..++.||++||+|||++||+||||||+||+++.++.++|+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            99999985 888887531           234566788899999999999999999999999999999999999999999


Q ss_pred             cccccCCC-------------------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 017083          191 LARTTSET-------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (377)
Q Consensus       191 ~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~  251 (377)
                      ++......                   .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99754211                   01123468999999999887 77899999999999999999999999764422


Q ss_pred             HHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       252 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .....  .....+.                          ....+..+++.+.+++.+||..||++||+..+.+.+
T Consensus       238 ki~~~--~~i~~P~--------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYR--DVILSPI--------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhh--hhccChh--------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21111  0000000                          001123678899999999999999999876665543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4e-39  Score=297.24  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCC-------CcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-------REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..|++....+.+++.||+|+||.||++++...       +..||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            45888888888999999999999999986432       2368999887542 334566788999999999 79999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      ++++.....     +++++||++ ++|.+++....                .++...+..++.||+.||+|||++|++|+
T Consensus        84 ~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~  158 (334)
T cd05100          84 LGACTQDGP-----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR  158 (334)
T ss_pred             eEEEccCCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999987654     899999998 59999886532                36778888999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf  245 (377)
                      ||||+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus       159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999876543221   122233467999999977 778899999999999999998 88899


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ...........+....                              ........+..+.+++.+||+.+|++|||+.|++
T Consensus       238 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell  287 (334)
T cd05100         238 PGIPVEELFKLLKEGH------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV  287 (334)
T ss_pred             CCCCHHHHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            8766554443332100                              0111234578899999999999999999999999


Q ss_pred             cC
Q 017083          326 RH  327 (377)
Q Consensus       326 ~~  327 (377)
                      ++
T Consensus       288 ~~  289 (334)
T cd05100         288 ED  289 (334)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.6e-39  Score=287.99  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=195.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+.+++++.||.|+||+||++.+..++.    .+++|.+.... .......+..|+.++++++||||+++++++....  
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~--   82 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS--   82 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECCCc--
Confidence            3456689999999999999999877776    47778775321 2233456778888999999999999999875332  


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          .++++||++ |+|.+.+.. .+.+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++..
T Consensus        83 ----~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          83 ----LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             ----cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence                678999997 699999875 45789999999999999999999999999999999999999999999999999975


Q ss_pred             cCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .....   ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...  ..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~------  229 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG--ER------  229 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--Cc------
Confidence            43221   1223345678999999877 678999999999999999998 99999876544332222110  00      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .......+.++.+++.+||..||++|||+.|+++
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 ----------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                  0001124667899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-39  Score=283.03  Aligned_cols=241  Identities=25%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEec
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  127 (377)
                      ++||.|++|.||++.+.. ++.|++|.+...... .....+.+|+.++++++|+||+++++++.....     .++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-----IYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC-----eEEEEEc
Confidence            469999999999999977 899999998765333 355678899999999999999999999887754     8999999


Q ss_pred             CC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc---c
Q 017083          128 MD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---T  202 (377)
Q Consensus       128 ~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~---~  202 (377)
                      ++ ++|.+.+.. ...++...+..++.+++.|+++||+++++|+||+|+||+++.++.++|+|||++.........   .
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            97 588888865 456889999999999999999999999999999999999999999999999998765422111   1


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....                   
T Consensus       154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-------------------  213 (251)
T cd05041         154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-------------------  213 (251)
T ss_pred             cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-------------------
Confidence            1223566999999876 678999999999999999998 8888877654433332221000                   


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                 .......+.++.+++.+||+.+|++|||+.|+++
T Consensus       214 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -----------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                       0011245788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=287.07  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=191.1

Q ss_pred             ccccCCccceEEEEEeCCCCc--EEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.||+|+||.||++.++.++.  .+++|.+.... .......+.+|+.++.++ +||||+++++++.....     ++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-----~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-----LYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC-----ceEE
Confidence            358999999999999988876  46888876432 233456778899999999 79999999999987754     8999


Q ss_pred             EecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          125 YELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      |||++ ++|.+++....                .+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99997 69999886532                47888999999999999999999999999999999999999999999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      |||++..............+..|+|||.+.. ..++.++||||||+++|+|++ |..||...........+...      
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------  227 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------  227 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence            9999863322211112223567999999876 778999999999999999997 99999765543333222110      


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                              .........+.++.+++.+||..||.+|||+.+++.
T Consensus       228 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 ------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                    000111245788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=287.97  Aligned_cols=286  Identities=30%  Similarity=0.505  Sum_probs=219.5

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-----C---CCceeEeeeecC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----H---ENVIAIKDIIRP  112 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~  112 (377)
                      .+|. +.++||+|-|+|||+|.|....+.||+|+.+..   ..-.+..+.|+.+|++++     |   .+||++++.|..
T Consensus        78 gRY~-v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYH-VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEE-EEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            4566 899999999999999999999999999999753   334456678999999884     2   379999999998


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccC--------
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNAS--------  181 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~--------  181 (377)
                      .+.++ .++|+|+|+.+.+|+.+|...  +.++...++.|+.||+.||.|||. .||+|-||||+|||+-.+        
T Consensus       154 sGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  154 SGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             cCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence            88766 559999999999999999763  579999999999999999999995 599999999999998100        


Q ss_pred             --------------------------------------------------------------------------------
Q 017083          182 --------------------------------------------------------------------------------  181 (377)
Q Consensus       182 --------------------------------------------------------------------------------  181 (377)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------CC
Q 017083          182 ------------------------------------------------------------------------------CD  183 (377)
Q Consensus       182 ------------------------------------------------------------------------------~~  183 (377)
                                                                                                    -+
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                                                                          00


Q ss_pred             eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC------CChHHHHHHH
Q 017083          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG------KDYVHQLRLI  257 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~------~~~~~~~~~i  257 (377)
                      +||.|||.+......  ......|.-|+|||++.+ ..|+..+||||++|++|||+||...|..      ..+++.++.|
T Consensus       393 vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  393 VKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEEeeccchhhhhhh--hchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            233333333222111  222344566999999999 8999999999999999999999988854      3367899999


Q ss_pred             HHHhCCCCccccccccchhHHHHHHhccccccccccccCC-------------CCChhHHHHHHHhcCCCCCCCCCHHHH
Q 017083          258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-------------NKSSGAVDLLEKMLVFDPNKRITVEEA  324 (377)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~li~~~L~~dp~~Rps~~el  324 (377)
                      +++++..|....  ......+.+++.....+-.....-|+             .-..++.+|+.-||+.+|++||||.++
T Consensus       470 ~ELLG~iPr~ia--~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  470 MELLGKIPRKIA--LGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHhhccHHHH--hcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            999999887642  22233444444433322222222222             125568899999999999999999999


Q ss_pred             hcCccccCCcCC
Q 017083          325 LRHPYLQSLHDL  336 (377)
Q Consensus       325 l~~p~f~~~~~~  336 (377)
                      |+|||+......
T Consensus       548 l~hPwLn~~~~~  559 (590)
T KOG1290|consen  548 LKHPWLNPVAGP  559 (590)
T ss_pred             hcCccccCCCCC
Confidence            999999987765

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.3e-39  Score=289.77  Aligned_cols=268  Identities=26%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             cccccCCcccccCCccceEEEEEe----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .++++.+++.||+|+||.||++..    +.++..||+|.++... .......+.+|+.++++++|||++++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            356778999999999999999974    5678899999987542 33345678899999999999999999999876532


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         ..++++|||++ ++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        81 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 ---NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             ---CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence               23789999997 5899888654 458999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .......    .....++..|+|||.+.+ ..++.++||||||+++|+|+++..|+.....     ......+.....  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~--  229 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ--  229 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc--
Confidence            6543321    223445677999999877 6788999999999999999998766533211     011111100000  


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                           ............   ....+....++..+.+|+.+||+.||++|||++++++.
T Consensus       230 -----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         230 -----MTVTRLVRVLEE---GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -----ccHHHHHHHHHc---CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                 000001111110   01112234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.5e-39  Score=283.61  Aligned_cols=245  Identities=28%  Similarity=0.449  Sum_probs=201.5

Q ss_pred             CCcccccCCccceEEEEEeCCCC----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.+.||.|+||.||++.+...+    ..+|+|.+...... .....+..|+.+++.++|+||+++++.+.....     
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   75 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP-----   75 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe-----
Confidence            46788999999999999998766    88999999654322 255678899999999999999999999988754     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      .+++|||++ ++|.+.+.....  +++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            899999998 599998876544  89999999999999999999999999999999999999999999999999976554


Q ss_pred             Ccccc--ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          198 TDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       198 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .....  ...++..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+.....            
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  222 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR------------  222 (258)
T ss_pred             ccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------
Confidence            42221  1235678999999866 778999999999999999998 8888877655444443322110            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                        .......+.++.+++.+||+.||++|||+.++++
T Consensus       223 ------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                              0111236889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.6e-39  Score=300.46  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~  107 (377)
                      ...|++..+.+.+.++||+|+||.||+++++     .+++.||+|+++... .......+.+|+.++.++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            3458888888889999999999999999864     345689999997643 2333456889999999998 99999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC----------------------------------------------
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------------------------------------  140 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------------------------------------------  140 (377)
                      +++.....     +++++||++ |+|.+++...+                                              
T Consensus       108 ~~~~~~~~-----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (401)
T cd05107         108 GACTKGGP-----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS  182 (401)
T ss_pred             EEEccCCC-----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence            99987654     899999998 59998885421                                              


Q ss_pred             ----------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhcCCcee
Q 017083          141 ----------------------------------------------------QLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (377)
Q Consensus       141 ----------------------------------------------------~~~~~~~~~i~~qi~~al~~LH~~~i~H  168 (377)
                                                                          .++...+..++.||+.||+|||+.+++|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  262 (401)
T cd05107         183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH  262 (401)
T ss_pred             CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence                                                                2456677889999999999999999999


Q ss_pred             cCCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 017083          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (377)
Q Consensus       169 ~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~p  244 (377)
                      +||||.||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999987543221   1122345778999999977 678899999999999999998 8899


Q ss_pred             CCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 017083          245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  324 (377)
Q Consensus       245 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el  324 (377)
                      |..............  ...                           .......++.++.+|+.+||..+|.+||++++|
T Consensus       342 ~~~~~~~~~~~~~~~--~~~---------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         342 YPELPMNEQFYNAIK--RGY---------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             CCCCCchHHHHHHHH--cCC---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            876543332221111  000                           001123468899999999999999999999999


Q ss_pred             hcC
Q 017083          325 LRH  327 (377)
Q Consensus       325 l~~  327 (377)
                      ++.
T Consensus       393 l~~  395 (401)
T cd05107         393 VHL  395 (401)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.6e-39  Score=288.03  Aligned_cols=266  Identities=22%  Similarity=0.386  Sum_probs=198.1

Q ss_pred             ccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+.+++++.||+|+||+||.+.    +..++..||+|.+...  .......+.+|++++++++||||+++++++...+. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR-   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC-
Confidence            3456689999999999999997    4567889999998654  34455678899999999999999999998755432 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                        ..+++++||++ ++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          80 --RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             --CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence              33899999997 599998865 35689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccc----cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......    ....++..|+|||.+.+ ..++.++||||||+++++|++|..++....... .    ...+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~----~~~~~~~~~~--  229 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-M----RMMGNDKQGQ--  229 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-h----hhcccccccc--
Confidence            5433211    11223456999999877 678899999999999999999887765433111 0    0001000000  


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                          ............   ....+....++..+.+|+.+||..+|++|||+.|+++
T Consensus       230 ----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 ----MIVYHLIELLKN---NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             ----cchHHHHHHHhc---CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                000001111100   0111223457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.8e-39  Score=286.70  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ++++.+.||+|+||.||++.++.+++   .||+|.+.... .......+..|+.++++++||||+++++++..+..    
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP----   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc----
Confidence            45588999999999999999887765   59999987643 34455678899999999999999999999987654    


Q ss_pred             cEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          120 DVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                       +++++||+++ +|.+++.. .+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 -VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             -eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence             8999999985 88888865 45689999999999999999999999999999999999999999999999999875433


Q ss_pred             Cccc---cccc---cccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          198 TDFM---TEYV---VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       198 ~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ....   ....   .+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--------  229 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--------  229 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--------
Confidence            2211   1111   1346999999876 778999999999999999886 9999977665544433321100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .+.....+..+.+++.+||+.+|++||++.+++.
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 ----------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0112356788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-39  Score=289.52  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +....+++++.||.|+||.||++.+..     ++..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            345567789999999999999998753     67889999987543 233456788899999999999999999999876


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSD----------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                      ..     .++++||++ ++|.+++...                      ..+++..+..++.|++.||++||+++++|+|
T Consensus        81 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~d  155 (288)
T cd05050          81 KP-----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD  155 (288)
T ss_pred             Cc-----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            54     899999998 5999888642                      2467888899999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~  246 (377)
                      |+|+||+++.++.++|+|||++........   ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999875433211   122234567999999877 778999999999999999997 888987


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .....+....+....                              ........+..+.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         235 GMAHEEVIYYVRDGN------------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            766554433322100                              00111245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=298.78  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=193.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      .-..||+|+||.||++..... ..||||.+.......  ..+|.+|+.++.+++|||+|+++|+|.+.+.    ..++|+
T Consensus        79 ~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~LVY  151 (361)
T KOG1187|consen   79 ESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLLVY  151 (361)
T ss_pred             hhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEEEE
Confidence            456899999999999988554 889999886643322  4559999999999999999999999998752    279999


Q ss_pred             ecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCceEEccCCCeEEeeeecccccCC-C
Q 017083          126 ELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  198 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-~  198 (377)
                      ||++ |+|.+.+....  +++|.....|+.++++||+|||+..   |+|||||++|||+|++.+.||+|||++..... .
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            9998 79999997655  8999999999999999999999753   99999999999999999999999999976654 4


Q ss_pred             cccccc-ccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCccccccccc
Q 017083          199 DFMTEY-VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ---LRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...... .||.+|+|||.+.. +..+.++||||||++++||++|+.+.........   ..-.......           
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~-----------  299 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE-----------  299 (361)
T ss_pred             cceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC-----------
Confidence            333333 88999999999987 8899999999999999999999988765321111   1100000000           


Q ss_pred             hhHHHHHHhcccccccccc-ccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFA-TRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .....+++       .... ..+.  ..-..+..+..+|++.+|..||++.||++
T Consensus       300 ~~~~eiiD-------~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  300 GKLREIVD-------PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cchhheeC-------CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            00000000       0000 0011  01122667888999999999999999854

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-38  Score=283.17  Aligned_cols=242  Identities=24%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             ccccCCccceEEEEEeCC-CCc--EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSE-TRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~-~~~--~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.||+|++|+||++.+.. .+.  .||+|.+...... .....+.+|+.++++++||||+++++.+.. ..     ++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~-----~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP-----LMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce-----EEEE
Confidence            468999999999999865 333  6899999775433 456778899999999999999999999876 33     8999


Q ss_pred             EecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          125 YELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +||++ ++|.+.+....  .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99997 69999987654  68999999999999999999999999999999999999999999999999987654321  


Q ss_pred             --cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        ......++..|+|||.+.+ ..++.++||||||+++++|++ |..||......+....+......             
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  219 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-------------  219 (257)
T ss_pred             eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-------------
Confidence              1122345678999999876 678899999999999999998 99999876655544444321000             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                      .......+..+.+++.+||+.+|++|||+.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 ----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                            0011245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-38  Score=284.52  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=199.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+.+.||.|++|.||++.+..+|+.||+|.++... ........+.+|+.++++++|++++++++.+.....     .+
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~-----~~   78 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE-----LN   78 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-----EE
Confidence            347888999999999999999999999999886432 233345678899999999999999999999987644     89


Q ss_pred             EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ++|||++ ++|.+++..    ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999998 489888753    34589999999999999999999999999999999999999999999999999875543


Q ss_pred             Cc-cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 TD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      .. ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...... ...........             
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------------  223 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC-------------  223 (267)
T ss_pred             CCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC-------------
Confidence            32 2233467888999999877 67889999999999999999999999654311 00001110000             


Q ss_pred             HHHHHHhcccccccccccc-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          277 ARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                    ...+. ....+..+.++|.+||..+|++|||+.++++
T Consensus       224 --------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 --------------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             --------------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                          00011 1245778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=301.50  Aligned_cols=261  Identities=24%  Similarity=0.419  Sum_probs=231.0

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.-..++++..||-||||.|-++..+.....+|+|++++.. .+..+.+.+..|-++|..++.|+||++|..|.++..  
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky--  494 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY--  494 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh--
Confidence            44456678899999999999999887776679999998653 344455677789999999999999999999999876  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +|++||.|- |.+...++.++.|++..++.++..+++|++|||++||++|||||+|.+++.+|-+||.|||+++..+
T Consensus       495 ---vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  495 ---VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             ---hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence               899999985 6999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ......+++||+.|.|||.+.+ +..+.++|.||||+++|||++|.+||.+.+....+..|.+-+....-          
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~----------  640 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF----------  640 (732)
T ss_pred             cCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc----------
Confidence            9998999999999999999999 88899999999999999999999999999988888777663322211          


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                         ...++..+.+||+++...+|.+|.     ...++-+|-||.+..
T Consensus       641 -------------------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  641 -------------------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             -------------------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence                               125688899999999999999998     489999999997654

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-39  Score=291.30  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=202.4

Q ss_pred             eeecccccCCcccccCCccceEEEEEeC-------CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEee
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD  108 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  108 (377)
                      |.+....+.+.+.||+|+||.||++++.       .++..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            5566677778999999999999999753       234579999987542 234456788999999999 7999999999


Q ss_pred             eecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 017083          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       109 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      .+.....     ++++|||++ ++|.+++...                ..++...+..++.||+.||.|||++|++|+||
T Consensus        89 ~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl  163 (304)
T cd05101          89 ACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL  163 (304)
T ss_pred             EEecCCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            9987754     899999998 5999888653                24677888999999999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG  247 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~  247 (377)
                      ||+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||..
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999976543321   122334567999999977 678899999999999999998 7888877


Q ss_pred             CChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       248 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .........+....                              ........+..+.+||.+||..+|++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         243 IPVEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            66554443332110                              001123568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-38  Score=284.16  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=201.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |++..+.+++.++||+|+||.||++.+. .+..+++|.+...   ......+.+|+.++++++|+||+++++.+.. .. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~-   74 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP-   74 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC-
Confidence            5677888889999999999999999864 4567999988643   2345678889999999999999999999876 22 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .++++||++ ++|.+++..  ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          75 ----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             ----eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence                799999997 599999875  3457888899999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      .......  .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+...   .      
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~------  220 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---Y------  220 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---C------
Confidence            5443221  122234567999999876 678899999999999999998 99999876654443332211   0      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           ..+.....+.++.+++.+||+.+|++||++.++++
T Consensus       221 ---------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ---------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 01112356888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-38  Score=282.32  Aligned_cols=240  Identities=19%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             cccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           49 PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      .||+|+||.||++.++  ..+..||+|++.... .....+.+.+|+.++++++||||+++++++...      ..+++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------ALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC------CeEEEEE
Confidence            4899999999999775  445679999987542 233456788999999999999999999987543      2799999


Q ss_pred             cCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc----
Q 017083          127 LMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----  200 (377)
Q Consensus       127 ~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~----  200 (377)
                      |++ ++|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........    
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            998 588888864 45789999999999999999999999999999999999999999999999999875443221    


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...   .               
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~---------------  215 (257)
T cd05115         155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG---K---------------  215 (257)
T ss_pred             cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---C---------------
Confidence            111222467999999876 678899999999999999996 99999876654433322210   0               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                  ........++++.++|.+||+.+|++||++.++.+
T Consensus       216 ------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 ------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        01112345889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-38  Score=284.73  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=199.5

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ...+...+.||+|+||.||++.++.++.   .+++|.+.... .......+..|+.++++++|||++++.+++.....  
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP--   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC--
Confidence            3445578889999999999999876654   69999986542 23345678899999999999999999999987754  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         .+++|||+++ +|.+++.. ...+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        81 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 ---AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             ---cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence               8999999985 88888865 457899999999999999999999999999999999999999999999999998755


Q ss_pred             CCCccc----cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       196 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......    .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~--------  228 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR--------  228 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC--------
Confidence            432111    11122456999999877 678899999999999999997 9999977665444443322100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .+.....+..+.+++.+||+.+|++||++.++++
T Consensus       229 ----------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 ----------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                  0111245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-38  Score=284.63  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ++..+.+.+.+.||+|+||.||++.+...   ...|++|...... .....+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   80 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP   80 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC
Confidence            45566666889999999999999987544   3468999886543 2345567889999999999999999999887542


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            .+++|||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        81 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          81 ------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             ------cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence                  589999998 59999987643 5899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccc--cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          193 RTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       193 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .........  ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...........+...         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---------  224 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG---------  224 (270)
T ss_pred             eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence            765433211  12223457999999876 678899999999999999986 99999877655443332210         


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                           ......+.++..+.+++.+||..+|++|||+.++++.
T Consensus       225 ---------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         225 ---------------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ---------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 0011224568899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-38  Score=284.93  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .+++.+.||+|+||.||++.++.++.   .+|+|.+..... ......+.+|+.++++++||||+++++++..+..    
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   79 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP----   79 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc----
Confidence            34578999999999999999865543   699999865432 3345678889999999999999999999977654    


Q ss_pred             cEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          120 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                       ++++|||++ ++|.+.+... +.++...+..++.|++.|+++||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        80 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 -VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence             899999998 5898888754 5689999999999999999999999999999999999999999999999999876543


Q ss_pred             Ccc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          198 TDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       198 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...    .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+.+...          
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----------  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----------
Confidence            321    111222457999999977 678999999999999999886 9999977665444333322100          


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                          .+.....++.+.+++.+||+.+|.+||++.++++
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 --------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                0112346788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-38  Score=287.40  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             cCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +++.+.||+|+||+||++++..     ....+++|.+..... ......+.+|+.+++.++||||+++++.+.....   
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP---   77 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence            3478899999999999998753     235688888865432 3345678899999999999999999999887755   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~  173 (377)
                        .++++||+. ++|.+++...                        .++++..+..++.|++.||+|||+++++|+||+|
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          78 --LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             --cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence              799999998 5888887532                        2477888999999999999999999999999999


Q ss_pred             CceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017083          174 SNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  249 (377)
Q Consensus       174 ~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~  249 (377)
                      +||++++++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++++|++ |..||....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999999875433221   122334667999999876 678999999999999999998 999997765


Q ss_pred             hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       250 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .......+....                              .......++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY------------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            444332221100                              00112346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-38  Score=279.58  Aligned_cols=241  Identities=22%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEec
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  127 (377)
                      +.||+|+||.||++.+. ++..+|+|.+..... ......+.+|++++++++||||+++++++.....     .+++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-----IYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-----cEEEEEC
Confidence            36899999999999864 678999999876532 2334567889999999999999999999987754     8999999


Q ss_pred             CC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc--cc
Q 017083          128 MD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TE  203 (377)
Q Consensus       128 ~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~--~~  203 (377)
                      ++ ++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........  ..
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            97 588888764 346789999999999999999999999999999999999999999999999998654332211  11


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....                     
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---------------------  211 (250)
T cd05085         154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---------------------  211 (250)
T ss_pred             CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            233567999999876 778899999999999999998 999998765544333332110                     


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                               .......++..+.+++.+||..+|++||++.++++
T Consensus       212 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 ---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                     00112346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.8e-38  Score=287.96  Aligned_cols=257  Identities=22%  Similarity=0.340  Sum_probs=197.4

Q ss_pred             cccccCCcccccCCccceEEEEEeCC----------------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV  103 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  103 (377)
                      +.+.|++.+.||+|+||+||++.+..                ++..+|+|.+.... .......+.+|+.+++.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            33445689999999999999986532                34578999987542 23345678899999999999999


Q ss_pred             eeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 017083          104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       104 v~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      +++++++.....     .+++|||++ ++|.+++....           .+++..+..++.||+.||+|||++|++|+||
T Consensus        82 ~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          82 IRLLAVCITSDP-----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             ceEEEEEecCCc-----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            999999987755     899999997 59988886532           3566789999999999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP  246 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~--g~~pf~  246 (377)
                      ||+||+++.++.++|+|||++........   ......+..|++||...+ ..++.++|+|||||++|+|++  |..||.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999876533221   112233567999998876 678999999999999999998  778887


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..................                       ......+.....++.+.+|+.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         236 QLSDEQVIENTGEFFRDQ-----------------------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccChHHHHHHHHHHHhhc-----------------------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            665444333222111000                       000111122346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.7e-38  Score=283.69  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             cccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..+.+++++.||.|+||+||+++.+.+     ...+++|.+.... .......+.+|++++++++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            445666899999999999999997543     4578999886532 2224567889999999999999999999988765


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCe
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~v  184 (377)
                      .     .+++|||++ ++|.+++....         .+++..+..++.||+.||+|||+++++|+||||+||+++.++.+
T Consensus        82 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          82 P-----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             c-----ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence            4     799999998 69999987655         68999999999999999999999999999999999999999999


Q ss_pred             EEeeeecccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017083          185 KIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      +|+|||++.......  ......++..|+|||.+.+ ...+.++||||||+++|+|++ |..||...........+....
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~  235 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK  235 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence            999999986443221  1233355677999999876 667889999999999999998 788997655443333222100


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                        .                           .......++..+.+++.+||+.+|++|||+.+++..
T Consensus       236 --~---------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 --L---------------------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --c---------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence              0                           001112567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-38  Score=288.03  Aligned_cols=258  Identities=22%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             cCCcccccCCccceEEEEEeC---CCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      |.+.+.||+|++|.||++++.   .+++.||+|.+.+...  .......+..|+.++.+++ ||+|+++++.+.....  
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~--   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK--   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE--
Confidence            347888999999999999864   4678899999865321  1223456778999999994 9999999999887654  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         ++++|||++ ++|.+.+.....+++..++.++.|+++||.|||+.+++|+||+|.||+++.++.++|+|||++....
T Consensus        80 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          80 ---LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             ---EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence               899999998 4899988877889999999999999999999999999999999999999999999999999987644


Q ss_pred             CCcc--ccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCccccccc
Q 017083          197 ETDF--MTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE-LIGSPDDASLGFL  272 (377)
Q Consensus       197 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~  272 (377)
                      ....  .....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...........+.+ .....        
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  228 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--------  228 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--------
Confidence            3321  22345788999999986622 368899999999999999999999964332211111111 11100        


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  334 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~ell~~p~f~~~~  334 (377)
                                          ......++..+.++|.+||+.||++|||   +.++|+||||+++.
T Consensus       229 --------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         229 --------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence                                1112346788999999999999999998   56779999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-39  Score=284.78  Aligned_cols=238  Identities=16%  Similarity=0.263  Sum_probs=187.1

Q ss_pred             ccccCCccceEEEEEeCCCCcE-------EEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           48 RPIGRGAYGIVCAAVNSETREE-------VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~-------valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.||.|+||+||++.++..+..       +++|.+...  .....+.+.+|+.+++.++|||++++++++..+..     
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-----   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-----   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-----
Confidence            4699999999999998665543       888887543  23344567889999999999999999999987644     


Q ss_pred             EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC--------eEEeeee
Q 017083          121 VYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--------LKIGDFG  190 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~--------vkl~Dfg  190 (377)
                      .+++|||++ |+|.+++...+ .+++..+..++.||+.||+|||++||+|+||||+||+++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            799999998 58888887644 5899999999999999999999999999999999999987765        6999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ++......   ....++..|+|||++.+...++.++||||||+++|+|++|. .||..............    .     
T Consensus       154 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----~-----  221 (258)
T cd05078         154 ISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----R-----  221 (258)
T ss_pred             cccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----c-----
Confidence            88654432   23456788999999976456789999999999999999984 66655443322211110    0     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                             .......+.++.+|+.+||+.||++|||++++++.
T Consensus       222 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 -----------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                   00111345779999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=283.55  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      ...+++++.||+|+||+||++.++.+|.    .+|+|.+..... ......+.+|+.++++++||||+++++++.. .. 
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ-   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc-
Confidence            3455688999999999999999877665    589998865532 3345678899999999999999999999876 22 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          .++++||++ ++|.+.+.. ...+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        83 ----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          83 ----VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             ----eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence                799999997 599998876 45689999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCcccc---ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ........   ...++..|+|||.+.. ..++.++|+||||++++++++ |..||...........+....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE---------  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC---------
Confidence            54332111   1222467999999876 678899999999999999998 999998766544333332100         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           ........+..+.+++.+||..||+.||++.++++
T Consensus       229 ---------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 ---------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                 00111235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-38  Score=281.57  Aligned_cols=238  Identities=21%  Similarity=0.283  Sum_probs=184.4

Q ss_pred             ccccCCccceEEEEEeCCC------------CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           48 RPIGRGAYGIVCAAVNSET------------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~------------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      +.||+|+||+||++.....            ...+++|.+...  .......+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4689999999999975322            235888987643  22334567788999999999999999999887654


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC-------eEE
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-------LKI  186 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~-------vkl  186 (377)
                           .+++|||+++ +|..++.. ...+++..+..++.||++||+|||+++++|+||||+||+++.++.       +++
T Consensus        79 -----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          79 -----NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             -----CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence                 7899999985 66666654 456899999999999999999999999999999999999987664       899


Q ss_pred             eeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      +|||++......   ....++..|+|||.+.+...++.++||||||+++|+|+ .|..||.......... ...   .. 
T Consensus       154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~---~~-  225 (262)
T cd05077         154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE---GQ-  225 (262)
T ss_pred             CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh---cC-
Confidence            999988654322   23456778999998875467889999999999999998 5888886644322111 100   00 


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                 .......+.++.+||.+||+.||.+||++.+++++
T Consensus       226 ---------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ---------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ---------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                       00011235678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-38  Score=282.98  Aligned_cols=248  Identities=28%  Similarity=0.490  Sum_probs=197.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccc---cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +.+.||+|+||+||++.+..++..+++|.++...   ........+..|+.+++.++||||+++++++.....     .+
T Consensus         4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~   78 (260)
T cd08222           4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-----FC   78 (260)
T ss_pred             eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc-----eE
Confidence            7889999999999999998887777777665322   122234456678999999999999999999987754     89


Q ss_pred             EEEecCCC-CHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++||+++ +|.+.+.    ....+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999985 8877764    3457899999999999999999999999999999999999975 5699999999876543


Q ss_pred             C-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 T-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      . .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+.   ....           
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~---~~~~-----------  222 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV---EGPT-----------  222 (260)
T ss_pred             CcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---cCCC-----------
Confidence            3 22334556788999999866 667889999999999999999999997655433332221   1111           


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                      ......++.++.++|.+||+.||++||++.++++||||
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 ----------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                            01112457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-38  Score=283.82  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=198.7

Q ss_pred             cccccCCcccccCCccceEEEEEeCC----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSE----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+.|.+.+.||+|+||.||++.+..    ++..|++|.+... ........+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            33444578899999999999999876    3578899988643 344456778899999999999999999998765422


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD--------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                          ..+++++|++ ++|.+++...        ..+++..++.++.||+.||+|||+++++|+||+|+||+++.++.+||
T Consensus        83 ----~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          83 ----PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             ----CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence                2789999997 6888887642        45889999999999999999999999999999999999999999999


Q ss_pred             eeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017083          187 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      +|||+++.......   .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||...........+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            99999975533221   122344667999999977 678999999999999999998 999998765443332222100 


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                   .......+++++.+++.+||..||++|||+.++++
T Consensus       237 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 -----------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                         00112245788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.4e-38  Score=280.87  Aligned_cols=249  Identities=24%  Similarity=0.428  Sum_probs=200.5

Q ss_pred             cCCcccccCCccceEEEEEeCC-CCcEEEEEeccccc--------cCHHHHHHHHHHHHHHHh-cCCCCceeEeeeecCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAF--------DNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPP  113 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-~~~~valK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~  113 (377)
                      |.+.+.||+|+||.||++.+.. ++..+|+|.+....        ........+..|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4578899999999999999988 67889999885432        223344566778888875 6899999999999877


Q ss_pred             CCCCCCcEEEEEecCCC-CHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEe
Q 017083          114 KKDTFNDVYIVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~-~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      ..     .++++||+++ +|.+.+.    ....+++..++.++.|++.||.+||+ .+++|+||+|.||+++.++.++|+
T Consensus        82 ~~-----~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          82 DR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             Ce-----EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            54     8999999985 8877763    34568999999999999999999996 689999999999999999999999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......+.  
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  233 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--  233 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence            9999987655544455677889999999987 6789999999999999999999999977665544433322111000  


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                 .....++.+.++|.+||+.||++||++.|+..+
T Consensus       234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                       011457889999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.3e-38  Score=282.99  Aligned_cols=237  Identities=19%  Similarity=0.223  Sum_probs=184.2

Q ss_pred             cccCCccceEEEEEeCCC------------------------CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCce
Q 017083           49 PIGRGAYGIVCAAVNSET------------------------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~------------------------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv  104 (377)
                      .||+|+||.||++....+                        ...|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            599999999999975322                        245889988643  223345677889999999999999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~  182 (377)
                      ++++++.....     .++||||+++ +|..++.. .+.+++..+..++.||++||+|||+++++||||||.||+++..+
T Consensus        80 ~~~~~~~~~~~-----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVRGSE-----NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEeCCc-----eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            99999987754     7999999985 77777754 56789999999999999999999999999999999999998654


Q ss_pred             -------CeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 017083          183 -------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQL  254 (377)
Q Consensus       183 -------~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell-~g~~pf~~~~~~~~~  254 (377)
                             .++++|||++......   ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||.........
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             cccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                   3799999987543322   22345778999999876566899999999999999995 689999765543322


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .......                                ......++.+.++|.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYEKKH--------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhcc--------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2111100                                0001235679999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.8e-38  Score=313.57  Aligned_cols=144  Identities=24%  Similarity=0.416  Sum_probs=129.0

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      .++++||+|+||+||++.+..+++.||||++.... ........+..|+.+++.++||||+++++.+.....     +|+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-----~~l   81 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN-----VYL   81 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE-----EEE
Confidence            37899999999999999999999999999997532 233345677889999999999999999998876644     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ||||+. ++|.+++...+.+++..++.++.||+.||+|||.++|+|+||||+|||++.++.++|+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999996 5999999887889999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-38  Score=280.04  Aligned_cols=245  Identities=19%  Similarity=0.374  Sum_probs=196.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .+++.+.||.|++|.||++.+. ++..+|+|.+......   ...+..|++++++++||+++++++++.....     .+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~   75 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-----IC   75 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCc-----eE
Confidence            4457889999999999999885 4678999998754322   3467789999999999999999999887754     89


Q ss_pred             EEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          123 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +++||+.+ +|.+.+... ..+++..++.++.|++.|+++||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            99999984 888887653 4688999999999999999999999999999999999999999999999999875543321


Q ss_pred             --ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          201 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       201 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....               
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------  219 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---------------  219 (256)
T ss_pred             cccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC---------------
Confidence              122334567999999877 778899999999999999998 9999987665444433321100               


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                     .......+..+.+|+.+||+.+|++|||+.++++.
T Consensus       220 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ---------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           00012347889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.3e-38  Score=285.86  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=197.8

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ....++..+.||+|+||.||++.+..+|.    .+|+|.+.... .......+.+|+.+++.++||||+++++++.... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-
Confidence            34566688999999999999999887776    47888886542 2333446788999999999999999999986542 


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           .++++||++ |+|.+.+.... .+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++.
T Consensus        83 -----~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 -----IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             -----ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence                 578999998 68998887643 68899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .......   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+... .       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~-------  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-E-------  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-C-------
Confidence            6543221   122334678999999876 778999999999999999997 89999765533322222110 0       


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            .....+..+..+.+++.+||..+|++||++.++++.
T Consensus       229 ----------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 ----------------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  001122457789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.5e-38  Score=278.97  Aligned_cols=241  Identities=24%  Similarity=0.367  Sum_probs=194.9

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.+.+.+.||+|+||.||.+.  .+++.||+|.+....    ....+.+|+.++++++|||++++++++..+.      
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------   72 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG------   72 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC------
Confidence            3455689999999999999985  467889999986532    3456788999999999999999999986542      


Q ss_pred             EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          121 VYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      .+++|||++ ++|.+++....  .+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            689999998 59999987543  578899999999999999999999999999999999999999999999999875432


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      .  ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....               
T Consensus       153 ~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  214 (254)
T cd05083         153 G--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------  214 (254)
T ss_pred             c--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence            2  122333567999999876 678899999999999999997 999998776544333222100               


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                     .......++..+.+++.+||+.+|+.||++++++.
T Consensus       215 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ---------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           00112356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.5e-38  Score=277.76  Aligned_cols=228  Identities=22%  Similarity=0.333  Sum_probs=184.9

Q ss_pred             CccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC-CC
Q 017083           53 GAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TD  131 (377)
Q Consensus        53 G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~  131 (377)
                      |.+|.||+++++.+++.||+|.+....       ....|...+....||||+++++++.....     .+++|||++ ++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDS-----VFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCe-----EEEEEecCCCCC
Confidence            899999999999999999999996542       12234444555679999999999887644     899999998 59


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccC
Q 017083          132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR  211 (377)
Q Consensus       132 L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~  211 (377)
                      |.+.+....++++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+......  .....++..|+
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            9999888778999999999999999999999999999999999999999999999999987655432  22344567799


Q ss_pred             CCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcccccccc
Q 017083          212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ  291 (377)
Q Consensus       212 aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (377)
                      |||.+.+ ..++.++|+||+|+++|+|++|..|+......     +..                              ..
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~------------------------------~~  193 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT------------------------------HT  193 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc------------------------------cc
Confidence            9999866 66788999999999999999999876432100     000                              00


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccc
Q 017083          292 FATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYL  330 (377)
Q Consensus       292 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~ell~~p~f  330 (377)
                      .......+++.+.++|.+||+.||++||++     +++++||||
T Consensus       194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         194 TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            000112468889999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5e-38  Score=284.69  Aligned_cols=262  Identities=14%  Similarity=0.150  Sum_probs=191.4

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHH---------HHHHHHHHHHHhcCCCCceeE
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDA---------RRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      +..+.|.+.+.||+|+||+||++.+..+   +..+|+|+...........         .....++..+..++|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4444555889999999999999998877   6677887654322111000         112234445566789999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                      +++........ ...+++++++..++.+.+......++..++.++.|++.||+|||+++++||||||+||+++.++.++|
T Consensus        89 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRM-YYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCc-eEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765443211 22467888888888888776666788889999999999999999999999999999999999999999


Q ss_pred             eeeecccccCCC--------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 017083          187 GDFGLARTTSET--------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLI  257 (377)
Q Consensus       187 ~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~-~~~~~~i  257 (377)
                      +|||+++.....        .......||+.|+|||++.+ ..++.++|||||||++++|++|..||..... .......
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            999998754321        11223468999999999887 7789999999999999999999999987632 2222111


Q ss_pred             HHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ...                   +...+..     .....+..++.+.++++.|++.+|++||++.++++
T Consensus       247 ~~~-------------------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCD-------------------FIKRLHE-----GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHH-------------------HHHHhhh-----hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            110                   0011000     00112356888999999999999999999999874

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-37  Score=277.15  Aligned_cols=247  Identities=22%  Similarity=0.290  Sum_probs=187.9

Q ss_pred             ccccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||.||++...  .++..+|+|.+..... ......+.+|+.++++++||||+++++++.....     ++++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP-----YLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC-----cEEEE
Confidence            46999999999999754  3456799999876532 2334567889999999999999999999887654     79999


Q ss_pred             ecCC-CCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          126 ELMD-TDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       126 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ||++ ++|.+++...     ...++..+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9998 5898888642     245667788899999999999999999999999999999999999999999987543322


Q ss_pred             c---ccccccccccCCCcccccc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          200 F---MTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       200 ~---~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .   .....++..|+|||++.+.      ..++.++||||||+++|+|++ |..||......+...........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL------  228 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC------
Confidence            1   2234557789999998642      135789999999999999996 99999776544432221110000      


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                         ...........++.+.+++++|+ .+|++|||++||+.
T Consensus       229 -------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                               00001111245778899999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-37  Score=278.67  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             CCcccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC-CCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT-FND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-~~~  120 (377)
                      .+.+.||+|+||+||++.++.   ++..+|+|.+..........+.+.+|++++++++||||+++++++....... ...
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            367889999999999998643   5788999999876656666778889999999999999999999886643221 123


Q ss_pred             EEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          121 VYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .+++++|+. ++|.+++...      ..++...++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence            578899997 5887776432      247888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .......   .....+++.|++||.+.+ ..++.++||||||+++|+|++ |..||...........+...   .     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG---N-----  232 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC---C-----
Confidence            6543221   122234567999999876 677889999999999999998 88998766543322222110   0     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            .....+..+..+.+++.+||+.+|+.|||+.+++..
T Consensus       233 ----------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 ----------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  001113457889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=312.61  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=213.0

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCC-----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .-++..+-+...+.||+|.||.||.+......     ..||+|.+++. .+.....+|++|..+|.+++|||||+++|++
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            34567778888999999999999999875543     24899998764 4566788999999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~  182 (377)
                      ...+.     .+|++|||. |+|..+++..       ..++...+..++.+|++|+.||+++++|||||...|+|++...
T Consensus       765 l~~~~-----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r  839 (1025)
T KOG1095|consen  765 LDSGP-----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR  839 (1025)
T ss_pred             cCCCC-----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC
Confidence            98765     899999998 6999999865       3588999999999999999999999999999999999999999


Q ss_pred             CeEEeeeecccccCCCcccc-c--cccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017083          183 DLKIGDFGLARTTSETDFMT-E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~~~~~~~-~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~  258 (377)
                      .+||+|||+++..-..+... .  ..-...|||||.+.. +.++.++|||||||++||+++ |..||...++.+.+....
T Consensus       840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             cEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            99999999998443332111 1  122467999999988 899999999999999999998 899999988776655333


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +--                              ..+....++..+.+++.+||+.+|++||++..+++
T Consensus       919 ~gg------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  919 EGG------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             hCC------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            311                              12223467999999999999999999999999997

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.6e-38  Score=280.24  Aligned_cols=242  Identities=26%  Similarity=0.422  Sum_probs=192.8

Q ss_pred             ccccCCccceEEEEEeCCCC------cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           48 RPIGRGAYGIVCAAVNSETR------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.||+|+||.||+++++...      ..+|+|.+.... .......+.+|+.+++.++||||+++++++.....     .
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-----Q   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC-----e
Confidence            36999999999999886544      679999886542 22345678889999999999999999999887654     8


Q ss_pred             EEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-----CeEEee
Q 017083          122 YIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGD  188 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-----~vkl~D  188 (377)
                      ++++||++ ++|.+.+...       ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999998 5999888642       3477889999999999999999999999999999999999887     899999


Q ss_pred             eecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017083          189 FGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       189 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      ||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  229 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence            999875433221   122344678999999977 778999999999999999998 99999876654433332110    


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                ........++..+.++|.+||..+|++||+++++++
T Consensus       230 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 --------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                      001112356788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6e-38  Score=278.83  Aligned_cols=235  Identities=20%  Similarity=0.285  Sum_probs=186.2

Q ss_pred             ccccCCccceEEEEEeCCCC----------cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           48 RPIGRGAYGIVCAAVNSETR----------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~----------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.||+|+||.||++.+..++          ..+++|.+....   .....+.+|+.++++++||||+++++++.. ..  
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~--   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE--   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC--
Confidence            46999999999999998776          357888775432   115678899999999999999999998876 33  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-------CeEEee
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-------DLKIGD  188 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-------~vkl~D  188 (377)
                         .++++||++ ++|.+++.... .++...+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|
T Consensus        75 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          75 ---NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             ---cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence               689999998 58888887655 789999999999999999999999999999999999999887       799999


Q ss_pred             eecccccCCCccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       189 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ||++.....   .....++..|+|||.+.+. ..++.++||||||+++++|++ |..||..............    .. 
T Consensus       152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~-  223 (259)
T cd05037         152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QH-  223 (259)
T ss_pred             CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CC-
Confidence            999876543   2233456779999998773 368899999999999999999 5777766542221111110    00 


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                 .........+.+++.+||..+|++|||+.++++
T Consensus       224 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 ---------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                       000011367899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=277.01  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=187.1

Q ss_pred             ccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.||+|+||+||++.+..   .+..+|+|.+... ........+.+|+.+++.++||||+++++++.....    ..+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG----SPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC----CcEEE
Confidence            468999999999998643   3457999988543 233445677889999999999999999997654322    26899


Q ss_pred             EecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc---
Q 017083          125 YELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  199 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---  199 (377)
                      +||+. ++|.+++... ...++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99998 5999988753 446777888899999999999999999999999999999999999999999987543221   


Q ss_pred             --cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        ......++..|+|||.+.+ ..++.++||||||+++|+|++| ..||...........+..   ..            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~~------------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---GR------------  219 (262)
T ss_pred             ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CC------------
Confidence              1112334667999999877 6788999999999999999995 566765543332222111   00            


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                     ........+..+.+++.+||..+|++||++.++++.
T Consensus       220 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 ---------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                           000112357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-37  Score=277.49  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=187.1

Q ss_pred             ccccCCccceEEEEEeCC--CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++....  ....+++|.+.... .......+.+|+.+++.++||||+++++.+.....     ++++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~-----~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP-----YLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc-----eEEEE
Confidence            469999999999996533  34578888876432 23345667889999999999999999999887654     89999


Q ss_pred             ecCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          126 ELMD-TDLHQIIRSDQ-----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ||++ ++|.+++....     ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9998 59999886533     24677888999999999999999999999999999999999999999999986533221


Q ss_pred             c---ccccccccccCCCccccc------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          200 F---MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       200 ~---~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||........+...........+   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---  231 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP---  231 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC---
Confidence            1   122334667999999743      1356789999999999999998 78888776654433332221100000   


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            ........++.+.+++..|+ .||++|||+++|++
T Consensus       232 ----------------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         232 ----------------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----------------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                  00112346788889999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.1e-38  Score=281.46  Aligned_cols=266  Identities=24%  Similarity=0.376  Sum_probs=199.8

Q ss_pred             ccccCCcccccCCccceEEEEEeC----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+++.+++.||+|+||.||++...    .++..+|+|.+...... .....+.+|+.+++.++|+||+++++++..... 
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~-   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG-   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC-
Confidence            456778999999999999999864    34789999999765333 356678899999999999999999998876432 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                        ...++++||++ ++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence              33899999997 59999887644 689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          195 TSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       195 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++++|++|..|+.........     ..+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~----  228 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQG----  228 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc-----ccccccc----
Confidence            653211    112233556999999877 67889999999999999999999988654321100     0000000    


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                         ...............   ........+.++.+++.+||+.+|++|||+.|+++
T Consensus       229 ---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 ---QMIVTRLLELLKEGE---RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---cccHHHHHHHHHcCC---cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               000011111110000   11112345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=283.95  Aligned_cols=268  Identities=22%  Similarity=0.422  Sum_probs=213.8

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc--C---HHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--N---IIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      +...+.++|. .+..||+|||+.||++.|....+.||+|+-.....  .   ....+...+|..|.+.|+||.||++|++
T Consensus       457 DHptLn~RYL-lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  457 DHPTLNDRYL-LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             cCcchHHHHH-HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            3445677788 99999999999999999999999999998753211  1   1122345689999999999999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCceEEcc---CCC
Q 017083          110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNA---SCD  183 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dik~~NIli~~---~~~  183 (377)
                      |..+...    +|.|.|||+| +|.-+++..+.+++.+++.|+.||+.||.||.+.  .|+|-||||.|||+-.   -|.
T Consensus       536 fslDtds----FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  536 FSLDTDS----FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeecccc----ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            9876543    7999999998 7777778888999999999999999999999976  5999999999999843   567


Q ss_pred             eEEeeeecccccCCCc--------cccccccccccCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 017083          184 LKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~  252 (377)
                      +||+|||+++.+....        ......||.||++||.|.-   ....+.++||||+||++|.++.|+.||......+
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            9999999998765432        3455778999999999854   2456889999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       253 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .+-....++.                        -....+ +.-|.++.++.+||++||..--++|..+.++..||+|..
T Consensus       692 dILqeNTIlk------------------------AtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  692 DILQENTILK------------------------ATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHhhhchhc------------------------ceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            3322211111                        011111 112357899999999999999999999999999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=272.78  Aligned_cols=274  Identities=22%  Similarity=0.356  Sum_probs=224.2

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhc-CCCCceeEeee
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHM-EHENVIAIKDI  109 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~  109 (377)
                      -.+..+.++.+++.+++.||.|+|++|-.++++.+.+.||+|+++++..+. ....-.+.|..+..+- +||.+|-++.+
T Consensus       240 g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  240 GIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             ccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            344568899999999999999999999999999999999999998875433 2345556777777766 59999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEee
Q 017083          110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~D  188 (377)
                      |..++.     +++|.||++| +|--.++...+++++.++.+...|+.||.|||+.||++||||.+|||++..|.+||+|
T Consensus       320 fqtesr-----lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  320 FQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             hcccce-----EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecc
Confidence            998866     9999999984 8888888889999999999999999999999999999999999999999999999999


Q ss_pred             eecccc-cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          189 FGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       189 fg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +|..+. ....+...+++||+.|.|||.+.+ ..|+.++|.|+||++++||+.|+.||.-....                
T Consensus       395 ygmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~----------------  457 (593)
T KOG0695|consen  395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD----------------  457 (593)
T ss_pred             cchhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCC----------------
Confidence            999875 445567889999999999999999 89999999999999999999999999432100                


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC------CHHHHhcCccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI------TVEEALRHPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------s~~ell~~p~f~~~~  334 (377)
                          ....+.+.++-++...++...   ...+|..+..+++..|++||.+|.      .+.++-.|+||+++.
T Consensus       458 ----n~d~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  458 ----NPDMNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ----CcccchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence                011122222222221111111   235677788999999999999997      678999999998654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=278.99  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=221.4

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  116 (377)
                      +...++..+..||+|+||.|-++..+.+.+.||||++++... .....+-.+.|-++|.... -|.++.++.+|..-.. 
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR-  424 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR-  424 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh-
Confidence            334455578999999999999999999999999999988642 2223444556777777664 7899999999987755 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          +|+||||+. |+|--.|+.-+++.+..+..++..|+-||-+||++||++||||.+||+++.+|.+||.|||+++..
T Consensus       425 ----LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 ----LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             ----eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence                999999998 589889999999999999999999999999999999999999999999999999999999999753


Q ss_pred             -CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          196 -SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       196 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                       -......+.+||+.|+|||.+.= .+|+.++|.||+|+++|||+.|+.||.+.+..+....|++-...-          
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy----------  569 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY----------  569 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC----------
Confidence             33455778999999999999865 789999999999999999999999999999999888887743222          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                           ...+|.++.++.+..|.+.|.+|..     -.++-.||||+.+.
T Consensus       570 ---------------------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  570 ---------------------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             ---------------------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence                                 2357999999999999999999973     36788899998764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=297.10  Aligned_cols=266  Identities=26%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-CCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~iv  124 (377)
                      --+.||+|+||.||+++++.+|+.||||.++... .....+...+|++++++|+|+|||+++++-+.... ..-....++
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3456999999999999999999999999998754 33456677799999999999999999998766541 001336799


Q ss_pred             EecCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc--cCCC--eEEeeeecccccC
Q 017083          125 YELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCD--LKIGDFGLARTTS  196 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~--~~~~--vkl~Dfg~~~~~~  196 (377)
                      ||||. |+|...+..   ..++++.+.+.++.++..||.|||++||+||||||.||++-  .+|+  -||+|||.|+...
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            99998 599999864   34799999999999999999999999999999999999874  3454  5999999999999


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccccccccch
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .+.......||+.|.+||++..++.++..+|.|||||++|+++||..||....... ....+-......+....-.....
T Consensus       176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~  255 (732)
T KOG4250|consen  176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE  255 (732)
T ss_pred             CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence            88888999999999999999855889999999999999999999999996654442 22233333333333221111100


Q ss_pred             hHHHHHHhccccccccccccCCCCCh----hHHHHHHHhcCCCCCCCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSS----GAVDLLEKMLVFDPNKRI  319 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dp~~Rp  319 (377)
                      ..+       ........+....+++    .+..++..||..+|.+|.
T Consensus       256 eNg-------pv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  256 ENG-------PVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cCC-------ceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            000       0011111111122332    345778889999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-38  Score=296.95  Aligned_cols=266  Identities=25%  Similarity=0.398  Sum_probs=218.8

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  114 (377)
                      .+-.+..-+++.+.||.|.+|.||+++++.+++..|+|+.....+   ..+++..|.++++.+. |||++.+|++|....
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334445556689999999999999999999999999999976433   3356778999999885 999999999988777


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .....++|+|||||+ |+..++++.  +.++.+..+..|++.++.|+.+||.+.++|||||-.|||++.++.|||.|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence            677788999999998 588888765  56789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSET-DFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +...... ....+..||+.|||||++...    ..++..+|+||||++..||..|.+|+........+..|   ...||+
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP  246 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP  246 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc
Confidence            8765543 556788999999999998542    34677999999999999999999999776544333222   222322


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      ....                         +..-+.++.++|..||.+|..+||+..++|+|||++.
T Consensus       247 kLkr-------------------------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  247 KLKR-------------------------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             cccc-------------------------hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            2211                         1223778999999999999999999999999999973

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.5e-36  Score=268.36  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=185.0

Q ss_pred             ccccCCccceEEEEEeCCC--CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.||+|+||+||++....+  ...+++|.+.... .......+.+|+.+++.++||||+++++.+.....     .+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-----~~lv~   74 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP-----YLLVF   74 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc-----cEEEE
Confidence            3699999999999975433  2356777765432 23345678899999999999999999999987644     89999


Q ss_pred             ecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          126 ELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       126 e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      ||++ ++|.+++...    ...+...++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||++......  
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9998 5999888653    34566778899999999999999999999999999999999999999999987643221  


Q ss_pred             -ccccccccccccCCCcccccc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          199 -DFMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                       .......++..|+|||++...      ..++.++||||||+++|+|++ |..||...........+.......      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence             112345667889999997431      235778999999999999997 577887665544333322110000      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                         .........+++.+.+++..|| .+|++||++.++++
T Consensus       229 -------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                               0001111245778899999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=283.41  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=217.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      -+++.+-..++++||+|-||.|-+|.-. .+.+||+|+++.....+ ....|.+|+++|.+|+||||+.++++|..++. 
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-  609 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-  609 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-
Confidence            4777888889999999999999999763 37899999998764333 35789999999999999999999999998876 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          +++++||++ |+|.+++....  ........+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++
T Consensus       610 ----icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  610 ----LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             ----hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence                899999998 79999998763  33556677899999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          194 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM--TREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       194 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ..-..+.   .....-...|||+|.+.. ++++.++|+|++|+++||++  +...||....+++.......++...+.  
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~--  762 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR--  762 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc--
Confidence            5543322   223344788999999988 89999999999999999985  578899888877776666555444332  


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                           ..+....+-++..+.+++.+||..|-++|||++++  |-+|++
T Consensus       763 ---------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  763 ---------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             ---------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence                                 22344455678999999999999999999999998  445543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=284.33  Aligned_cols=256  Identities=21%  Similarity=0.366  Sum_probs=220.3

Q ss_pred             EEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        31 ~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .+..+.|+....++...++||-|.||.||.+.++.-...||||.++.   +....++|++|+.+|+.++|||+|+++++|
T Consensus       256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             cCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            45568899999999999999999999999999999889999999975   345678999999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      ..+..     +|||+|||. |+|+++++...  .++...+.+++.||..|++||..++++||||-..|.||.++..||++
T Consensus       333 T~EpP-----FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  333 THEPP-----FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             ccCCC-----eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEee
Confidence            98866     999999997 89999998643  46777889999999999999999999999999999999999999999


Q ss_pred             eeecccccCCCcccc--ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017083          188 DFGLARTTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      |||+++.+.......  ..-....|+|||-+-- +.++.++|||+||++|||+.+ |-.||++.+.-+.+..+.+-..+.
T Consensus       408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD  486 (1157)
T ss_pred             ccchhhhhcCCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence            999999887664332  2233677999998865 788999999999999999987 888999887666655554432221


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                                                    ...++++.+.+|++.||+++|.+||++.|+-
T Consensus       487 ------------------------------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  487 ------------------------------GPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ------------------------------CCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                                          1236799999999999999999999999873

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.1e-38  Score=283.75  Aligned_cols=285  Identities=33%  Similarity=0.551  Sum_probs=224.2

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC------CCCceeEeeeec
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME------HENVIAIKDIIR  111 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~  111 (377)
                      ++-+.-|++....|+|=|++|..|.+..-|..||||++...   +.-...=+.|+++|++|+      --|.++++..|.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            44455555888999999999999999999999999999752   323344468999999996      237889998888


Q ss_pred             CCCCCCCCcEEEEEecCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEe
Q 017083          112 PPKKDTFNDVYIVYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIG  187 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~  187 (377)
                      ..     +++|+|+|-..-+|.++++.   +-.+....++.++.|++.||..|...||+|.||||+||||++.. .+|||
T Consensus       505 hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  505 HK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence            77     55999999999999999986   34688899999999999999999999999999999999999866 47999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||.|...+.+. ...+.-+..|.|||.+.+ ..|+...|+||+||+||||.+|+..|++..+.+++...+++-+..|..
T Consensus       580 DfGSA~~~~ene-itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  580 DFGSASFASENE-ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             cCcccccccccc-ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            999998777664 334455677999999999 899999999999999999999999999999999999999999887765


Q ss_pred             cccc--ccchhHHHH----HHhcc------------cccc-----------ccccccCCCCChhHHHHHHHhcCCCCCCC
Q 017083          268 SLGF--LRSDNARRY----VRQLP------------RCRK-----------QQFATRFPNKSSGAVDLLEKMLVFDPNKR  318 (377)
Q Consensus       268 ~~~~--~~~~~~~~~----~~~~~------------~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dp~~R  318 (377)
                      .+..  ....++..-    ...+.            ...+           +.....-+.+-.++.+|+.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            4321  111111000    00000            0000           00000011123468899999999999999


Q ss_pred             CCHHHHhcCccccC
Q 017083          319 ITVEEALRHPYLQS  332 (377)
Q Consensus       319 ps~~ell~~p~f~~  332 (377)
                      .|.+++|.||||+.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-36  Score=265.93  Aligned_cols=242  Identities=38%  Similarity=0.657  Sum_probs=200.8

Q ss_pred             ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCC-CH
Q 017083           54 AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL  132 (377)
Q Consensus        54 ~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L  132 (377)
                      +||.||++.+..+++.+++|++........ ...+.+|++.+++++|++++++++.+.....     .++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDK-----LYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCE-----EEEEEeCCCCCCH
Confidence            589999999999999999999976533221 5778899999999999999999999887644     8999999996 99


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccCC
Q 017083          133 HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA  212 (377)
Q Consensus       133 ~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~a  212 (377)
                      .+.+.....++...+..++.++++++.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..|+|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            99988766689999999999999999999999999999999999999999999999999987766544556677888999


Q ss_pred             CccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcccccccc
Q 017083          213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ  291 (377)
Q Consensus       213 PE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (377)
                      ||.+.+ ...+.++||||||+++++|++|..||... ........+......                            
T Consensus       155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------  205 (244)
T smart00220      155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------------------  205 (244)
T ss_pred             HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------------------
Confidence            999876 67788999999999999999999999773 322222222110000                            


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          292 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       292 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      .......++..+.+++.+||..+|++||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            000111267889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=286.58  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=207.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .+..++.||-|+||+|.++....+...||.|.+++. ............|-.||..-+.+-||++|..|.++..     +
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn-----L  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-----L  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-----e
Confidence            344788999999999999999999999999999764 2334445556678899999999999999999999977     9


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      |+||+|++ |++-+++-.-+-|.++.++.++..+..|+++.|..|++||||||+|||||.+|.|||+|||+++-....  
T Consensus       705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999998 589998888889999999999999999999999999999999999999999999999999998521100  


Q ss_pred             ------------c-----------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHH
Q 017083          199 ------------D-----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  237 (377)
Q Consensus       199 ------------~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~e  237 (377)
                                  +                             ......||+.|+|||++.. ..++...|.||.|++|||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHH
Confidence                        0                             0123678999999999988 889999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC
Q 017083          238 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  317 (377)
Q Consensus       238 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  317 (377)
                      |+.|+.||-.......-.++.+                 ++.+          ........++.++.+||.+++. +++.
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~n-----------------w~~~----------l~~~~~~~ls~e~~~li~kLc~-sad~  915 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVIN-----------------WRNF----------LHIPYQGNLSKEALDLIQKLCC-SADS  915 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeee-----------------hhhc----------cccccccccCHHHHHHHHHHhc-Chhh
Confidence            9999999977553332222211                 0100          0111123679999999988554 4556


Q ss_pred             CC---CHHHHhcCccccCCcC
Q 017083          318 RI---TVEEALRHPYLQSLHD  335 (377)
Q Consensus       318 Rp---s~~ell~~p~f~~~~~  335 (377)
                      |.   -+++|..||||+.|.-
T Consensus       916 RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  916 RLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             hhcccchhhhhcCccccccch
Confidence            65   6778999999988763

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.8e-36  Score=294.69  Aligned_cols=276  Identities=20%  Similarity=0.253  Sum_probs=176.4

Q ss_pred             cccccCCcccccCCccceEEEEEeCCC----CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC-
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSET----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK-  114 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-  114 (377)
                      ..+.|.+.+.||+|+||+||++++..+    +..||+|++......    +....+  .++...+.++..+...+.... 
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            344566899999999999999999988    899999988643211    111111  112222233333332221111 


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQ--------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~  173 (377)
                      ......+++++||++ ++|.+++.....                    .....+..++.||+.||+|||+++|+||||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence            112244899999998 488888764321                    12344678999999999999999999999999


Q ss_pred             CceEEcc-CCCeEEeeeecccccCCC--ccccccccccccCCCccccccC---------------------CCCCcchHH
Q 017083          174 SNLLLNA-SCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCT---------------------EYTAAIDIW  229 (377)
Q Consensus       174 ~NIli~~-~~~vkl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Diw  229 (377)
                      +|||++. ++.+||+|||++......  .......+++.|+|||.+....                     .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 578999999999754322  2234567789999999764311                     133456999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcccccc---ccccccCCCCChhHHHH
Q 017083          230 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK---QQFATRFPNKSSGAVDL  306 (377)
Q Consensus       230 slG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l  306 (377)
                      ||||++|||+++..++.  .....+..+....+...            ..+.........   ...............+|
T Consensus       364 SlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDL------------VAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             HHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcH------------HHHHHhhccccchhhhhhhhhccccchHHHHH
Confidence            99999999998765543  22222222222111100            001000000000   00001111224456799


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          307 LEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       307 i~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      |.+||+.||++|||+.++|+||||+....
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999999999987554

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=282.21  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=210.8

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCC--CC--cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE--TR--EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~--~~--~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      ++.+++....+.+.+.||.|-||.||.+..-.  .|  -.||||..+...+ ....+.|+.|..+|++++||||++++|+
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeee
Confidence            45688999999999999999999999997522  23  3488998876533 3347889999999999999999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      +.+..      .|||||.++ |.|..+++.+ ..++...+..+++||+.||+|||+.++|||||-..||||....=|||+
T Consensus       460 ~~e~P------~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  460 CVEQP------MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             eeccc------eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeec
Confidence            98864      699999999 8999999864 468889999999999999999999999999999999999999889999


Q ss_pred             eeecccccCCCcccccccc--ccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017083          188 DFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      |||+++............+  ...|||||-+.- ..++.++|||.||+.+||++. |..||.+..+.+-+-.+       
T Consensus       534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------  605 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------  605 (974)
T ss_pred             ccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------
Confidence            9999998876654433333  567999999865 788999999999999999976 99999886543332222       


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                                             ......+..+.+|+.+..|..+||..+|.+||.+.|+.
T Consensus       606 -----------------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  606 -----------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             -----------------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                   22223444568899999999999999999999887764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=243.52  Aligned_cols=218  Identities=26%  Similarity=0.418  Sum_probs=186.3

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRP  112 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  112 (377)
                      .+.|++..+....+..||+|++|.|-+.+|..+|...|+|.+..+.. .+..++.++|+.+..+. ..|++|.+|+.+..
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            34499999999999999999999999999999999999999987654 45667777888887766 59999999999888


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEe
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      .+.     ++|.||.|..+|..+.    +.++..++..+-.|+..|+.||.|||++ .++|||+||+||||+.+|++|+|
T Consensus       117 egd-----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  117 EGD-----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             ccc-----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEc
Confidence            766     9999999999888765    4578899999999999999999999976 89999999999999999999999


Q ss_pred             eeecccccCCCccccccccccccCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLI  257 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ll~ell~g~~pf~~-~~~~~~~~~i  257 (377)
                      |||.+....++-...-..|.-.|+|||.+..   +..|+.++||||||++++||.+++.||.. ....+++..+
T Consensus       192 DFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  192 DFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             ccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            9999987776654554667778999999853   35788999999999999999999999965 3444444443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=283.16  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=216.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCC-C--cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET-R--EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~-~--~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      |+.+.+.+.++||+|+||+|+++.+... |  ..||||.++...... ....|++|+.+|.+|+|+|++++||++.+.. 
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp-  184 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP-  184 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch-
Confidence            5667788899999999999999988553 3  358999998765443 6789999999999999999999999999743 


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                           ..+|+|.++ |+|++.+..  ...|-...++.++.||+.|+.||.++++|||||-..|+++-....|||+|||++
T Consensus       185 -----~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  185 -----AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             -----hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence                 579999999 799999976  446788899999999999999999999999999999999998888999999999


Q ss_pred             cccCCCccccccc----cccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETDFMTEYV----VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~~~~~~~----~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +..+.........    -...|.|||.+.. ..++.++|+|++||++|||++ |..||.+....+.+++|.+        
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--------  330 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--------  330 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--------
Confidence            9777654333222    2566999999988 889999999999999999998 8999999988877776642        


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                            ....+..+.++.++.+++++||..+|.+|||+..+...-+.+....
T Consensus       331 ----------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  331 ----------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             ----------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence                                  1122334567999999999999999999999999976666554443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=288.21  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=220.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ++|...|+.|-+.||.|.||.||.++.+..|+   .||||.++... .+....+|+.|+.||-+++||||+++-+++...
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            37888899999999999999999999988774   59999998764 445678899999999999999999999999988


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ..     +.||+|||+ |+|..+++. .+.|+..++..+++.|+.|+.||-++|+|||||-..||||+.+..+|++|||+
T Consensus       703 ~P-----vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  703 KP-----VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             ce-----eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence            66     899999998 799999975 56799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-ccc-cccc--ccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETD-FMT-EYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~-~~~-~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ++...+.. ... ...|  ...|+|||++.- .+++.++|+||+|++++|.++ |..||=...+.+-+..|..-..-|++
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP  856 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP  856 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence            99765442 111 1222  577999999977 789999999999999999876 99999888888888888776555543


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                    .++|..+..|+..||++|-..||.+.+++.
T Consensus       857 ------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 ------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                          267999999999999999999999999886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=287.06  Aligned_cols=249  Identities=30%  Similarity=0.394  Sum_probs=193.1

Q ss_pred             ccCCcccccCCccce-EEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCc
Q 017083           43 YVPPIRPIGRGAYGI-VCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~-vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+..-+.+|.|+.|+ ||++.-  .|+.||||.+-.     .......+|+..|+.-+ |||||++|+.-.+...     
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-----  577 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-----  577 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce-----
Confidence            333556689999986 599965  578999998843     34556779999999986 9999999998887755     


Q ss_pred             EEEEEecCCCCHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CC--CeEEeeeec
Q 017083          121 VYIVYELMDTDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SC--DLKIGDFGL  191 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~--~vkl~Dfg~  191 (377)
                      .||..|.|..+|.+++.....    ......+.++.|++.|+++||+.+|+||||||.||||+.   ++  +++|+|||+
T Consensus       578 ~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  578 LYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             EEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            999999999999999987411    122456788999999999999999999999999999976   34  589999999


Q ss_pred             ccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ++......    ......||.+|+|||.+.+ ...+.++|||||||++|+.++| ..||......+.  .|   +.....
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NI---l~~~~~  731 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NI---LTGNYT  731 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhhh--hh---hcCccc
Confidence            99876543    2456788999999999988 6667899999999999999885 999976542221  11   110000


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      -              ..         .  -+....++.+||.+|+.++|..||+|.+||.||||....
T Consensus       732 L--------------~~---------L--~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  732 L--------------VH---------L--EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             e--------------ee---------e--ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            0              00         0  001111789999999999999999999999999997543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=274.87  Aligned_cols=273  Identities=19%  Similarity=0.266  Sum_probs=184.6

Q ss_pred             ecccccCCcccccCCccceEEEEEeC----------------CCCcEEEEEeccccccCHHHHH--------------HH
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNS----------------ETREEVAIKKIGNAFDNIIDAR--------------RT   88 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~----------------~~~~~valK~~~~~~~~~~~~~--------------~~   88 (377)
                      ...+.|.+.++||+|+||+||++.+.                ..++.||||.+.....  ....              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~--~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ--GVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch--hhHHHHHhhhhhhhcccchh
Confidence            34556779999999999999998642                3456799999864321  1111              22


Q ss_pred             HHHHHHHHhcCCCCc-----eeEeeeecCCCCC---CCCcEEEEEecCC-CCHHHHHHhC--------------------
Q 017083           89 LREIKLLRHMEHENV-----IAIKDIIRPPKKD---TFNDVYIVYELMD-TDLHQIIRSD--------------------  139 (377)
Q Consensus        89 ~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~---~~~~~~iv~e~~~-~~L~~~l~~~--------------------  139 (377)
                      ..|+.++.+++|.++     ++++++|.....+   .....++|+||++ ++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346677777766544     6667766543211   1133799999998 5888877531                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc--cccccccCCC
Q 017083          140 ----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAP  213 (377)
Q Consensus       140 ----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~--~~~~~~y~aP  213 (377)
                          ..+++..++.++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++...........  ..+++.|+||
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                1235667889999999999999999999999999999999999999999999875443322222  2337889999


Q ss_pred             ccccccCC---------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCChHH-HHHHHHHHhCCCCccccc
Q 017083          214 ELLLNCTE---------------------YTAAIDIWSVGCILGEIMTREP-LFPGKDYVH-QLRLITELIGSPDDASLG  270 (377)
Q Consensus       214 E~~~~~~~---------------------~~~~~DiwslG~ll~ell~g~~-pf~~~~~~~-~~~~i~~~~~~~~~~~~~  270 (377)
                      |.+.....                     .....|+||+||++|+|++|.. ||....... .+....            
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~------------  447 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD------------  447 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc------------
Confidence            99854211                     1234799999999999999875 664322111 000000            


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCC---CCCCCHHHHhcCccccC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP---NKRITVEEALRHPYLQS  332 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rps~~ell~~p~f~~  332 (377)
                           .....+......  ......+...++..++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       448 -----~~~~~~r~~~~~--~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        448 -----NDLNRWRMYKGQ--KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             -----chHHHHHhhccc--CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                 000001111000  11112345678999999999999766   68999999999999964

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=278.27  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=221.2

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ++..|+.+..+|+|.+|.||+++++.+++..|+|+++.....  ...-+.+|+-+++..+||||+.+++.|.....    
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dk----   86 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK----   86 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcC----
Confidence            344555999999999999999999999999999999876443  45667789999999999999999999998866    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                       ++|+||||+ |+|.+.....+++++.++.++.+..+++++|||+.|-+|||||-.||++++.|.+|+.|||.+......
T Consensus        87 -lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   87 -LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             -cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence             899999998 599999999999999999999999999999999999999999999999999999999999988765543


Q ss_pred             -ccccccccccccCCCcccc--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 -DFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                       .....+.||++|||||+..  ..+.+...+|||++|++..|+..-+.|.........+..+.+....++.-..      
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD------  239 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD------  239 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC------
Confidence             4567789999999999962  2367899999999999999999989888777666666655554333322110      


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                       +   ..-++.+-+|++.+|.++|++|||+..+|.|||.+.-
T Consensus       240 -----------------k---~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  240 -----------------K---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             -----------------C---ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                             0   1236778899999999999999999999999998654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.7e-35  Score=258.28  Aligned_cols=284  Identities=30%  Similarity=0.445  Sum_probs=212.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  116 (377)
                      .+++.++.+||.|.|++||++.+..   ..+.||+|.+...    ....++..|+++|..+. +.||+++.+++..++. 
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~-  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ-  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccCCe-
Confidence            3455599999999999999999988   7889999999654    23456889999999997 8999999999998876 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~  194 (377)
                          +.+|+||++. ...+++.   .++...++.+++.++.||.++|.+||+||||||+|++++. .++-.|.|||++..
T Consensus       110 ----v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 ----VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             ----eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence                8999999995 6777764   3668889999999999999999999999999999999986 45789999999861


Q ss_pred             cC---------C-------C-----------------------------ccccccccccccCCCccccccCCCCCcchHH
Q 017083          195 TS---------E-------T-----------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIW  229 (377)
Q Consensus       195 ~~---------~-------~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  229 (377)
                      ..         .       .                             ...-...||++|+|||++......+.++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            00         0       0                             0011246799999999999988889999999


Q ss_pred             HHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCccccc----c------ccchhHHHHHHhcccc-----cc--c-
Q 017083          230 SVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLG----F------LRSDNARRYVRQLPRC-----RK--Q-  290 (377)
Q Consensus       230 slG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~----~------~~~~~~~~~~~~~~~~-----~~--~-  290 (377)
                      |.|++++.++++..||.. .++...+..+..+++...-....    .      ............+...     .+  + 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999754 44555566555555532211100    0      0001111111111111     11  1 


Q ss_pred             -cccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          291 -QFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       291 -~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                       -....+.+ .+..+.+|+.+||..||.+|.|++++|+||||....+.
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence             01112223 45689999999999999999999999999999866543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=267.05  Aligned_cols=198  Identities=28%  Similarity=0.417  Sum_probs=176.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHH-----HHHHHHHHHHHhcC---CCCceeEeeeecCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDA-----RRTLREIKLLRHME---HENVIAIKDIIRPPK  114 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~-----~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~  114 (377)
                      |..++.||.|+||.|++|.++.+...|+||++.++.. -..+.     -..-.|++||..|+   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            4589999999999999999999999999999977531 11111     22346999999998   999999999999997


Q ss_pred             CCCCCcEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      .     +||+||-.+ | +|.++|.....+++.+++.|+.||+.|+++||+.||+|||||-+||+++.+|-+||+|||.+
T Consensus       643 ~-----yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  643 Y-----YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             e-----eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            7     999999987 5 99999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~  247 (377)
                      ...... ....+.||..|.|||++.+....+..-|||+||+++|.+.....||..
T Consensus       718 a~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            776654 366788999999999999967779999999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-33  Score=292.25  Aligned_cols=249  Identities=18%  Similarity=0.269  Sum_probs=181.2

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ..+.||+|+||.||+++++.++..||+|.+.....      ....|+..+++++|||||++++++.....     .++||
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~-----~~lv~  762 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKG-----AYLIH  762 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCC-----CEEEE
Confidence            45679999999999999999999999999864321      11246888999999999999999987754     79999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---cCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH---SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      ||++ |+|.+++.   .+++..+..++.||++|++|||   +.+++||||||+||+++.++..++. |+.......   .
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~  835 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---D  835 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---C
Confidence            9998 58998885   4889999999999999999999   6699999999999999998887775 655433221   1


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .............          .....+
T Consensus       836 ~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~  904 (968)
T PLN00113        836 TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----------CHLDMW  904 (968)
T ss_pred             CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----------cchhhe
Confidence            22356889999999877 77899999999999999999999998532110 0000000000000          000000


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .+...    ............++.+++.+||+.||++|||+.|+++.
T Consensus       905 ~~~~~----~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        905 IDPSI----RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             eCccc----cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000    00000000112357789999999999999999999865

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=270.02  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=209.8

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCce
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVI  104 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv  104 (377)
                      ....|++..+...+.+.||.|.||+|+++.-+.       ....||+|+++..... .....+..|+.+|+.+. |+||+
T Consensus       287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchh
Confidence            334899999999899999999999999997431       1457999999877655 67788999999999995 99999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCce
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVL  167 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~  167 (377)
                      .+++++...+.     ++++.||+. |+|.++++..+                .++...+..++.||+.|++||++.+++
T Consensus       366 ~llG~~t~~~~-----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v  440 (609)
T KOG0200|consen  366 NLLGACTQDGP-----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV  440 (609)
T ss_pred             hheeeeccCCc-----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence            99999988544     899999998 79999998655                388889999999999999999999999


Q ss_pred             ecCCCCCceEEccCCCeEEeeeecccccCCCccc--cccc--cccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 017083          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYV--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  242 (377)
Q Consensus       168 H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~  242 (377)
                      ||||-..|||++.+..+||+|||+++........  ....  -...|||||.+.. ..++.++||||+|+++|||.+ |.
T Consensus       441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCC
Confidence            9999999999999999999999999864443322  2122  2445999999988 889999999999999999988 88


Q ss_pred             CCCCCCC-hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          243 PLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       243 ~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                      .||++-. .......+..                              ....+.....++++.++++.||+.+|++||++
T Consensus       520 ~PYp~~~~~~~l~~~l~~------------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F  569 (609)
T KOG0200|consen  520 TPYPGIPPTEELLEFLKE------------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTF  569 (609)
T ss_pred             CCCCCCCcHHHHHHHHhc------------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence            9998744 2222222211                              11112223568899999999999999999999


Q ss_pred             HHHhc
Q 017083          322 EEALR  326 (377)
Q Consensus       322 ~ell~  326 (377)
                      .++.+
T Consensus       570 ~~~~~  574 (609)
T KOG0200|consen  570 SECVE  574 (609)
T ss_pred             HHHHH
Confidence            99874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=250.23  Aligned_cols=262  Identities=22%  Similarity=0.283  Sum_probs=189.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHH--hcCCCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR--HMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +..++.||+|.||.||+++.  +++.||||++..     ...+.+..|-.|..  .++|+||+.+++.-+..... -..+
T Consensus       212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            34788899999999999966  448999999954     45667777777766  55799999999987766533 2448


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCceEEccCCCeEEeeeec
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ++|++|.+ |+|.++++. ..+++...++|+..+++||+|||+-         .|+|||||..||||..++...|+|||+
T Consensus       284 wLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999998 799999875 6799999999999999999999952         499999999999999999999999999


Q ss_pred             ccccCCC---ccccccccccccCCCccccccCCCC-----CcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhC
Q 017083          192 ARTTSET---DFMTEYVVTRWYRAPELLLNCTEYT-----AAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIG  262 (377)
Q Consensus       192 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~  262 (377)
                      +-+....   ...-...||..|||||++.+.-...     .+.||||+|.+++||++....+.. .-.+-++..-. .++
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~-evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA-EVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH-Hhc
Confidence            9865533   2344578999999999997743333     478999999999999987654421 11000000000 011


Q ss_pred             CCCccccccccchhHHHHHHhcc-ccccccccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          263 SPDDASLGFLRSDNARRYVRQLP-RCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      .          -...+.....+. ...+......|..  -..-+.+.+..||+.||+.|.|+.=+-
T Consensus       442 ~----------hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  442 N----------HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             C----------CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            1          111222222222 1222223333332  234588999999999999999986543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=245.17  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=185.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHH--hcCCCCceeEeeeecCCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR--HMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      +.+.+.+.||+|.||.||++.++  |+.||||++..+     ..+...+|.+|.+  .|+|+||+.+++.-..+. +...
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceE
Confidence            44558899999999999999774  679999999764     2334445555555  568999999998865543 4557


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-----C---CceecCCCCCceEEccCCCeEEeeee
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----A---SVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-----~---~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ++|+|++|.+ |+|.+++.. ..++.+....++..++.||++||.     +   .|.|||||..||||+.+|..-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            7999999999 899999987 789999999999999999999994     2   39999999999999999999999999


Q ss_pred             cccccCCC-----ccccccccccccCCCccccccCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCCCC-
Q 017083          191 LARTTSET-----DFMTEYVVTRWYRAPELLLNCTEY-----TAAIDIWSVGCILGEIMTR----------EPLFPGKD-  249 (377)
Q Consensus       191 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~ll~ell~g----------~~pf~~~~-  249 (377)
                      ++-.....     ...+..+||-.|||||++...-..     -..+||||||++++|++..          +.||...- 
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99654433     235667899999999999763221     2468999999999999752          45664311 


Q ss_pred             hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCC--ChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       250 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ....++.+.++.           +.           +......+..|...  =..+.++++.||..||.-|.||-.+-
T Consensus       442 ~DPs~eeMrkVV-----------Cv-----------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  442 SDPSFEEMRKVV-----------CV-----------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CCCCHHHHhcce-----------ee-----------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            111111121110           00           01111122222222  12466889999999999999987664

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-33  Score=232.17  Aligned_cols=262  Identities=20%  Similarity=0.323  Sum_probs=202.0

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeee-ecC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDI-IRP  112 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~  112 (377)
                      .+..+.+.|- |.+.||+|.||.+-+|.|+.+...+++|.+.+.   ..+.++|.+|...---|. |.||+.-|+. |+.
T Consensus        18 ~kv~l~d~y~-I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   18 KKVDLEDVYT-INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cccchhhhhh-HHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            3445555665 899999999999999999999999999999875   345678888887766665 8999988765 444


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc--CCCeEEeee
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDF  189 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~--~~~vkl~Df  189 (377)
                      .+.     +++++||++ |+|.+-+.. ..+-+...+.++.|++.||.|||++++||||||.+||||-+  ..+||||||
T Consensus        94 ~d~-----YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDA-----YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             Cce-----EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence            433     789999999 799988765 45888999999999999999999999999999999999943  337999999


Q ss_pred             ecccccCCCccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          190 GLARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       190 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      |+++..+..  .........|.+||++..    .-...+.+|||+||+++|.+++|..||.....               
T Consensus       168 G~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---------------  230 (378)
T KOG1345|consen  168 GLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---------------  230 (378)
T ss_pred             ccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---------------
Confidence            998766533  223334667999998753    23357899999999999999999999974321               


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCcccc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALRHPYLQ  331 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---ps~~ell~~p~f~  331 (377)
                             .......++.. ....-...+..++.+++.+.++.++-|..++++|   .+++......|..
T Consensus       231 -------~d~~Y~~~~~w-~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  231 -------MDKPYWEWEQW-LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             -------cCchHHHHHHH-hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                   11112222222 2222234555677889999999999999999999   7787777777764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3e-32  Score=257.54  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=201.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +..++||+|+||+||++.+...|+    +||+|++... .......++++|+.+|.+++|||++++++++....      
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            356789999999999999866665    5788888653 33344577889999999999999999999998764      


Q ss_pred             EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      +.||++|++ |.|.++++. +.++-.+....|..||++|+.|||.++++||||-..||||+.-..+|+.|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            579999999 799999975 567888999999999999999999999999999999999999999999999999987655


Q ss_pred             cccccccc---ccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 DFMTEYVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~~~~~~~~---~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .......+   .+.|+|-|.+.. ..++.++||||+||++||++| |..|+.+....+.-..+..-              
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------------  916 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------------  916 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------------
Confidence            43332222   566899998887 889999999999999999987 99999887755443333221              


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                      ...++.+..+.++.-++.+||..|+..||+++++..
T Consensus       917 ----------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 ----------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ----------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                            112344567889999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1e-30  Score=224.09  Aligned_cols=211  Identities=36%  Similarity=0.625  Sum_probs=182.3

Q ss_pred             ccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC
Q 017083           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD  129 (377)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~  129 (377)
                      ||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++++++++++.....     .++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH-----LYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe-----EEEEEecCC
Confidence            689999999999998889999999997653221 35678899999999999999999999988644     899999999


Q ss_pred             -CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCCCc-cccccc
Q 017083          130 -TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-FMTEYV  205 (377)
Q Consensus       130 -~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~~~-~~~~~~  205 (377)
                       ++|.+++... ..++...+..++.++++++++||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             6999988765 57899999999999999999999999999999999999999 8999999999987655432 123345


Q ss_pred             cccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhcc
Q 017083          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  285 (377)
Q Consensus       206 ~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (377)
                      +...|++||.+......+.++|+|+||+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            677899999987733778999999999999999                                               


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 017083          286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  328 (377)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p  328 (377)
                                     ..+.+++.+|++.||++||++.++++++
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           1267999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.7e-29  Score=219.28  Aligned_cols=197  Identities=35%  Similarity=0.612  Sum_probs=171.8

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+.+.||.|++|+||++.+..+++.+++|.+...... .....+.+|+..+++++|+|++++++++.....     .+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-----~~~v   75 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP-----LYLV   75 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc-----eEEE
Confidence            3678899999999999999988999999999765333 246678889999999999999999999887644     8999


Q ss_pred             EecCCC-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--c
Q 017083          125 YELMDT-DLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  200 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--~  200 (377)
                      +|++++ +|.+.+..... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......  .
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            999997 99999887666 8999999999999999999999999999999999999999999999999988765442  3


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~  247 (377)
                      .....++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34556778899999984336777899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.1e-30  Score=266.27  Aligned_cols=205  Identities=16%  Similarity=0.246  Sum_probs=147.6

Q ss_pred             hcCC-CCceeEeeeecCCCCCCC--CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 017083           97 HMEH-ENVIAIKDIIRPPKKDTF--NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (377)
Q Consensus        97 ~l~h-~~iv~~~~~~~~~~~~~~--~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik  172 (377)
                      .++| +||+++++.|.....+..  ..+++++|+++++|.+.+.. ...+++..++.++.||++||+|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            4455 578888888744332221  23778899999999999965 4569999999999999999999999999999999


Q ss_pred             CCceEEccCC-------------------CeEEeeeecccccCCCc-----------------cccccccccccCCCccc
Q 017083          173 PSNLLLNASC-------------------DLKIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPELL  216 (377)
Q Consensus       173 ~~NIli~~~~-------------------~vkl~Dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~  216 (377)
                      |+||||+..|                   .+|++|||+++......                 ......+|++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996544                   45555666554321100                 00113568889999999


Q ss_pred             cccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccC
Q 017083          217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF  296 (377)
Q Consensus       217 ~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (377)
                      .+ ..++.++|||||||++|||++|..|+....  .....+..... +                             +..
T Consensus       188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~-----------------------------~~~  234 (793)
T PLN00181        188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-P-----------------------------PQI  234 (793)
T ss_pred             cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-C-----------------------------hhh
Confidence            87 678999999999999999999888764321  11111111000 0                             000


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          297 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       297 ~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ....+...+++.+||+++|.+||++.|+++||||....
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            11134567899999999999999999999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.7e-30  Score=247.21  Aligned_cols=281  Identities=26%  Similarity=0.306  Sum_probs=216.8

Q ss_pred             EEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccc---cccCHHHH-HHHHHHHHHHHhcCCCCce
Q 017083           29 QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN---AFDNIIDA-RRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        29 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~---~~~~~~~~-~~~~~e~~~l~~l~h~~iv  104 (377)
                      ..........+..+|....+.+|.|++|.|+.+......+.++.|.+..   ........ ..+..|+.+-..+.|+|++
T Consensus       305 ~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~  384 (601)
T KOG0590|consen  305 SLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNII  384 (601)
T ss_pred             ccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchh
Confidence            3444555667778898899999999999999998887777777776652   11222222 2266788888999999998


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCe
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~v  184 (377)
                      .....+.....     ..-.||||+++|..++.....+....+..++.|++.|++|||+.||.|+|+|++|++++.+|.+
T Consensus       385 e~l~~~~~~~~-----~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~l  459 (601)
T KOG0590|consen  385 ETLDIVQEIDG-----ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGIL  459 (601)
T ss_pred             hhHHHHhhccc-----chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCce
Confidence            88887776644     3334999999999999988899999999999999999999999999999999999999999999


Q ss_pred             EEeeeecccccCCC-----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          185 KIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       185 kl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                      ||+|||.+......     .......|+..|.|||++.+........||||.|++++.|.+|+.||......+....   
T Consensus       460 ki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---  536 (601)
T KOG0590|consen  460 KIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---  536 (601)
T ss_pred             EEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---
Confidence            99999998754322     3356778899999999999844446689999999999999999999976543322110   


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                          ....               .............+..++...+.+|.+||++||.+|.|++++++.+||+.+.-.
T Consensus       537 ----~~~~---------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  537 ----TNNY---------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ----hhcc---------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence                0000               000011111222234568889999999999999999999999999999988743

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-28  Score=214.87  Aligned_cols=254  Identities=19%  Similarity=0.265  Sum_probs=203.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCC-----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      ..+.+..++....+-+|.||.||.+.+++..     +.|.+|.++.. ....+...++.|--++..+.|||+..+.++.-
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            3455555666777889999999999776543     34566666543 34456677889999999999999999999866


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~  182 (377)
                      +...    ..++++.+.+ |+|..++..        -+.++..++..++.|++.|++|||+.|++|.||-..|.+|++.-
T Consensus       358 e~~~----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  358 EDYA----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eccC----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence            5432    2689999998 899999872        12467778889999999999999999999999999999999999


Q ss_pred             CeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017083          183 DLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~  258 (377)
                      ++||+|=.+++.....+.   -........||+||.+.+ ..++.++|+||||+++|||++ |+.|+-.-+..++...+.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            999999999986544322   122334667999999998 899999999999999999987 899998888877776664


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +-.                              ...+..++|+++..++.-||..+|++||+++++..
T Consensus       513 dGy------------------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  513 DGY------------------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ccc------------------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            411                              12223478999999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=6.7e-28  Score=201.60  Aligned_cols=166  Identities=22%  Similarity=0.276  Sum_probs=127.7

Q ss_pred             CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccccccccc
Q 017083          130 TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  208 (377)
Q Consensus       130 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~  208 (377)
                      |+|.+++.. +.++++..++.++.||+.||+|||+.+      ||+||+++.++.+++  ||++.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            688899876 456999999999999999999999999      999999999999999  99987654332    25789


Q ss_pred             ccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccccccccchhHHHHHHhcccc
Q 017083          209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC  287 (377)
Q Consensus       209 ~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (377)
                      .|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+............                  
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------  129 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------------  129 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------------
Confidence            9999999987 77899999999999999999999999654322 222222111111000000                  


Q ss_pred             ccccccccCCCCCh--hHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          288 RKQQFATRFPNKSS--GAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       288 ~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                            .....++.  .+.+++.+||..||.+||++.|+++|+|+..
T Consensus       130 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      130 ------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                  00011222  6899999999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-26  Score=196.16  Aligned_cols=213  Identities=18%  Similarity=0.257  Sum_probs=176.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.++||+|+||+++.+.+.-+++.||||.-....    .+.++..|++..+.|. .++|...|.+=.++-.     -.+|
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~-----NiLV  102 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY-----NILV  102 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccch-----hhhh
Confidence            8999999999999999999999999999886542    3456778888889887 6788887766554433     3689


Q ss_pred             EecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-----CeEEeeeecccccCCC
Q 017083          125 YELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGDFGLARTTSET  198 (377)
Q Consensus       125 ~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-----~vkl~Dfg~~~~~~~~  198 (377)
                      +|..+.+|.+++. .+.+|+...+..++.|++.-++++|++.+++|||||+|+||..-+     .|.++|||+++....+
T Consensus       103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            9999999999986 477899999999999999999999999999999999999996533     4899999999876554


Q ss_pred             cc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          199 DF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       199 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ..        .....||..||+-..+.+ .+-+.+.|+-|||-+++..|-|..||.+......-.+.+++-.....+.
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            33        245678999999999998 7789999999999999999999999998776666555555443333333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-25  Score=183.40  Aligned_cols=212  Identities=24%  Similarity=0.333  Sum_probs=174.0

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC-CCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~  117 (377)
                      +..+|. ++++||+|+||.+|.+....+|+.||||+-......    .++..|..+.+.|++ ..|..+..+..+...  
T Consensus        13 v~gky~-lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y--   85 (341)
T KOG1163|consen   13 VGGKYK-LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY--   85 (341)
T ss_pred             eccceE-EEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccc--
Confidence            344554 899999999999999999999999999998655333    356688999999984 677777777776654  


Q ss_pred             CCcEEEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeeeccc
Q 017083          118 FNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg~~~  193 (377)
                         -.+||+..+.+|.+++. .+..++...+.-++-|++.-++|+|.++++||||||+|+|+.-   ..++.|+|||+++
T Consensus        86 ---nvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   86 ---NVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ---ceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence               58999999999999886 4678999999999999999999999999999999999999964   3469999999998


Q ss_pred             ccCCCcc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017083          194 TTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       194 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      ...+...        .....||..|.+-.++.+ ...+...|+-|+|.++....-|..||.+........+..++.
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            6544322        234567899999988887 677899999999999999999999999877665554444443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-24  Score=197.26  Aligned_cols=248  Identities=20%  Similarity=0.199  Sum_probs=186.2

Q ss_pred             CcccccCCccceEEEEEeCCCC-cEEEEEeccccccCHHHHHHHHHHHHHHHhcC----CCCceeEeeeec-CCCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHME----HENVIAIKDIIR-PPKKDTFN  119 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~~-~~~~~~~~  119 (377)
                      +.++||+|+||.||.+.+..++ ..+|+|..........  ..+..|..++..+.    .+++..+++... .+..    
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~----   95 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF----   95 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce----
Confidence            8999999999999999997775 6788888765422211  14557788888776    258888888874 4433    


Q ss_pred             cEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-----CCeEEeeeecc
Q 017083          120 DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-----CDLKIGDFGLA  192 (377)
Q Consensus       120 ~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-----~~vkl~Dfg~~  192 (377)
                       -++||+.++.+|.++....  +.++...+..++.|++.+|++||+.|++||||||.|+.+...     ..+.|.|||++
T Consensus        96 -~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 -NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             -eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence             6899999999999988543  689999999999999999999999999999999999999765     35899999999


Q ss_pred             c--ccCCCc--------c-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017083          193 R--TTSETD--------F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       193 ~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      +  ......        . .....||..|.++.++.+ ...+.+.|+||++.++.+++.|..||...........+....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            8  321111        1 223458999999999988 888999999999999999999999997755433322222211


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .......                          .....+..+.++...+-..+...+|....+...
T Consensus       254 ~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDR--------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhcccc--------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            1000000                          112345667777777777899999988777554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=8e-25  Score=199.94  Aligned_cols=159  Identities=19%  Similarity=0.244  Sum_probs=121.8

Q ss_pred             cCCcccccCCccceEEEEEeCC-CCcEEEEEecccccc---CHHHHHHHHHHHHHHHhcCCCCcee-EeeeecCCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTF  118 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~  118 (377)
                      |.+.+.||+|+||+||+|+++. +++.+|||++.....   .......+.+|++++++++|++++. +++.    .    
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~----   91 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G----   91 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C----
Confidence            3388999999999999999876 677789998753311   2234556889999999999999985 4432    1    


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di-k~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                       ..|++|||++| +|. .+..   ..   ...++.++++||.|||++||+|||| ||+||+++.+++++|+|||++....
T Consensus        92 -~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         92 -KDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             -CcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence             26999999986 564 3211   11   1467899999999999999999999 9999999999999999999998554


Q ss_pred             CCcc---------ccccccccccCCCccccc
Q 017083          197 ETDF---------MTEYVVTRWYRAPELLLN  218 (377)
Q Consensus       197 ~~~~---------~~~~~~~~~y~aPE~~~~  218 (377)
                      ....         .....++..|++||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3321         134556778999998853

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=2.5e-23  Score=190.69  Aligned_cols=263  Identities=31%  Similarity=0.503  Sum_probs=204.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHH-HHHHHHHHHHHHHhcCCC-CceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.+.+.||.|+||.||.+.+.   ..+++|.+........ ....+.+|+.+++.+.|+ +++++++.+.....     .
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-----L   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-----E
Confidence            347788999999999999887   6799999987655543 567788999999999988 79999999955533     7


Q ss_pred             EEEEecCCC-CHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccC
Q 017083          122 YIVYELMDT-DLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  196 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~  196 (377)
                      +++++++.+ ++.+.+....   .+.......++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+....
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            899999985 7776666654   799999999999999999999999999999999999999998 69999999987544


Q ss_pred             CCc-------cccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCC
Q 017083          197 ETD-------FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGS  263 (377)
Q Consensus       197 ~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~  263 (377)
                      ...       ......++..|++||.+.+.  .......|+|++|+++++++.|..||.....    ......+......
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            432       34677889999999999874  4788899999999999999999999877653    2222222221111


Q ss_pred             -CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          264 -PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                       ........                    .   .......+.+++.+++..+|..|.+..+...++|........
T Consensus       234 ~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~  285 (384)
T COG0515         234 SLASPLSPS--------------------N---PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE  285 (384)
T ss_pred             ccccccCcc--------------------c---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence             00000000                    0   011235789999999999999999999999887776555443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=5e-25  Score=192.95  Aligned_cols=236  Identities=23%  Similarity=0.297  Sum_probs=151.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcC----------CCCceeEeeeecCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHME----------HENVIAIKDIIRPPK  114 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~~~~  114 (377)
                      ..+.||.|+++.||.++|..+++.+|+|++...... ....+.+.+|.-....+.          |-.++..++.....+
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            677899999999999999999999999988654322 223455555554443322          223333333322111


Q ss_pred             C---------CCCC---cEEEEEecCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 017083          115 K---------DTFN---DVYIVYELMDTDLHQIIR---SDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN  175 (377)
Q Consensus       115 ~---------~~~~---~~~iv~e~~~~~L~~~l~---~~~~----~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~N  175 (377)
                      .         ....   ..+++|+-+.++|.+++.   ....    +.......+..|+++.+++||+.|++|+||+|+|
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~n  175 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPEN  175 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred             CCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceee
Confidence            1         0001   257889999999888764   2222    2233445667999999999999999999999999


Q ss_pred             eEEccCCCeEEeeeecccccCCCccccccccccccCCCcccccc-------CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 017083          176 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (377)
Q Consensus       176 Ili~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~ll~ell~g~~pf~~~  248 (377)
                      ++++.+|.++|+||+.....+.....  ...+..|.|||.....       -.++.+.|.|+||+++|.|+++..||...
T Consensus       176 fll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  176 FLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             EEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred             EEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence            99999999999999987766554322  3345779999987442       24688999999999999999999999764


Q ss_pred             ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCC
Q 017083          249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  318 (377)
Q Consensus       249 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  318 (377)
                      ......                                  ...+.. ..++|..+++||+.||+.||.+|
T Consensus       254 ~~~~~~----------------------------------~~~f~~-C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  254 SPEADP----------------------------------EWDFSR-CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             GGGSTS----------------------------------GGGGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred             Cccccc----------------------------------cccchh-cCCcCHHHHHHHHHHccCCcccC
Confidence            311100                                  001122 22789999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=208.31  Aligned_cols=241  Identities=24%  Similarity=0.372  Sum_probs=197.3

Q ss_pred             cccCCccceEEEEEe---CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEE
Q 017083           49 PIGRGAYGIVCAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~---~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .+|+|++|.|++++.   ...|.-+|+|..++.............|-.++...+ ||.+|++...++.+..     .+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-----l~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-----LYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-----hhHh
Confidence            379999999988754   345677899988765433333334456788888887 9999999999998866     8999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      .++..| .|...+.....+.+...+.+...++-|++++|+.+++|+|+|++||+++.+|.+++.|||+++..-.....  
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            999975 89888888888999999999999999999999999999999999999999999999999999865433222  


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                       +|+..|||||++.   ....++|.||+|++.++|++|..||..    +....|....-                     
T Consensus       154 -cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------------------  204 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------------------  204 (612)
T ss_pred             -ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc---------------------
Confidence             8999999999986   467899999999999999999999987    33333333111                     


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLHD  335 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~~  335 (377)
                                .....++..+.+++..++..+|..|.     -+.|+++|+||+.+.-
T Consensus       205 ----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~  251 (612)
T KOG0603|consen  205 ----------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW  251 (612)
T ss_pred             ----------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence                      11235578899999999999999997     4589999999998764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=212.61  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=181.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC--HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +...+.||++.|=+|.+|++.+.  .|++|++-+..+.  -....+.+.|++ ...+++||.+++..+.....-     -
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA-----A   96 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA-----A   96 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH-----H
Confidence            33678899999999999988653  4999998765422  222344445555 556689999999887655533     6


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc--cCCCc
Q 017083          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETD  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~--~~~~~  199 (377)
                      |+|.+|...+|.+.+..++-+...+.+-|+.|++.|+.-+|..||+|||||.+||||+.-+.+.|+||..-+-  .....
T Consensus        97 ylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen   97 YLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            8999999999999998888888899999999999999999999999999999999999999999999987642  11111


Q ss_pred             c------ccccccccccCCCcccccc---------C-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017083          200 F------MTEYVVTRWYRAPELLLNC---------T-EYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       200 ~------~~~~~~~~~y~aPE~~~~~---------~-~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      .      ..+......|.|||.|...         . ..+++.||||+||++.||++ |..||...+-..    .+.   
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a----Yr~---  249 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA----YRS---  249 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh----Hhc---
Confidence            1      1122234569999998651         1 25789999999999999987 788884322111    100   


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .         ..+..+..+.++.              +..++.||..|++.||++|.+|++.|+.
T Consensus       250 ~---------~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 G---------NADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             c---------CccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0         0111111222221              3468999999999999999999999984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=8.6e-24  Score=177.88  Aligned_cols=142  Identities=19%  Similarity=0.219  Sum_probs=110.2

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHH------------------------HHHHHHHHHHHHhcCCCC
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID------------------------ARRTLREIKLLRHMEHEN  102 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~  102 (377)
                      .+.||+|++|+||++.+. +|+.||+|+++........                        ......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            567999999999999997 8999999999754221111                        112235999999998877


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-hcCCceecCCCCCceEEcc
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~L-H~~~i~H~dik~~NIli~~  180 (377)
                      +.....+....       .++||||++| ++........+++...+..++.|++.+|.++ |+.||+||||||+||+++ 
T Consensus        81 v~~p~~~~~~~-------~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILLKS-------HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEecC-------CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            64433332211       3799999997 4444444567899999999999999999999 699999999999999998 


Q ss_pred             CCCeEEeeeecccccCC
Q 017083          181 SCDLKIGDFGLARTTSE  197 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~  197 (377)
                      ++.++|+|||++.....
T Consensus       153 ~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCcEEEEEccccccCCC
Confidence            47899999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.90  E-value=1.1e-23  Score=205.52  Aligned_cols=222  Identities=28%  Similarity=0.393  Sum_probs=168.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ..+..++.|..|++|-||.++|+.+.+.+|+ ++++..       .+.+-  ++.....|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-------lilRn--ilt~a~np--------------------  132 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-------LILRN--ILTFAGNP--------------------  132 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccc-------hhhhc--cccccCCc--------------------
Confidence            3455899999999999999999999999999 444320       01110  11222222                    


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      ++|     |+=...++.-++++.+.        +.|++|||+.||+|+|+||+|.+|+.-|++|++|||+++......  
T Consensus       133 fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  133 FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence            222     44444555555666555        778999999999999999999999999999999999997533211  


Q ss_pred             --------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          200 --------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       200 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                                    .....+||+.|.|||++.. ..|+..+|.|+||+++|+.+.|+.||.+...++.+.........-+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                          1234588999999999987 7899999999999999999999999999887777765554332222


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLHD  335 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~ell~~p~f~~~~~  335 (377)
                      +.                            ...++++++++|.++|+.+|..|.   .+-++.+|+||+.+..
T Consensus       279 E~----------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  279 EE----------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             cc----------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            21                            235689999999999999999996   7888999999987664

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.8e-23  Score=175.95  Aligned_cols=174  Identities=13%  Similarity=0.153  Sum_probs=129.2

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHH-HHH------HHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID-ARR------TLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|++++.||.|+||.||++.+  ++..+|+|.+......... ...      +.+|++.+.+++|++|..+.+++.....
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            445899999999999999755  4668999999755433322 222      5689999999999999999988665432


Q ss_pred             CC---CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          116 DT---FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       116 ~~---~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ..   ....+++|||++| +|.+..    .+++    ....+++.++..||+.|++|||++|+||+++.+| ++|+|||.
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence            11   1347899999997 776663    2333    2456999999999999999999999999999998 99999998


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHH
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  239 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell  239 (377)
                      ............           .+.. ..++.++|+|+||+++....
T Consensus       181 ~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            765533221111           2222 34557899999999877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.7e-22  Score=170.63  Aligned_cols=143  Identities=19%  Similarity=0.161  Sum_probs=112.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHH------------------------HHHHHHHHHHHHHhcCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII------------------------DARRTLREIKLLRHMEHE  101 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~  101 (377)
                      +.+.||+|++|+||++.+. +|+.||||+++.......                        .......|+..+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999987 899999999876421100                        012234789999999999


Q ss_pred             CceeEeeeecCCCCCCCCcEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEc
Q 017083          102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  179 (377)
Q Consensus       102 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~  179 (377)
                      ++.....+....       .+++|||++|. +........+++......++.|++.++.+||+ .||+|+||||+||+++
T Consensus        80 ~i~~p~~~~~~~-------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLKK-------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEecC-------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            875544433222       47999999974 44333345678888999999999999999999 9999999999999999


Q ss_pred             cCCCeEEeeeecccccCC
Q 017083          180 ASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~~~~  197 (377)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999976553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=9.2e-23  Score=179.76  Aligned_cols=195  Identities=22%  Similarity=0.280  Sum_probs=143.7

Q ss_pred             CCCCceeEeeeecCCC----------------------CCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 017083           99 EHENVIAIKDIIRPPK----------------------KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR  156 (377)
Q Consensus        99 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~  156 (377)
                      +|||||++...|.+.-                      ...-..+|+||.....+|+.++-.+ ..+....+-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence            5999999998876421                      1112338999999999999998764 4667777889999999


Q ss_pred             HHHHHhcCCceecCCCCCceEE--ccCC--CeEEeeeecccccCCC-------ccccccccccccCCCccccccCCC---
Q 017083          157 GLKYVHSASVLHRDLKPSNLLL--NASC--DLKIGDFGLARTTSET-------DFMTEYVVTRWYRAPELLLNCTEY---  222 (377)
Q Consensus       157 al~~LH~~~i~H~dik~~NIli--~~~~--~vkl~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~---  222 (377)
                      |+.|||.+|+.|||+|.+|||+  ++++  .++|+|||++-.....       .......|....||||+.......   
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            9999999999999999999998  3443  3799999987543321       123345667779999998642221   


Q ss_pred             --CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCC
Q 017083          223 --TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  300 (377)
Q Consensus       223 --~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (377)
                        -.++|.|+.|.+.||++....||..........+                             ...+.+.+.....++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-----------------------------~Yqe~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-----------------------------TYQESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheechh-----------------------------hhhhhhCCCCcccCC
Confidence              2489999999999999999999987432211110                             011222333334678


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHH
Q 017083          301 SGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       301 ~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      +.+.+++..+|+.||++|++++=
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccH
Confidence            99999999999999999998653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=5e-21  Score=159.53  Aligned_cols=183  Identities=15%  Similarity=0.063  Sum_probs=134.5

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +...|++|+||+||.+..  .+.+++.+.+.....  .......+.+|+++|++|. |+++++++++.         ..+
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~   74 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH   74 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence            577899999999997754  667888777765322  1111225779999999996 58899998861         168


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di-k~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++|||+.| +|...+..      . ...++.|++++|.++|++||+|+|| ||+||+++.+|.++|+|||++........
T Consensus        75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99999987 55443211      1 1347789999999999999999999 79999999999999999999985443321


Q ss_pred             c--------------cccccccccCCCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCC
Q 017083          201 M--------------TEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEIMTREPLFP  246 (377)
Q Consensus       201 ~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~ll~ell~g~~pf~  246 (377)
                      .              .....++.|++|+...-....+ ...+.++.|.-+|.++|+..++-
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            1              0112366677777654323333 56789999999999999987753

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=7.2e-22  Score=165.98  Aligned_cols=245  Identities=18%  Similarity=0.225  Sum_probs=186.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      |.-....++.+|...-.|..|++++..  ..++.|+++.+.......+.|..|.-.|+-+.||||+.+++.+.....   
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn---  261 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN---  261 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC---
Confidence            444455578889999999999998754  477888887665555566778899999999999999999999988855   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCCCeEE--eeeec
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKI--GDFGL  191 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~~vkl--~Dfg~  191 (377)
                        +.++..|++ |+|.+.+.....  .+..++.+++.+|++|++|||+..  |.--.+....++|+++...+|  +|--+
T Consensus       262 --lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  262 --LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             --ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence              899999999 799999876443  567788999999999999999874  555568888999999876554  44433


Q ss_pred             ccccCCCccccccccccccCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      +...      ......+.|++||.+.....  .-.++|+|||+++++|+.+...||......+.-.+|.-          
T Consensus       340 sfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------  403 (448)
T KOG0195|consen  340 SFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------  403 (448)
T ss_pred             eeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------
Confidence            3221      12234788999999976222  23579999999999999999999987665443222210          


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                                         ........++++..+..|+.-|++.||.+||.++.++
T Consensus       404 -------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 -------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                               0111223468899999999999999999999988764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.1e-21  Score=194.66  Aligned_cols=197  Identities=21%  Similarity=0.300  Sum_probs=159.3

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC---CCCceeEeeeec
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIR  111 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~  111 (377)
                      ..++++++.+-|-+.||.|+||+||.|.+.. |+.||||+-+..     ...++.--.+++.+|+   -+.|..+..++.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~-----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP-----NPWEFYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC-----CceeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence            3467777777789999999999999999977 999999987543     2223333334445554   345666666555


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-------CCC
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCD  183 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-------~~~  183 (377)
                      ....     -++++||.+ |+|.+++...+-+++..+..++.|++..+++||..+|+||||||+|+++..       .--
T Consensus       765 ~~~~-----S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  765 FQNA-----SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             cCCc-----ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            4433     589999999 899999998899999999999999999999999999999999999999943       223


Q ss_pred             eEEeeeeccccc---CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 017083          184 LKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (377)
Q Consensus       184 vkl~Dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~  243 (377)
                      ++|+|||.+..+   .........++|-.+-.+|...| ..+++.+|.|+|+-+++.||.|++
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            899999998643   33445667788999999999988 899999999999999999999974

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.3e-20  Score=157.52  Aligned_cols=135  Identities=20%  Similarity=0.255  Sum_probs=105.5

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-----CCCCceeEeeeecCCCCCCCCc
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      -.+.||+|++|.||.  +..++.. +||++....  ....+.+.+|+.+++.+     +||||++++++++.+...  ..
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~--g~   78 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT--GY   78 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC--eE
Confidence            356799999999995  7777666 699886532  22446788999999999     579999999999887432  22


Q ss_pred             EE-EEEecCC---CCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHhcCCceecCCCCCceEEccC----CCeEEeeee
Q 017083          121 VY-IVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGL-KYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFG  190 (377)
Q Consensus       121 ~~-iv~e~~~---~~L~~~l~~~~~~~~~~~~~i~~qi~~al-~~LH~~~i~H~dik~~NIli~~~----~~vkl~Dfg  190 (377)
                      ++ +|+||.+   ++|.+++... .+++.  ..++.+++.++ +|||+++|+||||||+||+++.+    ++++|+||+
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            33 7899954   5999999663 46665  35678888777 99999999999999999999743    379999954

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.5e-20  Score=161.22  Aligned_cols=144  Identities=15%  Similarity=0.100  Sum_probs=111.1

Q ss_pred             cCCcccccCCccceEEEEE-eCCCCcEEEEEeccccccCH--------------------H--HHHHHHHHHHHHHhcCC
Q 017083           44 VPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNI--------------------I--DARRTLREIKLLRHMEH  100 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~-~~~~~~~valK~~~~~~~~~--------------------~--~~~~~~~e~~~l~~l~h  100 (377)
                      +.+.+.||+|++|.||+|. +..+|+.||+|+++......                    .  ....+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4588999999999999999 67789999999987542110                    0  11234579999999975


Q ss_pred             C--CceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCce
Q 017083          101 E--NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNL  176 (377)
Q Consensus       101 ~--~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dik~~NI  176 (377)
                      .  .+.++++.   ..      .++||||++| +|.........+....+..++.||+.++.+||+.| ++|+||||+||
T Consensus       110 ~~i~~p~~~~~---~~------~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW---RR------NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe---cC------ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            3  34444432   11      4799999998 55554444556677778899999999999999999 99999999999


Q ss_pred             EEccCCCeEEeeeecccccCC
Q 017083          177 LLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       177 li~~~~~vkl~Dfg~~~~~~~  197 (377)
                      +++ +++++|+|||.+.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 78999999998865443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.3e-19  Score=167.14  Aligned_cols=206  Identities=24%  Similarity=0.335  Sum_probs=153.7

Q ss_pred             HHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCc-eecCC
Q 017083           95 LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV-LHRDL  171 (377)
Q Consensus        95 l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i-~H~di  171 (377)
                      |+.+.|.|+.++++....+..     .++|.+||. |+|.+.+.. ..+++......++++|+.||.|||...| +||.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            357889999999999998844     899999998 899999876 5578888889999999999999998766 99999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCC---ccccccccccccCCCcccccc---C---CCCCcchHHHHHHHHHHHHhCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC---T---EYTAAIDIWSVGCILGEIMTRE  242 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---~---~~~~~~DiwslG~ll~ell~g~  242 (377)
                      +..|.+++....+||+|||+.......   ...........|.|||.+.+.   .   ..+++.||||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998766421   111122235669999999763   1   1477899999999999999999


Q ss_pred             CCCCCCChHHH-HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          243 PLFPGKDYVHQ-LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       243 ~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                      .||........ ...+..+........+..+                     ......++.+..++++||..+|..||++
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i---------------------~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSI---------------------ELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcch---------------------hhhhhcchHHHHHHHHhcccChhhCccH
Confidence            99976332211 1222222211111111110                     0011345679999999999999999999


Q ss_pred             HHHhc
Q 017083          322 EEALR  326 (377)
Q Consensus       322 ~ell~  326 (377)
                      +.+-.
T Consensus       215 ~~i~~  219 (484)
T KOG1023|consen  215 EQIRS  219 (484)
T ss_pred             HHHHh
Confidence            98753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=6.5e-20  Score=167.89  Aligned_cols=175  Identities=28%  Similarity=0.495  Sum_probs=134.2

Q ss_pred             cEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      .+||.|++|. .+|.+.+..+.   ..+......++.|++.|++|   ++.+|+|+||.||+...+..+||+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            3789999998 69999987543   46677889999999999999   99999999999999999999999999998765


Q ss_pred             CCCc-------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          196 SETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       196 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ....       ......||.+||+||.+.+ ..++.++||||||++++|++.- ..++..      ......+       
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~-------  472 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDI-------  472 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhh-------
Confidence            5443       4566788999999999998 8999999999999999999882 222211      1111111       


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                          +...+++.+..-.+.-..|+.+||...|.+||++.+.-.|+|.+
T Consensus       473 --------------------r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  473 --------------------RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             --------------------hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                                11111111112234456999999999999999888877777753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3e-18  Score=147.50  Aligned_cols=136  Identities=25%  Similarity=0.273  Sum_probs=109.1

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCH------HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ++.||+|++|.||++.+  .|..+++|+........      .....+.+|+.++..+.|+++.....++.....     
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-----   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-----
Confidence            36799999999999977  66789999865432211      122456789999999999988776666554433     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      .+++|||++| +|.+.+.....    ....++.+++.+|.+||+.+++|+|++|.||+++ ++.++|+|||.+..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            6899999986 88888765332    7788999999999999999999999999999999 78899999998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=5e-20  Score=179.31  Aligned_cols=258  Identities=27%  Similarity=0.367  Sum_probs=204.0

Q ss_pred             cCCcccccCCccceEEEEEeCCC-CcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +++.+.||+|+|+.|-.+....+ ...+|.|.+............+..|..+-..+. |+|++.+++.......     .
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~-----~   96 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS-----Y   96 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-----c
Confidence            44788899999999988877443 345677777655433444556667888888887 9999999999988866     7


Q ss_pred             EEEEecCCC-CHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCceEEccCC-CeEEeeeecccccC
Q 017083          122 YIVYELMDT-DLHQII-RSDQ-QLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  196 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l-~~~~-~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~  196 (377)
                      +++.++..| ++.+-+ .... ..+...+..++.|+..++.|+| ..++.|+||+|+|.+++..+ .+++.|||++....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            899999774 777776 4444 6777888889999999999999 99999999999999999999 99999999998654


Q ss_pred             C----Ccccccccc-ccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          197 E----TDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       197 ~----~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      .    .......+| ++.|.|||.+.+.....+..|+||.|+++..+++|..|+.........                 
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------------  239 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------------  239 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------------
Confidence            4    234556777 999999999987556788999999999999999999998765432210                 


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                               ...+...........|..++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       240 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 ---------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---------ceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                     0001111111123446678999999999999999999999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1e-17  Score=142.57  Aligned_cols=137  Identities=20%  Similarity=0.203  Sum_probs=103.6

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH--------------------HHHHHHHHHHHHHHhcCCCC--
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--------------------IDARRTLREIKLLRHMEHEN--  102 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~~--  102 (377)
                      .+.+.||+|+||.||++.+. +|+.||+|+++......                    ........|+.++..+.+++  
T Consensus        18 ~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          18 SLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            37889999999999999885 79999999876432110                    01123457888888887763  


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~  181 (377)
                      +...++.         ...+++|||++| +|.....      ......++.+++.++.++|+.|++|+||+|.||+++++
T Consensus        97 v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence            4444432         125899999997 5554322      13456788999999999999999999999999999999


Q ss_pred             CCeEEeeeecccccCC
Q 017083          182 CDLKIGDFGLARTTSE  197 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~  197 (377)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.3e-17  Score=142.24  Aligned_cols=131  Identities=25%  Similarity=0.287  Sum_probs=100.6

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEecccccc------CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .||+|++|+||++..  +|..+++|.......      ......++.+|+.+++.++|+++.....++.....     .+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-----KT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-----CE
Confidence            389999999999974  567899998643211      11123556789999999998765443333333322     68


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ++|||++| +|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999986 78777654321       7889999999999999999999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3.1e-17  Score=138.40  Aligned_cols=138  Identities=21%  Similarity=0.250  Sum_probs=97.8

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHH----------------------HHHHHHHHhcCCCC--
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT----------------------LREIKLLRHMEHEN--  102 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~~--  102 (377)
                      .+.||+|+||+||++.+. +++.||+|++.............                      ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999986 78999999986542221111111                      24566666665432  


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCCC-CHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEc
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  179 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~-~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~  179 (377)
                      +.+++++.         ..+++|||+++ .+. ..+... ... ..++.++.+++.++.++|. .|++|+||+|+||+++
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            44444431         15899999987 211 111111 111 6678899999999999999 9999999999999999


Q ss_pred             cCCCeEEeeeecccccCC
Q 017083          180 ASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~~~~  197 (377)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             88999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=1e-16  Score=156.50  Aligned_cols=135  Identities=23%  Similarity=0.291  Sum_probs=104.7

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEecc-cccc-----CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFD-----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~-~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ...+.||+|+||+||++.+...  .+++|+.. +...     .......+.+|+++++.++|++++....+......   
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~---  410 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE---  410 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC---
Confidence            3688999999999999976443  34444322 1111     11223567789999999999998887666555433   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                        .+++|||++| +|.+.+.        ....++.+++++|.+||+.|++||||||+||++ .++.++|+|||++...
T Consensus       411 --~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 --KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             --CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence              6899999985 8888774        356789999999999999999999999999999 6778999999998653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.7e-17  Score=152.59  Aligned_cols=258  Identities=26%  Similarity=0.286  Sum_probs=199.9

Q ss_pred             eecccccCCcccccC--CccceEEEEEe--CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecC
Q 017083           38 EVSSKYVPPIRPIGR--GAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~--G~~g~vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  112 (377)
                      +...+-..+...+|.  |.+|.||.+..  ..++..+|+|.-+...........-.+|+...++++ |++.++.+..+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            444455557788999  99999999998  999999999986544333333344456777777776 9999998888887


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHhcCCceecCCCCCceEEccC-CCeEE
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR----GLKYVHSASVLHRDLKPSNLLLNAS-CDLKI  186 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~----al~~LH~~~i~H~dik~~NIli~~~-~~vkl  186 (377)
                      .+.     .++-+|.++.+|.++...... ++...++..+.+..+    |+.++|+.+++|-|++|.||++..+ ...++
T Consensus       190 ~~~-----lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  190 SGI-----LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             CCc-----ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence            765     899999999999988876555 788899999999999    9999999999999999999999999 78999


Q ss_pred             eeeecccccCCCccc------cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHH
Q 017083          187 GDFGLARTTSETDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLIT  258 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~--~~~~~~~~i~  258 (377)
                      +|||+....+.....      ....+...|++||...+  .++...|||+||.++.+...+..+....  .....+    
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----  338 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----  338 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----
Confidence            999999877665422      22256777999999864  7789999999999999998887665443  111111    


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                                   +.... .+.....+.++...+.+|++.+|-.|+++..++.++++.+.-.
T Consensus       339 -----------------------------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~  387 (524)
T KOG0601|consen  339 -----------------------------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF  387 (524)
T ss_pred             -----------------------------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence                                         00001 1112345667777999999999999999999999998875443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.4e-15  Score=132.61  Aligned_cols=140  Identities=17%  Similarity=0.233  Sum_probs=104.7

Q ss_pred             ccccc-CCccceEEEEEeCCCCcEEEEEeccccc------c-----CHHHHHHHHHHHHHHHhcCCCCc--eeEeeeecC
Q 017083           47 IRPIG-RGAYGIVCAAVNSETREEVAIKKIGNAF------D-----NIIDARRTLREIKLLRHMEHENV--IAIKDIIRP  112 (377)
Q Consensus        47 ~~~lg-~G~~g~vy~~~~~~~~~~valK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~  112 (377)
                      ...|| .||.|+||.+...  +..++||.+....      .     .......+.+|+.++..|+|+++  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            44587 8999999999774  6789999885321      0     11233566789999999998775  666665433


Q ss_pred             CCCCCCCcEEEEEecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~--~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ... .....++|+|+++|  +|.+.+.. .++++..    +.+|+.++.+||++||+|+||||.|||++.++.++|+|||
T Consensus       114 ~~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            221 11224699999985  77777654 4455543    5789999999999999999999999999999999999999


Q ss_pred             cccc
Q 017083          191 LART  194 (377)
Q Consensus       191 ~~~~  194 (377)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=2.3e-15  Score=121.99  Aligned_cols=131  Identities=20%  Similarity=0.238  Sum_probs=107.4

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecCCCCCCCCcEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +++.||.|.++.||++....  ..+++|.......    ...+..|+.+++.+++  .++++++.++.....     .++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-----~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGW-----SYL   70 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-----cEE
Confidence            56789999999999998754  6899999865432    4567789999999976  588888888776533     799


Q ss_pred             EEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC---CceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          124 VYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       124 v~e~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ++||++|. +...       +......++.+++++++.||..   +++|+|++|.||++++.+.+++.|||.+..
T Consensus        71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99999863 3332       5566677899999999999985   699999999999999988999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=2.6e-16  Score=154.53  Aligned_cols=287  Identities=21%  Similarity=0.214  Sum_probs=206.8

Q ss_pred             CcccccccccccCceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHH-HHHHHHH
Q 017083           12 GATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLR   90 (377)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~   90 (377)
                      .+++|.+|...+..+..+.++..  +...-..+.+.+.+-+|.++.++.+.-..+|...+.|.......-.. ..+..+.
T Consensus       776 ss~eS~pgdp~~sls~sP~sp~~--yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~  853 (1205)
T KOG0606|consen  776 SSSESLPGDPTRSLSASPRSPTK--YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRS  853 (1205)
T ss_pred             cccccCCCCcccccccCCCCccc--ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCC
Confidence            34445556666666555544433  44555666678899999999999999888887777776643211110 1222222


Q ss_pred             HHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083           91 EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus        91 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      +-.++-...+|.++.....+.....     .+++++|.+ ++|...+...+..+.+.++..+..+.+++++||...+.|+
T Consensus       854 ~s~~~i~p~~P~v~~~~~s~~~rsP-----~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~  928 (1205)
T KOG0606|consen  854 KSNILITPRSPAVVRSFPSFPCRSP-----LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHR  928 (1205)
T ss_pred             ccCccccCCCCceecccCCCCCCCC-----cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcc
Confidence            2222222344666655544333333     789999997 5888888888889999999999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCC--------------------------------ccccccccccccCCCcccc
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSET--------------------------------DFMTEYVVTRWYRAPELLL  217 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~  217 (377)
                      |++|.|+++..+|..++.||++....+..                                .......+|+.|.+||...
T Consensus       929 ~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen  929 DLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred             cccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence            99999999999999999999843211100                                0112356688999999998


Q ss_pred             ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCC
Q 017083          218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP  297 (377)
Q Consensus       218 ~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (377)
                      + ......+|+|++|+++++.++|..||...........|..-....                            .....
T Consensus      1009 g-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~----------------------------p~g~~ 1059 (1205)
T KOG0606|consen 1009 G-RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW----------------------------PEGPE 1059 (1205)
T ss_pred             c-ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC----------------------------CCCcc
Confidence            8 788899999999999999999999998877666554432211111                            11112


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHH---HHhcCccccCCc
Q 017083          298 NKSSGAVDLLEKMLVFDPNKRITVE---EALRHPYLQSLH  334 (377)
Q Consensus       298 ~~~~~~~~li~~~L~~dp~~Rps~~---ell~~p~f~~~~  334 (377)
                      ..+..+++++...|..+|.+|..+.   ++-.|+||+...
T Consensus      1060 ~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1060 EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            4588899999999999999999888   999999998765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=2.3e-16  Score=136.45  Aligned_cols=243  Identities=21%  Similarity=0.221  Sum_probs=160.5

Q ss_pred             eEEEEEeCCCCcEEEEEeccccccCHHHH--HHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC-CCHH
Q 017083           57 IVCAAVNSETREEVAIKKIGNAFDNIIDA--RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLH  133 (377)
Q Consensus        57 ~vy~~~~~~~~~~valK~~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~  133 (377)
                      .||++-+...|..|+.-.++....++...  +....-+.-+-++-|.|||+++.++.+.....-....++.||+. |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            36777777777666655443221111111  11222334445567999999999998776644456889999998 7999


Q ss_pred             HHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCceEEccCCCeEEeeeecccccCC-----Ccccc
Q 017083          134 QIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-----TDFMT  202 (377)
Q Consensus       134 ~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-----~~~~~  202 (377)
                      ++++.    ...+.....++|+.||+.||.|||+.  -|+|+++..+.|++..+|-+|++.-.....-..     ..-..
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            88875    34578888999999999999999987  499999999999999999888864332211000     00011


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ...+.++|.+||.=.. ...+.++|||++|+...+|..+..-- ........-..+.+.+...                 
T Consensus       241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-----------------  302 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-----------------  302 (458)
T ss_pred             ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-----------------
Confidence            1233567899986433 45677899999999999998876432 1111111111111111100                 


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                       -..--.+++.+||+..|..||++.+++.||.+-+++
T Consensus       303 -----------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  303 -----------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             -----------------cCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence                             011234789999999999999999999999876555

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.57  E-value=8.6e-14  Score=131.59  Aligned_cols=168  Identities=18%  Similarity=0.364  Sum_probs=127.3

Q ss_pred             EEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhC
Q 017083           60 AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD  139 (377)
Q Consensus        60 ~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~  139 (377)
                      .+..+.++.++.+..+.....  .......+.++.++.++||+|+++++.++..+.     +|||+|.+.. |...++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~-----~ylvTErV~P-l~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT-----LYLVTERVRP-LETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCc-----eEEEeecccc-HHHHHHH-
Confidence            456677888888888865422  445667788999999999999999999998865     8999999863 2222322 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cccccccccccCCCcccc
Q 017083          140 QQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL  217 (377)
Q Consensus       140 ~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~  217 (377)
                        +........++||+.||-||| +.+++|++|....|+|+..|..||++|.++....... .......-..|..|+.+.
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence              226667778899999999998 6789999999999999999999999999886443322 122222233467776553


Q ss_pred             ccCCCCCcchHHHHHHHHHHHHhC
Q 017083          218 NCTEYTAAIDIWSVGCILGEIMTR  241 (377)
Q Consensus       218 ~~~~~~~~~DiwslG~ll~ell~g  241 (377)
                      . .  .-..|.|.|||++++++.|
T Consensus       179 ~-s--~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 P-S--EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c-c--ccchhhhhHHHHHHHHhCc
Confidence            3 1  1457999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.52  E-value=1.6e-13  Score=114.50  Aligned_cols=140  Identities=20%  Similarity=0.244  Sum_probs=100.9

Q ss_pred             cccccCCccceEEEEEeCC------CCcEEEEEeccccc------------c--------CHHHHHHH----HHHHHHHH
Q 017083           47 IRPIGRGAYGIVCAAVNSE------TREEVAIKKIGNAF------------D--------NIIDARRT----LREIKLLR   96 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~------~~~~valK~~~~~~------------~--------~~~~~~~~----~~e~~~l~   96 (377)
                      ...||.|--+.||.+....      .+..+|||+++...            +        +......+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4569999999999997653      35789999884321            0        01112223    37999999


Q ss_pred             hcC--CCCceeEeeeecCCCCCCCCcEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-hcCCceecCCC
Q 017083           97 HME--HENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLK  172 (377)
Q Consensus        97 ~l~--h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~L-H~~~i~H~dik  172 (377)
                      ++.  .-.+..++++.   .      -+|+|||++++ +..-......++......+..+++.+|..| |..|++||||+
T Consensus        82 rl~~~Gv~vP~pi~~~---~------~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---K------HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEec---C------CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            996  35666777651   1      48999999863 322222233455667778889999999998 89999999999


Q ss_pred             CCceEEccCCCeEEeeeecccccC
Q 017083          173 PSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       173 ~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      +.||+++ ++.+.|+|||.+-...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4679999999875544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=5.2e-14  Score=131.75  Aligned_cols=249  Identities=21%  Similarity=0.208  Sum_probs=182.5

Q ss_pred             cccCCcccccCCccceEEEEEeC-CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  119 (377)
                      -.+-.+..||.|.|+.|+.+..+ .++..|++|...+..........-+.|+.+...+. |.+++.++..+.....    
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----  340 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----  340 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----
Confidence            34457889999999999998765 67889999988776554444444457888888776 8899988887776655    


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeecccccCC
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~~~~~~~  197 (377)
                       .||--|||.+ ++...+.....+++...+.+..|++.++.++|++.++|+|++|+||++..+ +..+++|||+......
T Consensus       341 -~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  341 -GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             -ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence             6799999975 555444445668889999999999999999999999999999999999887 6789999998875322


Q ss_pred             CccccccccccccC-CCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 TDFMTEYVVTRWYR-APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ..  ......-.+. .+|.+.....+..+.|++|||..+.+.+++...-.....                          
T Consensus       420 ~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------------------  471 (524)
T KOG0601|consen  420 SS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------------------  471 (524)
T ss_pred             ec--ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------------------------
Confidence            21  1122233344 356666557889999999999999999988643222110                          


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                             +.. +.....+..+.....+..+.+.|+..++..||++.++..|.=|.
T Consensus       472 -------~~~-i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  472 -------SLT-IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -------cee-eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                   000 01111122334457788999999999999999999998876553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=5.1e-13  Score=126.55  Aligned_cols=142  Identities=21%  Similarity=0.287  Sum_probs=95.0

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHH----------------------------HH----------HHH
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID----------------------------AR----------RTL   89 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~----------------------------~~----------~~~   89 (377)
                      +.||.|++|+||+|+.+ +|+.||||+.+........                            .+          .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 6899999998643211100                            00          123


Q ss_pred             HHHHHHHhc----CCCCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHh
Q 017083           90 REIKLLRHM----EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR-GLKYVH  162 (377)
Q Consensus        90 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~-al~~LH  162 (377)
                      .|+..+.++    ++..-+.+...|.....    ..+++|||++| +|.+..... ...+   ...++.+++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            455555544    23333444444432221    15899999986 666654321 1222   2345555655 467889


Q ss_pred             cCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       163 ~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ..|++|+|+||.||+++.+++++|+|||++.....
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999999876553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3.9e-13  Score=111.37  Aligned_cols=126  Identities=19%  Similarity=0.189  Sum_probs=92.6

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecCCCCCCCCcEEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ++.|+.|.++.||++...  +..|++|.......   ....+..|+.+++.+.+.++ .+++......       .++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~-------~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPET-------GVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCCC-------CeEEE
Confidence            577899999999999864  67899999865421   12245678888888865443 4455443221       47999


Q ss_pred             ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCc-----eecCCCCCceEEccCCCeEEeeeeccc
Q 017083          126 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV-----LHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       126 e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i-----~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ||++| ++...        ......++.+++++|+.||..++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            99997 44322        11123456899999999999885     9999999999999 6689999999774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=1.8e-13  Score=131.07  Aligned_cols=139  Identities=16%  Similarity=0.289  Sum_probs=91.7

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCH---------------------------H-H----HHH------HH
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---------------------------I-D----ARR------TL   89 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~---------------------------~-~----~~~------~~   89 (377)
                      +.||+|++|+||.|+.+.+|+.||||+++......                           . .    .+.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            78999999999999998889999999997442110                           0 0    111      22


Q ss_pred             HHHHHHHhcC----CCCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHH--HHhCC----CCCHHHHHHHHHHHHHHH
Q 017083           90 REIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQ----QLTDDHCQYFLYQLLRGL  158 (377)
Q Consensus        90 ~e~~~l~~l~----h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~--l~~~~----~~~~~~~~~i~~qi~~al  158 (377)
                      +|+..+.++.    +...+.+..+|.+-.    ...+++|||+.| .+.+.  +...+    .+.+..+..++.|++   
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif---  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF---  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence            3444444442    444444444443322    125899999997 66553  22222    233344444445544   


Q ss_pred             HHHhcCCceecCCCCCceEEccCC----CeEEeeeecccccCC
Q 017083          159 KYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSE  197 (377)
Q Consensus       159 ~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~~~~~~  197 (377)
                          ..|++|+|+||.||+++.+|    +++++|||++...+.
T Consensus       278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                58999999999999999988    899999999876543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.42  E-value=8.1e-12  Score=114.97  Aligned_cols=171  Identities=15%  Similarity=0.225  Sum_probs=132.2

Q ss_pred             ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCC--C
Q 017083           54 AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--D  131 (377)
Q Consensus        54 ~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~--~  131 (377)
                      .-.+.|++....+|..|++|+++-....  .......-+++++++.|+|+|++.++|..... +...+++|++|.++  +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence            3467899999999999999999432211  12233456888999999999999999884333 23448999999984  7


Q ss_pred             HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          132 LHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       132 L~~~l~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      |.+..-.               +.+.++..+|.++.|++.||.++|+.|+..+-|.|.+|+++.+.+++|+..|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            8776532               2346789999999999999999999999999999999999999999999888776554


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p  244 (377)
                      ...           .  |.+    .--++-|.=.||.+++.|.+|..-
T Consensus       445 ~d~-----------~--~~l----e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP-----------T--EPL----ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC-----------C--cch----hHHhhhhHHHHHHHHHHHhhcccc
Confidence            432           1  111    123467999999999999999643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.37  E-value=2.5e-11  Score=109.19  Aligned_cols=261  Identities=11%  Similarity=0.078  Sum_probs=163.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeee---cCCCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDII---RPPKKDTFN  119 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~---~~~~~~~~~  119 (377)
                      +.+.+.||+|+.+.+|-.-...   ..+-|++........    . +.+..|.+. .||-+-.=+.+-   ..+.... .
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~----a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~-~   83 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ----A-QKVAELAATPDAPLLNYRVAWPQATLHGGRRG-K   83 (637)
T ss_pred             cCCCccccCCccceeeecchhh---chhheeecCCCchHH----H-HHHHHhccCCCCcchhhhhcccHHHhhCCCcc-c
Confidence            4478889999999999884322   246677765432221    1 122223333 455332211111   1111111 2


Q ss_pred             cEEEEEecCCC--CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          120 DVYIVYELMDT--DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       120 ~~~iv~e~~~~--~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ...++|..+.|  ....++..      -....++.+.+....++.+.+.||..|.+-||+.++|+||++++.|.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            26788998876  56666542      23467899999999999999999999999999999999999999999998665


Q ss_pred             ccccCCCccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      -....+....-...|...|++||...-    .-..+...|.|.||+++|++|.| ..||.+-...         ...+++
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~---------~~ap~p  234 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI---------SDAPNP  234 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc---------CCCCCc
Confidence            555555555556677889999998751    13456789999999999999886 9999763200         000100


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcC--CCCCCCCCHHH
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV--FDPNKRITVEE  323 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dp~~Rps~~e  323 (377)
                      .. ..+....+-.--++-...+.......+.-+++++.-|+.+|+.  .++.-|||++-
T Consensus       235 ~E-~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         235 LE-TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ch-hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            00 0000000000000111112222233344679999999999997  44678999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.5e-11  Score=99.36  Aligned_cols=131  Identities=23%  Similarity=0.275  Sum_probs=94.0

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEec-cccccCHH-----HHHHHHHHHHHHHhcCCC--CceeEeeeecCCCCCCCC
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNII-----DARRTLREIKLLRHMEHE--NVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~-~~~~~~~~-----~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~  119 (377)
                      ..+++|+-+.+|.+..  -|..+++|.- ++......     ...+..+|+.++.+++--  +...++++....      
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~------   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN------   73 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC------
Confidence            4578999999999955  3345666643 33332222     234455799999998744  444455554443      


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                       ..|+|||++| .|.+.+...       ...++..|-..+.-||.+||+||||.++||++..++ +.++|||++...
T Consensus        74 -~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          74 -GLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             -CEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence             5799999998 555576554       244667777788889999999999999999998886 999999998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=2.3e-11  Score=97.78  Aligned_cols=143  Identities=22%  Similarity=0.275  Sum_probs=102.9

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEec-cccccC-----HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDN-----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .+..|-+|+-+.|+++..  .|+..+||.- .+....     .-...+..+|.+.+.++.--.|.-..-++.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            467788999999999955  6778777743 233222     2233455679999999874444443333433322    


Q ss_pred             cEEEEEecCCC--CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeecc
Q 017083          120 DVYIVYELMDT--DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA  192 (377)
Q Consensus       120 ~~~iv~e~~~~--~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~  192 (377)
                       -.|+|||++|  ++.+++....  .........++..|-+.+..||.++|+||||.++||++..++.   +.++|||++
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence             4799999998  8888887532  2333334788999999999999999999999999999976653   589999998


Q ss_pred             ccc
Q 017083          193 RTT  195 (377)
Q Consensus       193 ~~~  195 (377)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=2.7e-12  Score=122.11  Aligned_cols=152  Identities=24%  Similarity=0.351  Sum_probs=110.5

Q ss_pred             HHHHHHHh-cCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc---------ccccccccccCCCccccccCCCC
Q 017083          155 LRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF---------MTEYVVTRWYRAPELLLNCTEYT  223 (377)
Q Consensus       155 ~~al~~LH-~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~---------~~~~~~~~~y~aPE~~~~~~~~~  223 (377)
                      +.|+.++| +.++||++|.|++|.++.++.+||+.|+++...... ..         ..-......|.|||.+.+ ...+
T Consensus       109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~  187 (700)
T KOG2137|consen  109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNT  187 (700)
T ss_pred             cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cccc
Confidence            38999999 569999999999999999999999999987644331 11         111222566999999988 7889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChh
Q 017083          224 AAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG  302 (377)
Q Consensus       224 ~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (377)
                      .++|+||||+++|.+.. |+..+...........-.......                           ..-.-..++.+
T Consensus       188 ~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~---------------------------~~~~s~~~p~e  240 (700)
T KOG2137|consen  188 PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG---------------------------AFGYSNNLPSE  240 (700)
T ss_pred             ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc---------------------------cccccccCcHH
Confidence            99999999999999984 554444433222211111100000                           00011468999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          303 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       303 ~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      +.+-+.++|..++.-||++.+++..|||++..
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999999999998643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.7e-10  Score=99.82  Aligned_cols=143  Identities=17%  Similarity=0.248  Sum_probs=99.7

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.|+.|..+.||++.... |..+++|+....... .....+..|+.+++.+.+  ..+.+++.+......  .+..+++
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~--~~~~~~v   78 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV--LGTPFYV   78 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc--cCCceEE
Confidence            4678999999999998743 678999998654221 134567789999999975  345667776654321  1236899


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS----------------------------------------  163 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~----------------------------------------  163 (377)
                      |||++| ++.+.+.. ..++......++.+++++|..||+                                        
T Consensus        79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999987 44433221 345555566666666666666663                                        


Q ss_pred             ----------------CCceecCCCCCceEEcc--CCCeEEeeeecccc
Q 017083          164 ----------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLART  194 (377)
Q Consensus       164 ----------------~~i~H~dik~~NIli~~--~~~vkl~Dfg~~~~  194 (377)
                                      ..++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23689999999999998  56689999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=9.4e-10  Score=97.13  Aligned_cols=135  Identities=13%  Similarity=0.066  Sum_probs=93.0

Q ss_pred             EEEEEeCCCCcEEEEEeccccccCHHH---------HHHHHHHHHHHHhcCCCC--ceeEeeeecCCCCCCCCcEEEEEe
Q 017083           58 VCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        58 vy~~~~~~~~~~valK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      |+.+..  .|+.|.||...........         ...+.+|+..+.+|..-+  .+.++++.+.........-++|+|
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            555533  5678999976432211100         113668888888885333  334444443322211233689999


Q ss_pred             cCCC--CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-------CCCeEEeeeecccc
Q 017083          127 LMDT--DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCDLKIGDFGLART  194 (377)
Q Consensus       127 ~~~~--~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-------~~~vkl~Dfg~~~~  194 (377)
                      ++++  +|.+++..  ..+.+......++.+++..+..||.+||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9997  68888753  345667778899999999999999999999999999999975       45799999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=3.4e-10  Score=94.30  Aligned_cols=127  Identities=24%  Similarity=0.281  Sum_probs=81.4

Q ss_pred             EEEEEeCCCCcEEEEEeccccc------------------------cCHHHHHHHHHHHHHHHhcCCC--CceeEeeeec
Q 017083           58 VCAAVNSETREEVAIKKIGNAF------------------------DNIIDARRTLREIKLLRHMEHE--NVIAIKDIIR  111 (377)
Q Consensus        58 vy~~~~~~~~~~valK~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~  111 (377)
                      ||.|.. .+|..+|+|+.+...                        ..........+|++.|.++..-  ++.+++++..
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            788877 456789999874321                        0111123446799999999855  5666765532


Q ss_pred             CCCCCCCCcEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCceEEccCCCeEEee
Q 017083          112 PPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY-VHSASVLHRDLKPSNLLLNASCDLKIGD  188 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~-LH~~~i~H~dik~~NIli~~~~~vkl~D  188 (377)
                               -+|||||++  |.....+... .++......++.+++..+.. +|..||+|||+.+.||+++++ .+.++|
T Consensus        81 ---------~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   81 ---------NVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---------TEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---------CEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence                     379999999  6332222221 12245567778888885555 579999999999999999988 899999


Q ss_pred             eecccccC
Q 017083          189 FGLARTTS  196 (377)
Q Consensus       189 fg~~~~~~  196 (377)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.13  E-value=4.4e-10  Score=96.30  Aligned_cols=141  Identities=20%  Similarity=0.178  Sum_probs=102.4

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH--------------------HHHHHHHHHHHHHHhcCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--------------------IDARRTLREIKLLRHMEHE  101 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~  101 (377)
                      ....+..+||-|--|.||.+.+. .|.++|+|.-+...+.-                    -......+|+.+|.+|...
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             hHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            34557889999999999999885 68899999763321111                    1112345789999988644


Q ss_pred             --CceeEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          102 --NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       102 --~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                        .+.+.+++         +.-+++||+++|-...-+    +++......++..|++-+..+-..|++|||+++-||+++
T Consensus       170 G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~  236 (304)
T COG0478         170 GVKVPKPIAW---------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCCCcccc---------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence              56666554         335899999998333222    224555666777777777777799999999999999999


Q ss_pred             cCCCeEEeeeecccccC
Q 017083          180 ASCDLKIGDFGLARTTS  196 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~~~  196 (377)
                      ++|.+.++||..+...+
T Consensus       237 ~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         237 EDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             cCCCEEEEeCcccccCC
Confidence            99999999998765444

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=1.3e-09  Score=93.05  Aligned_cols=129  Identities=21%  Similarity=0.250  Sum_probs=94.1

Q ss_pred             CCcEEEEEeccccccCH-----HHHHHHHHHHHHHHhcC--CCCceeEeeeecCCCCCCCCcEEEEEecCCC--CHHHHH
Q 017083           66 TREEVAIKKIGNAFDNI-----IDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQII  136 (377)
Q Consensus        66 ~~~~valK~~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~--~L~~~l  136 (377)
                      .++.|.+|.........     .......+|...+..|.  .-...+++++.+...... ..-++|+|++++  +|.+++
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHH
Confidence            44566666543221111     23345667888888775  333555666655433222 346899999986  788888


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeeccccc
Q 017083          137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTT  195 (377)
Q Consensus       137 ~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~~~  195 (377)
                      ......+......++.+++..++-||.+||+|+|+++.|||++.++   .+.|+||+-+...
T Consensus       110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            7755577888899999999999999999999999999999999887   7999999977543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.01  E-value=1.1e-08  Score=85.74  Aligned_cols=141  Identities=15%  Similarity=0.136  Sum_probs=102.6

Q ss_pred             cCCccceEEEEEeCCCCcEEEEEeccccc----cCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecCCCCCCCCcEEEE
Q 017083           51 GRGAYGIVCAAVNSETREEVAIKKIGNAF----DNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        51 g~G~~g~vy~~~~~~~~~~valK~~~~~~----~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      |.||-+.|+.....  |..+-+|......    ........+.+|+..+++|..  -.+.++. ++..........-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            55888889988653  3368888775221    112244677889999988862  2244444 3332333334557899


Q ss_pred             EecCCC--CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC--eEEeeeecccc
Q 017083          125 YELMDT--DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLART  194 (377)
Q Consensus       125 ~e~~~~--~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~--vkl~Dfg~~~~  194 (377)
                      +|-++|  +|.+.+...  .+.+......++.+|++++.-||+.|+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998885  888887552  34577778899999999999999999999999999999987777  99999986654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.88  E-value=2.7e-08  Score=100.28  Aligned_cols=213  Identities=21%  Similarity=0.247  Sum_probs=151.7

Q ss_pred             HHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Q 017083           88 TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV  166 (377)
Q Consensus        88 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i  166 (377)
                      ...|+..+.+..|+|++.++.+-......+ ....+..+++.+ ++...+..-+..+....+.+..++.+|+.++|+...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            345778888889999999999877665433 123456777875 888888888899999999999999999999999865


Q ss_pred             eecCCCCC---ceEEccCCCeEEe--eeecccccCCCccccccccccccCCCccccccCC--CCCcchHHHHHHHHHHHH
Q 017083          167 LHRDLKPS---NLLLNASCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIM  239 (377)
Q Consensus       167 ~H~dik~~---NIli~~~~~vkl~--Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~ll~ell  239 (377)
                      .|.-+..+   +--++..+.+..+  ||+.+.................+.+||.... ..  .....|+|++|.+...+.
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhhh
Confidence            55544444   3334555556665  8888887776665555666777888887755 33  334579999999999998


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC
Q 017083          240 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  319 (377)
Q Consensus       240 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp  319 (377)
                      .|..+-.......      .+..                                  ........+++.+|+..++++|+
T Consensus       387 ~~~~i~~~~~~~~------~~l~----------------------------------~~~~~~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  387 QGEDISEKSAVPV------SLLD----------------------------------VLSTSELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             hcCcccccccchh------hhhc----------------------------------cccchhhhhhhhhhcchhhhhcc
Confidence            8765432211000      0000                                  01111577899999999999999


Q ss_pred             CHHHHhcCccccCCcCCCCCCCC
Q 017083          320 TVEEALRHPYLQSLHDLNDEPVC  342 (377)
Q Consensus       320 s~~ell~~p~f~~~~~~~~~~~~  342 (377)
                      ++.+++.|+|...-.+.......
T Consensus       427 ~~~~ll~~~f~~~~~~~~~~~~~  449 (1351)
T KOG1035|consen  427 SALELLTHPFLRFPTDNESSEFA  449 (1351)
T ss_pred             chhhhhhchhccccccccccccc
Confidence            99999999999866655544433

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.83  E-value=2.3e-08  Score=84.20  Aligned_cols=143  Identities=15%  Similarity=0.154  Sum_probs=84.2

Q ss_pred             cccCCcccccCCccceE---------EEEEeCCCCcEEEEEeccccccCHHH-HHH------HHHHHHHHHhcC---CCC
Q 017083           42 KYVPPIRPIGRGAYGIV---------CAAVNSETREEVAIKKIGNAFDNIID-ARR------TLREIKLLRHME---HEN  102 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~v---------y~~~~~~~~~~valK~~~~~~~~~~~-~~~------~~~e~~~l~~l~---h~~  102 (377)
                      +|.++.+.+-.|.+..+         |.+.-..+|..+++|..+......+. ...      ..+.+..+.+++   .-.
T Consensus        20 ~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   20 KYLELGEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HHHHHHHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            45555555555555542         33333456778889987654221111 111      122333333332   334


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~  181 (377)
                      ...++.+.+.....-....+++|||++| .|.+...    +++    .+...+.+++.-||+.|++|||++|.|++++++
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence            4444444333322222335689999998 5554421    222    244667788999999999999999999999966


Q ss_pred             CCeEEeeeeccc
Q 017083          182 CDLKIGDFGLAR  193 (377)
Q Consensus       182 ~~vkl~Dfg~~~  193 (377)
                      + ++++||+..+
T Consensus       172 ~-i~iID~~~k~  182 (229)
T PF06176_consen  172 G-IRIIDTQGKR  182 (229)
T ss_pred             c-EEEEECcccc
Confidence            5 9999998554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.82  E-value=4.2e-08  Score=83.46  Aligned_cols=139  Identities=18%  Similarity=0.129  Sum_probs=96.7

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHH----------------------HHHHHHHHHHHHhcC--CCC
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID----------------------ARRTLREIKLLRHME--HEN  102 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~--h~~  102 (377)
                      ...|.+|.-+.||.+.. .++..+|+|+++........                      ..-..+|+.-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888899999976 56789999998543211111                      011246777787775  445


Q ss_pred             ceeEeeeecCCCCCCCCcEEEEEecCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEcc
Q 017083          103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~-l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~  180 (377)
                      +.+.+.+..         -.++|||++....-. ....-++....+..+..++++.+.-|-. .++||+||+..|||+. 
T Consensus       132 vP~Pi~~~~---------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         132 VPEPIAFRN---------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             CCCceeecC---------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence            555555543         379999998531000 0112234444788888999999999876 8999999999999999 


Q ss_pred             CCCeEEeeeecccccC
Q 017083          181 SCDLKIGDFGLARTTS  196 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~  196 (377)
                      ++.+.++||+.+....
T Consensus       202 ~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEECccccccC
Confidence            7789999999886554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=4e-07  Score=87.23  Aligned_cols=142  Identities=18%  Similarity=0.264  Sum_probs=89.9

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCH----------------------------HHHHH----------HH
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----------------------------IDARR----------TL   89 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----------------------------~~~~~----------~~   89 (377)
                      ..|+.++.|+||.|+.+. |+.||||+.+......                            ...++          +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678999999999999965 9999999884331100                            01111          12


Q ss_pred             HHHHHHHhc----CCCCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHH--HHhCCCCCHHHHHHHHHHHHHHH-HHH
Q 017083           90 REIKLLRHM----EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQQLTDDHCQYFLYQLLRGL-KYV  161 (377)
Q Consensus        90 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~--l~~~~~~~~~~~~~i~~qi~~al-~~L  161 (377)
                      +|..-+.++    +..--+.+-.+|.+-+.    .-.++|||++| .+.+.  ++. ...+...   ++..++++. .-+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHH
Confidence            344444444    33334444455543221    15899999998 45444  333 4455333   233333322 222


Q ss_pred             hcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       162 H~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      =..|++|.|.+|.||+|+.+|++.+.|||.....+..
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            3489999999999999999999999999998765543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=3.9e-07  Score=73.45  Aligned_cols=137  Identities=20%  Similarity=0.177  Sum_probs=97.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCcee-EeeeecCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPK  114 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~  114 (377)
                      +++....-.+..+.||+|.+|.||++.++  |..+|+|+-+.+    .....+..|+++|..+...++-+ +|.+-+   
T Consensus        16 ~~~~~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~---   86 (201)
T COG2112          16 NVEEGKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE---   86 (201)
T ss_pred             eeeccchhhhhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech---
Confidence            45555666667889999999999999774  458999988654    23456778999999998766544 443322   


Q ss_pred             CCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCC-CCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK-PSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik-~~NIli~~~~~vkl~Dfg~~  192 (377)
                            -++.|||+.| .|.+.....       -+.-+..++++.--|-..||-|+.|. |..+++..++++.|+||..+
T Consensus        87 ------~~i~me~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A  153 (201)
T COG2112          87 ------DFIRMEYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSA  153 (201)
T ss_pred             ------hhhhhhhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccch
Confidence                  2466999998 776654321       12345667777667888999999998 44444444448999999988


Q ss_pred             cc
Q 017083          193 RT  194 (377)
Q Consensus       193 ~~  194 (377)
                      +.
T Consensus       154 t~  155 (201)
T COG2112         154 TF  155 (201)
T ss_pred             hh
Confidence            73

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=1.1e-06  Score=76.02  Aligned_cols=133  Identities=18%  Similarity=0.208  Sum_probs=80.5

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC--ceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ..+||+|..+.||+.    .+..+++|......    ......+|.++++.+..-.  +.+++++......     .+++
T Consensus         6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-----~glv   72 (226)
T TIGR02172         6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-----LGLI   72 (226)
T ss_pred             heeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-----eeee
Confidence            357899999999984    24568899886532    2344678999999886433  4666666655433     6789


Q ss_pred             EecCCCC--HHHHH---------------------HhC--CCCCHHH-HHHHHH----------HHHH-HHHHHh----c
Q 017083          125 YELMDTD--LHQII---------------------RSD--QQLTDDH-CQYFLY----------QLLR-GLKYVH----S  163 (377)
Q Consensus       125 ~e~~~~~--L~~~l---------------------~~~--~~~~~~~-~~~i~~----------qi~~-al~~LH----~  163 (377)
                      ||+++|.  +...+                     ..-  ....... ...+..          .+.. ...+|.    .
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            9999883  11111                     000  0011000 000100          0111 111222    1


Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ..++|||++|.||++++++ +.++||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            2478999999999999988 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=1.8e-06  Score=82.51  Aligned_cols=142  Identities=18%  Similarity=0.237  Sum_probs=89.6

Q ss_pred             ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHH-----------------------------H------HHHHHH
Q 017083           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----------------------------R------RTLREI   92 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~-----------------------------~------~~~~e~   92 (377)
                      +.||.-+.|+|++++.+. |+.||||+.+.........                             +      ++.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999976 9999999886542211000                             0      012233


Q ss_pred             HHH----HhcCCCC---ceeEeeeecCCCCCCCCcEEEEEecCCC---CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-
Q 017083           93 KLL----RHMEHEN---VIAIKDIIRPPKKDTFNDVYIVYELMDT---DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-  161 (377)
Q Consensus        93 ~~l----~~l~h~~---iv~~~~~~~~~~~~~~~~~~iv~e~~~~---~L~~~l~~~~~~~~~~~~~i~~qi~~al~~L-  161 (377)
                      +-.    +.+.|-.   -|.+-.+|.+-..    .-.++|||++|   +-.+.|...+ ++..   .++..+.++...+ 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~g-i~~~---~i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRG-ISPH---DILNKLVEAYLEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcC-CCHH---HHHHHHHHHHHHHH
Confidence            332    2334544   2334444433221    16899999997   3334555433 4444   3445555554443 


Q ss_pred             hcCCceecCCCCCceEEcc----CCCeEEeeeecccccCCC
Q 017083          162 HSASVLHRDLKPSNLLLNA----SCDLKIGDFGLARTTSET  198 (377)
Q Consensus       162 H~~~i~H~dik~~NIli~~----~~~vkl~Dfg~~~~~~~~  198 (377)
                      =..|++|.|-+|.||+|+.    ++.+.+-|||+.......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3678999999999999984    567999999998766543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=3.3e-06  Score=73.44  Aligned_cols=76  Identities=20%  Similarity=0.237  Sum_probs=52.1

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC--CceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.|+.|..+.||.+....  ..+++|.....    .....+..|+.+++.+...  .+.+++.........  ...+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~--~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN--GFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET--SEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc--ccceEE
Confidence            4678999999999998865  48999997543    4556777888888888633  345666543222221  226899


Q ss_pred             EecCCC
Q 017083          125 YELMDT  130 (377)
Q Consensus       125 ~e~~~~  130 (377)
                      |++++|
T Consensus        74 ~~~i~g   79 (239)
T PF01636_consen   74 MEYIPG   79 (239)
T ss_dssp             EEEESS
T ss_pred             EEEecc
Confidence            999987

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=1e-05  Score=71.10  Aligned_cols=71  Identities=13%  Similarity=0.091  Sum_probs=48.5

Q ss_pred             ccccCCcc-ceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAY-GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~-g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +.|..|.. +.||++...  +..+++|+.....     ...+.+|+.+++.+. +--+.+++++....+.     .+++|
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-----~~lv~   71 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGR-----AWLLT   71 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc-----cEEEE
Confidence            44666666 788999653  3678889886432     335567888888875 4445667776655432     68999


Q ss_pred             ecCCC
Q 017083          126 ELMDT  130 (377)
Q Consensus       126 e~~~~  130 (377)
                      |+++|
T Consensus        72 e~i~G   76 (244)
T cd05150          72 SAVPG   76 (244)
T ss_pred             EeeCC
Confidence            99987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=2.8e-07  Score=87.73  Aligned_cols=246  Identities=17%  Similarity=0.100  Sum_probs=161.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~  120 (377)
                      +.+...+-+++|+++++++.+.-.+...+ .+.+...       ....-++++|.+++||| .+..++-+..+..     
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~-----  308 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY-----  308 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccc-----
Confidence            34446778999999999999775554433 5555332       34456888999999999 5555555555443     


Q ss_pred             EEEEEecCCCC--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          121 VYIVYELMDTD--LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       121 ~~iv~e~~~~~--L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      .+|.++++.+.  ....+. ..-.+..-+...+...-+++++++|+..-+|+|    ||+-++ +..++.+|+.......
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence            78999999853  222111 112233445555667777899999988778888    666555 5699999998877766


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ........+++.++|||+... +.+....|.|++|.-..+|.-|..|-..+....      ...+..+..          
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~------~~~g~~p~s----------  446 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL------PMIGNGPNS----------  446 (829)
T ss_pred             ccccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcccc------CCCCCCCCc----------
Confidence            656677888999999999877 788889999999988888888877765421000      000000000          


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ......          ..|....  -.++...|+..-|..|+....++.|.+|..-.
T Consensus       447 ~~L~~~----------~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  447 PMLTDK----------SAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             cccchh----------hhcCccc--ccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            000000          0011100  11466778999999999999999888886433

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=5e-05  Score=63.91  Aligned_cols=129  Identities=17%  Similarity=0.233  Sum_probs=88.6

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccc--------------cCHHHHHHHHHHHHHHHhcC------CCCceeE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF--------------DNIIDARRTLREIKLLRHME------HENVIAI  106 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~  106 (377)
                      ...||+|+.-.||.--+   ....+||+.....              .......+..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            45699999999997633   3457888886653              00112344455555555444      8899999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC---C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD---T----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~---~----~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                      +|+.+.+..     ..+|+|.+.   |    +|.+++.. +.++. ....   .+-+-.++|-+.+|+.+|++|.||++.
T Consensus        83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            999988755     788988872   2    78888754 44655 4333   344455678899999999999999996


Q ss_pred             cCC----CeEEee
Q 017083          180 ASC----DLKIGD  188 (377)
Q Consensus       180 ~~~----~vkl~D  188 (377)
                      .+.    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            533    467777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=3.3e-05  Score=67.47  Aligned_cols=73  Identities=15%  Similarity=0.189  Sum_probs=43.4

Q ss_pred             cccccCCccc-eEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC---CceeEeeeecCCCCCCCCcEE
Q 017083           47 IRPIGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        47 ~~~lg~G~~g-~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      ++.|+.|+.. .||.+.     ..+++|..+..    .....+..|+.+++.+...   -+.++++.....+  .....+
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~--~~~~~~   70 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGE--GYPWPW   70 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCcc--CCCcce
Confidence            5678877776 499872     35788876532    1234677899999887632   2333333322211  111247


Q ss_pred             EEEecCCC
Q 017083          123 IVYELMDT  130 (377)
Q Consensus       123 iv~e~~~~  130 (377)
                      ++|++++|
T Consensus        71 ~l~~~i~G   78 (235)
T cd05155          71 SVYRWLEG   78 (235)
T ss_pred             EEEEeecC
Confidence            88999876

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=7.9e-05  Score=76.94  Aligned_cols=83  Identities=13%  Similarity=0.189  Sum_probs=56.9

Q ss_pred             CcccccCCccceEEEEEeCCCC--cEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCc--eeEeeeecCCCCCCCCc
Q 017083           46 PIRPIGRGAYGIVCAAVNSETR--EEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV--IAIKDIIRPPKKDTFND  120 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~--~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~  120 (377)
                      .++.|+.|.++.+|++.....+  ..+++|+...... ......+.+|+.+++.+. |.++  .+++.++.+...  ...
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~  118 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGT  118 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCC
Confidence            3678899999999999765433  4688887754321 112346778999999996 6664  677776655421  233


Q ss_pred             EEEEEecCCCC
Q 017083          121 VYIVYELMDTD  131 (377)
Q Consensus       121 ~~iv~e~~~~~  131 (377)
                      .|+||||++|.
T Consensus       119 ~flVME~v~G~  129 (822)
T PLN02876        119 AFYIMEYLEGR  129 (822)
T ss_pred             ceEEEEecCCc
Confidence            68999999873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.01  E-value=8.5e-05  Score=62.08  Aligned_cols=137  Identities=20%  Similarity=0.208  Sum_probs=92.8

Q ss_pred             eeecccccCCcccccCCcc-ceEEEEEeCCCCcEEEEEeccc---ccc--------C-H-------HHHHHHHHHHHHHH
Q 017083           37 FEVSSKYVPPIRPIGRGAY-GIVCAAVNSETREEVAIKKIGN---AFD--------N-I-------IDARRTLREIKLLR   96 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~-g~vy~~~~~~~~~~valK~~~~---~~~--------~-~-------~~~~~~~~e~~~l~   96 (377)
                      |......++.++.||.|.. |.||++..  .|..||||++..   ...        . .       ....-|..|-+...
T Consensus        32 F~~h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg  109 (207)
T PF13095_consen   32 FTHHGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG  109 (207)
T ss_pred             cCCCCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence            3334466778999999999 99999966  567999999321   110        0 0       11234556777777


Q ss_pred             hcC---CCCc--eeEeeeecCCC-------------CCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 017083           97 HME---HENV--IAIKDIIRPPK-------------KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL  158 (377)
Q Consensus        97 ~l~---h~~i--v~~~~~~~~~~-------------~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al  158 (377)
                      +|+   +.++  |+.+|+..-..             ........||-||++..-        .+...    -+.+|.+-+
T Consensus       110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl  177 (207)
T PF13095_consen  110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDL  177 (207)
T ss_pred             HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHH
Confidence            775   4566  99999874331             112233578888887533        22222    246777888


Q ss_pred             HHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       159 ~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ..+|..||+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            8899999999999999987     4689999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.87  E-value=0.00012  Score=64.87  Aligned_cols=132  Identities=16%  Similarity=0.188  Sum_probs=74.4

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecCCCCCCCCcEEEEEec
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVYEL  127 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~e~  127 (377)
                      .+..|-.+.+|++.  .++..+++|.........  .-....|..+++.+....+ .+++....         -++|+||
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~---------~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE---------HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC---------CEEEEEe
Confidence            45678888999996  456789999765431110  0124568888888864333 33443321         2689999


Q ss_pred             CCC-CHH--------------HHHH---h----CCCCCHH-HHHHHHHHH---------HHHHHHHhc--------CCce
Q 017083          128 MDT-DLH--------------QIIR---S----DQQLTDD-HCQYFLYQL---------LRGLKYVHS--------ASVL  167 (377)
Q Consensus       128 ~~~-~L~--------------~~l~---~----~~~~~~~-~~~~i~~qi---------~~al~~LH~--------~~i~  167 (377)
                      ++| .+.              ..+.   .    ..+++.. .+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            986 221              1111   1    1112211 111211111         111222211        2489


Q ss_pred             ecCCCCCceEEccCCCeEEeeeecccc
Q 017083          168 HRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       168 H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      |+|+.|.||++++++ +.|+||..+..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999887 89999997753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.85  E-value=0.00042  Score=64.76  Aligned_cols=78  Identities=18%  Similarity=0.162  Sum_probs=53.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc---C--HHHHHHHHHHHHHHHhcC---CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---N--IIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~  117 (377)
                      -.+.||.|.++.||++.+...++.++||.-.....   .  ....++...|...|+.+.   -.++++++.+-...    
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~----  105 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEEL----  105 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCC----
Confidence            35679999999999999865446899997532110   1  123456667888888764   24577777774422    


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                         .++|||++++
T Consensus       106 ---~~lVME~L~~  115 (401)
T PRK09550        106 ---AVTVMEDLSD  115 (401)
T ss_pred             ---CEEEEecCCC
Confidence               5799999874

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.85  E-value=7.6e-05  Score=70.08  Aligned_cols=175  Identities=20%  Similarity=0.251  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 017083           85 ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  164 (377)
Q Consensus        85 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~  164 (377)
                      ..+++-..++++.+.|+|+..++++-.....    ...+|+|+++-+|.+.+..+. +......                
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~----r~IVV~e~~~~Sled~~~~~~-l~~~s~~----------------   84 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHE----RVIVVMEHYTMSLEDILKTGN-LKDESLL----------------   84 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccc----eEEEEehhhccchHHHHHhcc-cchhhhc----------------
Confidence            4566778899999999999999988766543    378999999999999987654 2211111                


Q ss_pred             CceecCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 017083          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p  244 (377)
                        +|+=+. -|+       ++.+| .+..                |. |      ....+++|||++|.++.++.-|...
T Consensus        85 --~~~~~~-~~~-------~~~td-~~~t----------------~~-~------~~~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   85 --AHGVLH-LNI-------IYITD-HFLT----------------KY-P------SPIGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             --ccccce-ehh-------hhccc-cccc----------------cC-C------CCCCcchhhhhHHHHHHHHHHhhHH
Confidence              233111 111       23333 0000                00 1      1112599999999999999999888


Q ss_pred             CCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 017083          245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  324 (377)
Q Consensus       245 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el  324 (377)
                      +.....-+....+.+....+..-.. .     .....             ....++..+..+..+|+-..|..||...++
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~-~-----a~e~~-------------~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLS-T-----AMEHL-------------IQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHH-H-----HHHHH-------------HHHhhhHhHHHHhccCCccccccccchhHH
Confidence            8777777777777665443322110 0     00000             011346678899999999999999999999


Q ss_pred             hcCccccCC
Q 017083          325 LRHPYLQSL  333 (377)
Q Consensus       325 l~~p~f~~~  333 (377)
                      .+++-|...
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00033  Score=61.08  Aligned_cols=72  Identities=14%  Similarity=0.253  Sum_probs=45.9

Q ss_pred             cccccCCccceEEEEEeCC-CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC-CceeEeeeecCCCCCCCCcEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++.|..|-...+|++.... .+..|++|+.......   .-....|+.+++.+... -.+++++... .        .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--------~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N--------GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--------cEE
Confidence            5668888889999997643 3568999987543111   12234688888888533 3444544332 1        479


Q ss_pred             EecCCC
Q 017083          125 YELMDT  130 (377)
Q Consensus       125 ~e~~~~  130 (377)
                      +||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999986

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.69  E-value=0.00018  Score=60.24  Aligned_cols=96  Identities=21%  Similarity=0.153  Sum_probs=77.4

Q ss_pred             HHHHHHHhcCC-CCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHhc-
Q 017083           90 REIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHS-  163 (377)
Q Consensus        90 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~---l~~~~~~~~~~~~~i~~qi~~al~~LH~-  163 (377)
                      .|.-+++.+++ +++++++|.+.         -+++.||.+. ++...   +..-...++..+..|+.++++.+.+|+. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            58888899985 69999999984         3678999984 44321   1122346899999999999999999997 


Q ss_pred             --CCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          164 --ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       164 --~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                        ..+.-.|++++|+-|+++|++|++|......
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence              3578889999999999999999999987753

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=8.3e-05  Score=66.04  Aligned_cols=135  Identities=17%  Similarity=0.193  Sum_probs=92.2

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHH------------------H--HHHHHHHHHHhcC-CCC-c
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA------------------R--RTLREIKLLRHME-HEN-V  103 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~------------------~--~~~~e~~~l~~l~-h~~-i  103 (377)
                      +..+||-|.-+-||.+-+ ..|...++|+-+.....-...                  .  ...+|+..|+.|. |.. +
T Consensus        96 vGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   96 VGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            677899999999999988 457889998653321111111                  1  1246888888875 332 3


Q ss_pred             eeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC
Q 017083          104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       104 v~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~  182 (377)
                      .+.+++         +.-++|||++.| .|...-.-      ..+..+...+..-+-.|-.+|++|+|+.--||+|++++
T Consensus       175 PkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  175 PKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence            334433         336899999987 55443211      12334455666667778899999999999999999999


Q ss_pred             CeEEeeeecccccC
Q 017083          183 DLKIGDFGLARTTS  196 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~  196 (377)
                      .++++||...-..+
T Consensus       240 ~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  240 KIVVIDFPQMVSTS  253 (465)
T ss_pred             CEEEeechHhhccC
Confidence            99999999765433

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.62  E-value=0.00028  Score=63.81  Aligned_cols=137  Identities=21%  Similarity=0.240  Sum_probs=93.5

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccc----------------------cCHHHH--HHHHHHHHHHHhcCCCCce
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAF----------------------DNIIDA--RRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~----------------------~~~~~~--~~~~~e~~~l~~l~h~~iv  104 (377)
                      -|..|--+.||.+.. .+|..+|||+++...                      .++...  --..+|++-|.+++...|.
T Consensus       151 CiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  151 CISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             ccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            456677788999876 567889999884331                      111111  1234688888888766644


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCceEEccCC
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dik~~NIli~~~~  182 (377)
                      -.--+...+       -.+||++++.+ -..=....-.++...+..+-.+++.-+.-|- ..++||.||.--|+|+.++ 
T Consensus       230 ~PePIlLk~-------hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-  301 (520)
T KOG2270|consen  230 CPEPILLKN-------HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-  301 (520)
T ss_pred             CCCceeeec-------ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC-
Confidence            433333332       47999999842 2111223456777788888888888888765 6799999999999998765 


Q ss_pred             CeEEeeeecccc
Q 017083          183 DLKIGDFGLART  194 (377)
Q Consensus       183 ~vkl~Dfg~~~~  194 (377)
                      .+.++|.+.+-.
T Consensus       302 ~lyiIDVSQSVE  313 (520)
T KOG2270|consen  302 KLYIIDVSQSVE  313 (520)
T ss_pred             EEEEEEcccccc
Confidence            699999987743

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.58  E-value=0.00043  Score=62.85  Aligned_cols=72  Identities=14%  Similarity=0.178  Sum_probs=45.0

Q ss_pred             cccccCCccceEEEEEeCC------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCCCCCC
Q 017083           47 IRPIGRGAYGIVCAAVNSE------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~  119 (377)
                      ++.|..|-...+|++....      .++.+++|+......   .......|+.++..+.... ..++++.+..       
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~-------   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN-------   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC-------
Confidence            4556677778999997643      257899999765321   2234557888888775332 3445555431       


Q ss_pred             cEEEEEecCCC
Q 017083          120 DVYIVYELMDT  130 (377)
Q Consensus       120 ~~~iv~e~~~~  130 (377)
                        .+|+||++|
T Consensus        73 --~~v~e~i~G   81 (302)
T cd05156          73 --GRIEEFIPS   81 (302)
T ss_pred             --CchhheeCC
Confidence              257888775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0031  Score=57.76  Aligned_cols=30  Identities=30%  Similarity=0.300  Sum_probs=25.7

Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .+++|+|+++.||+++++...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999966556899999774

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.0013  Score=59.55  Aligned_cols=141  Identities=14%  Similarity=0.032  Sum_probs=79.2

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC--ceeEeeeecCCCC-CCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK-DTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~-~~~~~~~  122 (377)
                      -++.|..|....+|++..  .+..+++|+....     ....+..|+.++..+...+  +.+++........ ...+..+
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            366788888889999854  3347999988641     2344566777777775322  4444432111000 0012368


Q ss_pred             EEEecCCCCHH-----HH-------H---Hh-CCCC----------CHHHH----------HHHHHHHHHHHHHHhc---
Q 017083          123 IVYELMDTDLH-----QI-------I---RS-DQQL----------TDDHC----------QYFLYQLLRGLKYVHS---  163 (377)
Q Consensus       123 iv~e~~~~~L~-----~~-------l---~~-~~~~----------~~~~~----------~~i~~qi~~al~~LH~---  163 (377)
                      ++++|++|...     ..       +   .. ...+          .+...          ......+..++..+..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            99999986211     00       0   00 0000          00000          0011112233444442   


Q ss_pred             ----CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ----ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ----~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          .+++|||+.|.||++++++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                469999999999999998777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.43  E-value=0.0018  Score=59.41  Aligned_cols=81  Identities=15%  Similarity=0.044  Sum_probs=51.8

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEeccccc-----cCHHHHHHHHHHHHHHHhcC--CC-CceeEeeeecCCCCCCCCc
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAF-----DNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  120 (377)
                      .||.|....||++.+...++.++||.-....     .-.....+..-|...|+...  -| .++++|.+-...       
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~-------   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEM-------   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcccc-------
Confidence            5899999999999986444679998653111     11233455567778887764  35 455566654433       


Q ss_pred             EEEEEecCCC--CHHHHH
Q 017083          121 VYIVYELMDT--DLHQII  136 (377)
Q Consensus       121 ~~iv~e~~~~--~L~~~l  136 (377)
                      ..++||+++.  .+...+
T Consensus        75 ~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             ceehHhhCccchHHHHHH
Confidence            4689999863  454444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.40  E-value=0.003  Score=57.47  Aligned_cols=142  Identities=14%  Similarity=0.131  Sum_probs=78.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC--ceeEeeeecCCC-CCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPK-KDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~  122 (377)
                      .++.++.|....+|++..  ++..+++|+.....    ....+..|+.++..|....  +.+++....... ....+..+
T Consensus        26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            467788888889999864  23468899875421    1233445666676664222  344443211110 00013368


Q ss_pred             EEEecCCCC-H-----HH------HH---Hh-CCCC--------CHH---H--HH----------HHHHHHHHHHHHHh-
Q 017083          123 IVYELMDTD-L-----HQ------II---RS-DQQL--------TDD---H--CQ----------YFLYQLLRGLKYVH-  162 (377)
Q Consensus       123 iv~e~~~~~-L-----~~------~l---~~-~~~~--------~~~---~--~~----------~i~~qi~~al~~LH-  162 (377)
                      ++++|++|. +     ..      .+   .. ...+        ...   .  ..          .....+.+.++++. 
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999762 1     11      01   10 0111        000   0  00          00112233444443 


Q ss_pred             ------cCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          163 ------SASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       163 ------~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                            ..+++|+|+++.||++++++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                  2579999999999999998767899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.34  E-value=0.0014  Score=60.82  Aligned_cols=83  Identities=18%  Similarity=0.142  Sum_probs=53.9

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEecccc----ccCHHHHHHHHHHHHHHHhcC--CC-CceeEeeeecCCCCCCCC
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNA----FDNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~----~~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  119 (377)
                      ++.||.|.-.-||++.+...++.++||.-...    ..-.-..++..-|...|+.+.  -| +++++|.+-.+.      
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~------  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM------  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH------
Confidence            67799999999999988544567898854211    112334566667888888774  45 455666654433      


Q ss_pred             cEEEEEecCCC--CHHHHH
Q 017083          120 DVYIVYELMDT--DLHQII  136 (377)
Q Consensus       120 ~~~iv~e~~~~--~L~~~l  136 (377)
                       ..+|||+++.  .|...+
T Consensus       108 -~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        108 -NCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             -hhHHHHhCcccHHHHHHH
Confidence             4688999863  344443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.32  E-value=0.0038  Score=55.77  Aligned_cols=31  Identities=23%  Similarity=0.462  Sum_probs=25.8

Q ss_pred             CceecCCCCCceEEccCCC-eEEeeeeccccc
Q 017083          165 SVLHRDLKPSNLLLNASCD-LKIGDFGLARTT  195 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~-vkl~Dfg~~~~~  195 (377)
                      .++|||+++.||+++++++ .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999998665 469999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.31  E-value=0.0057  Score=55.27  Aligned_cols=147  Identities=14%  Similarity=0.164  Sum_probs=82.6

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecCCCCCCCCcEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +++.+-.|.-..+|...+.  ++.++++ ...............+|+.+++.+.-  --+...++++..+.   ....+.
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~  102 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFY  102 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceE
Confidence            3444433444455666553  7788988 43222233345566678888887753  22334455555443   233689


Q ss_pred             EEecCCC-C------------------HHHHHH---h----CC-------CCCHHHHHHHHHHH--------------HH
Q 017083          124 VYELMDT-D------------------LHQIIR---S----DQ-------QLTDDHCQYFLYQL--------------LR  156 (377)
Q Consensus       124 v~e~~~~-~------------------L~~~l~---~----~~-------~~~~~~~~~i~~qi--------------~~  156 (377)
                      +|+|++| .                  +.+.+.   +    +.       .....++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            9999876 1                  111111   0    00       00111122222222              22


Q ss_pred             HHHHHhcC--------CceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          157 GLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       157 al~~LH~~--------~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ...+|+.+        .++|||+++.|++++.++.+-|.||+++......
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            33444432        3899999999999999999999999998765433

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=0.00018  Score=75.49  Aligned_cols=210  Identities=16%  Similarity=0.093  Sum_probs=135.4

Q ss_pred             HHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHh
Q 017083           88 TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVH  162 (377)
Q Consensus        88 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~LH  162 (377)
                      ...|..-++...|+++...+.-......   ...++.++++. |.+.+.+.++    ..+....+.....+.+.+..-+|
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3345555566789988877766554433   23678899987 6888887543    22333333333333366666666


Q ss_pred             cC-C----ceecCCCCCceEEccCCCeEEeeeeccc-ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHH
Q 017083          163 SA-S----VLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  236 (377)
Q Consensus       163 ~~-~----i~H~dik~~NIli~~~~~vkl~Dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~  236 (377)
                      +. |    .+|.++++-|.+|..+-+++++++|+.+ ............+++.|+.|+.... -.++.++|+|..|+.+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHH
Confidence            43 2    6899999999999999999999999998 3333344555677888899988765 66777799999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCC
Q 017083          237 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  316 (377)
Q Consensus       237 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  316 (377)
                      ..-.|..+|-.        .++.......+.                      ........-.|.+.-.....+|-....
T Consensus      1432 ~rs~~n~~fi~--------flq~~Lkgiidn----------------------~tf~sIe~l~pgdaNve~~~~Ll~K~~ 1481 (2724)
T KOG1826|consen 1432 LRSDGNAYFIF--------FLQPALKGIIDN----------------------HTFFSIEKLKPGDANVEALHRLLWKYM 1481 (2724)
T ss_pred             HHhcccHHHHH--------HHHHHHcCcccc----------------------cccccccccCCCcccHHHHHHHHHHhh
Confidence            99888766521        111111111100                      001111112345555666667777777


Q ss_pred             CCCCHHHHhcCcccc
Q 017083          317 KRITVEEALRHPYLQ  331 (377)
Q Consensus       317 ~Rps~~ell~~p~f~  331 (377)
                      .||.-...++.+.|-
T Consensus      1482 ~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1482 ERPGQYISLSRDHFA 1496 (2724)
T ss_pred             hcchhhhhccccccc
Confidence            899888888877764

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.08  E-value=0.01  Score=55.55  Aligned_cols=76  Identities=20%  Similarity=0.239  Sum_probs=50.8

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc--C---HHHHHHHHHHHHHHHhcC---CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--N---IIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--~---~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~  117 (377)
                      ..+.||.|....||++.+.  +..++||.-.....  .   .....+...|+..|+.+.   -.++.+++.+..+.    
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence            4677999999999999873  35689997652211  0   012344445666666654   24788888887754    


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                         -+++||++++
T Consensus       110 ---~vlvME~L~~  119 (418)
T PLN02756        110 ---ALIGMRYLEP  119 (418)
T ss_pred             ---CEEEEeecCC
Confidence               4688999965

>PLN02236 choline kinase

Probab=96.96  E-value=0.0095  Score=55.11  Aligned_cols=136  Identities=15%  Similarity=0.182  Sum_probs=76.5

Q ss_pred             CcccccCCccceEEEEEeCC----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCCCCCCc
Q 017083           46 PIRPIGRGAYGIVCAAVNSE----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~  120 (377)
                      -+..|..|-...+|++....    .++.|++|+......  ... ....|..+++.+..-+ -.++++.+..        
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~--------  108 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFF-DRDDEIRTFECMSRHGQGPRLLGRFPN--------  108 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eee-chHHHHHHHHHHHHcCCCCceEEEECC--------
Confidence            45567668888999987432    346899998865321  111 2256888888776333 3455565532        


Q ss_pred             EEEEEecCCC-CHHH-----------H---H---HhCC-C----C-CHHHHHHHHHHH-----------------HHHHH
Q 017083          121 VYIVYELMDT-DLHQ-----------I---I---RSDQ-Q----L-TDDHCQYFLYQL-----------------LRGLK  159 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~-----------~---l---~~~~-~----~-~~~~~~~i~~qi-----------------~~al~  159 (377)
                       ..+.+|+++ ++..           +   +   +... +    . ....+..+..++                 ...+.
T Consensus       109 -g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        109 -GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             -ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence             246888765 2211           0   1   1100 0    1 112222322111                 11111


Q ss_pred             HH----h----cCCceecCCCCCceEEcc-CCCeEEeeeeccc
Q 017083          160 YV----H----SASVLHRDLKPSNLLLNA-SCDLKIGDFGLAR  193 (377)
Q Consensus       160 ~L----H----~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~  193 (377)
                      .|    .    ...++|+|+++.||++++ ++.+.|+||..+.
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11    1    235899999999999986 4679999998774

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.76  E-value=0.0098  Score=54.71  Aligned_cols=73  Identities=11%  Similarity=0.218  Sum_probs=44.0

Q ss_pred             CcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecCCCCCCCCcE
Q 017083           46 PIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  121 (377)
                      -++.|..|-...+|++.....   +..|++|+......   ..-...+|..+++.+..-++ .++++++. +        
T Consensus        18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~--------   85 (330)
T PLN02421         18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-N--------   85 (330)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-C--------
Confidence            455666677788999875432   34799998864321   11223468888888764443 45555552 2        


Q ss_pred             EEEEecCCC
Q 017083          122 YIVYELMDT  130 (377)
Q Consensus       122 ~iv~e~~~~  130 (377)
                      .++.+|++|
T Consensus        86 G~i~~fi~g   94 (330)
T PLN02421         86 GMIQSFINA   94 (330)
T ss_pred             cEeehhhcC
Confidence            247888765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.53  E-value=0.048  Score=49.66  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=27.3

Q ss_pred             CceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          165 SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      +++|+|+.++||++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.46  E-value=0.022  Score=51.89  Aligned_cols=105  Identities=17%  Similarity=0.275  Sum_probs=73.0

Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .|++|++.++.+...    ......++..++.+.+..++-+..+ ..-||++...||+|+ +|+|.|+||-+++......
T Consensus       301 ~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~  375 (488)
T COG5072         301 LYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQG  375 (488)
T ss_pred             EEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccCCc
Confidence            678888887765432    2235677888899999988888855 789999999999999 9999999999998443332


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  236 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~  236 (377)
                      .    ......--|-+|.|  .-+..-+||-+--.+.
T Consensus       376 ~----isy~rldhp~lF~G--~dd~QFeIYrlMr~l~  406 (488)
T COG5072         376 I----ISYNRLDHPDLFNG--VDDYQFEIYRLMRRLL  406 (488)
T ss_pred             e----eeccccCchhhhcC--ccceeeeHHHHHHHHh
Confidence            1    11222344555554  3366778887544433

>PRK10593 hypothetical protein; Provisional

Probab=96.10  E-value=0.052  Score=49.12  Aligned_cols=107  Identities=11%  Similarity=0.079  Sum_probs=70.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC---CCceeEeeeecCCCCCCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH---ENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .-++.||.|..+.||...... + .+++|..+..    .....+..|...++.|.-   -.+.++++++.....  .+..
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~   88 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPD   88 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCe
Confidence            346779999999999996533 2 4777775321    123567789999988863   357778877654321  1226


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  164 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~  164 (377)
                      ++|||+++| ++.+ .    .........+..+++++++.||+.
T Consensus        89 ~LVmE~i~G~~~~~-~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         89 VLLLERLRGVSVEA-P----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEEeccCCEecCC-C----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            999999997 4443 1    123344555667777888888874

>PTZ00384 choline kinase; Provisional

Probab=96.08  E-value=0.074  Score=49.83  Aligned_cols=73  Identities=14%  Similarity=0.093  Sum_probs=43.5

Q ss_pred             CcccccCCccceEEEEEeCCCC-c-----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCC-CceeEeeeecCCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETR-E-----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~-~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~  118 (377)
                      .++.|..|-.+.+|++...... .     .|.++.....   ....-...+|+.+++.+... .-.++++.+..      
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------  124 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------  124 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence            4556766888899999754321 2     2444443211   11112234688999998744 44556666642      


Q ss_pred             CcEEEEEecCCC
Q 017083          119 NDVYIVYELMDT  130 (377)
Q Consensus       119 ~~~~iv~e~~~~  130 (377)
                         +++.||++|
T Consensus       125 ---g~l~efIeG  133 (383)
T PTZ00384        125 ---FTIQEWVEG  133 (383)
T ss_pred             ---EEEEEEecc
Confidence               589999986

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.58  E-value=0.11  Score=46.71  Aligned_cols=73  Identities=11%  Similarity=0.102  Sum_probs=45.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC---CCCceeEeeeecCCCCCCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .-.+.++.|....+|++.  .++..+.+|+-...     ....+..|+.-|+.|.   --.+.+++++-.....     -
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~   87 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----A   87 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----C
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----c
Confidence            346678989999999996  67788999987532     2345667777777773   3457778877655433     4


Q ss_pred             EEEEecCC
Q 017083          122 YIVYELMD  129 (377)
Q Consensus       122 ~iv~e~~~  129 (377)
                      ++++||++
T Consensus        88 fLlle~l~   95 (288)
T PF03881_consen   88 FLLLEFLE   95 (288)
T ss_dssp             EEEEE---
T ss_pred             eEEEEeec
Confidence            89999986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.49  E-value=0.48  Score=43.46  Aligned_cols=28  Identities=32%  Similarity=0.385  Sum_probs=23.6

Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .+++|+|+.+.||+++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 58899999664

>PTZ00296 choline kinase; Provisional

Probab=95.43  E-value=0.29  Score=46.85  Aligned_cols=76  Identities=14%  Similarity=0.183  Sum_probs=45.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCC--------CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSET--------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRP  112 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~--------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~  112 (377)
                      ..+ -++.|..|-...+|++.....        ++.|++++.......-   -....|..+++.+..-+| .++++.+. 
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l---IdR~~E~~v~~~ls~~gi~P~l~~~f~-  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL---YNPISEFEVYKTMSKYRIAPQLLNTFS-  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce---eCHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence            344 566777788888999975422        5689999886532111   123457777776653333 34555543 


Q ss_pred             CCCCCCCcEEEEEecCCC
Q 017083          113 PKKDTFNDVYIVYELMDT  130 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~  130 (377)
                      +        +.+.+|++|
T Consensus       181 g--------g~I~efi~g  190 (442)
T PTZ00296        181 G--------GRIEEWLYG  190 (442)
T ss_pred             C--------CEEEEeeCC
Confidence            1        467888875

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.22  E-value=0.11  Score=48.13  Aligned_cols=59  Identities=14%  Similarity=0.192  Sum_probs=41.4

Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCceEEcc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dik~~NIli~~  180 (377)
                      ..++-+|..| ++..+++. ...++...+.++.-.++|+-.|- -.+++|.|++|.||++..
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            4566667777 66666543 44555666777776777766654 568999999999999954

>PRK06148 hypothetical protein; Provisional

Probab=95.11  E-value=0.36  Score=51.36  Aligned_cols=31  Identities=35%  Similarity=0.500  Sum_probs=26.2

Q ss_pred             CCceecCCCCCceEEccCC--CeE-Eeeeecccc
Q 017083          164 ASVLHRDLKPSNLLLNASC--DLK-IGDFGLART  194 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~--~vk-l~Dfg~~~~  194 (377)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  554 999998753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.54  E-value=0.079  Score=48.18  Aligned_cols=29  Identities=24%  Similarity=0.384  Sum_probs=25.3

Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999998 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.50  E-value=0.095  Score=47.21  Aligned_cols=61  Identities=20%  Similarity=0.253  Sum_probs=38.9

Q ss_pred             EEEEEecCCC-----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-h---cCCceecCCCCCceEEccC
Q 017083          121 VYIVYELMDT-----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-H---SASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       121 ~~iv~e~~~~-----~L~~~l~~~~~~~~~~~~~i~~qi~~al~~L-H---~~~i~H~dik~~NIli~~~  181 (377)
                      -.||++.+.+     ++......+-..-.+-++.++.||+.-.-.+ .   ..+.+|.||||+||||-+.
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            3577777653     2323333222233456778888988766333 2   3479999999999999544

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.41  E-value=0.037  Score=45.96  Aligned_cols=29  Identities=34%  Similarity=0.467  Sum_probs=25.5

Q ss_pred             CceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          165 SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      -.+|+|+.|.||+++++| ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            369999999999998887 99999998754

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.07  E-value=0.11  Score=47.15  Aligned_cols=76  Identities=18%  Similarity=0.283  Sum_probs=45.8

Q ss_pred             EEEEEecCCCCHH-----HHHHhCCCCCHHHHHHHHHHHHHHHHHH---h-cCCceecCCCCCceEEccCC---------
Q 017083          121 VYIVYELMDTDLH-----QIIRSDQQLTDDHCQYFLYQLLRGLKYV---H-SASVLHRDLKPSNLLLNASC---------  182 (377)
Q Consensus       121 ~~iv~e~~~~~L~-----~~l~~~~~~~~~~~~~i~~qi~~al~~L---H-~~~i~H~dik~~NIli~~~~---------  182 (377)
                      -.||++.+.++..     .....+-..-.+-++.++.||+.-.-.+   - ..+.+|.||||+||||-+..         
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  325 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN  325 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence            3578888754322     2222222223455677788887644222   2 45799999999999994432         


Q ss_pred             ---------CeEEeeeecccccC
Q 017083          183 ---------DLKIGDFGLARTTS  196 (377)
Q Consensus       183 ---------~vkl~Dfg~~~~~~  196 (377)
                               +.+|.||.+++..+
T Consensus       326 ~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  326 RNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             eEEEecccceeeecccCHHHhcc
Confidence                     25777777776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	377
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-100
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-100
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-99
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-98
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-98
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-98
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-98
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-98
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-98
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-98
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-98
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-98
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-98
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-98
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-98
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-98
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-98
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-97
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-97
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-97
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-97
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-97
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-97
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-97
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-97
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-96
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-94
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-93
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-93
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-93
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-93
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-93
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-93
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-93
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-93
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-93
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-93
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-93
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-93
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-93
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-93
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-93
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-93
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-93
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-93
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-93
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-93
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-93
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-93
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-93
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-93
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-92
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-92
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-92
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-92
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-92
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-92
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-92
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-92
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-92
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-92
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-92
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-92
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-92
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-92
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-92
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-92
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-92
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-92
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-92
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-92
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-92
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-92
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-92
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-92
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-92
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-92
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-92
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-92
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-92
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-92
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-92
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-92
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-91
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-91
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-91
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-91
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-89
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-86
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-85
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-85
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-82
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-82
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-82
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-70
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-70
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-70
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-70
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-70
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-70
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-70
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-70
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-69
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-69
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-69
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-69
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-69
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-69
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-69
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-69
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-69
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-69
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-69
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-69
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-69
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-68
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-68
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-68
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-68
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-68
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-68
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-68
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-68
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-67
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-67
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-67
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-67
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-66
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-62
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-61
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-61
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-59
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-58
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-53
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-53
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-53
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-53
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-53
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-53
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-53
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-53
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-52
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-52
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-52
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-52
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-52
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-52
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-52
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-52
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-52
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-52
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-52
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-52
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-52
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-52
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-52
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-52
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-52
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-52
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-52
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-52
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-52
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-52
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-52
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-52
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-52
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-52
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-51
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-50
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-50
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-49
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-46
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-46
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-46
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-46
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-46
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-45
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-45
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-43
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-43
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-43
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-42
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-42
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-42
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-42
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-42
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-41
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-41
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-41
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-41
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-41
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-41
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-40
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-40
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-40
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-40
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-40
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-40
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-40
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-40
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-40
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-40
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-40
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-40
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-40
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-39
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-39
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-39
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-39
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-39
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-39
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-39
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-39
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-39
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-39
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-35
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-33
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-30
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-30
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-30
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-30
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-30
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-30
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-28
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		8e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-27
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-27
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-25
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-25
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-23
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-23
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-23
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-23
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-22
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-22
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-22
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-22
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-22
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-22
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-22
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-21
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-21
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-21
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-20
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-20
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-20
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-20
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-20
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-20
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-20
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-20
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-20
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-20
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
3soa_A	444	Full-Length Human Camkii Length = 444		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-19
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-18
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-18
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-18
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-18
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-17
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-17
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-17
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-16
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-15
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-15
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-14
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-14
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-14
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-14
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-14
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-14
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-13
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-13
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-08

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  362 bits (930), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 181/342 (52%), Positives = 241/342 (70%), Gaps = 7/342 (2%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V  +Y   I  IG GAYG+V +A    T ++VAIKKI NAFD + +A+RTLRE+K+L+
Sbjct: 50  FDVGDEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK 108
Query: 97  HMEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           H +H+N+IAIKDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLL
Sbjct: 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWY 210
           RGLKY+HSA V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWY
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           RAPEL+L+  EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A + 
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288
Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            + ++  R Y++ LP  +   + T +P     A+ LL +ML F+P+ RI+   ALRHP+L
Sbjct: 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348
Query: 331 QSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN 372
              HD +DEP C  PF F F+  + T + I+E I  E   F+
Sbjct: 349 AKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 390

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  362 bits (928), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 181/342 (52%), Positives = 241/342 (70%), Gaps = 7/342 (2%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V  +Y   I  IG GAYG+V +A    T ++VAIKKI NAFD + +A+RTLRE+K+L+
Sbjct: 51  FDVGDEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK 109
Query: 97  HMEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           H +H+N+IAIKDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLL
Sbjct: 110 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWY 210
           RGLKY+HSA V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWY
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           RAPEL+L+  EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A + 
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 289
Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            + ++  R Y++ LP  +   + T +P     A+ LL +ML F+P+ RI+   ALRHP+L
Sbjct: 290 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349
Query: 331 QSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN 372
              HD +DEP C  PF F F+  + T + I+E I  E   F+
Sbjct: 350 AKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 391

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  356 bits (914), Expect = 9e-99,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 241/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP+  
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQE 248
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 308
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 309 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  356 bits (914), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 22  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 79
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 80  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 138
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 258
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 259 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 318
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  356 bits (914), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  356 bits (913), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 313 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  356 bits (913), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  356 bits (913), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 330
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 331 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  355 bits (912), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 248
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 308
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 309 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  355 bits (912), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 76
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 255
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 315
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 316 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  355 bits (912), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 20  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 77
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 78  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 136
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 256
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 257 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 316
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 317 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  355 bits (912), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 11  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 68
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 69  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 127
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 247
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 248 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 307
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 308 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  355 bits (912), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  355 bits (911), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL   +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 313 PYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  354 bits (909), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 179/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL+++++  Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  354 bits (909), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 240/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAI+KI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  353 bits (907), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 251 DLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  353 bits (905), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 251 DLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  352 bits (904), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYXQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  352 bits (903), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 250
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 310
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 311 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  352 bits (902), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  351 bits (901), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 239/346 (69%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G  F+V  +Y   ++ IG GAYG+V +A +   +  VAIKKI + F++    +RTLRE
Sbjct: 34  VKGQPFDVGPRYTQ-LQYIGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           I++L    HENVI I+DI+R    +   DVYIV +LM+TDL+++++S QQL++DH  YFL
Sbjct: 92  IQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-QQLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLL+N +CDLKI DFGLAR        T F+TE V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y++ LP   K  +A  FP   S A+DLL++ML F+PNKRITVEEAL H
Sbjct: 271 DLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAH 330
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D  DEPV   PF F  E     ++ ++ELI++E+ +F P
Sbjct: 331 PYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  350 bits (899), Expect = 6e-97,   Method: Compositional matrix adjust.
 Identities = 177/346 (51%), Positives = 238/346 (68%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 315 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  350 bits (899), Expect = 6e-97,   Method: Compositional matrix adjust.
 Identities = 177/346 (51%), Positives = 238/346 (68%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 76
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 255
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 315
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 316 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  350 bits (898), Expect = 8e-97,   Method: Compositional matrix adjust.
 Identities = 178/346 (51%), Positives = 237/346 (68%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 252
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L    +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 253 DLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 312
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL   +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 313 PYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  348 bits (893), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 176/346 (50%), Positives = 236/346 (68%), Gaps = 7/346 (2%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP   
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 270
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
            L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL H
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 330
Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           PYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 331 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  340 bits (873), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 172/334 (51%), Positives = 224/334 (67%), Gaps = 18/334 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   MTEYV TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNA 277
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  + S  A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
           R Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+ HD N
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 338 D----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           D    EP+ P  F FD    + T   +++LIW E
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  338 bits (866), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 228/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 319 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  338 bits (866), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 170/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   PF   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPFDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  338 bits (866), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 35  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 210
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 271 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 331 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 371

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  337 bits (865), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 211
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 332 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  337 bits (865), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 26  TIWEVPERY-QNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 143
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 201
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 322 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 362

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 324 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 318 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 308 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  337 bits (865), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 171/334 (51%), Positives = 223/334 (66%), Gaps = 18/334 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   MTE V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNA 277
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  + S  A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
           R Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+ HD N
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 338 D----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           D    EP+ P  F FD    + T   +++LIW E
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  337 bits (865), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 170/334 (50%), Positives = 223/334 (66%), Gaps = 18/334 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNA 277
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  + S  A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
           R Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+ HD N
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 338 D----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           D    EP+ P  F FD    + T   +++LIW E
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 324 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 28  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 324 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 318 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 27  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 323 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 363

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  337 bits (863), Expect = 8e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 211
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 272 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 332 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  337 bits (863), Expect = 8e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 14  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 131
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 189
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 310 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 350

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  337 bits (863), Expect = 8e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  337 bits (863), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 35  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 210
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 271 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 331 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 371

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  337 bits (863), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 198
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 319 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  337 bits (863), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 314 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  337 bits (863), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 39  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 214
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 335 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 375

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  337 bits (863), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 314 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 15  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 132
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 190
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 351

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 318 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 314 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 13  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 309 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 349

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 13  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 309 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 349

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  336 bits (862), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 308 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  336 bits (861), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+    E      D  + L + E + F P P
Sbjct: 319 HDPDDEPVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  335 bits (859), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D+GLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  335 bits (859), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++   +LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQ 129
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 308 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  335 bits (858), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P    FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPTDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  335 bits (858), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 168/341 (49%), Positives = 226/341 (66%), Gaps = 6/341 (1%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 40  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 157
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  YV TRWYRAPE
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPE 215
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
           ++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    H
Sbjct: 276 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335
Query: 335 DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           D +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 336 DPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 375

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  335 bits (858), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 227/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 23  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAP 198
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+    E      D  + L + E + F P P
Sbjct: 319 HDPDDEPVA-DPYDQSSESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  335 bits (858), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 167/342 (48%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  334 bits (857), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 167/342 (48%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 12  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 187
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 308 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  334 bits (857), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P    FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPQDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  334 bits (857), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 167/342 (48%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  334 bits (856), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P    FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVAD-PRDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  334 bits (856), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  334 bits (856), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI  FGLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  334 bits (856), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 22  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 318 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  333 bits (855), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DF LAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  333 bits (855), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 18  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 314 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  333 bits (855), Expect = 8e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT  V TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  333 bits (855), Expect = 8e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  333 bits (854), Expect = 9e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 27  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 323 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 363

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  333 bits (854), Expect = 9e-92,   Method: Compositional matrix adjust.
 Identities = 169/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + PIG GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 21  TIWEVPERY-QNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  333 bits (854), Expect = 9e-92,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  333 bits (853), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 HDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  333 bits (853), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 168/342 (49%), Positives = 226/342 (66%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 21  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  332 bits (852), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 167/342 (48%), Positives = 225/342 (65%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 36  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M   V TRWYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAP 211
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 332 HDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 167/342 (48%), Positives = 225/342 (65%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++L
Sbjct: 16  TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++S Q+LTDDH Q+ +YQ
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQ 133
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGL R T   D MT YV TRWYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAP 191
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + 
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEPV   P+    E      D  + L + E + F P P
Sbjct: 312 HDPDDEPVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  327 bits (837), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 163/342 (47%), Positives = 223/342 (65%), Gaps = 6/342 (1%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
            ++EV  +Y   + P+G GAYG VC++ + ++  ++A+KK+   F +II A+RT RE++L
Sbjct: 45  TIWEVPERY-QTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 95  LRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+HM+HENVI + D+  P    + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 162
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAP
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 220
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++LN   Y   +DIWSVGCI+ E++T   LFPG D+++QL+ I  L G+P  + +  + 
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           S  AR Y+  LP+  K+ FA  F   +  AVDLLEKMLV D +KRIT  EAL HPY    
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           HD +DEP    P+   FE      +  + L + E   F   P
Sbjct: 341 HDPDDEPES-EPYDQSFESRQLEIEEWKRLTYEEVCSFETPP 381

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 149/328 (45%), Positives = 219/328 (66%), Gaps = 5/328 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N  C+L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 345
              ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EP 320
Query: 346 FHFDFEHSSCTEDHIRELIWRESVKFNP 373
           +    E    T +  +EL ++E + F P
Sbjct: 321 YDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  312 bits (800), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 148/326 (45%), Positives = 218/326 (66%), Gaps = 5/326 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++S Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 345
              ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EP 328
Query: 346 FHFDFEHSSCTEDHIRELIWRESVKF 371
           +    E    T +  +EL ++E + F
Sbjct: 329 YDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  310 bits (794), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 147/326 (45%), Positives = 217/326 (66%), Gaps = 5/326 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 345
              ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EP 328
Query: 346 FHFDFEHSSCTEDHIRELIWRESVKF 371
           +    E    T +  +EL ++E + F
Sbjct: 329 YDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  303 bits (776), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 152/348 (43%), Positives = 223/348 (64%), Gaps = 6/348 (1%)
Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + +  V    +EV + Y   ++P+G GAYG VC+AV+  T  +VAIKK+   F + + A+
Sbjct: 11  FYRQEVTKTAWEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 69
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE++LL+HM HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGED 128
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       M   V
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXV 186
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VTRWYRAPE++LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P 
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  L+SD A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  EAL
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HPY +SLHD  DEP   + +   F+    T D  + + ++E + F P
Sbjct: 307 AHPYFESLHDTEDEPQVQK-YDDSFDDVDRTLDEWKRVTYKEVLSFKP 353

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  302 bits (773), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 151/348 (43%), Positives = 214/348 (61%), Gaps = 6/348 (1%)
Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + + +V    +E+   YV P   +G GAYG VC+A++  + E+VAIKK+   F + I A+
Sbjct: 28  FYKQDVNKTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 86
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+    + +++
Sbjct: 87  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEE 144
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 202
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P 
Sbjct: 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  L    A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+T  +AL
Sbjct: 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322
Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HP+ +   D  +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 323 THPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 151/348 (43%), Positives = 214/348 (61%), Gaps = 6/348 (1%)
Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + + +V    +E+   YV P   +G GAYG VC+A++  + E+VAIKK+   F + I A+
Sbjct: 10  FYKQDVNKTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+    + +++
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEE 126
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P 
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  L    A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+T  +AL
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HP+ +   D  +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 305 THPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  261 bits (666), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 243
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 302
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 363 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  261 bits (666), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN 243
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 302
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 363 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  260 bits (665), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 28  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 204
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 205 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 263
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 264 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 323
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 324 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 358

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  260 bits (665), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 325 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  260 bits (665), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 265
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 266 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 325
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 326 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  260 bits (665), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 145/358 (40%), Positives = 215/358 (60%), Gaps = 19/358 (5%)
Query: 24  GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII 83
             ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N  
Sbjct: 1   ANQFYSVEVGDSTFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 59
Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQL 142
            A+R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L
Sbjct: 60  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MEL 117
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
             +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT
Sbjct: 118 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 177
Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 262
            YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G
Sbjct: 178 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 236
Query: 263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKM 310
           +P    +  L+    R YV   P+     F   FP+            K+S A DLL KM
Sbjct: 237 TPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 295
Query: 311 LVFDPNKRITVEEALRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           LV DP KRI+V++AL+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 296 LVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  260 bits (665), Expect = 9e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 325 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  260 bits (664), Expect = 9e-70,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 265
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 266 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 325
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 326 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 198
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 257
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 206/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 325 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 207/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 258
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 259 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 318
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 319 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 143/364 (39%), Positives = 219/364 (60%), Gaps = 50/364 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIA 105
           ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+RT REI +L  +  HEN++ 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + +++R    D   DVY+V++ M+TDLH +IR++  L   H QY +YQL++ +KY+HS  
Sbjct: 74  LLNVLRA---DNDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART------------------TSETD----FMTE 203
           +LHRD+KPSN+LLNA C +K+ DFGL+R+                  T   D     +T+
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  +I  
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249
Query: 264 PDDASLGFLRSDNARRYVRQLP------RCRKQQFATRFPNK----------SSGAVDLL 307
           P +  +  ++S  A+  +  L       +  K+   T++ N           +  A+DLL
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 308 EKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR----PFHFDFEHSSCTEDHIREL 363
           +K+L F+PNKRI+  +AL+HP++   H+ N+EP C      P + + +HS    D  R L
Sbjct: 310 DKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSI---DDYRNL 366
Query: 364 IWRE 367
           ++ E
Sbjct: 367 VYSE 370

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 145/361 (40%), Positives = 214/361 (59%), Gaps = 19/361 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 8   NQFYSVEVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 66
Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L 
Sbjct: 67  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELD 124
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 184
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YVVTR+YRAPE++L    Y A +DIWSVGCI+GE++    +F G D++ Q   + E +G+
Sbjct: 185 YVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGT 243
Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKML 311
           P    +  L+    R YV   P+    +F   FP+            K+S A DLL KML
Sbjct: 244 PSAEFMAALQP-TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKML 302
Query: 312 VFDPNKRITVEEALRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRESVK 370
           V DP+KRI+V+EALRHPY+   +D  + E   P+ +    E      +  +ELI++E + 
Sbjct: 303 VIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 362
Query: 371 F 371
           +
Sbjct: 363 W 363

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 206/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 139
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 198
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 257
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 206/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 325 YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 206/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 23  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 200 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 258
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 259 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 318
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 319 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 353

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 206/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 34  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 210
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 211 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 269
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 270 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 329
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 330 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 364

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  258 bits (659), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 204/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 145/357 (40%), Positives = 210/357 (58%), Gaps = 19/357 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 6   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 64
Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L 
Sbjct: 65  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELD 122
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART S    MT 
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTP 182
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E +G+
Sbjct: 183 YVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 241
Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKML 311
           P    +  L+    R YV   P      F   FP+            K+S A DLL KML
Sbjct: 242 PSAEFMAALQP-TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKML 300
Query: 312 VFDPNKRITVEEALRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           V DP+KRI+V+EALRHPY+   +D  + E   P+ +    E      +  +ELI++E
Sbjct: 301 VIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 357

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  257 bits (657), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 204/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  257 bits (656), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 203/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  256 bits (654), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 204/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 265
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 326 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 360

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  256 bits (654), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 205/335 (61%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P  A +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  256 bits (653), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 203/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  256 bits (653), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 141/335 (42%), Positives = 204/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  255 bits (652), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 203/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  254 bits (649), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 133/302 (44%), Positives = 191/302 (63%), Gaps = 17/302 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 324
Query: 334 HD 335
           +D
Sbjct: 325 YD 326

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  254 bits (649), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 142/344 (41%), Positives = 206/344 (59%), Gaps = 18/344 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT  VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 376
           +D ++ E   P+      +    T +  +ELI++E +     PT
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLPKRPT 368

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  254 bits (649), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 139/335 (41%), Positives = 202/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVG I+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 139/335 (41%), Positives = 203/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 31  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 148
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M  +VVTR+YRAPE++L    Y   
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKEN 207
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 208 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 266
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 267 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 326
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 327 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 361

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 139/335 (41%), Positives = 204/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  251 bits (641), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 132/297 (44%), Positives = 189/297 (63%), Gaps = 17/297 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +     F   FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+
Sbjct: 265 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  251 bits (640), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 138/335 (41%), Positives = 201/335 (60%), Gaps = 18/335 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIV AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIWSVG I+GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRP 264
Query: 286 RCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           +     F   FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   
Sbjct: 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324
Query: 334 HDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
           +D ++ E   P+      +    T +  +ELI++E
Sbjct: 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/343 (38%), Positives = 193/343 (56%), Gaps = 59/343 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G+YG VC A +   +  VAIKKI   F+++ID +R LREI +L  + H++V+ + DI
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           + P   + F+++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHR
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTS--------------ETDF--------------M 201
           DLKP+N L+N  C +K+ DFGLART                E D               +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPG--- 247
           T +VVTRWYRAPEL+L    YT AID+WS+GCI  E++            R PLFPG   
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 248 -----------------KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 290
                            +    QL +I  ++G+P +  +  L  ++A+RY+R  P+    
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360
Query: 291 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
             A RFP  S+ A+ LL++MLVF+PNKRIT+ E L HP+ + +
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 134/377 (35%), Positives = 203/377 (53%), Gaps = 52/377 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG+YG V  A +  T + VAIKK+   F+++ID +R LREI +L  ++ + +I + D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I P     F+++YIV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + ++HR
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-TSETDF----------------------MTEYVV 206
           DLKP+N LLN  C +K+ DFGLART  SE D                       +T +VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPGKD------ 249
           TRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG        
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 250 -----YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 298
                 VH      QL +I  +IG+P +  L  +      +Y++  P  +      ++P+
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
Query: 299 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTE 357
            S   ++LLE ML F+PNKRIT+++AL HPYL+ +     E    +     F+     +E
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSE 393
Query: 358 DHIRELIWRESVKFNPD 374
             +R +  +E   F+P+
Sbjct: 394 TQLRYIFLKEVQSFHPE 410

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 134/339 (39%), Positives = 193/339 (56%), Gaps = 18/339 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---- 80
           G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N       
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 81  -NIID----ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
            NI+      +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 136 IRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           I  DQ++  +  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF LAR
Sbjct: 124 IH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
             +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  + +Q
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEKMLV 312
           L  I E++G+P    +    S +AR Y+R  L     + +    P     A+DL+ KML 
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302
Query: 313 FDPNKRITVEEALRHPYLQSLHDLND--EPVCPRPFHFD 349
           F+P +RI+ E+ALRHPY +SL D  D  E +  R FHFD
Sbjct: 303 FNPQRRISTEQALRHPYFESLFDPLDLTEGLSER-FHFD 340

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 134/339 (39%), Positives = 193/339 (56%), Gaps = 18/339 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---- 80
           G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N       
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 81  -NIID----ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
            NI+      +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 136 IRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           I  DQ++  +  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF LAR
Sbjct: 124 IH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
             +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  + +Q
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEKMLV 312
           L  I E++G+P    +    S +AR Y+R  L     + +    P     A+DL+ KML 
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302
Query: 313 FDPNKRITVEEALRHPYLQSLHDLND--EPVCPRPFHFD 349
           F+P +RI+ E+ALRHPY +SL D  D  E +  R FHFD
Sbjct: 303 FNPQRRISTEQALRHPYFESLFDPLDLTEGLSER-FHFD 340

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 133/380 (35%), Positives = 198/380 (52%), Gaps = 55/380 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG+YG V  A +    + VAIKK+   F+++ID +R LREI +L  ++ + +I + D+
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I P     F+++YIV E+ D+DL ++ ++   LT+ H +  LY LL G K++H + ++HR
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-TSETDF-------------------------MTE 203
           DLKP+N LLN  C +KI DFGLART  S+ D                          +T 
Sbjct: 156 DLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPGKD--- 249
           +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG     
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 250 --------YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 295
                    VH      QL +I  +IG+P +  L  +      +Y++  P       + +
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKK 335
Query: 296 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SS 354
           + + S   +DLLE ML F+  KRIT+++AL HPYL+ +   N E          F+    
Sbjct: 336 YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMV 395
Query: 355 CTEDHIRELIWRESVKFNPD 374
            +E  +R +  +E   F+ D
Sbjct: 396 LSETQLRYIFLKEIQSFHAD 415

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  221 bits (564), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 130/325 (40%), Positives = 190/325 (58%), Gaps = 21/325 (6%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N++G  F++ S+Y+  ++P+G G  G+V +AV+++  + VAIKKI     +    +  LR
Sbjct: 3   NIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQ 141
           EIK++R ++H+N++ + +I+ P               N VYIV E M+TDL  ++     
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP- 116
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT----S 196
           L ++H + F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR      S
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
               ++E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++L
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           I E I    +     L S     Y+R       +      P  S  AVD LE++L F P 
Sbjct: 237 ILESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295
Query: 317 KRITVEEALRHPYLQSLHDLNDEPV 341
            R+T EEAL HPY+       DEP+
Sbjct: 296 DRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  204 bits (520), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 75  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 247
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 72  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 244
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +D DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 159/288 (55%), Gaps = 10/288 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 72  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 244
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 159/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  202 bits (513), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 159/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  202 bits (513), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+ KI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  202 bits (513), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+ KI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  201 bits (512), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 159/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  201 bits (511), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 159/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  200 bits (509), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 75  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 247
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  200 bits (508), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 113/290 (38%), Positives = 160/290 (55%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 174/300 (58%), Gaps = 31/300 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  +G G YG+V  A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N+++
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVS 83
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSA 164
           + D+I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H  
Sbjct: 84  LIDVIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY--V 281
            ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P           N R +  V
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-----------NPREWPQV 247
Query: 282 RQLPRCRKQQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++LP  +++ F        ++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 174/300 (58%), Gaps = 31/300 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  +G G YG+V  A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N+++
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVS 83
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSA 164
           + D+I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H  
Sbjct: 84  LIDVIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY--V 281
            ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P           N R +  V
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-----------NPREWPQV 247
Query: 282 RQLPRCRKQQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++LP  +++ F        ++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 110/287 (38%), Positives = 158/287 (55%), Gaps = 11/287 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 68
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   K  T     +V+E +D DL Q +     + + H  + FL+QLLRGL Y H   VLH
Sbjct: 69  IHTEKSLT-----LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++LL  T+Y+  ID
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPR 286
           +W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L ++  + Y    P+
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPK 241
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            R +   +  P   S   DLL K+L F+   RI+ E+A++HP+  SL
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 111/304 (36%), Positives = 172/304 (56%), Gaps = 22/304 (7%)
Query: 40  SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHM 98
           SS     +  +G G Y  V   +N  T   VA+K++    D+      T +REI L++ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKEL 60
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLY 152
           +HEN++ + D+I      T N + +V+E MD DL + + S       + L  +  +YF +
Sbjct: 61  KHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYR 211
           QLL+GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WYR
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA---S 268
           AP++L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI +++G+P+++   S
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 269 LGFLRSDNARRYVRQLPRCRKQ--QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
           +  L   N     R  PR  +Q  Q  T+ P      +D L  +L  +P+ R++ ++AL 
Sbjct: 236 VTKLPKYNPNIQQRP-PRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH 293
Query: 327 HPYL 330
           HP+ 
Sbjct: 294 HPWF 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 108/290 (37%), Positives = 157/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D++   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +
Sbjct: 67  HDVLHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N + +LK+ DFGLAR         +  VVT WYR P++L     Y+ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 225 AIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
           +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +      +    
Sbjct: 182 SIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P           P  ++   DLL+ +L  +P +RI+ EEAL+HPY    
Sbjct: 242 YP--ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 155/287 (54%), Gaps = 10/287 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNF 238
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 155/287 (54%), Gaps = 10/287 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNF 238
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 106/287 (36%), Positives = 155/287 (54%), Gaps = 10/287 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNF 238
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 157/290 (54%), Gaps = 10/290 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D++   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +
Sbjct: 67  HDVLHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L     Y+ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
           +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +      +    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            P           P  ++   DLL+ +L  +P +RI+ EEAL+HPY    
Sbjct: 242 YP--ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 168/294 (57%), Gaps = 7/294 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G+YG+V    N +T + VAIKK   + D+ +  +  LREI++L+ ++H N++ +
Sbjct: 8   IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++ R  ++     +++V+E  D T LH++ R  + + +   +   +Q L+ + + H  +
Sbjct: 68  LEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PELL+  T+Y  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W++GC+  E+++  PL+PGK  V QL LI + +G           ++     V+  
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
                +    +FPN S  A+ LL+  L  DP +R+T E+ L HPY +++ ++ D
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 157/303 (51%), Gaps = 17/303 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +G G +  V  A +  T + VAIKKI       A D I   R  LREIKLL+ + H N+I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
            + D          +++ +V++ M+TDL  II+ +   LT  H + ++   L+GL+Y+H 
Sbjct: 76  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLKP+NLLL+ +  LK+ DFGLA++  S        VVTRWYRAPELL     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +     + S       +
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 342
             P          F       +DL++ + +F+P  RIT  +AL+  Y  +          
Sbjct: 251 SFPGIPLHHI---FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307
Query: 343 PRP 345
           PRP
Sbjct: 308 PRP 310

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 157/292 (53%), Gaps = 14/292 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G G YG V  A+++ T E VAIK+I    +        +RE+ LL+ ++H N+I +
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G+ + HS   
Sbjct: 99  KSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 167 LHRDLKPSNLLLNASCD-----LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCT 220
           LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR PE+LL   
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I E++G PDD +   + +     +
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA--LPDW 271
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            +  P+ R +              +DLL  ML  DP KRI+ + AL HPY  
Sbjct: 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 101/300 (33%), Positives = 166/300 (55%), Gaps = 9/300 (3%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           NL+  S +    +  +G G+YG+V    N +T   VAIKK   + D+ +  +  +REIKL
Sbjct: 18  NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL 77
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+ + HEN++ + ++ +  K+      Y+V+E +D T L  +      L     Q +L+Q
Sbjct: 78  LKQLRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRA 212
           ++ G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRA
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PELL+   +Y  A+D+W++GC++ E+   EPLFPG   + QL  I   +G+         
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 273 RSDNARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +     VR LP  ++++    R+P  S   +DL +K L  DP+KR    E L H + Q
Sbjct: 253 NKNPVFAGVR-LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 110/296 (37%), Positives = 158/296 (53%), Gaps = 17/296 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HEN 102
           +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H N
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKY 160
           V+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 194
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D  R  
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 281 V--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
              RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q L
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 158/297 (53%), Gaps = 17/297 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HEN 102
           +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H N
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKY 160
           V+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 194
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D  R  
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 281 V--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
              RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q L 
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 108/327 (33%), Positives = 175/327 (53%), Gaps = 23/327 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   E+ +EVAIKK+      + D R   RE++++R ++H NV+ +K  
Sbjct: 48  IGNGSFGVVFQAKLVES-DEVAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 110 IRPPKKDTFNDVYI--VYELMDTDLHQIIRSDQQLTDDH----CQYFLYQLLRGLKYVHS 163
                 D  ++V++  V E +   +++  R   +L         + ++YQLLR L Y+HS
Sbjct: 101 FYS-NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             + HRD+KP NLLL+  S  LK+ DFG A+     +     + +R+YRAPEL+   T Y
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
           T  IDIWS GC++ E+M  +PLFPG+  + QL  I +++G+P       +++ N      
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ---IKTMNPNYMEH 276
Query: 283 QLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD----LN 337
           + P+ R   F+  F P     A+DL+ ++L + P+ R+T  EAL HP+   L      + 
Sbjct: 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMP 336
Query: 338 DEPVCPRPFHFDFEHSSCTEDHIRELI 364
           +    P  F++  E  S   D I  L+
Sbjct: 337 NGRELPPLFNWTKEELSVRPDLISRLV 363

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 109/294 (37%), Positives = 157/294 (53%), Gaps = 17/294 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HEN 102
           +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H N
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKY 160
           V+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 194
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D  R  
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 281 V--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
              RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 102/338 (30%), Positives = 179/338 (52%), Gaps = 48/338 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            E SSK     + +G G++GIVC   + E+ +  A+KK+      + D R   RE+ +++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMK 55
Query: 97  HMEHENVIAIKDII--------RPP-----------KKDTFND--------------VYI 123
            ++H N+I + D          +PP           K +  N+              + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 124 VYELMDTDLHQI----IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           + E +   LH++    IRS + +  +    ++YQL R + ++HS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 180 ASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
           +  + LK+ DFG A+    ++     + +R+YRAPEL+L  TEYT +ID+WS+GC+ GE+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 239 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 298
           +  +PLF G+  + QL  I +++G+P    +  +R +     VR  P  + + +    P 
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPE 292
Query: 299 KS-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
            + S A+DLLE++L ++P+ RI   EA+ HP+   L +
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 157/311 (50%), Gaps = 23/311 (7%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI---GNAFDNIIDARRTLR 90
           G L  +++    P+  IG GAYG V  A +  +   VA+K +               T+R
Sbjct: 1   GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 91  EIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDD 145
           E+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P 
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRIT 320
           +        D+  R V  LPR        R      P        LL +ML F+P+KRI+
Sbjct: 240 E--------DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 321 VEEALRHPYLQ 331
              AL+H YL 
Sbjct: 291 AFRALQHSYLH 301

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 160/305 (52%), Gaps = 25/305 (8%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y  P+  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +     
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE----- 232
Query: 272 LRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
              D+  R V  LPR        R      P        LL +ML F+P+KRI+   AL+
Sbjct: 233 ---DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288
Query: 327 HPYLQ 331
           H YL 
Sbjct: 289 HSYLH 293

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 160/305 (52%), Gaps = 25/305 (8%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y  P+  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +     
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE----- 232
Query: 272 LRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
              D+  R V  LPR        R      P        LL +ML F+P+KRI+   AL+
Sbjct: 233 ---DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288
Query: 327 HPYLQ 331
           H YL 
Sbjct: 289 HSYLH 293

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 160/305 (52%), Gaps = 25/305 (8%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y  P+  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +     
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE----- 232
Query: 272 LRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
              D+  R V  LPR        R      P        LL +ML F+P+KRI+   AL+
Sbjct: 233 ---DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288
Query: 327 HPYLQ 331
           H YL 
Sbjct: 289 HSYLH 293

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 164/300 (54%), Gaps = 26/300 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N  
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPN 253
Query: 279 RYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
               + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 163/300 (54%), Gaps = 26/300 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N  
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPN 253
Query: 279 RYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
                 P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 254 YTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 161 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 218 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 277
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 278 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 334
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 335 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 392

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 95  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 152 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 211
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 268
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 269 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 326

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 120 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 177 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 236
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 237 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 293
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 294 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 351

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 118 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 175 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 235 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 291
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 292 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 349

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 116 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 289
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 110 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 167 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 226
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 283
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 284 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 341

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 163/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 87  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 144 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 260
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 261 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 318

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 162/300 (54%), Gaps = 26/300 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N  
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPN 253
Query: 279 RYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
                 P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 254 YTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/304 (34%), Positives = 165/304 (54%), Gaps = 15/304 (4%)
Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           SKY   +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 101 ENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLR 156
           ENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  LL 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYR 211
           GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
            PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS       +
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--W 254
Query: 272 LRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
              DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 329 YLQS 332
           +  S
Sbjct: 315 FFWS 318

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/304 (34%), Positives = 165/304 (54%), Gaps = 15/304 (4%)
Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           SKY   +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 101 ENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLR 156
           ENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  LL 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYR 211
           GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
            PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS       +
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--W 254
Query: 272 LRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
              DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 329 YLQS 332
           +  S
Sbjct: 315 FFWS 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/304 (34%), Positives = 165/304 (54%), Gaps = 15/304 (4%)
Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           SKY   +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++H
Sbjct: 17  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 101 ENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLR 156
           ENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  LL 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYR 211
           GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
            PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS       +
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--W 253
Query: 272 LRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
              DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL H 
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 329 YLQS 332
           +  S
Sbjct: 314 FFWS 317

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 106/305 (34%), Positives = 167/305 (54%), Gaps = 17/305 (5%)
Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           SKY   +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++H
Sbjct: 18  SKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 101 ENVIAIKDIIRPPKKDTFN----DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLL 155
           ENV+ + +I R  K   +N     +Y+V++  + DL  ++ +   + T    +  +  LL
Sbjct: 77  ENVVNLIEICRT-KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWY 210
            GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WY
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           R PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS       
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV-- 253
Query: 271 FLRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRH 327
           +   DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL H
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 328 PYLQS 332
            +  S
Sbjct: 314 DFFWS 318

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 86  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 143 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 202
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 259
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 260 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 94  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 267
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 268 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 83  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 140 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 199
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 256
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 257 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 314

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 101 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 158 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 217
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 274
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 275 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 332

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 255
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 90  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 147 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 263
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 264 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 321

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 116 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 232
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 289
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 160/296 (54%), Gaps = 18/296 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHS 163
                 KKD    + +V + +   ++++ R    + Q L   + + ++YQL R L Y+HS
Sbjct: 82  FYSSGEKKDVVY-LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
           T++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEF 257
Query: 283 QLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
           + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 94  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYT 267
Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 268 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 155/304 (50%), Gaps = 25/304 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVI 104
           R  G+G +G V       T   VAIKK+      I D R   RE+++++ +    H N++
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 105 AIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS--DQQLTDDHC--QYFLYQLLRGL 158
            ++       +    D+Y  +V E +   LH+  R+   +Q+       + FL+QL+R +
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 159 KYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
             +H  S +V HRD+KP N+L+N A   LK+ DFG A+  S ++    Y+ +R+YRAPEL
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPEL 202
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     YT A+DIWSVGCI  E+M  EP+F G +   QL  I  ++G P   S   LR  
Sbjct: 203 IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP---SREVLRKL 259
Query: 276 NARRYVRQLPRCRKQQFATRFPNKS----SGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           N       L   +   ++  F + S      A DLL  +L + P +R+   EAL HPY  
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 332 SLHD 335
            LHD
Sbjct: 320 ELHD 323

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 156/303 (51%), Gaps = 33/303 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIA 105
           +R +GRG Y  V  A+N    E+V +K +     N I      REIK+L ++    N+I 
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPNIIT 96
Query: 106 IKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS 
Sbjct: 97  LADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 165 SVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLG 270
            ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D    
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 270
Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 271 DILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 331 QSL 333
            ++
Sbjct: 325 YTV 327

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 104/316 (32%), Positives = 157/316 (49%), Gaps = 42/316 (13%)
Query: 50  IGRGAYGIV--CAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V      + +  ++ A+K+I     ++       REI LLR ++H NVI+++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQ 84
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+  +         QL     +  LYQ+L G+
Sbjct: 85  KVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--------PGKDYVH-QLRLITELI 261
           RAPELLL    YT AIDIW++GCI  E++T EP+F            Y H QL  I  ++
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 262 GSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFPNK-SSGAVDLLEKMLVFD 314
           G P D     ++     S   + + R     C   ++  +   K  S A  LL+K+L  D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321
Query: 315 PNKRITVEEALRHPYL 330
           P KRIT E+A++ PY 
Sbjct: 322 PIKRITSEQAMQDPYF 337

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 82  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 240
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 241 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 75  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 233
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 234 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 234
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 235 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 234
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 235 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 234
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 235 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAI+ I      I  AR          EI++L+ + H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 201 CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 359
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 360 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAI+ I      I  AR          EI++L+ + H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 215 CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 218 NC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++             + 
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TS 373
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
               ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 374 GKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
            D+WS G IL  +++  P F GK+                      L+     +Y   LP
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKN------------------EYDILKRVETGKYAFDLP 244
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 245 QWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
            D+WS G IL  +++  P F GK+                      L+     +Y   LP
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKN------------------EYDILKRVETGKYAFDLP 244
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 245 QWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 140/286 (48%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
            D+WS G IL  +++  P F GK+    L+ +                     +Y   LP
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRV------------------ETGKYAFDLP 244
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 245 QWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 155/302 (51%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+VA+K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVAVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N+L++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/318 (29%), Positives = 161/318 (50%), Gaps = 39/318 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRS 274
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS     F+  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSX 335
Query: 275 DNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVF 313
               RY           V    R R+ +      +  + N   G      +D L++ L +
Sbjct: 336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395
Query: 314 DPNKRITVEEALRHPYLQ 331
           DP  R+T  +ALRHP+L+
Sbjct: 396 DPAVRMTPGQALRHPWLR 413

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/318 (29%), Positives = 161/318 (50%), Gaps = 39/318 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRS 274
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS     F+  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSX 335
Query: 275 DNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVF 313
               RY           V    R R+ +      +  + N   G      +D L++ L +
Sbjct: 336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395
Query: 314 DPNKRITVEEALRHPYLQ 331
           DP  R+T  +ALRHP+L+
Sbjct: 396 DPAVRMTPGQALRHPWLR 413

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 94/318 (29%), Positives = 160/318 (50%), Gaps = 39/318 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRS 274
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS     F+  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSX 335
Query: 275 DNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVF 313
               RY           V    R R+ +      +  + N   G      +D L++ L +
Sbjct: 336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395
Query: 314 DPNKRITVEEALRHPYLQ 331
           DP  R+T  +ALRHP+L+
Sbjct: 396 DPAVRMTPGQALRHPWLR 413

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 158/296 (53%), Gaps = 25/296 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E V +K +          +R ++ ++ LR     N+I +
Sbjct: 43  VRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNIIKL 98
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y HS  
Sbjct: 99  IDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKG 152
Query: 166 VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 153 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 212
Query: 225 AIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS------DNA 277
           ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+        + 
Sbjct: 213 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHF 270
Query: 278 RRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
              + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY 
Sbjct: 271 NDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 158/296 (53%), Gaps = 25/296 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E V +K +          +R ++ ++ LR     N+I +
Sbjct: 48  VRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNIIKL 103
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y HS  
Sbjct: 104 IDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKG 157
Query: 166 VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 158 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 217
Query: 225 AIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS------DNA 277
           ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+        + 
Sbjct: 218 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHF 275
Query: 278 RRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
              + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY 
Sbjct: 276 NDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 95
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 96  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 270 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 332 SL 333
           ++
Sbjct: 324 TV 325

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 96
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 97  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 271 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 332 SL 333
           ++
Sbjct: 325 TV 326

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 96
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 97  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 271 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 332 SL 333
           ++
Sbjct: 325 TV 326

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 47  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 102
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 103 ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 156
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 157 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 216
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 217 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 276
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 277 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 330
Query: 332 SL 333
           ++
Sbjct: 331 TV 332

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 152/299 (50%), Gaps = 31/299 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLGF 271
           ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D     
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 272 ILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 332 SL 333
           ++
Sbjct: 326 TV 327

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 146/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L   M   N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLMGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 37  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 92
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 93  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 267
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 268 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321
Query: 333 L 333
           +
Sbjct: 322 V 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 57  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 112
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 113 LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 167
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 168 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 227
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 228 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEAL 287
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 288 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341
Query: 333 L 333
           +
Sbjct: 342 V 342

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 37  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 92
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 93  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 267
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 268 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321
Query: 333 L 333
           +
Sbjct: 322 V 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 38  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 93
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 94  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 148
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 149 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 208
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 209 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 268
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 269 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322
Query: 333 L 333
           +
Sbjct: 323 V 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 29/301 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DASLGFL 272
           +D+WS+GC+  G I  +EP F G D   QL  I +++G+              D  L  L
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEAL 266
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ HPY Q 
Sbjct: 267 VGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 333 L 333
           +
Sbjct: 321 V 321

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 139/297 (46%), Gaps = 38/297 (12%)
Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           S+    ++ +G GAYG V    +  T  E AIK I     +     + L E+ +L+ ++H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 101 ENVIAIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            N++ + D     +      + Y   EL D  +H++     +  +      + Q+L G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVT 150
Query: 160 YVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+H  +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               +Y    D+WS+G IL  ++   P F G+     LR + +                 
Sbjct: 211 RK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK----------------- 251
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
             +Y    P          + N S GA DL+++ML FD  +RI+ ++AL HP+++ +
Sbjct: 252 -GKYTFDSPE---------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 146/297 (49%), Gaps = 42/297 (14%)
Query: 39  VSSKYVPP--IR-PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKL 94
           +S +++ P  IR  +G G++G V  A + +T+++VA+K I        D   R  REI  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           L+ + H ++I + D+I  P      D+ +V E    +L   I   +++T+D  + F  Q+
Sbjct: 63  LKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           +  ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++         +D+WS G +L  ++           V +L    E I +         + 
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVML-----------VGRLPFDDEFIPN-------LFKK 219
Query: 275 DNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            N+  YV               P+  S GA  L+ +M+V DP +RIT++E  R P+ 
Sbjct: 220 VNSCVYV--------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 98  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 209
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WS G IL  +++  P F G +                      L+     +Y
Sbjct: 210 -YDEKCDVWSTGVILYILLSGCPPFNGAN------------------EYDILKKVEKGKY 250
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +LP+ +K          S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 251 TFELPQWKKV---------SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 140/292 (47%), Gaps = 43/292 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 116 YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 227
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WS G IL  +++  P F G +    L+ + +                   +Y
Sbjct: 228 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------------GKY 268
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +LP+ +K          S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 269 TFELPQWKKV---------SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 311

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 140/292 (47%), Gaps = 43/292 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WS G IL  +++  P F G +    L+ + +                   +Y
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------------GKY 244
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +LP+ +K          S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 245 TFELPQWKKV---------SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 140/292 (47%), Gaps = 43/292 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 115 YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 226
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WS G IL  +++  P F G +    L+ + +                   +Y
Sbjct: 227 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------------GKY 267
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +LP+ +K          S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 268 TFELPQWKKV---------SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 310

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 138/286 (48%), Gaps = 37/286 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 13  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 73  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS G IL  ++ R   F                   DD S+  L   N    V  LP
Sbjct: 188 VDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NISNGVYTLP 227
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 228 KFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 138/286 (48%), Gaps = 37/286 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 69  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS G IL  ++ R   F                   DD S+  L   N    V  LP
Sbjct: 184 VDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NISNGVYTLP 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 224 KFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 138/286 (48%), Gaps = 37/286 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 78  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS G IL  ++ R   F                   DD S+  L   N    V  LP
Sbjct: 193 VDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NISNGVYTLP 232
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 233 KFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 138/286 (48%), Gaps = 37/286 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 19  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 79  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS G IL  ++ R   F                   DD S+  L   N    V  LP
Sbjct: 194 VDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NISNGVYTLP 233
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 234 KFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 95/330 (28%), Positives = 161/330 (48%), Gaps = 54/330 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 116
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 165 --SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL   
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  AR++
Sbjct: 235 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKF 291
Query: 281 VRQLP---------RCRKQQF-------------------ATRFPNKSSGAV-------D 305
             +LP         +  K+++                     R   +S   V       D
Sbjct: 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351
Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           L+ +ML +DP  RI    AL+H + +   D
Sbjct: 352 LILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 163/333 (48%), Gaps = 60/333 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 116
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 165 --SVLHRDLKPSNLLLNASCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
             S++H DLKP N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL
Sbjct: 177 ELSIIHCDLKPENILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLL 231
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  A
Sbjct: 232 GMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKA 288
Query: 278 RRYVRQLP---------RCRKQQF-------------------ATRFPNKSSGAV----- 304
           R++  +LP         +  K+++                     R   +S   V     
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 305 --DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
             DL+ +ML +DP  RI    AL+H + +   D
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/327 (27%), Positives = 148/327 (45%), Gaps = 50/327 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  +G GA+G V   ++ +     VA+K + N  D   +A R+  EI++L H+   N   
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTD 72
Query: 106 IKDIIRPPKK----DTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLK 159
                R  +     +    + IV+EL+    +  I+ +  L    DH +   YQ+ + + 
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 160 YVHSASVLHRDLKPSNLLLNAS-------------------CDLKIGDFGLARTTSETDF 200
           ++HS  + H DLKP N+L   S                    D+K+ DFG A  T + + 
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEH 190
Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 260
            +  V TR YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  +
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 261 IGSPDDASLGFLRS--------------DNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 306
           +G      +   R                +A RYV +  +  K+ F      +     DL
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDL 308
Query: 307 LEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++KML +DP KRIT+ EAL+HP+   L
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 95/330 (28%), Positives = 161/330 (48%), Gaps = 54/330 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 97
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 157
Query: 165 --SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL   
Sbjct: 158 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP 215
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  AR++
Sbjct: 216 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKF 272
Query: 281 VRQLP---------RCRKQQF-------------------ATRFPNKSSGAV-------D 305
             +LP         +  K+++                     R   +S   V       D
Sbjct: 273 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 332
Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           L+ +ML +DP  RI    AL+H + +   D
Sbjct: 333 LILRMLDYDPKTRIQPYYALQHSFFKKTAD 362

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 136/292 (46%), Gaps = 43/292 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N+  +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y H 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +    + + T +Y APE+L    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT- 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    D+WS G IL  +++  P F G +    L+ + +                   +Y
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------------GKY 244
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +LP+ +K          S  A DL+ K L + P+ RI+  +AL H ++Q+
Sbjct: 245 TFELPQWKKV---------SESAKDLIRKXLTYVPSXRISARDALDHEWIQT 287

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A    T +  A+K I       +  + +    EI +LR ++HEN++A++
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPK---KALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI   P     N +Y+V +L+   +L   I      T+      + Q+L  + Y+H   +
Sbjct: 87  DIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL    +    + I DFGL++   + D M+    T  Y APE+L     Y+
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQ-KPYS 200
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+D WS+G I   ++   P F                             +N  +   Q
Sbjct: 201 KAVDCWSIGVIAYILLCGYPPF---------------------------YDENDSKLFEQ 233
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
           + +   +  +  + + S  A D +  ++  DPNKR T E+A RHP++     LN
Sbjct: 234 ILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALN 287

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/327 (27%), Positives = 147/327 (44%), Gaps = 50/327 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  +G GA+G V   ++ +     VA+K + N  D   +A R+  EI++L H+   N   
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTD 72
Query: 106 IKDIIRPPKK----DTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLK 159
                R  +     +    + IV+EL+    +  I+ +  L    DH +   YQ+ + + 
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 160 YVHSASVLHRDLKPSNLLLNAS-------------------CDLKIGDFGLARTTSETDF 200
           ++HS  + H DLKP N+L   S                    D+K+ DFG A  T + + 
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEH 190
Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 260
            +  V  R YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  +
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 261 IGSPDDASLGFLRS--------------DNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 306
           +G      +   R                +A RYV +  +  K+ F      +     DL
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDL 308
Query: 307 LEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++KML +DP KRIT+ EAL+HP+   L
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 144/285 (50%), Gaps = 37/285 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I+   +++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 74  IQ---EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIW+ G IL  ++   P F  +D   Q RL  ++                A  Y    P
Sbjct: 188 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP 229
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 230 -----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 144/285 (50%), Gaps = 37/285 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 74  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIW+ G IL  ++   P F  +D   Q RL  ++                A  Y    P
Sbjct: 188 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP 229
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 230 -----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 144/285 (50%), Gaps = 37/285 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 73  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 186
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIW+ G IL  ++   P F  +D   Q RL  ++                A  Y    P
Sbjct: 187 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP 228
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 229 -----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 137/292 (46%), Gaps = 45/292 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G GAYG V    +  T  E AIK I  ++     ++   L E+ +L+ ++H N++ 
Sbjct: 26  VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L G  Y+H  
Sbjct: 86  LYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L    +
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--K 198
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y    D+WS G IL  ++   P F G+                 D  +            
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI------------ 230
Query: 282 RQLPRCRKQQFATRFPN---KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             L R  K +F+   P+    S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 231 --LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 133/305 (43%), Gaps = 49/305 (16%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           +   + FEV S+       +GRGA  IV       T++  A+K         +D +    
Sbjct: 49  DALSDFFEVESE-------LGRGATSIVYRCKQKGTQKPYALK----VLKKTVDKKIVRT 97
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY 149
           EI +L  + H N+I +K+I   P      ++ +V EL+   +L   I      ++     
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVV 206
            + Q+L  + Y+H   ++HRDLKP NLL         LKI DFGL++       M     
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD 265
           T  Y APE+L  C  Y   +D+WSVG I   ++   EP +                   D
Sbjct: 213 TPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFY-------------------D 252
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
           +    F+         R++  C     +  +   S  A DL+ K++V DP KR+T  +AL
Sbjct: 253 ERGDQFM--------FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 326 RHPYL 330
           +HP++
Sbjct: 305 QHPWV 309

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 144/285 (50%), Gaps = 37/285 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 97  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 210
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +DIW+ G IL  ++   P F  +D   Q RL  ++                A  Y    P
Sbjct: 211 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP 252
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 253 -----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 144/314 (45%), Gaps = 45/314 (14%)
Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHME 99
           +Y+     IG G+ GIVC A    T ++VA+KK+    D     RR L   E+ ++R   
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYH 100
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H+NV+ +            +++++V E ++      I +  ++ ++        +LR L 
Sbjct: 101 HDNVVDMYS-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS 155
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+H+  V+HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ APE +++
Sbjct: 156 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VIS 214
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              Y   +DIWS+G ++ E++  EP +  +  +  +R I + +                 
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLP---------------- 258
Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
                 PR +           SS     L+ MLV +P++R T +E L HP+L+    L  
Sbjct: 259 ------PRVKD------LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLK----LAG 302
Query: 339 EPVCPRPFHFDFEH 352
            P C  P    + H
Sbjct: 303 PPSCIVPLMRQYRH 316

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 137/292 (46%), Gaps = 45/292 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G GAYG V    +  T  E AIK I  ++     ++   L E+ +L+ ++H N++ 
Sbjct: 9   VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L G  Y+H  
Sbjct: 69  LYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L    +
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--K 181
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y    D+WS G IL  ++   P F G+                 D  +            
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI------------ 213
Query: 282 RQLPRCRKQQFATRFPN---KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             L R  K +F+   P+    S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 214 --LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 140/303 (46%), Gaps = 52/303 (17%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDAS 268
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+   
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE--- 252
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                                      + + S    DL+ + LV  P KR T EEAL HP
Sbjct: 253 ---------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285
Query: 329 YLQ 331
           + Q
Sbjct: 286 FFQ 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 140/303 (46%), Gaps = 52/303 (17%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 8   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 67
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 68  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 122
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDAS 268
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+   
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE--- 239
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                                      + + S    DL+ + LV  P KR T EEAL HP
Sbjct: 240 ---------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 272
Query: 329 YLQ 331
           + Q
Sbjct: 273 FFQ 275

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 151/326 (46%), Gaps = 49/326 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + ++Q+L  + ++H   ++H
Sbjct: 99  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVH 153
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL + C    +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 212
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIW+ G IL  ++   P F  +D   Q +L  ++     D                  
Sbjct: 213 PVDIWACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD-----------------F 252
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR 344
           P     ++ T  P     A +L+ +ML  +P KRIT ++AL+HP+           VC R
Sbjct: 253 P---SPEWDTVTPE----AKNLINQMLTINPAKRITADQALKHPW-----------VCQR 294
Query: 345 PFHFDFEHSSCTEDHIRELIWRESVK 370
                  H   T + +R+   R  +K
Sbjct: 295 STVASMMHRQETVECLRKFNARRKLK 320

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAI 106
           +P+G G++ I    V+ ++ +  A+K I    +       T +EI  L+  E H N++ +
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKL 71
Query: 107 KDIIRPPKKDTFND---VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            ++        F+D    ++V EL++  +L + I+  +  ++    Y + +L+  + ++H
Sbjct: 72  HEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 163 SASVLHRDLKPSNLLL---NASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLN 218
              V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y APE LLN
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLN 182
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              Y  + D+WS+G IL  +++ +  F   D                       RS    
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHD-----------------------RSLTCT 219
Query: 279 RYVRQLPRCRKQQFA---TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
             V  + + +K  F+     + N S  A DL++ +L  DPNKR+ +     + +LQ    
Sbjct: 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 336 LNDEPV 341
           L+  P+
Sbjct: 280 LSSNPL 285

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDW---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA+ +V   V   T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 126
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL + C    +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EAYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIW+ G IL  ++   P F  +D   Q +L  ++     D                  
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD-----------------F 225
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P     ++ T  P     A +L+ +ML  +P KRIT  EAL+HP++
Sbjct: 226 P---SPEWDTVTPE----AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDW---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 52/303 (17%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + +     T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEII 195
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDAS 268
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+   
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE--- 252
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                                      + + S    DL+ + LV  P KR T EEAL HP
Sbjct: 253 ---------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285
Query: 329 YLQ 331
           + Q
Sbjct: 286 FFQ 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 141/299 (47%), Gaps = 53/299 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--------NAFDNIIDARRTLREIKLLRHME-H 100
           IGRG   +V   V+  T  E A+K +            + + +A R  RE  +LR +  H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR--RETHILRQVAGH 159
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            ++I + D       ++ + +++V++LM   +L   +     L++   +  +  LL  + 
Sbjct: 160 PHIITLID-----SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+ +++HRDLKP N+LL+ +  +++ DFG +      + + E   T  Y APE+L  C
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL-KC 273
Query: 220 T------EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           +       Y   +D+W+ G IL  ++   P F  +  +  LR+I E              
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME-------------- 319
Query: 274 SDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                          + QF++  + ++SS   DL+ ++L  DP  R+T E+AL+HP+ +
Sbjct: 320 --------------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 137/289 (47%), Gaps = 45/289 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y +    ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V ELM     L +I+R  +  ++      L+ + + ++Y+H+  V
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 LHRDLKPSNLL-LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
           +HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + APE +L    
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQG 196
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y AA DIWS+G +L  ++T                 T     PDD     L    + ++ 
Sbjct: 197 YDAACDIWSLGVLLYTMLTG---------------YTPFANGPDDTPEEILARIGSGKFS 241
Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                         + + S  A DL+ KML  DP++R+T    LRHP++
Sbjct: 242 LS---------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 61
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 62  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 211
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 212 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 139/301 (46%), Gaps = 49/301 (16%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FD---------NIIDARRTL-REIKL 94
            +R +G GAYG V          E AIK I  + FD         NI      +  EI L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ 153
           L+ ++H N+I + D+    K       Y+V E  +  +L + I +  +  +      + Q
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +L G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
            APE+L    +Y    D+WS G I+  ++   P F G+                      
Sbjct: 215 IAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---------------------- 250
Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                N +  ++++ + +       + N S  A +L++ ML +D NKR T EEAL   ++
Sbjct: 251 -----NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305
Query: 331 Q 331
           +
Sbjct: 306 K 306

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SXQEYSDW---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A +  T++ VAIK I       ++ +      EI +L  ++H N++A+ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAK---KALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   +
Sbjct: 83  DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 LHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYS 196
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+D WS+G I   ++   P F                             +N  +   Q
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFEQ 229
Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           + +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++
Sbjct: 230 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 40/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G GA+  V  A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+ D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           I      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 168 HRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSK 197
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D WS+G I   ++   P F                             +N  +   Q+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFEQI 230
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++
Sbjct: 231 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 147/324 (45%), Gaps = 50/324 (15%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN-----K 81
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            +     D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 199
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ +++G  
Sbjct: 200 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 265 DDASL------------GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEK 309
               +            G +  +N+   RYV++   C+  + +  +   +     DL+ +
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRR 316
Query: 310 MLVFDPNKRITVEEALRHPYLQSL 333
           ML FDP +RIT+ EAL HP+   L
Sbjct: 317 MLEFDPAQRITLAEALLHPFFAGL 340

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 40/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G GA+  V  A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+ D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           I      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 168 HRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSK 197
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D WS+G I   ++   P F                             +N  +   Q+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFEQI 230
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++
Sbjct: 231 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 126/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI +   + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINAMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 213
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 214 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 40/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G GA+  V  A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+ D
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           I      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++
Sbjct: 84  IY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 168 HRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSK 197
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D WS+G I   ++   P F                             +N  +   Q+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFEQI 230
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++
Sbjct: 231 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I           Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 90  ISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 144
Query: 169 RDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL +      +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 203
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W+ G IL  ++   P F  +D   Q RL  ++     D                  
Sbjct: 204 PVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------F 243
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P     ++ T  P     A DL+ KML  +P+KRIT  EAL+HP++
Sbjct: 244 P---SPEWDTVTPE----AKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 147/324 (45%), Gaps = 50/324 (15%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 36  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN-----K 90
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            +     D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 91  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 150
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 151 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 208
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ +++G  
Sbjct: 209 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 265 DDASL------------GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEK 309
               +            G +  +N+   RYV++   C+  + +  +   +     DL+ +
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRR 325
Query: 310 MLVFDPNKRITVEEALRHPYLQSL 333
           ML FDP +RIT+ EAL HP+   L
Sbjct: 326 MLEFDPAQRITLAEALLHPFFAGL 349

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 146/295 (49%), Gaps = 48/295 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+GA+ +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++  
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV-- 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +++     D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 90  -ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP N+LL +   S  +K+GDFG+A    E+  +    V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               Y   +D+W  G IL  +++   P +  K+     RL   +I               
Sbjct: 207 R-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGII--------------- 245
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            +   +  PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 246 -KGKYKMNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 147/324 (45%), Gaps = 50/324 (15%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN-----K 113
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            +     D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 114 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 173
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 174 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 231
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ +++G  
Sbjct: 232 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 290
Query: 265 DDASL------------GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEK 309
               +            G +  +N+   RYV++   C+  + +  +   +     DL+ +
Sbjct: 291 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRR 348
Query: 310 MLVFDPNKRITVEEALRHPYLQSL 333
           ML FDP +RIT+ EAL HP+   L
Sbjct: 349 MLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   +   T +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 169 RDLKPSNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL   +    +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W+ G IL  ++   P F  +D   Q RL  ++     D                  
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------F 225
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P     ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 226 P---SPEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   +   T +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 169 RDLKPSNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL   +    +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W+ G IL  ++   P F  +D   Q RL  ++     D                  
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------F 225
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P     ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 226 P---SPEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 138/309 (44%), Gaps = 48/309 (15%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N+Y      S  YV     IG G+Y      V+  T  E A+K I  +       R    
Sbjct: 17  NLYFQSMVFSDGYVVK-ETIGVGSYSECKRCVHKATNMEYAVKVIDKS------KRDPSE 69
Query: 91  EIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHC 147
           EI+ LLR+ +H N+I +KD+      D    VY+V ELM     L +I+R  +  ++   
Sbjct: 70  EIEILLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQ-KFFSEREA 123
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTT-SETDFM 201
            + L+ + + ++Y+HS  V+HRDLKPSN+L      N  C L+I DFG A+   +E   +
Sbjct: 124 SFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLL 182
Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE+L     Y    DIWS+G +L  ++                  T   
Sbjct: 183 MTPCYTANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAG---------------YTPFA 226
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
             P D     L    + ++               +   S  A DL+ KML  DP++R+T 
Sbjct: 227 NGPSDTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTA 277
Query: 322 EEALRHPYL 330
           ++ L+HP++
Sbjct: 278 KQVLQHPWV 286

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 215 NSYL-----VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 269
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APEL+     Y   +
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEV 328
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 372
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 373 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 138 N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 192
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 251
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 295
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 296 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 47/290 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y      V+  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKS------KRDPSEEIEILLRYGQHPNIITLKD 88
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V ELM     L +I+R  +  ++    + L+ + + ++Y+HS  V
Sbjct: 89  VY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 167 LHRDLKPSNLLL-----NASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCT 220
           +HRDLKPSN+L      N  C L+I DFG A+   +E   +     T  + APE+L    
Sbjct: 143 VHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR-Q 200
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y    DIWS+G +L  ++                  T     P D     L    + ++
Sbjct: 201 GYDEGCDIWSLGILLYTMLAG---------------YTPFANGPSDTPEEILTRIGSGKF 245
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                          +   S  A DL+ KML  DP++R+T ++ L+HP++
Sbjct: 246 TLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 126/286 (44%), Gaps = 52/286 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GA G V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     +   +D+WS G +L  ++  E                     P D       SD
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP-----SD 212
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
           + + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 213 SCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 145/308 (47%), Gaps = 44/308 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-L 95
           FEV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++ + +
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 104
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFL 151
           R ++    +     +         DV+I  ELMDT L     Q+I   Q + +D      
Sbjct: 105 RTVDCPFTVTFYGALF-----REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 159
Query: 152 YQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
             +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    ++   T     + Y
Sbjct: 160 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPY 219
Query: 211 RAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
            APE +   LN   Y+   DIWS+G  + E+      FP   +    + + +++  P   
Sbjct: 220 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-- 275
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                            P+    +F+  F       VD   + L  +  +R T  E ++H
Sbjct: 276 -----------------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQH 311
Query: 328 PYLQSLHD 335
           P+  +LH+
Sbjct: 312 PFF-TLHE 318

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 95  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 149
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 208
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 252
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 253 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 93  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 147
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 206
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 250
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 251 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   TE   T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 221
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 222 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 140/290 (48%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA++ I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + + E+  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   RR ++ +KL RH    ++I 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH---PHIIK 80
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P     +D+++V E +   +L   I  + +L +   +    Q+L G+ Y H  
Sbjct: 81  LYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++        
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIWS G IL  ++                            +L F   D+     +++
Sbjct: 196 EVDIWSSGVILYALLC--------------------------GTLPF-DDDHVPTLFKKI 228
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             C    +  ++ N S   + LL+ ML  DP KR T+++   H + +
Sbjct: 229 --CDGIFYTPQYLNPS--VISLLKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 88  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 142
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 201
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 245
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 246 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 84  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 138
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 197
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           DIWS+G ++ E++  EP +  +  +  +++I                 DN    ++ L +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNLPPRLKNLHK 241
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                        S      L+++LV DP +R T  E L+HP+L
Sbjct: 242 V------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + + DF  E+V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/328 (23%), Positives = 155/328 (47%), Gaps = 44/328 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP---VC 342
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+ +DE    V 
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE-DDELKPYVA 281
Query: 343 PRPFHFDFEHSSCTEDHIRELIWRESVK 370
           P P   D++    TE  +     RE ++
Sbjct: 282 PLP---DYKDPRRTELMVSMGYTREEIQ 306

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 139/290 (47%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 45/289 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y +    ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V EL      L +I+R  +  ++      L+ + + ++Y+H+  V
Sbjct: 84  VY-----DDGKYVYVVTELXKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 LHRDLKPSNLL-LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
           +HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + APE +L    
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQG 196
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y AA DIWS+G +L   +T                 T     PDD     L    + ++ 
Sbjct: 197 YDAACDIWSLGVLLYTXLTG---------------YTPFANGPDDTPEEILARIGSGKFS 241
Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                         + + S  A DL+ K L  DP++R+T    LRHP++
Sbjct: 242 LS---------GGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMH 184
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 222
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 223 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/309 (22%), Positives = 137/309 (44%), Gaps = 61/309 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI------------------------GNAFDNIIDA 85
           IG+G+YG+V  A N       A+K +                        G         
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
            +  +EI +L+ ++H NV+ + +++  P +D    +Y+V+EL++      + + + L++D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEY 204
             +++   L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D  ++  
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 205 VVTRWYRAPELLLNCTEYTA--AIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELI 261
           V T  + APE L    +  +  A+D+W++G  L   +  + P    +      ++ ++ +
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
             PD                               P+ +    DL+ +ML  +P  RI V
Sbjct: 258 EFPDQ------------------------------PDIAEDLKDLITRMLDKNPESRIVV 287
Query: 322 EEALRHPYL 330
            E   HP++
Sbjct: 288 PEIKLHPWV 296

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 226
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 221
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 222 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 38/286 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A   I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I           Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 79  ISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 169 RDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           R+LKP NLLL +      +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 192
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W+ G IL  ++   P F  +D   Q RL  ++     D                  
Sbjct: 193 PVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------F 232
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           P     ++ T  P     A DL+ KML  +P+KRIT  EAL+HP++
Sbjct: 233 P---SPEWDTVTPE----AKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 209
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 247
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 248 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 71  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G+     L  I+ +    D+            
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY---------- 234
Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
                            F N S  A D + ++LV DP +R+T+ ++L H +++++   N
Sbjct: 235 -----------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 221
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 222 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 72  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 216
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 217 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 221
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 222 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 139/290 (47%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA++ I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 187
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 217
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 218 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 213
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 214 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 226
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 91  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 142
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 200
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 238
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 239 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 224
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 216
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 217 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 73  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 182
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 212
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 213 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL---REIKLLRHMEHENVIAI 106
           +G+G YGIV A  +   +  +AIK+I        D+R +     EI L +H++H+N++  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIV-- 82
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHS 163
              +    ++ F  +++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H 
Sbjct: 83  -QYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
             ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE +  T  Y APE++     
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 222 -YTAAIDIWSVGCILGEIMTREPLF 245
            Y  A DIWS+GC + E+ T +P F
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL---REIKLLRHMEHENVIAI 106
           +G+G YGIV A  +   +  +AIK+I        D+R +     EI L +H++H+N++  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIV-- 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHS 163
              +    ++ F  +++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H 
Sbjct: 69  -QYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
             ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE +  T  Y APE++     
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 222 -YTAAIDIWSVGCILGEIMTREPLF 245
            Y  A DIWS+GC + E+ T +P F
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 45/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG V  A++ ET + VAIK++    D     +  ++EI +++  +  +V+     
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K+T  D++IV E      +  IIR  ++ LT+D     L   L+GL+Y+H    +
Sbjct: 93  YF---KNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTA 224
           HRD+K  N+LLN     K+ DFG+A     TD M +    + T ++ APE++     Y  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG-YNC 204
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
             DIWS+G    E+   +P  P  D +H +R I  +  +P                    
Sbjct: 205 VADIWSLGITAIEMAEGKP--PYAD-IHPMRAIFMIPTNPP------------------- 242
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           P  RK +        S    D +++ LV  P +R T  + L+HP+++S
Sbjct: 243 PTFRKPELW------SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE +     +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXI-EGRXH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 226
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMI-EGRMH 184
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 222
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 223 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ +
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 77  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +    +  +  +  Y APEL          
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 221
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 222 RVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 270

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 134/295 (45%), Gaps = 56/295 (18%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ + D+Q T      ++ +L   L
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANAL 126
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++  
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-E 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              +   +D+WS+G +  E +  +P F    Y    + I+ +                  
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------------ 226
Query: 279 RYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                       +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 ------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +    +   T  Y  PE++     +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMI-EGRMH 209
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 247
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 248 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 54/296 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     +  T+E VA+K I  G A D  +      REI   R + H N++
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-----REIINHRSLRHPNIV 79
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + I+ E     +L++ I +  + ++D  ++F  QLL G+ Y HS
Sbjct: 80  RFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             + HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   E
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QE 193
Query: 222 YTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRS 274
           Y   I D+WS G  L     G     +P  P +DY   + R+++     PDD        
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSIPDD-------- 244
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                 +R  P C                  L+ ++ V DP  RI++ E   H + 
Sbjct: 245 ------IRISPEC----------------CHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 109 FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 220
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 221 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 251
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 252 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 136/290 (46%), Gaps = 37/290 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ +
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 80  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL          
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 224
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           R  + ++   F   S+   +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 225 RVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 92  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G+     L  I+ +    D+            
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY---------- 255
Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
                            F N S  A D + ++LV DP +R+ + ++L H +++++   N
Sbjct: 256 -----------------FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   + +  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 71  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 180
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 210
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 211 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 107 FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 160
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 218
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 219 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 249
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 250 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +    +   T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 216
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 217 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI +FG +   + +   T    T  Y  PE++     +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 185
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 223
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 224 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 187
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +   P F    Y    R I+ +                      
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV---------------------- 225
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  + ++R+T+ E L HP++++
Sbjct: 226 --------EFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 49/310 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+  
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRY 67
Query: 107 -------KDIIRP----PKKDTFNDVYIVYELMDTD-LHQIIRSDQ--QLTDDHCQYFLY 152
                  ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKST---LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SE 197
           Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+                   
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G + V+ L+ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 258 TEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             + I  P D        DN  +  +++ R          PNK  GA  LL    +   +
Sbjct: 242 RSVSIEFPPDF------DDNKMKVEKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKH 291
Query: 317 KRITVEEALR 326
           +   ++EAL+
Sbjct: 292 QDEVIKEALK 301

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 83  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 194
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 195 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 225
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 226 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 224
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 136/290 (46%), Gaps = 53/290 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR------EIKLLRHMEHENV 103
           IG G+ GIVC A    +  +VA+K        ++D R+  R      E+ ++R  +H NV
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 104 IAI-KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + K  +         +++++ E +       I S  +L ++        +L+ L Y+H
Sbjct: 105 VEMYKSYL------VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE +++ + 
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSL 217
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y   +DIWS+G ++ E++  EP +     V  ++ + +   SP                 
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP---------------- 258
Query: 282 RQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 330
              P+ +         +K S  + D LE+MLV DP +R T +E L HP+L
Sbjct: 259 ---PKLKNS-------HKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 213
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 214 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 133/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI +FG +   + +   T    T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 224
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 49/310 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+  
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRY 67
Query: 107 -------KDIIRP----PKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
                  ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKST---LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SE 197
           Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+                   
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G + V+ L+ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 258 TEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             + I  P D        DN  +  +++ R          PNK  GA  LL    +   +
Sbjct: 242 RSVSIEFPPDF------DDNKMKVEKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKH 291
Query: 317 KRITVEEALR 326
           +   ++EAL+
Sbjct: 292 QDEVIKEALK 301

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 220
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMH 185
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y    + I+ +                      
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------------- 223
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 224 --------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 52/293 (17%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELLLNCT 220
           S  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +     T  Y  PE++    
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPEMI-EGR 182
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            +   +D+WS+G +  E +  +P F    Y    + I+ +                    
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------- 222
Query: 281 VRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                     +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 223 ----------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 187
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 219
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 220
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 187
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 219
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 220
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 213
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 214 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 118/232 (50%), Gaps = 35/232 (15%)
Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-- 87
           YN   N F +  K       IGRG +  V  A        VA+KK+   FD ++DA+   
Sbjct: 28  YNTLAN-FRIEKK-------IGRGQFSEVYRAACLLDGVPVALKKV-QIFD-LMDAKARA 77
Query: 88  -TLREIKLLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--- 137
             ++EI LL+ + H NVI      I+D          N++ IV EL D  DL ++I+   
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIED----------NELNIVLELADAGDLSRMIKHFK 127
Query: 138 SDQQLTDDHCQY-FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-T 195
             ++L  +   + +  QL   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           S+T      V T +Y +PE +     Y    DIWS+GC+L E+   +  F G
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 130/292 (44%), Gaps = 44/292 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G GA+G V       +  E  IK I N   + +   +   EI++L+ ++H N+I I 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVH 162
           ++      + ++++YIV E  +    L +I+ +    + L++ +    + Q++  L Y H
Sbjct: 87  EVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 163 SASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           S  V+H+DLKP N+L   +     +KI DFGLA      +  T    T  Y APE+    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            + T   DIWS G ++  ++T    F G                             +  
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLTGCLPFTG----------------------------TSLE 231
Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            V+Q    ++  +A      +  AVDLL++ML  DP +R +  + L H + +
Sbjct: 232 EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F                               A  Y  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPF------------------------------EANTYQE 216
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
              R  + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 217 TYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 46/294 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 78  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G+     L             ++  +  D   
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------------TNISAVNYDFDE 239
Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            Y               F N S  A D + ++LV DP +R+ + ++L H ++++
Sbjct: 240 EY---------------FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 17/216 (7%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+   KYV  ++ IG G++G      ++E   +  IK+I  +  +  +   + RE+ +L 
Sbjct: 20  FQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA 78
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQL--TDDHCQYF 150
           +M+H N++  ++        +F +   +Y +MD     DL + I + + +   +D    +
Sbjct: 79  NMKHPNIVQYRE--------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRW 209
             Q+   LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T +     + T +
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           Y +PE+  N   Y    DIW++GC+L E+ T +  F
Sbjct: 191 YLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF 225

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G      L  ++ + 
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
              +D                             F N S+ A D + ++LV DP KR+T+
Sbjct: 234 YEFEDEY---------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 120/250 (48%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE++ N        D+WS+G I   +++    F G      L       
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------- 226
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                A++  +  +    Y               F N S+ A D + ++LV DP KR+T+
Sbjct: 227 -----ANVSAVNYEFEDEY---------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 44/250 (17%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                T  + APE ++N        D+WS+G I   +++    F G      L  ++ + 
Sbjct: 175 KNIFGTPAFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
              +D                             F N S+ A D + ++LV DP KR+T+
Sbjct: 234 YEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 322 EEALRHPYLQ 331
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G                           D
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------------D 220
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 52/296 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           + N        D+WS+G I   +++    F G      L  ++ +    +D         
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------- 239
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                               F N S+ A D + ++LV DP KR+T++++L+HP+++
Sbjct: 240 -------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 85  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 196
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 197 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 227
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 228 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 85  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 196
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 197 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 227
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 228 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 89  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 142
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 200
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+GCI                     + T L+G P      F  S     Y+   
Sbjct: 201 EVDVWSIGCI---------------------MYTLLVGKPP-----FETSCLKETYL--- 231
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            R +K +++    + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 232 -RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 277

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
                 D+WS+G I   +++    F G      L  IT +    D               
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------------- 238
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 133/295 (45%), Gaps = 56/295 (18%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ + D+Q T      ++ +L   L
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANAL 126
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++  
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMI-E 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              +   +D+WS+G +  E +  +P F    Y    + I+ +                  
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------------ 226
Query: 279 RYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                       +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 ------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
                 D+WS+G I   +++    F G      L  IT +    D               
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------------- 238
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
                 D+WS+G I   +++    F G      L  IT +    D               
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------------- 238
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 124/295 (42%), Gaps = 52/295 (17%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + +  E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI DFG ++ +         V T  Y APE+LL   E
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           Y   + D+WS G  L     G     +P  P        R++      PD          
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD---------- 242
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               YV   P CR                 L+ ++ V DP KRI++ E   H + 
Sbjct: 243 ----YVHISPECRH----------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 128/300 (42%), Gaps = 42/300 (14%)
Query: 50  IGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G+YG V   ++SET  R  V I K               +EI+LLR + H+NVI + 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 165
           D++   +K     +Y+V E     + +++ S  +     CQ   Y  QL+ GL+Y+HS  
Sbjct: 73  DVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ PE+      +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 223 TA-AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           +   +DIWS G  L  I T   L+P                            DN  +  
Sbjct: 190 SGFKVDIWSAGVTLYNITTG--LYP-------------------------FEGDNIYKLF 222
Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
             + +          P  S    DLL+ ML ++P KR ++ +  +H + +  H   + PV
Sbjct: 223 ENIGKGSYAIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 46/294 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+G + +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++  
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV-- 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +++     D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 92  -ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++ 
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               Y   +D+W  G IL  +++    F    Y  + RL   +I                
Sbjct: 209 R-EPYGKPVDVWGCGVILFILLSGCLPF----YGTKERLFEGII---------------- 247
Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           +   +  PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 248 KGKYKMNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A    ++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G +  E +  +P F    Y                        D  +R  R
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTY-----------------------QDTYKRISR 220
Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 221 V-------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 52/293 (17%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELLLNCT 220
           S  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +     T  Y  PE++    
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCG---TLDYLPPEMI-EGR 185
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            +   +D+WS+G +  E +   P F    Y    R I+ +                    
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-------------------- 225
Query: 281 VRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                     +F   FP+  + GA DL+ ++L  + ++R+T+ E L HP++++
Sbjct: 226 ----------EFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
                 D+WS+G I   +++    F G      L  IT +    D               
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------------- 238
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
                 D+WS+G I   +++    F G      L  IT +    D               
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------------- 238
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 143/295 (48%), Gaps = 48/295 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+G + +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++  
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV-- 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +++     D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 90  -ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               Y   +D+W  G IL  +++   P +  K+     RL   +I               
Sbjct: 207 R-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGII--------------- 245
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            +   +  PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 246 -KGKYKMNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++G V  AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I + + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
                 +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V H
Sbjct: 75  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 169 RDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P++L     Y   
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
            D WS G ++  ++   P F                 +P D  +              + 
Sbjct: 188 CDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV--------------ML 217
Query: 286 RCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H + +
Sbjct: 218 KIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++G V  AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I + + 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
                 +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V H
Sbjct: 92  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 169 RDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P++L     Y   
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 204
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
            D WS G ++  ++   P F                 +P D  +              + 
Sbjct: 205 CDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV--------------ML 234
Query: 286 RCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H + +
Sbjct: 235 KIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 138/306 (45%), Gaps = 50/306 (16%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++ + + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  +  +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+WS+G IL  +++    F G++ + +LR                              
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN-LKELR-----------------------------E 223
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-------------HPYLQS 332
           R  + ++   F   S+   +LL+K L+ +P+KR T+E+  +              PY++ 
Sbjct: 224 RVLRGKYRIPF-YXSTDCENLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDDELKPYVEP 282
Query: 333 LHDLND 338
           L D  D
Sbjct: 283 LPDYKD 288

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 142/308 (46%), Gaps = 44/308 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-L 95
            EV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++ + +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFL 151
           R ++    +     +         DV+I  ELMDT L     Q+I   Q + +D      
Sbjct: 61  RTVDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 152 YQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
             +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    +          + Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175
Query: 211 RAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
            APE +   LN   Y+   DIWS+G  + E+      FP   +    + + +++  P   
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-- 231
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                            P+    +F+  F       VD   + L  +  +R T  E ++H
Sbjct: 232 -----------------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQH 267
Query: 328 PYLQSLHD 335
           P+  +LH+
Sbjct: 268 PFF-TLHE 274

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 52/295 (17%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 23  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 77
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 78  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   E
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 191
Query: 222 YTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           Y   + D+WS G  L     G     +P  P        R++      PD          
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD---------- 241
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               YV   P CR                 L+ ++ V DP KRI++ E   H + 
Sbjct: 242 ----YVHISPECRH----------------LISRIFVADPAKRISIPEIRNHEWF 276

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+  
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVXLLASLNHQYVVRY 67
Query: 107 -------KDIIRP----PKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
                  ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  
Sbjct: 68  YAAWLERRNFVKPXTAVKKKST---LFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SE 197
           Q+L  L Y+HS  ++HR+LKP N+ ++ S ++KIGDFGLA+                   
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D +T  + T  Y A E+L     Y   ID +S+G I  E +   P   G + V+ L+ +
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKL 241
Query: 258 TEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
             + I  P D        DN  +  +++ R          PNK  GA  LL    +   +
Sbjct: 242 RSVSIEFPPDF------DDNKXKVEKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKH 291
Query: 317 KRITVEEALR 326
           +   ++EAL+
Sbjct: 292 QDEVIKEALK 301

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 126/293 (43%), Gaps = 48/293 (16%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+     + ++ E VA+K I    + I  A    REI   R + H N++  
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKI--AANVKREIINHRSLRHPNIVRF 80
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  
Sbjct: 81  KEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 166 VLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYD 194
Query: 224 AAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
             + D+WS G  L     G     +P  P        R++      PD            
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD------------ 242
Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             YV   P CR                 L+ ++ V DP KRI++ E   H + 
Sbjct: 243 --YVHISPECRH----------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/334 (23%), Positives = 139/334 (41%), Gaps = 58/334 (17%)
Query: 18  KGVLTHGGKYVQYNVYGNLFEVSSKYVP-PIR--------------PIGRGAYGIVCAAV 62
           +G +  G   V  N    +F++  +Y P P+                +G GA+G+V    
Sbjct: 12  QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 71
Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
              T    A K +    ++  D     +EI+ +  + H  ++ + D       +  N++ 
Sbjct: 72  ERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 124
Query: 123 IVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++   
Sbjct: 125 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 184
Query: 181 --SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILG 236
             S +LK+ DFGL         +     T  + APE+        YT   D+WSVG +L 
Sbjct: 185 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG-VLS 240
Query: 237 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 296
            I+              L  ++   G  DD +L            R +  C      + F
Sbjct: 241 YIL--------------LSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 274
Query: 297 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
              S    D + K+L+ DPN R+T+ +AL HP+L
Sbjct: 275 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T  Y APE+L     ++ 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSF 221
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +DIWS+GCIL  ++  +P F
Sbjct: 222 EVDIWSLGCILYTLLVGKPPF 242

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/334 (23%), Positives = 139/334 (41%), Gaps = 58/334 (17%)
Query: 18  KGVLTHGGKYVQYNVYGNLFEVSSKYVP-PIR--------------PIGRGAYGIVCAAV 62
           +G +  G   V  N    +F++  +Y P P+                +G GA+G+V    
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177
Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
              T    A K +    ++  D     +EI+ +  + H  ++ + D       +  N++ 
Sbjct: 178 ERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230
Query: 123 IVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++   
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 181 --SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILG 236
             S +LK+ DFGL         +     T  + APE+        YT   D+WSVG +L 
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG-VLS 346
Query: 237 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 296
            I+              L  ++   G  DD +L            R +  C      + F
Sbjct: 347 YIL--------------LSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 380
Query: 297 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
              S    D + K+L+ DPN R+T+ +AL HP+L
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYT 223
           V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLCGTPNYIAPEVLCK-KGHS 220
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
             +DIWS+GCIL  ++  +P F
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPF 242

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 92  HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T  Y APE+L     ++ 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSF 205
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +DIWS+GCIL  ++  +P F
Sbjct: 206 EVDIWSLGCILYTLLVGKPPF 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 103/203 (50%), Gaps = 6/203 (2%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + IG+G +  V  A +  T  EVA+K I     N    ++  RE+++++ + H N++ + 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   +
Sbjct: 81  EVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDLK  NLLL+   ++KI DFG +   +  + +  +  +  Y APEL          +
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEV 195
Query: 227 DIWSVGCILGEIMTREPLFPGKD 249
           D+WS+G IL  +++    F G++
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/331 (23%), Positives = 141/331 (42%), Gaps = 55/331 (16%)
Query: 25  GKY--VQYNVYGNLFE-VSSKYVPP---------------IRPIGRGAYGIVCAAVNSET 66
           GKY   + N Y   +E +  KYVP                +  +G GA+G+V   V   T
Sbjct: 16  GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 67  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 126
                 K I   +   +D      EI ++  + H  +I + D      +D +  V I+  
Sbjct: 76  GRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAF----EDKYEMVLILEF 129
Query: 127 LMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL--LNASCD 183
           L   +L  +I   D ++++     ++ Q   GLK++H  S++H D+KP N++     +  
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           +KI DFGLA   +  + +     T  + APE++ +        D+W++G +   +++   
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLS 248
Query: 244 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA 303
            F G+D +  L+                            + RC  +     F + S  A
Sbjct: 249 PFAGEDDLETLQ---------------------------NVKRCDWEFDEDAFSSVSPEA 281
Query: 304 VDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
            D ++ +L  +P KR+TV +AL HP+L+  H
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYT 223
           V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKXLCGTPNYIAPEVLCK-KGHS 220
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
             +DIWS+GCIL  ++  +P F
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPF 242

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 46/292 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T  E A K I         +RR +      RE+ +LR + H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVCREEIEREVSILRQVLHPNI 77
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 163 SASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G      L  IT +    D             
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD------------- 238
Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                      ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 -----------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   +R ++ +KL RH    ++I 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIK 75
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  + Y H  
Sbjct: 76  LYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+ +   +  Y APE++        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIWS G IL  ++     F   D  H   L  ++ G                  V  +
Sbjct: 191 EVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGG-----------------VFYI 230
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           P    +  AT           LL  ML  DP KR T+++   H + + 
Sbjct: 231 PEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 126/295 (42%), Gaps = 52/295 (17%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI  FG ++++       + V T  Y APE+LL   E
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           Y   + D+WS G  L     G     +P  P        R++      PD          
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD---------- 242
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               YV   P CR                 L+ ++ V DP KRI++ E   H + 
Sbjct: 243 ----YVHISPECRH----------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/327 (24%), Positives = 144/327 (44%), Gaps = 50/327 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--- 102
           +  +G G +G V   V+       VA+K I N       AR  +  ++ +   + +N   
Sbjct: 38  VSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNL 97
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLKY 160
            + + D       D    + I +EL+       ++ +  L       ++  +QL + +K+
Sbjct: 98  CVQMFDWF-----DYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 161 VHSASVLHRDLKPSNLL-LNASCDL------------------KIGDFGLARTTSETDFM 201
           +H   + H DLKP N+L +N+  +L                  ++ DFG A  T + +  
Sbjct: 153 LHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEHH 210
Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
           +  V TR YRAPE++L    ++   D+WS+GCI+ E      LF   D    L ++  ++
Sbjct: 211 STIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERIL 269
Query: 262 GSPDD--------------ASLGFLRSDNARRYVRQLPRCRK-QQFATRFPNKSSGAVDL 306
           G                    L +  + +A RYVR+   C+  +++ T    +     DL
Sbjct: 270 GPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRE--NCKPLRRYLTSEAEEHHQLFDL 327
Query: 307 LEKMLVFDPNKRITVEEALRHPYLQSL 333
           +E ML ++P KR+T+ EAL+HP+   L
Sbjct: 328 IESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 37  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 203
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 248
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 249 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 289
Query: 329 YLQSL 333
           + +S+
Sbjct: 290 FFESV 294

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/329 (25%), Positives = 153/329 (46%), Gaps = 53/329 (16%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 280
           +T + D WS G ++ E++T    F GKD    + +I +  +G P      FL S  A+  
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSL 256
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-- 338
           +R L +        R P    GA           P+    VEE  RH +  ++ D N   
Sbjct: 257 LRMLFK--------RNPANRLGA----------GPD---GVEEIKRHSFFSTI-DWNKLY 294
Query: 339 --------EPVCPRP---FHFDFEHSSCT 356
                   +P   RP   F+FD E ++ T
Sbjct: 295 RREIHPPFKPATGRPEDTFYFDPEFTAKT 323

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 41  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 252
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 253 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 293
Query: 329 YLQSL 333
           + +S+
Sbjct: 294 FFESV 298

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 125/295 (42%), Gaps = 52/295 (17%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI  FG ++++         V T  Y APE+LL   E
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           Y   + D+WS G  L     G     +P  P        R++      PD          
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD---------- 242
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               YV   P CR                 L+ ++ V DP KRI++ E   H + 
Sbjct: 243 ----YVHISPECRH----------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 44/288 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   +R ++ +KL RH    ++I 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIK 75
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  + Y H  
Sbjct: 76  LYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +DIWS G IL  ++     F   D  H   L  ++ G                  V  +
Sbjct: 191 EVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGG-----------------VFYI 230
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           P    +  AT           LL  ML  DP KR T+++   H + + 
Sbjct: 231 PEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 40/297 (13%)
Query: 39  VSSKY-VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           V+S Y V     +G G +G V     + T  ++A K I      + D      EI ++  
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQ 142
Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLL 155
           ++H N+I + D       ++ ND+ +V E +D      +II     LT+     F+ Q+ 
Sbjct: 143 LDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 156 RGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
            G++++H   +LH DLKP N+L     +  +KI DFGLAR     + +     T  + AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E ++N    +   D+WSVG I   +++    F G                          
Sbjct: 258 E-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-------------------------- 290
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
            DN    +  +  CR       F + S  A + + K+L+ + + RI+  EAL+HP+L
Sbjct: 291 -DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 37  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 203
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 248
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 249 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 289
Query: 329 YLQSL 333
           + +S+
Sbjct: 290 FFESV 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 251
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 252 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 292
Query: 329 YLQSL 333
           + +S+
Sbjct: 293 FFESV 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 249
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 250 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 329 YLQSL 333
           + +S+
Sbjct: 291 FFESV 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 249
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 250 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 329 YLQSL 333
           + +S+
Sbjct: 291 FFESV 295

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 249
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 250 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 329 YLQSL 333
           + +S+
Sbjct: 291 FFESV 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 41  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 252
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 253 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 293
Query: 329 YLQSL 333
           + +S+
Sbjct: 294 FFESV 298

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 22  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 188
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 189 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 233
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 234 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 274
Query: 329 YLQSL 333
           + +S+
Sbjct: 275 FFESV 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 251
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 252 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 292
Query: 329 YLQSL 333
           + +S+
Sbjct: 293 FFESV 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 132/304 (43%), Gaps = 66/304 (21%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 43  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
             TE +A  + D+W++GCI+ +++   P F                           R+ 
Sbjct: 210 --TEKSACKSSDLWALGCIIYQLVAGLPPF---------------------------RAG 240
Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPY 329
           N     +++ +      A  FP     A DL+EK+LV D  KR+  EE         HP+
Sbjct: 241 NEYLIFQKIIKLEYDFPAAFFPK----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 296
Query: 330 LQSL 333
            +S+
Sbjct: 297 FESV 300

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 251
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 252 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 292
Query: 329 YLQSL 333
           + +S+
Sbjct: 293 FFESV 297

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 56/299 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 76  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 188
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  D   ++
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF 235
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 333
               P+ R                DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 236 ---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 45  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 256
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 257 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 297
Query: 329 YLQSL 333
           + +S+
Sbjct: 298 FFESV 302

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 56/299 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 74  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 186
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  D   ++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF 233
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 333
               P+ R                DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 234 ---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 56/299 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 73  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 185
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  D   ++
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF 232
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 333
               P+ R                DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 233 ---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 56/299 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 75  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 187
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  D   ++
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF 234
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 333
               P+ R                DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 235 ---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 74
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 75  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +TE   T +Y APE +
Sbjct: 130 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-V 188
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 231
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 232 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 281 QSTKVPQTPL 290

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 136/314 (43%), Gaps = 56/314 (17%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           FEV +  + PI  +GRGAYG+V    +  + +  A+K+I  A  N  + +R L ++ +  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISX 87
Query: 97  HMEHENVIAIKDIIRPPKKDTF-------NDVYIVYELMDTDL----HQIIRSDQQLTDD 145
                        +  P   TF        DV+I  EL DT L     Q+I   Q + +D
Sbjct: 88  RT-----------VDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPED 136
Query: 146 HCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                   +++ L+++HS  SV+HRD+KPSN+L+NA   +K  DFG++    +       
Sbjct: 137 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID 196
Query: 205 VVTRWYRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
              + Y APE +   LN   Y+   DIWS+G    E+      FP   +    + + +++
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR--FPYDSWGTPFQQLKQVV 254
Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
             P                    P+    +F+  F       VD   + L  +  +R T 
Sbjct: 255 EEPS-------------------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTY 288
Query: 322 EEALRHPYLQSLHD 335
            E  +HP+  +LH+
Sbjct: 289 PELXQHPFF-TLHE 301

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 90  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 203
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSP 264
           +T + D WS G ++ E++T    F GKD    + +I +  +G P
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSP 264
           +T + D WS G ++ E++T    F GKD    + +I +  +G P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG+G +G+V        ++ R + AIK +      +      LRE  L+R + H NV+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
           A+  I+ PP  +    V + Y +   DL Q IRS Q+  T      F  Q+ RG++Y+  
Sbjct: 86  ALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT--- 220
              +HRDL   N +L+ S  +K+ DFGLAR   +     EY   + +R   L +  T   
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLPVKWTALE 198
Query: 221 -----EYTAAIDIWSVGCILGEIMTR 241
                 +T   D+WS G +L E++TR
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++     A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTTVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 249
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 250 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 329 YLQSL 333
           + +S+
Sbjct: 291 FFESV 295

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 134/305 (43%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      +  L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G +Y+   ++I              L  
Sbjct: 207 --TEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEY 251
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 252 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 292
Query: 329 YLQSL 333
           + +S+
Sbjct: 293 FFESV 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +E V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE----------------------- 235
Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E L+H +L+
Sbjct: 236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 25/273 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKD 108
           IG+G++G V   +++ T+E VAIK I +  +   +     +EI +L   +   +      
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            ++  K      ++I+ E +       +     L + +    L ++L+GL Y+HS   +H
Sbjct: 86  YLKSTK------LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIH 139
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE ++  + Y    D
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKAD 198
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL--- 284
           IWS+G    E+   EP  P  D +H +R++  LI      +L    S   + +V      
Sbjct: 199 IWSLGITAIELAKGEP--PNSD-LHPMRVLF-LIPKNSPPTLEGQHSKPFKEFVEACLNK 254
Query: 285 -PRCR-------KQQFATRFPNKSSGAVDLLEK 309
            PR R       K +F TR+  K+S   +L+++
Sbjct: 255 DPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 287

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   ++ +T E+VAIK+           R  L EI++++ + H NV++ +++
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 81
Query: 110 IRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSA 164
               +K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 165 SVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL    +
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KK 200
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFP 246
           YT  +D WS G +  E +T   P  P
Sbjct: 201 YTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   ++ +T E+VAIK+           R  L EI++++ + H NV++ +++
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 80
Query: 110 IRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSA 164
               +K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 165 SVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL    +
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KK 199
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFP 246
           YT  +D WS G +  E +T   P  P
Sbjct: 200 YTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 95/175 (54%), Gaps = 21/175 (12%)
Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-IVYELMDT-DLHQIIRSDQQLT 143
           +R  RE+     + H+N++++ D+      D  +D Y +V E ++   L + I S   L+
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLS 109
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MT 202
            D    F  Q+L G+K+ H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 203 EYVV-TRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
            +V+ T  Y +PE         CT      DI+S+G +L E++  EP F G+  V
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECT------DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 38/295 (12%)
Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K +   +  ++I D ++   EI++L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 77
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q
Sbjct: 78  RNLYHENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV------T 207
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V        
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPV 193
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
            WY APE L+    Y A+ D+WS G  L E++T    +   D    + L  ++IG P   
Sbjct: 194 FWY-APECLMQSKFYIAS-DVWSFGVTLHELLT----YCDSD-SSPMALFLKMIG-PTHG 245
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 322
            +   R  N  +  ++LP C         PN       L+ K   F P+ R + +
Sbjct: 246 QMTVTRLVNTLKEGKRLP-CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQ 291

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 38/295 (12%)
Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K +   +  ++I D ++   EI++L
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 65
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q
Sbjct: 66  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV------T 207
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V        
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPV 181
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
            WY APE L+    Y A+ D+WS G  L E++T    +   D    + L  ++IG P   
Sbjct: 182 FWY-APECLMQSKFYIAS-DVWSFGVTLHELLT----YCDSD-SSPMALFLKMIG-PTHG 233
Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 322
            +   R  N  +  ++LP C         PN       L+ K   F P+ R + +
Sbjct: 234 QMTVTRLVNTLKEGKRLP-CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQ 279

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G++G V  A   +T +  AIK +    D ++   D   T+ E ++L        +  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                  K++ F   +++  L   DL   I+S  +       ++  +++ GL+++HS  +
Sbjct: 84  MFCTFQTKENLF---FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAA 225
           ++RDLK  N+LL+    +KI DFG+ +     D  T E+  T  Y APE+LL   +Y  +
Sbjct: 141 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHS 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D WS G +L E++  +  F G+D         EL  S        +R DN         
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHS--------IRMDNP-------- 236
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 334
                 F  R+  K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 237 ------FYPRWLEKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 278

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 80
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 81  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 136 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 194
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 195 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 237
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 238 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 287 QSTKVPQTPL 296

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/341 (25%), Positives = 146/341 (42%), Gaps = 67/341 (19%)
Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G     G  ++ N   + ++V+S+       +G G  G V    N  T+E+ A+K +   
Sbjct: 1   GSHVKSGLQIKKNAIIDDYKVTSQV------LGLGINGKVLQIFNKRTQEKFALKMLQ-- 52
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-------IVYELMDT- 130
                D  +  RE++L  H        I  I+     D + ++Y       IV E +D  
Sbjct: 53  -----DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLYAGRKCLLIVMECLDGG 100
Query: 131 DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLK 185
           +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           + DFG A+ T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F
Sbjct: 161 LTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219
Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
                 H L +      SP   +                 R R  Q+   FPN     V 
Sbjct: 220 YSN---HGLAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVS 251
Query: 306 -----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
                L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 81
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 82  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 137 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 195
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 196 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 238
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 239 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 288 QSTKVPQTPL 297

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +RP+G+G +G V  A   + +  +A+K +  +  +      +  REI++  H+ H N++ 
Sbjct: 19  VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H  
Sbjct: 79  MYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRD+KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +  
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDE 191
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+W  G +  E +   P F    +    R I        +  L F             
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------NVDLKFP------------ 232
Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                       P  S G+ DL+ K+L + P +R+ ++  + HP++++
Sbjct: 233 ------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 82
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 83  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 138 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 196
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 197 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 239
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 240 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 289 QSTKVPQTPL 298

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 90
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 91  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 146 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 204
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 205 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 247
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 248 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 296
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 297 QSTKVPQTPL 306

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 75
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 76  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 131 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 189
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 190 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 232
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 233 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 282 QSTKVPQTPL 291

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 74
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 75  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 130 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 188
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 231
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 232 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 281 QSTKVPQTPL 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 76
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 77  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 190
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 233
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 234 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 283 QSTKVPQTPL 292

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 48/289 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AF-DNIIDARRTLREIKLLRHMEHENVIAI 106
           +G GA+  V       T +  A+K I    AF D+ ++      EI +L+ ++HEN++ +
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHENIVTL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +DI      ++    Y+V +L+   +L   I      T+      + Q+L  +KY+H   
Sbjct: 72  EDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLL      +  + I DFGL++   +   M+    T  Y APE+L     Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQ-KPY 184
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
           + A+D WS+G I   ++   P F  +        I E          G+           
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE----------GYY---------- 224
Query: 283 QLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                   +F + F +  S  A D +  +L  DPN+R T E+AL HP++
Sbjct: 225 --------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 132/303 (43%), Gaps = 64/303 (21%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
             +   ++ D+W++GCI+ +++   P F  G + +   ++I              L  D 
Sbjct: 208 EKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------------LEYDF 253
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYL 330
             ++    P+ R                DL+EK+LV D  KR+  EE         HP+ 
Sbjct: 254 PEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294
Query: 331 QSL 333
           +S+
Sbjct: 295 ESV 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 120
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 121 V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 234
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 277
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 278 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 327 QSTKVPQTPL 336

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 68/305 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRS 274
             TE +A  + D+W++GCI+ +++   P F  G + +   ++I              L  
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------------LEY 251
Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHP 328
           D   ++    P+ R                DL+EK+LV D  KR+  EE         HP
Sbjct: 252 DFPEKF---FPKAR----------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 292
Query: 329 YLQSL 333
           + +S+
Sbjct: 293 FFESV 297

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 126
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 127 V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 181
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 182 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 240
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D+WS+G I+  ++   P F      H L +      SP   +        
Sbjct: 241 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-------- 283
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R+T+ E + HP++ 
Sbjct: 284 ---------RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 333 QSTKVPQTPL 342

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/334 (22%), Positives = 143/334 (42%), Gaps = 62/334 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIA 105
           IR +G G +G V    + + ++  A+K +     NI    R+ + E  +L+ ++++++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHS 163
              +    K   ++ + +++E +   L++II  +       +  + +  ++L+ L Y+  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 164 ASVLHRDLKPSNLLLN-------------------------ASCDLKIGDFGLARTTSET 198
            S+ H DLKP N+LL+                          S  +K+ DFG A  T ++
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKS 213
Query: 199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           D+    + TR YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++ 
Sbjct: 214 DYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA--------------- 303
            +I       L      N  +YV       K +    +P  +S                 
Sbjct: 273 SIIQPIPKNMLYEATKTNGSKYV------NKDELKLAWPENASSINSIKHVKKCLPLYKI 326
Query: 304 ------VDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  D L  +L  DP  R +  E L+H +L+
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE----------------------- 235
Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E L+H +L+
Sbjct: 236 -----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 131/266 (49%), Gaps = 21/266 (7%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V      ++    A+K +  A   + D  RT  E  +L  + H  V
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L  GL ++H
Sbjct: 93  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++   + +     +  T  Y APE ++N   
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQG 206
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 280
           ++ + D WS G ++ E++T    F GKD    + LI +  +G P      FL S  A+  
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ-----FL-STEAQSL 260
Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDL 306
           +R L    K+  A R  +   GA ++
Sbjct: 261 LRAL---FKRNPANRLGSGPDGAEEI 283

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 50/295 (16%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +   +    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y    D+WS+G  L E+   EP        H+L                     N
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------N 244
Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             R + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 245 PMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   + +  +A+K +  +  +      +  REI++  H+ H N++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H   
Sbjct: 81  YNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           V+HRD+KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +   
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEK 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+W  G +  E +   P F    +    R I        +  L F              
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------NVDLKFP------------- 233
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                      P  S G+ DL+ K+L + P +R+ ++  + HP++++
Sbjct: 234 -----------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 50/295 (16%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +   +    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y    D+WS+G  L E+   EP        H+L                     N
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------N 244
Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             R + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 245 PMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 50/295 (16%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +   +    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y    D+WS+G  L E+   EP        H+L                     N
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------N 244
Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
             R + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 245 PMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H N I 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 106 IKDI-IRPPKKDTFNDVYIVYEL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +   +R       +  ++V E      +DL ++ +  + L +       +  L+GL Y+
Sbjct: 119 YRGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYL 170
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++L   E
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDE 227
Query: 222 --YTAAIDIWSVGCILGEIMTREP 243
             Y   +D+WS+G    E+  R+P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKP 251

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE----------------------- 235
Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E L+H +L+
Sbjct: 236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEH 100
           K    +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 101 ENVIAIKDI-IRPPKKDTFNDVYIVYEL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            N I  +   +R       +  ++V E      +DL ++ +  + L +       +  L+
Sbjct: 75  PNTIQYRGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQ 126
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVI 183
Query: 217 LNCTE--YTAAIDIWSVGCILGEIMTREP 243
           L   E  Y   +D+WS+G    E+  R+P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G++  V  A +  T  EVAIK I   A       +R   E+K+   ++H +++ + +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     N VY+V E+  + ++++ +++  +  +++  ++F++Q++ G+ Y+HS  +
Sbjct: 79  YFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           LHRDL  SNLLL  + ++KI DFGLA T  +      Y +  T  Y +PE+    + +  
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGL 191
Query: 225 AIDIWSVGCILGEIMTREPLF 245
             D+WS+GC+   ++   P F
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPF 212

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G++G V  A   +T +  AIK +    D ++   D   T+ E ++L        +  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                  K++ F   +++  L   DL   I+S  +       ++  +++ GL+++HS  +
Sbjct: 83  MFCTFQTKENLF---FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAA 225
           ++RDLK  N+LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  +
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHS 198
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D WS G +L E++  +  F G+D         EL  S        +R DN         
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHS--------IRMDNP-------- 235
Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 334
                 F  R+  K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 236 ------FYPRWLEKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG+G++G VC    ++T++  A+K +         + R   +E+++++ +EH  ++ 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +  +     D+++V +L+   DL   ++ +    ++  + F+ +L+  L Y+ + 
Sbjct: 80  LWYSFQDEE-----DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEY 222
            ++HRD+KP N+LL+    + I DF +A        +T    T+ Y APE+  +     Y
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 223 TAAIDIWSVGCILGEIM 239
           + A+D WS+G    E++
Sbjct: 195 SFAVDWWSLGVTAYELL 211

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 43  YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR------ 96
           Y+   + +GRG + +V   ++  T +E A K +             L EI +L       
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 97  -----HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
                H  +EN   I  I+             ++ L   +L +++      +++     +
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGGE------IFSLCLPELAEMV------SENDVIRLI 137
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTR 208
            Q+L G+ Y+H  +++H DLKP N+LL++     D+KI DFG++R       + E + T 
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            Y APE+L N    T A D+W++G I   ++T    F G+D                   
Sbjct: 198 EYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGED------------------- 237
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                  N   Y+  + +         F + S  A D ++ +LV +P KR T E  L H 
Sbjct: 238 -------NQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 329 YLQ 331
           +LQ
Sbjct: 290 WLQ 292

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 87  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDI 200
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE----------------------- 236
Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E ++H +L+
Sbjct: 237 -----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 54/303 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           IG GA  +V AA  +  +E+VAIK+I N           L+EI+ +    H N+++    
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 106 --IKDIIRPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQL 154
             +KD           ++++V +L+      D   H + + + +   L +      L ++
Sbjct: 77  FVVKD-----------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTR 208
           L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T 
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            + APE++     Y    DIWS G    E+ T     P   Y     L+  L   P    
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLE 243
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
            G    +  ++Y +   +                   ++   L  DP KR T  E LRH 
Sbjct: 244 TGVQDKEMLKKYGKSFRK-------------------MISLCLQKDPEKRPTAAELLRHK 284
Query: 329 YLQ 331
           + Q
Sbjct: 285 FFQ 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 54/303 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           IG GA  +V AA  +  +E+VAIK+I N           L+EI+ +    H N+++    
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 106 --IKDIIRPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQL 154
             +KD           ++++V +L+      D   H + + + +   L +      L ++
Sbjct: 82  FVVKD-----------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTR 208
           L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T 
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            + APE++     Y    DIWS G    E+ T     P   Y     L+  L   P    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLE 248
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
            G    +  ++Y +   +                   ++   L  DP KR T  E LRH 
Sbjct: 249 TGVQDKEMLKKYGKSFRK-------------------MISLCLQKDPEKRPTAAELLRHK 289
Query: 329 YLQ 331
           + Q
Sbjct: 290 FFQ 292

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y+V E M   D+   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y+V E M   D+   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 47  IRPIGRGAYGIVC---AAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            ++   D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L +
Sbjct: 82  FIV---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR- 195
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +  A+D WS+G ++ +++T  P F G++
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 47  IRPIGRGAYGIVC---AAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            ++   D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L +
Sbjct: 82  FIV---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR- 195
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +  A+D WS+G ++ +++T  P F G++
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKD 108
           +G+G +G      + ET E + +K++   FD   + +RT L+E+K++R +EH NV+    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR-FDE--ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           ++   K+  F   YI        L  II+S D Q        F   +  G+ Y+HS +++
Sbjct: 75  VLYKDKRLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLA-------------RTTSETDFMTEYVVTR--WYRA 212
           HRDL   N L+  + ++ + DFGLA             R+  + D    Y V    ++ A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           PE ++N   Y   +D++S G +L EI+ R
Sbjct: 191 PE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKL 94
           E+   YV     IG G +G VC   + +  ++E  VAIK +   +      R  L E  +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 70
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLY 152
           +   EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L 
Sbjct: 71  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYV 205
            +  G++Y+   S +HRDL   N+L+N++   K+ DFGL+R         +ET  +   +
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 186 PIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           ++K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 200
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 288
           WS+G +  E++  EP +  ++ +  L LI    G+P+                       
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE----------------------- 236
Query: 289 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 + P K S    D L + L  D  KR + +E ++H +L+
Sbjct: 237 -----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRT 88
           E S KY   + P+G GA+G V  AV+ E  +EV +K I    + +++          + T
Sbjct: 21  EYSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKK--EKVLEDCWIEDPKLGKVT 77
Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 148
           L EI +L  +EH N+I + DI    +   F  + +       DL   I    +L +    
Sbjct: 78  L-EIAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
           Y   QL+  + Y+    ++HRD+K  N+++     +K+ DFG A           +  T 
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
            Y APE+L+        +++WS+G  L  ++  E  F
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/328 (25%), Positives = 145/328 (44%), Gaps = 56/328 (17%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G+L  +  K +     +GRGA+G+VC A      ++VAIK+I    ++  + +  + E++
Sbjct: 1   GSLHMIDYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELR 54
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQL---TDDHCQY 149
            L  + H N++ +            N V +V E  +   L+ ++   + L   T  H   
Sbjct: 55  QLSRVNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 150 FLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYV 205
           +  Q  +G+ Y+HS    +++HRDLKP NLLL A    LKI DFG A        MT   
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNK 165
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
            +  + APE+    + Y+   D++S G IL E++TR   F             + IG P 
Sbjct: 166 GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF-------------DEIGGPA 211
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  + +      ++ LP+          P +S     L+ +    DP++R ++EE +
Sbjct: 212 FRIMWAVHNGTRPPLIKNLPK----------PIES-----LMTRCWSKDPSQRPSMEEIV 256
Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHS 353
           +       H +   P    P  +  +HS
Sbjct: 257 K----IMTHLMRYFPGADEPLQYPCQHS 280

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 136/320 (42%), Gaps = 58/320 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GA+  V   +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIE 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                ++D F   Y+V+E M    +   I   +   +      +  +   L ++H+  + 
Sbjct: 79  FFE--EEDRF---YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 168 HRDLKPSNLLL---NASCDLKIGDFGLARTTS--------ETDFMTEYVVTRWYRAPELL 216
           HRDLKP N+L    N    +KI DFGL              T  +     +  Y APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
              +E    Y    D+WS+G IL  +++  P F G+             GS      G+ 
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR------------CGS----DCGWD 237
Query: 273 RSDNARRYVRQLPRCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITV 321
           R +         P C+   F +       FP+K     S  A DL+ K+LV D  +R++ 
Sbjct: 238 RGEAC-------PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 322 EEALRHPYLQSLHDLNDEPV 341
            + L+HP++Q     N  P 
Sbjct: 291 AQVLQHPWVQGCAPENTLPT 310

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKL 94
           E+   YV     IG G +G VC   + +  ++E  VAIK +   +      R  L E  +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 68
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLY 152
           +   EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L 
Sbjct: 69  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-------TDFMTEYV 205
            +  G++Y+   S +HRDL   N+L+N++   K+ DFGL+R   E       T  +   +
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 184 PIRW-TAPEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 152/339 (44%), Gaps = 69/339 (20%)
Query: 22  THGGKYVQYNVYGNL--FEVSSK-YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           + GGK  + +   N+  FE S K  V   + +G G+ G V    + + R  VA+K++   
Sbjct: 10  SRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLID 68
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           F +I      L EIKLL   + H NVI           D F  +YI  EL + +L  ++ 
Sbjct: 69  FCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVE 118
Query: 138 SDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK---- 185
           S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ S        
Sbjct: 119 S-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 186 ---------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE--YTAAIDIW 229
                    I DFGL +   + +  F   +     T  +RAPELL   T+   T +IDI+
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 230 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 289
           S+GC+   I+++     G  Y  +  +I  +       SL  ++  + R  + +      
Sbjct: 238 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAE------ 285
Query: 290 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                        A DL+ +M+  DP KR T  + LRHP
Sbjct: 286 -------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 139/312 (44%), Gaps = 56/312 (17%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRGA+G+VC A      ++VAIK+I    ++  + +  + E++ L  + H N++ +   
Sbjct: 16  VGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS-- 163
                    N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS  
Sbjct: 70  -------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 164 -ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             +++HRDLKP NLLL A    LKI DFG A        MT    +  + APE+    + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SN 179
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y+   D++S G IL E++TR   F             + IG P    +  + +      +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLI 226
Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
           + LP+          P +S     L+ +    DP++R ++EE ++       H +   P 
Sbjct: 227 KNLPK----------PIES-----LMTRCWSKDPSQRPSMEEIVK----IMTHLMRYFPG 267
Query: 342 CPRPFHFDFEHS 353
              P  +  +HS
Sbjct: 268 ADEPLQYPCQHS 279

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V      
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                K     ++I+ E +       +       +      L ++L+GL Y+HS   +HR
Sbjct: 90  YLKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DI
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADI 203
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           WS+G    E+   EP  P  D +H +R++
Sbjct: 204 WSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 152/339 (44%), Gaps = 69/339 (20%)
Query: 22  THGGKYVQYNVYGNL--FEVSSK-YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           + GGK  + +   N+  FE S K  V   + +G G+ G V    + + R  VA+K++   
Sbjct: 10  SRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLID 68
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           F +I      L EIKLL   + H NVI           D F  +YI  EL + +L  ++ 
Sbjct: 69  FCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVE 118
Query: 138 SDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK---- 185
           S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ S        
Sbjct: 119 S-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 186 ---------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE--YTAAIDIW 229
                    I DFGL +   + +  F   +     T  +RAPELL   T+   T +IDI+
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 230 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 289
           S+GC+   I+++     G  Y  +  +I  +       SL  ++  + R  + +      
Sbjct: 238 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSLIAE------ 285
Query: 290 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                        A DL+ +M+  DP KR T  + LRHP
Sbjct: 286 -------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 48/306 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GAY  V  AV+ +  +E A+K I     +     R  RE++ L   + ++N++   +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH--SRSRVFREVETLYQCQGNKNIL---E 75
Query: 109 IIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +I   + DT    Y+V+E L    +   I+  +   +      +  +   L ++H+  + 
Sbjct: 76  LIEFFEDDT--RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 168 HRDLKPSNLLLNAS--------CDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPEL 215
           HRDLKP N+L  +         CD  +G  G+    S T   T  + T      Y APE+
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGS-GMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 216 LL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           +       T Y    D+WS+G +L  +++  P F G                   A  G+
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGH----------------CGADCGW 236
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALR 326
            R +  R    +L     Q+    FP+K     SS A DL+ K+LV D  +R++  + L+
Sbjct: 237 DRGEVCRVCQNKLFE-SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 327 HPYLQS 332
           HP++Q 
Sbjct: 296 HPWVQG 301

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 105
           IR +G G++G V    + ET    A+K        I+D ++ ++    L+ +EH  N   
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK----LKQIEHTLNEKR 94
Query: 106 IKDIIRPPK--------KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           I+  +  P         KD  N +Y+V E     ++   +R   + ++ H +++  Q++ 
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSN-LYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
             +Y+HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII 211
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L    Y  A+D W++G ++ E+    P F
Sbjct: 212 L-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 61/310 (19%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQ-------DCPKARREVEL--HWRASQCPHIVRI 120
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+         +   ++
Sbjct: 121 V-----DVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQ 175
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 234
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
           L   +Y  + D WS+G I   ++   P F      H L +      SP   +        
Sbjct: 235 LGPEKYDKSCDXWSLGVIXYILLCGYPPFYSN---HGLAI------SPGXKT-------- 277
Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQ 331
                    R R  Q+   FPN     V      L+  +L  +P +R T+ E   HP++ 
Sbjct: 278 ---------RIRXGQY--EFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 332 SLHDLNDEPV 341
               +   P+
Sbjct: 327 QSTKVPQTPL 336

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGLAR      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHS 163
             ++      T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++  
Sbjct: 76  HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCT 220
            + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE  +N  
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFG 187
Query: 221 EYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +T   D+WS G +L EI+T  R P +PG
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIP-YPG 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 248
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGL 158
             ++      T   +YI+ E M    L   ++SD+       +L D     F  Q+  G+
Sbjct: 249 HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGM 297
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPEL 215
            ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE 
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE- 355
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           +Y+  IR +G G +G V        N  T E VA+K +       + +    REI++LR 
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILRT 67
Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY- 152
           + HE+++  K       + +   V +V E +       + S +     HC    Q  L+ 
Sbjct: 68  LYHEHIVKYKGCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFA 118
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R   
Sbjct: 119 QQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDG 175
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 176 DSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 41  SKYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            +Y+  IR +G G +G V        N  T E VA+K +       + +    REI++LR
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILR 65
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY 152
            + HE+++  K       + +   V +V E +       + S +     HC    Q  L+
Sbjct: 66  TLYHEHIVKYKGCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLF 116
Query: 153 --QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-- 208
             Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R  
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRED 173
Query: 209 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                 WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 174 GDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 86  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSK 199
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 200 ADIWSLGITAIELARGEP 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAI 106
           R +G+G +G VCA     T +  A KK+              L E ++L  +    V+++
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KD    V  +    D   H          +    ++  ++  GL+ +H   +
Sbjct: 250 AYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSP 366
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           D W++GC+L E++  +                    SP       ++ +   R V+++P 
Sbjct: 367 DWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP- 405
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 334
              ++++ RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 406 ---EEYSERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 35/241 (14%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI- 104
           PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L  +EH  ++ 
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 105 --------AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH----CQYFLY 152
                      + ++P     +  +YI  +L   +  +   + +   ++     C +   
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVY--LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------------- 199
           Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +             
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             T  V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+P    + ++R +T+
Sbjct: 186 RHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTD 239
Query: 260 L 260
           +
Sbjct: 240 V 240

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL R      E  + T    +  RW  +PE +   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 224
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 109
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 110 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 222
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 223 RKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNII 80
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+ 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLL 217
               +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE + 
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA 194
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G +L E+M+
Sbjct: 195 -YRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 100 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNC 219
             +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE +   
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-Y 212
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            ++T+A D+WS G +L E+M+
Sbjct: 213 RKFTSASDVWSYGIVLWEVMS 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 91  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSK 204
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 205 ADIWSLGITAIELARGEP 222

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 71  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSK 184
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 185 ADIWSLGITAIELARGEP 202

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+  +    + E  VAIK + + +      R  L E  ++   +H NVI +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++    K T   V I+ E M+   L   +R +D Q T       L  +  G+KY+   
Sbjct: 100 EGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRWYRAPELLL 217
           + +HRDL   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW  APE  +
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AI 212
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G ++ E+M+
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNII 80
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+ 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLL 217
               +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  +PE + 
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA 194
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G +L E+M+
Sbjct: 195 -YRKFTSASDVWSYGIVLWEVMS 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 71  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSK 184
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 185 ADIWSLGITAIELARGEP 202

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAI 106
           R +G+G +G VCA     T +  A KK+              L E ++L  +    V+++
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KD    V  +    D   H          +    ++  ++  GL+ +H   +
Sbjct: 250 AYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSP 366
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           D W++GC+L E++  +                    SP       ++ +   R V+++P 
Sbjct: 367 DWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP- 405
Query: 287 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 334
              ++++ RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 406 ---EEYSERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFGLA+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 136/298 (45%), Gaps = 54/298 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G YG V    + +T +  AIK +    D   +     +EI +L+   H   IA    
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 106 --IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             IK    PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL 
Sbjct: 89  AFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLS 143
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN 218
           ++H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA- 202
Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           C E     Y    D+WS+G    E+    P  P  D +H +R +  +  +P         
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNP--------- 250
Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                      PR + ++++ +F +        +E  LV + ++R   E+ ++HP+++
Sbjct: 251 ----------APRLKSKKWSKKFQS-------FIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 135/320 (42%), Gaps = 58/320 (18%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GA+  V   +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIE 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                ++D F   Y+V+E M    +   I   +   +      +  +   L ++H+  + 
Sbjct: 79  FFE--EEDRF---YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 168 HRDLKPSNLLL---NASCDLKIGDFGLARTTS--------ETDFMTEYVVTRWYRAPELL 216
           HRDLKP N+L    N    +KI DF L              T  +     +  Y APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
              +E    Y    D+WS+G IL  +++  P F G+             GS      G+ 
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR------------CGS----DCGWD 237
Query: 273 RSDNARRYVRQLPRCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITV 321
           R +         P C+   F +       FP+K     S  A DL+ K+LV D  +R++ 
Sbjct: 238 RGEAC-------PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 322 EEALRHPYLQSLHDLNDEPV 341
            + L+HP++Q     N  P 
Sbjct: 291 AQVLQHPWVQGCAPENTLPT 310

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIA 105
           IG G +G V  A      +EVA+K   +  D   D  +T+    +E KL   ++H N+IA
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDE--DISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 106 IKDI-IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           ++ + ++ P      ++ +V E         + S +++  D    +  Q+ RG+ Y+H  
Sbjct: 71  LRGVCLKEP------NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 165 SV---LHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           ++   +HRDLK SN+L+    +        LKI DFGLAR    T  M+      W  AP
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM-AP 183
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           E ++  + ++   D+WS G +L E++T E  F G D
Sbjct: 184 E-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 37/211 (17%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 242
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGL 158
             ++      T   +YI+ E M    L   ++SD+       +L D     F  Q+  G+
Sbjct: 243 HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGM 291
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            ++   + +HRDL+ +N+L++AS   KI DFGLAR  ++          +W  APE  +N
Sbjct: 292 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW-TAPE-AIN 342
Query: 219 CTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
              +T   D+WS G +L EI+T  R P +PG
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 372

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 36/224 (16%)
Query: 48  RPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A        + +  VA+K + +A DN   AR+   RE +LL +++HE
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHE 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHC 147
           +++    +         + + +V+E M   DL++ +R+               +LT    
Sbjct: 76  HIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----E 203
            +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+       
Sbjct: 131 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 191 MLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 85/352 (24%), Positives = 139/352 (39%), Gaps = 81/352 (23%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNI--IDARRTLR 90
           G+L E+  KY      IG+G+YG+V  A+ ++TR   AIK +  N    I   D  R   
Sbjct: 19  GSLLELQKKYHLK-GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 91  EIKLLRHMEHENVIAIKDIIRPP-----------------KKDTFNDVYIVYELMDTDLH 133
           E++L++ + H N+  + ++                     K + F D       MD    
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 134 QII---RSDQQLTDDHCQYF----------------LYQLLRGLKYVHSASVLHRDLKPS 174
           QI      +++  +     F                + Q+   L Y+H+  + HRD+KP 
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 175 NLLL--NASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAI 226
           N L   N S ++K+ DFGL++        E   MT    T ++ APE+L    E Y    
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 286
           D WS G +L  ++     FPG   V+    I++++                         
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPG---VNDADTISQVL------------------------- 289
Query: 287 CRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
              ++     PN    S  A DLL  +L  + ++R     AL+HP++    D
Sbjct: 290 --NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG G +G VC+    +  +    VAIK +   +      R  L E  ++   +H NV+
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK-QRRDFLCEASIMGQFDHPNVV 107
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G++Y+ 
Sbjct: 108 HLEGVVTRGKP-----VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELL 216
               +HRDL   N+L+N++   K+ DFGL+R   E D    Y  T      RW  APE  
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGGKIPVRW-TAPE-A 219
Query: 217 LNCTEYTAAIDIWSVGCILGEIMT 240
           +   ++T+A D+WS G ++ E+M+
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 137/312 (43%), Gaps = 70/312 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G G+ G V    + + R  VA+K++   F +I      L EIKLL   + H NVI    
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY-- 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKY 160
                  D F  +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ +
Sbjct: 75  -YCSETTDRF--LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLK-------------IGDFGLART--TSETDFMTEY- 204
           +HS  ++HRDLKP N+L++ S                 I DFGL +   + ++ F T   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 205 --VVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
               T  +RAPELL            T +IDI+S+GC+   I+++     G  Y  +  +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           I  +       SL  ++  + R  + +                   A DL+ +M+  DP 
Sbjct: 251 IRGIF------SLDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPL 285
Query: 317 KRITVEEALRHP 328
           KR T  + LRHP
Sbjct: 286 KRPTAMKVLRHP 297

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 130/301 (43%), Gaps = 51/301 (16%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVI 104
           P   +G GA G +      + R+ VA+K+I     +  D     RE++LLR   EH NVI
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFAD-----REVQLLRESDEHPNVI 81
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                    K   F   YI  EL    L + + + D           L Q   GL ++HS
Sbjct: 82  RY---FCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 164 ASVLHRDLKPSNLLL---NASCDLK--IGDFGLAR--TTSETDFMTEYVV--TRWYRAPE 214
            +++HRDLKP N+L+   NA   +K  I DFGL +        F     V  T  + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 215 LLL-NCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           +L  +C E  T  +DI+S GC+   +++      GK    Q  +   L+G+    SL  L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LLGA---CSLDCL 250
Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +     +                     A +L+EKM+  DP KR + +  L+HP+  S
Sbjct: 251 HPEKHEDVI---------------------ARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
Query: 333 L 333
           L
Sbjct: 290 L 290

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFGLA+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           E+ +  +   R IG G +G VC+    +  +    VAIK +   +      R  L E  +
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK-QRRDFLGEASI 76
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +   +H N+I ++ ++   K       Y+    +DT L    ++D Q T       L  +
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGI 133
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRW 209
             G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             APE +    ++T+A D+WS G ++ E+++
Sbjct: 194 -TAPEAIA-FRKFTSASDVWSYGIVMWEVVS 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 82
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILS-K 199
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 111/215 (51%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  +R +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLY 152
           +L+ ++H+N++  K +     +    ++ ++ E +    L + ++  ++  D H +   Y
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEFLPYGSLREYLQKHKERID-HIKLLQY 122
Query: 153 --QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-- 208
             Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +       
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 209 ---WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 183 PIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           E+ +  +   + IG G +G VC+    V  +    VAIK +   + +    R  L E  +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 83
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLY 152
           +   +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L 
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 138
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVT 207
            +  G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  
Sbjct: 139 GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 199 RW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 229

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTL--CGTPEYLAPEIILS-K 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--AGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 241 KKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 241 KKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 241 KKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 70  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 183
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 243
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 244 KKDPKQR 250

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N+ +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
           EI++L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLL 135
Query: 151 LY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +     
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 196 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 72  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 185
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 245
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 246 KKDPKQR 252

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N+ +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
           EI++L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLL 135
Query: 151 LY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +     
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 196 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 241 KKDPKQR 247

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  L+
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLM 61
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHC 147
           + ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D   
Sbjct: 62  KTLQHDKLVRLYAVVTKEEP-----IYIITEFMAKGSLLDFLKSDEGGKVLLPKLID--- 113
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 207
             F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++       
Sbjct: 114 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 171
Query: 208 ---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
              +W  APE  +N   +T   ++WS G +L EI+T   + +PG+
Sbjct: 172 FPIKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGR 214

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 140/326 (42%), Gaps = 52/326 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+  +   +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSI 196
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP---GKDYVHQLRLITELIG 262
            TR YR+PE+LL    +    DIWS  C++ E++T + LF    G  Y      I ++I 
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 263 SPDDASLGFLRSD-------NARRYVRQLPRCR----------KQQFATRFPNKSSGAVD 305
              +     LR+        N+R  +R + + +          K +F+    +++    D
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK---DEAKEISD 312
Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQ 331
            L  ML  DP KR      + HP+L+
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLK 338

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           + +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEAN 60
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDD 145
           L++ ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D 
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID- 114
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
               F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++     
Sbjct: 115 ----FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 170
Query: 206 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG+
Sbjct: 171 AKFPIKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGR 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 140/326 (42%), Gaps = 52/326 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+  +   +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSI 196
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP---GKDYVHQLRLITELIG 262
            TR YR+PE+LL    +    DIWS  C++ E++T + LF    G  Y      I ++I 
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 263 SPDDASLGFLRSD-------NARRYVRQLPRCR----------KQQFATRFPNKSSGAVD 305
              +     LR+        N+R  +R + + +          K +F+    +++    D
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK---DEAKEISD 312
Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQ 331
            L  ML  DP KR      + HP+L+
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLK 338

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GFL 272
           +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+      SP+  SL  G L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 273 RSDNARR 279
           + D  +R
Sbjct: 241 KKDPKQR 247

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 83
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 200
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 6/131 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE     +   A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPG 247
           E++T EP F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/362 (24%), Positives = 151/362 (41%), Gaps = 82/362 (22%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           IR +G G +  V  + + + ++ VA+K + +A      A   +R +K +R+ +      E
Sbjct: 26  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 85
Query: 102 NVIAIKDIIRPPKKDTFNDVYI--VYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRG 157
            V+ + D     K    N  +I  V+E++   L + II+S+ Q     C +  + Q+L+G
Sbjct: 86  MVVQLLDDF---KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 142
Query: 158 LKYVHS-ASVLHRDLKPSNLLLNAS----------------------------------- 181
           L Y+H+   ++H D+KP N+LL+ +                                   
Sbjct: 143 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 202
Query: 182 --------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
                           +KI D G A    +    TE + TR YR+ E+L+  + Y    D
Sbjct: 203 NFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPAD 259
Query: 228 IWSVGCILGEIMTREPLF---PGKDYVH---QLRLITELIGS-------PDDASLGFLRS 274
           IWS  C+  E+ T + LF    G++Y      + LI EL+G            S  F   
Sbjct: 260 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 319
Query: 275 DNARRYVRQL-PRCRKQQFATRFP---NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               +++ +L P    +    ++     +++G  D L  ML   P KR T  E LRHP+L
Sbjct: 320 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 379
Query: 331 QS 332
            S
Sbjct: 380 NS 381

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 227
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 228 EVLTGEPPFTGDSPV 242

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 92  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 206
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 209
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 89  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 203
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           E+ +  +   + IG G +G VC+    V  +    VAIK +   + +    R  L E  +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 68
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLY 152
           +   +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L 
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVT 207
            +  G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 184 RW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 115 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 229
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           E+ +  +   + IG G +G VC+    V  +    VAIK +   + +    R  L E  +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 62
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLY 152
           +   +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L 
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 117
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVT 207
            +  G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  
Sbjct: 118 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 178 RW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 208

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 44/292 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +   +    + EI++L   +H  ++ +   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K     ++I+ E         I    D+ LT+   Q    Q+L  L ++HS  ++
Sbjct: 77  YYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL----LNCTEY 222
           HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE++    +  T Y
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
               DIWS+G  L E+   EP        H+L                     N  R + 
Sbjct: 192 DYKADIWSLGITLIEMAQIEPPH------HEL---------------------NPMRVLL 224
Query: 283 QLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++ +       T  P+K S    D L+  L  +P  R +  + L HP++ S+
Sbjct: 225 KIAKSDPPTLLT--PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 210
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/362 (24%), Positives = 151/362 (41%), Gaps = 82/362 (22%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           IR +G G +  V  + + + ++ VA+K + +A      A   +R +K +R+ +      E
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 102 NVIAIKDIIRPPKKDTFNDVYI--VYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRG 157
            V+ + D     K    N  +I  V+E++   L + II+S+ Q     C +  + Q+L+G
Sbjct: 102 MVVQLLDDF---KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 158 LKYVHS-ASVLHRDLKPSNLLLNAS----------------------------------- 181
           L Y+H+   ++H D+KP N+LL+ +                                   
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 182 --------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
                           +KI D G A    +    TE + TR YR+ E+L+  + Y    D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPAD 275
Query: 228 IWSVGCILGEIMTREPLF---PGKDYVH---QLRLITELIGS-------PDDASLGFLRS 274
           IWS  C+  E+ T + LF    G++Y      + LI EL+G            S  F   
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 275 DNARRYVRQL-PRCRKQQFATRFP---NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
               +++ +L P    +    ++     +++G  D L  ML   P KR T  E LRHP+L
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
Query: 331 QS 332
            S
Sbjct: 396 NS 397

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 116 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 230
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 94  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 208
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     E+   +   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPG 177
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 178 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +   +    + EI++L   +H  ++ +   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K     ++I+ E         I    D+ LT+   Q    Q+L  L ++HS  ++
Sbjct: 85  YYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL----LNCTEY 222
           HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE++    +  T Y
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 223 TAAIDIWSVGCILGEIMTREP 243
               DIWS+G  L E+   EP
Sbjct: 200 DYKADIWSLGITLIEMAQIEP 220

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+  +    + E  VAIK + + +      R  L E  ++   +H NVI +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++    K T   V I+ E M+   L   +R +D Q T       L  +  G+KY+   
Sbjct: 74  EGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRWYRAPELLL 217
           + +HR L   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW  APE  +
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AI 186
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G ++ E+M+
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 91
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 208
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 95/360 (26%), Positives = 150/360 (41%), Gaps = 80/360 (22%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE----- 101
           IR +G G +  V    + + +  VA+K + +A      A   L EIKLL+ +        
Sbjct: 36  IRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETA---LDEIKLLKCVRESDPSDP 92
Query: 102 NVIAIKDIIRPPKKDTFNDVYI--VYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRG 157
           N   +  +I   K    N +++  V+E++   L + II+S+ Q     C +  + Q+L+G
Sbjct: 93  NKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQG 152
Query: 158 LKYVHS-ASVLHRDLKPSNLLL--------------------------------NASCDL 184
           L Y+HS   ++H D+KP N+L+                                  + DL
Sbjct: 153 LDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADL 212
Query: 185 ---------------KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 229
                          KI D G A    +    TE + TR YR+ E+L+    Y+   DIW
Sbjct: 213 LVNPLDPRNADKIRVKIADLGNACWVHK--HFTEDIQTRQYRSIEVLIGAG-YSTPADIW 269
Query: 230 SVGCILGEIMTREPLF---PGKDYVH---QLRLITELIGS-PDDASLGFLRSD---NARR 279
           S  C+  E+ T + LF    G+DY      +  I EL+GS P   +L    S    N R 
Sbjct: 270 STACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRG 329
Query: 280 YVRQLPRCRKQQF------ATRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            +R + + +             +P++ +    D L  ML   P KR +  E LRHP+L S
Sbjct: 330 ELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS 389

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y APE  L  T Y+   DIWS+G  L 
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLV 204
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN---- 102
           +R +G G++G V    +       A+K        ++     +R    L+ +EH N    
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMK--------VLKKEIVVR----LKQVEHTNDERL 58
Query: 103 ---VIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
              ++    IIR     TF D   ++ +MD     +L  ++R  Q+  +   +++  ++ 
Sbjct: 59  MLSIVTHPFIIR--MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
             L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +  +      T  Y APE 
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAPE- 173
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT 240
           +++   Y  +ID WS G ++ E++ 
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 64
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 121
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HR+L   N+L+     +KIGDFGL +   +     EY   +   
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPG 178
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 179 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 213

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 136/312 (43%), Gaps = 70/312 (22%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G G+ G V    + + R  VA+K++   F +I      L EIKLL   + H NVI    
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY-- 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKY 160
                  D F  +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ +
Sbjct: 75  -YCSETTDRF--LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLK-------------IGDFGLART--TSETDF---MT 202
           +HS  ++HRDLKP N+L++ S                 I DFGL +   + +  F   + 
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 203 EYVVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
               T  +RAPELL            T +IDI+S+GC+   I+++     G  Y  +  +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           I  +       SL  ++  + R  + +                   A DL+ +M+  DP 
Sbjct: 251 IRGIF------SLDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPL 285
Query: 317 KRITVEEALRHP 328
           KR T  + LRHP
Sbjct: 286 KRPTAMKVLRHP 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 102 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 216
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 156 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 270
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ ++    P F
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 28/274 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 7   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 63
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQL 154
              H N++        P+      + IV +  +     H +  S+ +           Q 
Sbjct: 64  KTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 117
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 211
            RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + 
Sbjct: 118 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 212 APEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----SPD 265
           APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    SPD
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPD 234
Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 297
              L  +RS+  +R  R +  C K++   R  FP
Sbjct: 235 ---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 265

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQL 154
              H N++        P+      + IV +  +     H +  S+ +           Q 
Sbjct: 76  KTRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWY 210
            RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W 
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 211 RAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----SP 264
            APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    SP
Sbjct: 190 -APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSP 245
Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 297
           D   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 246 D---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQL 154
              H N++        P+      + IV +  +     H +  S+ +           Q 
Sbjct: 76  KTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWY 210
            RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W 
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 211 RAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----SP 264
            APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    SP
Sbjct: 190 -APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSP 245
Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 297
           D   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 246 D---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 209
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +  + +  T      +W       L  
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--LQT 210
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 68
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 125
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 186 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 69
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 126
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 187 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 94
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 151
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 212 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 67
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 124
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 185 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 123
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 184 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 70
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 127
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 188 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 219

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 39/227 (17%)
Query: 48  RPIGRGAYGIVCAAVN---SETREE--VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A     S T+++  VA+K +    D  + AR+   RE +LL +++HE
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHE 77
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFL 151
           +++    +         + + +V+E M   DL++ +R+         D Q      +  L
Sbjct: 78  HIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 152 YQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-- 202
            Q+L        G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R    TD+    
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
               +  RW   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 193 GHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 181 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A+ D 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIK--------ILKKDVVIQDDDVECTMVEKRVLALLD- 77
Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  +    ++  ++  GL ++
Sbjct: 78  -KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCT 220
           H   +++RDLK  N++L++   +KI DFG+ +        T E+  T  Y APE++    
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY-Q 195
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +P F G+D     + I E
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 193
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 229
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 308
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 230 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 269
Query: 309 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 347
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 270 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 303

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 193
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 210
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 308
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 211 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 250
Query: 309 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 347
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 251 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 284

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFG A+      +      T  Y APE+++   
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIII-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 62
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 119
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 180 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 61
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 118
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 179 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 181 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 213
Query: 237 EI-MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 295
           E+ + R P+  G   +    L+  ++  P                    P+     F+  
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELLDYIVNEPP-------------------PKLPSGVFSLE 254
Query: 296 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           F        D + K L+ +P +R  +++ + H +++
Sbjct: 255 FQ-------DFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 72
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 73  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 126
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   +++  +  D H +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQAHAERID-HIKLLQYT 123
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 184 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 50  IGRGAYGIVCAAV--NSETREEV--AIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           IG G +G V   +   S  ++EV  AIK +   +    + +R   L E  ++    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNI 108
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ +I       +  + I+ E M+   L + +R  D + +       L  +  G+KY+
Sbjct: 109 IRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPEL 215
            + + +HRDL   N+L+N++   K+ DFGL+R   E D    Y  +      RW  APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRW-TAPE- 220
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT 240
            ++  ++T+A D+WS G ++ E+MT
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y AP ++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPAIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRGAYG V   V+  + + +A+K+I +  D     +  +    ++R  +   ++     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC-QYFLYQL----LRGLKYV-HS 163
           +         D +I  ELM T   +  +    + DD   +  L ++    ++ L ++  +
Sbjct: 90  LF-----REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCT 220
             ++HRD+KPSN+LL+ S ++K+ DFG++    ++   T     R Y APE +    +  
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI-GSPDDASLGFLRSDNARR 279
            Y    D+WS+G  L E+ T    FP   +      +T+++ G P               
Sbjct: 205 GYDVRSDVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPP-------------- 248
Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE 339
              QL    +++F+  F       ++ +   L  D +KR   +E L+HP++    +   E
Sbjct: 249 ---QLSNSEEREFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE 298
Query: 340 PVC 342
             C
Sbjct: 299 VAC 301

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 68
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 69  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 122
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 57
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 58  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 111
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 13  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 67
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 68  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 121
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I +   +    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNIITL---LGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQ 148
           NV+ +      P       + ++ E     +L   +RS +             LT +H  
Sbjct: 92  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---Y 204
            + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    
Sbjct: 148 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 208 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILR 71
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            + HE++I  K       + +     +V E +     +       +       F  Q+  
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 128
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------- 208
           G+ Y+HS   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R        
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVF 185
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           WY APE L     Y A+ D+WS G  L E++T
Sbjct: 186 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 443
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 444 TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----------------DQQLTD 144
           +N+I   +++    +D    V + Y     +L + +R+                ++Q+T 
Sbjct: 101 KNII---NLLGACTQDGPLYVIVAYA-SKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  + 
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 205 VVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T    APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEALAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  ++I DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I    ++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---HLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 116/249 (46%), Gaps = 26/249 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A +       A+K +          ++ + + K  +H+  E  + +
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVL---------QKKAILKKKEEKHIMSERNVLL 93
Query: 107 KDIIRPP------KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           K++  P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLN 218
           Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE +L+
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLH 212
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ--------LRLITELIGSPDDASLG 270
              Y   +D W +G +L E++   P F  ++            L+L   +  S      G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
Query: 271 FLRSDNARR 279
            L+ D  +R
Sbjct: 273 LLQKDRTKR 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D   +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D   +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTL 89
           G +  V+      ++ +G+G +G V       T    A+K +      +I A+     TL
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTL 57
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
            E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRAR 112
Query: 149 YFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVV 206
           ++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  
Sbjct: 113 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL---- 260
           T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+    
Sbjct: 173 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 231
Query: 261 IGSPDDASL--GFLRSDNARR 279
              P+  SL  G L+ D  +R
Sbjct: 232 TLGPEAKSLLSGLLKKDPKQR 252

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREI 92
           G  +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E 
Sbjct: 1   GPEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEA 55
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQY 149
            L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +    
Sbjct: 56  NLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
              Q+  G+ ++   + +HR+L+ +N+L++ +   KI DFGLAR   + ++         
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 169
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
            +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 IKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILR 71
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            + HE++I  K       + +     +V E +     +       +       F  Q+  
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 128
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------- 208
           G+ Y+H+   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R        
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVF 185
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           WY APE L     Y A+ D+WS G  L E++T
Sbjct: 186 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 68
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 69  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 122
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I  IG G +G V  A +    +   I+++   ++N     +  RE+K L  ++H N++  
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRV--KYNN----EKAEREVKALAKLDHVNIVHY 70
Query: 105 ------------AIKDIIRPPKKDTFND----------VYIVYELMDTD-LHQII--RSD 139
                          D +     D  N           ++I  E  D   L Q I  R  
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
           ++L          Q+ +G+ Y+HS  ++HRDLKPSN+ L  +  +KIGDFGL  +     
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
             T    T  Y +PE  ++  +Y   +D++++G IL E++
Sbjct: 191 KRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 16  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 70
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 71  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 124
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQ 148
           NV+ +      P       + ++ E     +L   +RS +             LT +H  
Sbjct: 92  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---Y 204
            + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    
Sbjct: 148 CYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 208 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G +G V  A +    +   IK++   ++N     +  RE+K L  ++H N++  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNN----EKAEREVKALAKLDHVNIVHY 69
Query: 107 KDIIRP----PKKDTFND-------VYIVYELMDTD-LHQII--RSDQQLTDDHCQYFLY 152
                     P+  + N        ++I  E  D   L Q I  R  ++L          
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +            T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIM 239
           PE  ++  +Y   +D++++G IL E++
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 17  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 71
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 72  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 125
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 90  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 205 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 88  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 203 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 241

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 123/248 (49%), Gaps = 24/248 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 72  LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED- 185
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GF 271
            +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+       P+  SL  G 
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 245
Query: 272 LRSDNARR 279
           L+ D  +R
Sbjct: 246 LKKDPKQR 253

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 93  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 208 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 246

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 123/248 (49%), Gaps = 24/248 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 70  LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED- 183
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GF 271
            +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+       P+  SL  G 
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 243
Query: 272 LRSDNARR 279
           L+ D  +R
Sbjct: 244 LKKDPKQR 251

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 10  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 64
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 65  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 118
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----------------DQQLTD 144
           +N+I   +++    +D    V + Y     +L + +R+                ++Q+T 
Sbjct: 101 KNII---NLLGACTQDGPLYVIVGYA-SKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  + 
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 205 VVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR----------------SDQQLTDDH 146
           ++ +               Y  Y     DL   +R                 ++QL+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEY 204
             +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y
Sbjct: 168 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNY 222
Query: 205 VV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 223 IVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 147 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 9   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 63
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       
Sbjct: 64  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 117
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 443
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 444 TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++T   +  V T  Y APE L   
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG- 209
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 250
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 251 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 365 VAYDSSADWFSLGCMLFKLL 384

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVY-----------ELMDTDLHQIIRSDQQLTDDHCQYFL 151
           ++ +               Y  Y            +++TD    I +    T D   +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD-LLHFS 170
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV--- 206
            Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 226 ARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 54/238 (22%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF-MTEYVV- 206
           ++  L + LK +H   ++HRD+KPSN L N       + DFGLA+ T +T   + ++V  
Sbjct: 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 207 ---------------------------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
                                      T  +RAPE+L  C   T AID+WS G I   ++
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 240 T-REPLFPGKDYVHQLRLITELIGSPD--DASLGFLRSDNARRYV-----RQL-PRCRKQ 290
           + R P +   D +  L  I  + GS +   A+  F +S    + V     R+L  R R  
Sbjct: 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301
Query: 291 QFAT-RFPNKSSGAVDLLE--------------KMLVFDPNKRITVEEALRHPYLQSL 333
             +T +  +   G    LE              K+L  +P  RIT EEAL HP+ + +
Sbjct: 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DAGPQHRSGWKQEIDILR 88
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            + HE++I  K         +     +V E +     +       +       F  Q+  
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 145
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------W 209
           G+ Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V         W
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVREDGDSPVFW 203
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           Y APE L     Y A+ D+WS G  L E++T
Sbjct: 204 Y-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 32/266 (12%)
Query: 25  GKYVQYNVY-GNLFEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNA 78
           G +   +VY  + +EV+ + +   R +G+G++G+V        V  E    VAIK +  A
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR 137
             ++ +    L E  +++     +V+ +  ++   +        ++ ELM   DL   +R
Sbjct: 61  -ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLR 114
Query: 138 SDQQLTDDH----------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           S +   +++                ++  G+ Y+++   +HRDL   N ++     +KIG
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 174
Query: 188 DFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE 242
           DFG+ R   ETD+  +     +  RW  +PE L +   +T   D+WS G +L EI T  E
Sbjct: 175 DFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAE 232
Query: 243 PLFPGKDYVHQLRLITE--LIGSPDD 266
             + G      LR + E  L+  PD+
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLLDKPDN 258

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 184
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 185 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 243 FVMEGGLLDKPDN 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 65
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 181 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 239 FVMEGGLLDKPDN 251

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 123/248 (49%), Gaps = 24/248 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 213 LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 326
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GF 271
            +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+       P+  SL  G 
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 386
Query: 272 LRSDNARR 279
           L+ D  +R
Sbjct: 387 LKKDPKQR 394

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 8   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 67  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 181 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 78
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 194 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 252 FVMEGGLLDKPDN 264

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 93
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--------------LTDDH 146
           NV+ +      P       + ++ E     +L   +RS +               LT +H
Sbjct: 94  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
              + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +         
Sbjct: 150 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 207 TRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            R    + APE + +   YT   D+WS G +L EI +
Sbjct: 210 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 100
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 216 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 274 FVMEGGLLDKPDN 286

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 7   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 65
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 66  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 180 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 60
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 61  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 175 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 330 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 378
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 437
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 438 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 123/248 (49%), Gaps = 24/248 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 210 LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 323
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL----IGSPDDASL--GF 271
            +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+       P+  SL  G 
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383
Query: 272 LRSDNARR 279
           L+ D  +R
Sbjct: 384 LKKDPKQR 391

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVY-----------ELMDTDLHQIIRSDQQLTDDHCQYFL 151
           ++ +               Y  Y            +++TD    I ++  L+     +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI-ANSTLSTRDLLHFS 170
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV--- 206
            Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 226 ARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 187 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 245 FVMEGGLLDKPDN 257

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 33  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 91
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 92  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 206 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 46/260 (17%)
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQ 148
           E++++  +++E  +  + II       +++VYI+YE M+ D   I++ D+   + D +  
Sbjct: 93  ELQIITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYT 145
Query: 149 YFL---------YQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
            F+           +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG      E+
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ES 199
Query: 199 DFMTEYVV-----TRWYRAPELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVH 252
           ++M +  +     T  +  PE   N + Y  A +DIWS+G  L  +      F  K  + 
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 253 QL--RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM 310
           +L   + T+ I  P D           R +       +K   +  F   S+  +D L+  
Sbjct: 260 ELFNNIRTKNIEYPLD-----------RNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLF 306
Query: 311 LVFDPNKRITVEEALRHPYL 330
           L  +P +RIT E+AL+H +L
Sbjct: 307 LRKNPAERITSEDALKHEWL 326

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++T      V T  Y APE L   
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG- 209
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 187 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 245 FVMEGGLLDKPDN 257

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 128
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 183
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 244 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M+   L   ++ +        QL D   Q     +  G+ Y
Sbjct: 78  VV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 127 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 185
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 186 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENV 103
           RP+G+G +G V  A   ++   VA+K +   F + I+      +  REI++  H+ H N+
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + +     ++     +Y++ E     +L++ ++      +      + +L   L Y H
Sbjct: 86  LRLYNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
              V+HRD+KP NLLL    +LKI DFG +         T    T  Y  PE++     +
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPEMI-EGRMH 198
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+W +G +  E++   P F    +    R I ++                      
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV---------------------- 236
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   +F    P   +GA DL+ K+L  +P++R+ + +   HP++++
Sbjct: 237 ------DLKFPASVP---TGAQDLISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 68
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 69  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 183 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  +   K GN     +     L+E ++++ + HE ++ +  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-----MSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 248 VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 296
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGL R   + ++          +W  APE  L
Sbjct: 297 VERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAAL 355
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 356 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 32/266 (12%)
Query: 25  GKYVQYNVY-GNLFEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNA 78
           G +   +VY  + +EV+ + +   R +G+G++G+V        V  E    VAIK +  A
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR 137
             ++ +    L E  +++     +V+ +  ++   +        ++ ELM   DL   +R
Sbjct: 61  -ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLR 114
Query: 138 SDQQLTDDH----------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           S +   +++                ++  G+ Y+++   +HRDL   N ++     +KIG
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 174
Query: 188 DFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE 242
           DFG+ R   ETD   +     +  RW  +PE L +   +T   D+WS G +L EI T  E
Sbjct: 175 DFGMTRDIXETDXXRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAE 232
Query: 243 PLFPGKDYVHQLRLITE--LIGSPDD 266
             + G      LR + E  L+  PD+
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLLDKPDN 258

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLRE 91
           + + +EV  + +  +  +G G  G V     N  T+  V   K G+   +       L E
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAE 58
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQ 148
             L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +   
Sbjct: 59  ANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
               Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +         
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF 172
Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 173 PIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 68
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +    ++    
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 184 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 242 FVMEGGLLDKPDN 254

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++         +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH------CQYFLYQLLR 156
           ++ +               Y  Y  +   L +   +D    D          +F  Q+ +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV-------T 207
           G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V        
Sbjct: 172 GMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPV 226
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 227 KW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 72  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 120
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 121 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 179
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 180 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 78
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +    ++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 194 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 252 FVMEGGLLDKPDN 264

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 70  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 118
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 119 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 177
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 178 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ--- 148
            +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++     
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 125
Query: 149 -------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
                      ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+ 
Sbjct: 126 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 185
Query: 202 TE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 RKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH------CQYFLYQLLR 156
           ++ +               Y  Y  +   L +   +D    D          +F  Q+ +
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV-------T 207
           G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V        
Sbjct: 164 GMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPV 218
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 219 KW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M+   L   ++ +        QL D   Q     +  G+ Y
Sbjct: 78  VV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 127 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW-TAPEAAL 185
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 186 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 198
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 199 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 256
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 257 EMAVGRYPIPP 267

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 67
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 68  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 182
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 183 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 91
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 92  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 38/242 (15%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 132
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 133 KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI 257
            +    R    + APE L +   YT   D+WS G +L EI T     +PG       +L+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 258 TE 259
            E
Sbjct: 307 KE 308

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 91
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 92  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 63
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 179 XRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 237 FVMEGGLLDKPDN 249

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 84
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 85  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 199
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 240

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 4/122 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    + +   E+V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 197
Query: 237 EI 238
           E+
Sbjct: 198 EM 199

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 74  VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 122
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 123 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 181
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 182 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 80
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 81  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 83
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 84  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 198
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 239

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 91
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 92  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 222 EMAVGRYPIPP 232

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 76
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 77  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 232

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 93
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LTD 144
           NV+ +      P       + ++ E     +L   +RS +                 LT 
Sbjct: 94  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE 203
           +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +
Sbjct: 150 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 204 ---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 210 GDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           I + D    P  D+F    ++ E M+   DL   I     L ++  + F +Q+L  +++ 
Sbjct: 76  IRLLDWFERP--DSF---VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 162 HSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H+  VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +    
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHR 189
Query: 221 EYTAAIDIWSVGCIL 235
            +  +  +WS+G +L
Sbjct: 190 YHGRSAAVWSLGILL 204

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 129/280 (46%), Gaps = 38/280 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 72
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 73  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 186
Query: 222 YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           Y  ++D W++G ++ E+M  R P               +++GS D+         N   Y
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPF--------------DIVGSSDNP------DQNTEDY 226
Query: 281 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI 319
           + Q+   ++     R P   S  A  +L+  L  DP +R+
Sbjct: 227 LFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERL 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 65
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---- 146
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 147 ------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N  +     +KIGDFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 181 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 256 LITE--LIGSPDD 266
            + E  L+  PD+
Sbjct: 239 FVMEGGLLDKPDN 251

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL  +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 129/280 (46%), Gaps = 38/280 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 10  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 68
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 69  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 182
Query: 222 YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           Y  ++D W++G ++ E+M  R P               +++GS D+         N   Y
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPF--------------DIVGSSDNP------DQNTEDY 222
Query: 281 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI 319
           + Q+   ++     R P   S  A  +L+  L  DP +R+
Sbjct: 223 LFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERL 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 92
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---------------LTDD 145
           NV+ +      P       + ++ E     +L   +RS +                LT +
Sbjct: 93  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +        
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 206 VTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             R    + APE + +   YT   D+WS G +L EI +
Sbjct: 209 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 76/284 (26%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L  +EH  ++ 
Sbjct: 10  PIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 106 IKD--IIRPPKK--DTFNDVYIVYELMDTDLH----------QIIRSDQ--------QLT 143
             +  +  PP+K  +  +++++  E  D  L           +I R D         QL 
Sbjct: 69  YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 144 DDHCQYFLY----------------------------------QLLRGLKYVHSASVLHR 169
               + +LY                                  Q+   ++++HS  ++HR
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR 188
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTSETDF-------MTEY------VVTRWYRAPELL 216
           DLKPSN+       +K+GDFGL     + +        M  Y      V T+ Y +PE  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE-Q 247
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 260
           ++   Y+  +DI+S+G IL E+     L+     + ++R+IT++
Sbjct: 248 IHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMERVRIITDV 286

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 187 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 228

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 110 --IRPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             + PP        YIV E M   +L   +R  + +++T     Y   Q+   ++Y+   
Sbjct: 97  CTLEPP-------FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L   T 
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT- 207
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 33  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 90  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++       V T  Y APE L   
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG- 203
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 204 -EITPKSDIYSFGVVLLEIITGLP 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K        I+     +++  +   M  + V+A+   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVK--------ILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 79  -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
            S  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE++    
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQ 196
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +  F G+D     + I E
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 25  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 83
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 84  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 197
Query: 222 YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           Y  ++D W++G ++ E+M  R P               +++GS D+         N   Y
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPF--------------DIVGSSDNP------DQNTEDY 237
Query: 281 VRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRI 319
           + Q+   ++     R P + S  A  +L+  L  DP +R+
Sbjct: 238 LFQVILEKQ----IRIPRSMSVKAASVLKSFLNKDPKERL 273

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K        I+     +++  +   M  + V+A+   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVK--------ILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 400 -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
            S  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE++    
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-Q 517
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +  F G+D     + I E
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 24  GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII 83
           G    Q   Y + + ++ K +  ++ IG+G +G V   +      +VA+K I     N  
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDA 56
Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ- 141
            A+  L E  ++  + H N++ +  +I   K      +YIV E M    L   +RS  + 
Sbjct: 57  TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 142 -LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
            L  D    F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T  
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171
Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
            T  +  +W  APE L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 172 DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 20/242 (8%)
Query: 17  VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
           +K  +  G    Q   Y + + ++ K +  ++ IG+G +G V   +      +VA+K I 
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI- 224
Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQI 135
               N   A+  L E  ++  + H N++ +  +I   K      +YIV E M    L   
Sbjct: 225 ---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDY 277
Query: 136 IRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           +RS  +  L  D    F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKD 249
             S T   T  +  +W  APE L    +++   D+WS G +L EI +      P  P KD
Sbjct: 338 EASSTQ-DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394
Query: 250 YV 251
            V
Sbjct: 395 VV 396

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 257
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q                SS    L+   L   P+ R T EE   HP++Q +
Sbjct: 258 Q--------------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 91
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 92  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXX 206
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 256
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q                SS    L+   L   P+ R T EE   HP++Q +
Sbjct: 257 Q--------------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G+ + ++ K +  ++ IG+G +G V   +      +VA+K I     N   A+  L E  
Sbjct: 4   GSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDATAQAFLAEAS 57
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYF 150
           ++  + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
              +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W 
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW- 171
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
            APE L     ++   D+WS G +L EI +      P  P KD V
Sbjct: 172 TAPEALREAA-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 256
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q                SS    L+   L   P+ R T EE   HP++Q +
Sbjct: 257 Q--------------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 257
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q                SS    L+   L   P+ R T EE   HP++Q +
Sbjct: 258 Q--------------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 224
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q                SS    L+   L   P+ R T EE   HP++Q +
Sbjct: 225 Q--------------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
               +      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 181 CTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R  ++  +        V  +W  APE  LN   Y+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYS 293
Query: 224 AAIDIWSVGCILGEIMT 240
           +  D+WS G +L E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G  G VC     V  +    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           + ++   +       Y+    +DT L      D Q T       L  +  G++Y+     
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCT 220
           +HRDL   N+L++++   K+ DFGL+R   E D    Y  T      RW  APE +   T
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRW-TAPEAIAFRT 230
Query: 221 EYTAAIDIWSVGCILGEIMT 240
            +++A D+WS G ++ E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +++E+  + +  I+ +G G +G V     N  T+  VAIK +       +     L E +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLK---PGTMSPESFLEEAQ 56
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYF 150
           +++ ++H+ ++ +  ++      +   +YIV E M+   L   ++  +   L   +    
Sbjct: 57  IMKKLKHDKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT--- 207
             Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + +           
Sbjct: 111 AAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPI 170
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKD 249
           +W  APE  L    +T   D+WS G +L E++T+  + +PG +
Sbjct: 171 KW-TAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/300 (22%), Positives = 136/300 (45%), Gaps = 45/300 (15%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLR 96
           E+  KY+     +GRG +GIV   V + +++    K +     D ++      +EI +L 
Sbjct: 2   ELYEKYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILN 56
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQL 154
              H N++ + +       ++  ++ +++E +   D+ + I +   +L +     +++Q+
Sbjct: 57  IARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV 111
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
              L+++HS ++ H D++P N++     S  +KI +FG AR     D          Y A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           PE+  +    TA  D+WS+G ++  +++   P     +         ++I +  +A   F
Sbjct: 172 PEVHQHDVVSTAT-DMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTF 222
Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
              + A                  F   S  A+D ++++LV +   R+T  EAL+HP+L+
Sbjct: 223 --DEEA------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ET +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 76
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 77  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 132
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 193 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 76
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 77  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 132
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 193 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 129/280 (46%), Gaps = 38/280 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A++ +       D  ID  +T + +   +   H  +
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 115
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 116 VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGED 229
Query: 222 YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           Y  ++D W++G ++ E+M  R P               +++GS D+         N   Y
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPF--------------DIVGSSDNP------DQNTEDY 269
Query: 281 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI 319
           + Q+   ++     R P   S  A  +L+  L  DP +R+
Sbjct: 270 LFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERL 305

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            EY  ++D +++G  L E++                           A+ G  R+   + 
Sbjct: 364 EEYDFSVDYFALGVTLYEMI---------------------------AARGPFRARGEKV 396
Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 324
             ++L + R  + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 397 ENKELKQ-RVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 9/208 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG V    + E     A+K+  + F    D  R L E+       HE V      
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQHPCC 119
Query: 110 IRPPKK-DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +R  +  +    +Y+  EL    L Q   +    L +     +L   L  L ++HS  ++
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           H D+KP+N+ L      K+GDFGL                  Y APELL     Y  A D
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAAD 237
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLR 255
           ++S+G  + E+     L  G +   QLR
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            EY  ++D +++G  L E++                           A+ G  R+   + 
Sbjct: 364 EEYDFSVDYFALGVTLYEMI---------------------------AARGPFRARGEKV 396
Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 324
             ++L + R  + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 397 ENKEL-KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 70
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 71  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 126
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 187 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 70
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 71  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 126
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 187 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            EY  ++D +++G  L E++                           A+ G  R+   + 
Sbjct: 364 EEYDFSVDYFALGVTLYEMI---------------------------AARGPFRARGEKV 396
Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 324
             ++L + R  + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 397 ENKEL-KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            EY  ++D +++G  L E++                           A+ G  R+   + 
Sbjct: 364 EEYDFSVDYFALGVTLYEMI---------------------------AARGPFRARGEKV 396
Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 324
             ++L + R  + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 397 ENKEL-KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 66
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 67  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 122
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 183 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 66
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 67  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 122
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 183 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLR 96
           +  +G G++G+V        S     VA+K +         A D+ I      RE+  + 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMH 66
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  
Sbjct: 67  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAE 122
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRA 212
           G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQLRLITELIGSPDD 266
           PE L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 183 PESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 73
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 74  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 186
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 187 PESLSD-NIFSRQSDVWSFGVVLYELFT 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPE-SLAYNK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 7/194 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V  A       +VA+K +     +       LRE+ +++ + H N++     
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VL 167
           +  P   +    Y+    +   LH+   + +QL +       Y + +G+ Y+H+ +  ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAI 226
           HRDLK  NLL++    +K+ DFGL+R  +     ++    T  + APE+L +      + 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 227 DIWSVGCILGEIMT 240
           D++S G IL E+ T
Sbjct: 221 DVYSFGVILWELAT 234

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 72
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 73  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 185
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 186 PESLSD-NIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 85
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 86  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 198
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 199 PESLSD-NIFSRQSDVWSFGVVLYELFT 225

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/341 (23%), Positives = 135/341 (39%), Gaps = 88/341 (25%)
Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G     G  ++ N   + ++V+S+       +G G  G V    N  T+E+ A+K +   
Sbjct: 1   GPHVKSGLQIKKNAIIDDYKVTSQV------LGLGINGKVLQIFNKRTQEKFALKMLQ-- 52
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-------IVYELMDT- 130
                D  +  RE++L  H        I  I+     D + ++Y       IV E +D  
Sbjct: 53  -----DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLYAGRKCLLIVMECLDGG 100
Query: 131 DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLK 185
           +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           + DFG A+ T+                        +Y  + D+WS+G I+  ++   P F
Sbjct: 161 LTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198
Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
                 H L +      SP   +                 R R  Q+   FPN     V 
Sbjct: 199 YSN---HGLAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVS 230
Query: 306 -----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
                L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V  A       +VA+K +     +       LRE+ +++ + H N++     
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VL 167
           +  P   +    Y+    +   LH+   + +QL +       Y + +G+ Y+H+ +  ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAI 226
           HR+LK  NLL++    +K+ DFGL+R  + T   ++    T  + APE+L +      + 
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 227 DIWSVGCILGEIMT 240
           D++S G IL E+ T
Sbjct: 221 DVYSFGVILWELAT 234

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 111 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 226
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 227 GRSAAVWSLGILL 239

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 70
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 71  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINF 184
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 99  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 155
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 156 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 214
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 215 GRSAAVWSLGILL 227

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 86
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 87  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINF 200
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 74
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 75  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINF 188
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 91  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 148 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 206
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 207 GRSAAVWSLGILL 219

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 157/335 (46%), Gaps = 54/335 (16%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARR 87
           N+ G+  +V  +    ++ +G GAYG   +V      +T +  A+K +  A   I+   +
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA--TIVQKAK 100
Query: 88  TLR----EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL 142
           T      E ++L H+     +    +       T   ++++ + ++  +L   +   ++ 
Sbjct: 101 TTEHTRTERQVLEHIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 156
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDF 200
           T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     ET+ 
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 201 MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             ++  T  Y AP+++    + +  A+D WS+G ++ E++T    F              
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT------------- 263
Query: 260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVFDPNKR 318
           + G  +       +++ +RR ++  P          +P + S  A DL++++L+ DP KR
Sbjct: 264 VDGEKNS------QAEISRRILKSEP---------PYPQEMSALAKDLIQRLLMKDPKKR 308
Query: 319 IT-----VEEALRHPYLQSLH--DLNDEPVCPRPF 346
           +       +E   H + Q ++  DL  + V P PF
Sbjct: 309 LGCGPRDADEIKEHLFFQKINWDDLAAKKV-PAPF 342

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 257
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q      Q               L+   L   P+ R T EE   HP++Q +
Sbjct: 258 QRVSXECQH--------------LIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 91  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 148 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 206
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 207 GRSAAVWSLGILL 219

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 124 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 180
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 181 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 239
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 240 GRSAAVWSLGILL 252

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 256
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q      Q               L+   L   P+ R T EE   HP++Q +
Sbjct: 257 QRVSXECQH--------------LIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             +  +WS+G +L +++  +  F   +         E+IG               + + R
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIG--------------GQVFFR 257
Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Q      Q               L+   L   P+ R T EE   HP++Q +
Sbjct: 258 QRVSXECQH--------------LIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 76  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 132
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 133 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 191
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 192 GRSAAVWSLGILL 204

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 119 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 176 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 234
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 235 GRSAAVWSLGILL 247

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 119 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 176 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 234
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 235 GRSAAVWSLGILL 247

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 79  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNK 189
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
               +      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 181 CTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R  ++           V  +W  APE  LN   Y+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPE-ALNYGRYS 293
Query: 224 AAIDIWSVGCILGEIMT 240
           +  D+WS G +L E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 82  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 192
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           + ++ K +  ++ IG+G +G V   +      +VA+K I     N   A+  L E  ++ 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDATAQAFLAEASVMT 54
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQ 153
            + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   
Sbjct: 55  QLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V   + AP
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 168
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
           E L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 169 EALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 220 GRSAAVWSLGILL 232

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 91  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 201
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 202 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 230

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 75  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 131
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 132 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 190
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 191 GRSAAVWSLGILL 203

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCILGEIM 239
             +  +WS+G +L +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 XGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 188 GRSAAVWSLGILL 200

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 52/232 (22%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHE 101
           + +G GA+G V  A       +    +VA+K +    D+  +    + E+K++  +  HE
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHE 109
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSD-QQLTDDHCQY---------- 149
           N++ +              +Y+++E     DL   +RS  ++ ++D  +Y          
Sbjct: 110 NIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 150 ------------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
                       F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 198 TDFMTE--YVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            D M++  YVV        +W  APE L     YT   D+WS G +L EI +
Sbjct: 221 -DIMSDSNYVVRGNARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 20/235 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V   V  +  ++V   K+ + F+ I  +        R+I     M   N
Sbjct: 80  VKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAFAN 133
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 134 SPWVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S  ++HRD+KP N+LL+    LK+ DFG      ET  +     V T  Y +PE+L +  
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 269
               Y    D WSVG  L E++  +  F     V     I +   S   P+DA +
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG---------NAFDNIIDARR 87
           +E+    +   + IG G++G V      +   +VA+K +           AF N +   R
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC 147
             R + +L  M +     +  + +  +  +   +Y    +++T    I     +L D   
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSS---LYHHLHIIETKFEMI-----KLID--- 108
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--- 204
                Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++   
Sbjct: 109 --IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 205 VVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 262
             +  + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVG 223
Query: 263 ----SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
               SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 224 RGYLSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHEN 102
           IR +G+G++G V  A   ET +  A+K +    D I+   D   T+ E ++L     H  
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKK--DVILQDDDVECTMTEKRILSLARNHPF 85
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           +  +    + P +     ++ V E ++  DL   I+  ++  +   +++  +++  L ++
Sbjct: 86  LTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
           H   +++RDLK  N+LL+     K+ DFG+ +        T  +  T  Y APE+L    
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y  A+D W++G +L E++     F  ++
Sbjct: 201 -YGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 285 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HR+L   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 395
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 432

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 114
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 231
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 232 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 5   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 61
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 62  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 111
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 112 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 228
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 229 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 276

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 51  GRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK+    +HEN++ + 
Sbjct: 31  GEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 108 DIIRPPKKDTFNDVYIVY------ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
                      +D+ +VY       L+D  L  +  +        C+        G+ ++
Sbjct: 88  GF-----SSDGDDLCLVYVYXPNGSLLDR-LSCLDGTPPLSWHXRCK-IAQGAANGINFL 140
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLN 218
           H    +HRD+K +N+LL+ +   KI DFGLAR +   ++    +  V T  Y APE L  
Sbjct: 141 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG 200
Query: 219 CTEYTAAIDIWSVGCILGEIMTREP 243
             E T   DI+S G +L EI+T  P
Sbjct: 201 --EITPKSDIYSFGVVLLEIITGLP 223

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 109
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 226
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 227 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++  V   +++ET  EVA  ++ +      + +R   E + L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VL 167
                K     V +        L   ++  +       + +  Q+L+GL+++H+ +  ++
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 168 HRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRDLK  N+ +   +  +KIGD GLA T     F    + T  + APE      +Y  ++
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEE--KYDESV 210
Query: 227 DIWSVGCILGEIMTRE 242
           D+++ G    E  T E
Sbjct: 211 DVYAFGXCXLEXATSE 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 324 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 376
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HR+L   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 434
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 435 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 463

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 16  YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETD 199
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET 
Sbjct: 126 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS 177
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +      RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 178 SVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 109
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVV 206
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F      
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 207 TRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-- 262
             W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G  
Sbjct: 170 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRG 225
Query: 263 --SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
             SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 226 YLSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 23  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 79
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 80  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 129
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVV 206
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F      
Sbjct: 130 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 207 TRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-- 262
             W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G  
Sbjct: 190 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRG 245
Query: 263 --SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
             SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 246 YLSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 294

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 114
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 231
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 232 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 30  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 86
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 87  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 136
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 137 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 253
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 254 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 301

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   + IV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 71  VV------SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 119
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L
Sbjct: 120 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 178
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G  G VC     V  +    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           + ++   +       Y+    +DT L      D Q T       L  +  G++Y+     
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCT 220
           +HRDL   N+L++++   K+ DFGL+R   E D       T      RW  APE +   T
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWT-APEAIAFRT 230
Query: 221 EYTAAIDIWSVGCILGEIMT 240
            +++A D+WS G ++ E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 87
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 137
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVT 207
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 208 RWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--- 262
             + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G   
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGY 254
Query: 263 -SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
            SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 255 LSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +   + IG G++G V      +   +VA+K +          +    E+ +LR
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 87
Query: 97  HMEHENVIAIKDIIRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
              H N++        P+          + +Y    +++T    I     +L D      
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----I 137
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVV 206
             Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F      
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 207 TRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-- 262
             W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G  
Sbjct: 198 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRG 253
Query: 263 --SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 311
             SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 254 YLSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 127
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 128 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G  +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K
Sbjct: 1   GGSWEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAK 56
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLT 143
           ++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++ 
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT- 202
            D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ + 
Sbjct: 112 KDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 163
Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                  RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 164 RGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 79  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 132
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 133 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 79  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 132
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 133 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 136/320 (42%), Gaps = 61/320 (19%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G            EVA+ K+ NA  + + A + L + ++L+  E       
Sbjct: 79  LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 124
Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQL 154
           +D++              F D   +Y +MD     DL  ++ + + +L ++  +++L ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRA 212
           +  +  VH    +HRD+KP N+L++ +  +++ DFG      E   +   V   T  Y +
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 213 PELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
           PE+L         Y    D WS+G  + E++  E  F  +  V                 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------------- 289
Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALR 326
                      Y + +    + QF T+  + S  A DL+ +++    ++  +  +E+  +
Sbjct: 290 -----------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338
Query: 327 HPYLQSLHDLNDEPVCPRPF 346
           HP+   + D ++   C  P+
Sbjct: 339 HPFFSGI-DWDNIRNCEAPY 357

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R   E+     +    ++ +   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 153
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 154 VR-----EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 169 RDLKPSNLLLN------ASCDLK----IGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD      +   GL ++    D++     T  + APE++L 
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG---TETHMAPEVVLG 265
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +D+WS  C++
Sbjct: 266 -RSCDAKVDVWSSCCMM 281

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 79  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T     ++   + APE  L   +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE-SLAYNK 189
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T     ++   + APE  L   +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE-SLAYNK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLI 257
           ++   D+W+ G +L EI T    P +PG D      L+
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R   E+     +    ++ +   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 134
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 135 VR-----EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 169 RDLKPSNLLLNA-SCDLKIGDFGLARTTSE----TDFMT-EYV-VTRWYRAPELLLNCTE 221
            D+K  N+LL++      + DFG A          D +T +Y+  T  + APE++L    
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RS 248
Query: 222 YTAAIDIWSVGCIL 235
             A +D+WS  C++
Sbjct: 249 CDAKVDVWSSCCMM 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 7   YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 61
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 62  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 116
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +
Sbjct: 117 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 168
Query: 203 EY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 169 SVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 30/220 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLL 95
           +E+ +  V     IG G++G V      +   +VA+K I    D   +  +  R E+ +L
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKG---KWHGDVAVK-ILKVVDPTPEQFQAFRNEVAVL 86
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQL 154
           R   H N++     +      T +++ IV +  + + L++       L     ++ ++QL
Sbjct: 87  RKTRHVNILLFMGYM------TKDNLAIVTQWCEGSSLYK------HLHVQETKFQMFQL 134
Query: 155 L-------RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEY 204
           +       +G+ Y+H+ +++HRD+K +N+ L+    +KIGDFGLA   S    +  + + 
Sbjct: 135 IDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP 194
Query: 205 VVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTRE 242
             +  + APE+  + +   ++   D++S G +L E+MT E
Sbjct: 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 16  YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +
Sbjct: 126 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177
Query: 203 EY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   RW  +P  +L  +++++  DIW+ G ++ EI +
Sbjct: 178 SVGSKFPVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 58
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDH 146
           ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++  D 
Sbjct: 59  NLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 113
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
           C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +    
Sbjct: 114 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 166 KFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDH 146
           ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++  D 
Sbjct: 60  NLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
           C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +    
Sbjct: 115 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 167 KFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 48/230 (20%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--------------SDQQLTDDH-- 146
           ++ +               Y  Y     DL   +R               D +  D    
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 147 -------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
                    +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----D 207
Query: 200 FM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 208 IMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+   S++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNAFDNIIDARRT 88
           G L E+S   V  +  +G   +G V           E  + VAIK + +  +  +  R  
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REE 58
Query: 89  LREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-----RSDQQL 142
            R   +LR  ++H NV+ +  ++    KD    +   Y     DLH+ +      SD   
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVV---TKDQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGS 114
Query: 143 TDDH-----------CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           TDD              + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL- 244
            R     D+        +  RW  APE ++   +++   DIWS G +L E+ +   +P  
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 245 -FPGKDYVHQLRLITELIGSPDD 266
            +  +D V  +R   +++  PDD
Sbjct: 233 GYSNQDVVEMIR-NRQVLPCPDD 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 223 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 134
Query: 110 IRP-PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R  P  + F ++     L    L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 135 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 246
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 247 -KPCDAKVDIWSSCCMM 262

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 77  VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 132 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 192 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 105
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 106 VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 221 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118
Query: 110 IR-PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R  P  + F ++     L    L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 119 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 230
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 231 -KPCDAKVDIWSSCCMM 246

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P +    ++ +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 70  IVKYRGVSYGPGRP---ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +  V R        WY A
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVREPGQSPIFWY-A 182
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 183 PESLSD-NIFSRQSDVWSFGVVLYELFT 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 82
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 83  VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 138 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 198 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 132
Query: 110 IR-PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R  P  + F ++     L    L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 133 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 244
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 245 -KPCDAKVDIWSSCCMM 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 48  RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G +G V  A   +   +  +VA+K +        D    LRE   ++  +H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLR 156
            +  + +R   K       ++   M   DLH  + + +       L       F+  +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRA 212
           G++Y+ S + +HRDL   N +L     + + DFGL+R     D+  +   +    +W   
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
             L  N   YT   D+W+ G  + EIMTR
Sbjct: 209 ESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVI 104
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A       E  +L + + + + 
Sbjct: 79  IKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 137
Query: 105 AIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           A+    +       N +Y+V +  +  DL  ++ + + +L +D  ++++ +++  +  +H
Sbjct: 138 ALHYAFQDE-----NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL--- 217
               +HRD+KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L    
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 252
Query: 218 -NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
               +Y    D WS+G  + E++  E  F  +  V
Sbjct: 253 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVI 104
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A       E  +L + + + + 
Sbjct: 95  IKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 153
Query: 105 AIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           A+    +       N +Y+V +  +  DL  ++ + + +L +D  ++++ +++  +  +H
Sbjct: 154 ALHYAFQDE-----NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL--- 217
               +HRD+KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L    
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 268
Query: 218 -NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
               +Y    D WS+G  + E++  E  F  +  V
Sbjct: 269 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 303

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    +++  VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 76
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ ++   +++   +    L+Q+  G+KY+   +
Sbjct: 77  GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTE 221
            +HRDL   N+LL      KI DFGL++     D + T     +W   + APE  +N  +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 189
Query: 222 YTAAIDIWSVGCILGEIMT 240
           +++  D+WS G  + E ++
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 56/319 (17%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRT 88
           N+Y     V  +    ++ IG G    V   +N E ++  AIK +    A +  +D+ R 
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 89  LREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH 146
             EI  L  ++   + +I + D      + T   +Y+V E  + DL+  ++  + +    
Sbjct: 76  --EIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWE 128
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTE 203
            + +   +L  +  +H   ++H DLKP+N L+     LK+ DFG+A      + +     
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 204 YVVTRWYRAPELLLNCTE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            V T  Y  PE + + +            +   D+WS+GCIL  +   +   P +  ++Q
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 245
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLV 312
           +  +  +I  P+                              FP+     + D+L+  L 
Sbjct: 246 ISKLHAII-DPN--------------------------HEIEFPDIPEKDLQDVLKCCLK 278
Query: 313 FDPNKRITVEEALRHPYLQ 331
            DP +RI++ E L HPY+Q
Sbjct: 279 RDPKQRISIPELLAHPYVQ 297

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    +++  VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 402
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ ++   +++   +    L+Q+  G+KY+   +
Sbjct: 403 GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTE 221
            +HR+L   N+LL      KI DFGL++     D + T     +W   + APE  +N  +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 515
Query: 222 YTAAIDIWSVGCILGEIMT 240
           +++  D+WS G  + E ++
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++ ++ HE ++ +
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQLLR 156
             +    +      ++I+ E M          ++    ++ Q  ++  D C+        
Sbjct: 65  YGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE-------- 111
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 213
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW   P
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPP 170
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E+L+  +++++  DIW+ G ++ EI +
Sbjct: 171 EVLMY-SKFSSKSDIWAFGVLMWEIYS 196

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 131/319 (41%), Gaps = 56/319 (17%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRT 88
           N+Y     V  +    ++ IG G    V   +N E ++  AIK +    A +  +D+ R 
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 89  LREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH 146
             EI  L  ++   + +I + D      + T   +Y+V E  + DL+  ++  + +    
Sbjct: 76  --EIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWE 128
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---E 203
            + +   +L  +  +H   ++H DLKP+N L+     LK+ DFG+A              
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDS 187
Query: 204 YVVTRWYRAPELLLNCTE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            V T  Y  PE + + +            +   D+WS+GCIL  +   +   P +  ++Q
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 245
Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLV 312
           +  +  +I  P+                              FP+     + D+L+  L 
Sbjct: 246 ISKLHAII-DPN--------------------------HEIEFPDIPEKDLQDVLKCCLK 278
Query: 313 FDPNKRITVEEALRHPYLQ 331
            DP +RI++ E L HPY+Q
Sbjct: 279 RDPKQRISIPELLAHPYVQ 297

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKD 108
            G+   G +      E  + VAIK + +  +  +  R   R   +LR  ++H NV+ +  
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLG 96
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQII-----RSDQQLTDDH-----------CQYFLY 152
           ++    KD    +   Y     DLH+ +      SD   TDD              + + 
Sbjct: 97  VV---TKDQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 208
           Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        +  R
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSP 264
           W  APE ++   +++   DIWS G +L E+ +   +P   +  +D V  +R   +++  P
Sbjct: 213 WM-APEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCP 269
Query: 265 DD 266
           DD
Sbjct: 270 DD 271

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHME----HE 101
           +G+G +G V A      R +VAIK I       +  + D+     E+ LL  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE--LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            VI + D       +T     +V E  L   DL   I     L +   + F  Q++  ++
Sbjct: 99  GVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 160 YVHSASVLHRDLKPSNLL--LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           + HS  V+HRD+K  N+L  L   C  K+ DFG      +  + T++  TR Y  PE + 
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWIS 211
Query: 218 NCTEYTAAIDIWSVGCIL 235
               +     +WS+G +L
Sbjct: 212 RHQYHALPATVWSLGILL 229

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 26/241 (10%)
Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G L       Q +  G   E+    +   R +  G +  V  A +  +  E A+K++ + 
Sbjct: 5   GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN---DVYIVYELMDTDLHQ 134
            +     R  ++E+  ++ +  H N++         K+++     +  ++ EL    L +
Sbjct: 65  EEE--KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 135 IIR---SDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDF 189
            ++   S   L+ D      YQ  R ++++H     ++HRDLK  NLLL+    +K+ DF
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 190 GLARTTS---------ETDFMTEYVVTR----WYRAPELLLNCTEYTAA--IDIWSVGCI 234
           G A T S         +   + E  +TR     YR PE++   + +      DIW++GCI
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 235 L 235
           L
Sbjct: 243 L 243

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/323 (22%), Positives = 127/323 (39%), Gaps = 56/323 (17%)
Query: 31  NVY--GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT 88
           N+Y  G++  + +K+   I+ +G G +  V            A+K+I        D    
Sbjct: 16  NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEA 73
Query: 89  LREIKLLRHMEHENVIAIKDII---RPPKKDTFNDV-YIVYELMDTDLHQIIRSDQQLTD 144
            RE  + R   H N++ +       R  K + +  + +     +  ++ ++      LT+
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-------ARTTSE 197
           D   + L  + RGL+ +H+    HRDLKP+N+LL       + D G           + +
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 198 TDFMTEYVVTRW---YRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
              + ++   R    YRAPEL     +C       D+WS+GC+L  +M  E         
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGE--------- 243
Query: 252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML 311
                       P D  + F + D+    V      + Q    + P  SS    LL  M+
Sbjct: 244 -----------GPYD--MVFQKGDSVALAV------QNQLSIPQSPRHSSALWQLLNSMM 284
Query: 312 VFDPNKR------ITVEEALRHP 328
             DP++R      ++  EAL+ P
Sbjct: 285 TVDPHQRPHIPLLLSQLEALQPP 307

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +   +    D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 68  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           SV+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 180
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 14  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 70
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 71  IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
              ++H DLKP+N L+     LK+ DFG+A      + +      V T  Y  PE + + 
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 220 TE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           +            +   D+WS+GCIL  +   +   P +  ++Q+  +  +I  P+    
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---- 237
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+     + D+L+  L  DP +RI++ E L HP
Sbjct: 238 ----------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275
Query: 329 YLQ 331
           Y+Q
Sbjct: 276 YVQ 278

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 13  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 70  IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 124
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
              ++H DLKP+N L+     LK+ DFG+A      + +      V T  Y  PE + + 
Sbjct: 125 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 220 TE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           +            +   D+WS+GCIL  +   +   P +  ++Q+  +  +I  P+    
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---- 236
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+     + D+L+  L  DP +RI++ E L HP
Sbjct: 237 ----------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 274
Query: 329 YLQ 331
           Y+Q
Sbjct: 275 YVQ 277

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 131 DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 189
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 17  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 73
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 74  IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
              ++H DLKP+N L+     LK+ DFG+A      + +      V T  Y  PE + + 
Sbjct: 129 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 220 TE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           +            +   D+WS+GCIL  +   +   P +  ++Q+  +  +I  P+    
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---- 240
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+     + D+L+  L  DP +RI++ E L HP
Sbjct: 241 ----------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 278
Query: 329 YLQ 331
           Y+Q
Sbjct: 279 YVQ 281

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 80  VRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 188
Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 220

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 103 VRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 156
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 157 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 211
Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 243

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 117
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 118 IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNC 219
              ++H DLKP+N L+     LK+ DFG+A   +  + +      V T  Y  PE + + 
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 220 TE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           +            +   D+WS+GCIL  +   +   P +  ++Q+  +  +I        
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDP------ 283
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+     + D+L+  L  DP +RI++ E L HP
Sbjct: 284 ---------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322
Query: 329 YLQ 331
           Y+Q
Sbjct: 323 YVQ 325

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 117
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 118 IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNC 219
              ++H DLKP+N L+     LK+ DFG+A   +  + +      V T  Y  PE + + 
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 220 TE----------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           +            +   D+WS+GCIL  +   +  F  +  ++Q+  +  +I  P+    
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---- 284
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+       D+L+  L  DP +RI++ E L HP
Sbjct: 285 ----------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322
Query: 329 YLQ 331
           Y+Q
Sbjct: 323 YVQ 325

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 192 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 61/114 (53%), Gaps = 9/114 (7%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 209
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +         TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 210 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG----KDYVHQLR 255
              + APE + +   Y+   D+WS G +L EI +     +PG    +D+  +LR
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR 316

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++  + H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKLNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 82
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++  + H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 132
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 193 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 251 SNQEVLEFVT 260

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--EN 102
           ++ IG G    V   +N E ++  AIK +    A +  +D+ R   EI  L  ++   + 
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQHSDK 117
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +I + D      + T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H
Sbjct: 118 IIRLYDY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTS--------ETDFMTEYVVTRW 209
              ++H DLKP+N L+     LK+ DFG+A      TTS          ++M    +   
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
             + E   + ++ +   D+WS+GCIL  +   +  F  +  ++Q+  +  +I  P+    
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---- 284
Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHP 328
                                     FP+     + D+L+  L  DP +RI++ E L HP
Sbjct: 285 ----------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322
Query: 329 YLQ 331
           Y+Q
Sbjct: 323 YVQ 325

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 15  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 73
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 74  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 123
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 184 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 241
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 242 SNQEVLEFVT 251

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 40  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 98
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 99  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 148
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 209 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 266
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 267 SNQEVLEFVT 276

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILMELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 82
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 132
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 193 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 251 SNQEVLEFVT 260

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 30  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 88
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 89  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 138
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 199 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 256
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 257 SNQEVLEFVT 266

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 81
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILMELMAGGDLKSFLRETRPRP 131
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 192 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 250 SNQEVLEFVT 259

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 50  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 108
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 109 MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 158
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 219 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 276
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 277 SNQEVLEFVT 286

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 81
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 131
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 192 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 250 SNQEVLEFVT 259
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	377
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	0.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	0.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	0.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-175
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-171
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-169
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-167
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-135
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-121
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-109
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-108
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-108
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-107
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-107
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-107
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-106
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-106
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-105
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-105
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-104
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-66
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-63
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-62
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-61
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-59
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-59
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-59
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-59
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-57
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-57
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-57
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-57
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-56
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-55
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-55
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-55
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-55
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-55
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-54
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-54
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-54
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-54
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-54
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-54
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-53
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-53
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-53
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-53
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-53
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-53
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-53
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-52
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-52
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-52
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-51
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-51
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-51
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-50
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-50
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-50
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-49
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-49
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-49
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-49
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-48
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-48
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-48
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-47
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-46
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-46
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-46
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-46
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-46
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-45
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-45
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-45
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-45
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-45
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-45
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-45
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-45
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-44
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-43
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-39
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-36
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-35
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-27
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-08
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  614 bits (1586), Expect = 0.0
 Identities = 179/358 (50%), Positives = 241/358 (67%), Gaps = 7/358 (1%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
           +          V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F+
Sbjct: 7   MAAAAAAGPEMVRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ 140
           +    +RTLREIK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q
Sbjct: 65  HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-Q 123

Query: 141 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---- 196
            L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
            T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           I  ++GSP    L  + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+
Sbjct: 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303

Query: 317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           KRI VE+AL HPYL+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P 
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 361

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  608 bits (1570), Expect = 0.0
 Identities = 130/363 (35%), Positives = 194/363 (53%), Gaps = 14/363 (3%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-- 78
           +   G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N   
Sbjct: 2   MQAKGEAAMRDLIAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVS 59

Query: 79  -------FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD 131
                    +    +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TD
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 132 LHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 190
           L Q+I   +  ++  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
           LAR  +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  +
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

Query: 251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEK 309
            +QL  I E++G+P    +    S +AR Y+R  L     + +    P     A+DL+ K
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299

Query: 310 MLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESV 369
           ML F+P +RI+ E+ALRHPY +SL D  D         F F+ S      + ++   E  
Sbjct: 300 MLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEVE 358

Query: 370 KFN 372
           +FN
Sbjct: 359 RFN 361

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  606 bits (1565), Expect = 0.0
 Identities = 151/354 (42%), Positives = 214/354 (60%), Gaps = 6/354 (1%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
           L     + + +V    +E+   YV     +G GAYG VC+A++  + E+VAIKK+   F 
Sbjct: 4   LIRKKGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSD 139
           + I A+R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+   
Sbjct: 63  SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-- 120

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
            + +++  QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR      
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--A 178

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I +
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

Query: 260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 319
           + G P    +  L    A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+
Sbjct: 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

Query: 320 TVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
           T  +AL HP+ +   D  +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 299 TAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  601 bits (1551), Expect = 0.0
 Identities = 168/351 (47%), Positives = 230/351 (65%), Gaps = 6/351 (1%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            + +  +   ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A
Sbjct: 14  TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +RT RE++LL+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTD
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD 131

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           DH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGY 189

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 324
               L  + S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +A
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309

Query: 325 LRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           L H Y    HD +DEPV   P+    E      D  + L + E + F P P
Sbjct: 310 LAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  600 bits (1548), Expect = 0.0
 Identities = 154/352 (43%), Positives = 224/352 (63%), Gaps = 6/352 (1%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
             + +  V    +EV + Y   ++P+G GAYG VC+AV+  T  +VAIKK+   F + + 
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 67

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE++LL+HM HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L 
Sbjct: 68  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLG 126

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
           +D  Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT 
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTG 184

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 323
           P    +  L+SD A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  E
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 324 ALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           AL HPY +SLHD  DEP     +   F+    T D  + + ++E + F P  
Sbjct: 305 ALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR 355

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  598 bits (1545), Expect = 0.0
 Identities = 171/347 (49%), Positives = 227/347 (65%), Gaps = 19/347 (5%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           + +SS +      +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+
Sbjct: 7   YNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILK 64

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I + Q L+DDH QYF+YQ LR
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYV 205
            +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP- 264
            TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 324
            D  L  + S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EA
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 325 LRHPYLQSLHDLNDEPVC----PRPFHFDFEHSSCTEDHIRELIWRE 367
           L HPYLQ+ HD NDEP      P  F FD    + T   +++LIW E
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  601 bits (1551), Expect = 0.0
 Identities = 134/403 (33%), Positives = 206/403 (51%), Gaps = 53/403 (13%)

Query: 24  GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII 83
            G+   Y        V   Y+     IGRG+YG V  A +  T + VAIKK+   F+++I
Sbjct: 9   SGRENLYFQGIKNVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI 67

Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           D +R LREI +L  ++ + +I + D+I P     F+++YIV E+ D+DL ++ ++   LT
Sbjct: 68  DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS------- 196
           ++H +  LY LL G  ++H + ++HRDLKP+N LLN  C +K+ DFGLART +       
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 197 ----------------ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                               +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++ 
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 241 -----------REPLFPG-----------------KDYVHQLRLITELIGSPDDASLGFL 272
                      R PLFPG                 K    QL +I  +IG+P +  L  +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                 +Y++  P  +      ++P+ S   ++LLE ML F+PNKRIT+++AL HPYL+ 
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

Query: 333 LHDLNDEPVCPRPFHFDFEHS-SCTEDHIRELIWRESVKFNPD 374
           +     E    +     F+     +E  +R +  +E   F+P+
Sbjct: 368 VRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPE 410

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  586 bits (1513), Expect = 0.0
 Identities = 139/433 (32%), Positives = 213/433 (49%), Gaps = 61/433 (14%)

Query: 2   AAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA 61
           +      S        +                + +++  +Y      IG G+YG VC A
Sbjct: 14  SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEI-RHLIGTGSYGHVCEA 72

Query: 62  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 121
            +   +  VAIKKI   F+++ID +R LREI +L  + H++V+ + DI+ P   + F+++
Sbjct: 73  YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 181
           Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N  
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD 192

Query: 182 CDLKIGDFGLARTTSETD----------------------------FMTEYVVTRWYRAP 213
           C +K+ DFGLART    +                             +T +VVTRWYRAP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPGKDYV----------- 251
           EL+L    YT AID+WS+GCI  E++            R PLFPG               
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGND 312

Query: 252 ---------HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 302
                     QL +I  ++G+P +  +  L  ++A+RY+R  P+      A RFP  S+ 
Sbjct: 313 FKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372

Query: 303 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTEDHIR 361
           A+ LL++MLVF+PNKRIT+ E L HP+ + +     E          F    +  E  +R
Sbjct: 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLR 432

Query: 362 ELIWRESVKFNPD 374
               +E  +++P+
Sbjct: 433 YAFVKEIQRYHPE 445

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  575 bits (1484), Expect = 0.0
 Identities = 137/378 (36%), Positives = 216/378 (57%), Gaps = 45/378 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
             V  KY   ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+RT REI +L 
Sbjct: 5   RHVLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63

Query: 97  HM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            +  HEN++ + +++R        DVY+V++ M+TDLH +IR+   L   H QY +YQL+
Sbjct: 64  ELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLI 119

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--------------------- 194
           + +KY+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R+                     
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 195 -TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
              +   +T+YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

Query: 254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF----------------P 297
           L  I  +I  P +  +  ++S  A+  +  L    + + + +                  
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299

Query: 298 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF-EHSSCT 356
           + +  A+DLL+K+L F+PNKRI+  +AL+HP++   H+ N+EP C         ++   +
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHS 359

Query: 357 EDHIRELIWRESVKFNPD 374
            D  R L++ E  +   +
Sbjct: 360 IDDYRNLVYSEISRRKRE 377

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  568 bits (1465), Expect = 0.0
 Identities = 143/364 (39%), Positives = 210/364 (57%), Gaps = 19/364 (5%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            +    +  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 10  NFYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDH 126

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P
Sbjct: 187 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLV 312
               +  L     R YV   P+     F   FP+            K+S A DLL KMLV
Sbjct: 246 CPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304

Query: 313 FDPNKRITVEEALRHPYLQSLHDLNDEPVC-PRPFHFDFEHSSCTEDHIRELIWRESVKF 371
            D +KRI+V+EAL+HPY+   +D ++     P+      +    T +  +ELI++E +  
Sbjct: 305 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 364

Query: 372 NPDP 375
               
Sbjct: 365 EHHH 368

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  565 bits (1458), Expect = 0.0
 Identities = 144/363 (39%), Positives = 214/363 (58%), Gaps = 19/363 (5%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L 
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELD 162

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+
Sbjct: 223 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKML 311
           P    +  L     R YV   P+     F   FP+            K+S A DLL KML
Sbjct: 282 PCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340

Query: 312 VFDPNKRITVEEALRHPYLQSLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVK 370
           V DP KRI+V++AL+HPY+   +D  +     P+ +    +    T +  +ELI++E + 
Sbjct: 341 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 400

Query: 371 FNP 373
              
Sbjct: 401 SEE 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  552 bits (1425), Expect = 0.0
 Identities = 129/326 (39%), Positives = 189/326 (57%), Gaps = 21/326 (6%)

Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
            N++G  F++ S+Y+  ++P+G G  G+V +AV+++  + VAIKKI     +    +  L
Sbjct: 2   MNIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHAL 56

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKK---------DTFNDVYIVYELMDTDLHQIIRSDQ 140
           REIK++R ++H+N++ + +I+ P               N VYIV E M+TDL  ++    
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-G 115

Query: 141 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS--- 196
            L ++H + F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR      
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 197 -ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
                ++E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235

Query: 256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 315
           LI E I    +     L S     Y+R       +      P  S  AVD LE++L F P
Sbjct: 236 LILESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 316 NKRITVEEALRHPYLQSLHDLNDEPV 341
             R+T EEAL HPY+       DEP+
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  511 bits (1318), Expect = 0.0
 Identities = 104/362 (28%), Positives = 161/362 (44%), Gaps = 21/362 (5%)

Query: 24  GGKYVQYNVYGNLFEVSSKYVP---PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
            G  +  N      E S K +      R  G+G +G V       T   VAIKK+     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQ 58

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS 138
           +     R L+ ++ L  + H N++ ++       +    D+Y  +V E +   LH+  R+
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118

Query: 139 ----DQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGL 191
                        + FL+QL+R +  +H  S +V HRD+KP N+L+N A   LK+ DFG 
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178

Query: 192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           A+  S ++    Y+ +R+YRAPEL+     YT A+DIWSVGCI  E+M  EP+F G +  
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC-RKQQFATRFPNKSSGAVDLLEKM 310
            QL  I  ++G P    L  L   +    +           F+      +  A DLL  +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298

Query: 311 LVFDPNKRITVEEALRHPYLQSLHDLNDE-----PVCPRPFHFDFEHSSCTEDHIRELIW 365
           L + P +R+   EAL HPY   LHD   +      +    F F         +  +  + 
Sbjct: 299 LQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

Query: 366 RE 367
           R+
Sbjct: 359 RK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  491 bits (1266), Expect = e-175
 Identities = 101/389 (25%), Positives = 182/389 (46%), Gaps = 61/389 (15%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            E SSK     + +G G++GIVC   + E+ +  A+KK+      + D R   RE+ +++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMK 55

Query: 97  HMEHENVIAIKDIIR---------------------------------PPKKDTFNDVYI 123
            ++H N+I + D                                             + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 124 VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           + E +   LH++++    S + +  +    ++YQL R + ++HS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 180 A-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
           +    LK+ DFG A+    ++    Y+ +R+YRAPEL+L  TEYT +ID+WS+GC+ GE+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 239 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 298
           +  +PLF G+  + QL  I +++G+P    +  +            P  + + +    P 
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPE 292

Query: 299 KS-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC-------------PR 344
            + S A+DLLE++L ++P+ RI   EA+ HP+   L +  +  V              P+
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352

Query: 345 PFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            F+F     S    ++   I  ++   N 
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKNFSPNY 381

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  482 bits (1243), Expect = e-171
 Identities = 105/375 (28%), Positives = 178/375 (47%), Gaps = 21/375 (5%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
                + S+ G    S     +     V     G        Y    + IG G++G+V  
Sbjct: 14  CKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQ 72

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFN 119
           A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       +K    
Sbjct: 73  AKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126

Query: 120 DVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
            + +V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP N
Sbjct: 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186

Query: 176 LLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           LLL+     LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+
Sbjct: 187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246

Query: 235 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 294
           L E++  +P+FPG   V QL  I +++G+P       +R  N      + P+ +   +  
Sbjct: 247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWTK 303

Query: 295 RF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP----FHFD 349
            F P     A+ L  ++L + P  R+T  EA  H +   L D N +    R     F+F 
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 363

Query: 350 FEHSSCTEDHIRELI 364
            +  S        LI
Sbjct: 364 TQELSSNPPLATILI 378

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  476 bits (1228), Expect = e-169
 Identities = 109/353 (30%), Positives = 176/353 (49%), Gaps = 22/353 (6%)

Query: 23  HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI 82
           +    V  +      +    Y    + IG G++G+V  A   E+ E VAIKK+      +
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTN-CKVIGNGSFGVVFQAKLVESDE-VAIKKV------L 73

Query: 83  IDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRS--- 138
            D R   RE++++R ++H NV+ +K        K     + +V E +   +++  R    
Sbjct: 74  QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK 133

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTS 196
             Q +     + ++YQLLR L Y+HS  + HRD+KP NLLL+     LK+ DFG A+   
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             +    Y+ +R+YRAPEL+   T YT  IDIWS GC++ E+M  +PLFPG+  + QL  
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDP 315
           I +++G+P       +++ N      + P+ R   F+  F P     A+DL+ ++L + P
Sbjct: 254 IIKVLGTPSRE---QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310

Query: 316 NKRITVEEALRHPYLQSLHDLN----DEPVCPRPFHFDFEHSSCTEDHIRELI 364
           + R+T  EAL HP+   L        +    P  F++  E  S   D I  L+
Sbjct: 311 SARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  468 bits (1207), Expect = e-167
 Identities = 89/319 (27%), Positives = 163/319 (51%), Gaps = 20/319 (6%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           +Y  Y  +   +     Y   +R +GRG Y  V  A+N    E+V +K +       +  
Sbjct: 21  EYWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKK 74

Query: 86  RRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           ++  REIK+L ++    N+I + DI++ P         +   + +TD  Q+    Q LTD
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVS--RTPALVFEHVNNTDFKQLY---QTLTD 129

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTE 203
              ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA           
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIG 262
            V +R+++ PELL++   Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249

Query: 263 SPD-DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPN 316
           + D    +     +   R+   L R  ++++     ++     S  A+D L+K+L +D  
Sbjct: 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309

Query: 317 KRITVEEALRHPYLQSLHD 335
            R+T  EA+ HPY  ++  
Sbjct: 310 SRLTAREAMEHPYFYTVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  387 bits (997), Expect = e-135
 Identities = 95/306 (31%), Positives = 169/306 (55%), Gaps = 8/306 (2%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KY   I  IG G+YG+V    N +T + VAIKK   + D+ +  +  LREI++L+ ++H 
Sbjct: 4   KYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++ + ++ R  ++     +++V+E  D  + H++ R  + + +   +   +Q L+ + +
Sbjct: 63  NLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
            H  + +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PELL+  
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
           T+Y   +D+W++GC+  E+++  PL+PGK  V QL LI + +G           ++    
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE 339
            V+       +    +FPN S  A+ LL+  L  DP +R+T E+ L HPY +++ ++ D 
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297

Query: 340 PVCPRP 345
                 
Sbjct: 298 AKEHDK 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  351 bits (903), Expect = e-121
 Identities = 99/301 (32%), Positives = 165/301 (54%), Gaps = 12/301 (3%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+   KY   +  +G G+YG+V    N +T   VAIKK   + D+ +  +  +REIKLL+
Sbjct: 21  FQSMEKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLL 155
            + HEN++ + ++ +  K+      Y+V+E +D  +   +      L     Q +L+Q++
Sbjct: 80  QLRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
            G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRAPE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLR 273
           LL+   +Y  A+D+W++GC++ E+   EPLFPG   + QL  I   +G+        F  
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF-- 252

Query: 274 SDNARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           + N      +LP  ++++    R+P  S   +DL +K L  DP+KR    E L H + Q 
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312

Query: 333 L 333
            
Sbjct: 313 D 313

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  318 bits (818), Expect = e-108
 Identities = 103/295 (34%), Positives = 147/295 (49%), Gaps = 19/295 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHM---EHE 101
           IG GAYG V  A +  +   VA+K +     N           T+RE+ LLR +   EH 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLK 159
           NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LRGL 
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNAR 278
           T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +      +      
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG- 252

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
                 P    +   +  P        LL +ML F+P+KRI+   AL+H YL   
Sbjct: 253 ----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  319 bits (819), Expect = e-108
 Identities = 109/307 (35%), Positives = 162/307 (52%), Gaps = 25/307 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHE 101
           +  +G G Y  V    +  T   VA+K+I       ++         +RE+ LL+ ++H 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           N++ + DII   K      + +V+E +D DL Q +      +   + + FL+QLLRGL Y
Sbjct: 61  NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL  
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNAR 278
           T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L ++  +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
            Y    P+ R +   +  P   S   DLL K+L F+   RI+ E+A++HP+  SL     
Sbjct: 236 TY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL----G 289

Query: 339 EPVCPRP 345
           E +   P
Sbjct: 290 ERIHKLP 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  318 bits (818), Expect = e-107
 Identities = 100/292 (34%), Positives = 151/292 (51%), Gaps = 19/292 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVI 104
           +G G +  V  A +  T + VAIKKI     +  +A+       LREIKLL+ + H N+I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
            + D          +++ +V++ M+TDL  II+     LT  H + ++   L+GL+Y+H 
Sbjct: 76  GLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 190

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYV 281
              +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +          +     
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY---- 246

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
                         F       +DL++ + +F+P  RIT  +AL+  Y  + 
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  316 bits (812), Expect = e-107
 Identities = 105/296 (35%), Positives = 162/296 (54%), Gaps = 23/296 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  +G G YG+V  A +S     VA+K+I       +DA         +REI LL+ + H
Sbjct: 26  LEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHH 78

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
            N++++ D+I   +      + +V+E M+ DL +++      L D   + +LYQLLRG+ 
Sbjct: 79  PNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           + H   +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+ 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNA 277
             +Y+ ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P+             
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           ++         K+ +++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 254 KQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  314 bits (807), Expect = e-107
 Identities = 105/296 (35%), Positives = 153/296 (51%), Gaps = 24/296 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  IG G YG+V  A N    E  A+KKI       ++         T+REI +L+ ++H
Sbjct: 7   LEKIGEGTYGVVYKAQN-NYGETFALKKI------RLEKEDEGIPSTTIREISILKELKH 59

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
            N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNA 277
             +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  +          
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV---TEL 231

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            +Y           + +         +DLL KML  DPN+RIT ++AL H Y +  
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  314 bits (808), Expect = e-106
 Identities = 107/321 (33%), Positives = 156/321 (48%), Gaps = 30/321 (9%)

Query: 50  IGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHM---E 99
           IG GAYG V  A +       VA+K++       +          T+RE+ +LRH+   E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRG 157
           H NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRG
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDN 276
             + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +      +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 336
                        Q       +      DLL K L F+P KRI+   AL HPY Q L   
Sbjct: 252 Q-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL--- 303

Query: 337 NDEPVCPRPFHFDFEHSSCTE 357
            +        H      + +E
Sbjct: 304 -ERCKENLDSHL-PPSQNTSE 322

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  314 bits (808), Expect = e-106
 Identities = 104/301 (34%), Positives = 158/301 (52%), Gaps = 28/301 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           I  +G G YG V  A+++ T E VAIK+I       ++          +RE+ LL+ ++H
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            N+I +K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G+ +
Sbjct: 93  RNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 161 VHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
            HS   LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR PE
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLR 273
           +LL    Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I E++G PDD +  G   
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             +   + +  P+ R +              +DLL  ML  DP KRI+ + AL HPY   
Sbjct: 268 LPD---WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

Query: 333 L 333
            
Sbjct: 325 N 325

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  310 bits (797), Expect = e-105
 Identities = 106/297 (35%), Positives = 158/297 (53%), Gaps = 24/297 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  IG G YG V  A N ET E VA+K++       +D          LREI LL+ ++H
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKH 60

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           +N++ + D++   KK     + +V+E  D DL +   S +  L  +  + FL+QLL+GL 
Sbjct: 61  KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           + HS +VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 219 CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDN 276
              Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +       +  +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            + Y                P  ++   DLL+ +L  +P +RI+ EEAL+HPY    
Sbjct: 236 YKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  311 bits (800), Expect = e-105
 Identities = 104/324 (32%), Positives = 166/324 (51%), Gaps = 27/324 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAI 106
           IG+G +G V  A + +T ++VA+KK+   N  +   I A   LREIK+L+ ++HENV+ +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA---LREIKILQLLKHENVVNL 81

Query: 107 KDII---RPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            +I      P       +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLL 217
              +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL
Sbjct: 142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 201

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDN 276
              +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS            + 
Sbjct: 202 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 261

Query: 277 ARRYVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 334
             +   +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL H +     
Sbjct: 262 YEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF----- 314

Query: 335 DLNDEPV-CPRPFHFDFEHSSCTE 357
               +P+            +S  E
Sbjct: 315 -FWSDPMPSDLKGMLSTHLTSMFE 337

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  309 bits (794), Expect = e-104
 Identities = 99/319 (31%), Positives = 163/319 (51%), Gaps = 32/319 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHE 101
           +  +G G Y  V   +N  T   VA+K++       +D+        +REI L++ ++HE
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHE 63

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLYQLL 155
           N++ + D+I    K     + +V+E MD DL + + S       + L  +  +YF +QLL
Sbjct: 64  NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
           +GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLR 273
           +L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI +++G+P+++       
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV-- 236

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHP 328
                +Y   + +   +                  +D L  +L  +P+ R++ ++AL HP
Sbjct: 237 -TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 329 YLQSLHDLNDEPVCPRPFH 347
           +    +            H
Sbjct: 296 WFAEYYHHASMGGSRSHHH 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  287 bits (735), Expect = 2e-94
 Identities = 102/320 (31%), Positives = 150/320 (46%), Gaps = 44/320 (13%)

Query: 50  IGRGAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A     +  ++ A+K+I      I  +    REI LLR ++H NVI+++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQ 84

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+            QL     +  LYQ+L G+
Sbjct: 85  KVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSE-----TDFMTEYVVTRW 209
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +       D     VVT W
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFW 200

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITEL 260
           YRAPELLL    YT AIDIW++GCI  E++T EP+F  +          +  QL  I  +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

Query: 261 IGSPDDA------SLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVF 313
           +G P D        +    +            C   ++         S A  LL+K+L  
Sbjct: 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320

Query: 314 DPNKRITVEEALRHPYLQSL 333
           DP KRIT E+A++ PY    
Sbjct: 321 DPIKRITSEQAMQDPYFLED 340

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  214 bits (548), Expect = 3e-66
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 43/320 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYV 161
            ++I     + F   N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +
Sbjct: 159 MNVIH--MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 162 HSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           H   ++H DLKP N+LL       +K+ DFG +    E   +  Y+ +R+YRAPE++L  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGA 274

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD--------ASLGF 271
             Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P          A    
Sbjct: 275 -RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333

Query: 272 LRSDNAR----------RYVRQLPRCRKQQFATRFPNKSSGA----------VDLLEKML 311
                 R            V    R R+ +      ++  G           +D L++ L
Sbjct: 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393

Query: 312 VFDPNKRITVEEALRHPYLQ 331
            +DP  R+T  +ALRHP+L+
Sbjct: 394 EWDPAVRMTPGQALRHPWLR 413

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  204 bits (521), Expect = 6e-63
 Identities = 48/318 (15%), Positives = 85/318 (26%), Gaps = 54/318 (16%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            P+  G   +V    + E  E+ A+K     A ++  +  R          +  E+    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 107 K---------DIIRPPKKDTFND------------VYIVYELMDTDLHQIIR-------S 138
           +         D +    +  F                ++      DL  +          
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
                         QL+R    + S  ++H    P NL +     L +GD          
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247

Query: 199 DFMTEYVVTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                  V   Y   E L  +   +T A++ W +G  +  +      F       +    
Sbjct: 248 --GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
              +  P   SL F               C                  L+ + L FD  +
Sbjct: 306 RPSLRVPGTDSLAF-------------GSC---------TPLPDFVKTLIGRFLNFDRRR 343

Query: 318 RITVEEALRHPYLQSLHD 335
           R+   EA+  P    L +
Sbjct: 344 RLLPLEAMETPEFLQLQN 361

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  203 bits (517), Expect = 4e-62
 Identities = 87/327 (26%), Positives = 147/327 (44%), Gaps = 50/327 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              IG+G++G V  A +   +E VAIK I N         +   E++LL  M   +    
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYV 161
             I+    K  F   N + +V+E++  +L+ ++R+     ++ +  + F  Q+   L ++
Sbjct: 116 YYIVHL--KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 162 HS--ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
            +   S++H DLKP N+LL       +KI DFG +        + +Y+ +R+YR+PE+LL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLL 231

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD------------ 265
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P             
Sbjct: 232 GM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290

Query: 266 ------DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA---------------V 304
                 D +    ++ + +R  +     +             G                 
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350

Query: 305 DLLEKMLVFDPNKRITVEEALRHPYLQ 331
           DL+ +ML +DP  RI    AL+H + +
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFK 377

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  200 bits (510), Expect = 6e-62
 Identities = 81/328 (24%), Positives = 129/328 (39%), Gaps = 66/328 (20%)

Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           Y + FE        I  +G+GA+G V  A N+      AIKKI +  +        L E+
Sbjct: 4   YASDFEE-------IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEV 53

Query: 93  KLLRHMEHENVIAIKD--------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLT 143
            LL  + H+ V+            +         + ++I  E  +   L+ +I S+    
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 144 D-DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---- 198
             D       Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+    +    
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 199 -----------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
                      D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTG 231

Query: 248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDL 306
            + V+ L+ +                            R    +F   F  NK      +
Sbjct: 232 MERVNILKKL----------------------------RSVSIEFPPDFDDNKMKVEKKI 263

Query: 307 LEKMLVFDPNKRITVEEALRHPYLQSLH 334
           +  ++  DPNKR      L   +L   H
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  198 bits (506), Expect = 2e-61
 Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 52/301 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 33  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 92  RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNC-- 219
            ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE + +   
Sbjct: 147 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 220 --------TEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLG 270
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I +           
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------- 254

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                    +  + P                   D+L+  L  DP +RI++ E L HPY+
Sbjct: 255 -------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

Query: 331 Q 331
           Q
Sbjct: 297 Q 297

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  199 bits (508), Expect = 7e-61
 Identities = 83/338 (24%), Positives = 134/338 (39%), Gaps = 46/338 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHE 101
           +R +G G +  V  A +      VA+K +               EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKE 80

Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+    + +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNASCD------LKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSI 196

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITE 259
            TR YR+PE+LL    +    DIWS  C++ E++T + LF   +          +  I E
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 260 LIGSPDDA-------SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA----VDLLE 308
           L+G            +  F  S    R + +L     +   T     S        D L 
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 309 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 346
            ML  DP KR      + HP+L+    + +  V  R  
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 353

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  193 bits (493), Expect = 1e-59
 Identities = 65/299 (21%), Positives = 112/299 (37%), Gaps = 56/299 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G +G V  A +    +   IK++        +  +  RE+K L  ++H N++  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHVNIVHY 69

Query: 107 KD-----------IIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLY 152
                          +   +     ++I  E  D   L Q I  R  ++L          
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +       T    T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE + +  +Y   +D++++G IL E++         +        ++             
Sbjct: 190 PEQISS-QDYGKEVDLYALGLILAELLH--VCDTAFE-------TSKFF----------- 228

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                          R    +  F         LL+K+L   P  R    E LR   + 
Sbjct: 229 ------------TDLRDGIISDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  194 bits (495), Expect = 3e-59
 Identities = 65/311 (20%), Positives = 118/311 (37%), Gaps = 54/311 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 14  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 73  RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--- 218
            ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE + +   
Sbjct: 128 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 219 -------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLG 270
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I             
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------------ 234

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                                    FP+       D+L+  L  DP +RI++ E L HPY
Sbjct: 235 ------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

Query: 330 LQSLHDLNDEP 340
           +Q      ++ 
Sbjct: 277 VQIQTHPVNQM 287

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  194 bits (494), Expect = 4e-59
 Identities = 85/328 (25%), Positives = 146/328 (44%), Gaps = 52/328 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           +  +G GA+G V   ++ +     VA+K + N     +D        EI++L H+   + 
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDP 73

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGL 158
            +    ++    + F     + IV+EL+    +  I+ +       DH +   YQ+ + +
Sbjct: 74  NSTFRCVQ--MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 159 KYVHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETD 199
            ++HS  + H DLKP N+L                      + D+K+ DFG A  T + +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDE 189

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             +  V TR YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  
Sbjct: 190 HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 260 LIGSP--------------DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
           ++G                    L +    +A RYV +  +  K+   ++         D
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER-LFD 307

Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSL 333
           L++KML +DP KRIT+ EAL+HP+   L
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLL 335

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  192 bits (490), Expect = 5e-59
 Identities = 68/323 (21%), Positives = 121/323 (37%), Gaps = 58/323 (17%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L  +EH  ++ 
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 106 IKD-------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLT---DDHCQYFLYQL 154
             +         +         +YI  +L    +L   +     +       C +   Q+
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM------------- 201
              ++++HS  ++HRDLKPSN+       +K+GDFGL     + +               
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
           T  V T+ Y +PE +     Y+  +DI+S+G IL E++   P     + V  L  +    
Sbjct: 188 TGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV---- 240

Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                                     R  +F   F  K      +++ ML   P +R   
Sbjct: 241 --------------------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA 274

Query: 322 EEALRHPYLQSLHDLNDEPVCPR 344
              + +   + L       +  R
Sbjct: 275 INIIENAVFEDLDFPGKTVLRQR 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  192 bits (490), Expect = 6e-59
 Identities = 69/288 (23%), Positives = 103/288 (35%), Gaps = 43/288 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  +G G+YG V    + E     A+K+  + F    D  R L E+     + +H   + 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           ++             +Y+  EL    L Q        L +     +L   L  L ++HS 
Sbjct: 122 LEQAWE-----EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            ++H D+KP+N+ L      K+GDFGL                  Y APELL     Y  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGT 234

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A D++S+G  + E+     L  G +   QLR   +    P                    
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLR---QGYLPP-------------------- 271

Query: 285 PRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                      F    SS    +L  ML  DP  R T E  L  P L+
Sbjct: 272 ----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  194 bits (495), Expect = 2e-58
 Identities = 75/299 (25%), Positives = 117/299 (39%), Gaps = 51/299 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD 108
           +G GA G +          +VA+K+I     +  D     RE++LLR   EH NVI    
Sbjct: 32  LGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFC 85

Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
             +          YI  EL    L + + + D           L Q   GL ++HS +++
Sbjct: 86  TEK-----DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 168 HRDLKPSNLLL-----NASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLN 218
           HRDLKP N+L+     +      I DFGL +            +    T  + APE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 219 CTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
             +   T  +DI+S GC+   +++      GK    Q      L+G+     L       
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGACSLDCL------- 250

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                                ++   A +L+EKM+  DP KR + +  L+HP+  SL  
Sbjct: 251 -----------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  191 bits (486), Expect = 8e-58
 Identities = 79/330 (23%), Positives = 139/330 (42%), Gaps = 52/330 (15%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           +  +G G +G V   + ++  + +VA+K I N     +   R     EI +L+ ++ ++ 
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDK 78

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGL 158
                 +     D F     + I +EL+  +  + ++  + Q     H ++  YQL   L
Sbjct: 79  ENKFLCVL--MSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 159 KYVHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETD 199
           +++H   + H DLKP N+L                      +  +++ DFG A  T + +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHE 194

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             T  V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ +
Sbjct: 195 HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 260 LIGSPD--------------DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
           ++G                    L +  + +  RYV++  +  K               D
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ-LFD 312

Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           L+ +ML FDP +RIT+ EAL HP+   L  
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTP 342

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  191 bits (487), Expect = 1e-57
 Identities = 64/311 (20%), Positives = 117/311 (37%), Gaps = 54/311 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 120 RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--- 218
            ++H DLKP+N L+     LK+ DFG+A        +      V    Y  PE + +   
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 219 -------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLG 270
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I             
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------------ 281

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
                                    FP+       D+L+  L  DP +RI++ E L HPY
Sbjct: 282 ------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

Query: 330 LQSLHDLNDEP 340
           +Q      ++ 
Sbjct: 324 VQIQTHPVNQM 334

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  190 bits (485), Expect = 1e-57
 Identities = 68/315 (21%), Positives = 128/315 (40%), Gaps = 41/315 (13%)

Query: 22  THGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN 81
            H    V        F+   KYV  ++ IG G++G      ++E   +  IK+I  +  +
Sbjct: 5   HHHSSGVDLGTENLYFQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63

Query: 82  IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ 140
             +   + RE+ +L +M+H N++  ++            +YIV +  +  DL + I + +
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 141 Q--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
                +D    +  Q+   LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 199 DFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +    + T +Y +PE+  N   Y    DIW++GC+L E+ T +  F      + +  I
Sbjct: 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

Query: 258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
                                     +             + S     L+ ++   +P  
Sbjct: 238 I-------------------SGSFPPVS-----------LHYSYDLRSLVSQLFKRNPRD 267

Query: 318 RITVEEALRHPYLQS 332
           R +V   L   ++  
Sbjct: 268 RPSVNSILEKGFIAK 282

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  191 bits (487), Expect = 3e-57
 Identities = 93/310 (30%), Positives = 146/310 (47%), Gaps = 51/310 (16%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLRE 91
            +  +Y+   + +G GA G V  A   +T ++VAI+ I        +      A     E
Sbjct: 132 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYF 150
           I++L+ + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ +
Sbjct: 191 IEILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVT 207
            YQ+L  ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 208 RWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP- 264
             Y APE+L++     Y  A+D WS+G IL              ++        L G P 
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL--------------FI--C-----LSGYPP 343

Query: 265 -DDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVE 322
             +           +  ++      K  F        S  A+DL++K+LV DP  R T E
Sbjct: 344 FSE--------HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395

Query: 323 EALRHPYLQS 332
           EALRHP+LQ 
Sbjct: 396 EALRHPWLQD 405

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  186 bits (475), Expect = 4e-57
 Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 47/297 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G+YG           + +  K++        + +  + E+ LLR ++H N++  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYV 161
            D I      T    YIV E  +  DL  +I    +    L ++     + QL   LK  
Sbjct: 71  YDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 162 HS-----ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H       +VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +     Y    DIWS+GC+L E+    P F           I E  G             
Sbjct: 188 MNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR---------- 234

Query: 276 NARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                              R P + S    +++ +ML      R +VEE L +P + 
Sbjct: 235 -------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  187 bits (477), Expect = 6e-57
 Identities = 56/312 (17%), Positives = 117/312 (37%), Gaps = 31/312 (9%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA   V    + +T +  AIK   N    +      +RE ++L+ + H+N++ + 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHS 163
            I    ++ T     ++ E      L+ ++        L +      L  ++ G+ ++  
Sbjct: 74  AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 164 ASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 216
             ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 217 ----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--GSPDDASLG 270
                +  +Y A +D+WS+G       T    F   +   + + +   I  G P  A  G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 271 FLRSDNAR-RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP- 328
             +++N    +   +P        +           +L  +L  D  K    ++      
Sbjct: 251 VQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305

Query: 329 ---YLQSLHDLN 337
              +  + H  +
Sbjct: 306 DILHRGNSHHHH 317

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  188 bits (479), Expect = 1e-56
 Identities = 72/339 (21%), Positives = 141/339 (41%), Gaps = 72/339 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVI 104
           IR +G G +G V    + + ++  A+K + N     I         E  +L+ +++++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDD-- 92

Query: 105 AIKD---IIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLR 156
              +   I++      F   + + +++E +   L++II  +       +  + +  ++L+
Sbjct: 93  --INNNNIVK--YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 157 GLKYVHSASVLHRDLKPSNLLLN-------------------------ASCDLKIGDFGL 191
            L Y+   S+ H DLKP N+LL+                          S  +K+ DFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           A  T ++D+    + TR YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 252 HQLRLITELIGSPDD-------------------ASLGFLRSDNARRYVRQLPRCRKQQF 292
             L ++  +I                          L +  + ++   ++ + +C     
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL-- 323

Query: 293 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 K     D L  +L  DP  R +  E L+H +L+
Sbjct: 324 --YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  189 bits (481), Expect = 1e-55
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 38/298 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + +G GAYG V    +  T  E AIK I     +     + L E+ +L+ ++H N++ + 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D       +   + Y+V E     +L   I    +  +      + Q+L G+ Y+H  ++
Sbjct: 103 DFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLLL        +KI DFGL+        M E + T +Y APE+L     Y 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YD 215

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+WS+G IL  ++   P F G+     LR +    G        F   +        
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYT-----FDSPE-------- 260

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
                       + N S GA DL+++ML FD  +RI+ ++AL HP+++ +    +  +
Sbjct: 261 ------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  183 bits (466), Expect = 1e-55
 Identities = 75/302 (24%), Positives = 129/302 (42%), Gaps = 42/302 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T +E A K I     ++    +      RE+ +LR + H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 71  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G+     L  I+         +  F       
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-------VNYDFDEEY--- 234

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
                            F N S  A D + ++LV DP +R+T+ ++L H +++++   N 
Sbjct: 235 -----------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

Query: 339 EP 340
             
Sbjct: 278 RG 279

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  188 bits (480), Expect = 1e-55
 Identities = 79/301 (26%), Positives = 135/301 (44%), Gaps = 39/301 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            +       +     Y+V E+    +L   I S ++ ++      + Q+L G+ Y+H   
Sbjct: 92  YEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLLL   +   +++I DFGL+     +  M + + T +Y APE+L     Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 204

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
               D+WS G IL  +++  P F G +    L+ +    G        F           
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYT-----FELPQ------- 250

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 342
                        +   S  A DL+ KML + P+ RI+  +AL H ++Q+          
Sbjct: 251 -------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

Query: 343 P 343
           P
Sbjct: 298 P 298

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  191 bits (486), Expect = 3e-55
 Identities = 70/303 (23%), Positives = 126/303 (41%), Gaps = 17/303 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G G +G V   ++ +T E+VAIK+      +  +  R   EI++++ + H NV++ 
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 107 KDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYV 161
           +++    +K   ND   +  E  +  DL + +        L +   +  L  +   L+Y+
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 162 HSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL  
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
             +YT  +D WS G +  E +T    F       Q           ++  + +     A 
Sbjct: 198 -KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEHIVVYDDLTGAV 254

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
           ++   LP              +      L+ ML++   +R T  +       Q+L  +  
Sbjct: 255 KFSSVLPTPNH-----LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309

Query: 339 EPV 341
             +
Sbjct: 310 LKL 312

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  182 bits (464), Expect = 3e-55
 Identities = 84/321 (26%), Positives = 134/321 (41%), Gaps = 55/321 (17%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-------GNAFDNIIDARRTLR 90
                Y P    +GRG   +V   ++  T +E A+K I        +A +       TL+
Sbjct: 14  GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 91  EIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
           E+ +LR +  H N+I +KD       +T    ++V++LM   +L   +     L++   +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
             +  LL  +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T 
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 209 WYRAPELL-----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
            Y APE++      N   Y   +D+WS G I+              Y   L     L GS
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM--------------YT--L-----LAGS 226

Query: 264 P---DDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRI 319
           P       +  LR   +  Y          QF +    + S    DL+ + LV  P KR 
Sbjct: 227 PPFWHRKQMLMLRMIMSGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276

Query: 320 TVEEALRHPYLQSLHDLNDEP 340
           T EEAL HP+ Q         
Sbjct: 277 TAEEALAHPFFQQYVVEEVRH 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  181 bits (461), Expect = 2e-54
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 45/307 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLRE 91
            +  +Y+   + +G GA G V  A   +T ++VAIK I        +      A     E
Sbjct: 7   ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYF 150
           I++L+ + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ +
Sbjct: 66  IEILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVT 207
            YQ+L  ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 208 RWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
             Y APE+L++     Y  A+D WS    LG I+          ++        L G P 
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWS----LGVIL----------FI----C---LSGYPP 218

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
                F           Q+   +       +   S  A+DL++K+LV DP  R T EEAL
Sbjct: 219 -----FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

Query: 326 RHPYLQS 332
           RHP+LQ 
Sbjct: 274 RHPWLQD 280

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  179 bits (457), Expect = 3e-54
 Identities = 75/290 (25%), Positives = 139/290 (47%), Gaps = 39/290 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D I        +  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  +
Sbjct: 72  DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 167 LHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 185

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
             +DIW+ G IL              Y+  L     L+G P      F   ++  R   Q
Sbjct: 186 KPVDIWACGVIL--------------YI--L-----LVGYPP-----F-WDEDQHRLYAQ 218

Query: 284 LPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           +       + +  +   +  A  L++ ML  +P KRIT ++AL+ P++ +
Sbjct: 219 IKAG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  181 bits (462), Expect = 3e-54
 Identities = 81/348 (23%), Positives = 145/348 (41%), Gaps = 56/348 (16%)

Query: 2   AAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA 61
            A AK  +      +        G   +   +    E   KY P    IGRG   +V   
Sbjct: 55  LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP-KDVIGRGVSSVVRRC 113

Query: 62  VNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK 114
           V+  T  E A+K +       +          T RE  +LR +  H ++I + D      
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169

Query: 115 KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 173
            ++ + +++V++LM   +L   +     L++   +  +  LL  + ++H+ +++HRDLKP
Sbjct: 170 -ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228

Query: 174 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-----YTAAIDI 228
            N+LL+ +  +++ DFG +      + + E   T  Y APE+L    +     Y   +D+
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288

Query: 229 WSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
           W+ G IL     G      P F  +  +  LR+I  + G           S         
Sbjct: 289 WACGVILFTLLAG-----SPPFWHRRQILMLRMI--MEGQYQ------FSSPE------- 328

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                       + ++SS   DL+ ++L  DP  R+T E+AL+HP+ +
Sbjct: 329 ------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  179 bits (456), Expect = 3e-54
 Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 38/288 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  ++
Sbjct: 88  EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y APE+L     Y 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+WS G IL  +++  P F GK+    L+ +    G        F            
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA-----FDLPQ-------- 245

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                       +   S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 246 ------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  184 bits (469), Expect = 5e-54
 Identities = 83/289 (28%), Positives = 137/289 (47%), Gaps = 38/289 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  ++
Sbjct: 88  EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y APE+L     Y 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+WS G IL  +++  P F GK+    L+ +    G                     
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA------FDLP-------- 244

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                      ++   S  A DL+ KML F P+ RIT  + L HP++Q 
Sbjct: 245 -----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  179 bits (456), Expect = 8e-54
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 42/297 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T  E A K I      A    +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G      L  IT         S  F       
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS-------VSYDFDEEF--- 241

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                            F + S  A D + K+LV +  KR+T++EALRHP++  + +
Sbjct: 242 -----------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  179 bits (457), Expect = 2e-53
 Identities = 75/298 (25%), Positives = 140/298 (46%), Gaps = 39/298 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D I        +  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  +
Sbjct: 95  DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149

Query: 167 LHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 208

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
             +DIW+ G IL              Y+  L     L+G P      F   ++  R   Q
Sbjct: 209 KPVDIWACGVIL--------------YI--L-----LVGYPP-----F-WDEDQHRLYAQ 241

Query: 284 LPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 340
           +       + +  +   +  A  L++ ML  +P KRIT ++AL+ P++ +   +    
Sbjct: 242 IKAG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  179 bits (456), Expect = 2e-53
 Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 46/304 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T  E A K I      A    +      RE+ +LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGFLRSDNA 277
                   D+WS+G I               Y+  L     L G SP      FL  D  
Sbjct: 192 YEPLGLEADMWSIGVIT--------------YI--L-----LSGASP------FL-GDTK 223

Query: 278 RRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 336
           +  +  +       F    F   S  A D + K+LV +  KR+T++EALRHP++  +   
Sbjct: 224 QETLANITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282

Query: 337 NDEP 340
               
Sbjct: 283 QAMV 286

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  180 bits (457), Expect = 4e-53
 Identities = 61/339 (17%), Positives = 128/339 (37%), Gaps = 28/339 (8%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA   V    + +T +  AIK   N    +      +RE ++L+ + H+N++ + 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHS 163
            I    ++ T     ++ E      L+ ++        L +      L  ++ G+ ++  
Sbjct: 74  AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 164 ASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 216
             ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 217 ----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--GSPDDASLG 270
                +  +Y A +D+WS+G       T    F   +   + + +   I  G P  A  G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 271 FLRSDNAR-RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             +++N    +   +P        +           +L  +L  D  K    ++      
Sbjct: 251 VQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305

Query: 330 -LQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 367
            +     ++   +     H  + HS  T     EL++++
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  182 bits (463), Expect = 5e-53
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 49/308 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-----------GNAFDNIIDARRTLREIKLLR 96
           R +G GAYG V          E AIK I            +  +          EI LL+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLL 155
            ++H N+I + D+      +     Y+V E  +  +L + I +  +  +      + Q+L
Sbjct: 102 SLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 156 RGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
            G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE+L     Y    D+WS G I+  ++   P F G++    ++ +    G        F 
Sbjct: 217 PEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYY-----FD 267

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            +D                    + N S  A +L++ ML +D NKR T EEAL   +++ 
Sbjct: 268 FND--------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

Query: 333 LHDLNDEP 340
             +  ++ 
Sbjct: 308 YANNINKS 315

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  177 bits (451), Expect = 5e-53
 Identities = 69/312 (22%), Positives = 135/312 (43%), Gaps = 44/312 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRG +GIV   V + +++    K +     + +  ++   EI +L    H N++ + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLH 67

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +       ++  ++ +++E +   D+  +I  S  +L +     +++Q+   L+++HS +
Sbjct: 68  ESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 166 VLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           + H D++P N++        +KI +FG AR     D          Y APE +      +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVS 181

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGFLRSDNARRYVR 282
            A D+WS+G ++              YV  L     L G +P      FL   N +    
Sbjct: 182 TATDMWSLGTLV--------------YV--L-----LSGINP------FLAETNQQII-E 213

Query: 283 QLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
            +    +  F    F   S  A+D ++++LV +   R+T  EAL+HP+L+   +     V
Sbjct: 214 NIMNA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272

Query: 342 CPRPFHFDFEHS 353
                H  + H+
Sbjct: 273 IRTLKHRRYYHT 284

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  175 bits (447), Expect = 6e-53
 Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 40/297 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IGRG++G V  AV   TR   A KKI      + D  R  +EI++++ ++H N+I + 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +       +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V
Sbjct: 73  ETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            HRDLKP N L    +    LK+ DFGLA        M   V T +Y +P++L     Y 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YG 185

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D WS G ++  ++   P F        +  I    G+       F   D        
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFT-----FPEKD-------- 230

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 340
                       + N S  A  L+ ++L   P +RIT  +AL H + +     +   
Sbjct: 231 ------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  177 bits (451), Expect = 7e-53
 Identities = 73/310 (23%), Positives = 130/310 (41%), Gaps = 45/310 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + +V       T  + A K I      +    +      RE+ +L+ ++H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L         +KI DFGLA      +       T  + APE ++N
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
                   D+WS+G I   +++    F G      L  ++         +  F       
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------VNYEFEDEY--- 240

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 338
                            F N S+ A D + ++LV DP KR+T++++L+HP+++     + 
Sbjct: 241 -----------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---PKDT 280

Query: 339 EPVCPRPFHF 348
           +    R    
Sbjct: 281 QQALSRKASA 290

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  177 bits (450), Expect = 9e-53
 Identities = 70/302 (23%), Positives = 131/302 (43%), Gaps = 40/302 (13%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
             ++ Y+   + +GRG + +V   ++  T +E A K +             L EI +L  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 98  MEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL-HQII-RSDQQLTDDHCQYFLYQ 153
            +    VI + ++      +  +++ ++ E     ++    +    + ++++     + Q
Sbjct: 85  AKSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +L G+ Y+H  +++H DLKP N+LL       D+KI DFG++R       + E + T  Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
            APE +LN    T A D+W++G I   ++T    F G+D       I++        ++ 
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ-------VNVD 251

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           +                        F + S  A D ++ +LV +P KR T E  L H +L
Sbjct: 252 YSEET--------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

Query: 331 QS 332
           Q 
Sbjct: 292 QQ 293

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  175 bits (446), Expect = 1e-52
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 44/292 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G GA+G V       +  E  IK I N   + +   +   EI++L+ ++H N+I I 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 108 DIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++      + ++++YIV E  +       +       + L++ +    + Q++  L Y H
Sbjct: 87  EVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 163 SASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           S  V+H+DLKP N+L    +    +KI DFGLA      +  T    T  Y APE+    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
            + T   DIWS G ++  ++T    F G       +        P+              
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPN-------------- 243

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                       +A      +  AVDLL++ML  DP +R +  + L H + +
Sbjct: 244 ------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  177 bits (452), Expect = 2e-52
 Identities = 65/298 (21%), Positives = 125/298 (41%), Gaps = 39/298 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+G+V   V   T      K I       +D      EI ++  + H  +I + 
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           D       +   ++ ++ E +   +L  +I   D ++++     ++ Q   GLK++H  S
Sbjct: 115 DAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 166 VLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           ++H D+KP N++     +  +KI DFGLA   +  + +     T  + APE +++     
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVG 228

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+W++G +   +++    F G+D +  L+ +             F            
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------CDWEFDEDA-------- 273

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
                       F + S  A D ++ +L  +P KR+TV +AL HP+L+  H      +
Sbjct: 274 ------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  176 bits (447), Expect = 3e-52
 Identities = 80/366 (21%), Positives = 133/366 (36%), Gaps = 85/366 (23%)

Query: 22  THGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI---GNA 78
              G+   Y   G+L E+  KY      IG+G+YG+V  A+ ++TR   AIK +      
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM---------- 128
             N  D  R   E++L++ + H N+  + ++      +    + +V EL           
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLN 120

Query: 129 -------------------------------DTDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                                           +        D    +      + Q+   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 158 LKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWY 210
           L Y+H+  + HRD+KP N L   N S ++K+ DFGL++        E   MT    T ++
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 211 RAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
            APE+L    E Y    D WS G +L  ++     FPG +    +  +           L
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKL 293

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            F   +                    +   S  A DLL  +L  + ++R     AL+HP+
Sbjct: 294 CFENPN--------------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333

Query: 330 LQSLHD 335
           +    D
Sbjct: 334 ISQFSD 339

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  175 bits (445), Expect = 3e-52
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 45/300 (15%)

Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRH 97
           + +    + IGRG +  V  A        VA+KK+     +++DA+     ++EI LL+ 
Sbjct: 32  ANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQ 88

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLY 152
           + H NVI              N++ IV EL D  DL ++I+  ++    + +     +  
Sbjct: 89  LNHPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYR 211
           QL   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y 
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           +PE +     Y    DIWS+GC+L E+   +  F G                 D  +L  
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG-----------------DKMNLYS 245

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
           L     +     LP            + S     L+   +  DP KR  V          
Sbjct: 246 LCKKIEQCDYPPLPS----------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  177 bits (451), Expect = 6e-52
 Identities = 78/327 (23%), Positives = 128/327 (39%), Gaps = 69/327 (21%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            + +  V   + +G G+ G V     S     VA+K++   F +I        EIKLL  
Sbjct: 12  SLKNLVVSE-KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTE 64

Query: 98  M-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-------RSDQQLTDDHCQY 149
             +H NVI            T   +YI  EL + +L  ++        + +   + +   
Sbjct: 65  SDDHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-------------CDLKIGDFGLART-- 194
            L Q+  G+ ++HS  ++HRDLKP N+L++ S               + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 195 ---TSETDFMTEYVVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTREPLF 245
              +S    +     T  +RAPELL            T +IDI+S+GC+   I+++    
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 305
            G  Y  +  +I  +    +   L                            +  + A D
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLH-------------------------DRSLIAEATD 274

Query: 306 LLEKMLVFDPNKRITVEEALRHPYLQS 332
           L+ +M+  DP KR T  + LRHP    
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWP 301

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  174 bits (443), Expect = 1e-51
 Identities = 82/331 (24%), Positives = 137/331 (41%), Gaps = 62/331 (18%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
           R +G+G +       +++T+E  A K        I+            +   EI + R +
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G
Sbjct: 99  AHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 153

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPEL 215
            +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEV 212

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     ++  +D+WS+GCI+  ++  +P F           I                  
Sbjct: 213 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------------ 253

Query: 276 NARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS-- 332
                       +K ++    P   +  A  L++KML  DP  R T+ E L   +  S  
Sbjct: 254 ------------KKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299

Query: 333 LHDLNDEPVCPRPFHFDFEHSSCTEDHIREL 363
           +           P  F    SS    + + L
Sbjct: 300 IPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  172 bits (439), Expect = 2e-51
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 60/298 (20%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
           R +G+G +       +++T+E  A K        I+            +   EI + R +
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G
Sbjct: 73  AHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPEL 215
            +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEV 186

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           L     ++  +D+WS+GCI+  ++  +P F           I                  
Sbjct: 187 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------------ 227

Query: 276 NARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                       +K ++    P   +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 228 ------------KKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  173 bits (441), Expect = 6e-51
 Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 40/299 (13%)

Query: 38  EVSSKY-VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            V+S Y V     +G G +G V     + T  ++A K I      + D      EI ++ 
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMN 141

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQL 154
            ++H N+I + D       ++ ND+ +V E +D  +L  +II     LT+     F+ Q+
Sbjct: 142 QLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 155 LRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
             G++++H   +LH DLKP N+L     +  +KI DFGLAR     + +     T  + A
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE ++N    +   D+WSVG I   +++    F G +    L  I               
Sbjct: 257 PE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-------CRWDLE 308

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
             +                    F + S  A + + K+L+ + + RI+  EAL+HP+L 
Sbjct: 309 DEE--------------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  172 bits (438), Expect = 1e-50
 Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 52/308 (16%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVI 104
             IG+G + +V   +N ET ++ A+K +  A       +      RE  +   ++H +++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDL-HQIIR---SDQQLTDDHCQYFLYQLLRGLK 159
            + +        +   +Y+V+E MD  DL  +I++   +    ++    +++ Q+L  L+
Sbjct: 90  ELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 160 YVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL 215
           Y H  +++HRD+KP  +LL     S  +K+G FG+A    E+       V T  + APE 
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE- 203

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP--DDASLGFLR 273
           ++    Y   +D+W  G IL              ++  L     L G             
Sbjct: 204 VVKREPYGKPVDVWGCGVIL--------------FI--L-----LSGCLPFYGTKERLFE 242

Query: 274 SDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                +Y          +   R + + S  A DL+ +ML+ DP +RITV EAL HP+L+ 
Sbjct: 243 GIIKGKY----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

Query: 333 LHDLNDEP 340
                 + 
Sbjct: 293 RDRYAYKI 300

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  170 bits (433), Expect = 2e-50
 Identities = 69/366 (18%), Positives = 127/366 (34%), Gaps = 106/366 (28%)

Query: 40  SSKYVP---PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +S+Y+    PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L 
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALA 59

Query: 97  HMEHENVIAIKD------------------------------------------------ 108
            +EH  ++   +                                                
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 109 ----IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTD---DHCQYFLYQLLRGLKY 160
               + +         +YI  +L    +L   +     L D     C +   Q+   +++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-------------MTEYVVT 207
           +HS  ++HRDLKPSN+       +K+GDFGL     + +               T  V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
           + Y +PE +     Y+  +DI+S+G IL E++         + V  +  +          
Sbjct: 240 KLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV---------- 286

Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                               R  +F   F  K      +++ ML   P +R    + + +
Sbjct: 287 --------------------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326

Query: 328 PYLQSL 333
              ++L
Sbjct: 327 AIFENL 332

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  176 bits (448), Expect = 3e-50
 Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 39/288 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+G+V       T    A K +     +  D     +EI+ +  + H  ++ + 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           D       +  N++ ++YE M   +L  ++     ++++D    ++ Q+ +GL ++H  +
Sbjct: 221 DAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 166 VLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +H DLKP N++     S +LK+ DFGL         +     T  + APE +       
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVG 334

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
              D+WSVG +   +++    F G++    LR +       +        S         
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWN-----MDDSA-------- 379

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                       F   S    D + K+L+ DPN R+T+ +AL HP+L 
Sbjct: 380 ------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  169 bits (430), Expect = 3e-50
 Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 66/311 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  IG G +G V   V        AIK+        +D +  LRE+     + +H +V+ 
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKY 160
                    +D  + + I  E  +   L   I    R      +   +  L Q+ RGL+Y
Sbjct: 76  YFSAW---AED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 161 VHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETDFM 201
           +HS S++H D+KPSN+ ++                        KIGD G     S     
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
                   + A E+L     +    DI+++   +      EPL    D  H++R      
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------ 241

Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                           +  + ++P+             S    +LL+ M+  DP +R + 
Sbjct: 242 ----------------QGRLPRIPQVL-----------SQEFTELLKVMIHPDPERRPSA 274

Query: 322 EEALRHPYLQS 332
              ++H  L S
Sbjct: 275 MALVKHSVLLS 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  168 bits (428), Expect = 1e-49
 Identities = 66/312 (21%), Positives = 107/312 (34%), Gaps = 48/312 (15%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G++  + +K+   I+ +G G +  V            A+K+I        D     RE  
Sbjct: 21  GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREAD 78

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQ 148
           + R   H N++ +       +       +++        L   I   +     LT+D   
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART------TSETDFMT 202
           + L  + RGL+ +H+    HRDLKP+N+LL       + D G           S      
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 203 EYVVTR----WYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
           +    +     YRAPEL             D+WS+GC+L  +M  E  +   D V Q   
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---DMVFQKGD 254

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
              L                           + Q    + P  SS    LL  M+  DP+
Sbjct: 255 SVALA-------------------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPH 289

Query: 317 KRITVEEALRHP 328
           +R  +   L   
Sbjct: 290 QRPHIPLLLSQL 301

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  167 bits (426), Expect = 1e-49
 Identities = 74/321 (23%), Positives = 136/321 (42%), Gaps = 77/321 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------------------------GNAFDNI 82
              IG+G+YG+V  A N       A+K +                        G      
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 83  IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE------LMDTDLHQII 136
               +  +EI +L+ ++H NV+ + +++  P +D    +Y+V+E      +M+      +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVME------V 128

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
            + + L++D  +++   L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++    
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 197 ETDFMTEYVV-TRWYRAPELLLNCT-EYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            +D +    V T  + APE L      ++  A+D+W++G  L              Y   
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL--------------YC-- 232

Query: 254 LRLITELIGS-P-DDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKM 310
              +    G  P  D  +  L S           + + Q       P+ +    DL+ +M
Sbjct: 233 --FVF---GQCPFMDERIMCLHS-----------KIKSQALEFPDQPDIAEDLKDLITRM 276

Query: 311 LVFDPNKRITVEEALRHPYLQ 331
           L  +P  RI V E   HP++ 
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  167 bits (425), Expect = 3e-49
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 40/289 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+  V       T +  A+K I  +            EI +L+ ++HEN++ ++
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++    Y+V +L+   +L   I      T+      + Q+L  +KY+H   +
Sbjct: 73  DIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL      +  + I DFGL++   +   M+    T  Y APE +L    Y+
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYS 185

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+D WS+G I   ++   P F  +        I E           F            
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE-------GYYEFESPF-------- 230

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                       + + S  A D +  +L  DPN+R T E+AL HP++  
Sbjct: 231 ------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  166 bits (422), Expect = 3e-49
 Identities = 67/301 (22%), Positives = 127/301 (42%), Gaps = 67/301 (22%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
             +G+G++  V  A +  T  EVAIK        +ID          +R   E+K+   +
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIK--------MIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
           +H +++ + +       +  N VY+V       E+       +    +  +++  ++F++
Sbjct: 69  KHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMH 119

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYR 211
           Q++ G+ Y+HS  +LHRDL  SNLLL  + ++KI DFGLA +     +       T  Y 
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           +PE+    + +    D+WS+GC+   ++   P F      + L  +              
Sbjct: 180 SPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------------- 224

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                               +    P+  S  A DL+ ++L  +P  R+++   L HP++
Sbjct: 225 ----------------VLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

Query: 331 Q 331
            
Sbjct: 267 S 267

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  170 bits (433), Expect = 4e-49
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 47/312 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
             + +Y      +G+GA+ +V   V     +E A   I     +  D ++  RE ++ R 
Sbjct: 8   RFTEEYQL-FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           ++H N++ + D I           Y++++L+   +L + I + +  ++    + + Q+L 
Sbjct: 67  LKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRA 212
            + + H   V+HR+LKP NLLL +      +K+ DFGLA     E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASL 269
           PE +L    Y   +D+W+ G IL              Y+  L     L+G P   D+   
Sbjct: 182 PE-VLRKDPYGKPVDLWACGVIL--------------YI--L-----LVGYPPFWDEDQH 219

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
              +   A  Y           F +      +  A DL+ KML  +P+KRIT  EAL+HP
Sbjct: 220 RLYQQIKAGAY----------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269

Query: 329 YLQSLHDLNDEP 340
           ++     +    
Sbjct: 270 WISHRSTVASCM 281

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  167 bits (426), Expect = 4e-49
 Identities = 86/318 (27%), Positives = 130/318 (40%), Gaps = 71/318 (22%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHM-EHENVI 104
             IG G+Y +    ++  T  E A+K        IID  +     EI++L    +H N+I
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVK--------IIDKSKRDPTEEIEILLRYGQHPNII 79

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +KD+      D    VY+V ELM   +L   I   +  ++      L+ + + ++Y+H+
Sbjct: 80  TLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 164 ASVLHRDLKPSNLLL-----NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLL 217
             V+HRDLKPSN+L      N    ++I DFG A+   +E   +     T  + APE +L
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 192

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP------DDASLGF 271
               Y AA DIWS+G +L   M                    L G        DD     
Sbjct: 193 ERQGYDAACDIWSLGVLL-YTM--------------------LTGYTPFANGPDDTPEEI 231

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALR 326
           L             R    +F            S  A DL+ KML  DP++R+T    LR
Sbjct: 232 LA------------RIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

Query: 327 HPYLQSLHDLNDEPVCPR 344
           HP++     L    +  +
Sbjct: 278 HPWIVHWDQLPQYQLNRQ 295

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  168 bits (427), Expect = 4e-49
 Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 44/309 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRGA  IV       T++  A+K +       +D +    EI +L  + H N+I +K
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I      +T  ++ +V EL+   +L   I      ++      + Q+L  + Y+H   +
Sbjct: 115 EIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL         LKI DFGL++       M     T  Y APE +L    Y 
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE-ILRGCAYG 228

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
             +D+WSVG I               Y+  L     L G        F      +   R+
Sbjct: 229 PEVDMWSVGIIT--------------YI--L-----LCGFEP-----FYDERGDQFMFRR 262

Query: 284 LPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS--LHDLNDEP 340
           +  C +  F +  +   S  A DL+ K++V DP KR+T  +AL+HP++     + ++ + 
Sbjct: 263 ILNC-EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDT 321

Query: 341 VCPRPFHFD 349
              +   F+
Sbjct: 322 AQKKLQEFN 330

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  166 bits (423), Expect = 1e-48
 Identities = 67/310 (21%), Positives = 123/310 (39%), Gaps = 40/310 (12%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            V+  Y    + +G G  G V    +  T ++ A+K +        D+ +  +E+     
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQ 77

Query: 98  -MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQ 153
                +++ I D+           + I+ E M+      +I  R DQ  T+      +  
Sbjct: 78  ASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +   ++++HS ++ HRD+KP NLL         LK+ DFG A+ T++    T    T +Y
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYY 195

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
            APE +L   +Y  + D+WS+G I+  ++   P F           +   I        G
Sbjct: 196 VAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---GQYG 251

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
           F   +                    +   S  A  L+  +L  DP +R+T+ + + HP++
Sbjct: 252 FPNPE--------------------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

Query: 331 QSLHDLNDEP 340
                +   P
Sbjct: 292 NQSMVVPQTP 301

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  167 bits (424), Expect = 3e-48
 Identities = 69/300 (23%), Positives = 124/300 (41%), Gaps = 39/300 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++L     +  +++ I
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 120

Query: 107 KDIIRPPKKDTFNDVYIVYELMD--TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D      +I  R DQ  T+      +  +   ++Y+HS
Sbjct: 121 VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 164 ASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL      +  LK+ DFG A+ T+  + +T    T +Y APE +L   
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPE 238

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +Y  + D+WS+G I+  ++   P F     +     +   I         F   +     
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPNPE----- 290

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 340
                          +   S     L+  +L  +P +R+T+ E + HP++     +   P
Sbjct: 291 ---------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  165 bits (419), Expect = 3e-48
 Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 43/308 (13%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHM 98
                 +P+G G++ I    V+ ++ +  A+K        II  R    T +EI  L+  
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK--------IISKRMEANTQKEITALKLC 62

Query: 99  -EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N++ + ++            ++V EL++  +L + I+  +  ++    Y + +L+ 
Sbjct: 63  EGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 157 GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 212
            + ++H   V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE LLN   Y  + D+WS+G IL  +++ +  F   D         E++         F 
Sbjct: 178 PE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                                  + N S  A DL++ +L  DPNKR+ +     + +LQ 
Sbjct: 237 GEA--------------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

Query: 333 LHDLNDEP 340
              L+  P
Sbjct: 277 GSQLSSNP 284

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  166 bits (421), Expect = 4e-48
 Identities = 48/328 (14%), Positives = 99/328 (30%), Gaps = 78/328 (23%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G+        A + ET E   +           + I   +  +  ++LLR ++++  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 104 I-------AIKDIIRPPKK-------DTFND-----VYIVYELMDTD-------LHQIIR 137
                      D+++ P+K           D      + +Y  M ++       L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
           + + L          Q++R L  +H   ++H  L+P +++L+    + +  F        
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 198 TDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPG 247
                   V+R +  PEL              T  T + D W++G ++  I   +     
Sbjct: 259 R---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 307
              +     I                     R  + +P                    LL
Sbjct: 316 DAALGGSEWI--------------------FRSCKNIP---------------QPVRALL 340

Query: 308 EKMLVFDPNKRITVEEALRHPYLQSLHD 335
           E  L +    R+   +A+  P  + L  
Sbjct: 341 EGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  163 bits (415), Expect = 4e-48
 Identities = 65/294 (22%), Positives = 128/294 (43%), Gaps = 56/294 (19%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           RP+G+G +G V  A   +++  +A+K +      +  A    +  RE+++  H+ H N++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +        +     VY++ E      +++ ++   +  +     ++ +L   L Y HS
Sbjct: 73  RLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLN 218
             V+HRD+KP NLLL ++ +LKI DFG +     +         +Y+       PE++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIEG 181

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              +   +D+WS+G +  E +  +P F    Y    + I                     
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------------------- 219

Query: 279 RYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                     + +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ 
Sbjct: 220 ---------SRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  160 bits (406), Expect = 9e-47
 Identities = 65/306 (21%), Positives = 124/306 (40%), Gaps = 56/306 (18%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           RP+G+G +G V  A   + +  +A+K +      +       +  REI++  H+ H N++
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNIL 77

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            + +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H 
Sbjct: 78  RMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLN 218
             V+HRD+KP NLL+    +LKI DFG +         T     +Y+       PE++  
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIEG 186

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
              +   +D+W  G +  E +   P F    +    R I                     
Sbjct: 187 K-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--------------------- 224

Query: 279 RYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 337
                           +FP   S G+ DL+ K+L + P +R+ ++  + HP++++     
Sbjct: 225 ---------VNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273

Query: 338 DEPVCP 343
             PV  
Sbjct: 274 LPPVYQ 279

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  159 bits (405), Expect = 1e-46
 Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 68/304 (22%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V  AVN  T E VA+K     +  +  +NI       +EI + + + HE
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHE 65

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           NV+              N  Y+   Y    EL D      I  D  + +   Q F +QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRA 212
            G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 213 PELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           PELL    E+ A  +D+WS G +L                    ++            G 
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVL--------------TA----MLA-----------GE 205

Query: 272 L----RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
           L     SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+ +  + 
Sbjct: 206 LPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 328 PYLQ 331
            +  
Sbjct: 263 RWYN 266

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  161 bits (408), Expect = 2e-46
 Identities = 69/312 (22%), Positives = 116/312 (37%), Gaps = 57/312 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEH 100
           + P+G GA+G V  AV+ E  +EV +K I       + +       +   EI +L  +EH
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
            N+I + DI      +      +V E   +  DL   I    +L +    Y   QL+  +
Sbjct: 89  ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y+    ++HRD+K  N+++     +K+ DFG A           +  T  Y APE+L+ 
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203

Query: 219 CTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
              Y    +++WS+G  L              Y     L+                    
Sbjct: 204 -NPYRGPELEMWSLGVTL--------------YT----LVF-----------EENPFCEL 233

Query: 278 RRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ---SL 333
              V               P   S   + L+  +L   P +R T+E+ +  P++    +L
Sbjct: 234 EETVEAAIHP---------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284

Query: 334 HDLNDEPVCPRP 345
            D   E V    
Sbjct: 285 ADYTWEEVFRVN 296

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  159 bits (405), Expect = 3e-46
 Identities = 75/326 (23%), Positives = 148/326 (45%), Gaps = 49/326 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ + ++
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   ++H
Sbjct: 83  I-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAID 227
           RDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL     +Y    +D
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVD 196

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 287
           +WS+G IL  +++    F                   D  +L  LR            R 
Sbjct: 197 VWSLGVILYTLVSGSLPF-------------------DGQNLKELRE-----------RV 226

Query: 288 RKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP--VCPR 344
            + ++  R P   S+   +LL++ LV +P KR T+E+ ++  ++ + H+ ++    V P 
Sbjct: 227 LRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPE 284

Query: 345 PFHFDFEHSS------CTEDHIRELI 364
               D +          +++ I+E +
Sbjct: 285 LDISDQKRIDIMVGMGYSQEEIQESL 310

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  159 bits (404), Expect = 5e-46
 Identities = 89/331 (26%), Positives = 134/331 (40%), Gaps = 70/331 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V  AVN  T E VA+K     +  +  +NI       +EI + + + HE
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHE 65

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           NV+              N  Y+   Y    EL D      I  D  + +   Q F +QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRA 212
            G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 213 PELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
           PELL    E+ A  +D+WS G +L                    ++            G 
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVL--------------TA----MLA-----------GE 205

Query: 272 L----RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
           L     SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+ +  + 
Sbjct: 206 LPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 328 PYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 358
            +      L      PR        S     
Sbjct: 263 RWYN--KPLKKGAKRPRVTSGGVSESPSGFS 291

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  160 bits (406), Expect = 6e-46
 Identities = 85/331 (25%), Positives = 140/331 (42%), Gaps = 55/331 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-----REIKLLRHMEHE 101
           ++ IG G +G+     +  T+E VA+K         I+    +     REI   R + H 
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVK--------YIERGAAIDENVQREIINHRSLRHP 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++  K++I      T   + I+ E     +L++ I +  + ++D  ++F  QLL G+ Y
Sbjct: 77  NIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131

Query: 161 VHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            HS  + HRDLK  N LL  + +  LKI DFG ++++         V T  Y APE+LL 
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191

Query: 219 CTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
             EY     D+WS G  L              YV        L+G     +  F   +  
Sbjct: 192 -QEYDGKIADVWSCGVTL--------------YVM-------LVG-----AYPFEDPEEP 224

Query: 278 RRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHP-YLQSL 333
           R Y + + R    ++    P+    S     L+ ++ V DP  RI++ E   H  +L++L
Sbjct: 225 RDYRKTIQRILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282

Query: 334 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
                          + E    + D I ++I
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQSLDTIMQII 313

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  156 bits (397), Expect = 2e-45
 Identities = 60/286 (20%), Positives = 125/286 (43%), Gaps = 36/286 (12%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++  V   +++ET  EVA  ++ +      + +R   E ++L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASV 166
                K     + +V ELM +  L   ++  + +     + +  Q+L+GL+++H+    +
Sbjct: 94  WESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRDLK  N+ +      +KIGD GLA     + F    + T  + APE+     +Y  +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDES 209

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D+++ G  + E+ T E  +       Q+         P  AS   +     +       
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK------- 260

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                              +++E  +  + ++R ++++ L H + Q
Sbjct: 261 -------------------EIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  157 bits (398), Expect = 2e-45
 Identities = 79/336 (23%), Positives = 137/336 (40%), Gaps = 64/336 (19%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK--------KIGNAFDNIIDARRTLREIKLLRHME 99
             +G G+YG V   ++SET    A+K        +I N   N+       +EI+LLR + 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV------KKEIQLLRRLR 64

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H+NVI + D++   +K     +Y+V E       ++   +  +++        +  QL+ 
Sbjct: 65  HKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLID 120

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 213
           GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 214 ELLLNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLG 270
           E+      ++   +DIWS G  L              Y     + T   G  P +  ++ 
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTL--------------YN----ITT---GLYPFEGDNIY 219

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
            L                K  +    P        DLL+ ML ++P KR ++ +  +H +
Sbjct: 220 KLFE-----------NIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 330 LQSLH--DLNDEPVCPRPFHFDFEHSSCTEDHIREL 363
            +  H       P+ P P   D   S     ++ +L
Sbjct: 267 FRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  157 bits (400), Expect = 3e-45
 Identities = 63/318 (19%), Positives = 126/318 (39%), Gaps = 59/318 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI---------------GNAFDNIIDARRTLRE 91
           IR + +G +  +      +  +  A+KK                 +             E
Sbjct: 36  IRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQ---L 142
           ++++  +++E  +  + II       +++VYI+  Y     ++  D +  +        +
Sbjct: 94  LQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 143 TDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
                +  +  +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG +    +    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 202 T-----EYVVTRWYRAPELLLNCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL- 254
                 E++       PE   N + Y  A +DIWS+G  L  +      F  K  + +L 
Sbjct: 209 GSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

Query: 255 -RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF 313
             + T+ I  P D +               L     ++        S+  +D L+  L  
Sbjct: 263 NNIRTKNIEYPLDRN-------------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309

Query: 314 DPNKRITVEEALRHPYLQ 331
           +P +RIT E+AL+H +L 
Sbjct: 310 NPAERITSEDALKHEWLA 327

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  157 bits (399), Expect = 3e-45
 Identities = 89/330 (26%), Positives = 151/330 (45%), Gaps = 53/330 (16%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G++G V  A + +T+++VA+K I            R  REI  L+ + H ++I +
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D+I      T  D+ +V E    +L   I   +++T+D  + F  Q++  ++Y H   +
Sbjct: 75  YDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AA 225
           +HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE++     Y    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPE 188

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVRQ 283
           +D+WS G +L              YV        L+G  P DD  +  L           
Sbjct: 189 VDVWSCGIVL--------------YV-------MLVGRLPFDDEFIPNLFK--------- 218

Query: 284 LPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHP--------YLQSLH 334
             +     +    P+  S GA  L+ +M+V DP +RIT++E  R P        YL+ + 
Sbjct: 219 --KVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPME 274

Query: 335 DLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
           ++       R      E    +ED+I E +
Sbjct: 275 EVQGSYADSRIVSKLGEAMGFSEDYIVEAL 304

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  156 bits (397), Expect = 4e-45
 Identities = 71/321 (22%), Positives = 120/321 (37%), Gaps = 58/321 (18%)

Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH- 97
               Y      +G GA+  V   +N  T +E A+K I           R  RE+++L   
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQC 67

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H NV+ + +       +  +  Y+V+E M    +   I   +   +      +  +  
Sbjct: 68  QGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 157 GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR--------TTSETDFMTEYV 205
            L ++H+  + HRDLKP N+L    N    +KI DF L          +   T  +    
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 206 VTRWYRAPELLLNCTE----YTAAIDIWSVGCIL-----------GEIMTREPLFPGKDY 250
            +  Y APE++   +E    Y    D+WS+G IL           G   +      G+  
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242

Query: 251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM 310
                ++ E I         F   D                    + + S  A DL+ K+
Sbjct: 243 PACQNMLFESIQE---GKYEFPDKD--------------------WAHISCAAKDLISKL 279

Query: 311 LVFDPNKRITVEEALRHPYLQ 331
           LV D  +R++  + L+HP++Q
Sbjct: 280 LVRDAKQRLSAAQVLQHPWVQ 300

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  156 bits (396), Expect = 4e-45
 Identities = 67/319 (21%), Positives = 116/319 (36%), Gaps = 57/319 (17%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLR----HME 99
             +G+G +G V A      R +VAIK I       +  + D+     E+ LL        
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           H  VI + D       +T     +V E      DL   I     L +   + F  Q++  
Sbjct: 97  HPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 158 LKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           +++ HS  V+HRD+K  N+L++      K+ DFG      +  +   +  TR Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210

Query: 217 LNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
               +Y A    +WS+G +L              Y     ++            G +  +
Sbjct: 211 SR-HQYHALPATVWSLGILL--------------YD----MVC-----------GDIPFE 240

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS-LH 334
             +  +                + S     L+ + L   P+ R ++EE L  P++Q+   
Sbjct: 241 RDQEILEAELHFP--------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

Query: 335 DLNDEPVCPRPFHFDFEHS 353
           D+   P    P    +   
Sbjct: 293 DVPLNPSKGGPAPLAWSLL 311

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  155 bits (395), Expect = 5e-45
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 42/293 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YGIV A  +   +  +AIK+I               EI L +H++H+N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87

Query: 110 IRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSAS 165
                      + I  E +    L  ++RS     +  +    ++  Q+L GLKY+H   
Sbjct: 88  FS-----ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 166 VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE-LLLNCTEY 222
           ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE    T  Y APE +      Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             A DIWS+GC + E+ T +P  P  +       +   +G                    
Sbjct: 203 GKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMF-KVGMFKVH--------------P 245

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
           ++P            + S+ A   + K    DP+KR    + L   +L+    
Sbjct: 246 EIP-----------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  157 bits (398), Expect = 5e-45
 Identities = 63/290 (21%), Positives = 116/290 (40%), Gaps = 49/290 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+      +   R    E+     +    ++ +   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRV--EELVACAGLSSPRIVPLYGA 118

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 119 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 169 RDLKPSNLLLNAS-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCTE 221
            D+K  N+LL++      + DFG A         ++    +Y+  T  + APE+++    
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 232

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
             A +DIWS  C++  ++      P   Y  +  L    I S                  
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH--PWTQY-FRGPLCL-KIASEPPPIR------------ 276

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
            ++P           P+ +      +++ L  +P  R +  E  R     
Sbjct: 277 -EIP-----------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  156 bits (396), Expect = 5e-45
 Identities = 66/315 (20%), Positives = 120/315 (38%), Gaps = 60/315 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEHE- 101
              +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +    
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 102 -NVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
             VI + D       +  +   ++ E  +   DL   I     L ++  + F +Q+L  +
Sbjct: 108 SGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 159 KYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           ++ H+  VLHRD+K  N+L++    +LK+ DFG      +T +   +  TR Y  PE + 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIR 221

Query: 218 NCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               Y      +WS+G +L              Y     ++            G +  ++
Sbjct: 222 Y-HRYHGRSAAVWSLGILL--------------YD----MVC-----------GDIPFEH 251

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS---- 332
               +R     R           SS    L+   L   P+ R T EE   HP++Q     
Sbjct: 252 DEEIIRGQVFFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303

Query: 333 --LHDLNDEPVCPRP 345
               +++   + P P
Sbjct: 304 QETAEIHLHSLSPGP 318

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  154 bits (391), Expect = 1e-44
 Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 46/290 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G +G V    +  T  +VA+K +      ++    +  REI+ L+   H ++I +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             +I      T  D ++V E +   +L   I    ++ +   +    Q+L  + Y H   
Sbjct: 77  YQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-A 224
           V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++     Y   
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGP 190

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVR 282
            +DIWS G IL              Y   L     L G+ P DD  +  L          
Sbjct: 191 EVDIWSCGVIL--------------YA--L-----LCGTLPFDDEHVPTLFK-------- 221

Query: 283 QLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
              + R   F    P   +     LL  ML  DP KR T+++   H + +
Sbjct: 222 ---KIRGGVF--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  158 bits (400), Expect = 1e-44
 Identities = 48/322 (14%), Positives = 91/322 (28%), Gaps = 71/322 (22%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRH------ 97
             +G+        A + ET E   +           + I   +  +  ++LLR       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 98  -MEHENVIAIKDIIRPPKKDTFNDV------------YIVYELMDTDLHQIIRS------ 138
              H   I   D+++ P+K     V            + +Y  M ++L            
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + L          Q++R L  +H   ++H  L+P +++L+    + +  F        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 198 TDFM--TEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           +               A  +L     + T  T A D W++G  +  I   +        +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML 311
                I                             C          N       LLE  L
Sbjct: 324 GGSEWI--------------------------FRSC---------KNIPQPVRALLEGFL 348

Query: 312 VFDPNKRITVEEALRHPYLQSL 333
            +    R+   +A+  P  + L
Sbjct: 349 RYPKEDRLLPLQAMETPEYEQL 370

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  153 bits (389), Expect = 8e-44
 Identities = 64/319 (20%), Positives = 123/319 (38%), Gaps = 59/319 (18%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G   E+    +   R +  G +  V  A +  +  E A+K++    +     R  ++E+ 
Sbjct: 20  GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVC 77

Query: 94  LLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ--LTDDH 146
            ++ +  H N++         K+++         L +      +  + + + +  L+ D 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 147 CQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLART---------T 195
                YQ  R ++++H     ++HRDLK  NLLL+    +K+ DFG A T         +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 196 SETDFMTEYVVTR----WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           ++   + E  +TR     YR PE+  L +        DIW++GCIL  +  R+  F    
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG- 256

Query: 250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 309
                                 LR  N  +Y   +P             + +    L+  
Sbjct: 257 --------------------AKLRIVNG-KY--SIP---------PHDTQYTVFHSLIRA 284

Query: 310 MLVFDPNKRITVEEALRHP 328
           ML  +P +R+++ E +   
Sbjct: 285 MLQVNPEERLSIAEVVHQL 303

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  150 bits (380), Expect = 7e-43
 Identities = 62/300 (20%), Positives = 111/300 (37%), Gaps = 60/300 (20%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++L     +  +++ I
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 76

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D      +I  R DQ  T+      +  +   ++Y+HS
Sbjct: 77  VDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 164 ASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL      +  LK+ DFG                     A E      
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG--E 173

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +Y  + D+WS+G I+  ++   P F     +     +   I         F   +     
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPNPE----- 225

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 340
                          +   S     L+  +L  +P +R+T+ E + HP++     +   P
Sbjct: 226 ---------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  152 bits (386), Expect = 4e-42
 Identities = 82/322 (25%), Positives = 139/322 (43%), Gaps = 51/322 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G +G V    +  T  +VA+K +      ++    +  REI+ L+   H ++I +
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             +I      T +D+++V E +   +L   I  + +L +   +    Q+L G+ Y H   
Sbjct: 82  YQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-A 224
           V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++     Y   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGP 195

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVR 282
            +DIWS G IL              Y   L     L G+ P DD  +  L          
Sbjct: 196 EVDIWSSGVIL--------------YA--L-----LCGTLPFDDDHVPTLFK-------- 226

Query: 283 QLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
              +     F    P   +   + LL+ ML  DP KR T+++   H + +      D P 
Sbjct: 227 ---KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-----DLPK 276

Query: 342 CPRPFHFDFEHSSCTEDHIREL 363
              P    +  +   ++ ++E+
Sbjct: 277 YLFPEDPSYSSTMIDDEALKEV 298

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  139 bits (352), Expect = 8e-39
 Identities = 77/309 (24%), Positives = 136/309 (44%), Gaps = 53/309 (17%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LL 95
            EV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++   +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60

Query: 96  RHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDH 146
           R ++    +       ++           DV+I  ELMDT       Q+I   Q + +D 
Sbjct: 61  RTVDCPFTVTFYGALFRE----------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 110

Query: 147 CQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
                  +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    +        
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170

Query: 206 VTRWYRAPE---LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 262
             + Y APE     LN   Y+   DIWS+G  + E+      FP   +    + + +++ 
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVE 228

Query: 263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 322
            P                    P+    +F       S+  VD   + L  +  +R T  
Sbjct: 229 EPS-------------------PQLPADKF-------SAEFVDFTSQCLKKNSKERPTYP 262

Query: 323 EALRHPYLQ 331
           E ++HP+  
Sbjct: 263 ELMQHPFFT 271

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  139 bits (352), Expect = 7e-38
 Identities = 84/368 (22%), Positives = 141/368 (38%), Gaps = 94/368 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHE 101
           IR +G G +  V  + + + ++ VA+K +  + ++  +      EI+LL+ +        
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRNSDPNDP 98

Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLY 152
           N    ++++     D F         + +V+E++   L + I     Q L     +  + 
Sbjct: 99  N----REMVVQLL-DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------------------------------ 181
           Q+L+GL Y+H+   ++H D+KP N+LL+ +                              
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 182 -------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
                                +KI D G A    +    TE + TR YR+ E+L+    Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-GY 270

Query: 223 TAAIDIWSVGCILGEIMTREPLFPG-------KDYVHQLRLITELIGSPD-------DAS 268
               DIWS  C+  E+ T + LF         +D  H + LI EL+G            S
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH-IALIIELLGKVPRKLIVAGKYS 329

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKS----SGAVDLLEKMLVFDPNKRITVEEA 324
             F       +++ +L      +        S    +G  D L  ML   P KR T  E 
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389

Query: 325 LRHPYLQS 332
           LRHP+L S
Sbjct: 390 LRHPWLNS 397

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  136 bits (345), Expect = 4e-37
 Identities = 64/319 (20%), Positives = 129/319 (40%), Gaps = 33/319 (10%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
             + E+       I  +G G  G+V    +  +   +A K I +         + +RE++
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQ 83

Query: 94  LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHC 147
           +L       ++        D           ++ I  E MD   L Q+++   ++ +   
Sbjct: 84  VLHECNSPYIVGFYGAFYSD----------GEISICMEHMDGGSLDQVLKKAGRIPEQIL 133

Query: 148 QYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
                 +++GL Y+     ++HRD+KPSN+L+N+  ++K+ DFG++    ++   + +V 
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVG 192

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI----- 261
           TR Y +PE L   T Y+   DIWS+G  L E+       P  D      +    +     
Sbjct: 193 TRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 262 ------GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVF 313
                  +P      F         + +L      +   + P+   S    D + K L+ 
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311

Query: 314 DPNKRITVEEALRHPYLQS 332
           +P +R  +++ + H +++ 
Sbjct: 312 NPAERADLKQLMVHAFIKR 330

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  135 bits (341), Expect = 2e-36
 Identities = 60/332 (18%), Positives = 106/332 (31%), Gaps = 46/332 (13%)

Query: 47  IRPIGRGA--YGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G      V  A    T E V +++I     +         E+ + +   H N++
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
             +         TF   N++++V   M      DL      D  + +    Y L  +L+ 
Sbjct: 90  PYRA--------TFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKA 140

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRW 209
           L Y+H    +HR +K S++L++    + +              R     DF    V    
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 210 YRAPELLL-NCTEYTAAIDIWSVGCILGEIMTREP----------LF-------PGKDYV 251
           + +PE+L  N   Y A  DI+SVG    E+               L        P     
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 252 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML 311
             +      +      +   L         R            R    S      +E+ L
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR--TFSPHFHHFVEQCL 318

Query: 312 VFDPNKRITVEEALRHPYLQSLHDLNDEPVCP 343
             +P+ R +    L H + + +     E +  
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALPE 350

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  132 bits (335), Expect = 3e-36
 Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 58/305 (19%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIA-- 105
           IG GA  +V AA  +  +E+VAIK+I       ++ +  +   EI+ +    H N+++  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHHPNIVSYY 79

Query: 106 ---IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ-----LTDDHCQYFLYQ 153
              +            +++++V +L+      D+ + I +  +     L +      L +
Sbjct: 80  TSFVVK----------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVT 207
           +L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 267
             + APE++     Y    DIWS G    E+ T     P   Y   ++++          
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKY-PPMKVL---------- 236

Query: 268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALR 326
               L   N        P             K       ++   L  DP KR T  E LR
Sbjct: 237 ---MLTLQNDP------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

Query: 327 HPYLQ 331
           H + Q
Sbjct: 288 HKFFQ 292

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  132 bits (333), Expect = 6e-36
 Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 61/299 (20%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
              IG+GA G V  A++  T +EVAI+++        + II       EI ++R  ++ N
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII------NEILVMRENKNPN 78

Query: 103 VIAIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           ++   D        ++   +++++V E +     TD    + ++  + +        + L
Sbjct: 79  IVNYLD--------SYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECL 126

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPE 214
           + L+++HS  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
           ++     Y   +DIWS+G +  E++  EP  P  +  + LR +             +L +
Sbjct: 187 VVTR-KAYGPKVDIWSLGIMAIEMIEGEP--PYLN-ENPLRAL-------------YLIA 229

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHPYLQS 332
            N        P  +        P K S    D L + L  D  KR + +E L+H +L+ 
Sbjct: 230 TNGT------PELQN-------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  132 bits (334), Expect = 7e-36
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 73/305 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
              IG G+ GIVC A    +  +VA+K +        + +        E+ ++R  +H N
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF------NEVVIMRDYQHFN 103

Query: 103 VIAIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           V+ +          ++    +++++ E +     TD+   +R    L ++        +L
Sbjct: 104 VVEMYK--------SYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVL 151

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPE 214
           + L Y+H+  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTRE------PLFPGKDYVHQLRLITELIGSPDDAS 268
           ++   + Y   +DIWS+G     IM  E      P F        ++ +           
Sbjct: 212 VISR-SLYATEVDIWSLG-----IMVIEMVDGEPPYF----SDSPVQAM----------- 250

Query: 269 LGFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                 D+        P+ +   + +           D LE+MLV DP +R T +E L H
Sbjct: 251 --KRLRDSPP------PKLKNSHKVSPVL-------RDFLERMLVRDPQERATAQELLDH 295

Query: 328 PYLQS 332
           P+L  
Sbjct: 296 PFLLQ 300

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  132 bits (335), Expect = 8e-36
 Identities = 68/295 (23%), Positives = 130/295 (44%), Gaps = 51/295 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +     +  + + +E++ L+ + H N I 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 106 IKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
            +          +   +  ++V E        ++    + L +       +  L+GL Y+
Sbjct: 119 YRG--------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS +++HRD+K  N+LL+    +K+GDFG A   +  +     V T ++ APE++L   E
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDE 227

Query: 222 --YTAAIDIWSVG--CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
             Y   +D+WS+G  CI  E+  R+P  P  + ++ +  +             +  + N 
Sbjct: 228 GQYDGKVDVWSLGITCI--ELAERKP--PLFN-MNAMSAL-------------YHIAQN- 268

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                + P  +   ++  F        + ++  L   P  R T E  L+H ++  
Sbjct: 269 -----ESPALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 1e-35
 Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 44/297 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  +G G YG V    + +T +  AIK +    D   + ++   EI +L+    H N+  
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIAT 85

Query: 106 IKDI-IRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
                I+       + +++V E       TDL +  +    L ++   Y   ++LRGL +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSH 144

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC 219
           +H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++   
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204

Query: 220 TE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
                 Y    D+WS+G    E+    P  P  D +H +R +             FL   
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPR 248

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
           N        PR + ++++ +F          +E  LV + ++R   E+ ++HP+++ 
Sbjct: 249 N------PAPRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  130 bits (328), Expect = 1e-35
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIK 107
           IG G +G V  A       EVA+K   +  D  I        +E KL   ++H N+IA++
Sbjct: 15  IGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 108 DI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-- 163
            + ++ P       + +V E      L++++   +++  D    +  Q+ RG+ Y+H   
Sbjct: 73  GVCLKEPN------LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 164 -ASVLHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
              ++HRDLK SN+L+    +        LKI DFGLAR    T  M+      W  APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           ++   + ++   D+WS G +L E++T E  F G D +
Sbjct: 185 VI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  131 bits (331), Expect = 2e-35
 Identities = 65/313 (20%), Positives = 135/313 (43%), Gaps = 51/313 (16%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
              ++ +++ +  +  IGRGAYG V   V+  + + +A+K+I  +  +  + ++ L ++ 
Sbjct: 14  EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLD 72

Query: 94  -LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-----DQQL 142
            ++R  +   ++       ++           D +I  ELM T   +  +      D  +
Sbjct: 73  VVMRSSDCPYIVQFYGALFRE----------GDCWICMELMSTSFDKFYKYVYSVLDDVI 122

Query: 143 TDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
            ++         ++ L ++     ++HRD+KPSN+LL+ S ++K+ DFG++    ++   
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182

Query: 202 TEYVVTRWYRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           T     R Y APE +    +   Y    D+WS+G  L E+ T    FP   +      +T
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR--FPYPKWNSVFDQLT 240

Query: 259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 318
           +++                     QL    +++F       S   ++ +   L  D +KR
Sbjct: 241 QVVKGD----------------PPQLSNSEEREF-------SPSFINFVNLCLTKDESKR 277

Query: 319 ITVEEALRHPYLQ 331
              +E L+HP++ 
Sbjct: 278 PKYKELLKHPFIL 290

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (328), Expect = 3e-35
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 24/227 (10%)

Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           +L  +  K +     +GRGA+G+VC A       +VAIK+I    ++  + +  + E++ 
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQI----ESESERKAFIVELRQ 54

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ---QLTDDHCQYF 150
           L  + H N++ +            N V +V E  +   L+ ++   +     T  H   +
Sbjct: 55  LSRVNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107

Query: 151 LYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVV 206
             Q  +G+ Y+HS    +++HRDLKP NLLL A    LKI DFG A        MT    
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKG 165

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
           +  + APE +   + Y+   D++S G IL E++TR   F        
Sbjct: 166 SAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (325), Expect = 5e-35
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTL----REIKLLRHMEHENVI 104
           IG+G +G+V      + +  VAIK +     +   +         RE+ ++ ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
            +  +   PP         +V E +   DL+  +      +        +  +  G++Y+
Sbjct: 87  KLYGLMHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 162 HS--ASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
            +    ++HRDL+  N+ L     NA    K+ DFGL++ +  +  ++  +    + APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196

Query: 215 LLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
            +    E YT   D +S   IL  I+T E  F    Y  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (325), Expect = 1e-34
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 55/296 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  +G G+YG V  A++ ET + VAIK++   +    II      +EI +++  +  +V+
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII------KEISIMQQCDSPHVV 87

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                       ++    D++IV E       +D+ ++   ++ LT+D     L   L+G
Sbjct: 88  KYYG--------SYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKG 137

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL 216
           L+Y+H    +HRD+K  N+LLN     K+ DFG+  + T         + T ++ APE++
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                Y    DIWS+G    E+   +P  P  D +H +R I             F+   N
Sbjct: 198 QE-IGYNCVADIWSLGITAIEMAEGKP--PYAD-IHPMRAI-------------FMIPTN 240

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                   P  RK +        S    D +++ LV  P +R T  + L+HP+++S
Sbjct: 241 PP------PTFRKPE------LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  127 bits (321), Expect = 2e-34
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 16/213 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + IG G++G V          +VA+K +          +    E+ +LR   H N++   
Sbjct: 30  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                P+      + IV +  +   L+  + + + +           Q  RG+ Y+H+ S
Sbjct: 87  GYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTE- 221
           ++HRDLK +N+ L+    +KIGDFGLA      S +    +   +  + APE++      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 222 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            Y+   D+++ G +L E+MT +  +   +   Q
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (322), Expect = 3e-34
 Identities = 68/335 (20%), Positives = 128/335 (38%), Gaps = 59/335 (17%)

Query: 10  SGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREE 69
           S G++    G LT GG+          ++     +  +  +G G  G V      +T   
Sbjct: 2   SSGSSGKQTGYLTIGGQ---------RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHV 52

Query: 70  VAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYI 123
           +A+K++  + +   + +R L ++  +L+  +   ++      I +           DV+I
Sbjct: 53  IAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITN----------TDVFI 101

Query: 124 VYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS 181
             ELM T   ++  R    + +         +++ L Y+     V+HRD+KPSN+LL+  
Sbjct: 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161

Query: 182 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE----LLLNCTEYTAAIDIWSVGCILGE 237
             +K+ DFG++    +            Y APE          +Y    D+WS+G  L E
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

Query: 238 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 297
           + T +  FP K+      ++T+++                      LP      F     
Sbjct: 222 LATGQ--FPYKNCKTDFEVLTKVLQEE----------------PPLLP--GHMGF----- 256

Query: 298 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
             S      ++  L  D  KR    + L H +++ 
Sbjct: 257 --SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  127 bits (320), Expect = 5e-34
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKD 108
           IG G++G V  A    +  +VA+K +     +       LRE+ +++ + H N++  +  
Sbjct: 45  IGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS- 163
           + +PP       + IV E +    L++++      +QL +       Y + +G+ Y+H+ 
Sbjct: 103 VTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 164 -ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTE 221
              ++HR+LK  NLL++    +K+ DFGL+R  + T         T  + APE +L    
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEP 215

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
                D++S G IL E+ T +  +   +  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  126 bits (318), Expect = 8e-34
 Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 62/308 (20%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G GA+G V  A N ET    A K I        ++ I       EI++L   +H  
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI------VEIEILATCDHPY 77

Query: 103 VIAIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           ++ +           +     ++I+ E         +  ++  D+ LT+   Q    Q+L
Sbjct: 78  IVKLLG--------AYYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQML 127

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPE 214
             L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 215 LLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
           +++  T     Y    DIWS+G  L E+   EP  P  + ++ +R++             
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVL------------- 231

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
              + +        P           P+K S    D L+  L  +P  R +  + L HP+
Sbjct: 232 LKIAKSDP------PTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278

Query: 330 LQSLHDLN 337
           + S+    
Sbjct: 279 VSSITSNK 286

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  126 bits (318), Expect = 8e-34
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA-IK 107
           +G+G +G      + ET E + +K++    +   + +RT L+E+K++R +EH NV+  I 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +  +      +  + E +    L  II+S D Q        F   +  G+ Y+HS +
Sbjct: 75  VLYKDKR------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---------------MTEYVVTRWY 210
           ++HRDL   N L+  + ++ + DFGLAR   +                      V   ++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
            APE++     Y   +D++S G +L EI+ R    P 
Sbjct: 189 MAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 1e-33
 Identities = 42/307 (13%), Positives = 85/307 (27%), Gaps = 68/307 (22%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
              +G GA+  V  A      +++ +++  +K    A  N  +     + ++ L+     
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQH 127

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR-----SDQQLTDDHCQYFLYQLL 155
             +              N   +V EL     L   I       ++ +       F  ++L
Sbjct: 128 MFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCD-----------LKIGDFGLARTTS---ETDFM 201
             ++ VH   ++H D+KP N +L                L + D G +       +    
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 261
           T    T  ++  E+L N   +   ID + V   +  ++    +    +            
Sbjct: 243 TAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------- 292

Query: 262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 321
                           RR                         +    ML       +  
Sbjct: 293 ---------CKPEGLFRRL-----------------PHLDMWNEFFHVMLNIPDCHHLPS 326

Query: 322 EEALRHP 328
            + LR  
Sbjct: 327 LDLLRQK 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  124 bits (314), Expect = 5e-33
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-I 106
             IG+G +G V          EVAI+ I    DN    +   RE+   R   HENV+  +
Sbjct: 39  ELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
              + PP       + I+  L     L+ ++R     L  +  +    ++++G+ Y+H+ 
Sbjct: 96  GACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY----VVTRWYR--APELLLN 218
            +LH+DLK  N+  + +  + I DFGL   +             +   W    APE++  
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 219 CTE--------YTAAIDIWSVGCILGEIMTREPLFPGKD 249
            +         ++   D++++G I  E+  RE  F  + 
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (312), Expect = 6e-33
 Identities = 72/296 (24%), Positives = 133/296 (44%), Gaps = 56/296 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVT 83

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                       ++     ++I+ E +      DL +       L +      L ++L+G
Sbjct: 84  KYYG--------SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKG 131

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL 216
           L Y+HS   +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
              + Y +  DIWS+G    E+   EP  P  +  H ++++             FL    
Sbjct: 192 KQ-SAYDSKADIWSLGITAIELARGEP--PHSEL-HPMKVL-------------FL---- 230

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                  +P+         +   S    + +E  L  +P+ R T +E L+H ++  
Sbjct: 231 -------IPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  122 bits (308), Expect = 1e-32
 Identities = 35/205 (17%), Positives = 70/205 (34%), Gaps = 16/205 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +     G +          ++ +K +     +   +R    E   LR   H NV+ +   
Sbjct: 18  LNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSAS- 165
            + P         ++   M    L+ ++        D  Q   F   + RG+ ++H+   
Sbjct: 76  CQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 166 -VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEY 222
            +    L   +++++     +I    +  +      M       W  APE L        
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTN 188

Query: 223 TAAIDIWSVGCILGEIMTREPLFPG 247
             + D+WS   +L E++TRE  F  
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFAD 213

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 2e-30
 Identities = 68/309 (22%), Positives = 112/309 (36%), Gaps = 43/309 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA- 105
           ++ IG+G YG V         E+VA+K     F     +     EI     M HEN++  
Sbjct: 42  VKQIGKGRYGEVWMGKWRG--EKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I   I+     T   +Y++ +  +   L+  ++S   L         Y  + GL ++H+ 
Sbjct: 97  IAADIKGTGSWT--QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 165 --------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYR 211
                   ++ HRDLK  N+L+  +    I D GLA      T          V T+ Y 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 212 APELL-----LNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPD 265
            PE+L      N  +     D++S G IL E+  R       ++Y      +      P 
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-----PS 268

Query: 266 DASLGFLRSDNARRYVR-QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 324
           D S   +R     + +R   P         R          L+ +    +P  R+T    
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLR------QMGKLMTECWAHNPASRLTALRV 322

Query: 325 LRHPYLQSL 333
            +   L  +
Sbjct: 323 KK--TLAKM 329

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  116 bits (293), Expect = 3e-30
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-I 106
           +G+G YG V         E VA+K       +  D +   RE  +     + HEN++  I
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
              +      T   ++++    +   L+  ++    L    C   +  +  GL ++H   
Sbjct: 69  ASDMTSRHSST--QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 165 -------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRA 212
                  ++ HRDLK  N+L+  +    I D GLA   S++    +        T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 213 PELL-----LNCTEYTAAIDIWSVGCILGEIMTRE 242
           PE+L     ++C +    +DIW+ G +L E+  R 
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  112 bits (282), Expect = 2e-28
 Identities = 68/315 (21%), Positives = 119/315 (37%), Gaps = 52/315 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
             RG +G V  A      E VA+K        ++ N         E+  L  M+HEN++ 
Sbjct: 32  KARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNE-------YEVYSLPGMKHENILQ 82

Query: 106 -IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I    R    D   D++++    +   L   +++   ++ +   +    + RGL Y+H 
Sbjct: 83  FIGAEKRGTSVDV--DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE 139

Query: 164 A----------SVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWY 210
                      ++ HRD+K  N+LL  +    I DFGLA               V TR Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 211 RAPELL----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 266
            APE+L        +    ID++++G +L E+ +R     G    + L    E+      
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI---GQH 256

Query: 267 ASLGFLRSDNARRYVR-QLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---V 321
            SL  ++     +  R  L    +K               + +E+    D   R++   V
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML-------CETIEECWDHDAEARLSAGCV 309

Query: 322 EEALRHPYLQSLHDL 336
            E +    +Q L ++
Sbjct: 310 GERITQ--MQRLTNI 322

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  115 bits (290), Expect = 2e-28
 Identities = 58/263 (22%), Positives = 104/263 (39%), Gaps = 23/263 (8%)

Query: 47  IRPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
              I  G  G +  A+  N   R  V +K + ++ D        + E + L  + H +++
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAE-AQAMAMAERQFLAEVVHPSIV 142

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I + +    +      YIV E +    L +     Q+L       +L ++L  L Y+HS
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHS 200

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++   T  T
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR--TGPT 254

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASLGFLRSDNARRY 280
            A DI++VG  L  +    P   G  YV  L     ++ +           +  D  +R+
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313

Query: 281 ------VRQLPRCRKQQFATRFP 297
                   QL    ++  A    
Sbjct: 314 TTAEEMSAQLTGVLREVVAQDTG 336

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 3e-28
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 32/222 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-I 106
           IG+G +G V         EEVA+K       +  + R   RE  I     + HEN++  I
Sbjct: 50  IGKGRFGEVWRGKWRG--EEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
               +     T   +++V +  +   L   +     +T +           GL ++H   
Sbjct: 103 AADNKDNGTWT--QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 165 -------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRA 212
                  ++ HRDLK  N+L+  +    I D GLA          +        T+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 213 PELL-----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           PE+L     +   E     DI+++G +  EI  R  +    +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  110 bits (278), Expect = 7e-28
 Identities = 56/259 (21%), Positives = 112/259 (43%), Gaps = 26/259 (10%)

Query: 23  HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNA 78
           H   + Q     +      +++  I  +G+G +G V           T   VA+K++   
Sbjct: 4   HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-- 61

Query: 79  FDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII 136
             +  D +R   REI++L+ +  + ++  + +   P + +   + +V E + +  L   +
Sbjct: 62  -HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFL 117

Query: 137 RS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           +    +L       +  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+  
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177

Query: 196 SETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP 246
                   YVV         WY APE L +   ++   D+WS G +L E+ T   +   P
Sbjct: 178 PLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP 233

Query: 247 GKDYVHQLRLITELIGSPD 265
             +++  +    ++     
Sbjct: 234 SAEFLRMMGCERDVPALSR 252

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (275), Expect = 1e-27
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 30/233 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           IR +G G +G V           T E+VA+K  K  +  ++I D     +EI++LR++ H
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYH 82

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGL 158
           EN++  K I     +D  N + ++ E + +  L + +     ++       +  Q+ +G+
Sbjct: 83  ENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYR 211
            Y+ S   +HRDL   N+L+ +   +KIGDFGL +          Y V         WY 
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY- 196

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           APE L+    +  A D+WS G  L E++T             + L  ++IG  
Sbjct: 197 APECLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  109 bits (275), Expect = 4e-27
 Identities = 62/298 (20%), Positives = 133/298 (44%), Gaps = 50/298 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           +R IG+G++G VC    ++T++  A+K +       +   + R   +E+++++ +EH  +
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--QKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F    D+++V +L+   DL   ++ +    ++  + F+ +L+  L 
Sbjct: 78  VNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN- 218
           Y+ +  ++HRD+KP N+LL+    + I DF +A        +T    T+ Y APE+  + 
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 219 -CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               Y+ A+D WS+G    E++     +  +                         S ++
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS------------------------STSS 225

Query: 278 RRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-TVEEALRHPYLQSL 333
           +  V              +P+  S   V LL+K+L  +P++R   + +    PY+  +
Sbjct: 226 KEIVHTFETTVV-----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (270), Expect = 4e-27
 Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V           T E VA+KK+ ++ +     R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIE 63

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFL 151
           +L+ ++H+N++  K +     +     + ++ E +    L   ++   +++       + 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---- 207
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +      + V     
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPGE 178

Query: 208 ---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               WY APE L     ++ A D+WS G +L E+ T
Sbjct: 179 SPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 5e-27
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           ++ +G+G +G V           T E VA+KK+ ++ +     R   REI++L+ ++H+N
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDN 103

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           ++  K +     +     + ++ E +    L   ++   +++       +  Q+ +G++Y
Sbjct: 104 IVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 213
           + +   +HRDL   N+L+     +KIGDFGL +   +      Y V         WY AP
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-AP 217

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E L     ++ A D+WS G +L E+ T
Sbjct: 218 ESLTESK-FSVASDVWSFGVVLYELFT 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  108 bits (271), Expect = 1e-26
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
            ++ + +     IGRG +G V +         VA+K  +     D        L+E ++L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF---LQEARIL 166

Query: 96  RHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFL 151
           +   H N++ +  +   + P       +YIV EL+   D    +R+   +L        +
Sbjct: 167 KQYSHPNIVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---- 207
                G++Y+ S   +HRDL   N L+     LKI DFG++R  ++  +     +     
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           +W  APE L     Y++  D+WS G +L E  +    P +P 
Sbjct: 280 KWT-APEALNYGR-YSSESDVWSFGILLWETFSLGASP-YPN 318

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (267), Expect = 2e-26
 Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 60/300 (20%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            + +G G++  V  A    T  E AIK +     +II         RE  ++  ++H   
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          TF D   +Y  +      +L + IR      +   +++  +++  L+
Sbjct: 93  VKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELL 216
           Y+H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
                   + D+W++GCI+ +++   P F   +      LI + I          ++ + 
Sbjct: 205 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKI----------IKLE- 248

Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRIT------VEEALRHPY 329
                              FP K    A DL+EK+LV D  KR+             HP+
Sbjct: 249 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (262), Expect = 6e-26
 Identities = 46/213 (21%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        +  + VA+K + N  ++       L E  +++ +++  ++ 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 106 IKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +  I              +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  
Sbjct: 83  MIGICEAES-------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 216
           ++ +HRDL   N+LL      KI DFGL++     +    Y          +WY APE  
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-C 191

Query: 217 LNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           +N  ++++  D+WS G ++ E  +  ++P + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (262), Expect = 1e-25
 Identities = 65/232 (28%), Positives = 93/232 (40%), Gaps = 30/232 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           IR +G G +G V        N  T E VA+K  K      +        +EI +LR + H
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYH 92

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           E++I  K         +   + +V E +    L   +     +       F  Q+  G+ 
Sbjct: 93  EHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMA 148

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 212
           Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V         WY A
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-A 205

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           PE L     +  A D+WS G  L E++T                  ELIG  
Sbjct: 206 PECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA 251

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (260), Expect = 2e-25
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           I+ +G GA+G V   +      + +  VAIK  +   +     +    L E  ++  +++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +V  +  I            V ++ +LM    L   +R     +   +   +  Q+ +G
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 211
           + Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W  
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           A E  +    YT   D+WS G  + E+MT   +P + G
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  102 bits (257), Expect = 3e-25
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           +E+  + +   R IG G +G V   +          VAIK  K   +          L+E
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF---LQE 66

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
              +R  +H +++ +  +I   P       V+I+ EL    +L   ++     L      
Sbjct: 67  ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLI 119

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            + YQL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++     Y    
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 175

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T+A D+W  G  + EI+    +P F G
Sbjct: 176 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (258), Expect = 3e-25
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENV 103
            R +GRG  G V  A ++     VA+K +     +  D     R  RE +    ++  +V
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHV 96

Query: 104 IAIKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + I D          +   Y+   L++  DL  ++R    L        + Q+   L   
Sbjct: 97  VPIHDF------GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAA 150

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNC 219
           H+A   HRD+KP N+L++A     + DFG+A  T++         V T +Y APE     
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPG 247
           +  T   DI+++ C+L E +T  P + G
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQG 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (265), Expect = 3e-25
 Identities = 66/327 (20%), Positives = 129/327 (39%), Gaps = 54/327 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            R +GRG +G V A     T +  A KK+      +      +  + E K+L  +    +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNK--KRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           +++              + +V  +M+       ++ +   +    +    ++  Q++ GL
Sbjct: 248 VSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLL 217
           +++H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
              EY  ++D +++G  L E++     F  +    + + + + +                
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-----------LEQAV 410

Query: 278 RRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ 331
                             +P+K S  + D  E +L  DP KR+     + +    HP  +
Sbjct: 411 -----------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

Query: 332 SL--HDLNDEPVCPRPFHFDFEHSSCT 356
            +    L    + P PF  D       
Sbjct: 454 DISWRQLEAGMLTP-PFVPDSRTVYAK 479

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  106 bits (265), Expect = 4e-25
 Identities = 68/299 (22%), Positives = 120/299 (40%), Gaps = 48/299 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            R +G+G +G VCA     T +  A KK+      I         L E ++L  +    V
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGEAMALNEKQILEKVNSRFV 246

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DL-HQIIRSDQQ-LTDDHCQYFLYQLLRGLKY 160
           +++              + +V  LM+  DL   I    Q    +    ++  ++  GL+ 
Sbjct: 247 VSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N  
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-E 360

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            YT + D W++GC+L E++  +  F  +    +   +  L+                   
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV------------------- 401

Query: 281 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 333
                    ++    +  + S  A  L  ++L  DP +R+     +  E   HP  + L
Sbjct: 402 ---------KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (255), Expect = 6e-25
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 26/226 (11%)

Query: 35  NLFEVSSKYVPPI--------RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNII 83
            L +     V             IGRG +G V       N   +   A+K + N   +I 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68

Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQ 141
           +  + L E  +++   H NV+++  I    +        +V   M   DL   IR+    
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHN 124

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
            T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ 
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184

Query: 202 TEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           + +  T      +W  A E  L   ++T   D+WS G +L E+MTR
Sbjct: 185 SVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (253), Expect = 1e-24
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G G++G+V        S     VA+K +  +           +RE+  +  ++H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 103 VIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           +I +  ++  PP       + +V EL     L   +R             +  Q+  G+ 
Sbjct: 83  LIRLYGVVLTPP-------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 212
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    YV+         W  A
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-A 192

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           PE  L    ++ A D W  G  L E+ T  +EP + G
Sbjct: 193 PE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIG 227

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  100 bits (251), Expect = 2e-24
 Identities = 46/224 (20%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  + +  ++ +G G +G+V       +    VA+K I    +  +      +E + + 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIK---EGSMSEDEFFQEAQTMM 58

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
            + H  ++    +     P       +YIV E +    L   +RS  + L         Y
Sbjct: 59  KLSHPKLVKFYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +  G+ ++ S   +HRDL   N L++    +K+ DFG+ R   +     +YV +     
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKF 167

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE + +  +Y++  D+W+ G ++ E+ +  + P +  
Sbjct: 168 PVKWS-APE-VFHYFKYSSKSDVWAFGILMWEVFSLGKMP-YDL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =   99 bits (250), Expect = 3e-24
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 35/223 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREI 92
            ++ K +  ++ IG+G +G V        +  VA+K I       AF         L E 
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAF---------LAEA 65

Query: 93  KLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDH 146
            ++  + H N++ +  +I   +         +YIV E M    L   +RS     L  D 
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
              F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 178

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +W  APE  L   +++   D+WS G +L EI +  R P +P 
Sbjct: 179 -KWT-APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (250), Expect = 3e-24
 Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 28/206 (13%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V   V    + + +VAIK  K G    +  +    +RE +++  +++  ++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVR 74

Query: 106 IKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
           +  +            + +V E+     LH+ +    +++   +    L+Q+  G+KY+ 
Sbjct: 75  LIGVCQAEA-------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPEL 215
             + +HRDL   N+LL      KI DFGL++     D  + Y          +WY APE 
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE- 183

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTR 241
            +N  ++++  D+WS G  + E ++ 
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSY 209

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  101 bits (252), Expect = 3e-24
 Identities = 73/338 (21%), Positives = 117/338 (34%), Gaps = 57/338 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           IGRG YG V      E    VA+K         F N        + I  +  MEH+N+  
Sbjct: 21  IGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFIN-------EKNIYRVPLMEHDNIAR 71

Query: 106 -IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I    R           +V E      L + +               + + RGL Y+H+
Sbjct: 72  FIVGDERVTADGRME-YLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLHT 129

Query: 164 A---------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---------MTEYV 205
                     ++ HRDL   N+L+       I DFGL+   +                 V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 206 VTRWYRAPELL------LNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYV-HQLRLI 257
            T  Y APE+L       +       +D++++G I  EI  R   LFPG+    +Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 258 TELIGSPDDASLGFLRSDNARRYVR-QLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDP 315
           TE+    +  +   ++   +R   R + P   ++   A R         + +E     D 
Sbjct: 250 TEV---GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR------SLKETIEDCWDQDA 300

Query: 316 NKRITVEEALRHPYLQSLHDLNDEPVCPRPF-HFDFEH 352
             R+T + A     +  L  + +      P  H    H
Sbjct: 301 EARLTAQXAEE--RMAELMMIWERNKSVSPTAHHHHHH 336

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  100 bits (252), Expect = 4e-24
 Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 32/229 (13%)

Query: 35  NLFEVSSKYVPPI--------RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNII 83
            L +     V             IGRG +G V       N   +   A+K + N   +I 
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 132

Query: 84  DARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRS- 138
           +  + L E  +++   H NV+++  I                +V   M   DL   IR+ 
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS-------PLVVLPYMKHGDLRNFIRNE 185

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
               T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + 
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 199 DFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           +F + +  T      +W  A E  L   ++T   D+WS G +L E+MTR
Sbjct: 246 EFDSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 292

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           E+    +     +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 65

Query: 98  MEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLY 152
           ++H N++ +  +    PP        YI+ E M   +L   +R    Q+++     Y   
Sbjct: 66  IKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
           Q+   ++Y+   + +HRDL   N L+  +  +K+ DFGL+R     D    Y        
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGD---TYTAHAGAKF 174

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE  L   +++   D+W+ G +L EI T    P +PG
Sbjct: 175 PIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (250), Expect = 4e-24
 Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 26/224 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
             +    +   + +G G +G V          T  +VA+K  K+ N+     +    L E
Sbjct: 29  VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSE 86

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTD 144
              ++   H NVI +  +             ++   M   DLH  +         + +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                F+  +  G++Y+ + + LHRDL   N +L     + + DFGL++     D    Y
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YY 203

Query: 205 VVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
                     +W  A E L +   YT+  D+W+ G  + EI TR
Sbjct: 204 RQGRIAKMPVKWI-AIESLAD-RVYTSKSDVWAFGVTMWEIATR 245

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (250), Expect = 6e-24
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 25/217 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           E+    V   + IG G +G V   +    + +    VAIK +  A          L E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 98

Query: 94  LLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQY 149
           ++    H N+I ++ +I    P       + I+ E M+   L + +R  D + +      
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKP-------MMIITEYMENGALDKFLREKDGEFSVLQLVG 151

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
            L  +  G+KY+ + + +HRDL   N+L+N++   K+ DFGL+R   E D    Y  +  
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGG 210

Query: 208 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW  APE  ++  ++T+A D+WS G ++ E+MT
Sbjct: 211 KIPIRWT-APE-AISYRKFTSASDVWSFGIVMWEVMT 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           + ++ + V   R +G G +G V   V   +   +  VA+K  K     DN       + E
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
             ++++++H +++ +  II   P        +I+ EL    +L   +      L      
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEP-------TWIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            +  Q+ + + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D    Y    
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKAS 172

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  +PE  +N   +T A D+W     + EI++  ++P F  
Sbjct: 173 VTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQP-FFW 217

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.4 bits (246), Expect = 6e-24
 Identities = 44/224 (19%), Positives = 97/224 (43%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            +    +  ++ IG G +G+V      ++ +  VAIK I    +  +     + E +++ 
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIR---EGAMSEEDFIEEAEVMM 58

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
            + H  ++ +  +   + P       + +V E M+   L   +R+       +       
Sbjct: 59  KLSHPKLVQLYGVCLEQAP-------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +  G+ Y+  A V+HRDL   N L+  +  +K+ DFG+ R   +     +Y  +     
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKF 167

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  +PE + + + Y++  D+WS G ++ E+ +  + P +  
Sbjct: 168 PVKWA-SPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YEN 208

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  K +  ++ +G G +G+V       +   +VAIK I    +  +     + E K++ 
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIK---EGSMSEDEFIEEAKVMM 74

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
           ++ HE ++ +  +   + P       ++I+ E M    L   +R    +           
Sbjct: 75  NLSHEKLVQLYGVCTKQRP-------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   +     EY  +     
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF 183

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             RW   PE+L+    +++  DIW+ G ++ EI +  + P +  
Sbjct: 184 PVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMP-YER 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENV 103
           +  +G G    V  A ++    +VAIK I             +R  RE+     + H+N+
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE--KEETLKRFEREVHNSSQLSHQNI 73

Query: 104 IAIKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           +++ D+      D  +D  Y+V E ++   L + I S   L+ D    F  Q+L G+K+ 
Sbjct: 74  VSMIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNC 219
           H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T +V+ T  Y +PE     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG- 186

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPG 247
                  DI+S+G +L E++  EP F G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREE--VAIK--KIGNAFDNIIDARRTLREI 92
           E+ +  +   + +G G +G VC+      +++E  VAIK  K+G         R  L E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK---QRRDFLGEA 97

Query: 93  KLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
            ++   +H N+I ++ ++    P       V IV E M+   L   +R  D Q T     
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
             L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL R   E D    Y    
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRG 209

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  +PE  +   ++T+A D+WS G +L E+M+
Sbjct: 210 GKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 23/213 (10%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R +G+G +G V  A       +  +VA+K +        D    LRE   ++  +H +V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 104 IAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTDDHCQYFLYQLL 155
             +  + +R   K       ++   M   DLH  + +         L       F+  + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 208
            G++Y+ S + +HRDL   N +L     + + DFGL+R     D    Y          +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVK 204

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           W  A E L +   YT   D+W+ G  + EIMTR
Sbjct: 205 WL-ALESLAD-NLYTVHSDVWAFGVTMWEIMTR 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           I+ +G GA+G V   +      + +  VAIK  +   +     +    L E  ++  +++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +V  +  I            V ++ +LM    L   +R     +   +   +  Q+ +G
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 211
           + Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W  
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           A E  +    YT   D+WS G  + E+MT 
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTF 215

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (252), Expect = 2e-23
 Identities = 69/300 (23%), Positives = 125/300 (41%), Gaps = 50/300 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLL---RHMEH 100
            R IGRG +G V     ++T +  A+K +      I         L E  +L      + 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDK--KRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K     +  + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKG 365

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y ++ D +S+GC+L +++     F      H+ +   E+                  R
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF----RQHKTKDKHEID-----------------R 404

Query: 280 YVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 333
               +            P+  S     LLE +L  D N+R+       +E    P+ +SL
Sbjct: 405 MTLTMA--------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 25/220 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           EV  + +  +  +G G +G V     N  T+  VA+K +       +     L E  L++
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLK---QGSMSPDAFLAEANLMK 63

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       Q
Sbjct: 64  QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RW 209
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++ T         +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 176

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE +   T +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 T-APEAINYGT-FTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 26/217 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIK 93
           E+ +  +   + IG G  G VC        +    VAIK +     +     R  L E  
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEAS 102

Query: 94  LLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQY 149
           ++   +H N+I ++ ++              IV E M+   L   +R+ D Q T      
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRL-------AMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
            L  +  G++Y+     +HRDL   N+L++++   K+ DFGL+R   E D    Y  T  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGG 214

Query: 208 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW  APE  +    +++A D+WS G ++ E++ 
Sbjct: 215 KIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  100 bits (250), Expect = 3e-23
 Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V   V    + + +VAIK  K G    +  +    +RE +++  +++  ++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVR 400

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
           +  +           + +V E+     LH+ +    +++   +    L+Q+  G+KY+  
Sbjct: 401 LIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 216
            + +HR+L   N+LL      KI DFGL++     D  + Y          +WY APE  
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-C 510

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTR 241
           +N  ++++  D+WS G  + E ++ 
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSY 535

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 52/306 (16%), Positives = 109/306 (35%), Gaps = 56/306 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+  V      +T +  A+K +     +++   +      E  +L + +   +
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK--WDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGL 158
             +           F D   +Y +M+     DL   + +  +++  +  +++L +++  +
Sbjct: 124 TQLHF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELL 216
             VH    +HRD+KP N+LL+    +++ DFG   +  ++    +   V T  Y +PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235

Query: 217 LN------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 270
                      Y    D W++G    E+   +  F           I             
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI------------- 282

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRH 327
                        +                  A D ++++L   P  R+      +   H
Sbjct: 283 -------------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328

Query: 328 PYLQSL 333
           P+   L
Sbjct: 329 PFFFGL 334

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 107 KDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYV 161
             +    PP        YI+ E M   +L   +R    Q+++     Y   Q+   ++Y+
Sbjct: 282 LGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPE 214
              + +HR+L   N L+  +  +K+ DFGL+R  +       Y          +W  APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE 389

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
             L   +++   D+W+ G +L EI T    P +PG D
Sbjct: 390 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGID 424

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  100 bits (250), Expect = 4e-23
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           +E+  + +   R IG G +G V   +          VAIK  K   +          L+E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK---FLQE 441

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
              +R  +H +++ +  +I   P       V+I+ EL    +L   ++     L      
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLI 494

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            + YQL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++     Y    
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 550

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T+A D+W  G  + EI+    +P F G
Sbjct: 551 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 595

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 39/235 (16%), Positives = 81/235 (34%), Gaps = 34/235 (14%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAV-------NSETREEVAIKKIGNAFDNIIDARRT 88
             ++ ++ +     +G+G +  +   V             EV +K +  A  N   +   
Sbjct: 2   FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESF 59

Query: 89  LREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTD 144
                ++  + H++++    +               +V E +    L   ++     +  
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQEFVKFGSLDTYLKKNKNCINI 112

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL--------KIGDFGLARTTS 196
                   QL   + ++   +++H ++   N+LL    D         K+ D G++ T  
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
             D + E +   W   PE + N      A D WS G  L EI +   +P     D
Sbjct: 173 PKDILQERI--PWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALD 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 42/219 (19%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           ++ +G G +G V   V        +  V IK  +  +   +          +  +  ++H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA---VTDHMLAIGSLDH 74

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +++ +  +            + +V + +    L   +R     L       +  Q+ +G
Sbjct: 75  AHIVRLLGLCPGSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWY 210
           + Y+    ++HR+L   N+LL +   +++ DFG+A      D   + ++        +W 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWM 184

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            A E  ++  +YT   D+WS G  + E+MT   EP + G
Sbjct: 185 -ALE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  + +   + +G G +G V  A  N  T+  VA+K +       +     L E  +++
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMK 238

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M    L   ++SD   +        F  Q
Sbjct: 239 TLQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------ 207
           +  G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   +     EY         
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFP 348

Query: 208 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 349 IKWT-APE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 35/255 (13%)

Query: 6   KDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE 65
              + G  T  +K  +  G    Q   Y + + ++ K +  ++ IG+G +G V       
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216

Query: 66  TREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDT 117
            +  VA+K I       AF         L E  ++  + H N++ +  +I   +      
Sbjct: 217 NK--VAVKCIKNDATAQAF---------LAEASVMTQLRHSNLVQLLGVIVEEKGG---- 261

Query: 118 FNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 174
              +YIV E M    L   +RS     L  D    F   +   ++Y+   + +HRDL   
Sbjct: 262 ---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318

Query: 175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           N+L++     K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGIL 375

Query: 235 LGEIMT--REPLFPG 247
           L EI +  R P +P 
Sbjct: 376 LWEIYSFGRVP-YPR 389

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 97.4 bits (243), Expect = 7e-23
 Identities = 63/304 (20%), Positives = 127/304 (41%), Gaps = 66/304 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENV 103
           I+ +G G++G V    + E+    A+K +      ++  ++   TL E ++L+ +    +
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + ++         +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +
Sbjct: 104 VKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPEL 215
           Y+HS  +++RDLKP NLL++    +++ DFG A+      +      E +      APE+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEI 209

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
           +L+   Y  A+D W++G ++ E+    P F     +     I  + G             
Sbjct: 210 ILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKV----------- 255

Query: 276 NARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 329
                              RFP+  SS   DLL  +L  D  KR       V +   H +
Sbjct: 256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 330 LQSL 333
             + 
Sbjct: 297 FATT 300

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH 162
           +  ++      +   +YIV E M    L   ++ +  + L          Q+  G+ YV 
Sbjct: 244 LYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNC 219
             + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE     
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALY 355

Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +T   D+WS G +L E+ T  R P +PG
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHE 101
            R IG+G +G+V        ++ R + AIK          +      LRE  L+R + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA---FLREGLLMRGLNHP 82

Query: 102 NVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR 156
           NV+    I               +++   M   DL Q IRS  +  T      F  Q+ R
Sbjct: 83  NVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWY 210
           G++Y+     +HRDL   N +L+ S  +K+ DFGLAR   + ++ +           +W 
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
            A E L     +T   D+WS G +L E++TR
Sbjct: 196 -ALESLQT-YRFTTKSDVWSFGVLLWELLTR 224

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH 162
           +  ++      +   +YIV E M    L   ++ +  + L          Q+  G+ YV 
Sbjct: 327 LYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNC 219
             + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE     
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALY 438

Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +T   D+WS G +L E+ T  R P +PG
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 59/304 (19%), Positives = 122/304 (40%), Gaps = 54/304 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+G V         +  A+K +      ++   +      E  +L + + + +
Sbjct: 79  LKVIGRGAFGEVAVVKLKNADKVFAMKILNK--WEMLKRAETACFREERDVLVNGDSKWI 136

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGL 158
             +           F D   +Y +MD     DL   + + + +L ++  +++L +++  +
Sbjct: 137 TTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELL 216
             VH    +HRD+KP N+L++ +  +++ DFG   +   +    +   V T  Y +PE+L
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
                    Y    D WS+G  + E++  E  F  +  V     I               
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--------------- 293

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPY 329
                      +    + QF T+  + S  A DL+ +++      R+    +E+  +HP+
Sbjct: 294 -----------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341

Query: 330 LQSL 333
              +
Sbjct: 342 FSGI 345

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 55/246 (22%)

Query: 35  NLFEVSSKYVPP-----------IRPIGRGAYGIVCAAV-----NSETREEVAIK--KIG 76
             F  +  YVP             R +G+G++G+V   V       E    VAIK     
Sbjct: 7   EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 66

Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DL 132
            +    I+    L E  +++     +V+ +  ++   +P          ++ ELM   DL
Sbjct: 67  ASMRERIE---FLNEASVMKEFNCHHVVRLLGVVSQGQPT--------LVIMELMTRGDL 115

Query: 133 HQIIRS----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
              +RS              +         ++  G+ Y+++   +HRDL   N ++    
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175

Query: 183 DLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCIL 235
            +KIGDFG+ R   ETD+   Y          RW  +PE L +   +T   D+WS G +L
Sbjct: 176 TVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVL 230

Query: 236 GEIMTR 241
            EI T 
Sbjct: 231 WEIATL 236

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENV 103
              +G G    V  A +     +VA+K +        D     R  RE +    + H  +
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAI 74

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +A+ D             YIV E +D   L  I+ ++  +T       +    + L + H
Sbjct: 75  VAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVV-TRWYRAPELLLN 218
              ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V+ T  Y +PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPG 247
                A  D++S+GC+L E++T EP F G
Sbjct: 194 -DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 30/253 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+G V    +  TR+  A+K +      +I   D+     E  ++       V
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWV 131

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +           F D   +Y +M+     DL  ++ +   + +   +++  +++  L 
Sbjct: 132 VQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALD 182

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLL 217
            +HS   +HRD+KP N+LL+ S  LK+ DFG   +   E     +  V T  Y +PE+L 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 218 NC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI---TELIGSPDDASLGF 271
           +      Y    D WSVG  L E++  +  F     V     I      +  PDD  +  
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-- 300

Query: 272 LRSDNARRYVRQL 284
             S  A+  +   
Sbjct: 301 --SKEAKNLICAF 311

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)

Query: 9   SSGGATSSVKGVLTHGGKYV----QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA--- 61
            SG + S  +G  +    ++    QY     +  +  + +     +G GA+G V  A   
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63

Query: 62  --VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDT 117
             +  + +  VA+K +  A ++    +   RE +LL  ++H++++    +     P    
Sbjct: 64  NLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP---- 117

Query: 118 FNDVYIVYELMDT-DLHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYV 161
              + +V+E M   DL++ +RS                  L          Q+  G+ Y+
Sbjct: 118 ---LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPE 214
                +HRDL   N L+     +KIGDFG++R    TD+   Y V        RW   PE
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPE 230

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT 240
            +L   ++T   D+WS G +L EI T
Sbjct: 231 SILY-RKFTTESDVWSFGVVLWEIFT 255

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 73/322 (22%), Positives = 138/322 (42%), Gaps = 78/322 (24%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G +G V       T    A+K +    + II   +   T+ E ++L++  H  + A+
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 107 KDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           K   +   +     +  V  Y    EL     H  +  ++  T++  +++  +++  L+Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFTEERARFYGAEIVSALEY 120

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------YRAPE 214
           +HS  V++RD+K  NL+L+    +KI DFGL +     + +++    +       Y APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE 175

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGSPDDASLGFL 272
           +L +  +Y  A+D W +G ++ E+M     F  +D   + +L L+ E+            
Sbjct: 176 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------ 222

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALR 326
                                 RFP   S  A  LL  +L  DP +R+       +E + 
Sbjct: 223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260

Query: 327 HPYLQSL--HDLNDEPVCPRPF 346
           H +  S+   D+  + + P PF
Sbjct: 261 HRFFLSINWQDVVQKKLLP-PF 281

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 72/303 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNII---DARRTLREIKLLRHMEH 100
           +R +G G++G V    +       A+K   K     + ++       T  E  +L  + H
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLMLSIVTH 65

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             +I +          TF D   ++ +MD     +L  ++R  Q+  +   +++  ++  
Sbjct: 66  PFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRA 212
            L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +  +      +Y+      A
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------A 171

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 272
           PE++     Y  +ID WS G ++ E++     F   + +     I  L            
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAEL-------- 220

Query: 273 RSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALR 326
                                 RFP   +    DLL +++  D ++R+       E+   
Sbjct: 221 ----------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258

Query: 327 HPY 329
           HP+
Sbjct: 259 HPW 261

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.0 bits (219), Expect = 5e-20
 Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 48/240 (20%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIK--KIGNAFDNIIDAR 86
           G L E+S   V  +  +G   +G V           E  + VAIK  K         +  
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-- 58

Query: 87  RTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS----- 138
               E  L   ++H NV+ +  ++    P       + +++      DLH+ +       
Sbjct: 59  -FRHEAMLRARLQHPNVVCLLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHS 110

Query: 139 -----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
                         L      + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI 
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 170

Query: 188 DFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D GL R     D    Y +        RW  APE ++    ++   DIWS G +L E+ +
Sbjct: 171 DLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEVFS 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 59/251 (23%), Positives = 91/251 (36%), Gaps = 48/251 (19%)

Query: 23  HGGKYVQYNVYGNLFEVSSKY-VPP-----IRPIGRGAYGIVCAAV-----NSETREEVA 71
           H      Y   G    +S    VP      IR +G GA+G V         N  +  +VA
Sbjct: 5   HHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 64

Query: 72  IK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI--IRPPKKDTFNDVYIVYEL 127
           +K      +  + +D    L E  ++    H+N++    +     P        +I+ EL
Sbjct: 65  VKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP-------RFILMEL 114

Query: 128 MDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           M   DL   +R           L      +    +  G +Y+     +HRD+   N LL 
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174

Query: 180 ASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIW 229
                   KIGDFG+AR      +   Y          +W   PE  +    +T+  D W
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFME-GIFTSKTDTW 229

Query: 230 SVGCILGEIMT 240
           S G +L EI +
Sbjct: 230 SFGVLLWEIFS 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 47/235 (20%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREI 92
            +  + +   R +G GA+G V  A       ++ +  VA+K + +        +   RE 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREA 68

Query: 93  KLLRHMEHENVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---------- 138
           +LL +++HE+++    +     P        + +V+E M   DL++ +R+          
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDP--------LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120

Query: 139 ------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
                   +L      +   Q+  G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 193 RTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           R    TD+   Y V        RW   PE ++   ++T   D+WS G IL EI T
Sbjct: 181 RDVYSTDY---YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFT 230

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 70/303 (23%), Positives = 129/303 (42%), Gaps = 66/303 (21%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G +G V       T    A+K +    + I+   +   TL E ++L++  H  + A+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKK--EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 107 KDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           K   +   +     +  V  Y    EL     H  +  ++  ++D  +++  +++  L Y
Sbjct: 214 KYSFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFSEDRARFYGAEIVSALDY 263

Query: 161 VHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLN 218
           +HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L +
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDN 276
             +Y  A+D W +G ++ E+M     F  +D   + +L L+ E+                
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------- 366

Query: 277 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL 330
                             RFP      A  LL  +L  DP +R+       +E ++H + 
Sbjct: 367 ------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

Query: 331 QSL 333
             +
Sbjct: 409 AGI 411

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 74/322 (22%), Positives = 133/322 (41%), Gaps = 75/322 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + +G+G++G V  A   +T +  AIK               L++  +L   + E  +  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIK--------------ALKKDVVLMDDDVECTMVE 67

Query: 107 KDIIRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K ++    +  F            +++ V E ++  DL   I+S  +       ++  ++
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
           + GL+++HS  +++RDLK  N+LL+    +KI DFG+ +     + M     T       
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTP 182

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            Y APE+LL   +Y  ++D WS G +L E++  +  F G+D       I       D+  
Sbjct: 183 DYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNP- 235

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALR- 326
                                      +P      A DLL K+ V +P KR+ V   +R 
Sbjct: 236 --------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

Query: 327 HPYLQSL--HDLNDEPVCPRPF 346
           HP  + +   +L  + + P PF
Sbjct: 270 HPLFREINWEELERKEIDP-PF 290

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 55/246 (22%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+GRGA+G V  A       + T   VA+K  K G            + E+K+L H+ 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---LMSELKILIHIG 88

Query: 99  EHENVI----AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
            H NV+    A      P        + ++ E     +L   +RS               
Sbjct: 89  HHLNVVNLLGACTKPGGP--------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
               LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 198 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGK 248
                +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGV 254

Query: 249 DYVHQL 254
               + 
Sbjct: 255 KIDEEF 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 66/332 (19%), Positives = 127/332 (38%), Gaps = 90/332 (27%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IR +G+G++G V  A   ET +  A+K               L++  +L+  + E  +  
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVK--------------VLKKDVILQDDDVECTMTE 73

Query: 107 KDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQY 149
           K I+   +   F           + ++ V  +    +LM    H  I+  ++  +   ++
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM---FH--IQKSRRFDEARARF 128

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 209
           +  +++  L ++H   +++RDLK  N+LL+     K+ DFG+ +     + +   V T  
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTAT 183

Query: 210 ------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
                 Y APE+L     Y  A+D W++G +L E++     F  ++       I      
Sbjct: 184 FCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---- 238

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI--- 319
            D+                             +P      A  +L+  +  +P  R+   
Sbjct: 239 -DEV---------------------------VYPTWLHEDATGILKSFMTKNPTMRLGSL 270

Query: 320 ---TVEEALRHPYLQSL--HDLNDEPVCPRPF 346
                   LRHP+ + +    LN   + P PF
Sbjct: 271 TQGGEHAILRHPFFKEIDWAQLNHRQIEP-PF 301

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
           IR +G GA+G V         N  +  +VA+K      +  + +D    L E  ++    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFN 132

Query: 100 HENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS-------DQQLTDDHCQY 149
           H+N++    +     P        +I+ ELM   DL   +R           L      +
Sbjct: 133 HQNIVRCIGVSLQSLP-------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVV 206
               +  G +Y+     +HRD+   N LL         KIGDFG+AR      +   Y  
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRK 242

Query: 207 T-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   +W   PE  +    +T+  D WS G +L EI +
Sbjct: 243 GGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFS 281

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 47/228 (20%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EH 100
            + +G GA+G V  A     + S+    VA+K +     ++ +    + E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 101 ENVIAIKDI--IRPPKKDTFNDVYIVYELM-DTDLHQIIRS------------------D 139
            N++ +     I  P         ++ E     DL   +R                   +
Sbjct: 87  MNIVNLLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
             L  +    F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR      
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 200 FMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               YVV        +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 200 ---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFS 242

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.2 bits (211), Expect = 6e-19
 Identities = 31/257 (12%), Positives = 63/257 (24%), Gaps = 51/257 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIA 105
           +   G         A+++    +VA+  +           + TL     L  ++   V  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D++      T     +V E +    L ++  +    +       +  L       H A
Sbjct: 96  VLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRA 148

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V      PS + ++   D+ +                                      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------------------NP 181

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLR-LITELIGSP--------------DDASL 269
             DI  +G  L  ++      P       L     +  G P                 + 
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241

Query: 270 GFLRSDNARRYVRQLPR 286
             ++ D   R    L  
Sbjct: 242 RSVQGDGGIRSASTLLN 258

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.7 bits (213), Expect = 8e-19
 Identities = 65/343 (18%), Positives = 132/343 (38%), Gaps = 82/343 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R IGRG+Y  V      +T    A+K               +++  +    + + V   
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMK--------------VVKKELVNDDEDIDWVQTE 59

Query: 107 KDIIRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K +        F           + ++ V E ++  DL   ++  ++L ++H +++  ++
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
              L Y+H   +++RDLK  N+LL++   +K+ D+G+ +     + +     T       
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTP 174

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            Y APE+L    +Y  ++D W++G ++ E+M     F                       
Sbjct: 175 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------- 220

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI------TV 321
                  N   Y+ Q+   ++     R P   S  A  +L+  L  DP +R+        
Sbjct: 221 ------QNTEDYLFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 270

Query: 322 EEALRHPYLQSL--HDLNDEPVCPRPF-----------HFDFE 351
            +   HP+ +++    +  + V P PF           +FD +
Sbjct: 271 ADIQGHPFFRNVDWDMMEQKQVVP-PFKPNISGEFGLDNFDSQ 312

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 53/229 (23%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            + +G GA+G V  A        +   +VA+K  K     D        + E+K++ H+ 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSELKIMSHLG 107

Query: 99  EHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-------------- 138
           +HEN++ +          P        V ++ E     DL   +R               
Sbjct: 108 QHENIVNLLGACTHG--GP--------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           +   +     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

Query: 199 DFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 218 S---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 47/224 (20%)

Query: 47  IRPIGRGAYGIVCAAV--NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHM-EHEN 102
              IG G +G V  A       R + AIK++   A  +  D R    E+++L  +  H N
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPN 87

Query: 103 VIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +I +      R         +Y+  E     +L   +R                    L+
Sbjct: 88  IINLLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R          
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------V 194

Query: 204 YVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           YV         RW  A E  LN + YT   D+WS G +L EI++
Sbjct: 195 YVKKTMGRLPVRWM-AIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 64/343 (18%), Positives = 132/343 (38%), Gaps = 82/343 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R IGRG+Y  V      +T    A++               +++  +    + + V   
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMR--------------VVKKELVNDDEDIDWVQTE 102

Query: 107 KDIIRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K +        F           + ++ V E ++  DL   ++  ++L ++H +++  ++
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
              L Y+H   +++RDLK  N+LL++   +K+ D+G+ +     + +     T       
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTP 217

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
            Y APE+L    +Y  ++D W++G ++ E+M     F                       
Sbjct: 218 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------- 263

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI------TV 321
                  N   Y+ Q+   ++     R P   S  A  +L+  L  DP +R+        
Sbjct: 264 ------QNTEDYLFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 313

Query: 322 EEALRHPYLQSL--HDLNDEPVCPRPF-----------HFDFE 351
            +   HP+ +++    +  + V P PF           +FD +
Sbjct: 314 ADIQGHPFFRNVDWDMMEQKQVVP-PFKPNISGEFGLDNFDSQ 355

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 61/331 (18%), Positives = 127/331 (38%), Gaps = 95/331 (28%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K               L++  +++  + E  +  K +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVEKRV 73

Query: 110 IRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
           +  P K  F           + +Y V  Y    +LM    + I +  +   + H  ++  
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFYAA 128

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYV 205
           ++  GL ++ S  +++RDLK  N++L++   +KI DFG+ +        T       +Y+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGS 263
                 APE++     Y  ++D W+ G +L E++  +  F G+D   + Q  +   +   
Sbjct: 189 ------APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--- 238

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI--- 319
                                           +P   S  AV + + ++   P KR+   
Sbjct: 239 -------------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCG 267

Query: 320 --TVEEALRHPYLQSL--HDLNDEPVCPRPF 346
                +   H + + +    L  + + P P+
Sbjct: 268 PEGERDIKEHAFFRYIDWEKLERKEIQP-PY 297

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 62/334 (18%), Positives = 128/334 (38%), Gaps = 95/334 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G+G++G V  +    T E  A+K               L++  +++  + E  +  
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVE 391

Query: 107 KDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQY 149
           K ++  P K  F           + +Y V  Y    +LM    H  I+   +  + H  +
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVF 446

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT------- 202
           +  ++  GL ++ S  +++RDLK  N++L++   +KI DFG+ +        T       
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITEL 260
           +Y+      APE++     Y  ++D W+ G +L E++  +  F G+D   + Q  +   +
Sbjct: 507 DYI------APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559

Query: 261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI 319
                                              +P   S  AV + + ++   P KR+
Sbjct: 560 ----------------------------------AYPKSMSKEAVAICKGLMTKHPGKRL 585

Query: 320 -----TVEEALRHPYLQSL--HDLNDEPVCPRPF 346
                   +   H + + +    L  + + P P+
Sbjct: 586 GCGPEGERDIKEHAFFRYIDWEKLERKEIQP-PY 618

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 62/238 (26%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
            + +G G +G V  A             VA+K  K   +   + D    L E  +L+ + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD---LLSEFNVLKQVN 84

Query: 100 HENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
           H +VI +     +D   P          ++ E      L   +R                
Sbjct: 85  HPHVIKLYGACSQD--GPL--------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 139 ---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 189
                    ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 190 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           GL+R   E D    YV         +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 195 GLSRDVYEED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 67/311 (21%), Positives = 128/311 (41%), Gaps = 73/311 (23%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            ++ +    +   K     +Y++  Y    EL    +   +  +    +D   ++L ++ 
Sbjct: 82  FIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEIS 131

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYVVTR 208
             L ++H   +++RDLKP N++LN    +K+ DFGL + +     +T       EY+   
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM--- 188

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
              APE+L+  + +  A+D WS+G ++ +++T  P F G++    +  I           
Sbjct: 189 ---APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI----------- 233

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVE 322
              L+                       P   +  A DLL+K+L  +   R+        
Sbjct: 234 ---LKCK------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272

Query: 323 EALRHPYLQSL 333
           E   HP+ + +
Sbjct: 273 EVQAHPFFRHI 283

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 73/346 (21%), Positives = 138/346 (39%), Gaps = 105/346 (30%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +       A+K               L++  +L+  E +++++ +++
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVK--------------VLQKKAILKKKEEKHIMSERNV 91

Query: 110 ----IRPP----KKDTF---NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
               ++ P       +F   + +Y V  Y    EL     H  ++ ++   +   +++  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF---YH--LQRERCFLEPRARFYAA 146

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYV 205
           ++   L Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T       EY+
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL 206

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGS 263
                 APE+L     Y   +D W +G +L E++   P F  ++   ++   L   L   
Sbjct: 207 ------APEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--- 256

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRI--- 319
                                          +   N ++ A  LLE +L  D  KR+   
Sbjct: 257 -------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAK 285

Query: 320 -TVEEALRHPYLQSL--HDLNDEPVCPRPF-----------HFDFE 351
               E   H +   +   DL ++ + P PF           HFD E
Sbjct: 286 DDFMEIKSHVFFSLINWDDLINKKITP-PFNPNVSGPNDLRHFDPE 330

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 64/283 (22%)

Query: 7   DSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPP-------------IRPIGRG 53
            + S  + +S   ++    +         L  VS   +P               +P+G G
Sbjct: 33  SAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEG 92

Query: 54  AYGIVCAAV-------NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM-EHENV 103
            +G V  A          +    VA+K  K      ++ D    + E+++++ + +H+N+
Sbjct: 93  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNI 149

Query: 104 IAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLTD 144
           I +        P       +Y++ E     +L + +R+                ++Q+T 
Sbjct: 150 INLLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D    Y
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YY 259

Query: 205 VVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             T       +W  APE L +   YT   D+WS G ++ EI T
Sbjct: 260 KKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 57/233 (24%)

Query: 47  IRPIGRGAYGIVCAAV-------NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRH 97
            +P+G GA+G V  A          +    VA+K  K      ++ D    + E+++++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKM 96

Query: 98  M-EHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS------------ 138
           + +H+N+I +     +D   P         Y++ E     +L + +R+            
Sbjct: 97  IGKHKNIINLLGACTQD--GPL--------YVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 139 ----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
               ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206

Query: 195 TSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +  D    Y  T       +W  APE L +   YT   D+WS G ++ EI T
Sbjct: 207 INNID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 58/319 (18%), Positives = 136/319 (42%), Gaps = 81/319 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIA 105
           ++ +G GAYG V          +++    G  +     A + L++  +++  +  E+   
Sbjct: 59  LKVLGTGAYGKVFLV------RKISGHDTGKLY-----AMKVLKKATIVQKAKTTEHTRT 107

Query: 106 IKDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQ 148
            + ++   ++  F             ++++  Y    EL     H  +   ++ T+   Q
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF---TH--LSQRERFTEHEVQ 162

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     +F+ +     
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-----EFVADETERA 217

Query: 209 W-------YRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 260
           +       Y AP+++      +  A+D WS+G ++ E++T    F      +    I+  
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277

Query: 261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI 319
           I          L+S+                    +P + S+ A DL++++L+ DP KR+
Sbjct: 278 I----------LKSE------------------PPYPQEMSALAKDLIQRLLMKDPKKRL 309

Query: 320 -----TVEEALRHPYLQSL 333
                  +E   H + Q +
Sbjct: 310 GCGPRDADEIKEHLFFQKI 328

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 54/234 (23%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            + +G GA+G V  A       +    +VA+K  K              + E+K++  + 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA---LMSELKMMTQLG 106

Query: 99  EHENVI------AIKD---II----------------RPPKKDTFNDVYIVYELMDTDLH 133
            HEN++       +     +I                R    +   +      L + +  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 134 QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
            ++  +  L       F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR
Sbjct: 167 NVLTFEDLL------CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 194 TTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                     YVV        +W  APE L     YT   D+WS G +L EI +
Sbjct: 221 DIMSDS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIFS 269

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 66/313 (21%), Positives = 127/313 (40%), Gaps = 79/313 (25%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHMEHE 101
           ++ +G+G++G V        S+ R+  A+K +      +   D  RT  E  +L  + H 
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK--ATLKVRDRVRTKMERDILVEVNHP 86

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            ++ +    +   K     +Y++  +    +L        +  +   T++  +++L +L 
Sbjct: 87  FIVKLHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELA 136

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYVVTR 208
             L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +          EY+   
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM--- 193

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDD 266
              APE++     +T + D WS G ++ E++T    F GKD      + L  +L      
Sbjct: 194 ---APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL------ 243

Query: 267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----T 320
                                         P   S  A  LL  +   +P  R+      
Sbjct: 244 ----------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDG 275

Query: 321 VEEALRHPYLQSL 333
           VEE  RH +  ++
Sbjct: 276 VEEIKRHSFFSTI 288

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 62/238 (26%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
           +R IG GA+G V  A     +  E    VA+K  K   + D   D     RE  L+   +
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD---FQREAALMAEFD 108

Query: 100 HENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
           + N++ +         +P          +++E M   DL++ +RS               
Sbjct: 109 NPNIVKLLGVCAVG--KPM--------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 139 ---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 189
                       L+         Q+  G+ Y+     +HRDL   N L+  +  +KI DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218

Query: 190 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           GL+R     D    Y          RW   PE +     YT   D+W+ G +L EI +
Sbjct: 219 GLSRNIYSAD---YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFS 271

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 47/228 (20%)

Query: 47  IRPIGRGAYGIVCAAV-------NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+G GA+G V  A              +VA+K +  +     D    + E+++++ + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 99  EHENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------D 139
           +H+N+I +        P       +Y++ E     +L + +++                +
Sbjct: 133 KHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
           +QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 200 FMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               Y  T       +W  APE L +   YT   D+WS G +L EI T
Sbjct: 246 ---YYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFT 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
              ++ +          LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 185 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           KI DFGLAR   +     +YV         +W  APE + +   YT   D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 238 IMT 240
           I +
Sbjct: 288 IFS 290

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.6 bits (177), Expect = 2e-14
 Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 56/242 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID------ARRTLREIKLLRHME- 99
              IG G +G V   +       VAIK I     ++++          L EI + + +  
Sbjct: 25  CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82

Query: 100 --------HENVIAIKDII-------------------------RPPKKDTFNDVYIVYE 126
                    E  I +  +                            P     + ++IV E
Sbjct: 83  LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142

Query: 127 LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLK 185
                +       +  +    +  L+QL   L    ++    HRDL   N+LL  +   K
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202

Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +      ++++                  L ++  +YT +        +  ++   E LF
Sbjct: 203 LHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249

Query: 246 PG 247
            G
Sbjct: 250 TG 251

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 210
            G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            APE L    E T   DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 16/154 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            + IG G +G +    N  T E VAIK      + +      L  E +  + +   +   
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG--SGDG 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I  +        +N   +V EL+   L  +    D+  +         QL+  ++YVHS 
Sbjct: 67  IPQVYYFGPCGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 165 SVLHRDLKPSNLLL-----NASCDLKIGDFGLAR 193
           ++++RD+KP N L+          + I DF LA+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            R IG G++G +    +    EEVAIK      + +      L  E K+ + M+    + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ--GGVG 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I  I     +  +N   +V EL+   L  +     ++ +         Q++  ++Y+HS 
Sbjct: 67  IPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
           + +HRD+KP N L+        + I DFGLA+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 23/165 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
            + IG G +G++  A  +   E+ A    K+        +      E+K  + +  ++ I
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQ-----ENGPLFSELKFYQRVAKKDCI 96

Query: 105 AIKDIIRPPKKDTFNDVY--------------IVYELMDTDLHQIIRSDQQLTDDHCQYF 150
                 +          Y              +V E +  DL +I   +           
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
             ++L  L+Y+H    +H D+K +NLLL      ++   D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 156 RGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW--- 209
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 210 --YRAPELLLN--CTEYTAAIDIWSVGCILGEIMT 240
             + APE L     +E T   D++  G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 21/106 (19%)

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 210
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 211 RAPELLLNCTEY------TAAIDIWSVGCILGEIMT-REPLFPGKD 249
             P       EY      T   D++S G +L E++  R  +     
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 35/170 (20%), Positives = 71/170 (41%), Gaps = 23/170 (13%)

Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL- 89
           NV G  ++V        R IG G++G++    N    ++VAIK     F+        L 
Sbjct: 6   NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLR 53

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQ 148
            E +  + +       I ++    ++   N   +V +L+   L  ++    ++ +     
Sbjct: 54  DEYRTYKLLA--GCTGIPNVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVA 109

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK-----IGDFGLAR 193
               Q+L  ++ +H  S+++RD+KP N L+            + DFG+ +
Sbjct: 110 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 14/152 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            R IG G++G +    N +T EEVAIK      +N+      L  E K+ R ++      
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ--GGTG 64

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I ++     +  +N   +V +L+   L  +     ++L+         Q++  +++VHS 
Sbjct: 65  IPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
           S LHRD+KP N L+        + I DFGLA+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 25/179 (13%), Positives = 60/179 (33%), Gaps = 48/179 (26%)

Query: 47  IRPIGRGAYGIVCAAVNSETR--------EEVAIK---KIGNAFDNIIDARRTLR--EIK 93
                R   GI+  A  + T         ++ ++K   K G  F+     +R  +  ++ 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 94  LLRHMEHENVIAIKDIIRPPK-------KDTFNDVYIVYELMDTDLHQIIRSDQ------ 140
             + +    ++AI      P        +D +   ++V   +   L   +          
Sbjct: 107 KWKKLYSTPLLAI------PTCMGFGVHQDKYR--FLVLPSLGRSLQSALDVSPKHVLSE 158

Query: 141 ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
               Q+          +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 159 RSVLQVAC--------RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 34/166 (20%), Positives = 62/166 (37%), Gaps = 22/166 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             PIG+G +G +  A +  + E V             D      E+K  +       I  
Sbjct: 40  GLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 107 KDIIRPPK----------------KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQY 149
               R  K                  ++   +++ +   +DL +I  +  ++ +      
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYR--FMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
              ++L  L+Y+H    +H D+K SNLLLN     ++   D+GLA 
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 26/120 (21%), Positives = 47/120 (39%), Gaps = 18/120 (15%)

Query: 80  DNIIDARRTLREIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           D  I   RT RE + L  ++   + A  I D+      D  N   ++  +       +I 
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDV------DLDNKRIMMSYINGKLAKDVIE 431

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
            +            Y++   +  +H   V+H DL  SN + +    + I DFGL + ++ 
Sbjct: 432 DNLD--------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI-I-DFGLGKISNL 481

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 5e-04
 Identities = 52/340 (15%), Positives = 100/340 (29%), Gaps = 94/340 (27%)

Query: 85  ARRTLREIKLLRHMEHENV--IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ-- 140
           A       K+   M+   +  + +K+   P  +     +  +   +D +     RSD   
Sbjct: 167 ALDVCLSYKVQCKMDF-KIFWLNLKNCNSP--ETVLEMLQKLLYQIDPNWTS--RSDHSS 221

Query: 141 --QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL--LNASCDLKIGDFGLA--RT 194
             +L     Q  L +LL+   Y +   VL  +++ +      N SC  KI    L   R 
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSC--KI----LLTTRF 274

Query: 195 TSETDFMTEYVVTRWY-----------RAPELLLNCTEYTAAIDIWSVGC--------IL 235
              TDF++    T                  LLL   +     D+             I+
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSII 333

Query: 236 GEIMTREPLFPGKDYVHQLRL--ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 293
            E +         D    +    +T +I    ++SL  L     R+   +L         
Sbjct: 334 AESIRDGLATW--DNWKHVNCDKLTTII----ESSLNVLEPAEYRKMFDRL--------- 378

Query: 294 TRFPNKSSGAVDLLEKML--VFDPNKRITVEE----------ALRHP--YLQSLHDLNDE 339
           + FP        +   +L  ++    +  V              + P     S+  +   
Sbjct: 379 SVFPPS----AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI--- 431

Query: 340 PVCPRPFHFDFEHSSCTED---HIRELI--WRESVKFNPD 374
                  + +        +   H R ++  +     F+ D
Sbjct: 432 -------YLEL-KVKLENEYALH-RSIVDHYNIPKTFDSD 462

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	377
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.09
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.93
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.93
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.73
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.07
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.94
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.75
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.54
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.24
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.18
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.55

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-66  Score=486.39  Aligned_cols=338  Identities=53%  Similarity=0.944  Sum_probs=291.9

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ...|+++++|. +++.||+|+||+||+|+++.+|+.||||++++..........+.+|+.+|+.++|||||++++++...
T Consensus        47 ~~~~~i~~~Y~-~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  125 (398)
T 4b99_A           47 DVTFDVGDEYE-IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT  125 (398)
T ss_dssp             -CCCCCCSSEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCCCCCCCCeE-EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence            34466777766 99999999999999999999999999999987766666778889999999999999999999998754


Q ss_pred             CC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      .. .....+|||||||+|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus       126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          126 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             SCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence            21 22345999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +.....     ......+||+.|+|||++.+...++.++|||||||++|||++|..||.+.+....+..|....+.++..
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            865332     234567999999999999886678999999999999999999999999999999999999999999887


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  347 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~  347 (377)
                      ............................++.+++++.+||.+||..||++|||+.|+|+||||+...+...++.+..++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~  365 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFD  365 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCC
Confidence            77666666666666666665555555667789999999999999999999999999999999999988888888888888


Q ss_pred             CCcCCCCCChHHHHHHHHHHHhhcC
Q 017083          348 FDFEHSSCTEDHIRELIWRESVKFN  372 (377)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~  372 (377)
                      +++.....+.+++++.+.+|...|+
T Consensus       366 ~~~~~~~~~~~~~k~~i~~ei~~~~  390 (398)
T 4b99_A          366 FAFDREALTRERIKEAIVAEIEDFH  390 (398)
T ss_dssp             CHHHHSCCCHHHHHHHHHHHHHHHH
T ss_pred             CccchhhcCHHHHHHHHHHHHHHHH
Confidence            8888888888999999888877664

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-62  Score=435.31  Aligned_cols=253  Identities=27%  Similarity=0.483  Sum_probs=206.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||+|+++.+|+.||+|++.+.... ......+.+|+.++++++|||||++++++..+..     +|
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-----~~   89 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-----II   89 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-----EE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-----EE
Confidence            34899999999999999999999999999999765332 2334678899999999999999999999988755     99


Q ss_pred             EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccc
Q 017083          123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      +||||++|+|.+.+...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        90 ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           90 MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998877666667


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ..+||+.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.....                    
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------------------  229 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------------------  229 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------------------
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            789999999999998844457899999999999999999999998876666655543111                    


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                 .....+|+++.+||++||+.||++|||+.|+++||||+.
T Consensus       230 -----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 -----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                       112356899999999999999999999999999999973

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.7e-63  Score=444.08  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=223.5

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.++++++|||||+++++|.++..     
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-----  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-----  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-----
Confidence            446699999999999999999999999999999975421 22235678899999999999999999999998755     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +|||||||+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999984 99999999899999999999999999999999999999999999999999999999999999876432 


Q ss_pred             --ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          199 --DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       199 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.+....             
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------------  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD-------------  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------
T ss_pred             CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence              33556799999999999988 78899999999999999999999999988877766666542110             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e------ll~~p~f~~~~  334 (377)
                                        ....+++++.+||++||+.||++|||+.|      +++||||+++.
T Consensus       253 ------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          253 ------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence                              11356899999999999999999999988      58999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.7e-62  Score=442.88  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=217.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.++++|+|||||++++++..+..     +||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-----~yi  100 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS-----LYI  100 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE-----EEE
Confidence            449999999999999999999999999999998776666677889999999999999999999999998755     999


Q ss_pred             EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      |||||+ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999998 5999999754  457899999999999999999999999999999999999999999999999998765442 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....                  
T Consensus       181 ~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------------  241 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS------------------  241 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------------
T ss_pred             cccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------------
Confidence            3456789999999999988 789999999999999999999999999988777666554411                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                  .......+|+++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       242 ------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 ------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                        11123467999999999999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.1e-62  Score=442.08  Aligned_cols=257  Identities=26%  Similarity=0.491  Sum_probs=222.6

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .++|+++++||+|+||+||+|+++.+|+.||||++......  ..+.+.+|+.+|++++|||||+++++|..+..     
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-----  145 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-----  145 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE-----
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-----
Confidence            35677999999999999999999999999999999754322  23567899999999999999999999998755     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +|||||||+| +|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999985 88888765 57999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+..+.......              
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------------  289 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------------  289 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC--------------
T ss_pred             CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence            44567899999999999977 789999999999999999999999999888777666664421111              


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    ...+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       290 --------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 --------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             --------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                          112346799999999999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.1e-61  Score=427.13  Aligned_cols=261  Identities=22%  Similarity=0.369  Sum_probs=217.6

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ..+|+++.++||+|+||+||+|.++.++..||+|++..........+.+.+|+.++++++|||||+++++|..... ...
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCc
Confidence            4566667788999999999999999999999999998766566667889999999999999999999999865311 113


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEcc-CCCeEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~  195 (377)
                      .+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+..
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            3899999998 599999998899999999999999999999999998  999999999999985 789999999999764


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .. ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||........+...  +.....+.        
T Consensus       183 ~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--i~~~~~~~--------  249 (290)
T 3fpq_A          183 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPA--------  249 (290)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCCCG--------
T ss_pred             CC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--HHcCCCCC--------
Confidence            43 33556789999999999865  5899999999999999999999999775544333221  11111110        


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                        ......++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       250 ------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 ------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                              112346888999999999999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-60  Score=443.96  Aligned_cols=257  Identities=26%  Similarity=0.488  Sum_probs=223.1

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .++|+++++||+|+||+||+|+++.+|+.||||++......  ..+.+.+|+.+|++++|||||+++++|..+..     
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-----  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-----  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE-----
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE-----
Confidence            35677999999999999999999999999999999754322  34567899999999999999999999998755     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      +|||||||+| +|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999985 88888765 56999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+..+......               
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------  365 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------  365 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------------
T ss_pred             ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence            44567899999999999987 78999999999999999999999999988877766666442110               


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                   ....+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       366 -------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 -------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             -------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                         1122346799999999999999999999999999999998643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6e-61  Score=430.38  Aligned_cols=256  Identities=25%  Similarity=0.423  Sum_probs=215.0

Q ss_pred             cccCCcccccCCccceEEEEEeC---CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ..|++++.||+|+||+||+|++.   .+++.||+|++++..........+.+|+.++++++|||||++++++..+..   
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK---  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE---
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE---
Confidence            45669999999999999999874   467899999997654333333467789999999999999999999998755   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        +|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       101 --~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          101 --LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             --EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             --EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence              999999998 59999999989999999999999999999999999999999999999999999999999999986543


Q ss_pred             C-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 T-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+...              
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------------  243 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--------------  243 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred             CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------------
Confidence            3 34556789999999999987 7889999999999999999999999999887777666654111              


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                       .....+|+++.+||++||+.||++|||     ++|+++||||+++.
T Consensus       244 -----------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          244 -----------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                             112357999999999999999999998     58999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.7e-60  Score=427.82  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=215.4

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ...++++.++||+|+||+||+|+++.+|+.||||+++.....       .+|+.++++++|||||++++++..+..    
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~----  124 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPW----  124 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTE----
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCE----
Confidence            345666888999999999999999999999999999764322       369999999999999999999988755    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCC
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSE  197 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~  197 (377)
                       +|||||||+ |+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+| ++||+|||+++....
T Consensus       125 -~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          125 -VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             -EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             -EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence             999999998 59999999888999999999999999999999999999999999999999988 699999999986543


Q ss_pred             Cc------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          198 TD------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       198 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ..      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...   +       
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~-------  272 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---P-------  272 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---C-------
T ss_pred             CCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---C-------
Confidence            32      1234579999999999988 78999999999999999999999999876544444333321   0       


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH-------------hcCccccCCcCC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA-------------LRHPYLQSLHDL  336 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el-------------l~~p~f~~~~~~  336 (377)
                                        ......++.+++.+.+||.+||+.||++|||+.|+             |+|||++..++.
T Consensus       273 ------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          273 ------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             ------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             ------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence                              01112345789999999999999999999999998             579999877654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.7e-57  Score=431.51  Aligned_cols=341  Identities=40%  Similarity=0.774  Sum_probs=280.9

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ...|.+.++|. +++.||+|+||+||+++++.+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus        46 ~~~~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           46 HSDWQIPDRYE-IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CSSCCSCTTEE-ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCcCccCCCeE-EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            34567777776 99999999999999999999999999999987766777778899999999999999999999999766


Q ss_pred             CCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          114 KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .......+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             CcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            55455669999999999999999988899999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc----------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-----
Q 017083          194 TTSETD----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----  240 (377)
Q Consensus       194 ~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-----  240 (377)
                      ......                            .....+||++|+|||++.....++.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654221                            23456779999999987655779999999999999999998     


Q ss_pred             ------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc
Q 017083          241 ------REPLFPGKD--------------------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT  294 (377)
Q Consensus       241 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (377)
                            |..+|.+..                    ....+..+.+.++.++..............+..............
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  666676644                    357788888999999888877777777777777777777777777


Q ss_pred             cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCC-CCCChHHHHHHHHHHHhhcCC
Q 017083          295 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       295 ~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      .++..++++.+||++||..||++|||+.|+|+||||+++.....+..+..+..+.+.+ ...+...++..+.+|..++.|
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  444 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHP  444 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCc
Confidence            8889999999999999999999999999999999999998777666666555555544 567888999999999999998


Q ss_pred             CC
Q 017083          374 DP  375 (377)
Q Consensus       374 ~~  375 (377)
                      ..
T Consensus       445 ~~  446 (458)
T 3rp9_A          445 EI  446 (458)
T ss_dssp             TC
T ss_pred             cc
Confidence            64

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-56  Score=425.47  Aligned_cols=341  Identities=38%  Similarity=0.734  Sum_probs=291.5

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.+.+.++|. +++.||+|+||+||+|+++.+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus        20 ~~~~i~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           20 KNVHVPDNYI-IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GGCCCCTTEE-EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CcceecCCEE-EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3567777776 999999999999999999999999999999877667777788999999999999999999999998776


Q ss_pred             CCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          115 KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ...+..+|+||||++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A           99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            55556699999999999999999888899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCc-----------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC----------
Q 017083          195 TSETD-----------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR----------  241 (377)
Q Consensus       195 ~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g----------  241 (377)
                      .....                       ......+|++|+|||++.....++.++|||||||++|+|++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            54332                       235678899999999976657799999999999999999974          


Q ss_pred             -CCCCCCCC-----------------hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhH
Q 017083          242 -EPLFPGKD-----------------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA  303 (377)
Q Consensus       242 -~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (377)
                       ..+|.+..                 ...++..+.+.++.++..............+...............++.+++.+
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence             44444433                 467888899999999988877777778888888777776666677788899999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCC-CCCChHHHHHHHHHHHhhcCCCCC
Q 017083          304 VDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTEDHIRELIWRESVKFNPDPT  376 (377)
Q Consensus       304 ~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
                      .+||++||+.||++|||+.|+|+||||+++.....++.+..++...+.+ ...+...++..+.+|..+|.|..+
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  412 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV  412 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence            9999999999999999999999999999999888887777777776665 457888999999999999998754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-56  Score=414.17  Aligned_cols=339  Identities=45%  Similarity=0.833  Sum_probs=283.3

Q ss_pred             EEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        31 ~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      ......|++.++|. +++.||+|+||+||++.++.+|+.||||++............+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           15 EVTKTAWEVRAVYR-DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             ECSSSEECCBSSEE-EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             EecCceeeecceEE-EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            34456688888777 99999999999999999999999999999977666666677889999999999999999999999


Q ss_pred             cCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          111 RPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       111 ~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      ..... .....+|++|||++++|.+++.. .++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence            87632 22345799999998899999876 67999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       190 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      |++......  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.++....
T Consensus       173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999875543  445678999999999987667899999999999999999999999999999999999999999988877


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD  349 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~  349 (377)
                      ..........++..............++..++.+.+||.+||+.||++|||+.|+|+||||+...+...++.+. ++..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~~~  329 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDS  329 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCCCC
Confidence            77777778888888777777777777788999999999999999999999999999999999998877666654 56777


Q ss_pred             cCCCCCChHHHHHHHHHHHhhcCCC
Q 017083          350 FEHSSCTEDHIRELIWRESVKFNPD  374 (377)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~  374 (377)
                      +.+.....+.++.++.+|.+.|.|.
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~  354 (367)
T 1cm8_A          330 FDDVDRTLDEWKRVTYKEVLSFKPP  354 (367)
T ss_dssp             -----CCHHHHHHHHHHHHHTCCC-
T ss_pred             hhhhcCCHHHHHHHHHHHHHHhccc
Confidence            7777788899999999999998874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7e-56  Score=412.26  Aligned_cols=343  Identities=49%  Similarity=0.884  Sum_probs=280.9

Q ss_pred             EEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEe
Q 017083           28 VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK  107 (377)
Q Consensus        28 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  107 (377)
                      ......+..|++.++|. +++.||+|+||+||++.+..+|+.||||++............+.+|+.+++.++||||++++
T Consensus        16 ~~~~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~   94 (367)
T 2fst_X           16 YRQELNKTIWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   94 (367)
T ss_dssp             EEEEETTEEEEEETTEE-EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             ceEeecCcccCCCCceE-EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            33455667789998887 99999999999999999999999999999987666666778888999999999999999999


Q ss_pred             eeecCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          108 DIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       108 ~~~~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                      +++..... .....+++++|+++++|.+++.. .++++..++.++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X           95 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             EEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEE
Confidence            99876421 22244899999999899888865 67999999999999999999999999999999999999999999999


Q ss_pred             eeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +|||++......  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+..+.+..
T Consensus       174 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          174 LDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             CC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999999765433  345678999999999987677899999999999999999999999999999999999999999988


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCC
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF  346 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~  346 (377)
                      .....+.......+...............++..++.+.+||++||+.||++|||+.|+|+||||+...+...++.++ ++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~  330 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PY  330 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CC
Confidence            87777777777777777766666566666778899999999999999999999999999999999988877666555 67


Q ss_pred             CCCcCCCCCChHHHHHHHHHHHhhcCCCC
Q 017083          347 HFDFEHSSCTEDHIRELIWRESVKFNPDP  375 (377)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (377)
                      .+++.......+.++..+.+|..+|.|.+
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          331 DQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             CGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             CcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            77777777888999999999999998864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-56  Score=406.57  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=210.0

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEe
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK  107 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  107 (377)
                      ......+..+++.+.++||+|+||+||+++++     .++..||||+++..  .....+.+.+|+.+|++++|||||+++
T Consensus        32 ~~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~  109 (329)
T 4aoj_A           32 DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFF  109 (329)
T ss_dssp             -CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            34456777788888999999999999999865     46789999999754  455567899999999999999999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      +++.....     ++||||||+ |+|.+++...               .++++..+..++.||+.||+|||+++|+||||
T Consensus       110 g~~~~~~~-----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDL  184 (329)
T 4aoj_A          110 GVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL  184 (329)
T ss_dssp             EEECSSSS-----EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEECCE-----EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence            99988755     899999998 6999998653               35899999999999999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG  247 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~  247 (377)
                      ||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..
T Consensus       185 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             CGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             cHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999998654332   2345678999999999987 789999999999999999998 8999998


Q ss_pred             CChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       248 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ....+.+..+..-..                              .+....+++++.+|+.+||+.||++|||+.||+++
T Consensus       264 ~~~~~~~~~i~~g~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          264 LSNTEAIDCITQGRE------------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             SCHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCC------------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            877666655543110                              11123578999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-56  Score=398.69  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=212.1

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ...|+|..+.+.+.++||+|+||+||+++++.   .||||+++.........+.+.+|+.++++++|||||++++++..+
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  104 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD  104 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence            34689999999999999999999999998754   599999987666666778899999999999999999999987643


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                       .     ++||||||+ |+|.+++.. ..++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus       105 -~-----~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          105 -N-----LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             -S-----CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             -e-----EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence             2     799999998 699999875 46799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---ccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      |+.....   .......||+.|+|||++.+.  ..++.++|||||||++|||++|..||........+..+.......+ 
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-  257 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-  257 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-
Confidence            9865432   234566899999999998642  4589999999999999999999999988665544433322111111 


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                              ........+++.+.+|+.+||+.||++|||+.|++++
T Consensus       258 ------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          258 ------------------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ------------------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ------------------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                    1122334678999999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-57  Score=406.65  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=198.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC-------
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------  116 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-------  116 (377)
                      |++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.++++++|||||+++++|......       
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            458999999999999999999999999999997542 344556788999999999999999999998754321       


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~---~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ....+|++||||+ |+|.+++.....+   +...++.++.||++||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence            1123789999998 5999999876554   44668899999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          193 RTTSETD-------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       193 ~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                      +......             .....+||+.|+|||++.+ ..++.++|||||||++|||++   ||...  .+....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~  239 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTD  239 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHH
Confidence            8654332             1234579999999999987 789999999999999999995   77542  222333333


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ......                           ++.++..++.+.+||++||+.||++|||+.|+|+||||+++.
T Consensus       240 ~~~~~~---------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          240 VRNLKF---------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHTTCC---------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HhcCCC---------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            222111                           111123466788999999999999999999999999998764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-54  Score=405.57  Aligned_cols=359  Identities=43%  Similarity=0.777  Sum_probs=298.2

Q ss_pred             CCCcccccccccccCceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHH
Q 017083           10 SGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL   89 (377)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~   89 (377)
                      |+|..+.-+......+.+...+.....|++.++|. +.+.||+|+||+||++.++.+|+.||+|++............+.
T Consensus        11 ~~~~~~~~~m~~~~~~g~~~~~~~~~~~~l~~~y~-~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~   89 (371)
T 4exu_A           11 SSGLVPRGSMSLIRKKGFYKQDVNKTAWELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY   89 (371)
T ss_dssp             ----------CCSSCTTEEEEEETTEEEEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHH
T ss_pred             ccCccccCceeeeccccceeeeeccceecccccEE-EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHH
Confidence            34444455666666777777788888899999888 89999999999999999999999999999987666666678888


Q ss_pred             HHHHHHHhcCCCCceeEeeeecCCCCC-CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCcee
Q 017083           90 REIKLLRHMEHENVIAIKDIIRPPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (377)
Q Consensus        90 ~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H  168 (377)
                      +|+.+++.++||||+++++++...... ....++++|||++++|.+.+.  ..+++..++.++.||+.||+|||++||+|
T Consensus        90 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  167 (371)
T 4exu_A           90 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVH  167 (371)
T ss_dssp             HHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            999999999999999999999876541 222359999999999988873  45999999999999999999999999999


Q ss_pred             cCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 017083          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (377)
Q Consensus       169 ~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~  248 (377)
                      |||||+||+++.++.+||+|||++......  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||...
T Consensus       168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          168 RDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             SCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999999865443  345677999999999987677899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 017083          249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  328 (377)
Q Consensus       249 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p  328 (377)
                      .....+..+....+.++..............+...............++.+++.+.+||++||+.||++|||+.|+|+||
T Consensus       246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence            99999999999999888877666666666666666666555555566678899999999999999999999999999999


Q ss_pred             cccCCcCCCCCCCCCCCCCCCcCCCCCChHHHHHHHHHHHhhcCC
Q 017083          329 YLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       329 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      ||+.......+.....++.-.......+.+.++..+.+|.++|.|
T Consensus       326 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          326 FFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             GGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             ccccCCCcccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            999888776666666677767677777889999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.4e-56  Score=411.40  Aligned_cols=283  Identities=28%  Similarity=0.452  Sum_probs=217.0

Q ss_pred             ecccccCCcccccCCccceEEEEEeC---CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  114 (377)
                      +.++| +++++||+|+||+||+|+++   .+++.||+|.+....    ...++.+|+++++.+ +||||++++++|....
T Consensus        19 l~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            44444 49999999999999999875   467899999986542    234577899999998 5999999999998875


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~~  192 (377)
                      .     +|+||||++ |+|.+.+   +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus        94 ~-----~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 H-----VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             E-----EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             E-----EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            4     999999998 5899988   469999999999999999999999999999999999999877 78999999999


Q ss_pred             cccCCCc-----------------------------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 017083          193 RTTSETD-----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (377)
Q Consensus       193 ~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~  243 (377)
                      +......                             .....+||+.|+|||++.+...++.++||||+||++|+|++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            7543221                             12345799999999999885678999999999999999999999


Q ss_pred             CCC-CCChHHHHHHHHHHhCCCCcccc-----------ccccchhHHHHHHhcccc------------ccccccccCCCC
Q 017083          244 LFP-GKDYVHQLRLITELIGSPDDASL-----------GFLRSDNARRYVRQLPRC------------RKQQFATRFPNK  299 (377)
Q Consensus       244 pf~-~~~~~~~~~~i~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~  299 (377)
                      ||. +.+..+++..|....+.+.....           ..................            ........+..+
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            985 45666788888877664321110           001111111111111100            001122345678


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          300 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       300 ~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ++++.+||++||+.||++|||++|+|+||||++++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999999999764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-56  Score=400.11  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=214.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .|..+.+.+.++||+|+||+||++++.     .++..||||+++..  .....+.+.+|+.++++++|||||++++++..
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            566667778999999999999999875     35788999999754  44556789999999999999999999999988


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                      +..     ++||||||+ |+|.+++...             ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        87 ~~~-----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl  161 (299)
T 4asz_A           87 GDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  161 (299)
T ss_dssp             SSS-----EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCE-----EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence            755     899999998 6999999753             368999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017083          179 NASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~  254 (377)
                      +.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+..
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999998654332   2234568999999999988 789999999999999999998 89999988776666


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ..+..-..                              .+....+|+++.+|+.+||+.||++|||+.++  ++|++++.
T Consensus       241 ~~i~~~~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          241 ECITQGRV------------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HHHHcCCC------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            55543110                              11223578999999999999999999999999  56776654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-54  Score=407.46  Aligned_cols=326  Identities=41%  Similarity=0.768  Sum_probs=257.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++.++.+|+.||+|++............+.+|+.+++.+. ||||+++++++.....   ..+|
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~~   87 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---RDVY   87 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---SCEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---CEEE
Confidence            34899999999999999999999999999999877667777788889999999998 9999999999976543   3489


Q ss_pred             EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-----
Q 017083          123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-----  197 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-----  197 (377)
                      +||||++++|...+.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....     
T Consensus        88 lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           88 LVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             EEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            9999999999999876 5799999999999999999999999999999999999999999999999999975432     


Q ss_pred             -----------------CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017083          198 -----------------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL  260 (377)
Q Consensus       198 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~  260 (377)
                                       ........||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  246 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV  246 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                             112344678999999999987677899999999999999999999999999999999999999


Q ss_pred             hCCCCccccccccchhHHHHHHhccccc---ccccc-------------ccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 017083          261 IGSPDDASLGFLRSDNARRYVRQLPRCR---KQQFA-------------TRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  324 (377)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~el  324 (377)
                      .+.+...............+........   .....             ......++.+.+||++||+.||++|||+.|+
T Consensus       247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~  326 (388)
T 3oz6_A          247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA  326 (388)
T ss_dssp             HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence            9888776554444433333333222111   01111             1122678999999999999999999999999


Q ss_pred             hcCccccCCcCCCCCCCCCCCCCCCcCC-CCCChHHHHHHHHHHHhhcCC
Q 017083          325 LRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       325 l~~p~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      |+||||+...+...++.+...+...+.. ...+.+..++.+.+|..++.+
T Consensus       327 l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (388)
T 3oz6_A          327 LKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR  376 (388)
T ss_dssp             TTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred             hCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence            9999999999888888888877777765 345678888888888776654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.5e-54  Score=400.30  Aligned_cols=338  Identities=52%  Similarity=0.943  Sum_probs=285.0

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ++.+.++.+|. +++.||+|+||+||++.+..++..||+|++... ........+.+|+.++++++||||+++++++...
T Consensus        20 g~~~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           20 GQVFDVGPRYT-NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             -CBCCCTTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             cEeccccccEE-EEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            45677777776 999999999999999999999999999999753 2344557788999999999999999999999876


Q ss_pred             CCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          114 KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .......+++++|+++++|.+.+.. +++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             STTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            5444455899999999999998875 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ......    ......||+.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.+.....
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            655332    2345578999999999876566899999999999999999999999999999999999999988887766


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD  349 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~  349 (377)
                      ..........+................+.+++.+.+||.+||+.||++|||+.|+|+||||+.......++....++.++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  336 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD  336 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcc
Confidence            65555555666655555444445555677899999999999999999999999999999999988777777778888888


Q ss_pred             cCCCCCChHHHHHHHHHHHhhcCCC
Q 017083          350 FEHSSCTEDHIRELIWRESVKFNPD  374 (377)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~  374 (377)
                      ........+.+++.+.+|..++.|.
T Consensus       337 ~~~~~~~~~~~~~~~~~e~~~~~~~  361 (364)
T 3qyz_A          337 MELDDLPKEKLKELIFEETARFQPG  361 (364)
T ss_dssp             -----CCHHHHHHHHHHHTGGGCC-
T ss_pred             cccccCCHHHHHHHHHHHHHHhhhh
Confidence            8888888899999999999998874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-54  Score=414.20  Aligned_cols=344  Identities=42%  Similarity=0.766  Sum_probs=261.6

Q ss_pred             ceeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCce
Q 017083           25 GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        25 ~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv  104 (377)
                      +.+.........|.+.++|. +++.||+|+||+||++.+..+++.||||++............+.+|+.+++.++||||+
T Consensus        46 ~~~~~~~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  124 (464)
T 3ttj_A           46 NQFYSVEVGDSTFTVLKRYQ-NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII  124 (464)
T ss_dssp             CCEEEEEC--CEEEEETTEE-EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccceeeecCCcceeecCCeE-EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCC
Confidence            34445555566677777777 99999999999999999999999999999987666666778888999999999999999


Q ss_pred             eEeeeecCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC
Q 017083          105 AIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (377)
Q Consensus       105 ~~~~~~~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~  183 (377)
                      ++++++..... .....+|+||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus       125 ~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~  202 (464)
T 3ttj_A          125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (464)
T ss_dssp             CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred             cEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC
Confidence            99999976543 23355899999999999888753  5899999999999999999999999999999999999999999


Q ss_pred             eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      +||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.+..+.
T Consensus       203 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          203 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             EEECCCCCC-----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999999987776656667889999999999988 78899999999999999999999999999999999999999988


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCC------------CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      +.+....... .....+...............++.            .++.+.+||++||+.||++|||+.|+|+||||+
T Consensus       282 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          282 PCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             CCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             CCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence            8766544332 223333322222111111111111            156799999999999999999999999999999


Q ss_pred             CCcCCCCC-CCCCCCCCCCcCCCCCChHHHHHHHHHHHhhcCC
Q 017083          332 SLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       332 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      ...+.... ...+..+...........+.+++.+.+|..+++.
T Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  403 (464)
T 3ttj_A          361 VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE  403 (464)
T ss_dssp             GGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC---
T ss_pred             hccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence            77654332 2344455566666677788899888888776654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-55  Score=426.99  Aligned_cols=263  Identities=24%  Similarity=0.360  Sum_probs=217.0

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc----CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.-++|++++.||+|+||+||+|+++.+|+.||+|++.+...    ..........++.+++.++|||||+++++|...
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            4455667799999999999999999999999999999965421    111222333456777788999999999999988


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ..     +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus       265 ~~-----lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          265 DK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             SE-----EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CE-----EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence            65     999999998 599999999899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ....... ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.................        
T Consensus       340 ~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------  410 (689)
T 3v5w_A          340 CDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------  410 (689)
T ss_dssp             EECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--------
T ss_pred             eecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--------
Confidence            8765443 4567999999999999754678999999999999999999999997643222211111111111        


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                          ...+..+|+++.+||.+||+.||++|++     +.|+++||||+++.
T Consensus       411 --------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          411 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                                1112467999999999999999999998     89999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.6e-55  Score=425.14  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=226.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||+|+++.+|+.||+|++...  .....+.+.+|+.+|+.++|||||+++++|.....     +|
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-----~~  230 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-----MV  230 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE-----EE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-----EE
Confidence            345899999999999999999999999999999764  34456678899999999999999999999998755     99


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC--CCeEEeeeecccccCCC
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLARTTSET  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~--~~vkl~Dfg~~~~~~~~  198 (377)
                      ++||||+ |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999998 599998864 4679999999999999999999999999999999999999854  78999999999988777


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.......+             
T Consensus       311 ~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------  376 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------------  376 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred             CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC-------------
Confidence            76777899999999999988 7889999999999999999999999999887777766654222111             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                    ...+..+++++.+||++||+.||.+|||+.|+|+||||+....
T Consensus       377 --------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          377 --------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             --------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             --------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence                          2234578999999999999999999999999999999987554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.8e-55  Score=392.79  Aligned_cols=255  Identities=20%  Similarity=0.311  Sum_probs=212.6

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      ..+|....++++++||+|+||+||+|...     .+++.||||+++.... ....+.+.+|+.++++++|||||++++++
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            34667777778999999999999999853     4678899999975432 23456789999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~  173 (377)
                      ..+..     +++|||||+ |+|.+++...                ..+++..+..++.||+.||+|||+++|+||||||
T Consensus        99 ~~~~~-----~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~  173 (308)
T 4gt4_A           99 TKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT  173 (308)
T ss_dssp             CSSSS-----CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EECCE-----EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            88755     899999998 6999999643                3588999999999999999999999999999999


Q ss_pred             CceEEccCCCeEEeeeecccccCCC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017083          174 SNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  249 (377)
Q Consensus       174 ~NIli~~~~~vkl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~  249 (377)
                      +|||+++++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus       174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999865433   23345678999999999987 789999999999999999998 899999887


Q ss_pred             hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          250 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       250 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ..+....+..-.                              ..+....+++.+.+|+.+||+.||++|||+.||+++
T Consensus       253 ~~~~~~~i~~~~------------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          253 NQDVVEMIRNRQ------------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            766555443210                              011224678999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.7e-53  Score=389.74  Aligned_cols=340  Identities=44%  Similarity=0.818  Sum_probs=285.0

Q ss_pred             EEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEee
Q 017083           29 QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD  108 (377)
Q Consensus        29 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  108 (377)
                      ..+.....|++.++|. +.+.||+|+||+||+++++.+|+.||||++............+.+|+.+++.++||||+++++
T Consensus        12 ~~~~~~~~~~l~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   90 (353)
T 3coi_A           12 KQDVNKTAWELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD   90 (353)
T ss_dssp             EEEETTEEEEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             EEeecCcccccCceEE-EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhh
Confidence            3455556788888887 899999999999999999999999999999876666666778889999999999999999999


Q ss_pred             eecCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          109 IIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       109 ~~~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      ++..... .....++++|||++++|.+.+.  .++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus        91 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A           91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             EECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred             eEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence            9987643 1123369999999999888764  459999999999999999999999999999999999999999999999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||++......  .....+++.|+|||++.+...++.++||||||+++|+|++|..||........+..+....+.++..
T Consensus       169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  246 (353)
T ss_dssp             STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred             ecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99999765433  3445779999999998775678999999999999999999999999999999999999888888776


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  347 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~  347 (377)
                      ............+...............++.+++.+.+||.+||+.||++|||+.++++||||+.......+.....++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~  326 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD  326 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCc
Confidence            66665555566666666555555555556778999999999999999999999999999999998887666666666777


Q ss_pred             CCcCCCCCChHHHHHHHHHHHhhcCC
Q 017083          348 FDFEHSSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      ........+.++++..+.+|.++|.|
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          327 DSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             CTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             cchhhccCCHHHHHHHHHHHHHhhcc
Confidence            66677778889999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-53  Score=390.95  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=213.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC-CCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~  107 (377)
                      .+.|+|+.+.+++.+.||+|+||+||+|.+..+     ++.||+|++.... .....+.+.+|+.+|.+++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            456899999999999999999999999987654     3679999997643 33456778899999999975 8999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                      +++.....    .++||||||+ |+|.++++..                ..+++..+..++.||++||+|||+++|+|||
T Consensus       135 g~~~~~~~----~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD  210 (353)
T 4ase_A          135 GACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  210 (353)
T ss_dssp             EEECCTTS----CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEEecCC----EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence            99865432    2799999998 6999999753                3488999999999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~  246 (377)
                      |||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998654332   2345678999999999988 789999999999999999998 999998


Q ss_pred             CCChHHHH-HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          247 GKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       247 ~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      +......+ ..+..-. .                             ......+++++.+|+.+||+.||++|||+.|++
T Consensus       290 ~~~~~~~~~~~i~~g~-~-----------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGT-R-----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             TCCCSHHHHHHHHHTC-C-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHcCC-C-----------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            86543333 2222210 0                             111235689999999999999999999999999


Q ss_pred             cC
Q 017083          326 RH  327 (377)
Q Consensus       326 ~~  327 (377)
                      +|
T Consensus       340 ~~  341 (353)
T 4ase_A          340 EH  341 (353)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-52  Score=381.70  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=226.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++++..+|+.||+|++............+.+|+.+++.++||||+++++++.....     +|+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----~~l   91 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-----LYL   91 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-----EEE
Confidence            338999999999999999999999999999998776666677888899999999999999999999987754     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      ||||++ ++|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence            999997 5999999888899999999999999999999999999999999999999999999999999998776666667


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ..+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+.....                    
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------  231 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--------------------  231 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------------
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence            788999999999998844446899999999999999999999998876666555543111                    


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                 .....+++.+.+||++||+.||.+|||+.|+++||||+...+.
T Consensus       232 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          232 -----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             -----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                       0112468899999999999999999999999999999876643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.5e-52  Score=377.04  Aligned_cols=281  Identities=37%  Similarity=0.695  Sum_probs=227.4

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      +++.||+|+||+||++++. +|+.||+|++............+.+|+.++++++||||+++++++.....     +++||
T Consensus        25 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~~lv~   98 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVF   98 (311)
T ss_dssp             EEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC-----EEEEE
T ss_pred             hhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE-----EEEEE
Confidence            8999999999999999995 58999999997654444455778899999999999999999999987754     89999


Q ss_pred             ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccccc
Q 017083          126 ELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  203 (377)
Q Consensus       126 e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~~~  203 (377)
                      ||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus        99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A           99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            99999999988764 45999999999999999999999999999999999999999999999999999876533 33445


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.+.+..+......  ..+...
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~  256 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL--PLWKQR  256 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS--HHHHSC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc--chhhhc
Confidence            678999999999987567899999999999999999999999998888888888888887765543321111  111110


Q ss_pred             c-cccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          284 L-PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       284 ~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      . ............+.+++++.+||++||+.||++|||+.|+|+||||+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            0 01111112223456789999999999999999999999999999999765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-51  Score=385.35  Aligned_cols=342  Identities=42%  Similarity=0.749  Sum_probs=251.2

Q ss_pred             eeEEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCcee
Q 017083           26 KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA  105 (377)
Q Consensus        26 ~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~  105 (377)
                      .+.+...-...+.+.++|. +++.||+|+||+||++.+..+++.||||++............+.+|+.+++.++||||++
T Consensus        10 ~~~~~~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   88 (371)
T 2xrw_A           10 NFYSVEIGDSTFTVLKRYQ-NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG   88 (371)
T ss_dssp             GEEEEEETTEEEEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cceEeecCCcccchhhhee-EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccc
Confidence            3344444444566666666 999999999999999999999999999999876556666778889999999999999999


Q ss_pred             EeeeecCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCe
Q 017083          106 IKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       106 ~~~~~~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~v  184 (377)
                      +++++..... .....+++||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A           89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             EEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred             eEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCE
Confidence            9999976542 2223589999999999999886  468999999999999999999999999999999999999999999


Q ss_pred             EEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017083          185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      ||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+..+.+
T Consensus       167 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             EECCCCC----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             EEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999987665544556788999999999987 778999999999999999999999999998888777777666655


Q ss_pred             CccccccccchhHHHHHHhccccccccccc-----cCC-------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFAT-----RFP-------NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-------~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .+....... .....+..............     .++       ..+..+.+||++||+.||++|||+.|+|+||||+.
T Consensus       246 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          246 CPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CHHHHTTSC-HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHhh-hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            443322211 11111111111100000000     001       12567999999999999999999999999999987


Q ss_pred             CcCCCC-CCCCCCCCCCCcCCCCCChHHHHHHHHHHHhhcC
Q 017083          333 LHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN  372 (377)
Q Consensus       333 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (377)
                      ..+... ....|..............+.+++.+..+..++|
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 2xrw_A          325 WYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE  365 (371)
T ss_dssp             TCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred             hcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence            655322 2222233333444556677899999999888876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-51  Score=371.07  Aligned_cols=284  Identities=37%  Similarity=0.638  Sum_probs=231.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++.++.+++.||+|++............+.+|+.++++++||||+++++++..+..     +++
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   78 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-----LTL   78 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE-----EEE
Confidence            348999999999999999999999999999998766566666788899999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      ||||+++++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            999999988887765 678999999999999999999999999999999999999999999999999999866533 334


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ....+|+.|+|||++.+...++.++|||||||++|+|++|..| |........+..+....+.+....+........  .
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~  236 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--Y  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--C
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc--c
Confidence            4567899999999998755589999999999999999987776 677777788888888887766554322110000  0


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ................+.++..+.+||++||+.||++|||+.|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            000000001112223446789999999999999999999999999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-50  Score=374.94  Aligned_cols=330  Identities=51%  Similarity=0.903  Sum_probs=264.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +.+.++|. +.+.||+|+||+||++.+..+|+.||||++... ........+.+|+.++++++||||+++++++......
T Consensus         7 ~~i~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            7 YNISSDFQ-LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCSCTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccccceE-EeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            34555555 899999999999999999999999999999643 3444566778999999999999999999998776444


Q ss_pred             CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          117 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      .....+++|||++++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            4456899999999999998876 579999999999999999999999999999999999999999999999999997654


Q ss_pred             CCc-----------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          197 ETD-----------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       197 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      ...           ......|++.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            321           122356799999999987657789999999999999999999999999998888888888887765


Q ss_pred             cc-ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC---
Q 017083          266 DA-SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV---  341 (377)
Q Consensus       266 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~---  341 (377)
                      .. ............+...............++.+++.+.+||++||+.||++|||+.|+++||||+..........   
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~  323 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP  323 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCC
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCC
Confidence            33 23333444455555554444334444456688999999999999999999999999999999998876543322   


Q ss_pred             -CCCCCCCCcCCCCCChHHHHHHHHHHHh
Q 017083          342 -CPRPFHFDFEHSSCTEDHIRELIWRESV  369 (377)
Q Consensus       342 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (377)
                       .+..+.++......+.+.+++++.+|..
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 2b9h_A          324 IPPSFFEFDHYKEALTTKDLKKLIWNEIF  352 (353)
T ss_dssp             CCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred             CCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence             2222334444566778888888888764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=372.69  Aligned_cols=288  Identities=36%  Similarity=0.585  Sum_probs=230.5

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC---HHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKK  115 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~  115 (377)
                      ..|++++.||+|+||+||+++++.+++.||+|++......   ......+.+|+.+++.+   +||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3445899999999999999999999999999998643211   11123444566666655   59999999999987654


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .....++++|||++++|.+++.....  +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  168 (308)
T 3g33_A           89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR  168 (308)
T ss_dssp             SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred             CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence            43345899999999999999987554  9999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....+.++...+....
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (308)
T 3g33_A          169 IYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  247 (308)
T ss_dssp             TSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred             ccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence            7776666677788999999999987 778999999999999999999999999999999999998888877665432211


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ....    ...............+.+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       248 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          248 SLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            1000    01111122222334567899999999999999999999999999999998644

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-51  Score=379.35  Aligned_cols=258  Identities=28%  Similarity=0.451  Sum_probs=222.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .|++++.||+|+||+||+++++.+|+.||+|++.+.....    ...+.+.+|+.++++++||||+++++++.....   
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---   89 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD---   89 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE---
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE---
Confidence            3448999999999999999999999999999997653221    124678899999999999999999999988754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC----CeEEeeeeccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  193 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~~  193 (377)
                        +++||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        90 --~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           90 --VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             --EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             --EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence              899999996 69999998888999999999999999999999999999999999999998877    79999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  238 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------  238 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence            7766655667789999999999977 7789999999999999999999999998876666655543211111        


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                         ...+..+++.+.+||++||..||++|||+.|+|+||||+..
T Consensus       239 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 -------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             -------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                               12234678999999999999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=372.73  Aligned_cols=285  Identities=32%  Similarity=0.635  Sum_probs=225.3

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++++.||+|+||+||++.+..+|+.||+|++............+.+|+.++++++||||+++++++.....     .++|
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv   80 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-----LHLV   80 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----EEEE
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe-----EEEE
Confidence            48999999999999999999999999999997765555566778899999999999999999999987754     8999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cccc
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMT  202 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~~  202 (377)
                      |||+++ +|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999996 66677777788999999999999999999999999999999999999999999999999999865533 3344


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...+++.|+|||++.+...++.++||||||+++|+|++|..||...........+.+..+...+...........   ..
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  237 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY---FS  237 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG---GT
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc---cc
Confidence            567899999999998757789999999999999999999999999998888888888776654322110000000   00


Q ss_pred             hcc---ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          283 QLP---RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       283 ~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      ...   ..........++.++..+.+||++||+.||++|||+.|+++||||+++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            000   0000111122457899999999999999999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-50  Score=375.94  Aligned_cols=327  Identities=38%  Similarity=0.681  Sum_probs=251.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc---------CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      |++++.||+|+||+||++.+.. |..||+|++.....         .......+.+|+.++++++||||+++++++....
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE  102 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred             eEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence            4489999999999999999865 89999999865422         2334577889999999999999999999986544


Q ss_pred             CCCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 KDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ......+++||||++++|.+.+... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.
T Consensus       103 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  182 (362)
T 3pg1_A          103 EPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR  182 (362)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC--
T ss_pred             CCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccc
Confidence            4334568999999999999988754 479999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ............+++.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.+.........
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (362)
T 3pg1_A          183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFS  262 (362)
T ss_dssp             -------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTS
T ss_pred             ccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhcc
Confidence            76665556667889999999998876678999999999999999999999999999999999998888877655433222


Q ss_pred             chhHHHHHHhcc-ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcCC
Q 017083          274 SDNARRYVRQLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH  352 (377)
Q Consensus       274 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~~  352 (377)
                      ......+..... ...........+..++.+.+||.+||+.||++|||+.|+|+||||+++.+....... ..-.+++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~  341 (362)
T 3pg1_A          263 SPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG-LSERFHFDE  341 (362)
T ss_dssp             CHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT-CCCCCCCCT
T ss_pred             chhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc-cccccChhh
Confidence            222222222111 111112223345678999999999999999999999999999999998765432221 122345556


Q ss_pred             CCCChHHHHHHHHHHHhhcC
Q 017083          353 SSCTEDHIRELIWRESVKFN  372 (377)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~  372 (377)
                      +..+...++..+.+|..+|+
T Consensus       342 ~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          342 SVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             TCCCHHHHHHHHHHHHHHHC
T ss_pred             hhhhHHHHHHHHHHHHHHhc
Confidence            67778899999999988876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-51  Score=374.91  Aligned_cols=284  Identities=36%  Similarity=0.652  Sum_probs=220.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++++..+++.||+|++............+.+|+.++++++||||+++++++..+..     +++
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l  110 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-----LHL  110 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE-----EEE
Confidence            338999999999999999999999999999998665444455677899999999999999999999987755     899


Q ss_pred             EEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc-----cCCCeEEeeeecccccCCC
Q 017083          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-----ASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~-----~~~~vkl~Dfg~~~~~~~~  198 (377)
                      ||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++     .++.+||+|||++......
T Consensus       111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            99999999999999988999999999999999999999999999999999999995     4455999999999765433


Q ss_pred             -ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                       .......+++.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.++..........  
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  268 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL--  268 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh--
Confidence             23445577999999999987566899999999999999999999999999998888888888877665543211100  


Q ss_pred             HHHHHhccccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ..+.............. ....+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            00000000000000000 0112688999999999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.3e-51  Score=368.80  Aligned_cols=282  Identities=37%  Similarity=0.657  Sum_probs=223.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++++ .+|+.||+|++............+.+|+.++++++||||+++++++.....     +++
T Consensus         4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   77 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVL   77 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-----EEE
T ss_pred             chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-----EEE
Confidence            34899999999999999999 678999999997654333334667899999999999999999999987754     899


Q ss_pred             EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      +|||++++|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999999999999876 467999999999999999999999999999999999999999999999999999765432 223


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+|+.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.+....+......  ..+.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYD  235 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc--cccc
Confidence            45577999999999977566899999999999999999999999999888888888887776654432211000  0000


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      .................+++.+.+||++||+.||++|||+.|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            0000001111122234679999999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=373.93  Aligned_cols=289  Identities=36%  Similarity=0.665  Sum_probs=230.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++.++.+++.||+|++...... .....+.+|+.++++++||||+++++++.....     +++
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~l   77 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-----LTL   77 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC-----EEE
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE-----EEE
Confidence            34899999999999999999999999999999654211 111234579999999999999999999987755     899


Q ss_pred             EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      ||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           78 VFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             EecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            9999999999988764 45899999999999999999999999999999999999999999999999999765533 233


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....+++.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.+.+..+.......... .
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~  236 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-T  236 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH-H
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc-c
Confidence            455779999999999875678999999999999999999999999999999999999998887766543322211111 1


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE  339 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~  339 (377)
                      ...............+.+++.+.+||.+||+.||++|||+.|+|+||||+++......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence            1112222222334456789999999999999999999999999999999988765433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-50  Score=372.47  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=220.2

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .+.|++++.||+|+||+||+++++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++.....    
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----   79 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR----   79 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE----
Confidence            3456689999999999999999999999999999975421 12234567789999999999999999999988755    


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC-C
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-E  197 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~-~  197 (377)
                       +|+||||++| +|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.... .
T Consensus        80 -~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           80 -LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             -EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             -EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence             8999999985 999999888899999999999999999999999999999999999999999999999999998643 3


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....               
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------  222 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------  222 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------
T ss_pred             CCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            334566789999999999987 7789999999999999999999999988776655554433100               


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                      .....+++++.+||++||+.||++||     ++.|+++||||+.+.
T Consensus       223 ----------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          223 ----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                            01125689999999999999999999     999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-50  Score=368.30  Aligned_cols=287  Identities=34%  Similarity=0.640  Sum_probs=219.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||++.++.+|+.||+|++.... .......+.+|+.++++++||||+++++++.....     ++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~~   79 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENK-----LT   79 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE-----EE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe-----EE
Confidence            4458999999999999999999999999999997543 22233567789999999999999999999987754     89


Q ss_pred             EEEecCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          123 IVYELMDTDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      +||||++++|.+++...      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            99999999999988653      458999999999999999999999999999999999999999999999999998665


Q ss_pred             CC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          197 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       197 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.+++..+......
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            33 23445678999999999987557899999999999999999999999999999888888888877655433211100


Q ss_pred             hHHHHHHhccccccc-----cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          276 NARRYVRQLPRCRKQ-----QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      .  .+..........     ........++..+.+||.+||+.||++|||+.|+|+||||++.....
T Consensus       240 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          240 P--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             T--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             h--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            0  000000000000     01112235788999999999999999999999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-50  Score=374.53  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=224.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++.++.+|+.||+|++............+.+|+.++++++||||+++++++.....     .++
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~~l  105 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-----HYL  105 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-----EEE
Confidence            448999999999999999999999999999998765566667788899999999999999999999988755     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeecccccCCCc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~~~~~~~  199 (377)
                      ||||+.| +|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.......
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999985 9999998888899999999999999999999999999999999999998654   49999999998777665


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......               
T Consensus       186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---------------  249 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY---------------  249 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred             ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence            5566789999999999987 778999999999999999999999998877666555554321111               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  ....+..+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       250 ------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  292 (362)
T 2bdw_A          250 ------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  292 (362)
T ss_dssp             ------------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred             ------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence                        1122346789999999999999999999999999999998643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.2e-50  Score=380.85  Aligned_cols=258  Identities=27%  Similarity=0.438  Sum_probs=222.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++.....     .++
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-----~~l   87 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH-----HYL   87 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE-----EEE
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE-----EEE
Confidence            338999999999999999999999999999998765555566778899999999999999999999988755     899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc---cCCCeEEeeeecccccCCC-
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~---~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      ||||+. |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+||+++   .++.+||+|||++...... 
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            999997 59999999989999999999999999999999999999999999999998   4578999999999766544 


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......              
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------  232 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF--------------  232 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------
T ss_pred             ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------------
Confidence            23456788999999999987 778999999999999999999999998887766666554422111              


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                   ..+.++.+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       233 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          233 -------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             -------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred             -------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence                         1233457799999999999999999999999999999997543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.6e-50  Score=361.43  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=217.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++++.||+|+||+||++.+..+++.||+|++......  ..+.+.+|+.++++++||||+++++++.....     +
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~   92 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-----L   92 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----E
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE-----E
Confidence            3455999999999999999999999999999998654322  24567899999999999999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++||||++ ++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999996 5898888764 6999999999999999999999999999999999999999999999999998765543 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+........              
T Consensus       172 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  236 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------  236 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------------
T ss_pred             ccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence            3445678999999999987 7789999999999999999999999988776665554433211110              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    .....++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus       237 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 --------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             --------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                          11235688899999999999999999999999999998654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.8e-51  Score=374.18  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=214.3

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ++++.||+|+||+||++.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++.....     +++
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----~~l   86 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD-----IVM   86 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-----EEE
Confidence            38999999999999999999999999999986532111 112467799999999999999999999988754     899


Q ss_pred             EEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       124 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      ||||++|+|.+.+...+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999988777666677


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                      .+||+.|+|||++.+....+.++||||||+++|+|++|..||.........                             
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------------------  217 (336)
T 3h4j_B          167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------------------  217 (336)
T ss_dssp             CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------------------
T ss_pred             ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------------------
Confidence            889999999999987444478999999999999999999999764311100                             


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                        .............+++.+.+||++||+.||.+|||+.|+++||||+..
T Consensus       218 --~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          218 --KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             --CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             --HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence              000011111223578999999999999999999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=375.16  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=215.9

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .+.|++++.||+|+||+||+++++.+|+.||+|++++.. ........+..|..+++.+ +||||+++++++.....   
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~---   98 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR---   98 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE---
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE---
Confidence            345558999999999999999999999999999997542 1222345677899999988 69999999999988755   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        +|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        99 --~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A           99 --LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             --EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             --EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence              899999998 59999998888999999999999999999999999999999999999999999999999999986432


Q ss_pred             -CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 -TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                       .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......             
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------  242 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------------  242 (353)
T ss_dssp             ---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred             CCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence             334556789999999999987 77899999999999999999999999998877766666541110             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~ell~~p~f~~~~  334 (377)
                                        ....+++.+.+||++||+.||++||++      .++++||||+.+.
T Consensus       243 ------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          243 ------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             ------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             ------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence                              012468899999999999999999998      8999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-50  Score=367.98  Aligned_cols=259  Identities=24%  Similarity=0.420  Sum_probs=222.4

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.++|. +++.||+|+||+||++.++.+++.||+|.+...   ......+.+|+.+++.++||||+++++++.....   
T Consensus         3 ~~~~y~-~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---   75 (321)
T 1tki_A            3 LYEKYM-IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE---   75 (321)
T ss_dssp             CTTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE---
T ss_pred             hhhceE-eeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE---
Confidence            334444 899999999999999999999999999998753   3345667899999999999999999999987754   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc--CCCeEEeeeecccc
Q 017083          119 NDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~--~~~vkl~Dfg~~~~  194 (377)
                        ++++|||++| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.  ++.+||+|||++..
T Consensus        76 --~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           76 --LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             --EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             --EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence              8999999985 999998764 47999999999999999999999999999999999999987  78999999999988


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......+         
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------  223 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---------  223 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------
T ss_pred             CCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC---------
Confidence            766655666788999999999987 6689999999999999999999999998877766665554221111         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                        ...++.++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                              122356799999999999999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=367.56  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=222.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +|++.+.||+|+||+||++.++.+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.....   
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---   88 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD---   88 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE---
Confidence            3448999999999999999999999999999997643221    135678899999999999999999999987754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC----CeEEeeeeccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  193 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~~  193 (377)
                        +++||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        89 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           89 --VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             --EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             --EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence              899999997 59999998888999999999999999999999999999999999999999887    79999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......+        
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------  237 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--------  237 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC--------
Confidence            7765555566789999999999977 7789999999999999999999999988776666655544221111        


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                         ...+..++..+.+||++||+.||++|||+.|+|+||||+...
T Consensus       238 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 -------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             -------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence                               112346788999999999999999999999999999998543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-49  Score=357.08  Aligned_cols=264  Identities=27%  Similarity=0.464  Sum_probs=228.3

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ++|. +++.||+|+||+||++.++.+++.||+|++............+.+|+.++++++||||+++++++.....     
T Consensus         6 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   79 (284)
T 3kk8_A            6 DNYD-VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-----   79 (284)
T ss_dssp             TTEE-EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-----
T ss_pred             hhhh-hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE-----
Confidence            3444 8999999999999999999999999999998766666667788899999999999999999999987754     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeecccccC
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTS  196 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~~~~~  196 (377)
                      .+++|||+++ +|.+.+.....+++..+..++.||+.||+|||++|++||||||+||+++.++.   +||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            8999999985 89999888888999999999999999999999999999999999999987665   9999999998777


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      .........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......            
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  226 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------------  226 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------------
T ss_pred             cCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC------------
Confidence            6665666788999999999987 778999999999999999999999998877666655554422111            


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND  338 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~  338 (377)
                                     ....+..+++.+.+||.+||+.||++|||+.|+++||||++......
T Consensus       227 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          227 ---------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             ---------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ---------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                           11223467899999999999999999999999999999988765543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.3e-50  Score=375.89  Aligned_cols=297  Identities=33%  Similarity=0.569  Sum_probs=231.6

Q ss_pred             EEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        31 ~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      ...+...+.....|.+++.||+|+||+||++++..++. +|+|++.....      ...+|+.+++.++||||+++++++
T Consensus        29 ~~~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~  101 (394)
T 4e7w_A           29 ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFF  101 (394)
T ss_dssp             EEESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecCCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEE
Confidence            33444444444455599999999999999999987766 88887754321      122699999999999999999998


Q ss_pred             cCCCC-CCCCcEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc-cCCCe
Q 017083          111 RPPKK-DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDL  184 (377)
Q Consensus       111 ~~~~~-~~~~~~~iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~-~~~~v  184 (377)
                      ..... .....+++||||+++++...+.    ....+++..++.++.||+.||+|||++||+||||||+||+++ .++.+
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred             EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcE
Confidence            65432 2223378999999988776554    367899999999999999999999999999999999999999 78999


Q ss_pred             EEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017083          185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      ||+|||++.............+++.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.+..+.+
T Consensus       182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999999877666556677889999999999875678999999999999999999999999999999999999888877


Q ss_pred             CccccccccchhHHHHHHhccccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      ..............   ............. ..+..++++.+||.+||+.||++|||+.|+++||||+.+....
T Consensus       262 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          262 SREQIKTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             CHHHHHHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             CHHHHHhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            65432211100000   0000001111111 1234789999999999999999999999999999999887654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.6e-50  Score=373.40  Aligned_cols=265  Identities=22%  Similarity=0.443  Sum_probs=221.4

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+..+.|++++.||+|+||+||+++++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3455566779999999999999999999999999999986532 112234567899999999999999999999998755


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +|+||||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus        90 -----~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           90 -----MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             -----EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             -----EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence                 899999997 59999999888999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...........||+.|+|||++.+.  ..++.++|||||||++|+|++|..||...........+.......        
T Consensus       165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------  236 (384)
T 4fr4_A          165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------  236 (384)
T ss_dssp             CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------
T ss_pred             ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------
Confidence            7666666778899999999998642  458899999999999999999999997543322222111111110        


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCccccCCc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQSLH  334 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~ell~~p~f~~~~  334 (377)
                                          ......+++.+.+||++||+.||.+||+ +.++++||||+.+.
T Consensus       237 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          237 --------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             --------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence                                1112356899999999999999999998 99999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-50  Score=364.17  Aligned_cols=254  Identities=22%  Similarity=0.408  Sum_probs=219.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|++++.||+|+||+||+++++.+|+.||+|++.+... .....+.+.+|..+++.++||||+++++++.....     
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-----   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-----   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-----
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE-----
Confidence            445589999999999999999999999999999975421 11234567789999999999999999999987754     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...... 
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            899999998 599999998889999999999999999999999999999999999999999999999999999865543 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                       ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....                 
T Consensus       160 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  220 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----------------  220 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------------
T ss_pred             -cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence             345688999999999987 7789999999999999999999999988776666555543110                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                    ...+.+++++.+||++||+.||++||     ++.++++||||+.+.
T Consensus       221 --------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          221 --------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             --------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence                          01135688999999999999999999     999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9e-50  Score=373.24  Aligned_cols=260  Identities=22%  Similarity=0.405  Sum_probs=215.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  115 (377)
                      .+..+.|++++.||+|+||+||+++++.+++.||+|++++.... ......+..|..+++++ +||||+++++++.....
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            45556677999999999999999999999999999999765432 22345577899999887 79999999999988755


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +++||||++| +|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       128 -----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          128 -----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             -----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             -----EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence                 9999999985 9999998888999999999999999999999999999999999999999999999999999986


Q ss_pred             -cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHHHhCCC
Q 017083          195 -TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---------QLRLITELIGSP  264 (377)
Q Consensus       195 -~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~---------~~~~i~~~~~~~  264 (377)
                       ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......         ....+..     
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----  276 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----  276 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-----
T ss_pred             cccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-----
Confidence             333445667789999999999988 788999999999999999999999996532111         1111111     


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  334 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~ell~~p~f~~~~  334 (377)
                                                ........+++++.+||++||+.||++||++      .|+++||||+++.
T Consensus       277 --------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          277 --------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             --------------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             --------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence                                      0011123578999999999999999999985      8999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2e-49  Score=367.26  Aligned_cols=292  Identities=34%  Similarity=0.549  Sum_probs=229.4

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC---CCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DTFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~  119 (377)
                      .|++++.||+|+||+||+++++.+|+.||+|++............+.+|+.+++.++||||+++++++.....   ....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            3448999999999999999999999999999997655444445567799999999999999999999876432   0113


Q ss_pred             cEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC-
Q 017083          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-  197 (377)
Q Consensus       120 ~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~-  197 (377)
                      .+++||||++++|.+.+.. ..++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus        98 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  177 (351)
T 3mi9_A           98 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA  177 (351)
T ss_dssp             EEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCC
T ss_pred             eEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccc
Confidence            4899999999999888865 36799999999999999999999999999999999999999999999999999976542 


Q ss_pred             ----CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          198 ----TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       198 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                          ........+|+.|+|||++.+...++.++|||||||++|+|++|..||...........+....+.++........
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (351)
T 3mi9_A          178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD  257 (351)
T ss_dssp             SSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence                2223456779999999999875678999999999999999999999999999999999999988877665433221


Q ss_pred             chhHHHHHHhccccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          274 SDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ............ ..........  ...++.+.+||.+||+.||++|||+.|+|+||||++...
T Consensus       258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          258 NYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             GCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             cchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            110000000000 0000000000  013678999999999999999999999999999986553

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-49  Score=364.83  Aligned_cols=287  Identities=35%  Similarity=0.590  Sum_probs=227.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH---HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .|++++.||+|+||+||+++++.+|+.||+|++.......   .....+.+|+.+++.++||||+++++++.....    
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----   86 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----   86 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc----
Confidence            3448999999999999999999999999999997542221   112457789999999999999999999987654    


Q ss_pred             cEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          120 DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       120 ~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                       ++++|||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        87 -~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 -ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             -CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             -eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence             8999999999999988764 46899999999999999999999999999999999999999999999999999876443


Q ss_pred             -ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                       .......+|+.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.+....+...+....
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             3344567899999999997756689999999999999999999999999998888888888877765544322111000


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                      .   ..............+..++..+.+||++||+.||++|||+.|+|+||||++.....
T Consensus       246 ~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          246 Y---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             C---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             c---ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            0   00000000011122356789999999999999999999999999999998766543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.2e-50  Score=368.78  Aligned_cols=287  Identities=33%  Similarity=0.587  Sum_probs=224.7

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++++.||+|+||+||++++..+|+.||+|++............+.+|+.++++++||||+++++++.....     +
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~   99 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-----W   99 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----E
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE-----E
Confidence            34448999999999999999999999999999997765566666778899999999999999999999987754     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++||||+++ +|..++.....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999997 45555566778999999999999999999999999999999999999999999999999999765443 3


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||++.+...++.++||||||+++|+|++|..||...........+....+...+.............
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            34456789999999999875578999999999999999999999999999888888887776655433211000000000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      -...-...........++.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            000000001111222345789999999999999999999999999999999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-49  Score=364.15  Aligned_cols=258  Identities=22%  Similarity=0.403  Sum_probs=216.0

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  117 (377)
                      ..+.|++++.||+|+||+||+++++.+++.||+|++.+... .......+.+|..+++++ +||||+++++++.....  
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~--   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR--   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE--
Confidence            34456689999999999999999999999999999976543 344566778999999988 79999999999988754  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....
T Consensus        85 ---~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           85 ---LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             ---EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence               899999997 5999999888899999999999999999999999999999999999999999999999999998633


Q ss_pred             -CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCc
Q 017083          197 -ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---------HQLRLITELIGSPDD  266 (377)
Q Consensus       197 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~---------~~~~~i~~~~~~~~~  266 (377)
                       ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......         .....+..       
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-------  233 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------  233 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-------
T ss_pred             CCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-------
Confidence             3334566789999999999987 77899999999999999999999999653211         11111111       


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  334 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~ell~~p~f~~~~  334 (377)
                                      .     .   ......++..+.+||++||+.||++||++      .++++||||+++.
T Consensus       234 ----------------~-----~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          234 ----------------K-----Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             ----------------C-----C---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             ----------------C-----C---CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                            0     0   01123578999999999999999999995      8999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.9e-50  Score=367.59  Aligned_cols=259  Identities=26%  Similarity=0.392  Sum_probs=219.1

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  116 (377)
                      +..+.|++++.||+|+||+||+++++.+|+.||+|++++... .......+..|..++..+ +||||+++++++..... 
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~-   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE-
Confidence            344556689999999999999999999999999999975421 112245567888899877 89999999999988755 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...
T Consensus        93 ----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 ----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             ----EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence                999999997 599999988889999999999999999999999999999999999999999999999999999764


Q ss_pred             CC-CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          196 SE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       196 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....            
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------  235 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------  235 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred             ccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            32 234556789999999999987 7789999999999999999999999998877666655543110            


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-ell~~p~f~~~~  334 (377)
                                         .....+++.+.+||++||+.||++||++. ++++||||+.+.
T Consensus       236 -------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          236 -------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                               00124689999999999999999999998 999999998774

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=367.76  Aligned_cols=259  Identities=30%  Similarity=0.466  Sum_probs=201.5

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .-.+.|++.+.||+|+||+||+++++.+++.||+|++....    ..+.+.+|+.++++++||||+++++++.....   
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE---  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe---
Confidence            33445558999999999999999999999999999997542    34567789999999999999999999987754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeeecccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg~~~~  194 (377)
                        ++++|||++ ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++..
T Consensus       123 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 --ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             --EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             --EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence              899999997 599999988888999999999999999999999999999999999999975   88899999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ...........|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+...             
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~-------------  266 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-------------  266 (349)
T ss_dssp             ------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-------------
T ss_pred             cCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-------------
Confidence            665555566788999999999987 678999999999999999999999997755443 22222211             


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    ......+.+..++..+.+||++||+.||++|||+.++|+||||+...
T Consensus       267 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          267 --------------EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             --------------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             --------------CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                          01111223456799999999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-49  Score=367.10  Aligned_cols=261  Identities=21%  Similarity=0.350  Sum_probs=219.6

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  114 (377)
                      -.+....|++++.||+|+||+||+++++.+++.||+|++.+... .......+..|..++..+ +||+|+++++++....
T Consensus        15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            34455666799999999999999999999999999999975421 112345677899999888 6999999999998875


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .     +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.
T Consensus        95 ~-----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           95 R-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             E-----EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             E-----EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            4     899999997 5999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccC-CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....          
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------  238 (353)
T 2i0e_A          170 ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------  238 (353)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred             ccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence            643 2334556789999999999987 7789999999999999999999999998877666655544110          


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                           .....+++++.+||++||+.||.+||     ++.++++||||+.+.
T Consensus       239 ---------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          239 ---------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence                                 01135689999999999999999999     579999999998764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.5e-50  Score=361.17  Aligned_cols=265  Identities=19%  Similarity=0.235  Sum_probs=188.1

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      ++.+.++||+|+||+||++++  +|+.||||++....   ........|+..+.+++|||||++++++..+... ...+|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~-~~~~~   77 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WTQLW   77 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC-ceEEE
Confidence            344889999999999999987  57899999996531   1222334566667788999999999998765321 13489


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      |||||++ |+|.+++.. .++++..+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||+++
T Consensus        78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999998 699999875 5689999999999999999999987        99999999999999999999999999997


Q ss_pred             ccCCCc-----cccccccccccCCCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          194 TTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       194 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      ......     ......||+.|+|||++.+..     .++.++|||||||++|||++|..||........          
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~----------  226 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----------  226 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC----------
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc----------
Confidence            654332     223457999999999997521     356799999999999999999877643221000          


Q ss_pred             CCcccccccc-chhHHHHHHhcc-ccccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          264 PDDASLGFLR-SDNARRYVRQLP-RCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       264 ~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                         +...... ..........+. .......+..+.  ..+..+.+|+.+||+.||++|||+.||++.
T Consensus       227 ---p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          227 ---PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ---TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ---cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               0000000 000111111110 000111111111  123568899999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-49  Score=364.92  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=219.8

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .+.|++++.||+|+||+||+++++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.....    
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----  115 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN----  115 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE----
Confidence            3455589999999999999999999999999999965321 11234567889999999999999999999988754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                       +|+||||++ ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++......
T Consensus       116 -~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          116 -LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             -EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             -EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence             899999997 599999988888999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....                
T Consensus       195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------  255 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------------  255 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence              345688999999999987 7789999999999999999999999998876666555543110                


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                     .....+++.+.+||++||+.||.+||+     +.++++||||+.+.
T Consensus       256 ---------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          256 ---------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence                           011356899999999999999999998     99999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-49  Score=370.17  Aligned_cols=291  Identities=18%  Similarity=0.220  Sum_probs=215.6

Q ss_pred             cccCCcccccCC--ccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           42 KYVPPIRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        42 ~~~~~~~~lg~G--~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ..|++++.||+|  +||+||+++++.+|+.||+|++............+.+|+.+++.++||||+++++++.....    
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  100 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE----  100 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE----
Confidence            344489999999  99999999999999999999998776666667788899999999999999999999987754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          120 DVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                       +++||||++ ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus       101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          101 -LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             -EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence             899999998 5999998765  679999999999999999999999999999999999999999999999999875432


Q ss_pred             CC--------ccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCc
Q 017083          197 ET--------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-PDD  266 (377)
Q Consensus       197 ~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~  266 (377)
                      ..        .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||...........+...... ..+
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            11        223345778999999999763 46899999999999999999999999876654443322211000 000


Q ss_pred             cc---cc--------cccchhHHHHHH---hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          267 AS---LG--------FLRSDNARRYVR---QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       267 ~~---~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      ..   ..        ............   ................+++.+.+||++||+.||++|||+.|+|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence            00   00        000000000000   00000011111233467899999999999999999999999999999998


Q ss_pred             CcCCC
Q 017083          333 LHDLN  337 (377)
Q Consensus       333 ~~~~~  337 (377)
                      +....
T Consensus       340 ~~~~~  344 (389)
T 3gni_B          340 IKRRA  344 (389)
T ss_dssp             C---C
T ss_pred             Hhhcc
Confidence            87543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-49  Score=365.71  Aligned_cols=258  Identities=28%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||+++++.+++.||+|++......   ...+.+|+.+++.++||||+++++++.....     ++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----~~   92 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-----LA   92 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-----EE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE-----EE
Confidence            344899999999999999999999999999999754322   2457789999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC--eEEeeeecccccCCCc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETD  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~--vkl~Dfg~~~~~~~~~  199 (377)
                      +||||++ ++|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999997 599999988889999999999999999999999999999999999999987765  9999999998655544


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCccccccccchhHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR-LITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..||.......... .+........             
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------  239 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------------  239 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------------
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------------
Confidence            45667889999999999873333455999999999999999999997754321111 1111111110             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                   ..+....+++.+.+||++||+.||++|||+.|+++||||+...
T Consensus       240 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          240 -------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             -------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             -------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence                         0111235789999999999999999999999999999996543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-49  Score=367.86  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=219.8

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +|++++.||+|+||+||+|.++.+|+.||+|++...  .......+.+|+.++++++||||+++++++.....     ++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~~  124 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-----MV  124 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-----EE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE-----EE
Confidence            455899999999999999999999999999999754  23345578899999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc--CCCeEEeeeecccccCCC
Q 017083          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSET  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~--~~~vkl~Dfg~~~~~~~~  198 (377)
                      +||||++ ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.  ++.+||+|||++......
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999997 5999988764 47999999999999999999999999999999999999974  467999999999877666


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......               
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---------------  268 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------------  268 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred             cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence            55566688999999999987 77899999999999999999999999987766655555432111               


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  .....+..+++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus       269 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          269 ------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                        11223456799999999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-49  Score=382.30  Aligned_cols=261  Identities=31%  Similarity=0.528  Sum_probs=219.2

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +..+|. +++.||+|+||+||+|+++.++..||+|++.+..........+.+|+.+++.++||||+++++++.....   
T Consensus        35 ~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---  110 (494)
T 3lij_A           35 LSEMYQ-RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN---  110 (494)
T ss_dssp             HHHHEE-EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE---
T ss_pred             hhcCeE-EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE---
Confidence            333444 8999999999999999999999999999997654333345678899999999999999999999988754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC---CCeEEeeeecccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~---~~vkl~Dfg~~~~  194 (377)
                        +++||||++ |+|.+.+....++++..++.++.||+.||+|||++||+||||||+||+++..   +.+||+|||++..
T Consensus       111 --~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          111 --YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             --EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             --EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence              899999998 4999999888899999999999999999999999999999999999999764   4499999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+.......          
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------  256 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF----------  256 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----------
T ss_pred             CCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            776666667789999999999864  68999999999999999999999999888776666555422111          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                       ..+.+..+++.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       257 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          257 -----------------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             -----------------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             -----------------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                             1233457799999999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-49  Score=362.53  Aligned_cols=258  Identities=29%  Similarity=0.420  Sum_probs=210.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+++++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.....     .++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----~~l   82 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-----QYL   82 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-----EEE
Confidence            3389999999999999999999999999999865422 1233567799999999999999999999988754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---c
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---D  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---~  199 (377)
                      +|||+++ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......   .
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999975 99999988888999999999999999999999999999999999999999999999999999754322   2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..||..............  .                 
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~-----------------  223 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--E-----------------  223 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--T-----------------
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--c-----------------
Confidence            234567899999999998744457899999999999999999999977553321111111  0                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                               .......+..+++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus       224 ---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          224 ---------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ---------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ---------ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                     00111123457899999999999999999999999999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-49  Score=372.76  Aligned_cols=287  Identities=31%  Similarity=0.625  Sum_probs=226.5

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC----
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK----  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  115 (377)
                      ..+.|++++.||+|+||+||+|++..+|+.||+|++......      ..+|+.+++.++||||+++++++.....    
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            334455899999999999999999999999999998654211      2369999999999999999999854322    


Q ss_pred             -----------------------------CCCCcEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHh
Q 017083          116 -----------------------------DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVH  162 (377)
Q Consensus       116 -----------------------------~~~~~~~iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH  162 (377)
                                                   .....+++||||++++|.+.+.    .+..+++..++.++.||+.||+|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                         1223478999999998777664    4678999999999999999999999


Q ss_pred             cCCceecCCCCCceEEc-cCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC
Q 017083          163 SASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  241 (377)
Q Consensus       163 ~~~i~H~dik~~NIli~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g  241 (377)
                      ++||+||||||+||+++ .++.+||+|||++.............+++.|+|||++.+...++.++|||||||++|+|++|
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence            99999999999999998 68899999999998776666666778899999999998756689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCC
Q 017083          242 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRIT  320 (377)
Q Consensus       242 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps  320 (377)
                      ..||.+....+.+..+....+.+..............   ............. .....++.+.+||.+||+.||++|||
T Consensus       239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999999999999988887765432111100000   0000000000001 12347889999999999999999999


Q ss_pred             HHHHhcCccccCCcC
Q 017083          321 VEEALRHPYLQSLHD  335 (377)
Q Consensus       321 ~~ell~~p~f~~~~~  335 (377)
                      +.|+|+||||+.+.+
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=356.90  Aligned_cols=255  Identities=26%  Similarity=0.474  Sum_probs=205.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH------------------------HHHHHHHHHHHHHHhcC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------------------------IDARRTLREIKLLRHME   99 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~   99 (377)
                      |++.+.||+|+||+||++++..+++.||+|++.......                        ...+.+.+|+.++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            338899999999999999999999999999996542111                        12356789999999999


Q ss_pred             CCCceeEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       100 h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                      ||||+++++++.....   ..++++|||+++ +|.++ ....++++..++.++.||+.||+|||++||+|+||||+||++
T Consensus        95 h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             CTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCS-SCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999986432   348999999985 66654 345689999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCC-ccccccccccccCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 017083          179 NASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~  255 (377)
                      +.++.+||+|||++...... .......||+.|+|||.+.+...  .+.++||||||+++|+|++|..||..........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            99999999999999865543 23345678999999999976332  4778999999999999999999998876554443


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      .+.....                             ..+..+.+++.+.+||.+||+.||++|||+.|+++||||+
T Consensus       251 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          251 KIKSQAL-----------------------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHCCC-----------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHhcccC-----------------------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            3322100                             0111246789999999999999999999999999999996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=358.80  Aligned_cols=252  Identities=25%  Similarity=0.311  Sum_probs=206.8

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|+++++||+|+||+||+++++.+|+.||||++...............|+..+.++ +||||+++++++.....     
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~-----  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-----  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE-----
Confidence            345588999999999999999999999999999877655555666666677666666 89999999999987754     


Q ss_pred             EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++++|||++++|.+.+.. ..++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            899999999999998875 4569999999999999999999999999999999999999999999999999998776665


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|..|+.......   .+   .....              
T Consensus       212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~---~~~~~--------------  269 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QL---RQGYL--------------  269 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HH---TTTCC--------------
T ss_pred             CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH---hccCC--------------
Confidence            5666778999999999875  68999999999999999999977665432111   11   11000              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                  .......+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus       270 ------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                        01112357899999999999999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.3e-49  Score=359.40  Aligned_cols=259  Identities=28%  Similarity=0.457  Sum_probs=221.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .|++.+.||+|+||+||+++++.+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.....   
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   89 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD---   89 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE---
Confidence            3448999999999999999999999999999997643221    135678899999999999999999999987754   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC----CeEEeeeeccc
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  193 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~~  193 (377)
                        ++++|||++ ++|.+++.....+++..++.++.||+.||+|||++||+|+||||+||+++.++    .++|+|||++.
T Consensus        90 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           90 --VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             --EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             --EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence              899999997 59999998888899999999999999999999999999999999999999888    79999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ............+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......+        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------  238 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------  238 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC--------
Confidence            7766555566778999999999977 7789999999999999999999999988776665555443211111        


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                         ...+..++..+.+||++||+.||++|||+.|+++||||+...
T Consensus       239 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          239 -------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                               111246788999999999999999999999999999998654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.7e-49  Score=365.36  Aligned_cols=278  Identities=26%  Similarity=0.426  Sum_probs=221.2

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-----CCCceeEeeeecCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~  117 (377)
                      .|+++++||+|+||+||++++..+++.||+|++...   .........|+.+++.++     ||||+++++++.....  
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~--  110 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH--  110 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE--
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe--
Confidence            344899999999999999999999999999999642   344556778999999996     9999999999987754  


Q ss_pred             CCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---------------
Q 017083          118 FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---------------  180 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---------------  180 (377)
                         +++||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.               
T Consensus       111 ---~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          111 ---MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             ---EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             ---eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence               89999999889999998654  5999999999999999999999999999999999999975               


Q ss_pred             ----------CCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 017083          181 ----------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (377)
Q Consensus       181 ----------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~  250 (377)
                                ++.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                      788999999999865443  345678999999999987 7789999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCCccccccccchhHHHHHHhcccc--c-------------cccccccCCCCChhHHHHHHHhcCCCC
Q 017083          251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC--R-------------KQQFATRFPNKSSGAVDLLEKMLVFDP  315 (377)
Q Consensus       251 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~li~~~L~~dp  315 (377)
                      ......+.......+..............+.......  .             ...........++.+.+||.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            8888888888776664332111000000000000000  0             000000001235778899999999999


Q ss_pred             CCCCCHHHHhcCcccc
Q 017083          316 NKRITVEEALRHPYLQ  331 (377)
Q Consensus       316 ~~Rps~~ell~~p~f~  331 (377)
                      ++|||+.|+|+||||+
T Consensus       345 ~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          345 TLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGSCCHHHHTTSGGGC
T ss_pred             hhCCCHHHHhcCcccC
Confidence            9999999999999996

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-48  Score=358.76  Aligned_cols=259  Identities=25%  Similarity=0.449  Sum_probs=210.3

Q ss_pred             ecccccCCcccccCCccceEEEEEeC---CCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +..+.|++++.||+|+||+||++++.   .+++.||+|++.+...  .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            44455668999999999999999985   6889999999976532  223345677899999999999999999999887


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ..     +|+||||++ ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           94 GK-----LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SC-----EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CE-----EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            55     899999998 599999988888999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          193 RTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       193 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....         
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------  238 (327)
T 3a62_A          169 KESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL---------  238 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------
T ss_pred             cccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            754322 33445678999999999987 7789999999999999999999999998876666555543111         


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                            ...+.+++.+.+||.+||+.||++||     ++.|+++||||+.+.
T Consensus       239 ----------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          239 ----------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                                  11135688999999999999999999     899999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-48  Score=366.28  Aligned_cols=286  Identities=30%  Similarity=0.588  Sum_probs=225.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-CCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  121 (377)
                      .|++++.||+|+||+||+++++.+|+.||||++.....      ...+|+.+++.++||||+++++++..... .....+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            45589999999999999999999999999999865321      12369999999999999999998854322 112336


Q ss_pred             EEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeecccccC
Q 017083          122 YIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS  196 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~~~~~~  196 (377)
                      ++||||+++++.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            7999999998877664    35789999999999999999999999999999999999999965 568999999998766


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      .........+|+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.+..+.+....+.......
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            55555667889999999999875678999999999999999999999999999888888888887776543321100000


Q ss_pred             HHHHHHhccccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          277 ARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                       ..+  ............ ..+.+++++.+||++||..||.+|||+.|+++||||+.+....
T Consensus       289 -~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          289 -TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             -CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             -hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence             000  000000000000 1235688999999999999999999999999999999887554

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.6e-49  Score=354.35  Aligned_cols=264  Identities=26%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +++..+.|++++.||+|+||+||++.+..+|+.||+|++............+.++...++.++||||+++++++..... 
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~-   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS-
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC-
Confidence            4566677779999999999999999999999999999997654444444445566666888899999999999987755 


Q ss_pred             CCCcEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeec
Q 017083          117 TFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                          .+++|||++++|.+++.    ....+++..++.++.||+.||+|||++ |++|+||||+||+++.++.+||+|||+
T Consensus        81 ----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           81 ----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             ----EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             ----EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence                89999999998877765    367899999999999999999999998 999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccCCCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDA  267 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  267 (377)
                      +.............+++.|+|||.+.   ....++.++||||||+++|+|++|..||...... ........  ...+  
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--  232 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPSP--  232 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--SCCC--
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--cCCC--
Confidence            98776655555567899999999972   3367889999999999999999999999763322 22222211  0000  


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                               ......+++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus       233 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          233 -------------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             -------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                     011235688999999999999999999999999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-49  Score=380.55  Aligned_cols=260  Identities=32%  Similarity=0.559  Sum_probs=220.5

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .++|. +++.||+|+||+||+|.++.+++.||+|++............+.+|+.++++++||||+++++++.....    
T Consensus        21 ~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----   95 (486)
T 3mwu_A           21 AERYN-IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS----   95 (486)
T ss_dssp             HHHEE-EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----
T ss_pred             hcceE-EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE----
Confidence            33444 8999999999999999999999999999996543333345678899999999999999999999988754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc---cCCCeEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~---~~~~vkl~Dfg~~~~~  195 (377)
                       +++||||+. ++|.+.+...+++++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        96 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           96 -FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             -EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence             899999997 59999998888999999999999999999999999999999999999995   4567999999999877


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........||+.|+|||++.+  .++.++|||||||++|+|++|..||........+..+.......           
T Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------  241 (486)
T 3mwu_A          175 QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF-----------  241 (486)
T ss_dssp             CCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----------
T ss_pred             CCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence            66655667789999999999875  58999999999999999999999999888776666554421111           


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                      ..+.+..+++.+.+||++||+.||++|||+.++|+||||+...
T Consensus       242 ----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          242 ----------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ----------------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ----------------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                            1223456799999999999999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.6e-49  Score=377.90  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=212.6

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+....|++++.||+|+||+||++.++.+|+.||+|++.... ........+.+|+.+++.++||||+++++++..... 
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-  222 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-  222 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE-
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE-
Confidence            344455668999999999999999999999999999997542 122344567789999999999999999999987754 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          +++||||+++ +|.+.+...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       223 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          223 ----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ----EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             ----EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence                8999999985 999999888899999999999999999999998 9999999999999999999999999999976


Q ss_pred             cCC-CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          195 TSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       195 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      ... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....           
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------  366 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----------  366 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred             ccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            332 334556789999999999987 7889999999999999999999999988877666555543110           


Q ss_pred             chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                          .....+++.+.+||.+||+.||.+||     ++.|+++||||+++.
T Consensus       367 --------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          367 --------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             --------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                                01135689999999999999999999     999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-48  Score=356.45  Aligned_cols=290  Identities=36%  Similarity=0.580  Sum_probs=229.4

Q ss_pred             cccCCcccccCCccceEEEEEeC-CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.|++++.||+|+||+||++++. .+|+.||+|++............+.+|+.+++.+   +||||+++++++.......
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            34448999999999999999995 6789999999875433222223445666666665   8999999999987332222


Q ss_pred             CCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ...++++|||++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A           91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            2458999999999999998764  34899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....+.+....+......
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (326)
T 1blx_A          171 SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  249 (326)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence            65555556778999999999987 67899999999999999999999999999988888888887776655432211100


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ..    ...............+.++..+.+||.+||..||++|||+.|+++||||+.+...
T Consensus       250 ~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          250 PR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             CG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            00    0011111122233345789999999999999999999999999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-49  Score=366.86  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=211.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc---cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .|++.+.||+|+||+||++.++.+|+.||+|++....   ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----  100 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM----  100 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE----
Confidence            3448999999999999999999999999999986431   111134678899999999999999999999987754    


Q ss_pred             cEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeec
Q 017083          120 DVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGL  191 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~  191 (377)
                       +|+||||++ ++|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||+
T Consensus       101 -~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          101 -LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             -EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             -EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence             899999998 588877753    335899999999999999999999999999999999999987655   99999999


Q ss_pred             ccccCCCc-cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          192 ARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       192 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      +....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ......+.....        
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~--------  249 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY--------  249 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCC--------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCC--------
Confidence            98765543 2445678999999999987 678999999999999999999999998753 222222221100        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                         ......+..++..+.+||++||+.||++|||+.++|+||||+...
T Consensus       250 -------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          250 -------------------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------------------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                               011122346799999999999999999999999999999998644

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.8e-49  Score=380.12  Aligned_cols=263  Identities=29%  Similarity=0.477  Sum_probs=221.6

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH-----------HHHHHHHHHHHHHHhcCCCCceeE
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-----------IDARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      .+.++|. ++++||+|+||+||+|.++.++..||+|++.......           ...+.+.+|+.++++++||||+++
T Consensus        33 ~i~~~Y~-~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           33 KIGESYF-KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             CGGGTEE-EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcccceE-EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3455555 8999999999999999999999999999997643221           224567899999999999999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---  182 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---  182 (377)
                      ++++.....     +++||||++ ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++   
T Consensus       112 ~~~~~~~~~-----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEECSSE-----EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEcCCE-----EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            999988755     899999997 49999998888999999999999999999999999999999999999999876   


Q ss_pred             CeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017083          183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG  262 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~  262 (377)
                      .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||........+..+.....
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  264 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY  264 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            699999999987776655667789999999999864  689999999999999999999999999887776666654211


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ..                           ....+..+++.+.+||++||+.||.+|||+.|+|+||||+....
T Consensus       265 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          265 YF---------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CC---------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CC---------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            11                           11223567999999999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=366.23  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=212.7

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      .+.||+|+||+||++.+..+|+.||+|++...  .....+.+.+|+.++++++||||+++++++.....     +++|||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----~~lv~E  166 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVME  166 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----EEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-----EEEEEe
Confidence            56799999999999999999999999999764  33456778899999999999999999999988754     899999


Q ss_pred             cCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE--ccCCCeEEeeeecccccCCCcccc
Q 017083          127 LMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMT  202 (377)
Q Consensus       127 ~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli--~~~~~vkl~Dfg~~~~~~~~~~~~  202 (377)
                      |++ ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||++  +.++.+||+|||++..........
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence            997 588888765 3569999999999999999999999999999999999999  556789999999998776665566


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+.......                  
T Consensus       247 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~------------------  307 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL------------------  307 (373)
T ss_dssp             CCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS------------------
T ss_pred             cccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------------
Confidence            6779999999999876 778999999999999999999999999887776665554421111                  


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                               ....+..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       308 ---------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          308 ---------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ---------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ---------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                     1223456799999999999999999999999999999998654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-49  Score=371.28  Aligned_cols=264  Identities=25%  Similarity=0.332  Sum_probs=219.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+..+.|++++.||+|+||+||+++++.+++.||+|++.+... .......+.+|..+++.++||||+++++++..... 
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-  143 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY-  143 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE-
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-
Confidence            3445566799999999999999999999999999999865211 11112346789999999999999999999998755 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          +|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus       144 ----~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          144 ----LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             ----EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ----EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence                899999997 599988865 57999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCc--cccccccccccCCCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          196 SETD--FMTEYVVTRWYRAPELLLNCT---EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       196 ~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ....  .....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||...+.......+.......      
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------  292 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------  292 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------
Confidence            5443  234678999999999997632   27789999999999999999999999888777666664421100      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                           ..+....+++.+.+||++||+.+|.+  ||++.|+++||||+++.
T Consensus       293 ---------------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          293 ---------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             ---------------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             ---------------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence                                 01122467999999999999999988  99999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.9e-49  Score=365.26  Aligned_cols=258  Identities=22%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHH-HHhcCCCCceeEeeeecCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ....|++++.||+|+||+||+++++.+++.||+|++.+... .......+..|..+ ++.++||||+++++++.....  
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~--  113 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK--  113 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE--
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE--
Confidence            34556699999999999999999999999999999976532 22334455667666 467899999999999988754  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +|+||||++| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus       114 ---~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          114 ---LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             ---EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             ---EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence               9999999985 999999888899999999999999999999999999999999999999999999999999998633


Q ss_pred             -CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          197 -ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       197 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                       ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....              
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------  255 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------------  255 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------------
T ss_pred             cCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------
Confidence             3334566789999999999987 778999999999999999999999999887666665554310              


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  334 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~ell~~p~f~~~~  334 (377)
                                       ....+.++..+.+||++||+.||.+||++    .++++||||+.+.
T Consensus       256 -----------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          256 -----------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             -----------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             -----------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence                             01123578999999999999999999986    6999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-48  Score=350.65  Aligned_cols=257  Identities=29%  Similarity=0.453  Sum_probs=208.3

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.++|. +.+.||+|+||+||++.++.++..+|+|++...... ...+.+.+|+.++++++||||+++++++.....   
T Consensus        20 i~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---   94 (285)
T 3is5_A           20 IDDLFI-FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN---   94 (285)
T ss_dssp             HHHHEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE---
T ss_pred             hhhhee-ecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe---
Confidence            334444 899999999999999999999999999999765322 235678899999999999999999999987654   


Q ss_pred             CcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeee
Q 017083          119 NDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFG  190 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg  190 (377)
                        .++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++||+|+||||+||++   +.++.+||+|||
T Consensus        95 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 --MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             --EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             --EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence              8999999985 89888753    4789999999999999999999999999999999999999   456789999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++.............+++.|+|||.+.  ..++.++||||||+++|+|++|..||...........+......       
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------  243 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-------  243 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             cceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc-------
Confidence            998766665566678899999999985  46789999999999999999999999887755544333221100       


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                           .......+++.+.+||++||+.||++|||+.|+|+||||++
T Consensus       244 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 ---------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                 11112346889999999999999999999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-49  Score=374.67  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=218.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |.+++.||+|+||+||++++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.....     ++
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----~~   92 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD-----IF   92 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----EE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-----EE
Confidence            44899999999999999999999999999999653211 1124567899999999999999999999988754     89


Q ss_pred             EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccc
Q 017083          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~  201 (377)
                      +||||++ ++|.+++...+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            9999996 599999988889999999999999999999999999999999999999999999999999999887666666


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ...+|++.|+|||++.+....+.++|||||||++|+|++|..||...........+.....                   
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------  233 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------------------  233 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------------------
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------------------
Confidence            6778999999999998744457899999999999999999999988776655544432110                   


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                  .....+++.+.+||++||+.||.+|||+.|+++||||+..
T Consensus       234 ------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 ------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                        1112468899999999999999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.9e-49  Score=350.81  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=220.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++.+.||+|+||+||++.++.++..+|+|++......  ..+.+.+|+.++++++||||+++++++.....     .++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   83 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD-----IYL   83 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-----EEE
Confidence            34899999999999999999999999999999765332  35678899999999999999999999987754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeecccccCCCc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|||+++ +|.+.+...+.+++..++.++.|++.||+|||++|++|+||||+||++   +.++.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999975 999999888889999999999999999999999999999999999999   778899999999998776666


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||++.+  .++.++||||||+++|+|++|..||...........+.......+              
T Consensus       164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  227 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--------------  227 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred             chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence            6667788999999999865  489999999999999999999999998877666555544221111              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                   ...+..+++.+.+||.+||+.||++|||+.++|+||||++...
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          228 -------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             -------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             -------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence                         1122367899999999999999999999999999999986543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6e-49  Score=365.14  Aligned_cols=293  Identities=32%  Similarity=0.495  Sum_probs=219.1

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC--CCCCcEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--DTFNDVY  122 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~  122 (377)
                      ++.+.||+|+||+||+++++.+|+.||||++.....   ......+++..+..++||||+++++++.....  .....++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            388999999999999999999999999998865322   22345678888889999999999999865332  1123378


Q ss_pred             EEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHh--cCCceecCCCCCceEEcc-CCCeEEeeeeccccc
Q 017083          123 IVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  195 (377)
Q Consensus       123 iv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~  195 (377)
                      ++|||++++|...+.    ....+++..++.++.||+.||.|||  ++||+||||||+||+++. ++.+||+|||++...
T Consensus       103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~  182 (360)
T 3e3p_A          103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL  182 (360)
T ss_dssp             EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence            999999998776554    4667899999999999999999999  999999999999999997 889999999999887


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........+|+.|+|||++.+...++.++|||||||++|+|++|..||........+..+....+.++..........
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3e3p_A          183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS  262 (360)
T ss_dssp             CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence            76665667788999999999977566899999999999999999999999999999999998888877765432211100


Q ss_pred             hHHHHHH-hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 017083          276 NARRYVR-QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP  340 (377)
Q Consensus       276 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~  340 (377)
                      ....... .................++.+.+||.+||+.||.+|||+.|+|+||||+++.......
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~  328 (360)
T 3e3p_A          263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKL  328 (360)
T ss_dssp             CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCC
T ss_pred             hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccC
Confidence            0000000 0000000001111223577899999999999999999999999999999988655433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=367.48  Aligned_cols=290  Identities=35%  Similarity=0.586  Sum_probs=213.2

Q ss_pred             ecccccCCcccccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +.+.|....++||+|+||+||+|+++  .+++.||+|++......    ..+.+|+.++++++||||+++++++..... 
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-   92 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHAD-   92 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT-
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC-
Confidence            34445545678999999999999976  56889999999754322    356789999999999999999999954322 


Q ss_pred             CCCcEEEEEecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE----ccCCC
Q 017083          117 TFNDVYIVYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCD  183 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli----~~~~~  183 (377)
                        ..+++||||++++|.+.+...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.
T Consensus        93 --~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           93 --RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             --TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             --CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence              348999999999999887531         259999999999999999999999999999999999999    67789


Q ss_pred             eEEeeeecccccCCC----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------
Q 017083          184 LKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------  250 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~---------  250 (377)
                      +||+|||++......    .......||+.|+|||++.+...++.++|||||||++|+|++|..||.....         
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999865533    2234567899999999998756689999999999999999999999976554         


Q ss_pred             HHHHHHHHHHhCCCCccccccccc-hhHHHHHHhcccccccc------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 017083          251 VHQLRLITELIGSPDDASLGFLRS-DNARRYVRQLPRCRKQQ------FATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       251 ~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      ...+..+...++.++...+..... .................      ........++.+.+||++||+.||.+|||+.|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            477788888888877655433221 11122222221111000      00112234788999999999999999999999


Q ss_pred             HhcCccccCCcC
Q 017083          324 ALRHPYLQSLHD  335 (377)
Q Consensus       324 ll~~p~f~~~~~  335 (377)
                      +|+||||+....
T Consensus       331 ~L~hp~f~~~~~  342 (405)
T 3rgf_A          331 AMQDPYFLEDPL  342 (405)
T ss_dssp             HHTSGGGTSSSC
T ss_pred             HhcChhhccCCC
Confidence            999999987553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.4e-48  Score=366.48  Aligned_cols=278  Identities=31%  Similarity=0.540  Sum_probs=223.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc------CCCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM------EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~  117 (377)
                      |++++.||+|+||+||+|.+..+++.||||++...   ......+.+|+.+++.+      +|+||+++++++.....  
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~--  173 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH--  173 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE--
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe--
Confidence            34899999999999999999999999999999753   33445667788888877      57799999999987744  


Q ss_pred             CCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC--eEEeeeeccc
Q 017083          118 FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~--vkl~Dfg~~~  193 (377)
                         ++++|||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.
T Consensus       174 ---~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          174 ---ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             ---EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             ---EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence               89999999999999988654  5999999999999999999999999999999999999999987  9999999997


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  273 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  273 (377)
                      .....  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+.+..+.++........
T Consensus       251 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          251 YEHQR--VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             ETTCC--CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             ecCCc--ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            65433  445678999999999988 778999999999999999999999999999999999999988887765432211


Q ss_pred             chhHHHHHHhccccc--------------------cc-----cc-----cccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 017083          274 SDNARRYVRQLPRCR--------------------KQ-----QF-----ATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       274 ~~~~~~~~~~~~~~~--------------------~~-----~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      .  ...+........                    ..     ..     .......++.+.+||++||+.||++|||+.|
T Consensus       328 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          328 R--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             T--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             h--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence            1  111110000000                    00     00     0001124778999999999999999999999


Q ss_pred             HhcCccccCCc
Q 017083          324 ALRHPYLQSLH  334 (377)
Q Consensus       324 ll~~p~f~~~~  334 (377)
                      +|+||||+...
T Consensus       406 ~L~Hpw~~~~~  416 (429)
T 3kvw_A          406 ALRHPWLRRRL  416 (429)
T ss_dssp             HHTSTTTC---
T ss_pred             HhCChhhccCC
Confidence            99999998654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.2e-49  Score=371.03  Aligned_cols=266  Identities=21%  Similarity=0.369  Sum_probs=220.9

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+..+.|++++.||+|+||+||+++++.+++.||+|++.+... .......+.+|..++..++||||+++++++..... 
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~-  148 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN-  148 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE-
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE-
Confidence            3445566799999999999999999999999999999965311 11112236789999999999999999999998755 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          +|+||||++ |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus       149 ----~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          149 ----LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             ----EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ----EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence                999999996 699999987 57899999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCcc--ccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          195 TSETDF--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       195 ~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ......  ....+||+.|+|||++..    ...++.++|||||||++|||++|..||...+.......+......     
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----  299 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-----  299 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----
T ss_pred             cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-----
Confidence            544322  334689999999999862    356899999999999999999999999998877776666432110     


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  334 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~ell~~p~f~~~~  334 (377)
                                           ...+.....+++.+.+||++||..+|++  |+++.|+++||||+.+.
T Consensus       300 ---------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          300 ---------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             ---------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ---------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence                                 0111223467999999999999988888  99999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-48  Score=358.46  Aligned_cols=264  Identities=26%  Similarity=0.420  Sum_probs=218.4

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      +.++|+...+.||+|+||+||++.++.+++.||+|++............+.+|+.+++++. ||||+++++++.....  
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~--  103 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE--  103 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe--
Confidence            3445553338999999999999999999999999999876544445677889999999996 6999999999987755  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeeec
Q 017083          118 FNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGL  191 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg~  191 (377)
                         +++||||+.+ +|.+++..  ...+++..++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||+
T Consensus       104 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 ---IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             ---EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             ---EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence               8999999985 88888754  367999999999999999999999999999999999999998   78999999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      +.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......+      
T Consensus       181 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------  253 (327)
T 3lm5_A          181 SRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS------  253 (327)
T ss_dssp             CEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred             ccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC------
Confidence            987766655566788999999999977 7789999999999999999999999998887766665554322221      


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                           ...+..+++.+.+||.+||+.||.+|||+.++|+||||+++.-
T Consensus       254 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          254 ---------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             ---------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             ---------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence                                 2223467899999999999999999999999999999987653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-48  Score=356.97  Aligned_cols=259  Identities=27%  Similarity=0.491  Sum_probs=192.0

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      .+.||+|+||+||++.++.+++.||+|++...     ......+|+.+++.+. ||||+++++++.....     .++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-----~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-----TFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-----EEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-----EEEEE
Confidence            47899999999999999999999999999643     3456678999999997 9999999999987754     89999


Q ss_pred             ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeecccccCCC-cc
Q 017083          126 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       126 e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~~~~~~-~~  200 (377)
                      ||+++ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++...... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            99985 9999999989999999999999999999999999999999999999998766   7999999999865433 33


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..........                    .....
T Consensus       166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------------~~~~~  224 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------------------SAVEI  224 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------------------CHHHH
T ss_pred             ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------------------cHHHH
Confidence            455677999999999977 778999999999999999999999997654211000                    00011


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                      ...+...........+..+++++.+||.+||+.||.+|||+.|+++||||++....
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence            11111111111222334679999999999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=356.65  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=213.7

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRP  112 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~  112 (377)
                      .++.+..+.|++++.||+|+||+||++.+. +++.||+|++............+.+|+.++++++|  |||+++++++..
T Consensus         2 e~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            2 ECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             CCEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ceeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            456777777779999999999999999984 68899999998766666677888999999999986  999999999987


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ...     ++++||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~-----~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSE-----EEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCE-----EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            754     89999988889999999999999999999999999999999999999999999999997 578999999999


Q ss_pred             cccCCCc---cccccccccccCCCccccc----------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          193 RTTSETD---FMTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       193 ~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                      .......   ......||+.|+|||++.+          ...++.++|||||||++|+|++|..||.......  ..+..
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~  232 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHA  232 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--HHHHH
Confidence            8665432   2345678999999999854          2567889999999999999999999997643321  11222


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .......                          .......+..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       233 ~~~~~~~--------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          233 IIDPNHE--------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             HHCTTSC--------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HhcCCcc--------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            2111110                          011123467899999999999999999999999999998543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-48  Score=349.06  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=215.7

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|++++.||+|+||+||++.+..++..||+|++...... ......+.+|+.++++++||||+++++++.....     
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   83 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-----   83 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE-----
Confidence            4455899999999999999999999999999998653211 1124567789999999999999999999987754     


Q ss_pred             EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .+++|||++ ++|.+.+....++++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            899999998 5999999888889999999999999999999999999999999999999999999999999986554332


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                       .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......               
T Consensus       164 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  226 (279)
T 3fdn_A          164 -RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---------------  226 (279)
T ss_dssp             -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------------
T ss_pred             -ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC---------------
Confidence             345578999999999987 778899999999999999999999999887766665554421111               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                      ...+++.+.+||.+||+.||.+|||+.|+++||||+.....
T Consensus       227 ----------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          227 ----------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             ----------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             ----------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence                            12468889999999999999999999999999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.7e-48  Score=347.08  Aligned_cols=266  Identities=22%  Similarity=0.352  Sum_probs=219.9

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..+....+++++.+.||+|+||+||++.+..++..||+|++............+.+|+.++++++||||+++++++....
T Consensus        19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            34566677787899999999999999999999999999999876666667788899999999999999999999886532


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEc-cCCCeEEeeee
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFG  190 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~-~~~~vkl~Dfg  190 (377)
                      . ....+++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||
T Consensus        99 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A           99 K-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             S-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             C-CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            2 1134899999997 599999988888999999999999999999999999  99999999999998 78899999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++...... ......+++.|+|||++.+  .++.++||||||+++|+|++|..||.............  ......    
T Consensus       178 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~----  248 (290)
T 1t4h_A          178 LATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGVKP----  248 (290)
T ss_dssp             GGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCCC----
T ss_pred             Cccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH--hccCCc----
Confidence            99755443 2445678999999998864  58999999999999999999999998755443332111  111100    


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                            .......++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       249 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                  0112245788999999999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=353.57  Aligned_cols=295  Identities=42%  Similarity=0.739  Sum_probs=223.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+.++|. +++.||+|+||+||++.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus         6 ~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYM-DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEE-EEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCcee-EEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            356666766 999999999999999999999999999998654  44566788899999999999999999999864421


Q ss_pred             ---------CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc-cCCCeE
Q 017083          116 ---------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLK  185 (377)
Q Consensus       116 ---------~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~-~~~~vk  185 (377)
                               .....++++|||++++|.+.+.. +++++..++.++.||+.||+|||++||+|+||||+||+++ .++.+|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     12245899999999999998864 6799999999999999999999999999999999999997 566899


Q ss_pred             EeeeecccccCCC----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017083          186 IGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       186 l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      |+|||++......    .......++..|+|||.+.+...++.++||||||+++|+|++|..||...........+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999865432    223345668899999998765778999999999999999999999999988777777666654


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      .............. ....................+.++..+.+||++||+.||++|||+.|+|+||||+....
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            43332211100000 00000000011111122234578999999999999999999999999999999986554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7e-49  Score=378.83  Aligned_cols=259  Identities=29%  Similarity=0.500  Sum_probs=223.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++.+.||+|+||+||+++++.+|+.||+|++..... .......+.+|+.++++++||||+++++++.....     +
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----~  101 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-----F  101 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----E
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-----E
Confidence            34489999999999999999999999999999865432 23345678899999999999999999999988754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeecccccCC
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ++||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999997 5999999988999999999999999999999999999999999999999   5678899999999987766


Q ss_pred             CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+.......             
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------------  246 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF-------------  246 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred             ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence            665667789999999999865  68999999999999999999999999888776666554421111             


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                    ..+.+..+++.+.+||++||+.||++|||+.|+|+||||+....
T Consensus       247 --------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          247 --------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             --------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             --------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                          12234567999999999999999999999999999999987653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.4e-48  Score=356.60  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=219.5

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|.+.+.||+|+||+||++.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.....     +
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~  116 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----V  116 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----E
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-----E
Confidence            4448999999999999999999999999999987653 344456778899999999999999999999988754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      +++|||++ ++|.+++.....+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...... .
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999998 599999888889999999999999999999999999999999999999999999999999999865432 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....                 
T Consensus       197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------  258 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----------------  258 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------------
T ss_pred             cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-----------------
Confidence            3445678999999999987 7789999999999999999999999988776555444432110                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                    .....+++.+.+||++||+.||++|||+.|+++||||++...
T Consensus       259 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          259 --------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             --------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence                          011256888999999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=366.90  Aligned_cols=265  Identities=19%  Similarity=0.292  Sum_probs=218.5

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+..+.|++++.||+|+||+||+++++.+|+.||+|++++... .......+.+|..++..++||||+++++++..... 
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~-  135 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY-  135 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE-
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE-
Confidence            4555667799999999999999999999999999999965311 11123346789999999999999999999988754 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          +|+||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus       136 ----~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          136 ----LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             ----EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ----EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence                899999996 6999999764 5899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc--ccccccccccCCCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          195 TSETDF--MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       195 ~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ......  ....+||+.|+|||++..      ...++.++|||||||++|||++|..||...+.......+.......  
T Consensus       212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--  289 (412)
T 2vd5_A          212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL--  289 (412)
T ss_dssp             CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred             ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc--
Confidence            654432  334689999999999873      2568999999999999999999999999888776666654321000  


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCccccCCc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALRHPYLQSLH  334 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---ps~~ell~~p~f~~~~  334 (377)
                                              ........+++++.+||++||. +|.+|   |++.|+++||||+.+.
T Consensus       290 ------------------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          290 ------------------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ------------------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             ------------------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence                                    0011123679999999999999 99998   5999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.9e-48  Score=352.39  Aligned_cols=254  Identities=26%  Similarity=0.461  Sum_probs=213.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +...+.||+|+||+||+++++.+|+.||||++.....  ...+.+.+|+.++++++||||+++++++.....     .++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~l  119 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWV  119 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-----EEE
Confidence            3466789999999999999999999999999865432  234667899999999999999999999987754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-ccc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~~  201 (377)
                      +|||+++ +|.+++. ..++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus       120 v~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             EECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence            9999985 7877765 467999999999999999999999999999999999999999999999999998765543 234


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  281 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  281 (377)
                      ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....   ++.              
T Consensus       199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~--------------  260 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPK--------------  260 (321)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---CCC--------------
T ss_pred             ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCC--------------
Confidence            45678999999999977 778999999999999999999999998877665554443311   100              


Q ss_pred             HhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                 ......+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       261 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 -----------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -----------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -----------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                       011124688899999999999999999999999999998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-48  Score=358.21  Aligned_cols=259  Identities=31%  Similarity=0.487  Sum_probs=211.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  116 (377)
                      .+.++|. +++.||+|+||+||+|.++.+++.||+|++.+....      ..+|+.++.++ +||||+++++++..... 
T Consensus        19 ~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-   90 (342)
T 2qr7_A           19 QFTDGYE-VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKY-   90 (342)
T ss_dssp             CHHHHEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSE-
T ss_pred             CccccEE-EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE-
Confidence            3444444 889999999999999999999999999999765322      34688888888 69999999999987754 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-C---CeEEeeeec
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-C---DLKIGDFGL  191 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~---~vkl~Dfg~  191 (377)
                          +|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||++.++ +   .+||+|||+
T Consensus        91 ----~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           91 ----VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             ----EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             ----EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence                899999997 5999999988899999999999999999999999999999999999998543 3   499999999


Q ss_pred             ccccCCC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCcc
Q 017083          192 ARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRLITELIGSPDDA  267 (377)
Q Consensus       192 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~  267 (377)
                      +...... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|..||....   .......+..        
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--------  237 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--------  237 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--------
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--------
Confidence            9865433 33456688999999999977 668889999999999999999999997632   2222222221        


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                         .........++.+++.+.+||++||..||++|||+.++++||||......
T Consensus       238 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  287 (342)
T 2qr7_A          238 -------------------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL  287 (342)
T ss_dssp             -------------------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred             -------------------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence                               11111122345789999999999999999999999999999999775544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=358.98  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=211.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH------HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      |++++.||+|+||+||+++++.+++.||+|++.......      .....+.+|+.++++++||||+++++++.....  
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~--  103 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF--  103 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE--
T ss_pred             eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE--
Confidence            338999999999999999999999999999997653211      123355679999999999999999999987754  


Q ss_pred             CCcEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~-~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         ++++|||+. | +|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus       104 ---~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          104 ---FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             ---EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ---EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence               899999986 5 89999998889999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........||+.|+|||++.+....+.++||||||+++|+|++|..||......         .              
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~--------------  237 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------V--------------  237 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------T--------------
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------H--------------
Confidence            76666667789999999999987444488999999999999999999999652210         0              


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    .........+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus       238 --------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          238 --------------EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             --------------TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             --------------hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                          000111234689999999999999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-48  Score=356.25  Aligned_cols=283  Identities=29%  Similarity=0.567  Sum_probs=217.7

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  118 (377)
                      .++| ++++.||+|+||+||++++..+++.||+|++...     ....+.+|+.++++++ ||||+++++++.....   
T Consensus        35 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---  105 (330)
T 3nsz_A           35 QDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---  105 (330)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---
T ss_pred             CCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---
Confidence            3444 4899999999999999999999999999999643     2356789999999997 9999999999987433   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccC
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~  196 (377)
                      ...+++|||+++ +|.+++.   .+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            348999999984 7877774   489999999999999999999999999999999999999777 79999999998766


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCcccc----cc
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASL----GF  271 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~----~~  271 (377)
                      .........++..|+|||++.+...++.++|||||||++|+|++|..||.. ......+..+....+.+.....    ..
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            665566678899999999997767789999999999999999999999854 4444555555444432111000    00


Q ss_pred             ccchhHHHHHHhcccccccc--ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQ--FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ....................  .......+++.+.+||.+||+.||++|||+.|+|+||||+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            00011111111111100000  1111223789999999999999999999999999999999765

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1e-48  Score=379.56  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=217.6

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +..+.|++++.||+|+||+||+++++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.....  
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE--
Confidence            455667799999999999999999999999999999965321 11224567789999999999999999999988754  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                         +|+||||++ |+|.+.+...+  .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       259 ---l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          259 ---LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             ---EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence               999999997 59999887644  499999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...+...+         
T Consensus       336 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------  405 (576)
T 2acx_A          336 VPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------  405 (576)
T ss_dssp             CCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---------
T ss_pred             cccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---------
Confidence            766555566789999999999987 7789999999999999999999999987542111111111100000         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                        ......+++++.+||++||+.||.+||     ++.|+++||||+.+.
T Consensus       406 ------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          406 ------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             ------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence                              011235789999999999999999999     899999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-48  Score=365.35  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=202.2

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHH-hcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+.++|..+.+.||+|+||+||++.++.+++.||||++...       ..+.+|+.++. ..+||||++++++|..... 
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc-
Confidence            44555663447899999999999999999999999999632       34567888775 4579999999999865111 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeee
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg  190 (377)
                      ....+|+||||++| +|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            11348999999985 9999998643  5999999999999999999999999999999999999998   7889999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH----QLRLITELIGSPDD  266 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~  266 (377)
                      ++............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......    ....+..       
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-------  281 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------  281 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-------
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-------
Confidence            9987766555667788999999999977 788999999999999999999999997654211    1111111       


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                          .........+..++.++.+||++||+.||++|||+.|+++||||....
T Consensus       282 --------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          282 --------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             --------------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             --------------------CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                                001111223457899999999999999999999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.5e-48  Score=355.38  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=214.9

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|.+++.||+|+||+||++++..+++.||||++..... .......+.+|+.++++++||||+++++++.....     
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe-----
Confidence            345588999999999999999999999999999975432 33345678899999999999999999999987754     


Q ss_pred             EEEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .++||||+.|+|.+.+. ...++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus       129 ~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            89999999999998885 4678999999999999999999999999999999999999999999999999999765433 


Q ss_pred             cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                        ....|++.|+|||++.+  ...++.++|||||||++|+|++|..||...........+....  .+            
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--~~------------  271 (348)
T 1u5q_A          208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SP------------  271 (348)
T ss_dssp             --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC------------
T ss_pred             --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC------------
Confidence              34578999999999853  3678899999999999999999999998877655544333210  00            


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                     .......+..+.+||.+||+.||++|||+.++++||||+..
T Consensus       272 ---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          272 ---------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                           01113568889999999999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-47  Score=358.45  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=214.3

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC--CCCceeEeeeecC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRP  112 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~  112 (377)
                      ....+..+.|++++.||+|+||+||++.+.. ++.||||++............+.+|+.++++++  ||||+++++++..
T Consensus        49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             CCEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            3456666777799999999999999999865 899999999876556667788899999999997  5999999999987


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ...     +++|||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++
T Consensus       128 ~~~-----~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 DQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SSE-----EEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CCE-----EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            754     89999977789999999888999999999999999999999999999999999999995 578999999999


Q ss_pred             cccCCCc---cccccccccccCCCcccccc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          193 RTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       193 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                      .......   ......||+.|+|||++.+.          ..++.++|||||||++|+|++|..||.......  ..+..
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~~  279 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHA  279 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHHH
Confidence            8664332   23456789999999998641          367889999999999999999999997643221  11222


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .......                          .......+..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       280 ~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          280 IIDPNHE--------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHCTTSC--------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HhCcccc--------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            2211110                          001123477899999999999999999999999999998544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-48  Score=349.03  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=216.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      |++++.||+|+||+||++.++.+++.||+|++.......    ...+.+.+|+.++++++||||+++++++.....    
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----   82 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD----   82 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe----
Confidence            448999999999999999999999999999987543221    135678899999999999999999999987754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC----CeEEeeeecccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLART  194 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~~~  194 (377)
                       .+++|||++ ++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++    .++|+|||++..
T Consensus        83 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           83 -VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             -EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             -EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence             899999997 69999998888899999999999999999999999999999999999998877    799999999987


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......          
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  230 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF----------  230 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----------
T ss_pred             ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC----------
Confidence            665554556678999999999977 778999999999999999999999998877665554443211111          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                                       ....+..++..+.+||++||..||++|||+.++++||||+.+....
T Consensus       231 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          231 -----------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             -----------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             -----------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                             1112246788999999999999999999999999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-47  Score=355.10  Aligned_cols=256  Identities=28%  Similarity=0.507  Sum_probs=217.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC------HHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  116 (377)
                      |++.+.||+|+||+||+|+++.+|+.||||++......      ....+.+.+|+.+++++ +||||+++++++..... 
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-  174 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF-  174 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE-
T ss_pred             cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE-
Confidence            44789999999999999999999999999998654311      11245667899999999 79999999999987654 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          .++||||++| +|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       175 ----~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          175 ----MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             ----EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ----EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence                8999999985 99999988888999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ..........||+.|+|||++.+.     ..++.++|||||||++|+|++|..||...........+.......      
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  324 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF------  324 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            666556677899999999998641     357889999999999999999999998877665555444311111      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                           ..+.+..++..+.+||++||+.||++|||+.++|+||||+
T Consensus       325 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          325 ---------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             ---------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             ---------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                                 1122346788999999999999999999999999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-47  Score=346.85  Aligned_cols=258  Identities=28%  Similarity=0.450  Sum_probs=216.3

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      .++|. +++.||+|+||+||+++++.+|+.||+|++....  ......+.+|+.++++++||||+++++++.....    
T Consensus         8 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   80 (304)
T 2jam_A            8 RKTFI-FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH----   80 (304)
T ss_dssp             HHHEE-EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE----
T ss_pred             hccce-eeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE----
Confidence            34444 8999999999999999999999999999997542  2234567799999999999999999999987754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~~~  195 (377)
                       ++++|||++ ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++...
T Consensus        81 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           81 -YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             -EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence             899999997 5999999888889999999999999999999999999999999999999   77889999999998765


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......           
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----------  226 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF-----------  226 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC-----------
T ss_pred             CCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence            433 2344568999999999987 778999999999999999999999998877665555544321111           


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                      ....+..+++.+.+||.+||..||++|||+.++++||||+...
T Consensus       227 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          227 ----------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ----------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                            1122346789999999999999999999999999999998654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-47  Score=344.36  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=218.8

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEecccccc-------CHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCC
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-------NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  116 (377)
                      ++.+.||+|+||+||++.++.+|+.||+|++.....       .....+.+.+|+.+++++. ||||+++++++..... 
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-   98 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-   98 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe-
Confidence            389999999999999999999999999999965421       1223456778999999996 9999999999987654 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                          .+++|||++ ++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        99 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           99 ----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ----EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence                899999998 599999988889999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          196 SETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ..........+++.|+|||++.+     ...++.++||||||+++|+|++|..||...........+.......      
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  248 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF------  248 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc------
Confidence            66555666788999999999852     2567889999999999999999999998877665555444321111      


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                           ..+.+..++..+.+||.+||+.||.+|||+.++++||||++...
T Consensus       249 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          249 ---------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             ---------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             ---------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence                                 11223457889999999999999999999999999999987553

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.6e-47  Score=344.35  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=218.7

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|.+.+.||+|+||+||++.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.....     .
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~   90 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----V   90 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----E
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE-----E
Confidence            3448999999999999999999999999999987653 334456778899999999999999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      +++|||++ ++|.+.+...+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999998 599999888889999999999999999999999999999999999999999999999999999765432 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....                  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  231 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------------  231 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------
T ss_pred             ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc------------------
Confidence            3445678999999999977 778999999999999999999999998876555443332210                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                   ......+++.+.++|.+||+.||++|||+.++++||||++....
T Consensus       232 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          232 -------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             -------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence                         01113568889999999999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.7e-48  Score=350.66  Aligned_cols=275  Identities=24%  Similarity=0.362  Sum_probs=204.7

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      +.|....+.||+|+||+||++.+..+++.||||++.....  .....+.+|+.++.++ +||||+++++++.....    
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~----   85 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR----   85 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE----
Confidence            4444234789999999999999999999999999976532  2346778999999985 69999999999987754    


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~~~~  195 (377)
                       +++||||++ ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||++...
T Consensus        86 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           86 -FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             -EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             -EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence             899999998 699999988888999999999999999999999999999999999999998776   999999998754


Q ss_pred             CCC--------ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          196 SET--------DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       196 ~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      ...        .......|++.|+|||++.+    ...++.++|||||||++|+|++|..||.........         
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---------  235 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---------  235 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---------
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---------
Confidence            321        11234568999999999864    145788999999999999999999999765421000         


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                         .................+...........+..+++.+.+||++||+.||++|||+.|+|+||||++..
T Consensus       236 ---~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          236 ---WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             ---C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             ---ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence               00000000000001111111111111122346789999999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-48  Score=367.77  Aligned_cols=258  Identities=34%  Similarity=0.540  Sum_probs=201.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC------HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      |.+.+.||+|+||+||+|.++.+++.||+|++......      ......+.+|+.++++++||||+++++++..+    
T Consensus       137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  212 (419)
T 3i6u_A          137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE----  212 (419)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS----
T ss_pred             EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            44899999999999999999999999999998754211      11223467899999999999999999998643    


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeeccc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~  193 (377)
                        .+++||||++ ++|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.
T Consensus       213 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          213 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             --EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             --ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence              2789999997 59999988888999999999999999999999999999999999999997654   49999999998


Q ss_pred             ccCCCccccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ............||+.|+|||++.+  ...++.++|||||||++|+|++|..||........+.....            
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~------------  358 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT------------  358 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH------------
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh------------
Confidence            8776665667789999999999853  35678899999999999999999999976432211111110            


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                    ..........+..+++.+.+||++||+.||++|||+.|+|+||||+..
T Consensus       359 --------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          359 --------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             --------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             --------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence                          001111122345679999999999999999999999999999999753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-48  Score=356.33  Aligned_cols=265  Identities=27%  Similarity=0.434  Sum_probs=212.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc---cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ++.++|. +++.||+|+||+||++.++.++..||+|++....   ........+.+|+.++++++||||+++++++....
T Consensus        23 ~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           23 ELQKKYH-LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhee-ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            3444444 8999999999999999999999999999986532   12334567889999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh----------------------------------------CCCCCHHHHHHHHHH
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS----------------------------------------DQQLTDDHCQYFLYQ  153 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~q  153 (377)
                      .     .++||||++ ++|.+.+..                                        ...+++..++.++.|
T Consensus       102 ~-----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A          102 Y-----ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             E-----EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             e-----EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            4     899999997 599988842                                        112357788899999


Q ss_pred             HHHHHHHHhcCCceecCCCCCceEEccCC--CeEEeeeecccccCCC-----ccccccccccccCCCcccccc-CCCCCc
Q 017083          154 LLRGLKYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNC-TEYTAA  225 (377)
Q Consensus       154 i~~al~~LH~~~i~H~dik~~NIli~~~~--~vkl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~  225 (377)
                      |+.||+|||++||+||||||+||+++.++  .+||+|||++......     .......+++.|+|||++.+. ..++.+
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999999999998776  8999999999754321     123456789999999998642 567899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHH
Q 017083          226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD  305 (377)
Q Consensus       226 ~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (377)
                      +||||||+++|+|++|..||...........+.......                           ..+.+..+++.+.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~  309 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF---------------------------ENPNYNVLSPLARD  309 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT---------------------------TSGGGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc---------------------------CCcccccCCHHHHH
Confidence            999999999999999999999887776665554421111                           11223356899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          306 LLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       306 li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ||.+||+.||.+|||+.++|+||||++..+
T Consensus       310 li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          310 LLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999999999999999998664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.4e-48  Score=344.24  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=206.7

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++.+.||+|+||+||++.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.....     +
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   86 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-----F   86 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----E
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe-----E
Confidence            34489999999999999999999999999999865321 11124567899999999999999999999987754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +++|||++ ++|.+++...+++++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999997 59999998888899999999999999999999999999999999999999999999999999987766555


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....+++.|+|||.+.+....+.++||||||+++|+|++|..||...........+.....                  
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  228 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------------------  228 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------------
Confidence            55667899999999998733446899999999999999999999988766555444432110                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                   .....++..+.++|.+||+.||++|||+.++++||||++.
T Consensus       229 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 -------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                         0112468889999999999999999999999999999754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-47  Score=343.19  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=216.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|++.+.||+|+||+||++.+..++..||+|++...... ......+.+|+.++++++||||+++++++.....     
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR-----   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE-----
Confidence            4455899999999999999999999999999998653211 1123567889999999999999999999987654     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++++|||+++ +|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            8999999974 999999888889999999999999999999999999999999999999999999999999987654332


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                       .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....                 
T Consensus       169 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------  229 (284)
T 2vgo_A          169 -RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----------------  229 (284)
T ss_dssp             -BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------------
T ss_pred             -cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----------------
Confidence             345678999999999987 7789999999999999999999999988776554443332100                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                    ...+.++..+.++|.+||+.||.+|||+.++++||||+....
T Consensus       230 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          230 --------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             --------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                          111356889999999999999999999999999999986554

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-47  Score=347.86  Aligned_cols=281  Identities=29%  Similarity=0.524  Sum_probs=223.7

Q ss_pred             ccCCcccccCCccceEEEEEe-CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC------ceeEeeeecCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN------VIAIKDIIRPPKK  115 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~-~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~  115 (377)
                      .|++++.||+|+||+||++.+ +.+++.||+|++...   ......+.+|+.+++.++|++      ++++++++.....
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            344899999999999999998 568899999999653   344567788999999887654      9999999987754


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-------------
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------------  180 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-------------  180 (377)
                           ++++|||++++|.+.+...+  ++++..++.++.||+.||+|||++||+||||||+||+++.             
T Consensus        92 -----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 -----ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             -----EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             -----EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence                 89999999999999998765  6899999999999999999999999999999999999987             


Q ss_pred             ------CCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017083          181 ------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (377)
Q Consensus       181 ------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~  254 (377)
                            ++.+||+|||++......  .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                  668999999999765443  345678999999999987 77899999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCccccc--------------cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 017083          255 RLITELIGSPDDASLG--------------FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  320 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps  320 (377)
                      ..+....+..+.....              +................. ..........++.+.+||.+||+.||.+|||
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL-KEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcch-hhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            8888888766653211              111111111111111000 0011111223577899999999999999999


Q ss_pred             HHHHhcCccccCCcC
Q 017083          321 VEEALRHPYLQSLHD  335 (377)
Q Consensus       321 ~~ell~~p~f~~~~~  335 (377)
                      +.|+++||||+.+..
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999997653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-47  Score=382.12  Aligned_cols=262  Identities=21%  Similarity=0.348  Sum_probs=220.8

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPP  113 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  113 (377)
                      ...+....|++++.||+|+||+||+++++.+++.||||++++... .......+..|..++..+ +||+|+++++++...
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            334455667799999999999999999999999999999975421 122345667899999987 599999999999887


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ..     +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus       415 ~~-----~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          415 DR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             SE-----EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             CE-----EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence            55     899999998 599999998889999999999999999999999999999999999999999999999999999


Q ss_pred             cccC-CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          193 RTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       193 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      +... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||...+.......|.....         
T Consensus       490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  559 (674)
T 3pfq_A          490 KENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------  559 (674)
T ss_dssp             EECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred             eccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            8533 3334566789999999999987 7889999999999999999999999998877766655543110         


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~ell~~p~f~~~~  334 (377)
                                            .....+++++.+||++||+.||++||++     .|+++||||+.+.
T Consensus       560 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          560 ----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             ----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence                                  1113579999999999999999999997     9999999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=361.46  Aligned_cols=267  Identities=21%  Similarity=0.368  Sum_probs=212.3

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeC---CCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhc-CCCCceeEee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVIAIKD  108 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  108 (377)
                      ....+....|++++.||+|+||+||++++.   .+++.||||+++....  .......+.+|+.+++.+ +||||+++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            334455566779999999999999999984   5889999999875321  112234456799999999 5999999999


Q ss_pred             eecCCCCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       109 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      ++.....     +++||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus       127 ~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          127 AFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             EEEETTE-----EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             EEeeCce-----EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEe
Confidence            9987754     899999998 5999999888899999999999999999999999999999999999999999999999


Q ss_pred             eeecccccCCC--ccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCC
Q 017083          188 DFGLARTTSET--DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE-LIGS  263 (377)
Q Consensus       188 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~-~~~~  263 (377)
                      |||++......  .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.. ....
T Consensus       202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence            99999765432  223446789999999999752 3478899999999999999999999975432111111111 1100


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                                  .......++..+.+||.+||..||.+||     |+.|+++||||+.+.
T Consensus       282 ----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          282 ----------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             ----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence                                        0111235788999999999999999999     999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-48  Score=354.67  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=202.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC--------
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--------  115 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--------  115 (377)
                      |++++.||+|+||+||+++++.+|+.||||++.... .....+.+.+|+.++++++||||+++++++.....        
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            348899999999999999999999999999997543 33356778899999999999999999998865432        


Q ss_pred             --------------------------------------------CCCCcEEEEEecCCC-CHHHHHHhCCC---CCHHHH
Q 017083          116 --------------------------------------------DTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHC  147 (377)
Q Consensus       116 --------------------------------------------~~~~~~~iv~e~~~~-~L~~~l~~~~~---~~~~~~  147 (377)
                                                                  .....++++|||+++ +|.+++.....   .++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                        011237999999985 99999886543   455568


Q ss_pred             HHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-------------cccccccccccCCCc
Q 017083          148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAPE  214 (377)
Q Consensus       148 ~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE  214 (377)
                      +.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......             ......||+.|+|||
T Consensus       167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            9999999999999999999999999999999999999999999998665432             233457899999999


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc
Q 017083          215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT  294 (377)
Q Consensus       215 ~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (377)
                      ++.+ ..++.++||||||+++|+|++|..|+.     .....+........                           ..
T Consensus       247 ~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~---------------------------~~  293 (332)
T 3qd2_B          247 QIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF---------------------------PL  293 (332)
T ss_dssp             HHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC---------------------------CH
T ss_pred             HhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC---------------------------Cc
Confidence            9987 778999999999999999999876542     12222222111111                           11


Q ss_pred             cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          295 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       295 ~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      .+...++.+.+||.+||+.||++|||+.|+++||||+++
T Consensus       294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            112346778999999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-47  Score=342.92  Aligned_cols=262  Identities=27%  Similarity=0.415  Sum_probs=214.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ++|. +++.||+|+||.||++.+..+++.||+|++.....  .......+.+|+.++++++||||+++++++.....   
T Consensus         5 ~~y~-i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   80 (305)
T 2wtk_C            5 GKYL-MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---   80 (305)
T ss_dssp             CCBC-CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccee-EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---
Confidence            4444 89999999999999999999999999999975421  12345678899999999999999999999854332   


Q ss_pred             CcEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      ..++++|||++++|.+.+..  ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            33899999999888888765  4679999999999999999999999999999999999999999999999999997654


Q ss_pred             C---CccccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          197 E---TDFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       197 ~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .   ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...........+....           
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----------  229 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-----------  229 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----------
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-----------
Confidence            2   22234556899999999987622 34779999999999999999999998877655544443310           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                                          ......+++.+.+||.+||+.||.+|||+.|+++||||+......
T Consensus       230 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 --------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             --------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             --------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                                011235688999999999999999999999999999998766543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.1e-47  Score=343.38  Aligned_cols=268  Identities=22%  Similarity=0.330  Sum_probs=211.0

Q ss_pred             EEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEe
Q 017083           28 VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK  107 (377)
Q Consensus        28 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  107 (377)
                      -+....+..+++....|++.+.||+|+||+||++++  +|..||+|++............+.+|+.++++++||||++++
T Consensus        23 ~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~  100 (309)
T 3p86_A           23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM  100 (309)
T ss_dssp             ---------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eccCCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            334455667888888888999999999999999977  578899999987766666778889999999999999999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNAS  181 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~  181 (377)
                      +++.....     +++||||+++ +|.+++.....   +++..++.++.||+.||+|||++|  |+||||||+||+++.+
T Consensus       101 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~  175 (309)
T 3p86_A          101 GAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK  175 (309)
T ss_dssp             EEECSTTC-----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT
T ss_pred             EEEEECCc-----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC
Confidence            99987755     8999999985 99999876553   999999999999999999999999  9999999999999999


Q ss_pred             CCeEEeeeecccccCCCc-cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017083          182 CDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL  260 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~  260 (377)
                      +.+||+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...
T Consensus       176 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          176 YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             CCEEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred             CcEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            999999999997544332 2345678999999999987 77899999999999999999999999887766554443221


Q ss_pred             hCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 017083          261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  332 (377)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~--~p~f~~  332 (377)
                      ...                             ......+++.+.+||++||+.||.+|||+.++++  .+++++
T Consensus       255 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          255 CKR-----------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCC-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            110                             1112357899999999999999999999999997  566554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.9e-49  Score=366.26  Aligned_cols=260  Identities=17%  Similarity=0.217  Sum_probs=204.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHH---HHHHhcCCCCceeEe-----
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREI---KLLRHMEHENVIAIK-----  107 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-----  107 (377)
                      +....+.|++.+.||+|+||+||+++++.+|+.||||++.... ......+.+.+|+   +++++++||||++++     
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            3444566668999999999999999999999999999997542 2334567788999   455555799999998     


Q ss_pred             --eeecCCCC----------CC--CCcEEEEEecCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHhcCCc
Q 017083          108 --DIIRPPKK----------DT--FNDVYIVYELMDTDLHQIIRSDQQLTD-------DHCQYFLYQLLRGLKYVHSASV  166 (377)
Q Consensus       108 --~~~~~~~~----------~~--~~~~~iv~e~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~al~~LH~~~i  166 (377)
                        +++.....          ..  ....|++|||++|+|.+++...+.+++       ..+..++.||+.||+|||++||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence              44443321          00  012789999999999999987555555       7888899999999999999999


Q ss_pred             eecCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccCCCcccccc----------CCCCCcchHHHHHHHHH
Q 017083          167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILG  236 (377)
Q Consensus       167 ~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~  236 (377)
                      +||||||+|||++.++.+||+|||++.....  ......| +.|+|||++.+.          ..++.++|||||||++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986443  2345566 999999999873          27899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCC
Q 017083          237 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  316 (377)
Q Consensus       237 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  316 (377)
                      +|++|..||.........                                   .........+++.+.+||.+||+.||+
T Consensus       305 elltg~~Pf~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~  349 (377)
T 3byv_A          305 WIWCADLPITKDAALGGS-----------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKE  349 (377)
T ss_dssp             HHHHSSCCC------CCS-----------------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHCCCCCcccccccch-----------------------------------hhhhhhccCCCHHHHHHHHHHcCCCch
Confidence            999999999654311100                                   001112357799999999999999999


Q ss_pred             CCCCHHHHhcCccccCCc
Q 017083          317 KRITVEEALRHPYLQSLH  334 (377)
Q Consensus       317 ~Rps~~ell~~p~f~~~~  334 (377)
                      +|||+.++++||||+.+.
T Consensus       350 ~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          350 DRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             GCCCHHHHHTSHHHHHHH
T ss_pred             hCCCHHHHhhChHHHHHH
Confidence            999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-47  Score=368.59  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=215.1

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +..+.|++++.||+|+||+||+++++.+|+.||+|++.+.... ......+..|..++++++||||+++++++.....  
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--  259 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD--  259 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE--
Confidence            4446666899999999999999999999999999999654211 1224567789999999999999999999988754  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                         +|+||||++ |+|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++
T Consensus       260 ---l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          260 ---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             ---EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ---EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence               899999998 599988865    346999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc-ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  267 (377)
                      ........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....    ......+...   .   
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---~---  409 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---A---  409 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC---C---
T ss_pred             eeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc---c---
Confidence            87654432 344689999999999987 7889999999999999999999999977532    2222222110   0   


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                               ......+++.+.+||++||+.||++||+     +.++++||||+.+.
T Consensus       410 -------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          410 -------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             -------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             -------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence                                     0112357899999999999999999995     58999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.7e-47  Score=341.80  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=205.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++++.||+|+||+||++.++.+++.||+|++............+.+|+..+..+ +||||+++++++.....     ++
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~-----~~   87 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH-----ML   87 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE-----EE
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-----EE
Confidence            3489999999999999999999999999999987655556677888999999999 89999999999987754     89


Q ss_pred             EEEecCCC-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC----------------
Q 017083          123 IVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----------------  181 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~----------------  181 (377)
                      ++|||+++ +|.+++...    ..+++..++.++.||+.||+|||++||+|+||||+||+++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999975 999998754    679999999999999999999999999999999999999844                


Q ss_pred             ---CCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017083          182 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       182 ---~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~  258 (377)
                         ..++|+|||++.......   ...+++.|+|||++.+...++.++||||||+++|+|++|..++.......   .+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~  241 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR  241 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHH
T ss_pred             CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHH
Confidence               479999999998765443   34589999999999874566789999999999999999987765432111   111


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .                              .........+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus       242 ~------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          242 Q------------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             T------------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             c------------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            1                              001112236789999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-47  Score=342.91  Aligned_cols=256  Identities=32%  Similarity=0.539  Sum_probs=218.3

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ++++.||+|+||+||++.++.+++.||+|++............+.+|+.++++++||||+++++++.....     ++++
T Consensus        25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv   99 (287)
T 2wei_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-----FYIV   99 (287)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----EEEE
T ss_pred             eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe-----EEEE
Confidence            38999999999999999999999999999997654444456778899999999999999999999987654     8999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC---CeEEeeeecccccCCCcc
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSETDF  200 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~---~vkl~Dfg~~~~~~~~~~  200 (377)
                      +||+. ++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++   .+||+|||++........
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            99997 59999988888899999999999999999999999999999999999997644   699999999987665555


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||...........+......                 
T Consensus       180 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  240 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-----------------  240 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred             cccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence            556678999999999875  4889999999999999999999999887766555444331111                 


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                ...+.+..+++.+.++|++||+.||++|||+.++++||||+...
T Consensus       241 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          241 ----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             ----------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             ----------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence                      11122346789999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-47  Score=339.65  Aligned_cols=257  Identities=29%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++.++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.....     .++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l   82 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-----QYL   82 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE-----EEE
Confidence            3488999999999999999999999999999865432 2345678899999999999999999999987644     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---c
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---D  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---~  199 (377)
                      ++||+++ +|.+.+.....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999985 99999887788999999999999999999999999999999999999999999999999998754322   2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccccccccchhHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      ......+++.|+|||.+.+....+.++||||||+++|+|++|..||....... ....+..   .               
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------  224 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---K---------------  224 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---T---------------
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---c---------------
Confidence            23456789999999999874445788999999999999999999997754321 1111110   0               


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                 ......+..+++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus       225 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          225 -----------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             -----------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             -----------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                       0001122357889999999999999999999999999999987653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-46  Score=351.28  Aligned_cols=279  Identities=32%  Similarity=0.515  Sum_probs=219.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CC-----CceeEeeeecCCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HE-----NVIAIKDIIRPPKKD  116 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~  116 (377)
                      .|++++.||+|+||+||++.++.+++.||||++...   ......+..|+.+++.++ |+     +|+++++++..... 
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~-  130 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH-  130 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE-
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc-
Confidence            344899999999999999999999999999999753   334566778888888885 55     49999999887644 


Q ss_pred             CCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh--cCCceecCCCCCceEEc--cCCCeEEeeee
Q 017083          117 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLN--ASCDLKIGDFG  190 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dik~~NIli~--~~~~vkl~Dfg  190 (377)
                          +++||||++++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||
T Consensus       131 ----~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          131 ----LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             ----EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ----eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence                8999999999999999865  46999999999999999999999  47999999999999995  47789999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+....+.++.....
T Consensus       207 ~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          207 SSCQLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             TCEETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             Cceecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99876543  345678999999999988 678999999999999999999999999999999999998888776654332


Q ss_pred             cccchhHHHHHHhcccccccc----------ccc------------------cCCC-------CChhHHHHHHHhcCCCC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQ----------FAT------------------RFPN-------KSSGAVDLLEKMLVFDP  315 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~----------~~~------------------~~~~-------~~~~~~~li~~~L~~dp  315 (377)
                      ..  .....++..+.......          ...                  ...+       .++.+.+||++||+.||
T Consensus       284 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          284 QA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             TC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             hh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            21  11111111111100000          000                  0000       01368999999999999


Q ss_pred             CCCCCHHHHhcCccccCCc
Q 017083          316 NKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       316 ~~Rps~~ell~~p~f~~~~  334 (377)
                      ++|||+.|+|+||||+...
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=344.44  Aligned_cols=270  Identities=19%  Similarity=0.287  Sum_probs=201.3

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .+..|.+.-+.|++++.||+|+||+||++.++.+|+.||+|++............+.++..+++.++||||+++++++..
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            34556666677779999999999999999999999999999997654444344445556667888899999999999988


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ...     ++++|||+++.+..+... ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||
T Consensus        96 ~~~-----~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           96 NTD-----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             SSE-----EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCc-----EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence            754     899999997666666543 57899999999999999999999995 99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPD  265 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~  265 (377)
                      ++.............+++.|+|||++..    ...++.++||||||+++|+|++|..||...... .....+..   ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~  247 (318)
T 2dyl_A          171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEP  247 (318)
T ss_dssp             TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---SCC
T ss_pred             CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---cCC
Confidence            9977665555556678999999999852    256788999999999999999999999874332 22222221   100


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                               ...+....+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       248 -------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          248 -------------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             -------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             -------------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                                     001112357899999999999999999999999999999986553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-47  Score=353.89  Aligned_cols=288  Identities=20%  Similarity=0.301  Sum_probs=220.4

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .++..+.|++++.||+|+||+||++.+..++..||+|++.... .......+.+|+.++++++||||+++++++..... 
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE-
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE-
Confidence            3455566679999999999999999999999999999997653 34456778899999999999999999999987754 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          +++||||+++ +|.+++...+.+++..+..++.||+.||+|||+. ||+|+||||+||+++.++.++|+|||++..
T Consensus       106 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             ----EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             ----EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence                8999999975 9999998888999999999999999999999986 999999999999999999999999999865


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc--cc-
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL--GF-  271 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~~-  271 (377)
                      .... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+............  .. 
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            4322 2344578999999999987 77899999999999999999999999887765543332211111100000  00 


Q ss_pred             ------------ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          272 ------------LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                  ..................  .......++.++.+||++||+.||++|||+.|+|+||||+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                        000001111111111111  1111234688999999999999999999999999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-47  Score=347.96  Aligned_cols=257  Identities=35%  Similarity=0.556  Sum_probs=208.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc------CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      |++++.||+|+||+||++.++.+++.||||++.....      .......+.+|+.++++++||||+++++++..+.   
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   88 (322)
T 2ycf_A           12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---   88 (322)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred             eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc---
Confidence            3489999999999999999999999999999975421      1112345678999999999999999999987542   


Q ss_pred             CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeeccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~~  193 (377)
                         ++++|||+++ +|.+.+.....+++..++.++.||+.||+|||++||+|+||||+||+++.++.   +||+|||++.
T Consensus        89 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           89 ---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             ---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             ---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence               7999999975 99999988889999999999999999999999999999999999999987665   9999999998


Q ss_pred             ccCCCccccccccccccCCCcccc--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~  270 (377)
                      ............+++.|+|||++.  +...++.++||||||+++|+|++|..||........+ ..+...          
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  235 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG----------  235 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT----------
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC----------
Confidence            776554445667899999999974  2366789999999999999999999999764422111 111110          


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                       ........+..++..+.+||.+||+.||++|||+.++|+||||+..
T Consensus       236 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          236 -----------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             -----------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             -----------------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                             0001112234678999999999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.5e-47  Score=356.94  Aligned_cols=282  Identities=28%  Similarity=0.436  Sum_probs=216.9

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC--------CCCceeEeeeecCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--------HENVIAIKDIIRPP  113 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~~~  113 (377)
                      ..|++++.||+|+||+||++++..+++.||+|++...   ......+.+|+.+++.++        |+||+++++++...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            3344899999999999999999999999999999753   345567789999999986        78899999998732


Q ss_pred             CCCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCC--------
Q 017083          114 KKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASC--------  182 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~--------  182 (377)
                      ... ...+++||||++++|.+.+...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++        
T Consensus       114 ~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          114 GVN-GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             ETT-EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCC-CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            211 1348999999999998888654  5699999999999999999999998 999999999999999775        


Q ss_pred             -----------------------------------------CeEEeeeecccccCCCccccccccccccCCCccccccCC
Q 017083          183 -----------------------------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE  221 (377)
Q Consensus       183 -----------------------------------------~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  221 (377)
                                                               .+||+|||++......  .....+|+.|+|||++.+ ..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-SG  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-SC
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC-CC
Confidence                                                     7999999999866543  445578999999999987 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccc-----
Q 017083          222 YTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ-----  290 (377)
Q Consensus       222 ~~~~~DiwslG~ll~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  290 (377)
                      ++.++|||||||++|+|++|..||....      ....+..+....+.++..........  ..++.........     
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSSCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCccccccccccCC
Confidence            8999999999999999999999997655      45666777777776654321100000  0000000000000     


Q ss_pred             --------cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          291 --------QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       291 --------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                              .........+..+.+||.+||+.||++|||+.|+|+||||++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                    000001123567889999999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3e-47  Score=349.16  Aligned_cols=270  Identities=23%  Similarity=0.391  Sum_probs=196.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHH-HHHhcCCCCceeEeeeecC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~  112 (377)
                      ...|.+..+.|++++.||+|+||+||++.++.+|+.||+|++...... .....+..|+. +++.++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            345777778888999999999999999999999999999999765333 33444555555 7777899999999999987


Q ss_pred             CCCCCCCcEEEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEccCCCeEE
Q 017083          113 PKKDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~~~~vkl  186 (377)
                      ...     .+++|||++++|.+++..     ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||
T Consensus        93 ~~~-----~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           93 EGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             SSE-----EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             CCc-----eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            754     899999999998888763     67899999999999999999999999 9999999999999999999999


Q ss_pred             eeeecccccCCCccccccccccccCCCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      +|||++.............+++.|+|||++.   ....++.++||||||+++|+|++|..||.......  ..+....  
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~--  243 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVV--  243 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCC--
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHh--
Confidence            9999998766554445557899999999984   22568899999999999999999999997643211  0000000  


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                           ..............+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       244 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          244 ---------------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---------------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ---------------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                                 00001111122346789999999999999999999999999999998654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-47  Score=346.51  Aligned_cols=273  Identities=25%  Similarity=0.373  Sum_probs=194.0

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|.+..+.|++.+.||+|+||+||++.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.....
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            366777777799999999999999999999999999999865422 2335667789999999999999999999988755


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl  186 (377)
                           .+++|||++ ++|.+++..        ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|
T Consensus        88 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           88 -----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             -----EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             -----cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence                 899999997 599988863        456899999999999999999999999999999999999999999999


Q ss_pred             eeeecccccCCC------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017083          187 GDFGLARTTSET------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL  260 (377)
Q Consensus       187 ~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~  260 (377)
                      +|||++......      .......+++.|+|||++.+...++.++||||||+++|+|++|..||.............. 
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-  241 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-  241 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-
Confidence            999998754432      1223456899999999987645689999999999999999999999987664433322111 


Q ss_pred             hCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          261 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                       ..++...                   ...........++..+.+||.+||+.||.+|||+.++++||||++...
T Consensus       242 -~~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          242 -NDPPSLE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             -SSCCCTT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             -cCCCccc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence             1111000                   000011223467889999999999999999999999999999987664

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.2e-47  Score=341.90  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=209.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +...++| ++++.||+|+||+||++.++.++..||+|++....  ......+.+|+.+++.++||||+++++++..... 
T Consensus        15 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   90 (302)
T 2j7t_A           15 LDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-   90 (302)
T ss_dssp             SCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C-
T ss_pred             cCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe-
Confidence            3444444 48999999999999999999999999999987542  2235678899999999999999999999987754 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          ++++|||+++ +|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        91 ----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           91 ----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             ----EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             ----EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence                8999999985 88887764 56799999999999999999999999999999999999999999999999998753


Q ss_pred             cCCC-ccccccccccccCCCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          195 TSET-DFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       195 ~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .... .......+++.|+|||++.    ....++.++||||||+++|+|++|..||...........+....  .+.   
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---  241 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPT---  241 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC---
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Ccc---
Confidence            2211 1223456789999999984    23668899999999999999999999998877655544333211  100   


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                             ......++..+.+||.+||+.||++|||+.++++||||++..
T Consensus       242 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 -----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             -----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             -----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                                   011124588899999999999999999999999999998755

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-47  Score=347.37  Aligned_cols=267  Identities=24%  Similarity=0.354  Sum_probs=214.2

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.++|. +++.||+|+||+||++++..+++.||+|++..... .......+.+|+.++++++||||+++++++......+
T Consensus        10 ~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           10 LSDRYE-LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             ETTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             ecCcEE-EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            444444 89999999999999999999999999999976543 3445567889999999999999999999987654311


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                       ...|+||||++ ++|.+++...+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        89 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           89 -PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             -EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             -cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence             22589999997 5999999888899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          197 ETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       197 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...    ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...  ...       
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~-------  237 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DPI-------  237 (311)
T ss_dssp             --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCC-------
T ss_pred             ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCC-------
Confidence            332    2234568999999999987 77899999999999999999999999887765544333221  110       


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                        ........++.++.++|.+||+.||.+||++.+++.|+|++....
T Consensus       238 ------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          238 ------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ------------------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ------------------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                              111223467999999999999999999999999999999986554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=339.36  Aligned_cols=254  Identities=25%  Similarity=0.419  Sum_probs=187.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||+|+||+||++.+..+|+.||+|++...... ......+.+|+.++++++||||+++++++.....     .+
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~   87 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY-----VY   87 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE-----EE
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe-----EE
Confidence            44899999999999999999999999999999643211 1123567899999999999999999999987754     89


Q ss_pred             EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      ++|||++ ++|.+++... .++++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            9999997 4899988764 67999999999999999999999999999999999999999999999999999865533 2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+                      
T Consensus       168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------------------  224 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----------------------  224 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----------------------
T ss_pred             cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----------------------
Confidence            2334578999999999977 67889999999999999999999999765432211100                      


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                           ..    ........++..+.+||.+||+.||++|||+.++++||||+...
T Consensus       225 -----~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          225 -----VL----ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             -----CS----SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             -----hh----cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                 00    00011234688999999999999999999999999999998644

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-46  Score=346.28  Aligned_cols=281  Identities=27%  Similarity=0.490  Sum_probs=222.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCC-cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC------ceeEeeeecCCCC
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN------VIAIKDIIRPPKK  115 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~  115 (377)
                      .|++++.||+|+||+||++.+..++ ..||+|+++..   ......+.+|+.++++++|++      ++.+++++.....
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            3448999999999999999998877 68999999753   344567778999999997665      8899998887654


Q ss_pred             CCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---------------
Q 017083          116 DTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---------------  178 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---------------  178 (377)
                           ++++|||+++++.+.+...  .++++..++.++.||+.||+|||++||+||||||+||++               
T Consensus        97 -----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 -----MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             -----EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             -----EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence                 8999999999999888765  379999999999999999999999999999999999999               


Q ss_pred             ----ccCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017083          179 ----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (377)
Q Consensus       179 ----~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~  254 (377)
                          +.++.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                56788999999999765433  345678999999999987 77899999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCcccccccc--------------chhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 017083          255 RLITELIGSPDDASLGFLR--------------SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  320 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps  320 (377)
                      ..+....+..+........              ............... ..........+..+.+||++||+.||++|||
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            8888888776654221110              001111111100000 0000111123557899999999999999999


Q ss_pred             HHHHhcCccccCCcC
Q 017083          321 VEEALRHPYLQSLHD  335 (377)
Q Consensus       321 ~~ell~~p~f~~~~~  335 (377)
                      +.|+|+||||+.+..
T Consensus       328 ~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          328 LAEALLHPFFAGLTP  342 (355)
T ss_dssp             HHHHTTSGGGGGCCH
T ss_pred             HHHHhcChhhcCCCh
Confidence            999999999997653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-47  Score=356.70  Aligned_cols=270  Identities=16%  Similarity=0.157  Sum_probs=195.6

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhc--CCCCceeEe-------eee
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM--EHENVIAIK-------DII  110 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~  110 (377)
                      .+.|.+++.||+|+||+||+++++.+|+.||+|++..... .......+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3445589999999999999999999999999999987644 334455667785555555  699988855       333


Q ss_pred             cCCCCCC------------CCcEEEEEecCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHhcCCceecCC
Q 017083          111 RPPKKDT------------FNDVYIVYELMDTDLHQIIRSD-QQLTDDHC------QYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       111 ~~~~~~~------------~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~------~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      ...+...            ...+++||||++++|.+++... ..+.....      ..++.||+.||+|||++||+||||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            3222111            1337999999999999999763 34555555      677799999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCccccccccccccCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~  250 (377)
                      ||+|||++.++.+||+|||++.......  ....+++.|+|||++.+ ...++.++|||||||++|+|++|..||.....
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            9999999999999999999998765432  24556799999999964 24679999999999999999999999976531


Q ss_pred             HHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       251 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                      ...             ......         ..............++.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       299 ~~~-------------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          299 GIK-------------GSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             TCT-------------TCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             ccc-------------cchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            100             000000         0000001111122345789999999999999999999999999999999


Q ss_pred             cCCc
Q 017083          331 QSLH  334 (377)
Q Consensus       331 ~~~~  334 (377)
                      +++.
T Consensus       357 ~~~~  360 (371)
T 3q60_A          357 LQLQ  360 (371)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=338.89  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=210.1

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ....+.|++++.||+|+||+||++.+..+|+.||+|.+....    ....+.+|+.++++++||||+++++++.....  
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD--   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE--
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE--
Confidence            344455668999999999999999999999999999997542    23567889999999999999999999987644  


Q ss_pred             CCcEEEEEecCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         ++++|||+++ +|.+++. ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        99 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           99 ---LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ---EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence               8999999985 9999886 4678999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          196 SET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       196 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....  .+         
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------  243 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PP---------  243 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC---------
T ss_pred             hhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Cc---------
Confidence            443 22345578999999999987 678999999999999999999999998876554443332210  00         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                       .......++..+.+||.+||..||.+|||+.++++||||++..
T Consensus       244 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 -----------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             -----------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             -----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                             0001124588899999999999999999999999999998755

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-46  Score=337.59  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=210.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||++++..++..||+|.+.... ........+.+|+.++++++||||+++++++.....     +
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-----~   86 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC-----Y   86 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE-----E
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe-----E
Confidence            3448999999999999999999999999999986543 344556788899999999999999999999987754     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +++|||++| +|.+++...+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            999999975 999999988899999999999999999999999999999999999999999999999999998665432 


Q ss_pred             -cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       200 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                       ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.............  ....+             
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~-------------  230 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI--QDSVP-------------  230 (294)
T ss_dssp             --------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH--SSCCC-------------
T ss_pred             cccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hccCC-------------
Confidence             2334578999999999987 778999999999999999999999998876544332211  11111             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                 .......+.+++.+.++|.+||..||.+||+..+.+.+.|..-+.+
T Consensus       231 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          231 -----------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             -----------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             -----------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                       1111223567999999999999999999996666666777655443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-46  Score=349.73  Aligned_cols=292  Identities=26%  Similarity=0.397  Sum_probs=219.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-----------CCCceeEeeee
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIKDII  110 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~  110 (377)
                      ..|++++.||+|+||+||++++..+++.||+|++...   ......+.+|+.++++++           ||||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3444899999999999999999999999999999753   334566778999998886           88999999998


Q ss_pred             cCCCCCCCCcEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCceEEcc------C
Q 017083          111 RPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNA------S  181 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dik~~NIli~~------~  181 (377)
                      ....... ..++++||+++++|.+++..  ...+++..++.++.||+.||+|||++ ||+||||||+||+++.      .
T Consensus        96 ~~~~~~~-~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           96 NHKGPNG-VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEETTE-EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             hccCCCC-ceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            8653211 24899999998899999876  35699999999999999999999998 9999999999999954      3


Q ss_pred             CCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 017083          182 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLR  255 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~------~~~~~~  255 (377)
                      +.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....      ....+.
T Consensus       175 ~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            47999999999766543  344578999999999987 778999999999999999999999998654      455666


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHhcccccccc-------------ccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ-------------FATRFPNKSSGAVDLLEKMLVFDPNKRITVE  322 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~  322 (377)
                      .+....+..+.........  ...+...........             ........+..+.+||.+||+.||++|||+.
T Consensus       252 ~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            6777777665432111000  000000000000000             0000113467889999999999999999999


Q ss_pred             HHhcCccccCCcCCCCCCCC
Q 017083          323 EALRHPYLQSLHDLNDEPVC  342 (377)
Q Consensus       323 ell~~p~f~~~~~~~~~~~~  342 (377)
                      |+|+||||++..........
T Consensus       330 ell~hp~f~~~~~~~~~~~~  349 (373)
T 1q8y_A          330 GLVNHPWLKDTLGMEEIRVP  349 (373)
T ss_dssp             HHHTCGGGTTCTTCTTCCCT
T ss_pred             HHhhChhhhcccCcccccCc
Confidence            99999999987665544433

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-47  Score=350.52  Aligned_cols=271  Identities=22%  Similarity=0.345  Sum_probs=187.7

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      ...+.+.++|..+.+.||+|+||+||++.++.+++.||+|++...   ..   ...+....++.++||||+++++++...
T Consensus        21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            345677778774455799999999999999999999999998642   11   122233345677899999999998753


Q ss_pred             CCCCCCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC---CCeEEe
Q 017083          114 KKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIG  187 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~-~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~---~~vkl~  187 (377)
                      ... ...+++||||+++ +|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++.+   +.+||+
T Consensus        95 ~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           95 HHG-KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             ETT-EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCC-CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence            211 1337999999985 9999997653  69999999999999999999999999999999999999864   459999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....      
T Consensus       174 Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------  245 (336)
T 3fhr_A          174 DFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI------  245 (336)
T ss_dssp             CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             ccccceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh------
Confidence            99999765533 2345677999999999876 678899999999999999999999997654332211111100      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                       ...........+..+++.+.+||.+||+.||++|||+.|+|+||||++....
T Consensus       246 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  297 (336)
T 3fhr_A          246 -----------------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV  297 (336)
T ss_dssp             ----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred             -----------------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence                             0001111223345789999999999999999999999999999999875543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-46  Score=336.28  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=212.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||++.++.+++.||+|.+..........+.+.+|+.++++++||||+++++++.....   ..+++
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~l   84 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYI   84 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ceEEE
Confidence            348999999999999999999999999999998765566667788899999999999999999998754322   33899


Q ss_pred             EEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          124 VYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      +|||+++ +|.+++..    ...+++..++.++.||+.||+|||+.|     ++|+||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            9999985 99998864    335999999999999999999999999     9999999999999999999999999997


Q ss_pred             ccCCCc-cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....          
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----------  233 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------  233 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred             eeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----------
Confidence            655432 2334567899999999987 6789999999999999999999999988775554444433110          


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                          ......++..+.++|.+||+.||++|||+.|+++|+|+..-
T Consensus       234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                01123568899999999999999999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.9e-46  Score=336.05  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=214.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++++.||+|+||+||++++..+++.||+|++...... .....+.+|+.++++++||||+++++++.....     +
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   95 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----L   95 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----E
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-----E
Confidence            3445899999999999999999999999999999754322 245678899999999999999999999987654     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                      +++|||+++ +|.+++.. +++++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999985 88887754 679999999999999999999999999999999999999999999999999997655432 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....                  
T Consensus       175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  235 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN------------------  235 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------------
T ss_pred             ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC------------------
Confidence            2345678999999999987 778899999999999999999999998876555443332210                  


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                  .......++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       236 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                        011123568899999999999999999999999999999753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-45  Score=336.55  Aligned_cols=272  Identities=23%  Similarity=0.341  Sum_probs=214.1

Q ss_pred             EEEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC--CCCcee
Q 017083           28 VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIA  105 (377)
Q Consensus        28 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~  105 (377)
                      .+-+...+.+.+..+.|++++.||+|+||+||++.+. +++.||+|++............+.+|+.++++++  ||||++
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            3445566778888888889999999999999999985 4889999999776556667788899999999997  599999


Q ss_pred             EeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeE
Q 017083          106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (377)
Q Consensus       106 ~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vk  185 (377)
                      +++++.....     ++++||+.+++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||++++ +.+|
T Consensus        93 ~~~~~~~~~~-----~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           93 LYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEEEEECSSE-----EEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEE
T ss_pred             EEEEeecCCE-----EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEE
Confidence            9999988754     899999888899999998889999999999999999999999999999999999999964 7899


Q ss_pred             EeeeecccccCCCc---cccccccccccCCCcccccc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 017083          186 IGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (377)
Q Consensus       186 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~  252 (377)
                      |+|||++.......   ......+++.|+|||.+.+.          ..++.++||||||+++|+|++|..||.......
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            99999998654332   22345789999999998641          367889999999999999999999997654321


Q ss_pred             HHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       253 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .  .+.........                          .......+..+.+||.+||+.||++|||+.|+++||||+.
T Consensus       247 ~--~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          247 S--KLHAIIDPNHE--------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             H--HHHHHHCTTSC--------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             H--HHHHHHhcccc--------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            1  11121111100                          0111234788999999999999999999999999999986


Q ss_pred             Cc
Q 017083          333 LH  334 (377)
Q Consensus       333 ~~  334 (377)
                      ..
T Consensus       299 ~~  300 (313)
T 3cek_A          299 QT  300 (313)
T ss_dssp             C-
T ss_pred             CC
Confidence            44

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.2e-46  Score=345.87  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=210.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeC-------CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEee
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD  108 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  108 (377)
                      +++..+.|++.+.||+|+||+||++.+.       .++..||+|+++... .......+.+|+.+++++ +||||+++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            5666777789999999999999999874       345679999997652 444567888999999999 8999999999


Q ss_pred             eecCCCCCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 017083          109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (377)
Q Consensus       109 ~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~di  171 (377)
                      ++.....     +|+||||+++ +|.+++....                .+++..+..++.||+.||+|||++||+||||
T Consensus       155 ~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl  229 (370)
T 2psq_A          155 ACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL  229 (370)
T ss_dssp             EECSSSS-----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EEccCCC-----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            9987755     8999999985 9999987643                4789999999999999999999999999999


Q ss_pred             CCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 017083          172 KPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG  247 (377)
Q Consensus       172 k~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~  247 (377)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus       230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999998654332   2233455788999999987 778999999999999999999 9999987


Q ss_pred             CChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          248 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       248 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .........+....                              .......++.++.+||.+||+.||++|||+.|++++
T Consensus       309 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          309 IPVEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CCGGGHHHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66554443332210                              011223568899999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=341.81  Aligned_cols=281  Identities=17%  Similarity=0.251  Sum_probs=210.7

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++.+.||+|+||+||+++++.+++.||+|++..... ....+.+.+|+.++++++||||+++++++.....   ..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~   84 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHK   84 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceE
Confidence            344489999999999999999999999999999975422 2234667799999999999999999999876643   348


Q ss_pred             EEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE----ccCCCeEEeeeeccc
Q 017083          122 YIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLAR  193 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli----~~~~~vkl~Dfg~~~  193 (377)
                      ++||||++ ++|.+++....   .+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999997 59999987543   39999999999999999999999999999999999999    777789999999998


Q ss_pred             ccCCCccccccccccccCCCccccc-------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLN-------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPD  265 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~  265 (377)
                      ............+++.|+|||++..       ...++.++|||||||++|+|++|..||..... ......+.......+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            8776665666788999999999862       26788999999999999999999999965332 222222333332222


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                      ..............  ..+.. ...........++..+.+||++||+.||++|||++|+|+||-
T Consensus       245 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGP--IDWSG-DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCC--EEEES-SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCc--cccCc-cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            21111100000000  00000 000000111234667899999999999999999999999973

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=338.63  Aligned_cols=261  Identities=23%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCC-CCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD-TFN  119 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~  119 (377)
                      ..|++++.||+|+||+||++++..+++.||+|++.....   ....+.+|+.+++++ +||||+++++++...... ...
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            344489999999999999999999999999999865432   235677899999999 799999999998764311 124


Q ss_pred             cEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          120 DVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      .++++|||+++ +|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            48999999985 999998764  579999999999999999999999999999999999999999999999999987654


Q ss_pred             CC-ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          197 ET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       197 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      .. .......+++.|+|||++..    ...++.++||||||+++|+|++|..||...........+....  .+      
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------  252 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP------  252 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cc------
Confidence            33 22345578999999999862    2568899999999999999999999998876555443332210  00      


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                           ......++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence                                 011235688999999999999999999999999999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=330.83  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=204.2

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .....||+|+||+||++.+..++..||+|.+...  .......+.+|+.+++.++||||+++++++.....     .+++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv   97 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF-----IKIF   97 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE-----EEEE
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc-----EEEE
Confidence            3556899999999999999999999999998764  23345678899999999999999999999987654     8999


Q ss_pred             EecCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-CCCeEEeeeecccccCCC-
Q 017083          125 YELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-~~~vkl~Dfg~~~~~~~~-  198 (377)
                      |||++ ++|.+++...   ..+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||++...... 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99997 5999988764   24678899999999999999999999999999999999988 889999999999765443 


Q ss_pred             ccccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          199 DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                      .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...................             
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  244 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-------------  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-------------
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-------------
Confidence            223455789999999998762 237889999999999999999999997644332211111111100             


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                     ......+++.+.+||.+||+.||++|||+.++++||||+....
T Consensus       245 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          245 ---------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ---------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                           1112357899999999999999999999999999999986553

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-45  Score=328.32  Aligned_cols=252  Identities=19%  Similarity=0.343  Sum_probs=211.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|.+..+.|++++.||+|+||+||++.+. ++..||+|++......   .+.+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            47778788889999999999999999986 4678999999765333   3568899999999999999999999988755


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           .+++|||+++ +|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        80 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           80 -----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             -----EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             -----eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence                 8999999985 89998865 4568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------  225 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------  225 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred             cccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc--------
Confidence            654432  2334455778999999977 778999999999999999999 9999988776665544433111        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            .......++.+.+++.+||+.||++|||+.+++++
T Consensus       226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ----------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                  11122458889999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=344.13  Aligned_cols=260  Identities=24%  Similarity=0.321  Sum_probs=213.4

Q ss_pred             ceeeecccccCCcccccCCccceEEEEE-----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      +..++..+.+++++.||+|+||+||+++     +..++..||+|++... ........+.+|+.++++++||||++++++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4456777778899999999999999999     4567789999999654 234455678899999999999999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~  181 (377)
                      +.....     .++||||++ |+|.+++...       ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       143 ~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  217 (367)
T 3l9p_A          143 SLQSLP-----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  217 (367)
T ss_dssp             ECSSSS-----CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             EecCCC-----CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC
Confidence            987755     799999997 5999998754       358999999999999999999999999999999999999965


Q ss_pred             C---CeEEeeeecccccCC---CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017083          182 C---DLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (377)
Q Consensus       182 ~---~vkl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~  254 (377)
                      +   .+||+|||++.....   ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.........
T Consensus       218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            5   499999999974321   122334566889999999987 788999999999999999998 99999988766655


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      ..+.....                              ......++..+.+||.+||+.||++|||+.+++++.++.
T Consensus       297 ~~i~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          297 EFVTSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            44433111                              111235688899999999999999999999999998775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-46  Score=343.18  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=209.1

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcC--CCCceeEeeeecCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHME--HENVIAIKDIIRPP  113 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~  113 (377)
                      ....|++.+.||+|+||+||++.+..+++.||+|++.......    .....+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3444459999999999999999999999999999996543221    11234557999999996  59999999999877


Q ss_pred             CCCCCCcEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc-cCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~-~~~~vkl~Dfg  190 (377)
                      ..     +++++|++.  ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||
T Consensus       121 ~~-----~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SE-----EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             Cc-----EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            54     899999997  69999998888999999999999999999999999999999999999999 77899999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++....... .....+++.|+|||++.+....+.++||||||+++|+|++|..||.....      +..  ..       
T Consensus       196 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~-------  259 (320)
T 3a99_A          196 SGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ-------  259 (320)
T ss_dssp             TCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC-------
T ss_pred             ccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc-------
Confidence            998765432 34567899999999997744457889999999999999999999965310      000  00       


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                            ......+++.+.+||++||+.||++|||+.++++||||++..
T Consensus       260 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 ----------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ----------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                                  011235789999999999999999999999999999998765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.4e-46  Score=340.18  Aligned_cols=267  Identities=22%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +.+..+.|++++.||+|+||+||++.++.++.   .||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            45666667799999999999999999987765   899999987655555678889999999999999999999998776


Q ss_pred             CCC-CCCcEEEEEecCCC-CHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeE
Q 017083          114 KKD-TFNDVYIVYELMDT-DLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (377)
Q Consensus       114 ~~~-~~~~~~iv~e~~~~-~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vk  185 (377)
                      ... .....++++||+.+ +|.+++....      .+++..++.++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            441 11224899999985 9999886432      689999999999999999999999999999999999999999999


Q ss_pred             EeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017083          186 IGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       186 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      |+|||++........   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999976544322   223445778999999987 778999999999999999999 999998876554443332210


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-------HHHHhcCccccCCc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-------VEEALRHPYLQSLH  334 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-------~~ell~~p~f~~~~  334 (377)
                                                    .....+.+++.+.+||.+||+.||++|||       ++++++|||+.+..
T Consensus       257 ------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 ------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             ------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             ------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                                          01122467889999999999999999999       78888899997644

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=339.52  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=193.7

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPP  113 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  113 (377)
                      ..+++....|++.+.||+|+||+||++++..+++.||+|++...  .......+.+|+.+++++. ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            44566777777999999999999999999999999999998543  4445667889999999996 99999999998432


Q ss_pred             CC---CCCCcEEEEEecCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCCCeE
Q 017083          114 KK---DTFNDVYIVYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLK  185 (377)
Q Consensus       114 ~~---~~~~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~~vk  185 (377)
                      ..   .....+++++||++|+|.+++..   .+++++..++.++.||+.||+|||++|  |+|+||||+||+++.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence            11   22244899999999999998864   567999999999999999999999999  99999999999999999999


Q ss_pred             EeeeecccccCCCccc-------------cccccccccCCCcccc--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 017083          186 IGDFGLARTTSETDFM-------------TEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (377)
Q Consensus       186 l~Dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~  250 (377)
                      |+|||++.........             ....+++.|+|||++.  ....++.++||||||+++|+|++|..||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999999865543211             1445789999999983  226678899999999999999999999965432


Q ss_pred             HHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          251 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       251 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                      .....   ...                              ........+..+.+||++||+.||.+|||+.|++++-+
T Consensus       259 ~~~~~---~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          259 LRIVN---GKY------------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------C------------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHhhc---Ccc------------------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            21110   000                              01112345778999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=334.74  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=208.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +....|++.+.||+|+||+||++.++.+++.||+|++...  .......+.+|+.++++++||||+++++++.....   
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---   81 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR---   81 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE---
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe---
Confidence            3344555899999999999999999999999999988553  45566788899999999999999999999987754   


Q ss_pred             CcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          119 NDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                        .++||||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           82 --LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             --EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             --eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence              8999999985 99999987 6779999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccc---------------cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017083          197 ETDFM---------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       197 ~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      .....               ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--------  230 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--------  230 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--------
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--------
Confidence            33211               14578999999999987 7889999999999999999999998865321100        


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                ............          ...+.+++.+.++|.+||+.||++|||+.++++  |++.+.
T Consensus       231 ----------~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          231 ----------DFGLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             ----------TSSBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             ----------HHhhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                      000000111110          112467889999999999999999999999986  555443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-45  Score=341.77  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=212.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEE-----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      ...|++..+.|++++.||+|+||+||++.     +..+++.||+|++.... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            45678888888899999999999999999     66677999999997642 334557788999999999 699999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCC---------------------------------------------
Q 017083          108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---------------------------------------------  141 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~---------------------------------------------  141 (377)
                      +++.....    .++++|||+++ +|.+++.....                                             
T Consensus        93 ~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECSTTS----CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeecCCC----ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99877532    27899999985 99999876433                                             


Q ss_pred             ---------------------CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-
Q 017083          142 ---------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (377)
Q Consensus       142 ---------------------~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-  199 (377)
                                           +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                                 8899999999999999999999999999999999999999999999999998654332 


Q ss_pred             --cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||..................             
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------  314 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------  314 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-------------
T ss_pred             chhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-------------
Confidence              2334567889999999987 778999999999999999998 99999876644333322221111             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                      ......+++.+.++|.+||+.||++|||+.|+++|
T Consensus       315 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          315 ----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                            11123468899999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-46  Score=345.59  Aligned_cols=274  Identities=22%  Similarity=0.329  Sum_probs=212.6

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH---------------HHHHHHHHHHHHHHhcCCCCcee
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---------------IDARRTLREIKLLRHMEHENVIA  105 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~  105 (377)
                      ...|++++.||+|+||+||++.+  +++.||+|.+.......               .....+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            34555999999999999999998  88999999986532111               11267889999999999999999


Q ss_pred             EeeeecCCCCCCCCcEEEEEecCCC-CHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCc
Q 017083          106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQI------IRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN  175 (377)
Q Consensus       106 ~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~------l~~--~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~N  175 (377)
                      +++++.....     +++||||+++ +|.++      +..  ...+++..++.++.||+.||+|||+ +|++|+||+|+|
T Consensus       108 ~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDE-----VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSE-----EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEeeCCe-----EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999988754     8999999986 88887      655  5789999999999999999999999 999999999999


Q ss_pred             eEEccCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 017083          176 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFPGKDY-VHQ  253 (377)
Q Consensus       176 Ili~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~ll~ell~g~~pf~~~~~-~~~  253 (377)
                      |+++.++.++|+|||++...... ......++..|+|||++.+...++. ++||||||+++|+|++|..||..... ...
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999999875444 3455678999999999987435555 99999999999999999999988665 443


Q ss_pred             HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       254 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      ...+.......+.....+..            .............++..+.+||.+||+.||.+|||+.|+++||||++.
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLY------------PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTT------------TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHhccCcCCccchhhhhc------------cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            33332211111110000000            000000011124679999999999999999999999999999999864


Q ss_pred             c
Q 017083          334 H  334 (377)
Q Consensus       334 ~  334 (377)
                      .
T Consensus       330 ~  330 (348)
T 2pml_X          330 N  330 (348)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=335.98  Aligned_cols=253  Identities=22%  Similarity=0.322  Sum_probs=209.2

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .++....|++.+.||+|+||+||++.++.++.   .||||++.... .......+.+|+.++++++||||+++++++...
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            35666777799999999999999999986655   49999997643 344567788999999999999999999999876


Q ss_pred             CCCCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ..     +++||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus       123 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          123 RL-----AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             GC-----CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             Cc-----cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence            54     8999999974 999998654 6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +.......    ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....    
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----  272 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----  272 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC----
Confidence            98654432    1223344678999999977 778999999999999999999 9999988776665554433111    


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                ......+++.+.+||.+||..||++|||+.++++
T Consensus       273 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 --------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      1112357899999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3e-45  Score=328.92  Aligned_cols=252  Identities=20%  Similarity=0.328  Sum_probs=208.8

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|++..+.|++++.||+|+||+||++.+. ++..||+|++......   ...+.+|+.++++++||||+++++++.....
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            46777777889999999999999999886 5678999999765333   3567899999999999999999999987755


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           ++++|||++ ++|.+++.. ..++++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        94 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           94 -----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             -----EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             -----eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence                 899999997 599999876 5679999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+......       
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------  240 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------  240 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------
T ss_pred             cccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-------
Confidence            654432  2233445778999999987 678999999999999999998 99999887766655544332111       


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                             ......++.+.++|.+||+.||++|||+.++++|
T Consensus       241 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 -----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                   1112458889999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.1e-45  Score=331.61  Aligned_cols=257  Identities=28%  Similarity=0.402  Sum_probs=198.6

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC--------C
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--------D  116 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--------~  116 (377)
                      ++++.||+|+||+||++++..+++.||+|++...   ......+.+|+.++++++||||+++++++.....        .
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            3889999999999999999999999999999642   3456778899999999999999999998865321        1


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ....++++|||++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  165 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN  165 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence            1244899999997 5999999754 4678899999999999999999999999999999999999999999999999976


Q ss_pred             cCCC---------------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017083          195 TSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (377)
Q Consensus       195 ~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~  259 (377)
                      ....               .......+++.|+|||++.+...++.++||||||+++|+|++   ||......  ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~~~~~~  240 (303)
T 1zy4_A          166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--VNILKK  240 (303)
T ss_dssp             TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHHHH
T ss_pred             cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--HHHHHh
Confidence            5421               123445678999999999875578999999999999999998   55432211  111111


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      .....                        ...........+..+.++|++||+.||.+|||+.++++||||+..
T Consensus       241 ~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          241 LRSVS------------------------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHSTT------------------------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             ccccc------------------------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            11100                        000111123457789999999999999999999999999999753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-45  Score=344.80  Aligned_cols=256  Identities=21%  Similarity=0.351  Sum_probs=213.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.|.+..+.+.+.+.||+|+||+||++.++.+++.||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            4567888888889999999999999999999999999999997542 333456678999999999999999999999877


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ..     +++||||++ |+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus       185 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          185 QP-----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SS-----CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CC-----cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            54     899999997 6999998764 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc---cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          192 ARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       192 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +.........   ....++..|+|||++.+ ..++.++|||||||++|||++ |..||...........+.....     
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-----  333 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-----  333 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-----
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            9765433211   12234678999999987 678999999999999999998 9999988776554433322100     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               .+....+++.+.+||.+||+.||++|||+.++++
T Consensus       334 -------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 -------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                     0112346889999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=339.57  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=211.5

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .+++..+.|++++.||+|+||+||++++.     .+++.||+|++.... .......+.+|+.++++++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35677778889999999999999999987     456899999997653 344567788999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCCC-CHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q 017083          111 RPPKKDTFNDVYIVYELMDT-DLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSAS  165 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~LH~~~  165 (377)
                      .....     ++++|||+++ +|.+++...                        .++++..++.++.||+.||+|||++|
T Consensus       120 ~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  194 (343)
T 1luf_A          120 AVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  194 (343)
T ss_dssp             CSSSS-----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCc-----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            87654     8999999985 999998763                        57899999999999999999999999


Q ss_pred             ceecCCCCCceEEccCCCeEEeeeecccccCCC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 017083          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-R  241 (377)
Q Consensus       166 i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g  241 (377)
                      |+||||||+||+++.++.+||+|||++......   .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcC
Confidence            999999999999999999999999998754332   12334566888999999987 778999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          242 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       242 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                      ..||...........+....                              .......++..+.+||++||+.||++|||+
T Consensus       274 ~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             CCTTTTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcCCCCChHHHHHHHhCCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            99998877655544332210                              011123568899999999999999999999


Q ss_pred             HHHhcC
Q 017083          322 EEALRH  327 (377)
Q Consensus       322 ~ell~~  327 (377)
                      .+++++
T Consensus       324 ~~~~~~  329 (343)
T 1luf_A          324 CSIHRI  329 (343)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999763

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=339.49  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=214.4

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..|++..+.+++.+.||+|+||+||+|++..       .+..||+|++... ........+.+|+.+++++ +||||+++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            3467777888899999999999999999753       3457999999765 3445567888999999999 89999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      ++++.....     +++||||+++ +|.+++....                .+++..++.++.||+.||+|||++||+||
T Consensus       141 ~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  215 (382)
T 3tt0_A          141 LGACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  215 (382)
T ss_dssp             EEEECSSSS-----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeeeccCCc-----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            999988755     8999999975 9999997643                48999999999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf  245 (377)
                      ||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus       216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998655432   2334456788999999987 788999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ...........+.....                              ......+++.+.+||++||+.||++|||+.|++
T Consensus       295 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  344 (382)
T 3tt0_A          295 PGVPVEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  344 (382)
T ss_dssp             TTCCHHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            88776655444432110                              111235789999999999999999999999999


Q ss_pred             cC
Q 017083          326 RH  327 (377)
Q Consensus       326 ~~  327 (377)
                      ++
T Consensus       345 ~~  346 (382)
T 3tt0_A          345 ED  346 (382)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-45  Score=332.89  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=212.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .|++..+.|.+.+.||+|+||+||++.+     +.++..||+|++.... .......+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            4677788888999999999999999988     3456889999997543 345567788999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHhcCC
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------------LTDDHCQYFLYQLLRGLKYVHSAS  165 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~al~~LH~~~  165 (377)
                      .....     ++++|||++ ++|.+++.....                        +++..++.++.||+.||+|||++|
T Consensus        96 ~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           96 SQDGP-----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             CSSSS-----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ecCCc-----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            87755     899999998 699999976443                        889999999999999999999999


Q ss_pred             ceecCCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 017083          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-R  241 (377)
Q Consensus       166 i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g  241 (377)
                      |+|+||||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus       171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999997654432   1233455788999999987 778999999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          242 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       242 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                      ..||...........+....                              .......+++.+.++|.+||+.||++|||+
T Consensus       250 ~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  299 (314)
T 2ivs_A          250 GNPYPGIPPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVF  299 (314)
T ss_dssp             CCSSTTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            99998766544433332210                              011223678999999999999999999999


Q ss_pred             HHHhcC
Q 017083          322 EEALRH  327 (377)
Q Consensus       322 ~ell~~  327 (377)
                      .+++++
T Consensus       300 ~~l~~~  305 (314)
T 2ivs_A          300 ADISKD  305 (314)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-45  Score=325.16  Aligned_cols=251  Identities=19%  Similarity=0.316  Sum_probs=208.8

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +++..+.|++++.||+|+||+||++.++ ++..||+|++......   ...+.+|+.++++++||||+++++++..... 
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc-
Confidence            4566777779999999999999999886 5678999999765333   3567899999999999999999999987754 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                          .+++|||++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        78 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           78 ----IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             ----eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence                899999997 5899988764 4599999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          195 TSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       195 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....         
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  223 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------  223 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC---------
Confidence            554422  233445678999999977 678999999999999999998 9999988776655444332110         


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                           .......++.+.++|.+||+.||++|||+.+++++
T Consensus       224 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ---------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 01112458889999999999999999999999976

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-44  Score=329.81  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=213.6

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ....|++....|++.+.||+|+||+||++.+     ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            3456788888888999999999999999984     5678899999997543 334557788999999999 89999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCce
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVL  167 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~LH~~~i~  167 (377)
                      ++++.....     .+++|||+++ +|.+++....                  .+++..++.++.||+.||+|||++|++
T Consensus        93 ~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  167 (313)
T 1t46_A           93 LGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI  167 (313)
T ss_dssp             EEEECSSSS-----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEecCCC-----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            999987755     8999999985 9999987643                  489999999999999999999999999


Q ss_pred             ecCCCCCceEEccCCCeEEeeeecccccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 017083          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP  243 (377)
Q Consensus       168 H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~  243 (377)
                      |+||||+||+++.++.+||+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..
T Consensus       168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999986654422   233456788999999987 778999999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 017083          244 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       244 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      ||..................                             ......++..+.++|.+||+.||.+|||+.|
T Consensus       247 p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          247 PYPGMPVDSKFYKMIKEGFR-----------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             SSTTCCSSHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCcccchhHHHHHhccCCC-----------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            99876544333322221100                             0112356889999999999999999999999


Q ss_pred             HhcC
Q 017083          324 ALRH  327 (377)
Q Consensus       324 ll~~  327 (377)
                      ++++
T Consensus       298 ll~~  301 (313)
T 1t46_A          298 IVQL  301 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.2e-45  Score=327.61  Aligned_cols=253  Identities=22%  Similarity=0.389  Sum_probs=214.1

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.|++..+.|++.+.||+|+||+||++.++.++..||+|.+...   ....+.+.+|+.++++++||||+++++++....
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            45777778888999999999999999999999999999999753   234567889999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .     +++||||++ ++|.+++..  ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        83 ~-----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           83 P-----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             S-----EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             C-----EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence            5     899999998 599999976  34589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          192 ARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       192 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      +.......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------  230 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------  230 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------
T ss_pred             ceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------
Confidence            98765443  2233455778999999987 778999999999999999999 9999988765544443322110      


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                              ......+++.+.+||++||..||.+|||+.++++
T Consensus       231 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                    1122357899999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-45  Score=330.39  Aligned_cols=270  Identities=20%  Similarity=0.351  Sum_probs=205.3

Q ss_pred             eeecccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .++..+.|++++.||+|+||+||+++    +..+++.||+|++...  .......+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45666777799999999999999998    6778999999999754  44556778899999999999999999999865


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ...   ..+++||||++ ++|.+++...+ ++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           83 AGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            432   23799999997 59999997644 59999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          191 LARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       191 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ++.......    ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......     ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccc
Confidence            998654432    2233456778999999987 77899999999999999999999988653211     1111111111


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..      ..........   ......+....+++++.+||++||+.||++|||+.|+++
T Consensus       234 ~~------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQ------MIVFHLIELL---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TH------HHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cc------hhHHHHHHHH---hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00      0000011111   111112223467899999999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1e-44  Score=325.27  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=199.8

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      +.|++..+.|++.+.||+|+||+||++.+..+   +..||+|.+... ......+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            34677777888999999999999999998654   456999998754 23445677889999999999999999999985


Q ss_pred             CCCCCCCCcEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          112 PPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      .+      ..++||||+++ +|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+||
T Consensus        87 ~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           87 EN------PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             SS------SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             cC------ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence            43      26899999985 9999987644 7999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          190 GLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       190 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      |++........  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....     
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-----  234 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-----  234 (281)
T ss_dssp             ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred             ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-----
Confidence            99986654322  223345678999999977 778999999999999999996 999998776554443332210     


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                               .....+.+++.+.++|.+||+.||++|||+.+++++
T Consensus       235 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 -------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     011224678999999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.4e-45  Score=330.80  Aligned_cols=264  Identities=19%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      ....+.+..+.|.+.+.||+|+||+||++.+..   ++..||+|.+..........+.+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            344567777778799999999999999998765   56689999998766666667788999999999999999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIR------SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~------~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~  182 (377)
                      +...........++++||++ ++|.+++.      ....+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            98765544345799999998 59999884      345699999999999999999999999999999999999999999


Q ss_pred             CeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017083          183 DLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       183 ~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~  258 (377)
                      .+||+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            99999999997654332   1233455788999999987 778999999999999999999 899998766554443332


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...                              .......+++.+.++|.+||..||.+|||+.+++++
T Consensus       264 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          264 HGH------------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTC------------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCC------------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            210                              011123578899999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.6e-45  Score=332.92  Aligned_cols=249  Identities=19%  Similarity=0.204  Sum_probs=202.3

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.+|. +++.||+|+||+||++++..+++.||||++.....    ...+.+|+.+++++ +||||+++++++.....   
T Consensus         8 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---   79 (330)
T 2izr_A            8 GPNFR-VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY---   79 (330)
T ss_dssp             TTTEE-EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE---
T ss_pred             cCCeE-EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc---
Confidence            33443 89999999999999999999999999999865422    23577899999999 89999999999987654   


Q ss_pred             CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC-----eEEeeeecc
Q 017083          119 NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLA  192 (377)
Q Consensus       119 ~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~-----vkl~Dfg~~  192 (377)
                        .++||||++++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.     +||+|||++
T Consensus        80 --~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           80 --NAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             --EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             --cEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence              899999998899999986 578999999999999999999999999999999999999998887     999999999


Q ss_pred             cccCCCcc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh
Q 017083          193 RTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---QLRLITELI  261 (377)
Q Consensus       193 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~---~~~~i~~~~  261 (377)
                      ........        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......   ....+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            86543321        245678999999999988 778999999999999999999999998754332   222222211


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ...+.                          .......+ ++.++|.+||+.||.+||+++++++
T Consensus       237 ~~~~~--------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          237 RATPI--------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHSCH--------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccCCH--------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            00000                          00112234 8999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.4e-44  Score=324.18  Aligned_cols=259  Identities=22%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.++|....|++.+.||+|+||+||++.+..   .||+|+++...........+.+|+.++++++||||++++++....
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   92 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC
Confidence            34578888888899999999999999998754   499999987766777778899999999999999999999976443


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .      .+++|||++ ++|.+.+.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        93 ~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           93 Q------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             S------CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             c------cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            2      699999998 589888854 45799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC---CccccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSE---TDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +.....   ........+++.|+|||++..  ...++.++||||||+++|+|++|..||...........+.......+.
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            975443   222344578999999999862  256788999999999999999999999886655544433332111111


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               .......+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 -------------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             -------------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                     11123467899999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=334.27  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhc----CCCCceeEeeeecCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHM----EHENVIAIKDIIRPP  113 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~  113 (377)
                      +.|++.+.||+|+||+||++.+..+++.||+|++.......    .....+.+|+.+++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            44458999999999999999999999999999997543221    1223345799999998    899999999999876


Q ss_pred             CCCCCCcEEEEEec-CC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc-cCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYEL-MD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~-~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~-~~~~vkl~Dfg  190 (377)
                      ..     .++++|+ +. ++|.+++...+.+++..++.++.||+.||+|||++||+|+||||+||+++ .++.++|+|||
T Consensus       111 ~~-----~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          111 EG-----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             Ce-----EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            54     7999998 55 69999998888899999999999999999999999999999999999999 78899999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++....... .....++..|+|||++.+....+.++||||||+++|+|++|..||....      .+...          
T Consensus       186 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~----------  248 (312)
T 2iwi_A          186 SGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----------  248 (312)
T ss_dssp             SCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----------
T ss_pred             hhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----------
Confidence            998765443 3456789999999998773444568999999999999999999996531      01100          


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                           .......++..+.+||.+||+.||++|||+.|+++||||+...+
T Consensus       249 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                                 00112356889999999999999999999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=334.06  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=209.3

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD  108 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  108 (377)
                      ..|++..+.|++.+.||+|+||+||++.+     ..++..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            35788888888999999999999999997     3466789999997542 223456788999999999 8999999999


Q ss_pred             eecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcC
Q 017083          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------------------QLTDDHCQYFLYQLLRGLKYVHSA  164 (377)
Q Consensus       109 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~al~~LH~~  164 (377)
                      ++.....     ++++|||++ ++|.+++....                       .+++..++.++.||+.||+|||++
T Consensus       117 ~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  191 (344)
T 1rjb_A          117 ACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK  191 (344)
T ss_dssp             EECSSSS-----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEeeCCc-----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9988755     899999997 59999997643                       378999999999999999999999


Q ss_pred             CceecCCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-
Q 017083          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  240 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-  240 (377)
                      ||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ 
T Consensus       192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTT
T ss_pred             CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcC
Confidence            99999999999999999999999999997654332   2234456788999999987 778999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 017083          241 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  320 (377)
Q Consensus       241 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps  320 (377)
                      |..||...........+.....                             .......+++.+.+||.+||+.||.+|||
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  321 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPS  321 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCcccCCcHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence            9999987654433322221100                             01112356889999999999999999999


Q ss_pred             HHHHhcCcc
Q 017083          321 VEEALRHPY  329 (377)
Q Consensus       321 ~~ell~~p~  329 (377)
                      +.+++++..
T Consensus       322 ~~~l~~~l~  330 (344)
T 1rjb_A          322 FPNLTSFLG  330 (344)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999998643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-44  Score=324.66  Aligned_cols=251  Identities=16%  Similarity=0.166  Sum_probs=205.0

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ..+.|++++.||+|+||+||++.+..+++.||+|++.....    ...+.+|+.+++.+ +|++++++++++.....   
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~---   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH---   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE---
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce---
Confidence            33444489999999999999999999999999999865422    23567899999999 69999999999877644   


Q ss_pred             CcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC-----eEEeeeecc
Q 017083          119 NDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLA  192 (377)
Q Consensus       119 ~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~-----vkl~Dfg~~  192 (377)
                        .+++|||++++|.+++... .++++..++.++.||+.||+|||++||+||||||+||+++.++.     +||+|||++
T Consensus        81 --~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           81 --NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             --EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             --eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence              8999999988999999864 46999999999999999999999999999999999999987776     999999999


Q ss_pred             cccCCCc--------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHh
Q 017083          193 RTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRLITELI  261 (377)
Q Consensus       193 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~  261 (377)
                      .......        ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....   .......+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            8655432        2345678999999999987 778999999999999999999999998743   222222222211


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ...                          ......+.+++.+.+||.+||+.||++|||+.++++
T Consensus       238 ~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          238 QST--------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHS--------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCc--------------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            101                          111223467899999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.8e-44  Score=320.75  Aligned_cols=252  Identities=20%  Similarity=0.291  Sum_probs=202.5

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHH-----HHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +..+.|++.+.||+|+||+||++++..+++.||+|++..........     ..+.+|+.++++++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            44455558999999999999999999999999999986543222211     6778999999999999999999999765


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCCC-----e
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCD-----L  184 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~~-----v  184 (377)
                             .+++|||++ ++|.+.+.. ..++++..++.++.|++.||+|||++|  ++|+||||+||+++.++.     +
T Consensus        96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence                   369999998 699887765 457999999999999999999999999  999999999999988776     9


Q ss_pred             EEeeeecccccCCCccccccccccccCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      ||+|||++......  .....+++.|+|||++.+ ...++.++||||||+++|+|++|..||..................
T Consensus       169 kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          169 KVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             EECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             EeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            99999999755443  445678999999999843 245688999999999999999999999765533321111111000


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .                           .......+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 L---------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             C---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C---------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0                           01122357899999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-45  Score=326.53  Aligned_cols=248  Identities=17%  Similarity=0.259  Sum_probs=202.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCC-------cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      ++..+.|.+.+.||+|+||+||++.++.++       ..||+|++...  .....+.+.+|+.++++++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            455566679999999999999999998877       47999998654  233456788999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC-----
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----  183 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~-----  183 (377)
                      .....     .+++|||++ ++|.+++...+. +++..++.++.||+.||+|||++||+||||||+||+++.++.     
T Consensus        82 ~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           82 VCGDE-----NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             CCTTC-----CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             EeCCC-----CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence            87754     799999998 599999987554 999999999999999999999999999999999999999887     


Q ss_pred             ---eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 017083          184 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITE  259 (377)
Q Consensus       184 ---vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~-~pf~~~~~~~~~~~i~~  259 (377)
                         +||+|||++......   ....+++.|+|||++.+...++.++||||||+++|+|++|. .||..............
T Consensus       157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~  233 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED  233 (289)
T ss_dssp             CCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             cceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence               999999998655432   23456888999999987567899999999999999999954 55554443332222111


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                       .                               .......++.+.+||.+||+.||++|||+.+++++
T Consensus       234 -~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 -R-------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -T-------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -c-------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             0                               01112457889999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.9e-44  Score=323.93  Aligned_cols=253  Identities=19%  Similarity=0.289  Sum_probs=205.1

Q ss_pred             eeecccccCCcc-cccCCccceEEEE--EeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIR-PIGRGAYGIVCAA--VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~-~lg~G~~g~vy~~--~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +.+..+.|.+.+ .||+|+||+||++  .+..+++.||+|++..........+.+.+|+.+++.++||||+++++++..+
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   90 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE   90 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC
Confidence            344455555777 8999999999999  4567788999999987654455567888999999999999999999999432


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            .++++|||++ ++|.+++...+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        91 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           91 ------SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             ------SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ------CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence                  2799999998 599999998888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ........    .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------  237 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------  237 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------
Confidence            76544322    122344678999999977 678899999999999999999 999998877655443332210      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                              .......+++.+.++|.+||+.||++|||+.++++
T Consensus       238 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 ------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    01112357899999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-44  Score=335.51  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             eeecccccCCcccccCCccceEEEEEeC---CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .++....+.+.+.||+|+||+||+++++   .++..||||.++... .......+.+|+.++++++||||+++++++...
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4666677889999999999999999887   567789999997643 344567888999999999999999999999877


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ..     +++||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus       119 ~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          119 KP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             SS-----CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             Cc-----eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence            54     899999997 6999999764 4799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +........    .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....    
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~----  268 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR----  268 (373)
T ss_dssp             --------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE----
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            986543321    122234678999999987 778999999999999999997 9999988776554443322110    


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                .+....++..+.+||.+||+.||++||++.++++
T Consensus       269 --------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 --------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                      1112356888999999999999999999999886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-44  Score=319.99  Aligned_cols=252  Identities=19%  Similarity=0.334  Sum_probs=209.9

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .|.+..+.|++++.||+|+||+||++.+. ++..||+|++......   .+.+.+|+.++++++||||+++++++.....
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            46777777789999999999999999986 5678999999765333   3567899999999999999999999987654


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                           .+++|||++ ++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        78 -----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           78 -----ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             -----CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             -----eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence                 899999997 5999998764 568999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          194 TTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       194 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ......  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....        
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--------  223 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------  223 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred             ccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc--------
Confidence            654331  2233455778999999977 778999999999999999999 8999988776555444432110        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            .......+..+.+++.+||+.||++|||+.+++++
T Consensus       224 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ----------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                  01122458889999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.1e-44  Score=319.95  Aligned_cols=252  Identities=16%  Similarity=0.193  Sum_probs=209.2

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+++..+.|++.+.||+|+||+||++++.  +..||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            45666677779999999999999999885  7899999998776666667789999999999999999999999987633


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEccCCCeEEeeee
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                         ..++++|||++ ++|.+++....  .+++..++.++.||+.||+|||++|  ++|+||||+||+++.++.++|+|||
T Consensus        82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           82 ---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             ---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence               33799999998 59999998755  4899999999999999999999999  9999999999999999999999998


Q ss_pred             cccccCCCccccccccccccCCCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++.....    ....+|+.|+|||.+.+ ...   +.++||||||+++|+|++|..||...........+.....     
T Consensus       159 ~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----  228 (271)
T 3kmu_A          159 VKFSFQS----PGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-----  228 (271)
T ss_dssp             SCCTTSC----TTCBSCGGGSCHHHHHS-CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC-----
T ss_pred             ceeeecc----cCccCCccccChhhhcc-CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC-----
Confidence            8755332    34567899999999976 333   3379999999999999999999988776554433322110     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                              .......+++.+.++|.+||+.||++|||+.++++
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 ------------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    01122457899999999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-44  Score=321.57  Aligned_cols=251  Identities=26%  Similarity=0.362  Sum_probs=194.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC--HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ++....|++.+.||+|+||+||++.+.  +..||+|++......  ....+.+.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            444556668999999999999999874  789999998764322  2234677899999999999999999999987754


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCceEEcc--------CCC
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKPSNLLLNA--------SCD  183 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dik~~NIli~~--------~~~  183 (377)
                           .+++|||+++ +|.+++. .+++++..++.++.|++.||+|||++|   ++||||||+||+++.        ++.
T Consensus        81 -----~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           81 -----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             -----CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             -----eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence                 8999999975 7777664 568999999999999999999999999   899999999999986        677


Q ss_pred             eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017083          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  263 (377)
Q Consensus       184 vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  263 (377)
                      ++|+|||++....... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....  
T Consensus       155 ~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  230 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--  230 (271)
T ss_dssp             EEECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC--
T ss_pred             eEEccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC--
Confidence            9999999997655443 334578999999999987 778999999999999999999999998876554433322110  


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                 ........+++.+.++|.+||+.||++|||+.|++++
T Consensus       231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                       0011123568899999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.2e-44  Score=328.60  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=212.0

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeC-------CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..|++..+.|++.+.||+|+||+||++.+.       .++..||+|++.... .......+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            447788888889999999999999999975       456789999997643 344567788999999999 89999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      ++++.....     +++||||+++ +|.+++....                .+++..++.++.||+.||+|||++||+|+
T Consensus       107 ~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (334)
T 2pvf_A          107 LGACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  181 (334)
T ss_dssp             EEEECSSSC-----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEccCCc-----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            999987754     8999999975 9999997643                38899999999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf  245 (377)
                      ||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus       182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            999999999999999999999998655432   1233455788999999977 678999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ...........+.....                              ......++..+.++|.+||+.||.+|||+.+++
T Consensus       261 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  310 (334)
T 2pvf_A          261 PGIPVEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV  310 (334)
T ss_dssp             TTCCHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CcCCHHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            88776655444433110                              111235688999999999999999999999998


Q ss_pred             cC
Q 017083          326 RH  327 (377)
Q Consensus       326 ~~  327 (377)
                      ++
T Consensus       311 ~~  312 (334)
T 2pvf_A          311 ED  312 (334)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-44  Score=328.78  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=206.9

Q ss_pred             eeecccccCCcccccCCccceEEEEE-----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      .++..+.|++++.||+|+||+||+++     +..++..||+|.+... ........+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            45666677799999999999999999     5567889999999744 24445667889999999999999999999998


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC--
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--  181 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~--  181 (377)
                      ....     .+++|||++ ++|.+++...       ..+++..++.++.||+.||.|||++||+||||||+||+++.+  
T Consensus       104 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A          104 QSLP-----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             SSSS-----CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             CCCC-----cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            7755     799999996 5999999865       348899999999999999999999999999999999999954  


Q ss_pred             -CCeEEeeeecccccCCC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017083          182 -CDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (377)
Q Consensus       182 -~~vkl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~  256 (377)
                       ..++|+|||++......   .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence             45999999998743322   12234566889999999977 778999999999999999998 9999988775554443


Q ss_pred             HHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       257 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                      +.....                              ......++..+.++|.+||+.||.+|||+.+++++.|+.
T Consensus       258 ~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          258 VTSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            322100                              111235688999999999999999999999999998874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-44  Score=324.24  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||+|+||+||++.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.....     ++
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-----~~  110 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ-----LY  110 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-----EE
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe-----EE
Confidence            3389999999999999999999999999999976533 33345778899999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      +++||+++ +|.+++...+++++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999985 999999888889999999999999999999999999999999999999999999999999987654432  


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.   ...+              
T Consensus       191 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~--------------  252 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QAIP--------------  252 (309)
T ss_dssp             ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SCCC--------------
T ss_pred             cccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cCCC--------------
Confidence            2334578999999999987 778999999999999999999999998765432221111   1110              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALR  326 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~ell~  326 (377)
                                 ......+.+++.+.++|.+||+.||++|| |+.++++
T Consensus       253 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 -----------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -----------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -----------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                       01122356799999999999999999999 8888775

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.7e-44  Score=346.99  Aligned_cols=253  Identities=22%  Similarity=0.370  Sum_probs=213.5

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.|++....+.+.+.||+|+||+||++.++.++..||||+++....   ..+.+.+|+.++++++||||+++++++....
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            4588888888899999999999999999999999999999976432   3567889999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .     +++||||++ |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       290 ~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          290 P-----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             c-----EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence            5     899999998 6999999763  4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          192 ARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       192 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      +.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+....       
T Consensus       365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------  436 (495)
T 1opk_A          365 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------  436 (495)
T ss_dssp             EECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------
T ss_pred             ceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            98765432  1223345678999999977 778999999999999999998 999998876554433332210       


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                             .......+++.+.+||.+||+.||++|||+.++++
T Consensus       437 -----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 -----------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                   01122357899999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.4e-45  Score=344.40  Aligned_cols=260  Identities=28%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  114 (377)
                      .+.++...|.+.+.||+|+||+||. ....+++.||||++.....     ..+.+|+.+++.+ +||||+++++++....
T Consensus        18 ~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             cEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3455555566889999999999764 4456789999999865422     2245799999999 7999999999998775


Q ss_pred             CCCCCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---C--CCeEEee
Q 017083          115 KDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---S--CDLKIGD  188 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~--~~vkl~D  188 (377)
                      .     +|++|||++|+|.+++.... .+.+..++.++.||+.||+|||++||+||||||+||+++.   +  .++||+|
T Consensus        92 ~-----~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           92 F-----QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             E-----EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             E-----EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            4     89999999999999997644 4566677899999999999999999999999999999953   2  3578999


Q ss_pred             eecccccCCC----ccccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017083          189 FGLARTTSET----DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  261 (377)
Q Consensus       189 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~  261 (377)
                      ||++......    .......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||..........    ..
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----~~  242 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----LL  242 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----HT
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----Hh
Confidence            9999866533    22345678999999999974  2566789999999999999999 999996654332211    11


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      .......                        .......+..+.+||.+||+.||++|||+.++++||||+++.
T Consensus       243 ~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          243 GACSLDC------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             TCCCCTT------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ccCCccc------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            1110000                        000112245588999999999999999999999999997643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-44  Score=328.20  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=211.1

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .|++..+.|++.+.||+|+||+||++.++     .+++.||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            45666777779999999999999999886     467889999997542 334556788999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                      .....     .+++|||++ ++|.+++...          .++++..+..++.||+.||+|||++||+||||||+||+++
T Consensus        98 ~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           98 SQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             CSSSS-----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             ccCCc-----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence            87654     899999998 5999988642          4578999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017083          180 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (377)
Q Consensus       180 ~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~  255 (377)
                      .++.+||+|||++.......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..........
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            99999999999997654332   1233455788999999987 778999999999999999999 899998877655444


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .+....                              .......++..+.+||.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          252 FVMEGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            332210                              011123578899999999999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-44  Score=320.49  Aligned_cols=254  Identities=19%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .+.+..+.|++.+.||+|+||+||++.+..   ++..||+|.+.... .....+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            356666777799999999999999998643   34569999997653 33456778899999999999999999999875


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      +.      .+++|||++ ++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus        85 ~~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           85 EP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             SS------CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             CC------CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            43      589999998 599999875 4569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-----  232 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-----  232 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-----
T ss_pred             CCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-----
Confidence            998655432  1233455788999999976 778999999999999999998 9999987665544433332110     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                               ......+++.+.++|.+||+.||++|||+.|++++
T Consensus       233 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 -------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     11123568899999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-44  Score=329.07  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=210.6

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      ...|++..+.|++.+.||+|+||+||++.+     ..+++.||+|++.... .......+.+|+.+++++ +||||++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            345677778888999999999999999984     4577899999997653 334556788999999999 699999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----------------LTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~----------------~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                      +++.....    .++++|||+++ +|.+++.....                +++..++.++.||+.||.|||++||+|+|
T Consensus        98 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  173 (316)
T 2xir_A           98 GACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  173 (316)
T ss_dssp             EEECCTTS----CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEecCCC----ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            99876532    27999999985 99999986543                88999999999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~  246 (377)
                      |||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999998654332   2234556888999999987 778999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .................                             ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  303 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTR-----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  303 (316)
T ss_dssp             TCCCSHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHhccCcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            76533322222111100                             1112346889999999999999999999999997


Q ss_pred             C
Q 017083          327 H  327 (377)
Q Consensus       327 ~  327 (377)
                      |
T Consensus       304 ~  304 (316)
T 2xir_A          304 H  304 (316)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-44  Score=328.36  Aligned_cols=257  Identities=22%  Similarity=0.349  Sum_probs=210.9

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCc-----EEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      ...+++..+.|++.+.||+|+||+||++.+..++.     .||+|.+.... .......+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34578888888899999999999999999977664     79999997643 334567788999999999 899999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCCC-CHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik  172 (377)
                      +++.....     ++++|||+++ +|.+++..              ...+++..++.++.||+.||+|||++||+|+|||
T Consensus       117 ~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  191 (333)
T 2i1m_A          117 GACTHGGP-----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA  191 (333)
T ss_dssp             EEECSSSS-----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEecCCc-----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence            99987755     8999999985 99998864              3468999999999999999999999999999999


Q ss_pred             CCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 017083          173 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  248 (377)
Q Consensus       173 ~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~  248 (377)
                      |+||+++.++.+||+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...
T Consensus       192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999997654332   1233455788999999987 778999999999999999998 99999876


Q ss_pred             ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       249 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ........+.......                             ......++.+.+||.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          271 LVNSKFYKLVKDGYQM-----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CSSHHHHHHHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            5444333322211110                             112345888999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.5e-44  Score=320.61  Aligned_cols=259  Identities=22%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      ++.+.|++..+.|++++.||+|+||+||++.+. ++..||+|.+.....   ..+.+.+|+.++++++||||+++++++.
T Consensus         3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            345678898888889999999999999999975 567899999976432   2457889999999999999999999986


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEee
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~D  188 (377)
                      .+.      .+++|||++ ++|.+++....  .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|
T Consensus        79 ~~~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           79 QEP------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             SSS------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             CCC------cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECC
Confidence            432      689999997 59999986533  799999999999999999999999999999999999999999999999


Q ss_pred             eecccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          189 FGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       189 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      ||++.......  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....   
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---  228 (279)
T 1qpc_A          153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---  228 (279)
T ss_dssp             CTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred             CcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---
Confidence            99998665432  2233455778999999976 678999999999999999999 9999988776554444322100   


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--Ccccc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQ  331 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~--~p~f~  331 (377)
                                                 ......++..+.++|.+||+.||++|||+.++++  ..+|.
T Consensus       229 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          229 ---------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                                       0112356889999999999999999999999986  34444

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-44  Score=330.43  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcE----EEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +....|++++.||+|+||+||++++..+++.    ||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3344556899999999999999999888765    4777775432 2234467889999999999999999999998653


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            .+++++++. |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        91 ------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 ------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ------EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             ------eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence                  678899987 699998876 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          193 RTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       193 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....       
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------  236 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  236 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             eEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------
Confidence            86544322   223445778999999987 788999999999999999999 999998766544433332211       


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                             ........+..+.+++.+||+.||.+|||+.+++++
T Consensus       237 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 -----------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -----------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                   011123568889999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=319.54  Aligned_cols=255  Identities=18%  Similarity=0.293  Sum_probs=207.3

Q ss_pred             eeecccccCCcc-cccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIR-PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~-~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      +.+..+.+.+++ .||+|+||+||++.++  .++..||+|++.... .....+.+.+|+.++++++||||+++++++..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC
Confidence            344444444666 9999999999999864  467889999997652 345567788999999999999999999999433


Q ss_pred             CCCCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                            .++++|||+++ +|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus        83 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           83 ------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             ------SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             ------CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence                  27999999985 89998864 45699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +........    .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-----  230 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----  230 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-----
Confidence            986643321    223345788999999976 678999999999999999998 999998877655444332210     


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  329 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~  329 (377)
                                               .....+.+++.+.++|.+||+.||++|||+.+++++.+
T Consensus       231 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 -------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                     01122467899999999999999999999999998643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-44  Score=341.83  Aligned_cols=254  Identities=31%  Similarity=0.389  Sum_probs=190.8

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +++.+.+.||+|+||+||.+ ...+|+.||||++...     ..+.+.+|+.+++++ +||||+++++++.....     
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-----   83 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF-----   83 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE-----
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe-----
Confidence            34446788999999999875 4567999999998643     234567899999887 79999999999987754     


Q ss_pred             EEEEEecCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC------------
Q 017083          121 VYIVYELMDTDLHQIIRSDQQL-------TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS------------  181 (377)
Q Consensus       121 ~~iv~e~~~~~L~~~l~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~------------  181 (377)
                      ++++|||++|+|.+++......       ++..++.++.||+.||+|||++||+||||||+||+++.+            
T Consensus        84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            8999999999999999865433       233456799999999999999999999999999999754            


Q ss_pred             -CCeEEeeeecccccCCCc-----cccccccccccCCCccccc------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 017083          182 -CDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPGK  248 (377)
Q Consensus       182 -~~vkl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~ll~ell~-g~~pf~~~  248 (377)
                       +.+||+|||++.......     ......||+.|+|||++.+      ...++.++|||||||++|+|++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             379999999998765432     1234578999999999865      2567899999999999999998 99999765


Q ss_pred             ChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 017083          249 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  328 (377)
Q Consensus       249 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p  328 (377)
                      ....  ..+.......+..                        .......+++++.+||.+||+.||++|||+.++++||
T Consensus       244 ~~~~--~~i~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          244 YSRE--SNIIRGIFSLDEM------------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             TTHH--HHHHHTCCCCCCC------------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             hhhH--HHHhcCCCCcccc------------------------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            4332  1111110000000                        0000112357899999999999999999999999999


Q ss_pred             cccC
Q 017083          329 YLQS  332 (377)
Q Consensus       329 ~f~~  332 (377)
                      ||+.
T Consensus       298 ~f~~  301 (434)
T 2rio_A          298 LFWP  301 (434)
T ss_dssp             GGSC
T ss_pred             ccCC
Confidence            9974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=330.51  Aligned_cols=265  Identities=14%  Similarity=0.144  Sum_probs=198.8

Q ss_pred             ecccccCCcccccCCccceEEEEEeCC---CCcEEEEEeccccccCHHH---------HHHHHHHHHHHHhcCCCCceeE
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~valK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      +..+.|++.+.||+|+||+||++.+..   ++..+|+|++.........         ...+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            444555699999999999999999987   7889999998754221111         1234578888999999999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC--Ce
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--DL  184 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~--~v  184 (377)
                      ++++..... ....++++|||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++  .+
T Consensus       114 ~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFK-GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESS-SCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccC-CCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999876211 113489999999779999998877999999999999999999999999999999999999999887  99


Q ss_pred             EEeeeecccccCCCc--------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--CChHHHH
Q 017083          185 KIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG--KDYVHQL  254 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~--~~~~~~~  254 (377)
                      ||+|||++.......        ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..  .......
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999997653221        1245578999999999987 7789999999999999999999999955  2222222


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ..........+......                      .....++..+.++|.+||+.||++|||+.++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKW----------------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHTTTHHHHHH----------------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhcccccHHHHhh----------------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22222211111110000                      0012678899999999999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-44  Score=330.30  Aligned_cols=250  Identities=20%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcE----EEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      ..+.|++++.||+|+||+||++.+..++..    ||+|.+.... .......+.+|+.++++++||||+++++++...  
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS--   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS--
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            345566899999999999999999888876    7777764332 112234566899999999999999999998643  


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                          ..++|+||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        88 ----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           88 ----SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             ----SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             ----ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence                2789999998 6999988764 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ......   ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------  234 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE--------  234 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC--------
T ss_pred             ccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------
Confidence            754432   2344566788999999987 778999999999999999999 999998866554443332210        


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            .......++..+.++|.+||+.||.+|||+.+++++
T Consensus       235 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 ----------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  011112457789999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-44  Score=330.54  Aligned_cols=273  Identities=21%  Similarity=0.246  Sum_probs=202.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+..+.|++++.||+|+||+||++++.  ++.||+|++...   .........|+.++++++||||+++++++.....
T Consensus        18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            46677777779999999999999999875  689999999653   2334455679999999999999999999887543


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC----------CceecCCCCCceEEccCCCe
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA----------SVLHRDLKPSNLLLNASCDL  184 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~----------~i~H~dik~~NIli~~~~~v  184 (377)
                      . ...+++||||+++ +|.+++.. .++++..++.++.||+.||+|||+.          ||+||||||+||+++.++.+
T Consensus        93 ~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           93 V-DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             S-SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             C-CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            1 1347999999975 99999876 4599999999999999999999999          99999999999999999999


Q ss_pred             EEeeeecccccCCCc---cccccccccccCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017083          185 KIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (377)
Q Consensus       185 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i  257 (377)
                      ||+|||++.......   ......+|+.|+|||++.+.    ..++.++|||||||++|+|++|..||............
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            999999997654332   23345789999999998762    24556889999999999999999999764321111100


Q ss_pred             HHHhCCCCccccccccchhHHHHHHhccc-cccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          258 TELIGSPDDASLGFLRSDNARRYVRQLPR-CRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ......+           ........... .........+.  ..+..+.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHP-----------SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCC-----------chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0000000           01111111100 00111111111  12345999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-44  Score=340.04  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..|++..+.+++++.||+|+||+||++.+.  |+.||||+++...    ....+.+|+.++++++||||+++++++....
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            457788888889999999999999999875  6799999997642    3467889999999999999999999976653


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .    .+++||||++ |+|.+++...+.  +++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus       260 ~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          260 G----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             S----CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             C----ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            1    2899999998 599999986543  79999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      +......  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+..-.         
T Consensus       336 a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------  403 (450)
T 1k9a_A          336 TKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------  403 (450)
T ss_dssp             CEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---------
T ss_pred             ccccccc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            9754433  223356788999999987 788999999999999999998 999998765544433332210         


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                           .......+++.+.+||.+||+.||++|||+.++++
T Consensus       404 ---------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ---------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 01122367899999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.1e-44  Score=329.07  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=203.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEE--EEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEV--AIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~v--alK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  115 (377)
                      +....|++.+.||+|+||+||+++++.++..+  |+|.+.... .......+.+|+.+++++ +||||+++++++.....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            33355668999999999999999999988865  999886432 233456788999999999 89999999999987754


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                           ++++|||++ ++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||++
T Consensus       101 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A          101 -----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  175 (327)
T ss_dssp             -----EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             -----eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence                 899999997 59999987654                79999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017083          179 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i  257 (377)
                      +.++.+||+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             cCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            9999999999999875444333344556788999999977 678999999999999999998 99999887655443332


Q ss_pred             HHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...                              ........+++.+.+||.+||..||.+|||+.+++++
T Consensus       255 ~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGT------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            110                              0011123568899999999999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-43  Score=323.35  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCC----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .++..+.+.+.+.||+|+||+||++.++.++    ..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            3677777778999999999999999887653    459999997543 34455678899999999999999999999987


Q ss_pred             CCCCCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ...     +++||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus       118 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          118 YKP-----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             SSS-----EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CCC-----cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence            654     8999999985 999998764 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          191 LARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       191 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      ++.......    ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....   
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---  268 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---  268 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred             cchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---
Confidence            998654332    1122344678999999977 778999999999999999998 9999988766554443322100   


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                 ......++..+.++|.+||+.||++||++.+++++
T Consensus       269 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 ---------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       11123568899999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-43  Score=339.35  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=211.3

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.|++..+.+.+.+.||+|+||+||++.++ ++..||||+++....   ..+.+.+|+.++++++||||+++++++...
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTKE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeCC
Confidence            4568899898999999999999999999985 467899999976432   356788999999999999999999998633


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                            .+++||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       256 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          256 ------PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             ------SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             ------ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence                  2799999997 5999998753  368899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++.......  ......++..|+|||++.. ..++.++||||||+++|+|++ |..||...........+......    
T Consensus       330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----  404 (454)
T 1qcf_A          330 LARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----  404 (454)
T ss_dssp             GGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC----
T ss_pred             CceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            998654332  1223345778999999977 778999999999999999999 99999987766655554432111    


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                                +....+++.+.+||.+||+.||++|||+.++++
T Consensus       405 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 --------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                      112356889999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.6e-44  Score=322.06  Aligned_cols=270  Identities=24%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             eeecccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      ..+..+++++++.||+|+||+||+++    +..+++.||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            34556677799999999999999998    67789999999997543 22234678899999999999999999999987


Q ss_pred             CCCCCCCcEEEEEecCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~~-~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ...   ..++++|||+++ +|.+++. ....+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||
T Consensus        95 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           95 DGG---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             ------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCC---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            643   338999999975 9999984 45679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          191 LARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       191 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      ++.......    ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|+....     ............
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc
Confidence            998665442    2334566888999999987 678899999999999999999998864321     111222111111


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .       ............   .........+++.+.+||.+||+.||.+|||+.++++
T Consensus       246 ~-------~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 Q-------MTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             G-------GHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             c-------cCHHHHHHHHhc---cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0       011111111111   1112233467899999999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.2e-44  Score=328.27  Aligned_cols=268  Identities=21%  Similarity=0.327  Sum_probs=208.2

Q ss_pred             ecccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +..+.|++++.||+|+||+||+++    +..++..||+|++...  .....+.+.+|+.++++++||||+++++++....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            344566699999999999999998    6778999999999764  4445667889999999999999999999887543


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      .   ..+++||||++ ++|.+++.. ..++++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++
T Consensus        98 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 R---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             S---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             C---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence            3   34899999996 699999876 456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          193 RTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       193 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      .......    ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.........     ......   
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~---  245 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCER---  245 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC------
T ss_pred             eecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccccc---
Confidence            8654432    2233456788999999977 67899999999999999999999998654322111     000000   


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                          .............   ..........+++.+.+||.+||+.||++|||+.+++++
T Consensus       246 ----~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          246 ----DVPALSRLLELLE---EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -----CCHHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----ccccHHHHHHHhh---cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                0000111111111   111122235679999999999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-44  Score=335.53  Aligned_cols=266  Identities=15%  Similarity=0.142  Sum_probs=198.7

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCC-----CcEEEEEeccccccCHHHH---------HHHHHHHHHHHhcCCCCce
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDA---------RRTLREIKLLRHMEHENVI  104 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~valK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~~iv  104 (377)
                      +..+.|++++.||+|+||+||++.++.+     ++.||+|++..........         .....|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3344555899999999999999999775     5789999986542111111         1223466677788899999


Q ss_pred             eEeeeecCCCCCCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc--cC
Q 017083          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--AS  181 (377)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~--~~  181 (377)
                      ++++++..... .....++||||++++|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKN-GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEET-TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccC-CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            99999876422 11337999999977999999765 6899999999999999999999999999999999999999  88


Q ss_pred             CCeEEeeeecccccCCCcc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017083          182 CDLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (377)
Q Consensus       182 ~~vkl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~  253 (377)
                      +.+||+|||++........        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            9999999999976543221        133458999999999987 6789999999999999999999999985332222


Q ss_pred             HHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          254 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       254 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..........           ..........         -....++.++.+++..||..||.+||++.++++
T Consensus       270 ~~~~~~~~~~-----------~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYR-----------ENIASLMDKC---------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHH-----------HCHHHHHHHH---------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhh-----------hhHHHHHHHh---------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2111110000           0000000000         001467899999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.9e-44  Score=326.51  Aligned_cols=271  Identities=25%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             ceeeecccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      +.-.+.++|+++++.||+|+||+||++.    +..+++.||+|++... ........+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (318)
T 3lxp_A           24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCC  102 (318)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence            3455677888899999999999997774    4557899999999765 2344567788999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          111 RPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      .....   ..++++|||+++ +|.+++... ++++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+||
T Consensus       103 ~~~~~---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          103 EDAGA---ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EETTT---TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             ecCCC---ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence            87533   348999999984 999988654 5999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          190 GLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       190 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      |++.......    ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......     ........
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~  252 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQ  252 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCC
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccc
Confidence            9998765432    2334556788999999987 678899999999999999999999986532211     00000000


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ..       ..........   ...........++..+.+||++||+.||++|||+.|+++
T Consensus       253 ~~-------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          253 GQ-------MTVLRLTELL---ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HH-------HHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc-------hhHHHHHHHH---hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00       0000000111   011112223467899999999999999999999999984

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=325.80  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+.+..+.|++++.||+|+||+||++.+..+++.||+|++...  .......+.+|+.++++++||||+++++++.....
T Consensus        23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            3456666666999999999999999999999999999998653  44566778899999999999999999999863211


Q ss_pred             CCCCcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          116 DTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                       .....++++||+.+ +|.+++..    ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||
T Consensus       101 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          101 -AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             -TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             -CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             11348999999985 99988865    5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----------ccccccccccCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017083          191 LARTTSETDF----------MTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (377)
Q Consensus       191 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~  258 (377)
                      ++........          .....+++.|+|||++.+..  .++.++||||||+++|+|++|..||.......      
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------  253 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------  253 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------
Confidence            8875432211          12345688999999987522  36889999999999999999999994310000      


Q ss_pred             HHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          259 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                      .........      ....+..+.++..+.+||.+||+.||.+|||+.+++++
T Consensus       254 ----------------~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          254 ----------------DSVALAVQN------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ----------------SCHHHHHHC------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------chhhHHhhc------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                            000000000      00111224678999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-43  Score=319.25  Aligned_cols=253  Identities=21%  Similarity=0.227  Sum_probs=201.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      .+.++|. +.+.||+|+||+||++++..+++.||+|++......    ..+.+|+.+++.++|++++..+..+....   
T Consensus         6 ~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (296)
T 3uzp_A            6 RVGNRYR-LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG---   77 (296)
T ss_dssp             EETTTEE-EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET---
T ss_pred             eeccEEE-EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC---
Confidence            3455554 899999999999999999999999999998654322    35778999999999888776666554332   


Q ss_pred             CCcEEEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeeccc
Q 017083          118 FNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~  193 (377)
                       ...+++|||++++|.+++. ...++++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 -DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             -CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence             2379999999889999997 35679999999999999999999999999999999999999   488899999999998


Q ss_pred             ccCCCcc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 017083          194 TTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---HQLRLITELIG  262 (377)
Q Consensus       194 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~---~~~~~i~~~~~  262 (377)
                      .......        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            6554322        245678999999999987 77899999999999999999999999764321   11111111100


Q ss_pred             CCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          263 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .                          .........+++.+.+||.+||+.||++|||+.++++
T Consensus       236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             C--------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            0                          0011112467899999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-44  Score=329.71  Aligned_cols=260  Identities=21%  Similarity=0.285  Sum_probs=201.4

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|++.+.||+|+||+||++.++ +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.....     .
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~  110 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-----M  110 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-----C
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-----E
Confidence            44559999999999999999974 68999999987653  3346678899999999999999999999987654     8


Q ss_pred             EEEEecCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          122 YIVYELMD-TDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                      +++|||++ ++|.+.+....    .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999998 59988886533    58999999999999999999999999999999999999999999999999997644


Q ss_pred             CC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHhCCCCccccc
Q 017083          197 ET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT---ELIGSPDDASLG  270 (377)
Q Consensus       197 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~  270 (377)
                      ..   .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.............   ......      
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  263 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG------  263 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT------
T ss_pred             cccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc------
Confidence            32   22334567999999999987 778999999999999999999999997643211110000   000000      


Q ss_pred             cccchhHHHHHHhccccccc-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  328 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p  328 (377)
                                  ........ ......+..+..+.+++.+||+.||++|||+.|++++.
T Consensus       264 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          264 ------------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             ------------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ------------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                        00000000 00011123456789999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=316.96  Aligned_cols=244  Identities=29%  Similarity=0.438  Sum_probs=192.7

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +..+.|++.+.||+|+||+||++.+.  ++.||+|.+...    .....+.+|+.++++++||||+++++++...     
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLNP-----   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            44555668999999999999999874  678999999643    3456788999999999999999999988743     


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhc---CCceecCCCCCceEEccCCC-eEEeeee
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFG  190 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dik~~NIli~~~~~-vkl~Dfg  190 (377)
                        .++||||++ ++|.+++....   .++...+..++.||++||+|||+   +||+||||||+||+++.++. +||+|||
T Consensus        74 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             --TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             --cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence              689999997 59999998655   37889999999999999999999   89999999999999999887 7999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++......  .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ........       
T Consensus       152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~-------  220 (307)
T 2eva_A          152 TACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNG-------  220 (307)
T ss_dssp             C--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTT-------
T ss_pred             cccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcC-------
Confidence            99765433  234468999999999987 77899999999999999999999999754322111 11111000       


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                          ........++..+.++|.+||+.||++|||+.++++
T Consensus       221 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          221 --------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             --------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                011223467899999999999999999999999997

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-43  Score=318.02  Aligned_cols=249  Identities=23%  Similarity=0.353  Sum_probs=197.8

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ..|.+..+.|++++.||+|+||+||++.+.  |+.||+|++....    ..+.+.+|+.++++++||||+++++++....
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            346677777779999999999999999874  7899999997542    4567889999999999999999999876543


Q ss_pred             CCCCCcEEEEEecCCC-CHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMDT-DLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~-~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                          ..++++|||+++ +|.+++.....  +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           88 ----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             -----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             ----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence                227999999985 99999876443  89999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      +......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...          
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------  230 (278)
T 1byg_A          164 TKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------  230 (278)
T ss_dssp             --------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------
T ss_pred             ccccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------
Confidence            8765433  223356788999999977 778999999999999999998 99999876544433322110          


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                          ........+++.+.++|++||+.||++|||+.++++
T Consensus       231 --------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 --------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                                001122467899999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.1e-43  Score=317.24  Aligned_cols=248  Identities=29%  Similarity=0.422  Sum_probs=191.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccc-ccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      |++.+.||+|+||+||++.+..+|+.||+|++... .........+.+|+.++++++||||+++++++.....     .+
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~  108 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-----LN  108 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-----EE
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc-----EE
Confidence            44899999999999999999999999999999753 2344556778899999999999999999999987654     89


Q ss_pred             EEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          123 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                      ++|||+++ +|.+++..    ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999985 89888863    56799999999999999999999999999999999999999999999999999876544


Q ss_pred             Cc-cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccccccccc
Q 017083          198 TD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--HQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       198 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......  .....+.. ...+          
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~----------  256 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP----------  256 (310)
T ss_dssp             ----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC----------
T ss_pred             CCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC----------
Confidence            32 2344567899999999987 77899999999999999999999999754311  11111110 0000          


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                        ......++..+.+||.+||+.||++|||+.++++
T Consensus       257 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 ------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              0112356889999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.3e-43  Score=318.49  Aligned_cols=252  Identities=20%  Similarity=0.216  Sum_probs=197.8

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +.++|. +.+.||+|+||+||++++..+++.||+|++....    ....+.+|+.+++.++|++++..+..+....    
T Consensus         7 ~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----   77 (296)
T 4hgt_A            7 VGNRYR-LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----   77 (296)
T ss_dssp             ----CE-EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----
T ss_pred             cCCceE-EeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCC----
Confidence            344444 8999999999999999999999999999875432    2235678999999999888777666654332    


Q ss_pred             CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeecccc
Q 017083          119 NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~~  194 (377)
                      ...+++|||++++|.+++.. ..++++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            23799999998899999874 5679999999999999999999999999999999999999   7889999999999986


Q ss_pred             cCCCc--------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 017083          195 TSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---HQLRLITELIGS  263 (377)
Q Consensus       195 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~---~~~~~i~~~~~~  263 (377)
                      .....        ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||......   .....+..... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  235 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-
Confidence            54432        2235678999999999987 77899999999999999999999999764322   11111111000 


Q ss_pred             CCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               ..........+++.+.+||.+||+.||++|||+.++++
T Consensus       236 -------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 -------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                     00011122467899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-43  Score=316.81  Aligned_cols=246  Identities=26%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC--------
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--------  115 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--------  115 (377)
                      |++++.||+|+||+||++.+..+++.||+|++....      ..+.+|+.++++++||||+++++++.....        
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            348999999999999999999999999999997542      245689999999999999999998854110        


Q ss_pred             ---CCCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          116 ---DTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       116 ---~~~~~~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                         .....++++|||+++ +|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence               111337999999985 999999653  67999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       190 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      |++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+...     ..........      
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~------  234 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRDG------  234 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHTT------
T ss_pred             hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhcc------
Confidence            99987766555556678999999999987 77899999999999999999999887321     1111111000      


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                              .....++..+.++|.+||+.||.+|||+.|++++.+..
T Consensus       235 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          235 ------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                    01134688899999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.3e-43  Score=335.94  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=208.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.|++..+.+++.+.||+|+||+||++.++. +..||||+++....   ..+.+.+|+.++++++||||+++++++..+
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            35688888888899999999999999999865 46799999976432   245788999999999999999999998753


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                       .     +++||||++ |+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       252 -~-----~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          252 -P-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             -S-----CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             -c-----eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence             2     799999997 599999864  3569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++.......  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+.....     
T Consensus       326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----  399 (452)
T 1fmk_A          326 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----  399 (452)
T ss_dssp             TTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----
T ss_pred             cceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            998654332  1233445778999999987 778999999999999999999 9999988776655444432110     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  332 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~--~p~f~~  332 (377)
                                               .+....+++.+.+||.+||+.||++|||+.++++  ..++..
T Consensus       400 -------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 -------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                                     1112356889999999999999999999999986  345443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.1e-43  Score=348.27  Aligned_cols=242  Identities=19%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             ccccCCccceEEEEE--eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~--~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ++||+|+||+||++.  ++.+++.||||+++.........+.+.+|+.++++++||||+++++++..+.      +++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS------EEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC------EEEEE
Confidence            379999999999994  4567789999999876555555678999999999999999999999986432      78999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc----c
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----F  200 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~----~  200 (377)
                      ||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    .
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9998 5999999988899999999999999999999999999999999999999999999999999998654332    1


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....                 
T Consensus       529 ~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----------------  590 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-----------------  590 (635)
T ss_dssp             ------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred             ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            223345778999999977 788999999999999999998 9999998876655544433110                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                   ......+++++.+||.+||+.||++|||+.++++
T Consensus       591 -------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 -------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                         1112357899999999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=335.29  Aligned_cols=279  Identities=17%  Similarity=0.256  Sum_probs=207.0

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.|++.+.||+|+||+||+++++.+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.....   ..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~   83 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RH   83 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---Ce
Confidence            3444489999999999999999999999999999975422 2234667789999999999999999999887643   34


Q ss_pred             EEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE----ccCCCeEEeeeecc
Q 017083          121 VYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLA  192 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli----~~~~~vkl~Dfg~~  192 (377)
                      .++||||++ ++|.+++....   .+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999997 59999987533   39999999999999999999999999999999999999    77778999999999


Q ss_pred             cccCCCccccccccccccCCCcccccc-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSP  264 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~  264 (377)
                      .............|++.|+|||++.+.       ..++.++|||||||++|+|++|..||..... ......+.......
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            877666556667889999999998641       4567899999999999999999999964321 11222333333333


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +..............  ..+... ..........++..+.++|++||+.||++|||+.++++
T Consensus       244 p~~~~~~~~~~~~~~--~~~~~~-~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          244 PSGAISGVQKAENGP--IDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CTTCCEEEECSTTCC--EEEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CcccchhheeccCCC--cccCcc-CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            322111100000000  000000 00000011234667889999999999999999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=324.90  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=198.2

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEE----EEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEV----AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~v----alK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +....|++++.||+|+||+||++.+..+++.+    |+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            33455569999999999999999998888765    666664332 2234567889999999999999999999998653


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            .+++++++. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        91 ------~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 ------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ------EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ------ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence                  688899987 599998876 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc---ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          193 RTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       193 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....       
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-------  236 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  236 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             eEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            86543322   233445778999999987 788999999999999999999 999998876555443332211       


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                             .......++..+.+||++||..||.+|||+.|+++
T Consensus       237 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 -----------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -----------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                   11112356889999999999999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.3e-44  Score=349.53  Aligned_cols=284  Identities=23%  Similarity=0.311  Sum_probs=212.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-CCCCcEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVY  122 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~  122 (377)
                      |++.+.||+|+||+||++.++.+|+.||+|++.... .......+.+|+.++++++||||+++++++..... ......+
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            448999999999999999999999999999987642 44556778899999999999999999999866221 1124479


Q ss_pred             EEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCC---eEEeeeeccccc
Q 017083          123 IVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTT  195 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~---vkl~Dfg~~~~~  195 (377)
                      +||||++ ++|.+++....   .+++..++.++.||+.||+|||+.||+||||||+||+++.++.   ++|+|||++...
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999996 59999987644   6899999999999999999999999999999999999998775   899999999887


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........+++.|+|||++.+ ..++.++||||||+++|+|++|..||............   ............ ..
T Consensus       175 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~-~~  249 (676)
T 3qa8_A          175 DQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY-DD  249 (676)
T ss_dssp             TSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC-CC
T ss_pred             ccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh-hh
Confidence            76665667788999999999987 78899999999999999999999999775432211000   000000000000 00


Q ss_pred             hHHHHHHhccc-cccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          276 NARRYVRQLPR-CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       276 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                       ..   ..... ............+++.+.+||.+||..||++|||+.++++||||+.+.+.-
T Consensus       250 -l~---g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          250 -LT---GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             -CS---SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             -hc---cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence             00   00000 000001111223578899999999999999999999999999998777543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=327.43  Aligned_cols=252  Identities=10%  Similarity=0.113  Sum_probs=198.4

Q ss_pred             ccccCCcccccCCccceEEEEEeCC--------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeE------
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSE--------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI------  106 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~--------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~------  106 (377)
                      .+.|++.+.||+|+||+||++++..        .++.||+|++...       ..+.+|+.++++++||||+++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            3455589999999999999999987        4889999998653       356789999999999999984      


Q ss_pred             ---------eeeecCCCCCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 017083          107 ---------KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN  175 (377)
Q Consensus       107 ---------~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~N  175 (377)
                               ++++....    ..+++||||++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       114 ~~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQD----KYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             CTTCSCCCCCEEEEETT----TEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             CCccCccchhhccccCC----cEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                     44443311    338999999977999999875  789999999999999999999999999999999999


Q ss_pred             eEEccCC--CeEEeeeecccccCCCc--------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 017083          176 LLLNASC--DLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (377)
Q Consensus       176 Ili~~~~--~vkl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf  245 (377)
                      |+++.++  .+||+|||++.......        ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999998  89999999997654322        1234578999999999987 67899999999999999999999999


Q ss_pred             CCCC--hHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 017083          246 PGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  323 (377)
Q Consensus       246 ~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e  323 (377)
                      ....  ..............+....                      .....+..+++.+.+||.+||+.||++|||+.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFV----------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEE----------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhh----------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence            8753  2222222222211111100                      001112357899999999999999999999999


Q ss_pred             Hhc
Q 017083          324 ALR  326 (377)
Q Consensus       324 ll~  326 (377)
                      +++
T Consensus       327 l~~  329 (352)
T 2jii_A          327 LRN  329 (352)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=312.82  Aligned_cols=245  Identities=27%  Similarity=0.377  Sum_probs=198.0

Q ss_pred             CcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +.+.||+|+||+||++.+..++.   .+|+|.+... ......+.+.+|+.++++++||||+++++++.....    ..+
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~   99 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG----LPH   99 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----CCE
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC----CcE
Confidence            56889999999999999755544   7999998753 344556788899999999999999999999976543    148


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      +++||+. ++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......  
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            9999996 699999876 567899999999999999999999999999999999999999999999999999754432  


Q ss_pred             ---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                         .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.. ||...........+....             
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------------  245 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------------  245 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-------------
T ss_pred             cccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-------------
Confidence               22334566889999999987 778999999999999999999554 455444333332222211             


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                       .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       246 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          246 -----------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             01112356889999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-42  Score=313.29  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=196.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCC---cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      |++.+.||+|+||+||++.+..++   ..+|+|.+... ........+.+|+.++++++||||+++++++.....    .
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~  101 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----S  101 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----C
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC----c
Confidence            447889999999999999975443   35899998753 344556788899999999999999999998654332    2


Q ss_pred             EEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      .+++|||+++ +|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            7899999985 99999975 456899999999999999999999999999999999999999999999999999865433


Q ss_pred             c-----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          199 D-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       199 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .     ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....           
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----------  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----------  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-----------
T ss_pred             chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-----------
Confidence            2     2233456788999999977 778999999999999999999 566776655443332222110           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                         .......++..+.++|.+||+.||.+|||+.++++
T Consensus       250 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 -------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               01112346888999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.9e-43  Score=317.75  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=189.1

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHH-HhcCCCCceeEeeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL-RHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      .+.++|+.+.+.||+|+||+||++.++.+++.||+|++...       ....+|+.++ +.++||||+++++++..... 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC-
Confidence            45556663447899999999999999999999999999642       3456788887 55689999999999875111 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeee
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg  190 (377)
                      ....++++|||+++ +|.+++....  .+++..++.++.||+.||+|||++||+|+||||+||+++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            01338999999985 9999998654  6999999999999999999999999999999999999998   7889999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++....                     + ..++.++|||||||++|+|++|..||...........+       ..    
T Consensus       166 ~a~~~~---------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~----  212 (299)
T 3m2w_A          166 FAKETT---------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KT----  212 (299)
T ss_dssp             TCEECT---------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CC----
T ss_pred             cccccc---------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HH----
Confidence            885432                     1 45677999999999999999999999765422211000       00    


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  336 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~  336 (377)
                                  .............+..+++++.+||.+||+.||++|||+.|+++||||++....
T Consensus       213 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          213 ------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             ------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             ------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence                        000000011111224679999999999999999999999999999999876643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.8e-43  Score=314.72  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             eecccccCCcccccCCccceEEEEEeCC-CCc--EEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSE-TRE--EVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~--~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+..+.|++++.||+|+||+||++++.. ++.  .||+|+++.... .....+.+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3444556689999999999999998643 333  689999875432 234567788999999999999999999999865


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .      .++++||++ ++|.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus        94 ~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           94 P------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             S------CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             C------ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence            3      689999998 599998876 45799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 017083          192 ARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       192 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      +........    .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----  242 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----  242 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC----
Confidence            976544321    223455778999999977 678899999999999999999 9999988776555444322100    


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               .......++..+.++|.+||..||++|||+.++++
T Consensus       243 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          243 -------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                     01112367899999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-43  Score=335.05  Aligned_cols=258  Identities=16%  Similarity=0.155  Sum_probs=196.1

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCC-CCceeE---------e
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEH-ENVIAI---------K  107 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~---------~  107 (377)
                      ...+.+...+.||+|+||+||++++..+|+.||||++..... .....+.+.+|+.+++.++| ++...+         .
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            344445578899999999999999999999999999874322 22235678899999999987 322111         1


Q ss_pred             ------------eeecCCCCCCCCcEEEEEecCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHhcCCcee
Q 017083          108 ------------DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (377)
Q Consensus       108 ------------~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H  168 (377)
                                  .++..........++++|+.+.++|.+++..       ...+++..+..++.||+.||+|||++||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                        1111111111234789999999999988841       345778889999999999999999999999


Q ss_pred             cCCCCCceEEccCCCeEEeeeecccccCCCccccccccccccCCCcccc---------ccCCCCCcchHHHHHHHHHHHH
Q 017083          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---------NCTEYTAAIDIWSVGCILGEIM  239 (377)
Q Consensus       169 ~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~ll~ell  239 (377)
                      |||||+|||++.++.+||+|||++......  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999998765544  445566 9999999993         2255788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC
Q 017083          240 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  319 (377)
Q Consensus       240 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp  319 (377)
                      +|..||........                                   ..........+++.+.+||.+||+.||++||
T Consensus       312 tg~~Pf~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          312 CADLPNTDDAALGG-----------------------------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HSSCCCCTTGGGSC-----------------------------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HCCCCCCCcchhhh-----------------------------------HHHHHhhcccCCHHHHHHHHHHccCChhhCc
Confidence            99999976431110                                   0001122346789999999999999999999


Q ss_pred             CHHHHhcCccccCCc
Q 017083          320 TVEEALRHPYLQSLH  334 (377)
Q Consensus       320 s~~ell~~p~f~~~~  334 (377)
                      |+.++++||||+.+.
T Consensus       357 t~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          357 LPLQAMETPEYEQLR  371 (413)
T ss_dssp             CHHHHTTSHHHHHHH
T ss_pred             CHHHHHhCHHHHHHH
Confidence            999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=318.38  Aligned_cols=271  Identities=20%  Similarity=0.344  Sum_probs=206.3

Q ss_pred             eeeecccccCCcccccCCccceEEEEE----eCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      ...+..+.+++++.||+|+||+||+++    +..+++.||+|++...  .......+.+|+.++++++||||+++++++.
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            345666777799999999999999998    5678999999999764  3445677889999999999999999999987


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      ....   ..++++|||++ ++|.+++... ..+++..++.++.||+.||++||++||+|+||||+||+++.++.++|+||
T Consensus       113 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          113 SAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             C-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             ecCC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence            6542   23799999997 4999999765 46999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCcc----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          190 GLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       190 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      |++........    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.....     ......+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhcccc
Confidence            99986654321    223455778999999987 6788999999999999999999988864321     1111111111


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      ....      ...........   ....+....++..+.+||++||+.||++|||+.++++
T Consensus       264 ~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQM------IVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHH------HHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhh------hHHHHHHHhhc---CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000      00000011100   0111223467899999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=322.09  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=205.7

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      .....|++..+.|++.+.||+|+||+||++.+..   .+|+|++............+.+|+.++++++||||+++++++.
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            3556677887888899999999999999998864   4999999765433333455678999999999999999999998


Q ss_pred             CCCCCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       112 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      ....     +++++||++ ++|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++ ++.++|+||
T Consensus       100 ~~~~-----~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          100 SPPH-----LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             CSSC-----EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred             cCCc-----eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeec
Confidence            7754     899999998 59999987644 699999999999999999999999999999999999998 679999999


Q ss_pred             ecccccCC------CccccccccccccCCCccccc--------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 017083          190 GLARTTSE------TDFMTEYVVTRWYRAPELLLN--------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (377)
Q Consensus       190 g~~~~~~~------~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~  255 (377)
                      |++.....      ........+++.|+|||++.+        ...++.++||||||+++|+|++|..||..........
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99765432      122334567899999999864        2357889999999999999999999998877655444


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .+.....  +                           ......++..+.++|.+||..||++|||+.++++
T Consensus       254 ~~~~~~~--~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          254 QMGTGMK--P---------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHTTCC--C---------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HhccCCC--C---------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3322100  0                           0111256889999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.4e-43  Score=316.33  Aligned_cols=257  Identities=25%  Similarity=0.341  Sum_probs=199.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccc--cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      ..+.||+|+||+||++.+  +++.||+|++....  ........+.+|+.++++++||||+++++++.....     .++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~l  107 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-----LCL  107 (307)
T ss_dssp             TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-----CEE
T ss_pred             cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc-----eEE
Confidence            668999999999999986  57899999987542  233456778899999999999999999999987654     899


Q ss_pred             EEecCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          124 VYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|||++ ++|.+.+..   ..++++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence            999997 599998863   4569999999999999999999999999999999999999999999999999987654321


Q ss_pred             ---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 ---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                         ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...........+..........         
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  256 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT---------  256 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC---------
T ss_pred             ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh---------
Confidence               2334578999999999865  57899999999999999999999997654332222222211111000         


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      ...+   .    ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus       257 ~~~~---~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          257 IEDY---I----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHH---S----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhh---c----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000   0    000011112235678999999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-43  Score=322.61  Aligned_cols=272  Identities=22%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      +.+..+.|.+.+.||+|+||+||++.+. +++.||+|++...... .....+.+|+.++++++||||+++++++..... 
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  101 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-  101 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC-
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc-
Confidence            4555666779999999999999999864 6889999999764221 112357899999999999999999999987754 


Q ss_pred             CCCcEEEEEecCCC-CHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhcC---CceecCCCCCceEEccCCCeEEee
Q 017083          117 TFNDVYIVYELMDT-DLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGD  188 (377)
Q Consensus       117 ~~~~~~iv~e~~~~-~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dik~~NIli~~~~~vkl~D  188 (377)
                          .+++|||+++ +|.+++....    ++++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|
T Consensus       102 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A          102 ----RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             ----CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             ----eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence                7999999985 9999987543    489999999999999999999999   999999999999999999999999


Q ss_pred             eecccccCCC--ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHh
Q 017083          189 FGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-----YVHQLRLITELI  261 (377)
Q Consensus       189 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-----~~~~~~~i~~~~  261 (377)
                      ||++......  .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....     .......+.   
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---  253 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---  253 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT---
T ss_pred             CccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH---
Confidence            9999865433  22344568999999999977 678999999999999999999999995211     000000000   


Q ss_pred             CCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          262 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                      ...........            .  ............+..+.+++.+||+.||.+|||+.|+++|-.-..+
T Consensus       254 ~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          254 GLLKEKKLEAL------------V--DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTSSCCSTTS------------S--CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHhhchhhhhh------------c--ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            00000000000            0  0000000011234679999999999999999999999998654433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=338.22  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=210.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.|++..+.+++.+.||+|+||+||++.+.. +..||||+++....   ..+.+.+|+.++++++||||+++++++...
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEeec
Confidence            45688888888899999999999999999865 46799999976432   245788999999999999999999998753


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                       .     ++|||||+. |+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       335 -~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          335 -P-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             -S-----CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             -c-----ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence             2     799999998 499999864  3569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.....     
T Consensus       409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----  482 (535)
T 2h8h_A          409 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----  482 (535)
T ss_dssp             STTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-----
T ss_pred             cceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            998655332  1223445778999999987 778999999999999999999 9999988776655544432110     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               ......++..+.+||.+||+.||++|||+.+|++
T Consensus       483 -------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 -------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     0112356889999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.1e-42  Score=329.27  Aligned_cols=254  Identities=21%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~  117 (377)
                      +.++|. +++.||+|+||+||++++..+++.||||++......    ..+..|+.+++.++|++ +..+..+.....   
T Consensus         5 i~~~y~-i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~---   76 (483)
T 3sv0_A            5 VGNKFR-LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGD---   76 (483)
T ss_dssp             ETTTEE-CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETT---
T ss_pred             cCCcEE-EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC---
Confidence            344444 999999999999999999999999999988654322    34678999999998754 555544444443   


Q ss_pred             CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE---ccCCCeEEeeeeccc
Q 017083          118 FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR  193 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli---~~~~~vkl~Dfg~~~  193 (377)
                        ..+++|||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||++.
T Consensus        77 --~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           77 --YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             --EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             --EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence              3799999998899999975 6689999999999999999999999999999999999999   688899999999998


Q ss_pred             ccCCCcc--------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          194 TTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       194 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      .......        .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-  232 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-  232 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-
Confidence            6554322        225678999999999987 778999999999999999999999998754322222221110000 


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            ...........++.++.+||.+||+.||++||++.+|++
T Consensus       233 ----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          233 ----------------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ----------------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  000011112467899999999999999999999998876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-42  Score=314.58  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=189.1

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHh--cCCCCceeEeeeecCCCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      +.|++++.||+|+||+||++.+  +++.||+|++...     ....+..|.+++..  ++||||+++++++...... ..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~-~~   79 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS-ST   79 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT-EE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC-Cc
Confidence            4455899999999999999987  6889999998653     23445556666665  7899999999986543211 13


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------cCCceecCCCCCceEEccCCCeEEeeee
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      .++++|||+++ +|.+++. ...+++..+..++.||+.||+|||        +.||+||||||+||+++.++.+||+|||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             eeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            38999999984 9999885 457999999999999999999999        9999999999999999999999999999


Q ss_pred             cccccCCCcc-----ccccccccccCCCccccccC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCh
Q 017083          191 LARTTSETDF-----MTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTR----------EPLFPGKDY  250 (377)
Q Consensus       191 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~ll~ell~g----------~~pf~~~~~  250 (377)
                      ++........     .....||+.|+|||++.+..     .++.++||||||+++|+|++|          ..||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            9975443321     23347899999999997632     344789999999999999999          777754221


Q ss_pred             H-HHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          251 V-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT--RFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       251 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      . .....+........                      .......  .....++.+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQ----------------------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SSCCHHHHHHHHTTSC----------------------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCcchhhhhHHHhccC----------------------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            1 11111111111000                      0000000  01123567999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=323.82  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=190.2

Q ss_pred             cCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.+.+.||+|+||+||++.+..+   +..||+|.+... ......+.+.+|+.++++++||||+++++++.....    .
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~  165 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----S  165 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS----C
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC----C
Confidence            34678899999999999987543   346899998754 233456788999999999999999999998654322    2


Q ss_pred             EEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      .+++|||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            7899999985 999999764 45889999999999999999999999999999999999999999999999999755432


Q ss_pred             c-----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          199 D-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       199 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .     ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+....           
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-----------  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----------  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-----------
T ss_pred             ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-----------
Confidence            2     1233455778999999987 788999999999999999999 677887655333322221100           


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                         .......++..+.+++.+||+.||++|||+.+++++
T Consensus       314 -------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 -------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               011123568899999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=322.24  Aligned_cols=248  Identities=17%  Similarity=0.225  Sum_probs=196.8

Q ss_pred             cceeeecccccCCcccccCCccceEEEE-----EeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC---CCCcee
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIA  105 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~-----~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~  105 (377)
                      ...+++..+.|.+.+.||+|+||+||+|     .+..+++.||+|++...     ....+..|+.+++.++   |+||++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence            3557788888889999999999999999     46778999999999754     2345667777777776   999999


Q ss_pred             EeeeecCCCCCCCCcEEEEEecCC-CCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc
Q 017083          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (377)
Q Consensus       106 ~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~  179 (377)
                      +++++.....     .++||||++ |+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       132 ~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          132 FYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             EEEEEECSSC-----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             hheeeecCCC-----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence            9999988755     899999998 699999873     56799999999999999999999999999999999999999


Q ss_pred             c-----------CCCeEEeeeecccccC---CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 017083          180 A-----------SCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (377)
Q Consensus       180 ~-----------~~~vkl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf  245 (377)
                      .           ++.+||+|||++....   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcc
Confidence            8           8999999999996433   3334556778999999999988 67899999999999999999999998


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      .......              .                    ....... ....++.+.+++..||+.+|.+|++..+.+
T Consensus       286 ~~~~~~~--------------~--------------------~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          286 VKNEGGE--------------C--------------------KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             EEEETTE--------------E--------------------EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             ccCCCCc--------------e--------------------eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            5432100              0                    0000000 012356788999999999999996544444


Q ss_pred             cC
Q 017083          326 RH  327 (377)
Q Consensus       326 ~~  327 (377)
                      .+
T Consensus       331 ~~  332 (365)
T 3e7e_A          331 RQ  332 (365)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=338.20  Aligned_cols=243  Identities=19%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             Ccc-cccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIR-PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~-~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +.+ .||+|+||+||++.++  .++..||||+++... .....+.+.+|+.++++++||||+++++++..+ .     ++
T Consensus       339 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~-----~~  411 (613)
T 2ozo_A          339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A-----LM  411 (613)
T ss_dssp             EEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS-S-----EE
T ss_pred             EcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC-C-----eE
Confidence            444 7999999999999875  356679999997653 223457788999999999999999999998753 2     79


Q ss_pred             EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          123 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      +||||++ |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999998 589998865 45699999999999999999999999999999999999999999999999999987543321


Q ss_pred             ----ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          201 ----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       201 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                          .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+....              
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------------  556 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------------  556 (613)
T ss_dssp             ----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------------
T ss_pred             eeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence                122234578999999977 788999999999999999998 999998877665554443210              


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                      .......+++.+.+||.+||+.||++||++.++++
T Consensus       557 ----------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 ----------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            01112357899999999999999999999999854

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-41  Score=334.86  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeCCC---CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      .+++..+.+++.+.||+|+||+||++.+..+   +..||+|.+... ......+.+.+|+.++++++||||+++++++..
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4566777777999999999999999998654   457999998654 234455778899999999999999999999854


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      +      .+++||||++ |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       463 ~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 N------PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             S------SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             C------ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence            3      2799999998 69999987644 68999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ++........  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....     
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-----  610 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----  610 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            9987654322  223445778999999977 788999999999999999997 9999998776665554433111     


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                               ....+.+++.+.+||.+||..||++|||+.++++
T Consensus       611 -------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     1112357899999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=317.28  Aligned_cols=279  Identities=20%  Similarity=0.244  Sum_probs=192.0

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHH--HHHHHHHhcCCCCceeEeeeecCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKK  115 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~~  115 (377)
                      .+..+.|++++.||+|+||+||++++  +++.||+|++...     ....+.  .++..+..++||||+++++.+.....
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            44555666899999999999999976  6789999999643     122333  34444556889999999986544333


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCceEEccCCCeE
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLKPSNLLLNASCDLK  185 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~i~H~dik~~NIli~~~~~vk  185 (377)
                      .....+++||||++ |+|.+++... ..++..++.++.||+.||+|||+.         ||+||||||+||+++.++.+|
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            33345789999997 5999998664 458899999999999999999999         999999999999999999999


Q ss_pred             EeeeecccccCCC---------ccccccccccccCCCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 017083          186 IGDFGLARTTSET---------DFMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (377)
Q Consensus       186 l~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~ll~ell~g~~pf~~~~~  250 (377)
                      |+|||++......         .......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999765432         122345689999999998752      2456789999999999999999777643221


Q ss_pred             H-HHHHHHHHHhCCCCccccccccchhHHHHHHhc-cccccccccccCC---CCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          251 V-HQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP---NKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       251 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      . .....+.......          .......... ...........+.   ..++.+.+||.+||+.||++|||+.|++
T Consensus       241 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNH----------PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             CCCCCCTTHHHHCSS----------CCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hhHHHHhhhcccCCC----------chHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            0 0000000000000          0001111100 0111111111111   1345799999999999999999999996


Q ss_pred             c------CccccCCc
Q 017083          326 R------HPYLQSLH  334 (377)
Q Consensus       326 ~------~p~f~~~~  334 (377)
                      +      ++|-++-.
T Consensus       311 ~~L~~ll~~~~~~~~  325 (336)
T 3g2f_A          311 ERMAELMMIWERNKS  325 (336)
T ss_dssp             HHHHHHHHCCCC---
T ss_pred             HHHHHHHHHHHhccc
Confidence            5      56655433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=309.65  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=185.9

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHh--cCCCCceeEeeeecCCCCCCCCc
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .|++++.||+|+||+||++.+.  ++.||+|++...     .......|..++..  ++||||+++++++..... ....
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~  109 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQ  109 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCE
T ss_pred             ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCc
Confidence            3448999999999999999875  789999998543     22334445555554  489999999999876532 1134


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCceEEccCCCeEEeeeec
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ++++|||+++ +|.+++.. .++++..++.++.|++.||+|||++        ||+||||||+||+++.++.+||+|||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            8999999985 99999865 4799999999999999999999998        999999999999999999999999999


Q ss_pred             ccccCCCcc-----ccccccccccCCCccccccCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCh
Q 017083          192 ARTTSETDF-----MTEYVVTRWYRAPELLLNCTEYTAA------IDIWSVGCILGEIMTR----------EPLFPGKDY  250 (377)
Q Consensus       192 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~------~DiwslG~ll~ell~g----------~~pf~~~~~  250 (377)
                      +........     .....||+.|+|||++.+ ......      +|||||||++|+|++|          ..||.....
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            975543321     234578999999999977 444443      8999999999999999          555543211


Q ss_pred             H-HHHHHHHHHhCCCCccccccccchhHHHHHHhcccccccccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          251 V-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       251 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      . .....+.....                     .. .........  ...+++.+.+||.+||+.||++|||+.+++++
T Consensus       268 ~~~~~~~~~~~~~---------------------~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          268 SDPSYEDMREIVC---------------------IK-KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SSCCHHHHHHHHT---------------------TS-CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhhHHHHh---------------------hh-ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            0 00011111100                     00 000000000  11346679999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6e-43  Score=321.77  Aligned_cols=253  Identities=18%  Similarity=0.201  Sum_probs=185.8

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc------CHHHHHHHHHHHHHHHhcC---------CCCcee
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHME---------HENVIA  105 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~iv~  105 (377)
                      .+.|++++.||+|+||+||++++  +|+.||||++.....      .....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            34555999999999999999988  679999999976532      1223366778898888886         666665


Q ss_pred             Eeee-----------------ecCCC--------CCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 017083          106 IKDI-----------------IRPPK--------KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK  159 (377)
Q Consensus       106 ~~~~-----------------~~~~~--------~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~  159 (377)
                      +.++                 |....        ......+|+||||++ |++.+.+.. +.+++..++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            5554                 33200        001244999999997 456666543 67899999999999999999


Q ss_pred             HHh-cCCceecCCCCCceEEccCC--------------------CeEEeeeecccccCCCccccccccccccCCCccccc
Q 017083          160 YVH-SASVLHRDLKPSNLLLNASC--------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  218 (377)
Q Consensus       160 ~LH-~~~i~H~dik~~NIli~~~~--------------------~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  218 (377)
                      ||| ++||+||||||+|||++.++                    .+||+|||+++.....    ...||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999999987                    8999999999866533    3478999999999987


Q ss_pred             cCCCCCcchHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccC
Q 017083          219 CTEYTAAIDIWSVGCI-LGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF  296 (377)
Q Consensus       219 ~~~~~~~~DiwslG~l-l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (377)
                       .. +.++||||||++ .++++.|..||....... ....+........                        ......+
T Consensus       252 -~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~  305 (336)
T 2vuw_A          252 -DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------------------KCNTPAM  305 (336)
T ss_dssp             -CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------------------------CCCSHHH
T ss_pred             -CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------------------------ccchhhh
Confidence             33 889999998777 777888999884321111 1111111000000                        0001112


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHh-cCcccc
Q 017083          297 PNKSSGAVDLLEKMLVFDPNKRITVEEAL-RHPYLQ  331 (377)
Q Consensus       297 ~~~~~~~~~li~~~L~~dp~~Rps~~ell-~~p~f~  331 (377)
                      +.+++++.+||++||+.|     |+.|+| +||||+
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            245788999999999977     999999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-40  Score=305.78  Aligned_cols=254  Identities=20%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHh--cCCCCceeEeeeecCCCCCCCCc
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .|++.+.||+|+||+||++.+  +++.||+|++...     ....+.+|..+++.  ++||||+++++++..... ....
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~  114 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQ  114 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCC
T ss_pred             cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccce
Confidence            444899999999999999987  4889999999643     23556778888887  689999999999887642 1124


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------cCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ++++|||+++ +|.+++.. .++++..++.++.||+.||+|||        +.||+|+||||+||+++.++.+||+|||+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            8999999985 99999875 57999999999999999999999        89999999999999999999999999999


Q ss_pred             ccccCCCc-----cccccccccccCCCccccccC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCChH
Q 017083          192 ARTTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTR----------EPLFPGKDYV  251 (377)
Q Consensus       192 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~ll~ell~g----------~~pf~~~~~~  251 (377)
                      +.......     ......+++.|+|||++.+..     .++.++||||||+++|+|++|          ..||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            97654432     234557899999999987632     223689999999999999999          6777553211


Q ss_pred             -HHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          252 -HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       252 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                       .....+......                      ..........+  ...+..+.+||.+||+.||++|||+.+++++
T Consensus       274 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          274 DPSVEEMRKVVCE----------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCCHHHHHHHHTT----------------------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHH----------------------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             001111111100                      00000001111  1234578999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.7e-40  Score=293.98  Aligned_cols=223  Identities=13%  Similarity=0.040  Sum_probs=179.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccC-HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +.+.||+|+||+||++++..+++.||+|++...... ......+.+|+.++.+++||||+++++++.....     .|+|
T Consensus        35 i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-----~~lv  109 (286)
T 3uqc_A           35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG-----GLVV  109 (286)
T ss_dssp             EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-----EEEE
T ss_pred             EEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc-----EEEE
Confidence            889999999999999999999999999999865433 4456778899999999999999999999987754     8999


Q ss_pred             EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCccccc
Q 017083          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (377)
Q Consensus       125 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~  203 (377)
                      |||++ ++|.+++..+  .....+..++.||+.||+|||++||+||||||+||+++.+|.+||++++             
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            99998 5999988543  4666788899999999999999999999999999999999999998543             


Q ss_pred             cccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHh
Q 017083          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  283 (377)
Q Consensus       204 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (377)
                            |++        .++.++|||||||++|+|++|..||........+.           ...             .
T Consensus       175 ------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~-------------~  216 (286)
T 3uqc_A          175 ------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAE-------------R  216 (286)
T ss_dssp             ------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECC-------------B
T ss_pred             ------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHH-------------H
Confidence                  333        36789999999999999999999998754211000           000             0


Q ss_pred             ccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      .............+.+++.+.+||.+||+.||++| |+.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            00000011112235689999999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.3e-41  Score=334.46  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=196.9

Q ss_pred             cccCCcccccCCccceEEEEEeCC-CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      ..|++++.||+|+||+||++.+.. +|+.||||++... ........+.+|+.++++++||||+++++++......+...
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            344499999999999999999976 7899999998653 23445567889999999999999999999998764422233


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      .|+||||++| +|.+.+..  ++++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++...... 
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence            6999999985 78776643  79999999999999999999999999999999999999986 8999999999866543 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                        ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......           ..+.             
T Consensus       235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~-------------  286 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPE-------------  286 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCT-------------
T ss_pred             --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------cccc-------------
Confidence              44578999999999876  3488999999999999999998887642100           0000             


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                   .......++.+.+||.+||+.||++||+..+.+.|+|+..+
T Consensus       287 -------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 -------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                         00001235779999999999999999999999999998644

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.5e-33  Score=275.15  Aligned_cols=185  Identities=17%  Similarity=0.103  Sum_probs=135.1

Q ss_pred             cccCCccceEEEEEeCCCCcEEEEEecccccc--------CHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCCCC
Q 017083           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--------NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ..+.|++|.+..++....|+.|++|.+.+...        .....+++.+|+.+|+++ .|+||++++++++++..    
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----  316 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----  316 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE----
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE----
Confidence            46778888888888888899999999975421        234456788999999999 59999999999998866    


Q ss_pred             cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       120 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                       +||||||++| +|.+.+..++++++.   .|+.||+.||+|+|++||+||||||+|||++.+|++||+|||+++.....
T Consensus       317 -~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          317 -GWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             -EEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             -EEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence             9999999996 999999998888765   47899999999999999999999999999999999999999999866543


Q ss_pred             -ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 017083          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~  243 (377)
                       ......+||+.|+|||++.+  .+..++|+|++|++++++.++..
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             CccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence             34566789999999999976  46778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.2e-27  Score=230.40  Aligned_cols=184  Identities=22%  Similarity=0.224  Sum_probs=138.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccC------HHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      ...+.||+|+||+||++  ...+..+++|+.......      ....+++.+|+.++++++||||+++..+......   
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            35778999999999999  345678999986443211      1123457899999999999999944333333322   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        .|++|||++ ++|.+++..        +..++.||++||+|||++||+||||||+|||++.  ++||+|||+++....
T Consensus       414 --~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             --cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence              699999998 699998865        5689999999999999999999999999999999  999999999987765


Q ss_pred             Ccc--------ccccccccccCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 017083          198 TDF--------MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  245 (377)
Q Consensus       198 ~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~ll~ell~g~~pf  245 (377)
                      ...        .....||+.|+|||++... ..++...|+|+..+-..+...++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            422        2356889999999998651 34677789999999888887776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.4e-24  Score=193.88  Aligned_cols=146  Identities=18%  Similarity=0.209  Sum_probs=114.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----------------HHHHHHHHHHHHHHhcCCCCceeE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----------------IDARRTLREIKLLRHMEHENVIAI  106 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~iv~~  106 (377)
                      .+.+.+.||+|+||.||++.+ .+|+.||+|+++......                .....+.+|+.++++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            444669999999999999999 889999999996432111                13456789999999999  4 666


Q ss_pred             eeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeE
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vk  185 (377)
                      ++++..+      ..++||||++| +|.+ +.      ......++.||+.||.+||++||+||||||+||+++ ++.++
T Consensus       167 ~~~~~~~------~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          167 PKVYAWE------GNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             CCEEEEE------TTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             CeEEecc------ceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            6655432      26999999985 8877 42      233557999999999999999999999999999999 99999


Q ss_pred             EeeeecccccCCCccccccccccccCCCccccc
Q 017083          186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  218 (377)
Q Consensus       186 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  218 (377)
                      |+|||++..            +..+.|||.+..
T Consensus       233 l~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             EEECCCCeE------------CCCCCHHHHHHH
Confidence            999998853            233678888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.6e-21  Score=171.90  Aligned_cols=138  Identities=17%  Similarity=0.116  Sum_probs=107.2

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcE--EEEEeccccccC----------------------HHHHHHHHHHHHHHHhcC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDN----------------------IIDARRTLREIKLLRHME   99 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~--valK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~   99 (377)
                      +.+.+.||+|+||.||++.+..+|+.  ||||+++.....                      ......+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            34778999999999999999788999  999987543111                      011235678999999998


Q ss_pred             CCCc--eeEeeeecCCCCCCCCcEEEEEecCCC------CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-cCCceecC
Q 017083          100 HENV--IAIKDIIRPPKKDTFNDVYIVYELMDT------DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRD  170 (377)
Q Consensus       100 h~~i--v~~~~~~~~~~~~~~~~~~iv~e~~~~------~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~d  170 (377)
                      |+++  +.++..   .      ..++||||+++      .|.+....   .++..+..++.||+.||.+|| +.||+|||
T Consensus       129 ~~~i~~p~~~~~---~------~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY---M------KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE---E------TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             hCCCCCCeEEEc---C------CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            8754  334432   1      15899999952      67666432   235577889999999999999 99999999


Q ss_pred             CCCCceEEccCCCeEEeeeeccccc
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      |||+|||++.  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=4.2e-18  Score=156.11  Aligned_cols=136  Identities=14%  Similarity=0.100  Sum_probs=95.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC---------------HH-HH----HHHHHHHHHHHhcCCCCc
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---------------II-DA----RRTLREIKLLRHMEHENV  103 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~---------------~~-~~----~~~~~e~~~l~~l~h~~i  103 (377)
                      |++.+.||.|++|.||+|.+. +|+.||||+++.....               .. ..    ....+|+..|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            558999999999999999984 6899999987532110               00 00    112346666666654433


Q ss_pred             e--eEeeeecCCCCCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          104 I--AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       104 v--~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                      .  ..++..   .      .+|||||++| .|..+.      .......++.||+.+|.+||++||+||||||.|||+++
T Consensus       176 ~vp~p~~~~---~------~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQS---R------HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEEE---T------TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred             CCCeeeecc---C------ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence            2  222221   1      3799999997 554322      22345678899999999999999999999999999998


Q ss_pred             CCC----------eEEeeeeccccc
Q 017083          181 SCD----------LKIGDFGLARTT  195 (377)
Q Consensus       181 ~~~----------vkl~Dfg~~~~~  195 (377)
                      +|.          +.|+||+.+-..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            773          899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=7.3e-12  Score=110.15  Aligned_cols=134  Identities=14%  Similarity=0.114  Sum_probs=101.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +...++.|+.+.||++...  +..+++|........  ....+.+|+.+++.+. +..+.+++++....+.     .|++
T Consensus        18 ~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-----~~lv   88 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-----SNLL   88 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-----EEEE
T ss_pred             eEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc-----eEEE
Confidence            5667788888999999753  678999998653211  1235778999999885 6678888888776543     7999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS----------------------------------------  163 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~----------------------------------------  163 (377)
                      |||++| +|.+.+.     +......++.++.+++..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            999998 6665531     223345678899999999998                                        


Q ss_pred             -------------------CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 -------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 -------------------~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                                         ..++|||++|.||++++++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               348999999999999876556799998663

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=6.4e-11  Score=103.75  Aligned_cols=127  Identities=13%  Similarity=0.096  Sum_probs=90.4

Q ss_pred             cccc-CCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC--ceeEeeeecCCCCCCCCcEEEE
Q 017083           48 RPIG-RGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        48 ~~lg-~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      ..++ .|..+.||++.. .+|..+++|.....     ....+..|+.+++.+.+.+  +.+++++....+.     .+++
T Consensus        25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-----~~~v   93 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-----DWLL   93 (264)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-----EEEE
T ss_pred             EecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-----CEEE
Confidence            3454 555699999965 45778999997643     1234668888888886434  5568887766533     7999


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--------------------------------------  165 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------------------------------  165 (377)
                      |||++| ++ + ..   ...   ...++.++++++..||+..                                      
T Consensus        94 ~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999997 55 3 21   111   2356677777788888643                                      


Q ss_pred             --------------------ceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          166 --------------------VLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       166 --------------------i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                                          ++|||++|.||++++++.+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                9999999999999877656799999763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=3e-10  Score=104.58  Aligned_cols=142  Identities=13%  Similarity=0.188  Sum_probs=103.0

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecc--ccccCHHHHHHHHHHHHHHHhcC--CCCceeEeeeecCCCCCCCCcE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .++.|+.|.++.||++...  +..+++|+..  ... .......+.+|+.+++.+.  +..+++++.++.....  ....
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSC
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCe
Confidence            4678999999999999764  4678999876  321 1122356778999999997  4557888888766522  1336


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-------------------------------------  163 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-------------------------------------  163 (377)
                      ++||||++| .+.+..  -..++......++.+++++|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            899999997 442211  2346778888899999999999996                                     


Q ss_pred             ---------------------CCceecCCCCCceEEccCCC--eEEeeeecccc
Q 017083          164 ---------------------ASVLHRDLKPSNLLLNASCD--LKIGDFGLART  194 (377)
Q Consensus       164 ---------------------~~i~H~dik~~NIli~~~~~--vkl~Dfg~~~~  194 (377)
                                           ..++|||+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 35899999999999998763  58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=1.7e-10  Score=103.71  Aligned_cols=187  Identities=16%  Similarity=0.179  Sum_probs=116.2

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCC--ceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HEN--VIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .++.++.|..+.||++.     ..+++|+...    ......+..|+.+++.+. +..  +.+++.......  .....|
T Consensus        24 ~i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~   92 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSF   92 (304)
T ss_dssp             CCCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSC
T ss_pred             eeEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcce
Confidence            45668999999999873     4589998643    234567889999999884 333  334444332221  112247


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------------------------------------  163 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------  163 (377)
                      +||++++| .+.....  ..++......++.+++..+..||+                                      
T Consensus        93 ~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             EEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             EEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            89999997 4443222  245666677777777777777774                                      


Q ss_pred             --------------------CCceecCCCCCceEEcc--CCCeEEeeeecccccCCCccccccccccccCCCcccc---c
Q 017083          164 --------------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---N  218 (377)
Q Consensus       164 --------------------~~i~H~dik~~NIli~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~  218 (377)
                                          ..++|||++|.||++++  .+.+.|+||+.+.................-.+|+...   .
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                                13799999999999998  4457899999886533211000000000001222110   0


Q ss_pred             -c---------CCCCCcchHHHHHHHHHHHHhCCCCC
Q 017083          219 -C---------TEYTAAIDIWSVGCILGEIMTREPLF  245 (377)
Q Consensus       219 -~---------~~~~~~~DiwslG~ll~ell~g~~pf  245 (377)
                       .         .....-.+.|++|.+++.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             0         00112358999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=6.1e-07  Score=78.77  Aligned_cols=130  Identities=19%  Similarity=0.214  Sum_probs=89.1

Q ss_pred             ccCCccc-eEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEEEec
Q 017083           50 IGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (377)
Q Consensus        50 lg~G~~g-~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~e~  127 (377)
                      +..|..| .||+......+..+++|....     .....+..|...|+.+. +--+.+++++....+.     .+++||+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~-----~~lvme~  101 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD-----AWLLTTA  101 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-----EEEEEEC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-----EEEEEEe
Confidence            4445544 699998888888899998753     24556778999999885 3336677777766543     7999999


Q ss_pred             CCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 017083          128 MDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA------------------------------------------  164 (377)
Q Consensus       128 ~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~------------------------------------------  164 (377)
                      ++| ++.+.....    ......+..++...|..||..                                          
T Consensus       102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            997 555543321    122233444555555555521                                          


Q ss_pred             ----------------CceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          165 ----------------SVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       165 ----------------~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                                      .++|||+++.||++++++.+-|+||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                            17899999999999987767799998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=9.3e-07  Score=79.20  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=87.9

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC---CceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .++.++.|....||++     |..+++|+..    .......+..|+.+++.+.+.   .+.+++.+.....    ...+
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----g~~~   89 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----GNPF   89 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT----SCEE
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC----CceE
Confidence            4667888888899998     4678999853    233456788999999999742   2455555543211    2368


Q ss_pred             EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 017083          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------------------------------------  163 (377)
Q Consensus       123 iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------  163 (377)
                      ++||+++| .+.....  ..++......++.++.+.|..||+                                      
T Consensus        90 ~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            99999998 4443211  122333344444444444444442                                      


Q ss_pred             ----------------------CCceecCCCCCceEEcc---CCCe-EEeeeeccccc
Q 017083          164 ----------------------ASVLHRDLKPSNLLLNA---SCDL-KIGDFGLARTT  195 (377)
Q Consensus       164 ----------------------~~i~H~dik~~NIli~~---~~~v-kl~Dfg~~~~~  195 (377)
                                            ..++|+|+++.||+++.   ++.+ .|+||+.+...
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  24699999999999998   4565 89999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.38  E-value=2e-06  Score=79.95  Aligned_cols=78  Identities=17%  Similarity=0.082  Sum_probs=48.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEecccccc--CH---HHHHHHHHHHHHHHhcCC--CC-ceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NI---IDARRTLREIKLLRHMEH--EN-VIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~  117 (377)
                      .++.||.|..+.||++....+++.+++|.......  ..   ....+...|..+++.+..  +. +.+++.+...  .  
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~--~--  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--M--  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--T--
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCC--c--
Confidence            46679999999999998766678899997653211  00   112345678888887742  33 4455544321  1  


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                         .++|||+++|
T Consensus       110 ---~~lvmE~l~g  119 (397)
T 2olc_A          110 ---AVTVMEDLSH  119 (397)
T ss_dssp             ---TEEEECCCTT
T ss_pred             ---cEEEEEeCCC
Confidence               4799999976

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.28  E-value=9.4e-06  Score=67.39  Aligned_cols=99  Identities=15%  Similarity=0.113  Sum_probs=67.6

Q ss_pred             CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccccccccc
Q 017083          131 DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  208 (377)
Q Consensus       131 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~  208 (377)
                      +|.+++.. +.+++++++|.++.|.+.+|..+- .+.-...=+.|..|++..+|.|-+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            79998875 779999999999999999988862 22222334456999999999988774 1111           1123


Q ss_pred             ccCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 017083          209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (377)
Q Consensus       209 ~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~  243 (377)
                      .+.|||...  ...+.+.-|||||+++|..+-...
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence            477888763  355678899999999999987543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.09  E-value=4.3e-05  Score=69.17  Aligned_cols=30  Identities=20%  Similarity=0.292  Sum_probs=26.9

Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      ..++|||+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999663

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.93  E-value=8.2e-05  Score=69.61  Aligned_cols=79  Identities=9%  Similarity=-0.005  Sum_probs=45.6

Q ss_pred             hcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcccccccc--ccccCCCccccccC--CCCCcchHHHHHHHHHH
Q 017083          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCT--EYTAAIDIWSVGCILGE  237 (377)
Q Consensus       162 H~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~DiwslG~ll~e  237 (377)
                      +...++|||+++.||+++.++ +.|+||+.+..............  ...|.+|+......  ......++..+...+++
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999999877 99999998865432211111111  12345544332100  11123445566777776


Q ss_pred             HHhC
Q 017083          238 IMTR  241 (377)
Q Consensus       238 ll~g  241 (377)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6553

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.93  E-value=2.9e-05  Score=70.88  Aligned_cols=82  Identities=9%  Similarity=0.112  Sum_probs=51.3

Q ss_pred             cccc-cCCccceEEEEEeC--C----CCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcC-C--CCceeEeeeecCCCC
Q 017083           47 IRPI-GRGAYGIVCAAVNS--E----TREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-H--ENVIAIKDIIRPPKK  115 (377)
Q Consensus        47 ~~~l-g~G~~g~vy~~~~~--~----~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~  115 (377)
                      ++.| +.|..+.+|++...  .    ++..+++|+...... .......+..|+.+++.+. +  -.+.+++.+......
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88888999998653  0    256899998754320 0001134567888888775 3  346677777654421


Q ss_pred             CCCCcEEEEEecCCC
Q 017083          116 DTFNDVYIVYELMDT  130 (377)
Q Consensus       116 ~~~~~~~iv~e~~~~  130 (377)
                        ....+++||+++|
T Consensus       105 --~g~~~~v~e~l~G  117 (357)
T 3ats_A          105 --LGTPFFLMDYVEG  117 (357)
T ss_dssp             --TSSCEEEEECCCC
T ss_pred             --cCCceEEEEecCC
Confidence              1235899999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.73  E-value=0.00015  Score=64.45  Aligned_cols=68  Identities=12%  Similarity=0.077  Sum_probs=42.0

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecCCCCCCCCcEEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ++.|+.|....+|++      ..+++|+.......   ......|+.+++.+....+ .++++.....       -++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~-------~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPAT-------GVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTTT-------CCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECCC-------CEEEE
Confidence            677888999999999      45899988643111   1122357777776652222 4566554332       36899


Q ss_pred             ecC-CC
Q 017083          126 ELM-DT  130 (377)
Q Consensus       126 e~~-~~  130 (377)
                      ||+ +|
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 65

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.62  E-value=0.00024  Score=63.46  Aligned_cols=73  Identities=12%  Similarity=0.070  Sum_probs=54.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC---CCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      -++.|+.|....+|++..  ++..+++|+....     ....+..|+..|+.|.   ...+++++......+     ..+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g-----~~~  107 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG-----HSF  107 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS-----EEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC-----ceE
Confidence            356789999999999975  4678899987532     2456778888888874   255777777765543     379


Q ss_pred             EEEecCCC
Q 017083          123 IVYELMDT  130 (377)
Q Consensus       123 iv~e~~~~  130 (377)
                      ++|||++|
T Consensus       108 lvme~l~G  115 (312)
T 3jr1_A          108 LLLEALNK  115 (312)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeccC
Confidence            99999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.48  E-value=0.00021  Score=63.09  Aligned_cols=73  Identities=10%  Similarity=-0.029  Sum_probs=50.0

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC---CceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      -++.+|.|..+.||+++. .+|+.|++|+.......  ....+..|+..|+.|.-.   -+.++++.-   .      -+
T Consensus        19 ~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~------~~   86 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D------RT   86 (288)
T ss_dssp             EEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T------TE
T ss_pred             EEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc---C------ce
Confidence            567899999999999986 56889999987543211  123466889888888522   244444431   1      37


Q ss_pred             EEEecCCC
Q 017083          123 IVYELMDT  130 (377)
Q Consensus       123 iv~e~~~~  130 (377)
                      ++|||+.+
T Consensus        87 lv~e~l~~   94 (288)
T 3f7w_A           87 LAMEWVDE   94 (288)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeecc
Confidence            89999863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00069  Score=62.16  Aligned_cols=136  Identities=14%  Similarity=0.208  Sum_probs=80.2

Q ss_pred             CcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      -++.|..|-...+|++....       ++..+++|+.....   .......+|..+++.|. +.-..++++.+..     
T Consensus        54 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----  125 (379)
T 3feg_A           54 RVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE-----  125 (379)
T ss_dssp             CCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----
T ss_pred             EEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----
Confidence            45678778889999998742       35789999874321   12344558888888885 3334666666542     


Q ss_pred             CCcEEEEEecCCC-CHH-----------HH---H---Hh-----CCCCC--HHHHHHHHHHHHH----------------
Q 017083          118 FNDVYIVYELMDT-DLH-----------QI---I---RS-----DQQLT--DDHCQYFLYQLLR----------------  156 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~-----------~~---l---~~-----~~~~~--~~~~~~i~~qi~~----------------  156 (377)
                          .+|+||++| .|.           .+   +   ..     .+...  ..++..+..++-.                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                389999976 211           11   1   11     11122  3455555544422                


Q ss_pred             ---HHHHHh----c----CCceecCCCCCceEEccC----CCeEEeeeeccc
Q 017083          157 ---GLKYVH----S----ASVLHRDLKPSNLLLNAS----CDLKIGDFGLAR  193 (377)
Q Consensus       157 ---al~~LH----~----~~i~H~dik~~NIli~~~----~~vkl~Dfg~~~  193 (377)
                         .+..|.    .    ..++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               223332    2    248999999999999876    689999998774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.31  E-value=0.0016  Score=60.84  Aligned_cols=72  Identities=14%  Similarity=0.103  Sum_probs=48.1

Q ss_pred             CcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      -++.|+.|....+|++....       .+..+++|+.... ..   ...+..|+.+++.+. +.-..++++.+..     
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~-----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG-----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence            35678888889999998643       2578999988432 11   134447888888885 3334566666531     


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                          .+++||++|
T Consensus       148 ----g~v~e~l~G  156 (429)
T 1nw1_A          148 ----GRLEEYIPS  156 (429)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----CEEEEEeCC
Confidence                378999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.11  E-value=0.0012  Score=59.46  Aligned_cols=32  Identities=28%  Similarity=0.378  Sum_probs=27.1

Q ss_pred             CCceecCCCCCceEEccC----CCeEEeeeeccccc
Q 017083          164 ASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTT  195 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~----~~vkl~Dfg~~~~~  195 (377)
                      ..++|||+++.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999875    67899999987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.07  E-value=0.0011  Score=59.36  Aligned_cols=141  Identities=11%  Similarity=0.102  Sum_probs=72.8

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC--ceeEeeeecCCCC-CCCCcEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK-DTFNDVYI  123 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~-~~~~~~~i  123 (377)
                      ++.|+.|....+|++... +| .+++|+.....    ....+..|+.+++.+....  +.+++........ ......++
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            556788888999999753 23 68999886521    1234456777776664212  3333322100000 00023689


Q ss_pred             EEecCCCC-H-----HH------H---HH-hCCCC--------CHHHHHH---------------HHHHHHHHHHHHhc-
Q 017083          124 VYELMDTD-L-----HQ------I---IR-SDQQL--------TDDHCQY---------------FLYQLLRGLKYVHS-  163 (377)
Q Consensus       124 v~e~~~~~-L-----~~------~---l~-~~~~~--------~~~~~~~---------------i~~qi~~al~~LH~-  163 (377)
                      +++|++|. +     ..      .   +. ....+        .......               +...+...++.++. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            99999862 1     00      0   11 11111        1000000               00113334444442 


Q ss_pred             ------CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ------~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                            .+++|+|+++.||++++++.+.|+||+.+.
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  369999999999999987656899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.00  E-value=0.0087  Score=53.50  Aligned_cols=77  Identities=14%  Similarity=0.126  Sum_probs=45.0

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCC--CceeEeeeecCCCC--CCCCcEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKK--DTFNDVY  122 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~--~~~~~~~  122 (377)
                      +..|+ |....||++.. .+|+.+++|..+....   ....+..|+.+++.+...  .+++++..  .+..  ......+
T Consensus        31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~  103 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF  103 (328)
T ss_dssp             CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred             EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence            34566 77889998854 3466799999863211   234555677777777422  24444443  1110  0012357


Q ss_pred             EEEecCCC
Q 017083          123 IVYELMDT  130 (377)
Q Consensus       123 iv~e~~~~  130 (377)
                      +++++++|
T Consensus       104 ~l~~~i~G  111 (328)
T 1zyl_A          104 AVFPSVGG  111 (328)
T ss_dssp             EEEECCCC
T ss_pred             EEEEecCC
Confidence            89999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.94  E-value=0.0039  Score=56.95  Aligned_cols=72  Identities=15%  Similarity=0.161  Sum_probs=42.2

Q ss_pred             cccccCCccceEEEEEeCC--------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCC-ceeEeeeecCCCCCC
Q 017083           47 IRPIGRGAYGIVCAAVNSE--------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDT  117 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~--------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~  117 (377)
                      ++.|+.|....+|++....        .+..+++|+.......   ......|..+++.+...+ ..++++...      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~~------  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTFN------  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEecC------
Confidence            5568888889999997643        1368999987543111   112346777777775223 446665541      


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                         -+++++|++|
T Consensus       109 ---~~~v~e~i~G  118 (369)
T 3c5i_A          109 ---GGRIEEWLYG  118 (369)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CcEEEEEecC
Confidence               1689999986

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.75  E-value=0.015  Score=54.64  Aligned_cols=72  Identities=21%  Similarity=0.202  Sum_probs=46.2

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc-eeEeeeecCCCCCCCCcEEEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ++.|+.|-...+|++.....+..+++|+........   -....|+.+++.|...++ .++++.+. +        ..++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT-N--------GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET-T--------EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEEE
Confidence            556888888999999875545789999875421111   012478888888864433 56777663 1        3599


Q ss_pred             ecCCC
Q 017083          126 ELMDT  130 (377)
Q Consensus       126 e~~~~  130 (377)
                      ||++|
T Consensus       181 e~I~G  185 (458)
T 2qg7_A          181 EFMDG  185 (458)
T ss_dssp             ECCCS
T ss_pred             EeeCC
Confidence            99975

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.75  E-value=0.014  Score=52.64  Aligned_cols=31  Identities=19%  Similarity=0.260  Sum_probs=27.2

Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.61  E-value=0.053  Score=50.04  Aligned_cols=28  Identities=29%  Similarity=0.428  Sum_probs=24.0

Q ss_pred             ceecCCCCCceEE------ccCCCeEEeeeeccc
Q 017083          166 VLHRDLKPSNLLL------NASCDLKIGDFGLAR  193 (377)
Q Consensus       166 i~H~dik~~NIli------~~~~~vkl~Dfg~~~  193 (377)
                      ++|+|+.+.||++      ++++.+.++||..+.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      345679999999875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.24  E-value=0.2  Score=46.50  Aligned_cols=73  Identities=11%  Similarity=0.084  Sum_probs=46.2

Q ss_pred             CcccccCCccceEEEEEeCCC-------CcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSET-------REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      -++.|..|-...+|++.....       +..+++|+.......   .-...+|..+++.+. +.-..++++.+.      
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~------  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP------  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence            356677788889999987521       578999987543211   112346777777775 333455665432      


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                         -+.|++|++|
T Consensus       145 ---~~~I~efI~G  154 (424)
T 3mes_A          145 ---EGRIEEFIDG  154 (424)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CCEEEEEeCC
Confidence               1689999986

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.18  E-value=0.038  Score=52.07  Aligned_cols=62  Identities=11%  Similarity=0.043  Sum_probs=17.0

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEE------EeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAI------KKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~val------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      +.++||   ||.||++........||+      |..+...........+.++..+++.++|||+++.+.+.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            456776   999999988765567888      66543322333344567888889999999999987764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.55  E-value=7.2  Score=32.21  Aligned_cols=83  Identities=20%  Similarity=0.159  Sum_probs=57.4

Q ss_pred             CCCCceeEeeeecCCCCCCCCcEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCce
Q 017083           99 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL  176 (377)
Q Consensus        99 ~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NI  176 (377)
                      .||++  -..+-...+.     +.|.++.-+ + ++..+    ..++....++++.+|+.... -|...-+|--++|+||
T Consensus        48 ~~~~f--~~~I~~~eD~-----~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDE-----VKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSE-----EEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCE-----EEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceE
Confidence            47888  3333343332     566666654 3 55543    45788888888888888654 1235567888999999


Q ss_pred             EEccCCCeEEeeeeccc
Q 017083          177 LLNASCDLKIGDFGLAR  193 (377)
Q Consensus       177 li~~~~~vkl~Dfg~~~  193 (377)
                      +++.++.+++.-.|.-.
T Consensus       116 ~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EECTTCCEEESCCEETT
T ss_pred             EEeCCCcEEEEEcCCcc
Confidence            99999999999888543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	377
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-100
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-99
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-96
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-82
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-79
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-77
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-75
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-73
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-70
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-70
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-69
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-69
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-69
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-68
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-68
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-67
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-66
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-66
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-65
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-65
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-64
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-61
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-61
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-60
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-56
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-55
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-53
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-52
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-50
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-48
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-48
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-36
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  299 bits (767), Expect = e-100
 Identities = 176/345 (51%), Positives = 236/345 (68%), Gaps = 7/345 (2%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLREIK
Sbjct: 1   GQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIK 58

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           +L    HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFLYQ
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRW 209
           +LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRW
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 269
           YRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 329
             + +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPY
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 330 LQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 374
           L+  +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P 
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 342

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  296 bits (757), Expect = 4e-99
 Identities = 168/351 (47%), Positives = 230/351 (65%), Gaps = 6/351 (1%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            + +  +   ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A
Sbjct: 3   TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +RT RE++LL+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTD
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTD 120

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           DH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT Y
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 324
               L  + S++AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +A
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

Query: 325 LRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 375
           L H Y    HD +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 299 LAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  288 bits (737), Expect = 4e-96
 Identities = 154/348 (44%), Positives = 224/348 (64%), Gaps = 6/348 (1%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + +  V    +EV + Y   ++P+G GAYG VC+AV+  T  +VAIKK+   F + + A+
Sbjct: 4   FYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE++LL+HM HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGED 121

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 179

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 265
           VTRWYRAPE++LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P 
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
              +  L+SD A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  EAL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 326 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 373
            HPY +SLHD  DEP     +   F+    T D  + + ++E + F P
Sbjct: 300 AHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (648), Expect = 1e-82
 Identities = 144/358 (40%), Positives = 215/358 (60%), Gaps = 19/358 (5%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 2   QFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDH 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 264
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P
Sbjct: 179 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLV 312
               +  L+    R YV   P+     F   FP+            K+S A DLL KMLV
Sbjct: 238 CPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 313 FDPNKRITVEEALRHPYLQSLHDLNDEPVC-PRPFHFDFEHSSCTEDHIRELIWRESV 369
            DP KRI+V++AL+HPY+   +D  +     P+ +    +    T +  +ELI++E +
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 6e-79
 Identities = 103/304 (33%), Positives = 154/304 (50%), Gaps = 13/304 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---ARRTLREIKLLRHMEHENV 103
           +  +G G +  V  A +  T + VAIKKI     +       R  LREIKLL+ + H N+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D          +++ +V++ M+TD    I  +   LT  H + ++   L+GL+Y+H
Sbjct: 63  IGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTE 221
              +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y   +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +     + S       
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 341
           +  P          F       +DL++ + +F+P  RIT  +AL+  Y  +         
Sbjct: 238 KSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

Query: 342 CPRP 345
            PRP
Sbjct: 295 LPRP 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 2e-77
 Identities = 96/316 (30%), Positives = 166/316 (52%), Gaps = 20/316 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + IG G++G+V  A   ++ E VAIKK+        D R   RE++++R ++H N++ +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRL 78

Query: 107 KDIIRPP-KKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
           +       +K     + +V + +   ++++     R+ Q L   + + ++YQL R L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N    
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYT 255

Query: 281 VRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD---- 335
             + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D    
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315

Query: 336 LNDEPVCPRPFHFDFE 351
           L +    P  F+F  +
Sbjct: 316 LPNGRDTPALFNFTTQ 331

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (594), Expect = 6e-75
 Identities = 99/302 (32%), Positives = 158/302 (52%), Gaps = 10/302 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ +
Sbjct: 15  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            +I R            +Y+V++  + DL  +      + T    +  +  LL GL Y+H
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLL 217
              +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
              +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS        + +   
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254

Query: 278 RRYVRQL-PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 336
              +  +  + RK +   +   +   A+DL++K+LV DP +RI  ++AL H +  S    
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314

Query: 337 ND 338
           +D
Sbjct: 315 SD 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 8e-74
 Identities = 113/292 (38%), Positives = 161/292 (55%), Gaps = 10/292 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 283
            A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+    +    +   Y   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPS 239

Query: 284 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
            P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +  
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 3e-73
 Identities = 61/301 (20%), Positives = 125/301 (41%), Gaps = 23/301 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G G  G+V    +  +   +A K I           + +RE+++L       ++  
Sbjct: 11  ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPYIVGF 69

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
                     +  ++ I  E MD   L Q+++   ++ +         +++GL Y+    
Sbjct: 70  YGAFY-----SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +V TR Y +PE L     Y+ 
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSV 182

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPDD----------ASLGFLR 273
             DIWS+G  L E+       P  D    +L    ++ G   +              +  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  + +L      +   + P+   S    D + K L+ +P +R  +++ + H +++
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302

Query: 332 S 332
            
Sbjct: 303 R 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 1e-70
 Identities = 103/293 (35%), Positives = 151/293 (51%), Gaps = 11/293 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHEN 102
           +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+   EH N
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           V+ + D+    + D    + +V+E +  D   +     +  +  +  +  ++QLLRGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  +
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 190

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
            Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +         +    
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALP 246

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
            +       Q       +      DLL K L F+P KRI+   AL HPY Q L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 9e-70
 Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 38/289 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G GAYG V  AVN  T E VA+K + +    +       +EI + + + HENV+  
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               R       N  Y+  E          I  D  + +   Q F +QL+ G+ Y+H   
Sbjct: 69  YGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           + HRD+KP NLLL+   +LKI DFGLA      +    + +   T  Y APELL     +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS G +L  ++  E  +       Q                             
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------------- 218

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                 K+ +   +    S  + LL K+LV +P+ RIT+ +  +  +  
Sbjct: 219 ---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  220 bits (562), Expect = 1e-69
 Identities = 67/311 (21%), Positives = 125/311 (40%), Gaps = 39/311 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G GA+G+V       T    A K +    ++  D     +EI+ +  + H  ++ +
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNL 88

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            D          N++ ++YE M       ++     ++++D    ++ Q+ +GL ++H  
Sbjct: 89  HDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 165 SVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           + +H DLKP N++     S +LK+ DFGL         +     T  + APE+       
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPV 202

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
               D+WSVG +   +++    F G++    LR +     + DD                
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------------- 246

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 342
                      + F   S    D + K+L+ DPN R+T+ +AL HP+L   +    +   
Sbjct: 247 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295

Query: 343 PRPFHFDFEHS 353
           P   +     S
Sbjct: 296 PSSRYTKIRDS 306

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-69
 Identities = 98/291 (33%), Positives = 145/291 (49%), Gaps = 8/291 (2%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D++            +               +  L  +  + FL+QLL+GL + HS +V
Sbjct: 67  HDVLH----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 226 IDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +       Y    
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TKLPDYKPYP 240

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                       P  ++   DLL+ +L  +P +RI+ EEAL+HPY      
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  216 bits (550), Expect = 8e-69
 Identities = 103/287 (35%), Positives = 150/287 (52%), Gaps = 10/287 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D      +   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR            +VT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +       +Y    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNF 238

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                  + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-68
 Identities = 64/288 (22%), Positives = 125/288 (43%), Gaps = 40/288 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ 
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +              VY++ E      +++ ++   +  +     ++ +L   L Y HS 
Sbjct: 71  LYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRD+KP NLLL ++ +LKI DFG +     +   T    T  Y  PE++     +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG-RMHDE 183

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
            +D+WS+G +  E +  +P F    Y    + I+ +  +  D                  
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------------------ 225

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                          + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 226 -------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  214 bits (547), Expect = 6e-68
 Identities = 69/327 (21%), Positives = 135/327 (41%), Gaps = 42/327 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +   +    +  ++E++ L+ + H N I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            +           +  ++V E    +    +    + L +       +  L+GL Y+HS 
Sbjct: 80  YRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--Y 222
           +++HRD+K  N+LL+    +K+GDFG A   +       +V T ++ APE++L   E  Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              +D+WS+G    E+  R+P     + +  L  I                         
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------------------- 226

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPV 341
                + +  A +  + S    + ++  L   P  R T E  L+H ++           +
Sbjct: 227 ----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282

Query: 342 CPRPFHFDFEHSSCTEDHIRELIWRES 368
             R      E  +     +++++++E+
Sbjct: 283 IQRTKDAVRELDNLQYRKMKKILFQEA 309

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  213 bits (544), Expect = 2e-67
 Identities = 90/318 (28%), Positives = 168/318 (52%), Gaps = 22/318 (6%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           +Y  Y  +   +     Y   +R +GRG Y  V  A+N    E+V +K +       +  
Sbjct: 20  EYWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKK 73

Query: 86  RRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT 143
           ++  REIK+L ++    N+I + DI++ P   T     +V+E ++ TD  Q+ ++   LT
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT---LT 127

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMT 202
           D   ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA          
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI 261
             V +R+++ PELL++   Y  ++D+WS+GC+L  ++  +EP F G D   QL  I +++
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

Query: 262 GSPDDAS-LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDP 315
           G+ D    +     +   R+   L R  ++++     ++     S  A+D L+K+L +D 
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307

Query: 316 NKRITVEEALRHPYLQSL 333
             R+T  EA+ HPY  ++
Sbjct: 308 QSRLTAREAMEHPYFYTV 325

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  212 bits (541), Expect = 1e-66
 Identities = 65/293 (22%), Positives = 122/293 (41%), Gaps = 39/293 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G GA+G+V   V   T      K I       +D      EI ++  + H  +I +
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            D           ++ ++ E +   +L   I   D ++++     ++ Q   GLK++H  
Sbjct: 92  HDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 165 SVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S++H D+KP N++        +KI DFGLA   +  + +     T  + APE++      
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPV 205

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
               D+W++G +   +++    F G+D +  L+ +       D+                
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---------------- 249

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                        F + S  A D ++ +L  +P KR+TV +AL HP+L+  H 
Sbjct: 250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-66
 Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 48/308 (15%)

Query: 37  FEVSSKYVPP------IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           +E  ++ + P      I  +G GA+G V  A N ET    A K I    +   +    + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMV 58

Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQ 148
           EI +L   +H N++ + D          N+++I+ E          ++  ++ LT+   Q
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVT 207
               Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG++   T        ++ T
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 208 RWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 263
            ++ APE+++  T     Y    D+WS+G  L E+   EP     + +  L  I +    
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---- 229

Query: 264 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 323
                                    +     +    SS   D L+K L  + + R T  +
Sbjct: 230 ------------------------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265

Query: 324 ALRHPYLQ 331
            L+HP++ 
Sbjct: 266 LLQHPFVT 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 9e-66
 Identities = 79/295 (26%), Positives = 123/295 (41%), Gaps = 45/295 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G+YG           + +  K++        + +  + E+ LLR ++H N++  
Sbjct: 9   LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
            D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  
Sbjct: 69  YDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 162 HSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE 
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE- 184

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 275
            +N   Y    DIWS+GC+L E+    P F           I                  
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------------ 226

Query: 276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 330
                       R+ +F       S    +++ +ML      R +VEE L +P +
Sbjct: 227 ------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-65
 Identities = 70/306 (22%), Positives = 131/306 (42%), Gaps = 40/306 (13%)

Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           ++ +   KY      IG+GA G V  A++  T +EVAI+++             + EI +
Sbjct: 14  SVGDPKKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILV 70

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +R  ++ N++   D          +++++V E +       + ++  + +        + 
Sbjct: 71  MRENKNPNIVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAP 213
           L+ L+++HS  V+HRD+K  N+LL     +K+ DFG     T E    +  V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E++     Y   +DIWS+G +  E++  EP +  ++ +  L LI                
Sbjct: 186 EVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---------------- 228

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                                + P K S+   D L + L  D  KR + +E L+H +L+ 
Sbjct: 229 -------------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 333 LHDLND 338
              L+ 
Sbjct: 276 AKPLSS 281

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  206 bits (526), Expect = 2e-65
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 46/300 (15%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-------RTLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I         A         TL+E+ +LR +
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 99  -EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD       +T    ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 67  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 271
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I              
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------------- 228

Query: 272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                             Q  +  + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 229 --------------SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 4e-65
 Identities = 67/325 (20%), Positives = 138/325 (42%), Gaps = 41/325 (12%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           E+  KY+     +GRG +GIV   V + +++    K +        D     +EI +L  
Sbjct: 2   ELYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNI 57

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLL 155
             H N++ + +       ++  ++ +++E +   D+ + I +   +L +     +++Q+ 
Sbjct: 58  ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
             L+++HS ++ H D++P N++     S  +KI +FG AR     D          Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 273
           E+  +    + A D+WS+G ++  +++    F  +     +  I     + D+       
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------- 224

Query: 274 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
                                 F   S  A+D ++++LV +   R+T  EAL+HP+L+  
Sbjct: 225 --------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 334 HDLNDEPVCPRPFHFDFEHSSCTED 358
            +     V     H  + H+   +D
Sbjct: 265 IERVSTKVIRTLKHRRYYHTLIKKD 289

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 9e-64
 Identities = 75/333 (22%), Positives = 136/333 (40%), Gaps = 40/333 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++   R  +  +++ I
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 70

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS
Sbjct: 71  VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 164 ASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL  +      LK+ DFG A+ T+  + +T    T +Y APE+L    
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPE 188

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +Y  + D+WS+G I+  ++   P F     +     +   I                R  
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----------------RMG 232

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 340
             + P          +   S     L+  +L  +P +R+T+ E + HP++     +   P
Sbjct: 233 QYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 341 VC-PRPFHFDFEHSSCTEDHIRELIWRESVKFN 372
           +   R    D E     ++ +   +    V + 
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 318

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 1e-63
 Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G GA+  V  A +  T++ VAIK I        +      EI +L  ++H N++A+
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPNIVAL 72

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI           +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   
Sbjct: 73  DDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLL    +    + I DFGL++       ++    T  Y APE+L     Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 186

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
           + A+D WS+G I   ++   P F  ++       I +     D                 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---------------- 230

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                        + + S  A D +  ++  DP KR T E+AL+HP++ 
Sbjct: 231 -----------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 3e-61
 Identities = 58/294 (19%), Positives = 125/294 (42%), Gaps = 36/294 (12%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           +++     IGRG++  V   +++ET  EVA  ++ +      + +R   E ++L+ ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++   D      K     + +V ELM +  L   ++  + +     + +  Q+L+GL++
Sbjct: 69  NIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 161 VHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H+ +  ++HRDLK  N+ +   +  +KIGD GLA       F    + T  + APE+  
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
              +Y  ++D+++ G  + E+ T E  +       Q+         P             
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--------- 235

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 331
                                      +++E  +  + ++R ++++ L H + Q
Sbjct: 236 -------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 5e-61
 Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 48/298 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            + +G G++  V  A    T  E AIK +               RE  ++  ++H   + 
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +         +Y         +L + IR      +   +++  +++  L+Y+H  
Sbjct: 73  LYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL     
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KS 186

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
              + D+W++GCI+ +++   P F   +     + I +L     +               
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--------------- 231

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 333
                                A DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 232 ----------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 42/295 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
              +G G + +V       T  + A K I      +    +      RE+ +L+ ++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           VI + ++      +   DV ++ EL+    L   +   + LT++    FL Q+L G+ Y+
Sbjct: 75  VITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 162 HSASVLHRDLKPSNLLLN----ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           HS  + H DLKP N++L         +KI DFGLA      +       T  + APE++ 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV- 188

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
           N        D+WS+G I   +++    F G      L  ++ +    +D           
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED----------- 237

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 332
                             F N S+ A D + ++LV DP KR+T++++L+HP+++ 
Sbjct: 238 ----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-56
 Identities = 62/298 (20%), Positives = 118/298 (39%), Gaps = 52/298 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHM--EH 100
              +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
             VI + D    P     +   ++ E  +   DL   I     L ++  + F +Q+L  +
Sbjct: 69  SGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 159 KYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           ++ H+  VLHRD+K  N+L++ +  +LK+ DFG      +T   T++  TR Y  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
               +  +  +WS+G +L +++  +  F   + + + ++                     
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------------ 224

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                                 SS    L+   L   P+ R T EE   HP++Q +  
Sbjct: 225 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  182 bits (462), Expect = 9e-55
 Identities = 63/297 (21%), Positives = 119/297 (40%), Gaps = 44/297 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
            R IGRG +G V     ++T +  A+K +             A      + L+   +   
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++ +      P     + +  + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 69  IVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L     
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVA 182

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           Y ++ D +S+GC+L +++     F       +  +                         
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------------------ 218

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSL 333
               R           + S     LLE +L  D N+R+       +E    P+ +SL
Sbjct: 219 ----RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 57/294 (19%), Positives = 113/294 (38%), Gaps = 43/294 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + IG G++G V      +   +VA+K +          +    E+ +LR   H N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
                     T   + IV +  + + L+  +   + +           Q  +G+ Y+H+ 
Sbjct: 70  MGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL--NC 219
           S++HRDLK +N+ L+    +KIGDFGLA   S    +    +   +  + APE++   + 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
             Y+   D+++ G +L E+MT +  +   +   Q+  +                    R 
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------RG 225

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 333
           Y+                N       L+ + L    ++R    + L    ++ L
Sbjct: 226 YLSPDLS-------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELL 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-53
 Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRH-MEHENVI 104
            + +G+G++G V  A   +T +  AIK +  +      D   T+ E ++L    EH  + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +     T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS
Sbjct: 67  HMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+    +KI DFG+ +           +  T  Y APE+LL   +Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKY 180

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
             ++D WS G +L E++  +  F G+D       I                         
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------------------------- 215

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSL 333
                 +             A DLL K+ V +P KR+ V  +  +HP  + +
Sbjct: 216 ------RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  173 bits (438), Expect = 3e-52
 Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 36/295 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G G    V  A +     +VA+K +  +   +     R  RE +    + H  ++A
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D             YIV E +D   L  I+ ++  +T       +    + L + H  
Sbjct: 72  VYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++HRD+KP+N++++A+  +K+ DFG+AR    + +        + T  Y +PE      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-D 189

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
              A  D++S+GC+L E++T EP F G   V            P  A             
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------------- 236

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 335
                         R    S+    ++ K L  +P  R      +R   L  +H+
Sbjct: 237 --------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD-LVRVHN 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 60/295 (20%), Positives = 118/295 (40%), Gaps = 45/295 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G+G +G V       T    A+K +         +   T+ E ++L++  H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +       + +  V E  +   L   +  ++  T++  +++  +++  L+Y+HS 
Sbjct: 70  LKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V++RD+K  NL+L+    +KI DFGL +         +            +L   +Y  
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           A+D W +G ++ E+M     F  +D+     LI                           
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------------------------- 217

Query: 285 PRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 333
                ++   RFP   S  A  LL  +L  DP +R+       +E + H +  S+
Sbjct: 218 ---LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (425), Expect = 7e-50
 Identities = 57/294 (19%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R +G G++G V    +       A+K +       +     T  E  +L  + H  +I 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +         ++++ + ++  +L  ++R  Q+  +   +++  ++   L+Y+HS 
Sbjct: 69  MWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            +++RDLKP N+LL+ +  +KI DFG A+   +         T  Y APE +++   Y  
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNK 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 284
           +ID WS G ++ E++     F   + +     I                         + 
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------------------LNAELRF 220

Query: 285 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 333
           P           P  +    DLL +++  D ++R+       E+   HP+ + +
Sbjct: 221 P-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (422), Expect = 5e-49
 Identities = 73/351 (20%), Positives = 124/351 (35%), Gaps = 42/351 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +   +    
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 107 KDIIRP------------PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
             +                       +       +          + +   + +    QL
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 155 LRGLKYVH-SASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYVVT 207
           L GL Y+H    ++H D+KP N+L+           +KI D G A    E       + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQT 192

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITELI 261
           R YR+PE+LL    +    DIWS  C++ E++T + LF   +          +  I EL+
Sbjct: 193 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 262 GSPDDASL-------GFLRSDNARRYVRQLPRCRKQQFATR----FPNKSSGAVDLLEKM 310
           G      L        F  S    R + +L     +   T       +++    D L  M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 311 LVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR 361
           L  DP KR      + HP+L+    + +  V  R  +          + +R
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 57/285 (20%), Positives = 103/285 (36%), Gaps = 47/285 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 12  LQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS 163
             +I     +    +YIV E M    L   +RS     L  D    F   +   ++Y+  
Sbjct: 66  LGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + +HRDL   N+L++     K+ DFGL +  S T       +   + APE L    +++
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFS 178

Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 282
              D+WS G +L EI +     +P       +  + +                    Y  
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------------------GYKM 219

Query: 283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
             P                   ++++     D   R +  +    
Sbjct: 220 DAP-----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-48
 Identities = 52/297 (17%), Positives = 112/297 (37%), Gaps = 48/297 (16%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        +  + VA+K + N  ++       L E  +++ +++  ++ 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  I             +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  +
Sbjct: 73  MIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCT 220
           + +HRDL   N+LL      KI DFGL++      +     T       + APE +    
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY- 185

Query: 221 EYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 279
           ++++  D+WS G ++ E  +  +  + G        ++                      
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------------- 223

Query: 280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSL 333
                    K +             DL+     +D   R     VE  LR+ Y   +
Sbjct: 224 --------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (415), Expect = 5e-48
 Identities = 62/325 (19%), Positives = 129/325 (39%), Gaps = 26/325 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           I+ +G G++G V    + E+    A+K +       +     TL E ++L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           ++   +    D  N   ++  +   ++   +R   + ++ H +++  Q++   +Y+HS  
Sbjct: 106 LEFSFK----DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +++RDLKP NLL++    +++ DFG A+             T    APE++L+   Y  A
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKA 218

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 285
           +D W++G ++ E+    P F     +     I                S + +  +R   
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDLKDLLR--- 270

Query: 286 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 345
              +     RF N  +G  D+         +     +  +  P++       D       
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS----- 325

Query: 346 FHFDFEHSSCTEDHIRELIWRESVK 370
            +FD       E+ IR  I  +  K
Sbjct: 326 -NFD----DYEEEEIRVSINEKCGK 345

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 57/316 (18%), Positives = 126/316 (39%), Gaps = 48/316 (15%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V         +T +  A+K +              T  E ++L H+   
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
             +    +       T   ++++ + ++  +L   +   ++ T+   Q ++ +++  L++
Sbjct: 89  PFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 217
           +H   +++RD+K  N+LL+++  + + DFGL++                  +     +  
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
             + +  A+D WS+G ++ E++T    F      +    I+  I   +            
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------- 253

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS 332
                                 S+ A DL++++L+ DP KR+       +E   H + Q 
Sbjct: 254 ----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 333 LH--DLNDEPVCPRPF 346
           ++  DL  + V P PF
Sbjct: 298 INWDDLAAKKV-PAPF 312

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 49/296 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G+G +G V     + T   VAIK +       +     L+E ++++ + HE ++ +
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 107 KDIIRPPKKDTFNDVYIVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             ++      +   +YIV E M            + + L          Q+  G+ YV  
Sbjct: 78  YAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTE 221
            + +HRDL+ +N+L+  +   K+ DFGLAR   + ++           + APE  L    
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +T   D+WS G +L E+ T+    +PG      L  +      P                
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-------------- 236

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQSLH 334
                           P       DL+ +    +P +R T E        Y  S  
Sbjct: 237 ----------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-45
 Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 49/304 (16%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +EV  + +  +  +G G +G V     +   + VA+K +       +     L E  L++
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSL---KQGSMSPDAFLAEANLMK 63

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL---HQIIRSDQQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M+           S  +LT +       Q
Sbjct: 64  QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYR 211
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++           + 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLG 270
           APE  +N   +T   D+WS G +L EI+T     +PG      ++ +             
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 232

Query: 271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HP 328
                                      N       L+       P  R T +        
Sbjct: 233 --------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

Query: 329 YLQS 332
           +  +
Sbjct: 267 FFTA 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-45
 Identities = 52/294 (17%), Positives = 110/294 (37%), Gaps = 50/294 (17%)

Query: 50  IGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    ++  +VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ +    +++   +    L+Q+  G+KY+   +
Sbjct: 76  GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTE 221
            +HRDL   N+LL      KI DFGL++     D      +       + APE  +N  +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 188

Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 280
           +++  D+WS G  + E ++  +  +        +  I                       
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----------------------- 225

Query: 281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQ 331
                   + +     P        L+    ++    R     VE+ +R  Y  
Sbjct: 226 -------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 6e-44
 Identities = 62/315 (19%), Positives = 111/315 (35%), Gaps = 70/315 (22%)

Query: 47  IRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHME-H 100
            + +G GA+G V  A      +     +VA+K +    D+  +    + E+K++  +  H
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSH 100

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------ 141
           EN++ +              +Y+++E     DL   +RS ++                  
Sbjct: 101 ENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 142 -----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
                LT +    F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 197 ETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVH 252
                       +   + APE L     YT   D+WS G +L EI +     +PG     
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV 312
               + +                    +    P              +     +++    
Sbjct: 275 NFYKLIQ------------------NGFKMDQP-----------FYATEEIYIIMQSCWA 305

Query: 313 FDPNKRITVEEALRH 327
           FD  KR +       
Sbjct: 306 FDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-43
 Identities = 47/286 (16%), Positives = 104/286 (36%), Gaps = 45/286 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++ ++ HE ++ +
Sbjct: 9   LKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             +           ++I+ E M     L+ +     +            +   ++Y+ S 
Sbjct: 65  YGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEY 222
             LHRDL   N L+N    +K+ DFGL+R   + ++           +  PE+L+  +++
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 223 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           ++  DIW+ G ++ EI +  +  +           I + +                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--------------- 223

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                             S     ++        ++R T +  L +
Sbjct: 224 ---------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-43
 Identities = 55/289 (19%), Positives = 101/289 (34%), Gaps = 45/289 (15%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G G++G+V        S     VA+K +  +           +RE+  +  ++H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +I +  ++          + +V EL    + L ++ +            +  Q+  G+ Y
Sbjct: 73  LIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLL 217
           + S   +HRDL   NLLL     +KIGDFGL R   + D    M E+    +       L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 276
               ++ A D W  G  L E+ T  +  + G +    L  I                   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------------- 227

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
                      ++ +   R  +      +++ +     P  R T     
Sbjct: 228 ----------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 8e-43
 Identities = 50/307 (16%), Positives = 95/307 (30%), Gaps = 47/307 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            R IG G++G +    +    EEVAIK       +     +   E K+ + M+    I  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPT 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                       +   +V EL+   L  +     ++ +         Q++  ++Y+HS +
Sbjct: 68  IRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 166 VLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPE 214
            +HRD+KP N L         + I DFGLA+   +                 T  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
             L   E +   D+ S+G +L         + G     +                     
Sbjct: 184 THLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-------------------- 222

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQ 331
              ++Y R   +              S     L        + +     + +  R+ + +
Sbjct: 223 ---QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

Query: 332 SLHDLND 338
                + 
Sbjct: 280 QGFSYDY 286

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-42
 Identities = 48/286 (16%), Positives = 103/286 (36%), Gaps = 45/286 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 10  VQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD-DHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 66  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
            V+HRDL   N L+  +  +K+ DFG+ R     +    T       + +PE+    + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 223 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 281
           ++  D+WS G ++ E+ +  +  +  +     +  I+                       
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--------------- 224

Query: 282 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                             S+    ++       P  R      LR 
Sbjct: 225 ---------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-42
 Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 40/311 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IG+G +G V         EEVA+K   +  +    +     EI     + HEN++   
Sbjct: 9   ESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 63

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-- 164
                    T+  +++V +  +   L   +     +T +           GL ++H    
Sbjct: 64  AADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 165 ------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAP 213
                 ++ HRDLK  N+L+  +    I D GLA      T +        V T+ Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 214 ELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 268
           E+L +       E     DI+++G +  EI  R  +  G    +QL     +   P    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEE 240

Query: 269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 328
           +  +  +   R     P    +  +            ++ +    +   R+T        
Sbjct: 241 MRKVVCEQKLR-----PNIPNRWQSCEALRV---MAKIMRECWYANGAARLTALRI---- 288

Query: 329 YLQSLHDLNDE 339
             ++L  L+ +
Sbjct: 289 -KKTLSQLSQQ 298

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 52/292 (17%), Positives = 110/292 (37%), Gaps = 37/292 (12%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +     +G G YG V   V  +    VA+K +    ++ ++    L+E  +++
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMK 68

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N++ +  +            ++ Y  +   L +   + Q+++     Y   Q+  
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISS 126

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPEL 215
            ++Y+   + +HRDL   N L+  +  +K+ DFGL+R  T +T                 
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 274
            L   +++   D+W+ G +L EI T     +PG D      L+                 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------- 230

Query: 275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
              + Y  + P                   +L+     ++P+ R +  E  +
Sbjct: 231 ---KDYRMERP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 46/289 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R IG G +G V   +          VAIK   N   + +   + L+E   +R  +H ++
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHI 70

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +I      T N V+I+ EL         +      L       + YQL   L Y+
Sbjct: 71  VKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
            S   +HRD+   N+L++++  +K+GDFGL+R   ++ +   ++  +   + APE + N 
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NF 183

Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
             +T+A D+W  G  + EI+      F G      +  I                     
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------------------- 222

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                       +     PN       L+ K   +DP++R    E    
Sbjct: 223 ---------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (366), Expect = 3e-41
 Identities = 61/301 (20%), Positives = 108/301 (35%), Gaps = 47/301 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKL 94
           E+    V   + IG G +G VC+       +    VAIK + + +      R  L E  +
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 80

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLY 152
           +   +H NVI ++ ++          V I+ E M+         ++D Q T       L 
Sbjct: 81  MGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
            +  G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +      Y      + 
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 213 PELLL-----NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDD 266
           P            ++T+A D+WS G ++ E+M+  E  +        +  I +    P  
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255

Query: 267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
                                          +  S    L+      D N R    + + 
Sbjct: 256 ------------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 327 H 327
            
Sbjct: 286 T 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 2e-40
 Identities = 50/295 (16%), Positives = 98/295 (33%), Gaps = 32/295 (10%)

Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           NV G  ++V        R IG G++G++    N    ++VAIK       +    R   R
Sbjct: 1   NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYR 52

Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQY 149
             KLL       +  +                +V +L+   L  ++    ++ +      
Sbjct: 53  TYKLLAG--CTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 105

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGDFGLAR--------TTS 196
              Q+L  ++ +H  S+++RD+KP N L+          + + DFG+ +           
Sbjct: 106 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
                     T  Y +    L   E +   D+ ++G +    +     + G       + 
Sbjct: 166 PYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML 311
              +        L  L +     + + +   R   F    P+       L  K+L
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT-PDYDY-LQGLFSKVL 277

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-40
 Identities = 60/302 (19%), Positives = 103/302 (34%), Gaps = 58/302 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV 103
              IG G +G V  A   +   R + AIK++   + +  D R    E+++L  +  H N+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQLTDDH 146
           I +              +Y+  E     +L   +R                +   L+   
Sbjct: 74  INLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
             +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        T   +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD 265
              + A E  LN + YT   D+WS G +L EI++     + G         + +      
Sbjct: 189 PVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 325
                                           N      DL+ +     P +R +  + L
Sbjct: 248 P------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQIL 277

Query: 326 RH 327
             
Sbjct: 278 VS 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 59/334 (17%), Positives = 118/334 (35%), Gaps = 53/334 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           I+ +G GA+G V   +     E+V I    K      +    +  L E  ++  +++ +V
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             +  I           V ++ +LM     L  +      +   +   +  Q+ +G+ Y+
Sbjct: 74  CRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN 218
               ++HRDL   N+L+     +KI DFGLA+     +         V   + A E +L+
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 219 CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 277
              YT   D+WS G  + E+MT     + G        ++                    
Sbjct: 188 R-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------------------- 226

Query: 278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH-------PYL 330
                      K +   + P  +     ++ K  + D + R    E +         P  
Sbjct: 227 ----------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276

Query: 331 QSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 364
             +   ++    P P   +F  +   E+ + +++
Sbjct: 277 YLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 57/314 (18%), Positives = 101/314 (32%), Gaps = 71/314 (22%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           +R IG GA+G V  A     +  E    VA+K +       +      RE  L+   ++ 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNP 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------------------- 138
           N++ +  +           + +++E M   DL++ +RS                      
Sbjct: 77  NIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 139 --DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
                L+         Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 197 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVH 252
             D+        +   +  PE +     YT   D+W+ G +L EI +     + G  +  
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 253 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV 312
            +  +                              R         N      +L+     
Sbjct: 251 VIYYV------------------------------RDGNILACPENCPLELYNLMRLCWS 280

Query: 313 FDPNKRITVEEALR 326
             P  R +     R
Sbjct: 281 KLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 57/289 (19%), Positives = 103/289 (35%), Gaps = 47/289 (16%)

Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ--YFLYQLLRGLKYVHSA 164
             I    +        +V   M     +    ++           F  Q+ +G+K++ S 
Sbjct: 94  LGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNC 219
             +HRDL   N +L+    +K+ DFGLAR   + +F      T   +   + A E L   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 278
            ++T   D+WS G +L E+MTR  P +P  +       + +                   
Sbjct: 210 -KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259

Query: 279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 327
                                     +++ K        R +  E +  
Sbjct: 260 ---------------------PDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-39
 Identities = 65/310 (20%), Positives = 114/310 (36%), Gaps = 67/310 (21%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-H 100
            + +G GA+G V  A     + S+    VA+K +     ++ +    + E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS------------------DQQ 141
            N++ +                ++ E     DL   +R                   +  
Sbjct: 87  MNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSET 198
           L  +    F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR     S  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
                  +   + APE + NC  YT   D+WS G  L E+ +     +PG     +   +
Sbjct: 202 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPN 316
                                          K+ F    P    +   D+++     DP 
Sbjct: 261 I------------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 317 KRITVEEALR 326
           KR T ++ ++
Sbjct: 291 KRPTFKQIVQ 300

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 54/290 (18%), Positives = 107/290 (36%), Gaps = 48/290 (16%)

Query: 48  RPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           + IG G +G V   +   +  +    VAIK +   +         L E  ++    H N+
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNI 71

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ +I       +  + I+ E M        +   D + +       L  +  G+KY+
Sbjct: 72  IRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLL 217
            + + +HRDL   N+L+N++   K+ DFGL+R        T   +   +   + APE + 
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDN 276
                +A+ D+WS G ++ E+MT       +   H++ + I +    P            
Sbjct: 187 YRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---------- 235

Query: 277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 326
                                +  S    L+ +    +  +R    + + 
Sbjct: 236 --------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 65/335 (19%), Positives = 127/335 (37%), Gaps = 62/335 (18%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V   V       E    VAIK + N   ++ +    L E
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 73

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--------- 141
             +++     +V+ +  ++            ++ ELM   DL   +RS +          
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 142 -LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
             +         ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 201 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL 256
                + ++   + +PE L +   +T   D+WS G +L EI T  E  + G      LR 
Sbjct: 189 YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247

Query: 257 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 316
           +                               +     +  N      +L+     ++P 
Sbjct: 248 V------------------------------MEGGLLDKPDNCPDMLFELMRMCWQYNPK 277

Query: 317 KRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE 351
            R +  E      + S+ +  +       F++  E
Sbjct: 278 MRPSFLEI-----ISSIKEEMEPGFREVSFYYSEE 307

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-36
 Identities = 71/318 (22%), Positives = 124/318 (38%), Gaps = 64/318 (20%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
            +P+GRGA+G V  A       + T   VA+K +        + R  + E+K+L H+ H 
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHH 76

Query: 102 -NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LT 143
            NV+ +      P       + ++ E     +L   +RS +                 LT
Sbjct: 77  LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---F 200
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
             +  +   + APE + +   YT   D+WS G +L EI +     +PG     +      
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246

Query: 260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 319
                              R +++  R R           +      +      +P++R 
Sbjct: 247 ------------------CRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPSQRP 282

Query: 320 TVEEALRHPYLQSLHDLN 337
           T  E + H  L +L   N
Sbjct: 283 TFSELVEH--LGNLLQAN 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-36
 Identities = 62/310 (20%), Positives = 121/310 (39%), Gaps = 66/310 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE-------VAIKKIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+G GA+G V  A      ++       VA+K + +      D    + E+++++ + 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIG 76

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQ 141
           +H+N+I +              +Y++ E     +L + ++                 ++Q
Sbjct: 77  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 202 TE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
            +     +   + APE L +   YT   D+WS G +L EI T     +PG       +L+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 258 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 317
                                         ++     +  N ++    ++       P++
Sbjct: 251 ------------------------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280

Query: 318 RITVEEALRH 327
           R T ++ +  
Sbjct: 281 RPTFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 1e-22
 Identities = 27/198 (13%), Positives = 57/198 (28%), Gaps = 30/198 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR--------RTLREIKLLRHME 99
           + +G G    V    + E   E  +K       +    +                    E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
              +  ++ +  P     +    ++ EL+D      +R       ++    L  +L  + 
Sbjct: 65  FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVA 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPE 214
             +   ++H DL   N+L++    + I DF  +    E             +  ++    
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173

Query: 215 LLLNCTEYTAAIDIWSVG 232
                  Y    DI S  
Sbjct: 174 -----RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	377
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.23
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.84
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.21
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.53

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-60  Score=434.36  Aligned_cols=336  Identities=46%  Similarity=0.837  Sum_probs=276.8

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      ....|++.++|- ++++||+|+||+||+|+++.+|+.||||++++..........+.+|+.+|+.++|||||+++++|..
T Consensus        10 ~~~~~~~~~~Y~-~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~   88 (346)
T d1cm8a_          10 TKTAWEVRAVYR-DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP   88 (346)
T ss_dssp             SSSEECCBSSEE-EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred             cCceeecCCcEE-EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence            344578888776 9999999999999999999999999999998766666677888999999999999999999999987


Q ss_pred             CCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          113 PKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       113 ~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      ... .....+|+||||++.+|...++. .++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          89 DETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence            643 22345799999998788777654 6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      +......  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+....+.++......
T Consensus       168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            9876554  45568899999999998756789999999999999999999999999999999999999998888777666


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCcC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE  351 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~~  351 (377)
                      ...........................+++.+.+||++||+.||++|||+.|+|+||||+.+.+..+++..+ .+..++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~-~~~~~~~  324 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFD  324 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC--
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC-CCCCchh
Confidence            666666666777766666666667778999999999999999999999999999999999988766555443 3455555


Q ss_pred             CCCCChHHHHHHHHHHHhhcCC
Q 017083          352 HSSCTEDHIRELIWRESVKFNP  373 (377)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~  373 (377)
                      +...+.+.++.++.+|.+.|.|
T Consensus       325 ~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         325 DVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             ---CCHHHHHHHHHHHHHTCCC
T ss_pred             hhhcCHHHHHHHHHHHhhcCCC
Confidence            6667789999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-59  Score=429.24  Aligned_cols=338  Identities=51%  Similarity=0.929  Sum_probs=279.1

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      |+.|+|+.+|. ++++||+|+||+||+|+++.+|+.||||++.+.. .......+.+|+.+|++++||||+++++++...
T Consensus         1 ~~~~~i~~rY~-~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           1 GQVFDVGPRYT-NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             CCCCCCCTTEE-EEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CCccCcCCCeE-EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            57899999976 9999999999999999999999999999997542 344567788999999999999999999999876


Q ss_pred             CCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          114 KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .......+++++++++++|.+++.. +++++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            5544455778888777899999875 479999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCC----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          194 TTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       194 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      .....    .......|++.|+|||++.....++.++||||+||++|+|++|..||..................+.....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            65433    22455678999999999876577889999999999999999999999999988888888888887776655


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD  349 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~  349 (377)
                      ..........................++.+++++.+||.+||+.||++|||+.|+|+||||+...+..+++....++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~  317 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD  317 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC---
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCC
Confidence            55455555555555555555555556778899999999999999999999999999999999988887777777788888


Q ss_pred             cCCCCCChHHHHHHHHHHHhhcCCC
Q 017083          350 FEHSSCTEDHIRELIWRESVKFNPD  374 (377)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~  374 (377)
                      ....+...+++++++-+|..++-|+
T Consensus       318 ~~~~~~~~~~l~~l~~~e~~~~~~~  342 (345)
T d1pmea_         318 MELDDLPKEKLKELIFEETARFQPG  342 (345)
T ss_dssp             -----CCHHHHHHHHHHHSGGGSTT
T ss_pred             hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence            7777788889999999999998886

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=429.13  Aligned_cols=339  Identities=50%  Similarity=0.892  Sum_probs=285.7

Q ss_pred             EecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 017083           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (377)
Q Consensus        32 ~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  111 (377)
                      ..+..|+++++|. ++++||+|+||+||+|+++.+|+.||||++.+..........+.+|+.++++++|||+|++++++.
T Consensus         9 ~~~~~~~~~~rY~-i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1           9 LNKTIWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             CSSSEEEEETTEE-EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCccccCCCCeE-EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3466799998876 999999999999999999999999999999877666667778899999999999999999999987


Q ss_pred             CCCCC-CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          112 PPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       112 ~~~~~-~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      ..... ....+++++++.+|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence            55432 1233556666556799988754 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      ++......  .....|++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+....+.++.....
T Consensus       167 ~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         167 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             ---CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            99765433  4556789999999998875677999999999999999999999999999999999999988887776665


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF  350 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~~~~~~  350 (377)
                      .........................+..+++.+.+||++||+.||++|||+.|+|+||||++..+...++.+ .++..++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~-~~~~~~~  323 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSF  323 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCC-CCCCCGG
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCC-CCCCCcc
Confidence            555555666666655555555555677889999999999999999999999999999999998877666554 4677777


Q ss_pred             CCCCCChHHHHHHHHHHHhhcCCCC
Q 017083          351 EHSSCTEDHIRELIWRESVKFNPDP  375 (377)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~  375 (377)
                      ...+...+++++.+-+|.++|.|.|
T Consensus       324 ~~~~~~~~~~k~~~~~e~~~~~p~~  348 (348)
T d2gfsa1         324 ESRDLLIDEWKSLTYDEVISFVPPP  348 (348)
T ss_dssp             GGCCCCHHHHHHHHHHHHHTCCCCC
T ss_pred             cchhcCHHHHHHHHHHHhhccCCCC
Confidence            8888899999999999999999976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=417.90  Aligned_cols=252  Identities=26%  Similarity=0.447  Sum_probs=219.0

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+... .......+.+|+.++++++||||+++++++.++..     +
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~   81 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-----V   81 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-----E
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE-----E
Confidence            35589999999999999999999999999999865321 22234567899999999999999999999998755     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      |+||||++ |+|.+.+...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            99999998 5999999988899999999999999999999999999999999999999999999999999998665443 


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.+...                  
T Consensus       161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------------  221 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------------  221 (263)
T ss_dssp             CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------
T ss_pred             ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            456689999999999988 7789999999999999999999999998877666655533110                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                   .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       222 -------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 -------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                         011356899999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-60  Score=420.46  Aligned_cols=255  Identities=29%  Similarity=0.422  Sum_probs=211.5

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.++++++||||+++++++..+..     +|+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~-----~~i   80 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNI-----QYL   80 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTE-----EEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce-----eEE
Confidence            44899999999999999999999999999999764322 234568899999999999999999999998754     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC---c
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---D  199 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---~  199 (377)
                      ||||++| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....   .
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999984 99999988889999999999999999999999999999999999999999999999999999865432   2


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||..............  .                 
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~-----------------  221 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--E-----------------  221 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--T-----------------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--c-----------------
Confidence            345678999999999998734457889999999999999999999976543322211111  0                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                               .......+..+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus       222 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         222 ---------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ---------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ---------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                     00111223467899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-59  Score=417.25  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=218.4

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.|+++++||+|+||+||+|+++.+|+.||||++......  ..+.+.+|+.++++++|||||++++++..+..     +
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-----~   92 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-----L   92 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-----E
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE-----E
Confidence            3455999999999999999999999999999998764322  34678899999999999999999999988754     8


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      |+||||++| +|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus        93 ~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999985 88877655 57999999999999999999999999999999999999999999999999999876443 3


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.......               
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---------------  235 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------------  235 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------------
T ss_pred             cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence            4556789999999999988 788999999999999999999999998877666555444321111               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                   ......+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       236 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         236 -------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             -------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                         01123578999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-59  Score=410.30  Aligned_cols=260  Identities=22%  Similarity=0.376  Sum_probs=216.2

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  119 (377)
                      ..+|+++.++||+|+||+||+|+++.++..||+|++..........+.+.+|++++++++|||||++++++...... ..
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG-KK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS-CE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc-CC
Confidence            34566677789999999999999999999999999987655666677889999999999999999999998653211 13


Q ss_pred             cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCceEEc-cCCCeEEeeeeccccc
Q 017083          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFGLARTT  195 (377)
Q Consensus       120 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dik~~NIli~-~~~~vkl~Dfg~~~~~  195 (377)
                      .+|+||||++ |+|.+++.....+++..++.++.||++||+|||+++  |+||||||+|||++ +++.+||+|||+++..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            4899999998 599999998889999999999999999999999998  99999999999997 4789999999999765


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ... ......||+.|+|||++.+  .++.++|||||||++|+|++|..||........+..  .+.....+.        
T Consensus       166 ~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~--~i~~~~~~~--------  232 (270)
T d1t4ha_         166 RAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPA--------  232 (270)
T ss_dssp             CTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH--HHTTTCCCG--------
T ss_pred             cCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH--HHHcCCCCc--------
Confidence            443 3456789999999999865  589999999999999999999999987654433221  111111111        


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  331 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~  331 (377)
                                        ......++++.+||.+||+.||++|||+.|+|+||||+
T Consensus       233 ------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 ------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                              11235688899999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-59  Score=418.83  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=203.7

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.++++++||||+++++++..+..     +|+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-----~~l   84 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGH-----LYL   84 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-----EEE
Confidence            458999999999999999999999999999997653322 23557789999999999999999999988755     999


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc---cCCCeEEeeeecccccCCCc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~---~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ||||++ |+|.+++...+++++..++.++.||+.||+|||++||+||||||+||++.   +++.+||+|||++.......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999998 69999999989999999999999999999999999999999999999995   47889999999998777666


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....                 
T Consensus       165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-----------------  226 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-----------------  226 (307)
T ss_dssp             --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-----------------
T ss_pred             eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------
Confidence            6677889999999999987 7789999999999999999999999998776665554443111                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                ....+.++.+|+++.+||.+||+.||++|||+.|+++||||++.
T Consensus       227 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         227 ----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                      11122345789999999999999999999999999999999853

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=417.04  Aligned_cols=292  Identities=35%  Similarity=0.598  Sum_probs=231.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHH---HHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .++.||+|+||+||+|+++.+|+.||||+++.......   ....+.+|+.++++++|||||++++++..+..     +|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~-----~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-----IS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-----CE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc-----ee
Confidence            57889999999999999999999999999975432211   23467899999999999999999999998865     89


Q ss_pred             EEEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-cc
Q 017083          123 IVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (377)
Q Consensus       123 iv~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~~  200 (377)
                      +||||+.+++...+ ..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            99999997555544 44677999999999999999999999999999999999999999999999999999876544 33


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.+..+.+..............  
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~--  234 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY--  234 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--
Confidence            455688999999999977567899999999999999999999999999999999999998887766543221111000  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCC
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP  345 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~~~~~~~~~  345 (377)
                       ..............++.+++++.+||++||+.||++|||+.|+|+||||++..........|+|
T Consensus       235 -~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p  298 (299)
T d1ua2a_         235 -VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP  298 (299)
T ss_dssp             -CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred             -hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence             0000111111222345678999999999999999999999999999999976654433333443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=408.31  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=207.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||+|+++.+|+.||+|++..........+.+.+|++++++++|||||++++++.+...   ..+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~   81 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLY   81 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEEE
Confidence            4558999999999999999999999999999998776666667788999999999999999999999875433   3389


Q ss_pred             EEEecCC-CCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCceEEccCCCeEEeeeecc
Q 017083          123 IVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      +||||++ |+|.+++.    .+..+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999998 59999875    3567999999999999999999999876     999999999999999999999999999


Q ss_pred             cccCCC-ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          193 RTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       193 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.+..          
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~----------  230 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK----------  230 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred             eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            876543 33456788999999999977 778999999999999999999999999887766655554311          


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  330 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f  330 (377)
                                          .......+|+++.+||++||+.||++|||+.|+|+|||+
T Consensus       231 --------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 --------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                011123578999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=413.56  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=216.1

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++....  ....+.+.+|++++++++|||||++++++..+..     +
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-----~   84 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-----L   84 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE-----E
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe-----E
Confidence            45678999999999999999999999999999997642  3345678899999999999999999999988754     8


Q ss_pred             EEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-
Q 017083          122 YIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-  198 (377)
                      ++||||+++ +|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            999999984 88888664 567999999999999999999999999999999999999999999999999999754432 


Q ss_pred             ccccccccccccCCCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          199 DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      .......||+.|+|||++..    ...++.++|||||||++|+|++|..||......+.+..+....  ++         
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~---------  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP---------  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC---------
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC---------
Confidence            23445788999999999853    2557899999999999999999999998877666555444311  10         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                       .......+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus       234 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 -----------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                             01112356899999999999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=412.70  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=223.6

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.....    ...+.+.+|+.++++++|||||++++++.....  
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--   87 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD--   87 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--
Confidence            34558999999999999999999999999999986543221    235678899999999999999999999998755  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC----CeEEeeeecc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLA  192 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~----~vkl~Dfg~~  192 (377)
                         +|+||||++ |+|.+++...+++++..++.++.||+.||+|||++||+||||||+||+++.++    .+||+|||++
T Consensus        88 ---~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          88 ---VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             ---EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             ---EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence               999999998 59999998888999999999999999999999999999999999999998876    4999999999


Q ss_pred             cccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+       
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------  236 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------  236 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------
T ss_pred             hhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence            88776666677788999999999987 7789999999999999999999999998877666655543211111       


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                          ...++.+|+.+.+||++||+.||++|||++|+|+||||+...
T Consensus       237 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         237 --------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             --------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             --------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                122346799999999999999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-58  Score=419.26  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=224.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |++++.||+|+||+||+|+++.+|+.||||++...  .....+.+.+|+.++++++|||||++++++.....     +|+
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-----~~i  100 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-----MVM  100 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE-----EEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-----EEE
Confidence            44899999999999999999999999999999765  34456778899999999999999999999988754     999


Q ss_pred             EEecCC-CCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc--CCCeEEeeeecccccCCCc
Q 017083          124 VYELMD-TDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~--~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ||||++ |+|.+.+. ..+++++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++.......
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999998 59999885 4567999999999999999999999999999999999999964  5789999999999877776


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+              
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------  245 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------------  245 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------------
T ss_pred             ccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence            6777899999999999987 7789999999999999999999999998887777766655322221              


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                                   ...++.+++++.+||++||+.||++|||+.|+|+||||+....
T Consensus       246 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         246 -------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             -------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             -------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                         1223467899999999999999999999999999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=420.40  Aligned_cols=287  Identities=21%  Similarity=0.337  Sum_probs=218.8

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +|..+.|+++++||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.++++++|||||+++++|.....  
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--   78 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--   78 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE--
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--
Confidence            455566779999999999999999999999999999997653 23345678899999999999999999999998755  


Q ss_pred             CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         +|+||||++| +|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|...
T Consensus        79 ---~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          79 ---ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             ---EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence               9999999985 999999888899999999999999999999997 59999999999999999999999999999865


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCcccc-----
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ-LRLITELIGSPDDASL-----  269 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~-----  269 (377)
                      ... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ...+....+.......     
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CCC-ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            432 2445789999999999988 7899999999999999999999999987654322 1111111111111000     


Q ss_pred             ---------ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          270 ---------GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                               .......................  ....++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                     00000001111111111111000  1123588999999999999999999999999999998643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=411.78  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=216.8

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.++++++||||+++++++..+..     +
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-----~   83 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-----L   83 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE-----E
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE-----E
Confidence            4559999999999999999999999999999996532 122234668899999999999999999999988754     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++.....  
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999998 599999998899999999999999999999999999999999999999999999999999999866432  


Q ss_pred             -ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       199 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.+...               
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------------  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------------  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------------
T ss_pred             ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---------------
Confidence             23445679999999999987 7789999999999999999999999998876666555432110               


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCc
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRHPYLQSLH  334 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e------ll~~p~f~~~~  334 (377)
                                      .....+++++.+||++||+.||++|||++|      +++||||+++.
T Consensus       228 ----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         228 ----------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             ----------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ----------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence                            011357899999999999999999999988      58899998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.1e-58  Score=419.05  Aligned_cols=257  Identities=25%  Similarity=0.451  Sum_probs=224.7

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      +|++++.||+|+||+||+|+++.+|+.||||+++..  .......+.+|+.++++++|||||+++++|..+..     +|
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-----~~  102 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-----MV  102 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-----EE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-----EE
Confidence            355999999999999999999999999999999764  33345677899999999999999999999998755     89


Q ss_pred             EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEc--cCCCeEEeeeecccccCCC
Q 017083          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       123 iv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~--~~~~vkl~Dfg~~~~~~~~  198 (377)
                      +|||||+ |+|.+.+... .++++..++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||++......
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998 5898887654 4799999999999999999999999999999999999998  5789999999999988777


Q ss_pred             ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHH
Q 017083          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  278 (377)
Q Consensus       199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  278 (377)
                      .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.......+             
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------  248 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------------  248 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            66777889999999999987 7899999999999999999999999999887777766655322211             


Q ss_pred             HHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          279 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                    ...++.+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus       249 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         249 --------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             --------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             --------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                          123456899999999999999999999999999999998643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-58  Score=412.06  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=215.9

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.++++++|||||++++++..+..     
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-----   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-----
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE-----
Confidence            345689999999999999999999999999999976543 33445678899999999999999999999987754     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|+|||||.+ +|...+..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            8999999986 55555667788999999999999999999999999999999999999999999999999999865433 


Q ss_pred             cccccccccccCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhH
Q 017083          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  277 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  277 (377)
                        ....||+.|+|||++.+  .+.++.++|||||||++|+|++|..||........+..+......              
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--------------  232 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------------  232 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------------
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence              35679999999999864  246889999999999999999999999887766655544331110              


Q ss_pred             HHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          278 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                     ......+|+.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       233 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         233 ---------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ---------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                           0112356899999999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=413.35  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=224.1

Q ss_pred             cccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      .-+.|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.++++++||||++++++|.....   
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---   79 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR---   79 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE---
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc---
Confidence            34556689999999999999999999999999999975421 12235667899999999999999999999998855   


Q ss_pred             CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCC
Q 017083          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (377)
Q Consensus       119 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~  197 (377)
                        +|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        80 --~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          80 --LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             --EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             --cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence              999999998 59999999989999999999999999999999999999999999999999999999999999986543


Q ss_pred             -CccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          198 -TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       198 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                       .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....              
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--------------  222 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------------  222 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred             CCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC--------------
Confidence             344567889999999999988 7789999999999999999999999999887666655543110              


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                       .....+|+++.+||++||+.||++|+     ++.|+++||||+++.
T Consensus       223 -----------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         223 -----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                             11235799999999999999999999     499999999998763

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-58  Score=410.63  Aligned_cols=286  Identities=40%  Similarity=0.697  Sum_probs=232.4

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  122 (377)
                      .|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|++++++++|||||++++++..+..     +|
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~-----~~   77 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-----LY   77 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-----EE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc-----ee
Confidence            3448999999999999999999999999999997654333345678899999999999999999999998755     99


Q ss_pred             EEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          123 IVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       123 iv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      +||||+++++.+.+..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9999999887776643  457999999999999999999999999999999999999999999999999999866543 4


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+....+.+.+........  ...
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~  235 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPD  235 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STT
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--ccc
Confidence            455668899999999988756678999999999999999999999999998888888888877766544322111  000


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      .................+.+++++.+||++||+.||++|||+.|+|+||||+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            11111112222223345578899999999999999999999999999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=407.77  Aligned_cols=289  Identities=36%  Similarity=0.593  Sum_probs=232.7

Q ss_pred             cccCCcccccCCccceEEEEEeCCC-CcEEEEEeccccccCHHHHHHHHHHHHHHHhc---CCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.|   +||||++++++|.......
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            4455999999999999999999765 66799999976543333333455677776665   7999999999987544333


Q ss_pred             CCcEEEEEecCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                      ...+++++|++++++.....  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            45689999999987665544  3567899999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...........
T Consensus       167 ~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         167 SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            76666778899999999999987 78999999999999999999999999999999999999998887765543221111


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ...    ................+++.+.+||++||+.||++|||+.|+|+||||+++..
T Consensus       246 ~~~----~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         246 PRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             hhh----hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            000    11111122223334568999999999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.6e-57  Score=408.82  Aligned_cols=254  Identities=22%  Similarity=0.408  Sum_probs=221.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      +.|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++++++||||+++++++..+..     
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-----   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-----   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-----
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe-----
Confidence            345689999999999999999999999999999975421 22235678899999999999999999999998755     


Q ss_pred             EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       121 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      +|+||||+.| +|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999985 88888888999999999999999999999999999999999999999999999999999999876544 


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....                 
T Consensus       158 -~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----------------  218 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----------------  218 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------------
T ss_pred             -cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------------
Confidence             445789999999999987 7789999999999999999999999998877766655543111                 


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                    ...+.+++++.++|.+||+.||.+|+     |++++++||||+++.
T Consensus       219 --------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         219 --------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             --------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence                          11235789999999999999999996     999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-56  Score=397.72  Aligned_cols=257  Identities=29%  Similarity=0.472  Sum_probs=221.4

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccC-------HHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-------IIDARRTLREIKLLRHME-HENVIAIKDIIRPPKK  115 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  115 (377)
                      |++++.||+|+||+||+|+++.+|+.||||++.+....       ....+.+.+|+.++++++ ||||+++++++.++..
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            35899999999999999999999999999998654321       112345778999999997 9999999999998755


Q ss_pred             CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       116 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                           +|+||||++ |+|.+++...+++++..++.++.||++||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        85 -----~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          85 -----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             -----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             -----eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence                 999999998 59999999889999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCccccccccccccCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ...........||+.|+|||.+.+     ...++.++||||+||++|+|++|..||...........+.......     
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~-----  234 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF-----  234 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence            776655667789999999999863     2346889999999999999999999999988766665554421111     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                                            ..+.++.+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus       235 ----------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         235 ----------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ----------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ----------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                                  11223467999999999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=408.11  Aligned_cols=336  Identities=43%  Similarity=0.759  Sum_probs=251.9

Q ss_pred             EEEEecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEee
Q 017083           29 QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD  108 (377)
Q Consensus        29 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  108 (377)
                      +..+-...|.|.++|- ++++||+|+||+||+|+++.+|+.||||++.+...+.....++.+|+.++++++||||+++++
T Consensus         5 ~~~~~~~~f~i~~~Y~-i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~   83 (355)
T d2b1pa1           5 SVEVGDSTFTVLKRYQ-NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN   83 (355)
T ss_dssp             EEEETTEEEEEETTEE-EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             EEEeCCcceeecCCeE-EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            3444444788888866 999999999999999999999999999999877666666778899999999999999999999


Q ss_pred             eecCCCC-CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEe
Q 017083          109 IIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (377)
Q Consensus       109 ~~~~~~~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~  187 (377)
                      +|..... .....+|+||||+.+++.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++
T Consensus        84 ~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             EECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeee
Confidence            9976543 2235689999999998888774  568999999999999999999999999999999999999999999999


Q ss_pred             eeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      |||++.............+|+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+.......+......+.+.
T Consensus       162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CCCC---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhhhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            9999988777776777889999999999988 788999999999999999999999999999999888888888776655


Q ss_pred             ccccccchhHHHHHHhccccccccccc------------cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFAT------------RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  335 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~  335 (377)
                      ...... ....................            .....++++.+||++||..||++||||+|+|+||||+...+
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         241 FMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHTTSC-HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHHHhh-hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence            433322 22222222221111111110            11124678999999999999999999999999999997654


Q ss_pred             CC-CCCCCCCCCCCCcCCCCCChHHHHHHHHHHHh
Q 017083          336 LN-DEPVCPRPFHFDFEHSSCTEDHIRELIWRESV  369 (377)
Q Consensus       336 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (377)
                      .. ....++..+..+.+..+...+++++++-+|.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         320 PAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             HHHHTCCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred             cccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence            32 23334455555656667777889998888765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-56  Score=410.34  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=220.6

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccc-cCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+++.++||||+++++++.....     +
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~  116 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-----L  116 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----E
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc-----c
Confidence            4558999999999999999999999999999986532 122234667899999999999999999999998755     8


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCcc
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~~  200 (377)
                      ++||||+. |+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999998 589999988889999999999999999999999999999999999999999999999999999876544  


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....                  
T Consensus       195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------  255 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------------  255 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------------------
Confidence            445689999999999988 7789999999999999999999999998877766665544211                  


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                   .....+++++.+||++||+.||.+|+     |++++++||||+++.
T Consensus       256 -------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         256 -------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             -------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence                         11235789999999999999999995     999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=405.23  Aligned_cols=258  Identities=24%  Similarity=0.424  Sum_probs=223.7

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  118 (377)
                      +-++|. +++.||+|+||+||+|+++.+|+.||+|+++..   ......+.+|+.+|+.++||||++++++|.+...   
T Consensus         3 ~~~rY~-i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~---   75 (321)
T d1tkia_           3 LYEKYM-IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE---   75 (321)
T ss_dssp             CTTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE---
T ss_pred             CccceE-EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE---
Confidence            445665 899999999999999999999999999999764   2334567799999999999999999999998755   


Q ss_pred             CcEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC--CCeEEeeeecccc
Q 017083          119 NDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLART  194 (377)
Q Consensus       119 ~~~~iv~e~~~~-~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~--~~vkl~Dfg~~~~  194 (377)
                        +|+|||||+| +|.+.+...+ ++++..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||++..
T Consensus        76 --~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          76 --LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             --EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             --EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence              9999999985 9999997654 79999999999999999999999999999999999999854  4799999999988


Q ss_pred             cCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 017083          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  274 (377)
Q Consensus       195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  274 (377)
                      ...........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+.....+         
T Consensus       154 ~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  223 (321)
T d1tkia_         154 LKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---------  223 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------
T ss_pred             cccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            776666677788999999999987 7789999999999999999999999999887777766655322221         


Q ss_pred             hhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 017083          275 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  333 (377)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~  333 (377)
                                        ...++.+|+++.+||++||..||++|||++|+|+||||+..
T Consensus       224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                              12235679999999999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-56  Score=409.90  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=214.0

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc----CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+...    ..........++.+++.++|||||++++++.....  
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~--   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK--   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE--
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE--
Confidence            345689999999999999999999999999999864321    11112223345777778889999999999998755  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                         +|+||||++ |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        82 ---~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          82 ---LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             ---EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence               999999998 6999999988999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                      ... .....||+.|+|||++.+...++.++|||||||++|+|++|..||..................             
T Consensus       159 ~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------------  224 (364)
T d1omwa3         159 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------  224 (364)
T ss_dssp             SSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------------
T ss_pred             CCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------------
Confidence            543 455689999999999976467899999999999999999999999875533322222211111             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  334 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~ell~~p~f~~~~  334 (377)
                                     .......+++++.+||.+||+.||++|||     ++|+++||||+++.
T Consensus       225 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         225 ---------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             ---------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence                           11123467999999999999999999999     89999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.7e-56  Score=395.57  Aligned_cols=280  Identities=38%  Similarity=0.667  Sum_probs=227.4

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.++++++||||+++++++..+..     .+++
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~~i~   78 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLV   78 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-----EEEE
T ss_pred             eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-----eeEE
Confidence            48999999999999999995 78999999997654444445788899999999999999999999998865     8999


Q ss_pred             EecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-ccc
Q 017083          125 YELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  202 (377)
Q Consensus       125 ~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~~  202 (377)
                      +|++.+++...+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... ...
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999998666655 457789999999999999999999999999999999999999999999999999998755432 334


Q ss_pred             ccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHH
Q 017083          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  282 (377)
Q Consensus       203 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  282 (377)
                      ...+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+....+.+.........  .......
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  236 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDP  236 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG--GSTTCCT
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh--hhhhccc
Confidence            55678999999999876778999999999999999999999999999888888888888776654432211  1111111


Q ss_pred             hccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          283 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      ..............+.+++.+.+||++||+.||++|||+.|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            11112222233345568999999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=398.10  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=216.8

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHH-hcCCCCceeEeeeecCCCCCCCCcE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      |++++.||+|+||+||+|+++.+|+.||||++++... .....+.+..|..++. .++||||+++++++..+..     +
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~-----~   78 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-----L   78 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-----E
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc-----e
Confidence            4489999999999999999999999999999975321 1122345556666654 6899999999999998855     9


Q ss_pred             EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC-c
Q 017083          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~-~  199 (377)
                      |+||||++ |+|.+++....++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..... .
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999998 599999998899999999999999999999999999999999999999999999999999999865543 3


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...  .+               
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~---------------  220 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP---------------  220 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------------
T ss_pred             cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------------
Confidence            4455788999999999988 78899999999999999999999999988877766655431  11               


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  334 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-ell~~p~f~~~~  334 (377)
                                    .....+|+++.+||++||+.||++|||+. ++++||||+++.
T Consensus       221 --------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         221 --------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                          11135689999999999999999999995 899999998764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=398.50  Aligned_cols=283  Identities=31%  Similarity=0.577  Sum_probs=227.1

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC-CCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~iv  124 (377)
                      .+++||+|+||+||+|+++.+|+.||||++.....      ...+|+.++++++||||++++++|..... ....++++|
T Consensus        24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            78899999999999999999999999999976421      22379999999999999999999865432 222447899


Q ss_pred             EecCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCCCc
Q 017083          125 YELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  199 (377)
Q Consensus       125 ~e~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~~~  199 (377)
                      |||+++++...+    ....++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            999998765554    3466899999999999999999999999999999999999999876 79999999998877666


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      ......|+..|+|||.+.+...++.++|||||||++|||++|..||........+..+.+..+.+...............
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            67778899999999998876788999999999999999999999999999999999998888777654322111000000


Q ss_pred             HHHhccccccc-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 017083          280 YVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  337 (377)
Q Consensus       280 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~~~~  337 (377)
                         ........ ......+..++++.+||.+||+.||++|||+.|+|+||||+++.+..
T Consensus       258 ---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         258 ---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             ---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             ---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence               00000000 01112345789999999999999999999999999999999887643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=383.36  Aligned_cols=259  Identities=21%  Similarity=0.309  Sum_probs=211.7

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.|+|+...|++.+.||+|+||+||+++.+.   .||||+++.........+.+.+|+.++++++|||||++++++..+ 
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-   76 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-   76 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-
Confidence            3588998888899999999999999997643   599999987665666778899999999999999999999987543 


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                           .+++||||++ |+|.+++.. ..++++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 -----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          77 -----QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             -----SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             -----EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence                 2799999998 699999865 457999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC---ccccccccccccCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      ......   .......||+.|+|||++.+.  ..++.++|||||||++|||++|..||...........+.......+  
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--  229 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--  229 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence            765432   233456789999999998642  3578899999999999999999999988765554443332211111  


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                             ........+++++.+||.+||+.||++|||+.|++++
T Consensus       230 -----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 -----------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -----------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1112234678999999999999999999999999976

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=399.98  Aligned_cols=263  Identities=25%  Similarity=0.409  Sum_probs=209.6

Q ss_pred             ecccccCCc-ccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCC
Q 017083           39 VSSKYVPPI-RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        39 i~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  116 (377)
                      +-++|. ++ +.||+|+||+||+|+++.+++.||||+++..       ..+.+|+.++.++ +|||||+++++|..... 
T Consensus         9 i~~~y~-i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-   79 (335)
T d2ozaa1           9 IIDDYK-VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-   79 (335)
T ss_dssp             GGGTEE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             cccCEE-EeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-
Confidence            344555 55 4599999999999999999999999998642       3466799887655 79999999999875211 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeee
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg  190 (377)
                      ....+|+|||||+ |+|.+++...  .++++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence            1134899999998 5999999764  46999999999999999999999999999999999999986   4569999999


Q ss_pred             cccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 017083          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  270 (377)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  270 (377)
                      +++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...+.        
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~--------  230 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--------  230 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC--------
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh--------
Confidence            9988777766777899999999999987 7789999999999999999999999977654333322221110        


Q ss_pred             cccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          271 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                     ..........+..+|+++.+||++||+.||++|||+.|+|+||||++..
T Consensus       231 ---------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         231 ---------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             ---------------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             ---------------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence                           0011111122335789999999999999999999999999999997543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-54  Score=385.49  Aligned_cols=284  Identities=35%  Similarity=0.602  Sum_probs=230.6

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      |+++++||+|+||+||+|+++.+++.||||+++..........++.+|+.+++.++||||+++++++.....     .++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-----~~i   78 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-----LTL   78 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-----EEE
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-----eeE
Confidence            448999999999999999999999999999997766566677889999999999999999999999998865     899


Q ss_pred             EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc-cc
Q 017083          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (377)
Q Consensus       124 v~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~-~~  201 (377)
                      +++++.+ ++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... ..
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            9999986 666666778899999999999999999999999999999999999999999999999999998765543 34


Q ss_pred             cccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccccccccchhHHHH
Q 017083          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  280 (377)
Q Consensus       202 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  280 (377)
                      ....+++.|+|||++.+...++.++|||||||++|+|++|..|| ...+..+....+....+.+.+.........  ...
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  236 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL--PDY  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS--TTC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc--ccc
Confidence            45566888999999887566799999999999999999999885 556666777777777776655432211000  000


Q ss_pred             HHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          281 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ................+.+++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            000001111122333456789999999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=391.16  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=208.0

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCH----HHHHHHHHHHHHHHhcC--CCCceeEeeeecCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHME--HENVIAIKDIIRPPK  114 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~  114 (377)
                      ++| ++.+.||+|+||+||+|+++.+|+.||||++.+.....    ....++.+|+.++++++  ||||+++++++..+.
T Consensus         4 ~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           4 SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            444 38899999999999999999999999999987542211    11233568999999997  899999999998875


Q ss_pred             CCCCCcEEEEEecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccC-CCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~--~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~-~~vkl~Dfg~  191 (377)
                      .     +++||||+.+  ++.+.+..+..+++..++.++.||++||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus        83 ~-----~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 S-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             E-----EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             e-----EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            5     8999999974  788888888899999999999999999999999999999999999999854 7899999999


Q ss_pred             ccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      +...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+      .+..  ..        
T Consensus       158 a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~~--------  220 (273)
T d1xwsa_         158 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQ--------  220 (273)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CC--------
T ss_pred             ceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--cc--------
Confidence            9865544 34567899999999999874455778999999999999999999997531      1111  00        


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                                           ......+|+++.+||++||+.||++|||++|+|+||||+++.
T Consensus       221 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         221 ---------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ---------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                                 011235799999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=390.85  Aligned_cols=287  Identities=34%  Similarity=0.568  Sum_probs=224.5

Q ss_pred             CCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCC---CCCCcE
Q 017083           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DTFNDV  121 (377)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~  121 (377)
                      +++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|++++||||+++++++.....   .....+
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            38999999999999999999999999999997665444455678899999999999999999999865431   112448


Q ss_pred             EEEEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC--
Q 017083          122 YIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (377)
Q Consensus       122 ~iv~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~--  198 (377)
                      +++||++++++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        93 ~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~  172 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN  172 (318)
T ss_dssp             EEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC---
T ss_pred             EEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccc
Confidence            999999997666555 44678999999999999999999999999999999999999999999999999999754432  


Q ss_pred             ---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                         .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+....+.+++.........
T Consensus       173 ~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  252 (318)
T d3blha1         173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY  252 (318)
T ss_dssp             --CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC
T ss_pred             cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchh
Confidence               23344578999999999987667899999999999999999999999999999999999999888776654443332


Q ss_pred             hHHHHHHhccccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 017083          276 NARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  332 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~  332 (377)
                      .............. .....+  ...++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         253 ELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             -------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            22222211111110 000000  123778899999999999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-54  Score=384.69  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=211.2

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      +.|+|..+.+++.++||+|+||+||+|+++.+++.||||+++....   ..+++.+|+.++++++|||||++++++..+.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            3588888888899999999999999999999999999999976533   3457889999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                      .     ++++|||++ |+|.+.+..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        87 ~-----~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          87 P-----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             e-----eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence            5     899999998 689998865  35789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCccc
Q 017083          192 ARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       192 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ++......  ......+++.|+|||++.+ ..++.++|||||||++|||++|..||.. .........+...        
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------  232 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------  232 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------
T ss_pred             eeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------
Confidence            98765442  2334457889999999987 7889999999999999999997666544 4433332222110        


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            ...+....+++.+.+||.+||+.||++|||+.|+++
T Consensus       233 ----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 ----------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                  011122467899999999999999999999999965

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=381.58  Aligned_cols=259  Identities=22%  Similarity=0.377  Sum_probs=213.8

Q ss_pred             ecceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecC
Q 017083           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (377)
Q Consensus        33 ~~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  112 (377)
                      +.+.|+|+.+.+++++.||+|+||+||+|+++ ++..||||+++....   ..+.+.+|+.++++++|||||++++++..
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            45678999989999999999999999999985 568899999976432   24578899999999999999999998865


Q ss_pred             CCCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          113 PKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      +.      +++||||++ |+|.+.+..  ..++++..+..++.||++||+|||+++|+||||||+|||++.++.+||+||
T Consensus        80 ~~------~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          80 EP------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             SS------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CC------eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence            32      689999998 588887653  336999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCc
Q 017083          190 GLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDD  266 (377)
Q Consensus       190 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~  266 (377)
                      |+++......  ......+++.|+|||++.+ ..++.++|||||||++|||++|. .||...........+....     
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-----  227 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----  227 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----
T ss_pred             cceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----
Confidence            9998765442  2345577899999999987 77899999999999999999964 4555555444443332210     


Q ss_pred             cccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 017083          267 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  332 (377)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~--~p~f~~  332 (377)
                                               .......+++++.+|+.+||+.||++|||++++++  ++||++
T Consensus       228 -------------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 -------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                     01112357889999999999999999999999998  888864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=379.26  Aligned_cols=248  Identities=20%  Similarity=0.331  Sum_probs=203.7

Q ss_pred             ccccCCccceEEEEEeC--CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEEEE
Q 017083           48 RPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (377)
Q Consensus        48 ~~lg~G~~g~vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  125 (377)
                      ++||+|+||+||+|.++  .+++.||||+++.........+.+.+|+.++++++|||||++++++..+.      .++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~------~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS------EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC------EEEEE
Confidence            36999999999999864  45678999999766555556678999999999999999999999986532      68999


Q ss_pred             ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc----c
Q 017083          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----F  200 (377)
Q Consensus       126 e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~----~  200 (377)
                      ||++ |+|.+++....++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    .
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9998 5999999998999999999999999999999999999999999999999999999999999998654332    2


Q ss_pred             ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHH
Q 017083          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  279 (377)
Q Consensus       201 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  279 (377)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.+-  .                
T Consensus       167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~----------------  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E----------------  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C----------------
T ss_pred             ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--C----------------
Confidence            234567899999999987 778999999999999999997 89999987766554444321  0                


Q ss_pred             HHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCccccC
Q 017083          280 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRHPYLQS  332 (377)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el---l~~p~f~~  332 (377)
                                  ..+....+|+++.+||.+||+.||++|||+.++   |+|+|++.
T Consensus       228 ------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                        011224678999999999999999999999998   46776653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=385.63  Aligned_cols=257  Identities=24%  Similarity=0.354  Sum_probs=210.5

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCCc-----EEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD  108 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  108 (377)
                      .+|+++.+.+++++.||+|+||+||+|+++.+++     .||+|.+.... .......+.+|+.++.++ +|||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4578888888899999999999999999876543     69999986543 223456788999999998 7999999999


Q ss_pred             eecCCCCCCCCcEEEEEecCC-CCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcC
Q 017083          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-----------------------QQLTDDHCQYFLYQLLRGLKYVHSA  164 (377)
Q Consensus       109 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~al~~LH~~  164 (377)
                      ++.....     +++||||++ |+|.+++...                       ..+++..++.++.||++||+|||++
T Consensus       109 ~~~~~~~-----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~  183 (325)
T d1rjba_         109 ACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK  183 (325)
T ss_dssp             EECSSSS-----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEeeCCe-----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9988755     899999998 5999998754                       2488999999999999999999999


Q ss_pred             CceecCCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-
Q 017083          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  240 (377)
Q Consensus       165 ~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-  240 (377)
                      ||+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+ ..++.++|||||||++|||++ 
T Consensus       184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTT
T ss_pred             CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhC
Confidence            99999999999999999999999999998654432   2335567999999999987 789999999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 017083          241 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  320 (377)
Q Consensus       241 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps  320 (377)
                      |..||.+......+..+......                             .+....+++++.+||.+||+.||++|||
T Consensus       263 g~~Pf~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt  313 (325)
T d1rjba_         263 GVNPYPGIPVDANFYKLIQNGFK-----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPS  313 (325)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcC
Confidence            89999886655444433321100                             1122357899999999999999999999


Q ss_pred             HHHHhcC
Q 017083          321 VEEALRH  327 (377)
Q Consensus       321 ~~ell~~  327 (377)
                      ++||++|
T Consensus       314 ~~ei~~~  320 (325)
T d1rjba_         314 FPNLTSF  320 (325)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=376.88  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCc---EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      ++...++++.+.||+|+||+||+|+++.+++   .||+|.+.... .....+.+.+|+.+|++++|||||++++++..+.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            3555667788999999999999999987765   58899886543 3445677899999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      .     +++||||++ |+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       101 ~-----~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         101 P-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             S-----CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             E-----EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence            5     899999998 588887776 457999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc------ccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017083          193 RTTSETDF------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPD  265 (377)
Q Consensus       193 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  265 (377)
                      +.......      .....+|+.|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+.....   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---  251 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---  251 (299)
T ss_dssp             --------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            86543321      122456889999999987 788999999999999999998 8999988876665554432111   


Q ss_pred             ccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          266 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                                 .+....++..+.+|+.+||+.||++|||+.|++++
T Consensus       252 ---------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 ---------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                       11123578999999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=370.31  Aligned_cols=246  Identities=19%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcE
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      +.+++++.||+|+||+||++.++ ++..||||+++.....   .+++.+|+.++++++||||+++++++..+..     +
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-----~   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-----I   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-----C
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCc-----e
Confidence            44558999999999999999986 4678999999764333   3578899999999999999999999987755     8


Q ss_pred             EEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc
Q 017083          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~  199 (377)
                      ++||||++ |+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999998 689998765 4568899999999999999999999999999999999999999999999999998655432


Q ss_pred             --cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                        ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+......             
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-------------  221 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------  221 (263)
T ss_dssp             ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-------------
T ss_pred             ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence              2334567899999999987 789999999999999999999 56667666655555554431111             


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                       ......++++.+||.+||+.||++|||++|++++
T Consensus       222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1112458899999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-53  Score=385.75  Aligned_cols=281  Identities=29%  Similarity=0.541  Sum_probs=216.3

Q ss_pred             ccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcE
Q 017083           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (377)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  121 (377)
                      .|+++++||+|+||+||+|+++.+|+.||||+++..     ..+++.+|+.+|++++ ||||++++++|.....   ..+
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~  107 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTP  107 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---Cce
Confidence            355999999999999999999999999999999653     2456788999999996 9999999999976533   348


Q ss_pred             EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCC-CeEEeeeecccccCCCc
Q 017083          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  199 (377)
Q Consensus       122 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~-~vkl~Dfg~~~~~~~~~  199 (377)
                      ++||||+++ +|...   .+.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999995 66554   35799999999999999999999999999999999999999765 58999999998877666


Q ss_pred             cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccccc----cccc
Q 017083          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLG----FLRS  274 (377)
Q Consensus       200 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~----~~~~  274 (377)
                      ......+|+.|+|||.+.+...++.++|||||||++|+|++|..||.... .......+....+.+......    ....
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            67778889999999999875678999999999999999999999997654 334455555544422111000    0000


Q ss_pred             hhHHHHHHhccccc--cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 017083          275 DNARRYVRQLPRCR--KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  334 (377)
Q Consensus       275 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~p~f~~~~  334 (377)
                      ..............  ..........+++++.+||++||+.||++|||++|+|+||||+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            00000000000000  0011112234788999999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9e-53  Score=374.27  Aligned_cols=262  Identities=25%  Similarity=0.365  Sum_probs=209.9

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCCcEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      +.++|. +++.||+|+||+||+|+++.+|+.||||++++... +......+.+|+.+++.++||||+++++++.......
T Consensus         5 l~drY~-i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           5 LSDRYE-LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             ETTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             ccceeE-EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            455554 89999999999999999999999999999986543 3445567889999999999999999999987653311


Q ss_pred             CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccC
Q 017083          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (377)
Q Consensus       118 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~  196 (377)
                       ..+|+||||++| +|.+.+...+++++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+....
T Consensus        84 -~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          84 -PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             -EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             -ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence             237899999985 899999888899999999999999999999999999999999999999999999999999886543


Q ss_pred             CC----ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          197 ET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       197 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      ..    .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...  .+        
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~--~~--------  231 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DP--------  231 (277)
T ss_dssp             ----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CC--------
T ss_pred             cccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc--CC--------
Confidence            32    23445678999999999987 77899999999999999999999999987766555444321  11        


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhcCcccc
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALRHPYLQ  331 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~ell~~p~f~  331 (377)
                                       ......++.+|+++.+||++||+.||++|| |++++ .|+|++
T Consensus       232 -----------------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         232 -----------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             -----------------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             -----------------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence                             111223457899999999999999999999 56665 467764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=366.47  Aligned_cols=247  Identities=20%  Similarity=0.322  Sum_probs=209.3

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCc
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  120 (377)
                      .+.++++++||+|+||+||+++++ ++..||||++++....   .+.+.+|+.++++++||||+++++++..+..     
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~-----   73 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-----   73 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSS-----
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-----
Confidence            456679999999999999999985 6788999999865333   3578899999999999999999999987654     


Q ss_pred             EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCC
Q 017083          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (377)
Q Consensus       121 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~  198 (377)
                      +++||||++ |+|.+++.. ...+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            999999998 688887654 567899999999999999999999999999999999999999999999999999765443


Q ss_pred             c--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccch
Q 017083          199 D--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  275 (377)
Q Consensus       199 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  275 (377)
                      .  ......+|+.|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+.+....            
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------  220 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------  220 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------
T ss_pred             CceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence            2  2334677999999999987 788999999999999999998 89999988877665555431111            


Q ss_pred             hHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          276 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                        ......++.+.+||++||+.||++|||++++++|
T Consensus       221 ------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                              1113568899999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=373.54  Aligned_cols=259  Identities=19%  Similarity=0.299  Sum_probs=211.4

Q ss_pred             eecccccCCcc-cccCCccceEEEEEeCCC--CcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           38 EVSSKYVPPIR-PIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        38 ~i~~~~~~~~~-~lg~G~~g~vy~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      -+..+.+.+.+ +||+|+||+||+|.++.+  +..||||+++... .....+.+.+|+.++++++|||||++++++..+.
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~   82 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe
Confidence            35555565666 499999999999987643  4579999997643 3445678899999999999999999999986532


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            +|+||||++ |+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        83 ------~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          83 ------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             ------EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ------EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence                  799999998 599988764 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +......    ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+.+-.      
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~------  229 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------  229 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------
T ss_pred             hcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            8665432    2234467899999999987 788999999999999999998 999998877665554443210      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRHPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el---l~~p~f~~~~  334 (377)
                                              ..+..+.+|+++.+||.+||+.||++|||+.++   |+|+|+.-..
T Consensus       230 ------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         230 ------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                                    011224678999999999999999999999888   5688885433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=370.25  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      .+.|+|..+.+++.++||+|+||+||+|+++.+ ..||||+++.....   .+.+.+|+.++++++|||||++++++..+
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence            456888888899999999999999999999765 57999999765333   46788999999999999999999998653


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeee
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg  190 (377)
                      .      +++||||++ |+|...+..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        85 ~------~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          85 P------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             S------CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             C------eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence            2      689999998 577777753  4579999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcc
Q 017083          191 LARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       191 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +++......  ......+|+.|+|||++.+ +.++.++|||||||++|||++|..| +......+.+..+.+..      
T Consensus       159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------  231 (285)
T d1fmka3         159 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------  231 (285)
T ss_dssp             TTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------
T ss_pred             hhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------
Confidence            998654332  2344677999999999987 7889999999999999999996555 45455444444433211      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CccccCCc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQSLH  334 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~--~p~f~~~~  334 (377)
                                              ..+..+.+++++.+||.+||+.||++|||+++|++  ++||++..
T Consensus       232 ------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 ------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ------------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                                    11223467899999999999999999999999988  88987754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=365.45  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=201.3

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCC---cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  113 (377)
                      |+|+.+.|++++.||+|+||+||+|++..++   ..||+|.++... .......+.+|+.++++++||||+++++++..+
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            7888888889999999999999999986543   568999886542 444567788999999999999999999998643


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeec
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~  191 (377)
                            .+++||||++ |+|.+++.. ..++++..++.++.||++||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus        81 ------~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          81 ------PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             ------SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             ------eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence                  2799999998 588877654 55799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 017083          192 ARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  268 (377)
Q Consensus       192 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  268 (377)
                      ++......  ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+...        
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--------  225 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------  225 (273)
T ss_dssp             ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred             heeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence            98654332  2344567899999999987 788999999999999999997 89999887766555444321        


Q ss_pred             cccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          269 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                            ...+..+.+|+.+.+||.+||+.||++|||+.||+++
T Consensus       226 ----------------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         226 ----------------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  0112235679999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=360.79  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=195.4

Q ss_pred             ecccccCCcccccCCccceEEEEEeCCCC----cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      |....+.+.+.||+|+||+||+|.++.++    ..||||++.... .......+.+|+.++++++|||||++++++....
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            34444557889999999999999987655    469999997653 3344567889999999999999999999998775


Q ss_pred             CCCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      .     ++++|||+.+ ++.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~-----~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          83 P-----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             S-----EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             c-----eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence            5     8999999985 67776654 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +......    ......||+.|+|||++.+ ..++.++|||||||++|||++|..| +......+....+..-.      
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------  230 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------  230 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence            8654331    2334567899999999987 7899999999999999999996555 44444443333332210      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                              ..+....++..+.+||.+||+.||++|||+.|+++
T Consensus       231 ------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                    01122356889999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=375.88  Aligned_cols=263  Identities=21%  Similarity=0.361  Sum_probs=214.5

Q ss_pred             cccccCCcccccCCccceEEEEEe---CCCCcEEEEEecccccc--CHHHHHHHHHHHHHHHhcCC-CCceeEeeeecCC
Q 017083           40 SSKYVPPIRPIGRGAYGIVCAAVN---SETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPP  113 (377)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~  113 (377)
                      +-+.|++++.||+|+||+||+|++   +.+|+.||||++++...  +....+.+.+|+.++++++| |||+++++++...
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            335566899999999999999987   45789999999875421  22234567789999999986 8999999999887


Q ss_pred             CCCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       114 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                      ..     +++++||+. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++
T Consensus       102 ~~-----~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         102 TK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TE-----EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             Cc-----eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence            55     899999998 599999999899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC--ccccccccccccCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 017083          193 RTTSET--DFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  269 (377)
Q Consensus       193 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  269 (377)
                      ......  .......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||...........+.......     
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  251 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----  251 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence            765433  2345567899999999997633 46889999999999999999999997765433333332211000     


Q ss_pred             ccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 017083          270 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  334 (377)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~ell~~p~f~~~~  334 (377)
                                            .......+++.+.+||++||+.||++||     |++|+++||||+.++
T Consensus       252 ----------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         252 ----------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                                  1112236799999999999999999999     589999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=358.53  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             ecccccCCcccccCCccceEEEEEeCC-CC--cEEEEEecccccc-CHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCC
Q 017083           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE-TR--EEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (377)
Q Consensus        39 i~~~~~~~~~~lg~G~~g~vy~~~~~~-~~--~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  114 (377)
                      |..++|++++.||+|+||+||+|++.. ++  ..||||++.+... .....+.+.+|+.++++++||||+++++++..+.
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~   84 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   84 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc
Confidence            345667799999999999999998643 33  4689999976543 3334577899999999999999999999997542


Q ss_pred             CCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecc
Q 017083          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (377)
Q Consensus       115 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~  192 (377)
                            +++||||++ |++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        85 ------~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          85 ------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             ------CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ------hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence                  689999998 588876654 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 017083          193 RTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  267 (377)
Q Consensus       193 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  267 (377)
                      +......    ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.+..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~------  231 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG------  231 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC------
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC------
Confidence            8764432    2234456889999999987 788999999999999999997 899999888776665553311      


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                             ...+....+|+.+.+||.+||+.||++|||+.||++
T Consensus       232 -----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         232 -----------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                   111223467899999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=364.07  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      .+.|+|+.+.|+++++||+|+||+||+|+++.     +++.||+|+++... .......+.+|..++.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            35688988888899999999999999999754     45689999997543 333456677788888777 589999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecC
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  170 (377)
                      +++.....    .++++|||++ |+|.+++...                ..+++..+..++.||+.||+|||++||+|||
T Consensus        84 ~~~~~~~~----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD  159 (299)
T d1ywna1          84 GACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  159 (299)
T ss_dssp             EEECSTTS----CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eeeccCCC----eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence            98765432    2799999998 6999998643                3488999999999999999999999999999


Q ss_pred             CCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCC
Q 017083          171 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP  246 (377)
Q Consensus       171 ik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g-~~pf~  246 (377)
                      |||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++| ..||.
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999997654332   2345678999999999987 7889999999999999999986 56787


Q ss_pred             CCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          247 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       247 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      .......+..+......                             ......+++++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~  289 (299)
T d1ywna1         239 GVKIDEEFCRRLKEGTR-----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  289 (299)
T ss_dssp             TCCCSHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            75544333322221110                             1112356889999999999999999999999998


Q ss_pred             C
Q 017083          327 H  327 (377)
Q Consensus       327 ~  327 (377)
                      |
T Consensus       290 ~  290 (299)
T d1ywna1         290 H  290 (299)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=357.35  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             eeecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCC
Q 017083           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (377)
Q Consensus        37 ~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  116 (377)
                      |+|..+.+++++.||+|+||+||+++++  |..||||+++..    ...+.+.+|+.++++++||||+++++++.+... 
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC-
Confidence            7788888889999999999999999884  678999999754    234678899999999999999999998865322 


Q ss_pred             CCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       117 ~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                         .+++||||++ |+|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        75 ---~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 ---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             ---cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence               2799999998 5999998653  358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 017083          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  272 (377)
Q Consensus       194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  272 (377)
                      .....  .....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+.+.            
T Consensus       152 ~~~~~--~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------  216 (262)
T d1byga_         152 EASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------  216 (262)
T ss_dssp             ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------
T ss_pred             ecCCC--CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence            65543  334567889999999987 788999999999999999998 78888776655544443210            


Q ss_pred             cchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          273 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                        ...+....+++.+.+||++||+.||++|||+.+++++
T Consensus       217 ------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 ------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                              1112234578999999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=366.28  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             cccCCcccccCCccceEEEEEeCCCCc----EEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCC
Q 017083           42 KYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (377)
                      ..|++++.||+|+||+||+|.+..+|+    +||+|.++... .....+.+.+|+.++++++|||||++++++..+.   
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            446699999999999999999988876    58888876432 2234567889999999999999999999998653   


Q ss_pred             CCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeeccccc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~  195 (377)
                         .++++|++. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        85 ---~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 ---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             ---eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence               567777776 688887765 567999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 017083          196 SETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  271 (377)
Q Consensus       196 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  271 (377)
                      ....   ......||+.|+|||++.+ +.++.++|||||||++|||++ |..||......+....+..-..         
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~---------  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---------  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            4432   2334467899999999988 789999999999999999998 8999987765554444433110         


Q ss_pred             ccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          272 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                           .+..+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus       232 ---------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         232 ---------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ---------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                 11223568899999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-50  Score=360.18  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=210.4

Q ss_pred             eeeecccccCCcccccCCccceEEEEEeC-----CCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeee
Q 017083           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (377)
Q Consensus        36 ~~~i~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  110 (377)
                      .++++.+.++++++||+|+||+||+|+++     .+++.||||+++... ......++.+|+.++++++||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            36778778889999999999999999875     356789999997643 334566789999999999999999999999


Q ss_pred             cCCCCCCCCcEEEEEecCC-CCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHhcCC
Q 017083          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------------QLTDDHCQYFLYQLLRGLKYVHSAS  165 (377)
Q Consensus       111 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~al~~LH~~~  165 (377)
                      .....     .++++||++ |+|.+++....                        .+++..+..++.||+.||+|||+++
T Consensus        86 ~~~~~-----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  160 (301)
T d1lufa_          86 AVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  160 (301)
T ss_dssp             CSSSS-----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCc-----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence            88755     899999998 69999886432                        4888999999999999999999999


Q ss_pred             ceecCCCCCceEEccCCCeEEeeeecccccCCC---ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 017083          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  242 (377)
Q Consensus       166 i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~  242 (377)
                      ++||||||+|||++.++.+||+|||+++.....   .......+++.|+|||.+.+ ..++.++|||||||++|||++|.
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccC
Confidence            999999999999999999999999999754333   22334677899999999987 78999999999999999999985


Q ss_pred             -CCCCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 017083          243 -PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  321 (377)
Q Consensus       243 -~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  321 (377)
                       .||......+....+.+-.                              ..+....+++++.+||.+||+.||++|||+
T Consensus       240 ~~p~~~~~~~e~~~~v~~~~------------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCHHHHHHHHHcCC------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence             6787777666554443210                              112234678999999999999999999999


Q ss_pred             HHHhc
Q 017083          322 EEALR  326 (377)
Q Consensus       322 ~ell~  326 (377)
                      .||++
T Consensus       290 ~ev~~  294 (301)
T d1lufa_         290 CSIHR  294 (301)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99954

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-50  Score=358.27  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=207.9

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCCCC-------cEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeE
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  106 (377)
                      ..|+|+.+.|++++.||+|+||+||+|++..++       ..||||+++... .......+.+|+..+.++ +|||||++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            348888888889999999999999999876554       479999997654 344567788899999888 79999999


Q ss_pred             eeeecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceec
Q 017083          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (377)
Q Consensus       107 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  169 (377)
                      ++++..+..     +++||||+. |+|.+++...                ..+++..+..++.||+.||+|||+++|+||
T Consensus        85 ~~~~~~~~~-----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr  159 (299)
T d1fgka_          85 LGACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  159 (299)
T ss_dssp             EEEECSSSS-----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ccccccCCe-----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence            999998755     899999998 6999998644                358999999999999999999999999999


Q ss_pred             CCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017083          170 DLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (377)
Q Consensus       170 dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~pf  245 (377)
                      ||||+|||++.++.+||+|||++.......   ......+++.|+|||.+.+ +.++.++|||||||++|||++ |..||
T Consensus       160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            999999999999999999999998654432   2344677899999999987 789999999999999999997 78889


Q ss_pred             CCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 017083          246 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  325 (377)
Q Consensus       246 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell  325 (377)
                      ...........+..-  ..                            .+....+++++.+||.+||+.||++|||+.||+
T Consensus       239 ~~~~~~~~~~~i~~~--~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil  288 (299)
T d1fgka_         239 PGVPVEELFKLLKEG--HR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  288 (299)
T ss_dssp             TTCCHHHHHHHHHTT--CC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHcC--CC----------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            877765544433221  00                            111235789999999999999999999999998


Q ss_pred             c
Q 017083          326 R  326 (377)
Q Consensus       326 ~  326 (377)
                      +
T Consensus       289 ~  289 (299)
T d1fgka_         289 E  289 (299)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=357.21  Aligned_cols=262  Identities=24%  Similarity=0.401  Sum_probs=217.5

Q ss_pred             ceeeecccccCCcccccCCccceEEEEEeCC-----CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        35 ~~~~i~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      +.|+|..+.+.+++.||+|+||+||+|.++.     +++.||||+++... .......+.+|+.++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3588988888899999999999999998853     45789999997543 44456678899999999999999999999


Q ss_pred             ecCCCCCCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEE
Q 017083          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli  178 (377)
                      +.....     +++||||++ |+|.+++...          ..+++..+..++.|+++||.|||+++|+||||||+|||+
T Consensus        92 ~~~~~~-----~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          92 VSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  166 (308)
T ss_dssp             ECSSSS-----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             EecCCc-----eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence            987755     899999998 6898887532          347889999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHH
Q 017083          179 NASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQL  254 (377)
Q Consensus       179 ~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g-~~pf~~~~~~~~~  254 (377)
                      +.++++||+|||+++......   ......+++.|+|||.+.+ ..++.++||||||+++|||++| ..||......+.+
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998654332   2334467899999999987 7889999999999999999998 5788877766665


Q ss_pred             HHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc------Cc
Q 017083          255 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR------HP  328 (377)
Q Consensus       255 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~------~p  328 (377)
                      ..+.+-.                              ..+....+++.+.+||.+||+.||++|||+.+|++      +|
T Consensus       246 ~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         246 RFVMEGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHhCC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            5543311                              01122356889999999999999999999999998      67


Q ss_pred             cccCC
Q 017083          329 YLQSL  333 (377)
Q Consensus       329 ~f~~~  333 (377)
                      +|+++
T Consensus       296 ~~~~~  300 (308)
T d1p4oa_         296 GFREV  300 (308)
T ss_dssp             THHHH
T ss_pred             CCcCC
Confidence            77654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=354.74  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=212.2

Q ss_pred             cceeeecccccCCcccccCCccceEEEEEe-----CCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEe
Q 017083           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (377)
Q Consensus        34 ~~~~~i~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  107 (377)
                      ...|+++.+.+++.++||+|+||+||+|++     ..+++.||||+++... .......+.+|+.+++++ +|||||+++
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~   93 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL   93 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            346888888888999999999999999986     3467789999997653 344566788999999999 699999999


Q ss_pred             eeecCCCCCCCCcEEEEEecCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCcee
Q 017083          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (377)
Q Consensus       108 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~LH~~~i~H  168 (377)
                      +++.....     ++++|||++ |+|.+++....                  .+++..+..++.||+.||+|||+++++|
T Consensus        94 g~~~~~~~-----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          94 GACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             EEECSSSS-----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEeeCCE-----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            99988755     899999998 58888886533                  5889999999999999999999999999


Q ss_pred             cCCCCCceEEccCCCeEEeeeecccccCCCc---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 017083          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (377)
Q Consensus       169 ~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~-g~~p  244 (377)
                      |||||+||+++.++.++++|||.++......   ......+|+.|+|||.+.+ ..++.++|||||||++|||++ |..|
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765432   2344677999999999987 788999999999999999998 6666


Q ss_pred             CCCCChHHHHHHHHHHhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 017083          245 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  324 (377)
Q Consensus       245 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~el  324 (377)
                      |........+..+...-..                             .......++.+.+||.+||+.||++|||+.++
T Consensus       248 ~~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i  298 (311)
T d1t46a_         248 YPGMPVDSKFYKMIKEGFR-----------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (311)
T ss_dssp             STTCCSSHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCC-----------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            7665554444433321111                             11123568899999999999999999999999


Q ss_pred             hc
Q 017083          325 LR  326 (377)
Q Consensus       325 l~  326 (377)
                      ++
T Consensus       299 l~  300 (311)
T d1t46a_         299 VQ  300 (311)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=356.60  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=203.5

Q ss_pred             ccccCCcccccCCccceEEEEEeCCCCcE--EEEEeccccccCHHHHHHHHHHHHHHHhc-CCCCceeEeeeecCCCCCC
Q 017083           41 SKYVPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  117 (377)
                      -+.+++.+.||+|+||+||+|+++.+|..  ||||.+.... .....+.+.+|+.++.++ +|||||++++++..+..  
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~--   85 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--   85 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE--
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe--
Confidence            34555789999999999999999988875  6777775432 223456788999999998 69999999999988755  


Q ss_pred             CCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc
Q 017083          118 FNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (377)
Q Consensus       118 ~~~~~iv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~  180 (377)
                         +++||||++ |+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus        86 ---~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             ---EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             ---eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence               899999998 6999998643                57899999999999999999999999999999999999999


Q ss_pred             CCCeEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 017083          181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITE  259 (377)
Q Consensus       181 ~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~-~pf~~~~~~~~~~~i~~  259 (377)
                      ++.+||+|||+++............+|..|+|||.+.+ ..++.++|||||||++|||++|. .||......+....+.+
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            99999999999987665555556678999999999987 78899999999999999999965 56777665554433321


Q ss_pred             HhCCCCccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          260 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                      -                              ...+....+++++.+||.+||+.||++|||+.|++++
T Consensus       242 ~------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            0                              0112234678999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=345.08  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=194.2

Q ss_pred             cccccCCccceEEEEEeCCCC---cEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           47 IRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      -++||+|+||+||+|++..++   ..||||+++.. ......+.+.+|+.++++++||||+++++++....    ..+++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEE
Confidence            457999999999999986643   35899998753 35556788999999999999999999999876432    22899


Q ss_pred             EEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeeeecccccCCCc--
Q 017083          124 VYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~~~~~~--  199 (377)
                      ||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......  
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999998 5888877753 457788899999999999999999999999999999999999999999999998654432  


Q ss_pred             ---cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccchh
Q 017083          200 ---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  276 (377)
Q Consensus       200 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  276 (377)
                         ......||..|+|||.+.+ ..++.++||||||+++|||++|..||.........  ...+....            
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~~i~~g~------------  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGR------------  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HHHHHTTC------------
T ss_pred             cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HHHHHcCC------------
Confidence               2233567899999999987 78899999999999999999988887654322111  11111000            


Q ss_pred             HHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 017083          277 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  327 (377)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~~  327 (377)
                                     .......+++.+.+||.+||+.||++|||+.|++++
T Consensus       252 ---------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ---------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           011123568899999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-48  Score=345.71  Aligned_cols=261  Identities=19%  Similarity=0.208  Sum_probs=201.1

Q ss_pred             eecccccCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeE-eeeecCCCCC
Q 017083           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-KDIIRPPKKD  116 (377)
Q Consensus        38 ~i~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~-~~~~~~~~~~  116 (377)
                      .|+++|. +++.||+|+||+||+|+++.+|+.||||++......    ..+..|+.+++.++|++++.. ..++..+.. 
T Consensus         4 ~vg~rY~-l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~-   77 (299)
T d1ckia_           4 RVGNRYR-LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY-   77 (299)
T ss_dssp             EETTTEE-EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE-
T ss_pred             eECCEEE-EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCE-
Confidence            4566655 899999999999999999999999999988654222    346789999999987765554 455555433 


Q ss_pred             CCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc---CCCeEEeeeecc
Q 017083          117 TFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLA  192 (377)
Q Consensus       117 ~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~---~~~vkl~Dfg~~  192 (377)
                          .++||||+++++...+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||++
T Consensus        78 ----~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          78 ----NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             ----EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             ----EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence                889999999988887654 568999999999999999999999999999999999999864   456999999999


Q ss_pred             cccCCCc--------cccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017083          193 RTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       193 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      +......        ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||...........+...... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-  231 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-  231 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-
Confidence            8654322        2345678999999999988 77899999999999999999999999876554433332221100 


Q ss_pred             CccccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH---HhcCccccC
Q 017083          265 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE---ALRHPYLQS  332 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e---ll~~p~f~~  332 (377)
                                            ............+|+++.+||.+||+.||++||++.+   +|+|+|.+.
T Consensus       232 ----------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 ----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                  0000111223467999999999999999999999875   467777643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.5e-46  Score=334.84  Aligned_cols=245  Identities=16%  Similarity=0.177  Sum_probs=199.3

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC-CCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      +++.||+|+||+||+|++..+|+.||||++.....    ...+.+|++.++.++| +|++.+++++..+..     .++|
T Consensus         9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-----~~~v   79 (293)
T d1csna_           9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-----NVLV   79 (293)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-----EEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc-----cEEE
Confidence            88999999999999999999999999999865432    2346678899999975 899999999887754     8999


Q ss_pred             EecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEcc-----CCCeEEeeeecccccCCC
Q 017083          125 YELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----SCDLKIGDFGLARTTSET  198 (377)
Q Consensus       125 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~-----~~~vkl~Dfg~~~~~~~~  198 (377)
                      |||++++|.+.+... ..++...+..++.|++.||+|||++||+||||||+||+++.     ++.+||+|||+++.....
T Consensus        80 me~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             EEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            999999999998764 57999999999999999999999999999999999999974     567999999999864432


Q ss_pred             --------ccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCcc
Q 017083          199 --------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ---LRLITELIGSPDDA  267 (377)
Q Consensus       199 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  267 (377)
                              .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........   ...+......    
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~----  234 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS----  234 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH----
T ss_pred             ccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC----
Confidence                    12345678999999999988 7799999999999999999999999976443322   2222211100    


Q ss_pred             ccccccchhHHHHHHhccccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          268 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                                            .......+.+|+++.+++..|+..+|++||+++.+.+
T Consensus       235 ----------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 ----------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             ----------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ----------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                  0111223467899999999999999999999887754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=335.41  Aligned_cols=264  Identities=20%  Similarity=0.227  Sum_probs=186.9

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCceeEeeeecCCCCCCCCcEEE
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  123 (377)
                      +.+.+.||+|+||+||++++  +|+.||||+++..   .........|+..+.+++||||+++++++..... ....+++
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~~~l   78 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL   78 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceEEEE
Confidence            33888999999999999986  6789999999653   1122223345666667899999999999876542 1234899


Q ss_pred             EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc--------CCceecCCCCCceEEccCCCeEEeeeecccc
Q 017083          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (377)
Q Consensus       124 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~--------~~i~H~dik~~NIli~~~~~vkl~Dfg~~~~  194 (377)
                      ||||++ |+|.+++.. .++++..+..++.|++.||+|||+        +||+||||||+||||+.++.+||+|||++..
T Consensus        79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999998 599999876 468999999999999999999996        5999999999999999999999999999986


Q ss_pred             cCCCc-----cccccccccccCCCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017083          195 TSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  264 (377)
Q Consensus       195 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  264 (377)
                      .....     ......||+.|+|||++.+..     .++.++|||||||++|||++|..||........           
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-----------  226 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-----------  226 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-----------
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-----------
Confidence            54332     234567899999999986522     256789999999999999999887744221100           


Q ss_pred             CccccccccchhHHHHHHhcc-ccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 017083          265 DDASLGFLRSDNARRYVRQLP-RCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALR  326 (377)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~ell~  326 (377)
                      +...... ............. ...+......+  ......+.+|+.+||+.||++|||+.||++
T Consensus       227 ~~~~~~~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         227 PYYDLVP-SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTTTSC-SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             chhhccc-ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            0000000 0001111111111 01111111111  112345889999999999999999999976

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-46  Score=343.35  Aligned_cols=291  Identities=26%  Similarity=0.393  Sum_probs=209.1

Q ss_pred             cCCcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-----------CCCceeEeeeecC
Q 017083           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIKDIIRP  112 (377)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~  112 (377)
                      |+++++||+|+||+||+|+++.+|+.||||++++.   ....+.+.+|+.+++.++           |+||+++++++..
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45899999999999999999999999999999764   334456778888888775           5789999998865


Q ss_pred             CCCCCCCcEEEEEecCC--CCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCceEEccCCC----
Q 017083          113 PKKDTFNDVYIVYELMD--TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCD----  183 (377)
Q Consensus       113 ~~~~~~~~~~iv~e~~~--~~L~~~l--~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dik~~NIli~~~~~----  183 (377)
                      ...   ...+++++++.  ++.....  .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.    
T Consensus        92 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            433   22455555554  3333333  345678999999999999999999997 89999999999999987654    


Q ss_pred             --eEEeeeecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 017083          184 --LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLR  255 (377)
Q Consensus       184 --vkl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll~ell~g~~pf~~~~------~~~~~~  255 (377)
                        ++++|||.+......  .....+|+.|+|||++.+ ..++.++|||||||++++|++|+.||....      ....+.
T Consensus       169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence              899999998765433  456678999999999987 778999999999999999999999997543      234445


Q ss_pred             HHHHHhCCCCccccccccchhHHHHHHh--c-ccccccc----------ccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 017083          256 LITELIGSPDDASLGFLRSDNARRYVRQ--L-PRCRKQQ----------FATRFPNKSSGAVDLLEKMLVFDPNKRITVE  322 (377)
Q Consensus       256 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~  322 (377)
                      .....++.++.........  ...+...  . .......          ........++.+.+||.+||..||.+|||++
T Consensus       246 ~~~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHhCCCCHHHhhcccc--cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            5556666554332211000  0000000  0 0000000          0011123467899999999999999999999


Q ss_pred             HHhcCccccCCcCCCCCCCCCCC
Q 017083          323 EALRHPYLQSLHDLNDEPVCPRP  345 (377)
Q Consensus       323 ell~~p~f~~~~~~~~~~~~~~~  345 (377)
                      |+|+||||++.........++++
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~  346 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRE  346 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSC
T ss_pred             HHhcCcccCCCCCcccCCCCCcc
Confidence            99999999977655544444443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.9e-25  Score=186.01  Aligned_cols=170  Identities=16%  Similarity=0.136  Sum_probs=120.7

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccC----------------HHHHHHHHHHHHHHHhcCCCCceeEeee
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN----------------IIDARRTLREIKLLRHMEHENVIAIKDI  109 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~  109 (377)
                      +.++||+|+||+||+|++. +|+.||||+++.....                .........|+..+.++.|.+++..+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            5788999999999999985 6899999987532110                1112334568899999999999988876


Q ss_pred             ecCCCCCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhcCCceecCCCCCceEEccCCCeEEeee
Q 017083          110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (377)
Q Consensus       110 ~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dik~~NIli~~~~~vkl~Df  189 (377)
                      ..         .+++||++++...      ..++...+..++.|+++++++||++||+||||||+|||+++++ ++|+||
T Consensus        83 ~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          83 EG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             ET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             cC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence            32         3799999997432      2245566778999999999999999999999999999999765 999999


Q ss_pred             ecccccCCCccccccccccccCCCccccccCCCCCcchHHHHHHHH
Q 017083          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL  235 (377)
Q Consensus       190 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ll  235 (377)
                      |++.....+............ -.+.+ . ..++.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILERDVRN-IITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHHHH
Confidence            999766543221100000000 01222 2 4678899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.33  E-value=1.1e-06  Score=74.66  Aligned_cols=134  Identities=14%  Similarity=0.112  Sum_probs=80.7

Q ss_pred             CcccccCCccceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCCCCcEEEE
Q 017083           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  124 (377)
                      .++..+.++.+.||++.  .++..+++|+.......  ....+..|...++.+. +--+.+++.+...++.     .++|
T Consensus        18 ~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~-----~~lv   88 (263)
T d1j7la_          18 CVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-----SNLL   88 (263)
T ss_dssp             EEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-----EEEE
T ss_pred             EEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc-----eEEE
Confidence            34444445557899985  35567888887644211  2234567888877775 3335666666655533     7899


Q ss_pred             EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 017083          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS----------------------------------------  163 (377)
Q Consensus       125 ~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~LH~----------------------------------------  163 (377)
                      |++++| .+.+....     ......++.++.+.++.||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999987 44333211     01111222333333333331                                        


Q ss_pred             -------------------CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 -------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 -------------------~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                                         ..++|+|+.|.||++++++.+-|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                               127899999999999987666799998664

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.23  E-value=2.1e-06  Score=77.43  Aligned_cols=77  Identities=18%  Similarity=0.081  Sum_probs=47.0

Q ss_pred             cccccCCccceEEEEEeCCCCcEEEEEeccccc----c-CHHHHHHHHHHHHHHHhcC-C--CCceeEeeeecCCCCCCC
Q 017083           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF----D-NIIDARRTLREIKLLRHME-H--ENVIAIKDIIRPPKKDTF  118 (377)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~valK~~~~~~----~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  118 (377)
                      .+.||.|....||++.+..+++.+++|.-....    . ......+...|+..++.+. +  ..+++++.+-...     
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~-----  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM-----  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT-----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCC-----
Confidence            556899999999999988888899999643210    0 0112234456777777663 2  3455666554332     


Q ss_pred             CcEEEEEecCCC
Q 017083          119 NDVYIVYELMDT  130 (377)
Q Consensus       119 ~~~~iv~e~~~~  130 (377)
                        .+++||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              4789999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.84  E-value=2e-05  Score=66.09  Aligned_cols=70  Identities=11%  Similarity=0.068  Sum_probs=45.6

Q ss_pred             ccCCc-cceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCC--CCceeEeeeecCCCCCCCCcEEEEEe
Q 017083           50 IGRGA-YGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIVYE  126 (377)
Q Consensus        50 lg~G~-~g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~iv~e  126 (377)
                      +..|. .+.||++.. ..+..+++|......     ...+..|...++.+..  -.+.+++.+...++.     .+++|+
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~-----~~~v~~   86 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-----DWLLLG   86 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-----EEEEEE
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccc-----eEEEEE
Confidence            44454 367899976 456678899875442     2235567777776642  235667776665543     789999


Q ss_pred             cCCC
Q 017083          127 LMDT  130 (377)
Q Consensus       127 ~~~~  130 (377)
                      +++|
T Consensus        87 ~i~G   90 (255)
T d1nd4a_          87 EVPG   90 (255)
T ss_dssp             CCSS
T ss_pred             eeec
Confidence            9976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.21  E-value=0.00072  Score=60.37  Aligned_cols=72  Identities=14%  Similarity=0.103  Sum_probs=49.4

Q ss_pred             CcccccCCccceEEEEEeCC-------CCcEEEEEeccccccCHHHHHHHHHHHHHHHhcC-CCCceeEeeeecCCCCCC
Q 017083           46 PIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (377)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (377)
                      -++.|+.|-.-.+|++....       .++.|++++.... ..   .-...+|..+++.+. +.-..++++++..     
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG-----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence            45678888889999998643       3467888887532 12   223457888888886 4445677777642     


Q ss_pred             CCcEEEEEecCCC
Q 017083          118 FNDVYIVYELMDT  130 (377)
Q Consensus       118 ~~~~~iv~e~~~~  130 (377)
                          ++|+||++|
T Consensus       117 ----g~I~efi~g  125 (395)
T d1nw1a_         117 ----GRLEEYIPS  125 (395)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----ceEEEEecc
Confidence                578999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.0031  Score=54.45  Aligned_cols=132  Identities=16%  Similarity=0.145  Sum_probs=71.8

Q ss_pred             ceEEEEEeCCCCcEEEEEeccccccCHHHHHHHHHHHHHHHhcCCCCc--eeEeeeecCCCCCCCCcEEEEEecCCCC--
Q 017083           56 GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV--IAIKDIIRPPKKDTFNDVYIVYELMDTD--  131 (377)
Q Consensus        56 g~vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~iv~e~~~~~--  131 (377)
                      ..||++.. .+|..|++|+.+...   .+.+++..|+..+..|....+  +.....-...........+.++++++|.  
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            67999976 568889999986532   234567778888887752222  2221110000001113367889998751  


Q ss_pred             ----HHHH------H-------HhC-----CC-------------------CCHH---HHHHHHHHHHHHHHHHh----c
Q 017083          132 ----LHQI------I-------RSD-----QQ-------------------LTDD---HCQYFLYQLLRGLKYVH----S  163 (377)
Q Consensus       132 ----L~~~------l-------~~~-----~~-------------------~~~~---~~~~i~~qi~~al~~LH----~  163 (377)
                          ....      +       ...     ..                   ++..   .....+.++...+...-    .
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence                1111      0       000     01                   1111   12223334444333322    1


Q ss_pred             CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       164 ~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      .+++|+|+++.||+++++  ..++||+.+.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            368999999999999743  5689999775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.53  E-value=0.0038  Score=53.45  Aligned_cols=43  Identities=23%  Similarity=0.166  Sum_probs=31.9

Q ss_pred             HHHHHHHHHHHhc----CCceecCCCCCceEEccCCCeEEeeeeccc
Q 017083          151 LYQLLRGLKYVHS----ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (377)
Q Consensus       151 ~~qi~~al~~LH~----~~i~H~dik~~NIli~~~~~vkl~Dfg~~~  193 (377)
                      +..+...+...+.    .|++|+|+.++||+++.+...-|+||+.+.
T Consensus       166 l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         166 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            3344444444442    479999999999999988777899999774